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A B S T R A C T
This is a study of asbestos related disease in civilian workers at 3 Royal Naval 
Dockyards, namely: Devonport, Chatham and Portsmouth. Past work in these 
dockyards, along with Rosyth in Scotland (undertaken by the Institute of Naval 
Medicine and the Medical Research Council), has shown that just under 5% of this 
workforce might be expected to have radiographic abnormalities due to asbestos 
exposure. In the early 1970s workers in all 4 of these dockyards were invited to 
participate in health surveys, in which chest x-rays were performed and a 
health/employment history questionnaire given.
This work is an exact 17 year follow-up of these health surveys, analysing cause 
specific mortality its time trends and their correlates. The working population of 
the 3 dockyards, including female industrial workers and ‘outstation’ male workers 
was 32,931. However, excluding female workers and absolute non-responders 
reduced this to 28,265 male workers. The trace rate of this population, over the 
17 years, was 97.3% (Rosyth with a rate of less than 70% was excluded from this 
analysis), 18% of the population traced were found to be dead. The mortality 
patterns of this cohort were inspected on a yearly basis by the use of a regionally 
adjusted SMR analysis. Expected rates were calculated, using the OPCS historic 
mortality data files, to provide a reference set of background mortality levels.
The striking result from this study is one of no excess risk due to lung cancer at 
the three dockyards, producing SMRs of: 99 (95%CI: 87-122) at Devonport, 85 
(95%CI: 70-101) at Chatham, and 94 (95%CI: 81-106) at Portsmouth [X2=1.8, 
P>0.1]. However, an excessive risk was seen for pleural mesothelioma that 
produced SMRs of: 1983 (95%CI: 1505-2461) at Devonport, 1638(95%CI: 1049- 
2437) at Chatham, and 1042 (95%CI: 693-1506) at Portsmouth [X2 = 8.4, 
P <  0.025]. Excesses were also seen for peritoneal mesothelioma and asbestosis. 
No obvious relationships were seen when analysing lung cancer mortality by 
employment and asbestos exposure variables. A dose-response of lung cancer 
mortality to smoking habit was the only clear relationship found. Log-linear 
modelling supported the SMR findings of no overall excess or deficiency of lung 
cancer mortality compared to an excess of mesothelioma deaths. These results and 
their significance are discussed.
l
"If you poison your boss a little bit each day it’s called murder; if your boss 
poisons you a little each day it’s called a Threshold Limit Value."
J P Keogh
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Chapter 1: INTRODUCTION
1.1 General Introduction.
This work is concerned with asbestos exposure and asbestos-related disease in 
shipbuilding and repair. In particular it is concerned with the risk of disease and 
death among civilian employees of the four Royal Naval Dockyards: Devonport, 
Chatham, Portsmouth and Rosyth. At any time in the post World War II period 
there have been some 50,000 civilians employed in these four yards, all potentially 
with some risk of asbestos exposure from the insulating materials used in 
shipbuilding and repair. In this study the mortality patterns of these civilian 
workers will be considered with regard to intensity and duration of such exposure.
Historically this country has always had a strong seagoing and Royal Naval 
tradition, from the early days of the Spanish Maine and the Spanish Armada, to 
Lord Nelson and Trafalgar, to more recently the World Wars and, lastly, to the 
Falklands and Gulf Wars. Throughout these times and conflicts there have been 
four main Royal Dockyards serving the fleet in this country at Devonport, 
Chatham, Portsmouth and Rosyth (figure 1.1). These dockyards in past times 
built and repaired Royal Ships of the Line, battleships of the Royal Navy. 
However, as iron replaced wood the nature of these yards changed. Now the 
main work of Royal Dockyards is the refitting and repairing of navy ships, and 
tourism. This century has seen many changes, with not the least of these being 
the modernization of the Royal Navy and with it the closure and partial closure of 
Naval Dockyards. Linked with this closure are the appearances of Naval 
Museums, Historic Dockyards, as at Chatham and Portsmouth. These Historic 
Dockyards bring money into the exchequer and tourists into the dockyards, giving 
an insight into both naval history and past dockyard working conditions.
1
Royal Naval Dockyards.
FIGURE 1.1: Royal Naval Dockyards.
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Consequently in this century, the work of the Royal Dockyards has been mostly 
in refit and repair rather than shipbuilding, this last activity now being commonly 
undertaken in civilian contract yards. When civilian/commercial yards undertake 
refits, the extent of these can differ from the naval version. Naval refits are more 
frequent and extensive than merchant refits, routinely involving the complete 
removal and replacement of all insulating material in machinery spaces and both 
the environmental and structural insulation. As the removal of this material 
produces more dust than its application these should be considered very important 
differences.
When combined with the many engineering, construction, and workplace 
differences between naval and merchant ships, naval shipping containing much 
more machinery in smaller compartments and having no portholes, it is likely that 
the overall exposure to asbestos dust was higher in Naval Dockyards than in their 
commercial counterparts. It should be noted that asbestos has no respect for 
frontiers or nationalities and that in this respect the shipbuilding risk of asbestos 
exposure has been worldwide, from the UK to the USA to Japan.
1.2 Asbestos Materials in Shipbuilding.
The asbestos materials used in Royal Navy ships are largely the same as those 
used in Merchant ships only the amount applied differs. The various types of 
asbestos fibre used, have included chrysotile (white serpentine asbestos) and the 
iron silicates, crocidolite (blue asbestos) and amosite. Changes in the amount and 
type of material used may explain the emergence of asbestos-related diseases in 
dockyards, in particular asbestosis, lung cancer and mesothelioma.
Until the early 1950s most of the machinery insulation aboard naval ships was in 
the form of asbestos mattresses, that is, magnesia sections containing an amount 
of amosite asbestos (commonly 15-30% amosite), and asbestos cloth made entirely 
of chrysotile asbestos. These materials provided adequate insulation to the 
operating steam temperatures of below 750°F that existed until the 1950s. A
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certain amount of crocidolite asbestos would have been used in asbestos board and 
in magnesia sections as an available replacement for amosite. Crocidolite was also 
used in a sprayed asbestos process from the end of the war until the mid 1960s 
when this process was stopped.
Over the 1950s steam temperatures rose to 850°F and more efficient insulation 
was required. Magnesia sections were replaced by amosite sections (containing 
90-95% amosite). A decreasing stock of amosite lagging was still used through 
the early 1960s with calcium silicate sections (containing 10-15% amosite) 
introduced as its replacement in this period. Operating temperatures aboard ship 
had by this time reached 950°F.
From 1968, only materials containing chrysotile asbestos were used in naval 
dockyards. Presently shipping worldwide contains little asbestos insulation, man­
made mineral fibres are now used as its substitute. Obviously, the use of large 
amounts of amosite section and crocidolite in spraying processes up to the mid 
1960s implies a corresponding increase in potential asbestos exposure from 
insulation removal, over the preceding decades.
There have been many uses of asbestos containing materials in ships, apart from 
heat insulation. Table 1.1 lists some of these other materials. This table has been 
arranged into those uses producing dust in their handling and those not. The non- 
dusty uses are those that would not usually produce dust unless the materials were 
ground, polished or sawn. We see from table 1.1, that although most of the 
asbestos aboard ship has been used for heat insulation it could also be found in 
sound and electrical insulating materials.
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T A B L E  1.1*: Asbestos materials used in Naval Dockyards.
Dusty Non dusty
Blankets Cloth (treated)
Cement Condenser packing
Cloth (untreated) Sheets (compressed fibre)
Cord Gaskets
F i bre Oilproof jointing
Millboard Compressed fibre jointing
Packing fibre Graphite packing
Rope Rings
Soft sound insulation Compressed sound insulation
Jointing strips
Tape
Tubing
Twine
Washers
webbing
Coated electric wire
1.3 Asbestos Processes and Trades in Royal Naval Dockyards.
There have been three main asbestos processes employed in Royal Naval 
Dockyards: Asbestos spraying, lagging and sound insulation.
Asbestos spraying was used for environmental insulation, the sealing of outer wall 
and bulkhead surfaces; the spray consisted of a mixture of asbestos fibre and 
cement applied to a thickness of 2-4 ins. From the mid 1960s, the existing 
crocidolite material has been extensively removed during refits and replaced by 
glass fibre and other forms of man-made mineral fibre. The dust concentrations 
during application and removal have been established as being very high (for 
removal, many thousands of times higher than the current UK standards).[1,2]* * 
Workers employed as asbestos sprayers and painters were responsible for the 
application and removal of this ‘sprayed asbestos’.
« Adapted from: Harries PG (1967) "Asbestos Hazards in Naval Dockyards" 
Ann Occup Hyg 11:135-145.
** The referencing throughout this work is unique to each chapter, each 
forming a separate section of the bibliography.
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In the past, laggers were employed to insulate all hot surfaces in machinery spaces 
aboard ship with preformed ‘asbestos’ sections, covering them with asbestos cloth. 
The application and removal of these heat insulating materials would involve both 
cutting and fixing of the sections and cloth by hand and would produce high 
localized dust concentrations.
As with lagging, the application and removal of sound insulation involved the 
cutting and fitting by hand of asbestos boards of various types and thicknesses with 
again high localized dust concentrations. Sound insulation work would have been 
undertaken by joiners not laggers.
Other dockyard ‘asbestos trades’ have included shipwrights, sailmakers, 
boilermakers, masons, mattress makers, labourers and storemen. Of these, 
shipwrights and boilermakers cut and fitted asbestos boards in either bulkheads or 
boiler casings. Masons applied asbestos cement over sprayed asbestos.
Sailmakers carried out water pipe and ventilation duct insulation with asbestos 
cloth. Mattress makers produced mattresses filled with amosite fibre and made 
from asbestos cloth. Labourers were employed to clear up asbestos debris and 
storemen issued asbestos materials to all the ‘asbestos workers’.
In all of the above trades and processes there would have been a potential asbestos 
exposure hazard, but the main hazard would occur during what has been termed 
the vigorous tearing down of old m a t e r i a l . T h e  very nature of Royal Navy 
ships, with long thin watertight corridors, confined machinery spaces and a maze 
of pipes and fitments would only augment this problem.
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1.4 Project Introduction.
The origin of the asbestos disease problem associated with shipbuilding and repair 
can, therefore, be traced, in part, to the enormous quantities of asbestos materials 
used by the industry from the start of World War II. During this war period the 
concern was to build and repair enough ships to win the war; health problems from 
materials used in construction took second place.
However, along with increased ship production came the requirement to reduce 
accidents and health hazards that might slow manufacturing. The known hazards 
then included silica dust, welding fumes, solvents, lead, mercury and asbestos, with 
asbestos being considered the least dangerous. The risks associated with lead, silica 
dust and welding received far more attention in the 1940s, they were better 
understood by the medical and industrial health community and were believed to be 
more dangerous and widespread.t3,4,5,61 The stage was set, therefore, for future 
asbestos-related health problems to surface as the other diseases were controlled.
The work of Sheers and Templeton at Devonport Dockyard reported in 1968, 
highlighted this problem and acted as the catalyst for many Royal Naval research 
projects. These projects were all undertaken with the aim of improving the health 
of dockyard workers and settling the asbestos problem (they are reviewed extensively 
in chapter 2).
In the Devonport study 1,414 men, representing a 10% random sample of the 
dockyard workforce was drawn.171 From this sample it was seen that laggers and 
sprayers with up to 20 years of continuous asbestos exposure had the highest 
prevalence of asbestos-related disease, asbestosis. Asbestosis was also seen in a 
variety of intermittently exposed trades. It was also noted that 10 cases of 
mesothelioma had occurred among the workforce in the 3 years prior to this study. 
By 1980 Sheers was reporting on 96 mesothelioma cases in Devonport Dockyard; the 
incidence of mesothelioma correlating with time from first exposure and dockyard 
occupation.181
7
Also in 1980, Rossiter and Coles reported on the striking finding of an elevated 
mortality risk of mesothelioma and pulmonary fibrosis among Devonport dockyard 
workers, but with no obvious accompanying increased risk for lung cancer.^  In 
this study 6,292 male workers were identified from dockyard records and their 
mortality experience followed from January 1947 to the end of 1978. Of these 
workers 1,043 (16.6%) had died; 31 from mesothelioma, 9 from pulmonary fibrosis 
and 84 from lung cancer. The number of expected deaths, obtained using estimated 
South West England mortality rates, was: 998, 0.4, 0.03 and 100 respectively, with 
associated standardised mortality ratios (SMRs) of 104 for all causes, 7700 
(P < 0.0001) for mesothelioma, 32000 (P < 0.0001) for pulmonary fibrosis and 84 for 
lung cancer. These results were striking since much higher lung cancer death rates, 
along with increased mesothelioma rates, had previously been observed in Belfast 
shipyards and among American insulation workers; occupational groups which were 
considered to have similar levels of asbestos dust exposure as dockyard 
w orkers.0,111 However, these results were not completely unexpected. A 
proportional mortality study for the period 1958-1967 comparing Devonport 
dockyard workers with other Plymouth males showed only a slight (but not 
statistically significant) excess of lung cancer cases.[ 121 Nevertheless, the question 
remains, why in this Royal Naval Dockyard was the risk of lung cancer, a known 
asbestos-related disease, not significantly different from that observed in the general 
population when elevated risks were observed for the other known asbestos-related 
diseases? Was this an artefact, a result produced simply by statistical chance, or 
does it imply that the asbestos exposures were somehow not high enough to allow 
lung cancer to develop, but could generate mesothelioma and asbestosis?
Rossiter and Coles commented in this report that the pattern of dockyard asbestos use 
was such, reaching its peak between 1950 and 1960, that the effect of mesothelioma 
on mortality may just be starting in the Naval Dockyards. They made no comment 
on the absence of an excess lung cancer risk. In general it can be said that through 
the 1960s and 1970s a rising incidence of asbestos-related disease was seen in Royal 
Naval Dockyards and a large number of deaths reported from mesothelioma of the 
pleura or peritoneum, with many thousands of Royal Naval dockyard workers 
appearing potentially at risk. Blot and Fraumeni in 1981 commented that 420,000
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American shipyard workers might die of asbestos-related disease because of 
exposures in the 1940s.t13^ They suggested that mesothelioma now occurs 
exclusively in shipyard/dockyard workers and will probably continue to do so into 
the 1990s.
Over the period 1972-1973 all workers of the four Royal Naval Dockyards 
Devonport, Chatham, Portsmouth and Rosyth were invited to have a chest x-ray 
taken and complete a respiratory questionnaire. The results of these with 
employment history information will be used in this thesis to examine the relationship 
between dockyard occupation, exposure to asbestos, smoking habits and cause of 
death. A particular emphasis will be given to lung cancer and mesothelioma in an 
attempt to answer the questions produced in the work of Rossiter and Coles. 
Presented here is an exact 17 year follow-up of the civilian workforce employed in 
the Royal Naval dockyards during the period 1972-1973.
1.5 Project Aims.
The general aims of this work are twofold:
1. To identify dockyard mortality patterns, across time, and relate these to 
dockyard occupation, personal medical history, dockyard asbestos exposure, 
the prevalence of x-ray abnormalities and smoking habits.
2. To assess the relationship between asbestosis, lung cancer and mesothelioma 
mortality and dockyard employment, and place this relationship into the 
content of the ‘asbestos’ literature.
The specific question addressed in this thesis, its null hypothesis, arises directly from 
the work presented in 1980 by Charles Rossiter and Ruth Coles.[9] Simply stated 
it is: that there is no excess lung cancer risk in Royal Naval dockyard workers. 
Subsidiary questions concerning the level of this risk in relation to the mesothelioma 
risk (i.e. why was the lung cancer risk much lower than the mesothelioma risk) will 
also be considered.
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Chapter 2: LITERATURE REVIEW OF ASBESTOS RELATED DISEASE 
IN SHIPBUILDING AND REPAIR.
2.1 Introduction.
Asbestos is the collective name given to a group of minerals that are fibrous 
silicates sharing the common property of high resistance to destruction by physical 
or chemical means. These minerals include chrysotile and the amphibole group 
of amosite, crocidolite, anthophyllite, tremolite and actinolite. Chrysotile is the 
softest type of asbestos and is used in most woven asbestos products (figure 2.1). 
Amphiboles are harsher, with more bulk, and are more readily used in asbestos- 
cement and insulation products (figures 2.2 and 2.3). There are three diseases that 
may commonly develop because of exposure to these minerals: asbestosis, 
mesothelioma and bronchial carcinoma.
The risk of mesothelioma appears to be greatest in those exposed to crocidolite, 
slightly less after exposure to amosite, and much less after exposure to chrysotile. 
Brief exposure to amosite and crocidolite seems to carry a high risk of lung 
cancer, while prolonged exposure to chrysotile and anthophyllite much less of a 
risk. Asbestosis may develop from exposure to any type of asbestos, however, 
amosite appears more fibrogenic than chrysotile and tremolite.[1,2,3,4 ]
The study of asbestos-related disease has generated a vast amount of literature. 
It would not be practicable to provide here an exhaustive analysis of this literature; 
this review will concentrate on setting the scene for the asbestos-related health 
problems observed in naval dockyards. It will initially consider a historical 
overview of asbestos-related disease, then more specifically these problems in 
relation to shipbuilding and repair (with an emphasis on Royal Naval Dockyards 
studies), and will finally consider the very broad prevailing asbestos health related 
issues of present day concern. In most of the early reports no differentiation of
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asbestos fibre type was made. Where feasible, such differentiation is made in this 
work.
In 1965 Wagner gave a good description of the etiology of asbestosis.[5] He 
described how due to its fibrous nature asbestos dust does not follow the same 
physical laws as other dusts, and that its characteristics allow long fibres to be 
inhaled and retained in lung tissue. The primary lodging site is in the alveoli 
arising directly from the respiratory bronchioles. The diameter and length of the 
fibre are factors resulting in aggregation on this site. He described how the 
fibrosis later spreads down into the alveolar ducts and atria, resulting in a linkage 
of the lesions to form a widespread fibrotic network in the lung. Wagner stated 
that asbestosis is not a sudden explosive diathesis following a dormant period, 
rather a slow insidious disease. This description can be equally applied to the 
other asbestos diseases, lung cancer and mesothelioma.
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FIGURE 2.1: Chrysotile  - w h i te  asbes tos
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FIGURE 2.2: A m osite  -  varies f rom  white to  yellowish brown in colour.
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2.2 Historical Overview.
The Lady Inspectors of Factories in their 1898 report to the Chief Inspector of 
Factories and Workshops expressed the first concern about the hazards of asbestos 
d u s t/61 To quote: "three occupations can easily be demonstrated as a danger to 
the health of the workers, ascertained through injury to the bronchial tubes and 
lungs: asbestos sifting and carding, silk opening and counting, and hemp
spinning".
The first reported case of disease associated with the inhalation of asbestos dust 
was that of pulmonary fibrosis in an asbestos textile worker described by 
Montague Murray to the Departmental Committee on Compensation for Industrial 
Diseases in 1906/71 This worker had been employed for 10 years in the carding 
room of a textile factory and was the last survivor of a team of 10, all working in 
the carding room, each having died at around the age of thirty. This man first 
came to the attention of Murray in 1899 and died, aged 34, in 1900. No evidence 
was found at postmortem of pulmonary tuberculosis.
The second case, reported by Cooke in 1924, was of a woman aged 33 who died 
in 1924 having worked with asbestos for 18 years/81 Postmortem here revealed 
extensive fibrosis of the lungs, with pulmonary tuberculosis. Both these cases 
were important, since their publication directed attention to the possibility that 
inorganic dusts containing little or no free silica might be productive of extensive 
pulmonary fibrosis. Until then only the opposite view point had been considered, 
with silicosis occupying the attention of researchers. Cooke’s case, though slightly 
weakened by the presence of a tuberculous infection, was of greater importance, 
however, as it described the discovery of ‘curious’ bodies resembling asbestos 
fibre in the lung tissue. In 1927 Cooke was to call the disease "pulmonary 
asbestos"/91
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In 1928 Seiler reported the case of an asbestos worker with pulmonary fibrosis for 
which no other obvious infectious or occupational cause, other than asbestos dust, 
was found.1101 This report resulted in the Home Office (Factory Department) 
undertaking investigations into the effects of asbestos dust on the lungs. This case 
had the four vital conditions necessary to establish a relationship between the 
inhalation of asbestos dust and the development of fibrosis, namely:
1. Work involving exposure to asbestos dust.
2. The existence, demonstrable clinically and radiologically, of definite 
pulmonary fibrosis.
3. The absence of previous or present infections known to cause 
pulmonary fibrosis (for example, tuberculosis, influenza, or 
pneumonia).
4. The absence of previous or present work involving exposure to 
other dusts, which might cause pulmonary fibrosis.
By 1930 Merewether and Price, as a result of these Home Office investigations, 
had found a correlation between the incidence of the disease and the duration and 
intensity of dust exposure.(111 From this study, 95 of the 363 asbestos textile 
workers examined clinically showed definite pulmonary fibrosis and a further 21 
precursive signs. Of 133 workers examined radiologically, 52 showed signs of 
diffuse fibrosis and 22 early signs of fibrosis. The authors did not find any 
evidence of excess pulmonary tuberculosis among the asbestos workers (including 
those with asbestosis). A dose-response relationship in the development of 
asbestosis was suggested: fibrosis taking less than 10 years to develop with high 
exposure to asbestos, and between 15 to 25 years with low dust exposure.
Merewether and Price, in the same report, also reviewed the dust concentrations 
in textile factories, making numerous recommendations for dust suppression that 
formed the foundations of the Asbestos Industry Regulations of 1931.[ 121 Before 
these regulations were enforced, asbestosis was also recognised as a compensable 
disease under the 1930 Workmen’s Compensation Act (Silicosis and Asbestosis).
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Again in 1930, Merewether gave a more detailed account of the clinical findings 
of the Home office investigations carried out over 1928-29.1131 He described 
impairment of percussion note and reduced chest expansion as important physical 
signs of asbestosis, together with scattered fine rales (dry crackling sounds) at the
bases and axillae. He also mentioned cyanosis, dyspnoea, finger clubbing, cough
and sputum. The radiological changes were described as occurring in four stages:
Stage I increased linear striations;
II fairly definite fine dusty stippling;
III coarser mottling with increased linear striations;
IV gross lesions with pleural changes and displacements
due to the pull of fibrosing lesions.
To sum up developments, by 1930 it may be said that:
The signs, symptoms, x-ray appearances, and pathological aspects of 
asbestosis were well recognised.
The disease had been found to be fatal in a number of reported cases.
The disease was capable of progressing after exposure to asbestos dust had 
ceased.
People still actively employed in asbestos mining, milling and 
manufacturing showed a high prevalence of asbestosis. Approximately half 
of those with 10 or more years in the industry were diagnosed as having 
asbestosis.
In reviewing the pathology and histopathology of asbestosis in 1933 Gloyne 
described the finding of tough, old, pleural adhesions and reported a ‘ground 
glass’ effect to the pleura as thickening increased, with the pleura becoming stiff, 
yellow and horn like.[14) He noted that ‘asbestos’ bodies and fibres were found 
in the lungs of persons with asbestosis and that fibres were commonly found in the 
upper respiratory tract of asbestos workers. He also reported having seen a case 
of ‘squamous carcinoma of the pleura’ with asbestosis.
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In a comprehensive three-part article covering the years 1933-34 Merewether 
summarised the state of asbestosis knowledge, and noted the difficulty of making 
a diagnosis and what he coined as the "insidiousness of the disease",[151 He 
suggested that a minimum fibrosis-producing amount of asbestos had to be retained 
in the lung in order to produce disabling fibrosis, and that a certain development 
period was necessary before the fibrosis became disabling. He stressed that if dust 
concentrations could be kept below a certain level, the development of disabling 
asbestosis would not occur over an average working lifetime. The level he 
considered appropriate was the amount of dust produced by flyer spinning without 
dust exhaust. In effect Merewether recommended that flyer spinning of asbestos 
was acceptable uncontrolled.
Wood and Gloyne in 1934 analysed 100 cases of asbestosis, 12 of whom were 
autopsied; of these 2 also had lung cancer.[ 161 Dyspnoea was excessive in the 
100 cases and they suggested that asbestosis was a mono-symptomatic disease. It 
was noted that asbestosis was associated with tuberculosis to a much lower 
percentage level than was the case for silicosis.
In North America, the Industrial Health Service of the Metropolitan Life Insurance 
Company carried out similar investigations to the Home Office study of 
Merewether. This was reported in 1935 by Lanza et al.[1?1 They examined 126 
workers from asbestos mines and mills out of whom 67 had radiological signs of 
asbestosis, and another 37 doubtful signs. They could not correlate the 
development of asbestosis with dust exposure through lack of past dust data. The 
authors stated, without any supporting evidence, that asbestosis was clinically 
milder than silicosis.
Lynch and Smith in 1935 presented a case history of pulmonary asbestosis with 
associated bronchial carcinoma.1181 The subject had worked in a cotton mill for 
22 years and at an asbestos mill for 21 years. Their conclusion was that the 
carcinoma was due to chronic bronchial irritation bought on by occupational dust
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exposure. Figure 2.4 shows the dust created in stripping and cleaning a carding 
machine.”
By 1938 Gloyne and Merewether reported that of the 95 cases with asbestosis, and 
5 other cases of asbestosis with tuberculosis, found in the 1928 Home Office 
investigations 23 had died.^191 Of these, 12 had died from asbestosis, 9 from 
asbestosis and tuberculosis and one from asbestosis and carcinoma of the pancreas. 
The last case, whose underlying case of death was not recorded, was stated to 
have a "considerable degree of asbestosis" on autopsy. They noted that asbestosis 
was comparable with the most serious silicosis risks with respect to length of 
exposure that will cause a fatal degree of fibrosis. They also reported that the 
association between asbestosis and tuberculosis was less than that between silicosis 
and tuberculosis.
In 1938 Dreessen et al published a study of American asbestos textile plants that 
recommended that dust concentrations should be kept below 5 million particles per 
cubic foot (mppcf)“’. [20] This study was also reported on by Sayers and 
Dreessen in 1939.[ 21 ] Their work was based on a group of 511 workers from 
which only 3 doubtful cases of asbestosis were found. It was unfortunate that of 
the 511 workers examined only 66 had worked with asbestos for more than 10 
years; 333 had worked with asbestos for less than 5 years, and that, as the authors 
reported, 150 workers had been dismissed from the plants before the survey 
started as they were suspected cases of asbestosis. This large loss of men 
unfortunately reduced the value of this study.
Dreessen’s study was, however, one of the first in which dust counts were 
undertaken at various stages of textile manufacture to estimate asbestos exposure 
to workers. Dust concentrations ranged from 5-75 mppcf without exhaust control
* Photograph courtesy of the ’Donald Hunter slide collection’ held at the 
London School of Hygiene and Tropical Medicine. *
** They recommended 5 mppcf, 8 hours per day, 40 hours per week for a 
working lifetime as a safe level of exposure.
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and between 0.7-7 mppcf with control. The concentrations being highest for 
willowers, pickers, carders and cloth weavers, these along with spinners and 
twisters being more liable to develop severe asbestosis. Their value of 5 mppcf 
being used over the next thirty years as a tentative threshold limit.
In January 1943 the German Federal Government declared asbestosis in 
combination with lung cancer a compensable occupational disease.122 ] This was 
the first government to acknowledge that lung cancer occurs in clinically slight 
cases of asbestosis as well as in well-developed asbestosis.
In a thesis submitted to Glasgow University, Wyers in 1946 put forward the case 
that asbestosis was a clinical disease, not radiographical, and that x-ray change 
should be used only to confirm the clinical findings.123] He suggested that the 
‘ground glass’ effect may have been due to poorer techniques and was in fact 
innumerable small opacities. He speculated that as the disease had changed from 
an acute to a chronic disease, it might emerge as a neoplastic disease as lower dust 
concentrations enabled people to live long enough to develop malignant tumours.
In 1947 Wegelius reported on the prevalence of asbestosis in 126 workers from 
the asbestos mines and factories of Finland.[24] From this group 94 were 
described as Stage I asbestosis, 23 as Stages II and III and 9 as advanced Stage III, 
pleural and pericardial thickening being present in this last group. The 
radiological stages were given here as:
Stage I - very fine network in the middle of the basal fields.
II - denser picture with numerous small nodules.
III - marked shadowing of middle and lower fields with
confused heart shadow.
Smith in 1949 performed an analysis on data from current literature, on the 
etiologic relationship of pneumoconiosis with reference to silicosis, asbestosis and 
pulmonary cancer.[25J He stated that evidence incriminating silicosis and 
asbestosis as an aetiologic agent in the development of lung cancer was
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inadequate, but that such data should be reviewed frequently and cautioned against 
the use of insignificant data with respect to the referent community.
Published later in 1949, the Annual Report of the Chief Inspector of Factories for 
the year 1947, showed that of 235 cases of asbestosis reported 31 (13%) had lung 
cancer present either as a cause of death or as a concomitant.[261 In addition to 
these one case, a male aged 77, was diagnosed at postmortem as having ‘sarcoma’ 
of the lung.
The association of carcinoma of the lung with asbestosis was highlighted in 1955. 
The Annual Report of the Chief Inspector of Factories, showed that 24% of 222 
male and 12% of 143 female asbestos workers with asbestosis had accompanying 
lung cancer for the period 1922-55. ^ 271 Doll in the same year presented the 
postmortem findings of 105 workers from a single asbestos works.1281 Of these, 
75 had asbestosis, 15 having associated lung cancer, of the remaining 30 without 
asbestosis, 3 had lung tumours. The 15 with ‘asbestosis cancer’ had all worked 
for periods of 9-23 years before 1933.
In 1960, Leathart monitored the long term progression of asbestosis in 10 
subjects.^291 All had worked with chrysotile and amosite fibres. Sputum was 
routinely examined for asbestos and tubercle bacilli and the subjects were regularly 
x-rayed and examined clinically. Lung function tests were also performed. From 
this group, ‘asbestos’ bodies were found in 8 subjects; no tubercle bacilli was 
found. From the x-rays, the presence of hilar enlargement distinguished disease 
stage II from stage I, and the loss of cardiac outline indicated disease stage III. 
From the lung function tests, compliance was seen to be 20% of normal, vital and 
diffusing capacity 56% of normal and maximum voluntary ventilation was 45% 
of normal. Leathart concluded that the vital capacity of workers exposed to 
asbestos should be measured routinely as a decrease may warn of impending 
asbestosis. He also noted that lung function changes relate well to clinical 
abnormality, but not to radiological appearance.
22
The work of Wagner et al in South Africa in 1960 revealed the first major link 
between asbestos and mesothelioma.1301 Although considered uncommon, 
mesothelioma was found in 33 histologically proven cases, 28 of which had mainly 
a non-occupational association with the Cape amphibole asbestos field. Also in 
South Africa, Hurwitz reported in 1961 on the radiological changes in asbestosis, 
among asbestos exposed workers. He stated that pleural changes far outnumbered 
the cases of lower zone parenchymal fibrosis more commonly reported.[311
To sum up, by the early 1960s it was known that:
Lung function tests along with radiographs were a good aid in the diagnosis 
of asbestosis.
As factory dust levels were lowered, the attack rate of severe asbestosis 
was lowered. Consequently, asbestos workers begun living long enough 
to develop asbestos-induced cancer.
Mesothelioma occurs with ‘slight’ asbestos exposure.
In a series of articles from 1963 to 1968 Leathart confirmed and strengthened his 
earlier findings, but also suggested that diffusing capacity not vital capacity should 
now be used to aid diagnosis of asbestosis.[32,33,341 He further suggested that 
in asbestosis uneven alveolar perfusion existed, and that a restrictive ventilatory 
defect may have caused dyspnoea in cases with bronchitis. Leathart pointed out 
that reduced diffusing capacity limited exertion in subjects with ‘pure’ asbestosis.
Through 1964-65 the studies on insulators by Selikoff et al, finally confirmed the 
cancer hazard from occupational exposure to asbestos.[35'36,371 In this work 
lung cancer mortality was 7 times higher than expected, and mortality from 
gastrointestinal cancer 3 times its expected rate. The authors reported that 
asbestosis was seen radiologically in 86% of 392 workers with more than 20 years 
employment.
Enterline and Kendrick conducted a study in 1967 of 21,755 workers from three 
American asbestos products industries.1381 From the asbestos textile, asbestos
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building products and asbestos friction materials industries excess mortality rates 
were found for respiratory cancer and asbestosis. For the asbestos textile 
industry, excess rates were also found for digestive cancer and cor pulmonale. 
Physical inspection of the plants showed the textile factories to be the most dusty.
Also in 1967 the Advisory Panel on ‘Problems arising from the use of Asbestos’ 
presented their report and recommendations to HM Senior Medical Inspector.[391 
This report described the increasing number of asbestosis cases, particularly in 
workers not covered by the asbestos regulations (e.g. pipe laggers). It 
recommended extending the scope of existing regulations while reporting that 
bronchial carcinoma appeared to be a complication of asbestosis rather than 
asbestos exposure and that there was strong evidence linking asbestos exposure 
with the development of mésothélial tumours.
The panel also emphasized the importance of fibre counts in the assessment of the 
environment and reported on one textile mill were the standard use of exhaust 
ventilation gave the following results:
TABLE 2.1: Fibre counts from an asbestos textile mill.
Process Particles counts 
per cubic 
centimetre
Fibre counts 
per cubic 
centimetre
Carding 400-600 7.7
Beaming 150 4.5
Bag Slitting 100 4.3
Mechanical bagging 125 3.8
Weaving 120 1.9
Plaiting 150 3.8
The panel suggested that the above values should be regarded as immediate goals, 
but not as standards. Apart from carding, these values for particles not fibres 
were in the order of 15-45% lower than the American 1938 tentative limit of 5 
mppcf (1 mppcf = 35 particles per cubic centimetre).
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Correlation of environmental data with the mortality experience of 1,014 asbestos 
textile workers for the years 1931-1967 was undertaken by Doll and Knox in 
1968.t401 Analysis of trends in mortality showed a decrease in lung cancer and 
other deaths associated with asbestosis with reduction in length of employment 
before 1933, and an increase in lung cancer and other deaths, without asbestosis, 
with age. The authors concluded that the occupational risk of bronchial carcinoma 
had been largely eliminated, but that their data were insufficient to estimate the 
degree of any other remaining risk.
This work of Doll and Knox, finding a considerable excess of lung cancer in 
workers exposed before 1933 when the asbestos industry control regulations were 
enforced, but none in persons exposed for 10 years or more in the most dusty 
areas since then, was augmented in a study by Newhouse in 1969 at another textile 
factory.141 ] In this study of over 4,500 workers employed between 1st April 
1933 (the implementation date of the regulations) and 1st May 1964, Newhouse 
showed an excess risk of lung cancer mortality for heavily exposed workers 
followed for at least 16 years with less than 2 years employment. Both studies 
highlighted the importance of latency considerations when dealing with asbestos 
exposed cohorts.
A synergistic interaction between cigarette smoking and asbestos exposure was 
shown in 1968 by Selikoff et a l .[4?1 The authors showed that "asbestos workers 
who smoke have 92 times the risk of dying of bronchogenic carcinoma as men 
who neither work with asbestos nor smoke". Weiss in 1971 considered the 
interactive effects between smoking and x-ray abnormalities.[43] Here the 
prevalence of pulmonary fibrosis increased with amount and duration of cigarette 
smoking and with duration of exposure to asbestos dust.
In 1970 a standard of 2 fibres per cubic centimetre (f/cc) for chrysotile dust was 
adopted in Britain; this followed from a review of the work of Knox undertaken 
in 1968 by the subcommittee on asbestos of the British Occupational Hygiene 
Society.c44] The subcommittee concluded that if the risk of clinically significant
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disease was to be kept below 1%, for a working life of 50 years, then workers 
should not be exposed to dust concentrations higher than 2 f/cc. This was one of 
the many standards set that has lead ultimately to the limits of 0.5 f/ml for 
chrysotile and 0.2 f/ml for amosite and crocidolite, for daily average exposure, in 
the United Kingdom today.
The work of Doll, Knox and Newhouse presented in 1968-1969 acted as a spur 
to numerous studies but most notably to the work of McDonald in Canada 
examining Quebec chrysotile miners, and in the United Kingdom in the work of 
Harries in Royal Naval Dockyards. Harries work is considered in detail in section 
2.4 of this review. McDonald’s study of the Quebec industry was started in 1966, 
its aims were to relate dust exposure to mortality, radiographic appearances, 
respiratory symptoms, and lung function; the first reports of this study were 
presented in 1971-1972.[45'46-47’48]
In this work, Rossiter with McDonald investigated x-ray changes in chrysotile mill 
and mine workers from Quebec. At Thetford Mines, where dust levels were high 
(148-780 mppcf 'cumulative dust exposure’), they found that the prevalence of 
radiologic change was correlated with total dust level and with age; at Asbestos 
Mine, which was less dusty (101-300 mppcf), the main factors were age and years 
of exposure. Pleural calcification was common at Thetford but virtually absent at 
Asbestos. From these studies it was also seen that the overall mortality of the mill 
and mine workers was lower than expected for the population of Quebec but in the 
highest dust exposure category comprising 5% of the cohort, the age standardised 
death rate was 20% higher than in other groups. This excess was largely 
accounted for by an excess of bronchial carcinomas, 3 cases of mesothelioma were 
also found. McDonald’s work among Quebec miners and millers is considered in 
detail in section 2.5 of this thesis.
Selikoff et al in 1972 reported on the mortality experience of 230 workers 
employed at an asbestos products factory.[49] These workers had been employed 
during the war years in the manufacture of insulation, using amosite fibres, for
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shipbuilding and repair. Total deaths were twice the number expected, the excess 
death rate being limited to two categories, cancer and asbestosis. Fourteen deaths 
were from asbestosis, 25 from lung cancer and 5 from mesothelioma (2 pleural, 
3 peritoneal). It was concluded that occupational exposure to amosite can be 
associated with a serious cancer hazard, and its continued industrial use requires 
rigorous control.
In 1973, papers by Weill et al and Jones et al together produced a concise 
summary of the common radiological observation of the long latency of pleural 
effects of asbestos (particularly calcification), the frequent finding of extensive 
pleural abnormalities without parenchymal disease, and the correlation of 
progressive parenchymal disease, asbestosis, with heavy dust exposure/50,511 
Jones and Sheers in their paper also drew the following conclusions about pleural 
plaques:
1. There is ample evidence of an association between pleural plaques 
and all types of exposure to asbestos, and to all types of asbestos 
fibre. Asbestos is not the only cause of plaques but is certainly the 
most common.
2. There is insufficient evidence to establish a direct cause-effect 
relationship between pleural plaques and asbestos dust.
3. The prevalence of plaques is not related to total dust exposure; but, 
given a minimum initial exposure, the prevalence depends on age.
4. Pleural plaques are not harmful clinically, but they act as a useful 
marker to possible asbestos exposure.
5. The pathogenesis of plaque formation is unknown.
Webster in 1973 updated the information on the occurrence of mesotheliomas in 
South A frica/521 It was reported that 158 out of 360 recorded cases had definite 
exposure to asbestos but only 88 of these came from the mining areas where 
exposure to only one type of asbestos could be assumed. Of the 88 cases 84 had 
been exposed to crocidolite and four to amosite.
Newhouse and Berry in 1976, reporting on a group of workers exposed to 
chrysotile and a mixture of amphiboles, used a model relating mesothelioma risk
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with time since first employment to predict mesothelioma mortality rates in man 
to the year 2000.1531 They estimated a mortality rate of 7-11% per annum for 
male and 9-12% for female asbestos textile workers by 2000 AD. This model in 
many refined forms has been used extensively since then, in particular by 
Peto.[ 54,55,561 All of the models used make use of the fact that the 
relationship of mesothelioma to asbestos differs in several ways from the 
relationship for lung cancer, the hazard appearing to be more strongly dependent 
on the type of asbestos, to be largely or wholly unaffected by smoking and 
independent of the age at which exposure first occurs.
In 1979 Irwig et al reported studies on 1,144 men from South African crocidolite 
mines and 548 who were involved in the mining of amosite.1571 It was claimed 
that pleural abnormalities visible on chest radiographs were significantly more 
frequent among amosite workers than among those who had worked with 
crocidolite. There were no other differences in recorded pathology between the 
two groups.
By 1979 Hammond et al and Berry et al had carried the asbestos-smoking 
interaction a step further; to an increased risk of asbestosis.158,591 Hammond’s 
work clearly showed that a multiplicative relationship may exist between smoking 
and asbestos (see table 2.9, in section 2.5.3), it further showed that mortality from 
asbestosis was 2.8 times higher for asbestos workers who smoked than for their 
nonsmoking colleagues. Berry after allowing for age showed that there were 
significantly fewer signs of asbestosis in nonsmokers and light smokers than in 
heavier and ex-smokers, for men first exposed to asbestos after 1950.
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By the 1970s it was known that:
A high proportion of cancer deaths occur among subjects with asbestosis.
Asbestos acts synergistically with smoking to produce nonmalignant non- 
infectious pulmonary disease, although the synergism is not as strong as it is 
for lung cancer.
Asbestos-related cancer occurs after exposure to dust containing a high 
proportion of large asbestos fibres, i.e. fibres longer than 5 microns (5/jm).
Removal from exposure is unlikely to halt the progression of pleural changes 
once they have developed.
Amphibole asbestos, in particular amosite and crocidolite, appears more 
hazardous to health then chrysotile asbestos.
From the early 1970s the need for information on the occurrence of diseases related 
to asbestos, and their relationship to exposure levels was evident, and many studies 
followed, particularly in the USA and Britain. To review these here, extensively, 
would not be practicable as over 200 papers on diseases related to asbestos and its 
exposure have been published per annum. To summarise, however, the principal 
disorders related to asbestos exposure include:
Diffuse interstitial pulmonary fibrosis, termed asbestosis. Lung cancer and 
mesothelioma of the pleura and peritoneum. Pleural plaque formation and 
diffuse pleural thickening. It may also cause other cancers, including possibly 
cancers of the larynx and the gastrointestinal tract, and conceivably a wide 
range of others (figure 2.5).
Figure 2.6, taken from the ILO Encyclopaedia of Occupational Health and Safety 
(1983), outlines the rise in production of asbestos worldwide with the dates of 
acceptance of the causal relation between asbestos and the above diseases. Since the 
1980s the use of asbestos in the industrialised world has diminished, with the 
increasing use of man-made mineral fibres as a substitute material. However, in the 
developing world (e.g. India and South America) the use of asbestos continues 
unabated. The worldwide use of asbestos may therefore have slowed but has clearly 
not stopped altogether. The following sections of this review will now consider 
asbestos-related disease in shipbuilding and repair, and also the present day concerns 
generated by past and present asbestos exposure.
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FIGURE 2.5: Principal asbestos related diseases and conditions, and
their sites in the human body.
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Asbestosis
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Bronchial C a n ce r. . . ?
M esothe liom a
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FIGURE 2.6: Rise of production of asbestos 1890-1980, and the
dates of acceptance of the causal relationship between 
asbestos and various diseases.
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2.3 Asbestos Related Disease in Shipbuilding and Repair.
Health problems arising from the use of fibrous materials in Royal Naval 
Dockyards are not a new phenomenon. In a letter dated 17 June 1891, to the 
Fleet Surgeon, Naval Surgeon G Kirker“ reported on a workman suffering 
discomfort in his chest owing to breathing in the dust of cotton silicate, a fibrous 
silicate, used as a woven covering for boilers and steam pipes.[60) Eventually 
cotton silicate was replaced by a better insulator, asbestos.
There was a gradual increase in the use of asbestos in British Dockyards and 
American Shipyards over the next 30-40 years, followed by a massive increase in 
use during World War II. Between 1939-45 over 6,500 vessels, all containing 
asbestos, were built in American yards.[611 At the peak of the war more than 
1,700,000 workers were employed in this industry; throughout the war a total of 
over 4,500,000 men and women were employed in shipbuilding and repair.[6Z1
Expansion of the British and American shipbuilding and ship repair industries in 
the 1930s mirrored that of Germany. The first published reports linking asbestosis 
with shipbuilding coming from German researchers. Kuhn in 1940 reported on 
a fatal case of asbestosis that had occurred in a German shipyard insulation 
worker.1631 He described how workers in German shipyards were rotated out 
of asbestos insulation handling after 2 years of work.
A United States Maritime Commission field survey in 1944, by Dreessen and 
Fleischer, at a civilian contract shipyard revealed 2 pipe coverers (asbestos 
laggers) with x-ray evidence of well-established asbestosis and 4 others with 
possible asbestosis, in all 38 pipe coverers were examined.1641 They concluded 
that conditions in this yard presented a very real asbestosis hazard. *
* Kirker was the surgeon in Keyham Yard, now North Yard, HM Naval 
Base, Devonport.
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In August 1945, HM Chief Inspector of Factories issued a warning to the 
shipbuilding and ship repair industry over the danger to health from the increasing 
use of asbestos in ships.1651 This warning stressed that while asbestos dust had 
no immediately obvious effects on health, serious problems were likely to develop 
subsequently. Among the suggestions made were the need for better ventilation, 
damping the dust and the quick cleaning up of asbestos debris. The use of dust 
respirators was recommended for men fitting or removing dry asbestos, and during 
the spraying of asbestos.
Fleischer et al in 1946 conducted x-ray examinations and dust surveys at four US 
Naval Shipyards, this work was also reported on by Drinker in 1947.166,67] 
Total dust concentrations in these yards ranged from 7-32 mppcf, with an average 
on-ship exposure of 11-142 mppcf. They reported the lower values in units of 
‘mppcf asbestos dust’. Of the 1,074 workers examined, 948 had less than 5 years 
employment in the pipe covering industry and only 54 had more than 10 years 
employment. Three cases of asbestosis were found, all in workers with more than 
20 years of employment. They concluded that pipe covering in the shipbuilding 
industry was not hazardous. This conclusion conflicted with the earlier statement 
of Dreessen and Fleischer in 1944 of a very real hazard. The low asbestosis 
prevalence, shown by Fleischer and Drinker, was clearly an artifact caused by 
their inadvertent dilution of the at-risk population with briefly exposed workers. 
Although these early studies did not stand the test of time epidemiologically, they 
did represent the best occupational health methods of their era.
The use of respiratory protection for asbestos exposed workers in American 
shipyards during World War II was reviewed by Stoll et al in 1951, who noted 
that protection was advised but not insisted upon.1681 This was despite the US 
Navy’s publication in 1943 of the minimal requirements of health and safety in 
contract shipyards.1691 This document required the segregation of dusty work, 
use of exhaust ventilation and respirators, and periodic medical examinations of 
workers handling asbestos insulation materials. Stoll also reported on a 40 year 
old asbestos pipe coverer with bronchogenic carcinoma in association with
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pulmonary asbestosis. The authors noted that amosite was the most widely used 
form of asbestos in shipyards during the War.
In an account of the health hazards of asbestos at Portsmouth Royal Naval 
Dockyard, Walters in 1959 noted that only one case of asbestosis had been 
reported among pipe coverers between the years 1946-58, with a further 6 possible 
cases unconfirmed by the Pneumoconiosis Medical Panel.1701 Over the same 
years no cases were reported among asbestos sprayers.
Morgan in 1964 described a case of ‘rheumatoid pneumoconiosis' associated with 
asbestosis in an arc-welder, exposure to asbestos was traced to welding of asbestos 
lagged pipes in the interior of ships.1711 Also in 1964 Marr reported on 5 
workers from the Long Beach Naval Shipyard compensated for asbestosis, one of 
whom had died of the disease.1721 This study looked at the irregular exposure 
to asbestos occurring during its installation and removal in ship repair or overhaul. 
Total dust counts were given as 1-5 mppcf. These ‘low’ counts do not appear to 
give an adequate indication of the hazard, conflicting with the observation that 
"the work environment appears extremely dusty, respirator filters often clogging 
after an hour’s work removing insulation". The shipyard also stated that amosite 
was seldom applied due to the excessive dust created during its removal!
In a follow up study, at one of Fleischer’s four shipyards, Murphy and Ferris in 
1966 analysed 101 pipe coverers and 94 age-matched controls from departments 
with minimal asbestos exposure.1731 Of 68 pipe coverers with 5 or more years 
exposure significant differences were seen on comparison to their controls for 
symptoms of cough, phlegm, wheezing and shortness of breath. Over 25% of 
these workers were diagnosed as having asbestosis; no cases occurred with fewer 
than 8 years of exposure, the average length of exposure was 20 years. The study 
emphasized that low concentrations of asbestos can lead to pulmonary fibrosis and 
supported the need for lower threshold limit values. This work was extensively 
referred to by Murphy and Ferris in subsequent publications.174,75,761
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In 1967 Anton reported on 12 cases of multiple pleural plaques in shipyard 
workers.1771 He suggested that the presence of pleural plaques might be a sign 
of a milder form of asbestosis and considered that pleural fibrosis might have been 
responsible for earlier researchers description of a ‘ground glass’ effect in the 
lower lung fields. The frequency of asbestos bodies in the lungs was studied by 
Ashcroft in 1968, in a shipbuilding area where asbestos was used in insulation for 
boilers, pipes and bulkheads.[ 781 Asbestos bodies were found in 20% of all 
routine necropsy smears but there was no evidence of classical asbestosis.
Sheers and Templeton in 1966 carried out x-ray examinations of every tenth 
worker employed at Devonport Royal Naval Dockyard, this work was also 
reported on by James in 1971.[79,801 From the 1,414 workers examined with 
possible exposure to asbestos, 4 had pulmonary fibrosis due to asbestosis, 11 
extensive pleural fibrosis, 48 limited pleural plaques, 2 bronchogenic carcinoma 
and 1 mesothelioma. The intermittent nature of asbestos exposure in ship overhaul 
was suggested as the reason why pleural changes overshadowed parenchymal 
disease, exposure being insufficient to cause asbestosis except in high risk groups.
The work of Sheers and Templeton at Devonport Dockyard, and of Walters at 
Portsmouth Dockyard was extended in a series of Royal Naval Dockyard 
Asbestosis Research Project reports, to cover the four Royal Naval Dockyards: 
Devonport, Chatham, Portsmouth and Rosyth. This work together with other 
hygiene and medical reports from naval surgeons form a core of the published 
material from the United Kingdom for the 1970s and is considered in section 2.4 
of this review.
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By the late 1960s it was increasingly clear that:
The risk of disease was not confined solely to workers in mining and 
manufacturing asbestos. It extended to those workers who used asbestos 
products and in particular to insulation workers and dockyard workers.
That in the period of World War 11 through to the 1960s there was 
extensive use of asbestos in dock and shipyards with little control and 
minimum precautions in its use.
Horn in 1969 published a summary of the protective measures to be used when 
working with asbestos containing materials in shipbuilding.1811 The use in 
Germany of suction devices was highlighted, with the recommendation that suction 
be improved so that asbestos dust concentrations in room air of 30 particles per 
cubic centimetre for particles up to 10 micrograms is not exceeded. A stipulation 
against employment of workers with chronic respiratory diseases or youths aged 
under 18 in jobs handling asbestos materials was given. The author concluded that 
"strict prophylactic measures for handling materials containing asbestos must be 
administered because there is no effective treatment for asbestosis".
The chance finding of asbestos bodies without asbestosis in the lungs of a shipyard 
worker who had not worked directly with asbestos was recorded in the 
Netherlands, in 1969, by Stumphius.1821 This led Stumphius in 1971 to an 
investigation into the relationship between asbestos bodies in the sputum, 
occupation, and mesothelioma in the shipyard at Vlissingen on Walcheren 
Island.1831 Examination of the sputum of 277 workers revealed asbestos bodies 
in 60%, the frequency varying from 39% in workers with no obvious exposure to 
asbestos to 100% among those with slight but definite exposure. Between 1962- 
68, 25 cases of mesothelioma were discovered on Walcheren; the attack rate for 
mesothelioma was estimated to be 100 per 100,000 males per year, 100 times 
higher than the rate for Dutch provinces with heavy industry. For different 
occupational categories in the shipyard the rates varied from 50 for ‘clean work’ 
to 280 for men with some exposure to asbestos dust.
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The occupational classification used by Stumphius was based on exposure to both 
iron oxides or fumes and to asbestos. The categories used were:
I Iron Vapour: Apparently negligible asbestos exposure - welders and 
cutters.
II Iron Oxides (Rust): Some exposure to asbestos - fitters, welders, 
plumbers, etc. employed after launching or during repairs.
III Iron Vapour and Rust: Apparently negligible asbestos exposure - 
platers, shipwrights, and foundry men employed on initial 
construction.
IV Men exposed to other dust, including some asbestos, not exposed to 
iron vapour or rust: Painters, carpenters, etc. employed after 
launching or during repairs.
V Clean Work: Not apparently exposed to iron vapour or rust nor to 
asbestos dust.
As can be seen by these categories, no workers were regarded as working solely 
with asbestos or as being heavily exposed to its dust. Those men employed by 
contractors on asbestos insulation work were not studied. Stumphius aired the 
suspicion that iron oxide might be an important cofactor in the genesis of shipyard 
mesothelioma.
Evidence of chest disease noted in the x-rays of shipbuilding and engineering 
workers at an industrial clinic was shown, by Fletcher in 1971, to correlate with 
trade within the industry.t84) Joiners in particular were noted to have a high 
prevalence of pleural plaques, plaques occurring in approximately 30% of all 
joiners, followed to a lesser extent by caulkers, burners, drillers, laggers, and 
sheet metal workers. For joiners, the use of asbestos board containing 30% 
amosite in sound insulation was suggested as the probable cause of illness.
Ahlman and Siltanen in 1971 presented annotated tables of 56 cases of pulmonary 
asbestosis occurring among insulation workers in Finland during 1938-68.[851 
In this work they also presented data on Finish shipyard breathing zone exposures 
to asbestos dust. For pipe coverers, exposures ranged from 34-92 f/cc (fibres 
longer than 5 microns), total particle counts ranged from 26-50 mppcf. For 
workers sawing asbestos boards exposures ranged from 86-220 f/cc; 45-97 mppcf.
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These concentrations emphasise the importance of dust suppression methods, with 
the large number of cases suggesting past ignorance of the health hazards of 
insulation work.
Also in 1971, Whitwell and Rawcliffe in a retrospective study of 52 pleural 
mesothelioma patients from three Merseyside hospitals confirmed occupational 
exposure to asbestos in 80% of the cases, the most common industry involved 
being shipbuilding and repair.1861 The lungs of patients with industrial 
mesothelioma showed basal asbestosis in 17% of cases and excessive asbestos 
bodies in most others. The interval from first exposure to asbestos to the 
appearance of mesothelioma ranged from 13-63 years, with a reported mean of 42 
years.
Elmes in 1971 reported on a high incidence of lung fibrosis in Belfast insulation 
workers.1071 From 165 workers, over a 27 year period, 98 had died and from 
these 40 had radiological or postmortem evidence of extensive fibrosis (excluding 
tuberculosis). These workers were all trade union members who had worked 
either in the Belfast shipyards or on large Northern Ireland construction sites. 
Two other studies concerned with the health of Belfast insulators were presented 
by the same team of researchers in 1971.188,891 From these studies there was 
evidence suggesting that the pleural fibrosis was due to asbestos exposure in 
childhood, with many of the insulators family homes being in the shipyard area.
From the International Labour Office (ILO) publication on Safety and Health in 
Shipbuilding and Ship Repairing published in 1972 we are given the following 
asbestos exposure information by Cross:1901
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TABLE 2.2: Ranges of dust concentrations (data grouped across numerous yards).
Process monitored f/cc
Insulation rip-out 159 - 353
Spraying, undamped 150 - 1500
1 Spraying, damped 1 - 4.7
Pipe covering 11.2 - 61
i Hand sawing board, without exhaust 1 4 - 5 8
Hand sawing board, with exhaust 1.1 - 3.4
Power sawing, without exhaust 63 - 200
Power sawing, with exhaust 1.4 - 4.5
These data were supplied to Cross by industry and government in the UK. It 
should be noted that for ‘rip-out’ the values given were averages; the maximum 
was 3815 f/cc for sweeping and bagging debris. This value is approximately 
20,000 times the current UK limit for amosite and crocidolite exposure and was 
obtained at Devonport Dockyard.c911 In the same ILO publication Nicholson 
reported on electron microscopy findings that showed that some processes yielded 
only small fractions of airborne fibres longer than 5 microns (e.g. cutting asbestos 
block, 3.5%; removal of pipecovering, 5.9%).[92] Nicholson believed exposures 
could be kept below 0.7 f/cc with the use of improved industrial hygiene practices.
At this point, the mid 1970s, it was clear that:
There was a high prevalence of pleural plaques in ship and dockyard 
workers and that asbestos bodies were being seen with and without 
asbestosis in these workers.
That asbestos-related diseases were occurring in ‘non-asbestos’ shipyard 
trades and were also present from childhood exposures.
In 1976, Stumphius continued his initial work on Walcheren Island, reporting that 
52 cases of mesothelioma had occurred in shipyard workers during 1962-76.[931 
None of the cases was a typical asbestos worker but the majority had worked in 
the same areas as asbestos workers, their exposure was of an indirect occupational 
type. No asbestosis was seen. As a result of Stumphius work the Dutch 
authorities stopped the use of asbestos insulation aboard Royal Dutch Navy ships.
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Blot with Harrington in 1978 investigated the high lung cancer rate among male 
residents in coastal areas of Georgia USA. 1941 This study consisted of 458 lung 
cancer cases and 553 controls (subjects hospitalised for reasons other than lung 
cancer) from 11 coastal counties. The occupational risk of lung cancer was 
calculated for 16 industrial categories, including shipbuilding. It was found that 
95 cases (21%) and 80 controls had worked in shipyards during World War II. 
The relative risk for shipbuilding adjusted for smoking, age, race, occupation and 
county of residence was estimated to be 1.6; a synergistic relationship was found 
between shipyard employment and smoking. The authors concluded that asbestos 
and other shipyard exposures account in part for the excess mortality from lung 
cancer in coastal Georgia.
Renke in 1978 reported on a study which examined lung function in 60 Polish 
shipyard workers, 21 male and 39 female, over a four year period.1951 Two 
cases of asbestosis were diagnosed in this group over the study period; the average 
duration of asbestos exposure being 5.8 years for men and 10.7 years for women. 
Renke noted on an increase in the number of obstructive and restrictive ventilation 
disturbances across the 4 years.
In a continuation of their previous work Murphy and Ferris in 1978 re-evaluated 
their cohort of 101 pipe coverers and 94 controls.1961 Clinical findings indicative 
of asbestosis were noted in 16% of the pipe coverers compared to 9% in the 
earlier surveys. Asbestosis was considered present if three of the following chest 
abnormalities were found: bibasilar fine rales, irregular x-ray opacifications, 
forced vital capacity less than 80% of normal, or single breath diffusing capacity 
less than 80%. Eight pipe coverers had died since the original study, 3 of 
confirmed and 1 of suspected asbestosis, 1 from peritoneal mesothelioma and 1 
suffered a fatal myocardial infarction; his lungs showing slight pulmonary fibrosis. 
Three pipe coverers had retired because of pulmonary insufficiency. Asbestosis 
was 11 times more common among pipe covers than their controls. The authors 
noted that the increasing prevalence of asbestosis was in spite of a massive 
reduction in the amount of asbestos used in the shipyard since 1969.
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Blot continued his earlier work on lung cancer producing a succession of reports 
over 1979-81. In the first of these, lung cancer mortality rates over 20 years were 
calculated for 49 US shipyard counties, 80 urban counties of similar size but with 
no involvement in the construction of cargo vessels or warships served as 
controls.197,981 For females, 80% of the shipyard counties had higher lung 
cancer rates than the control counties; for males the cancer rates for all shipyard 
counties were at least 30% higher than their controls. In his later work, increased 
lung and laryngeal cancer risk among shipyard workers from Virginia USA 
employed before 1950 was reported.1" 1 The relative risk, adjusted for smoking, 
was 1.7. This was of the same order of magnitude among those who had only 
worked in shipbuilding during the war years as among those whose careers were 
spent in the industry. This was followed by a study of 61 cases of mesothelioma, 
47 from shipyards in Virginia.11001 The median time between tumour diagnosis 
and first shipyard employment was 34 years. The conclusion from these studies 
was that shipyard exposures to asbestos are implicated as being partially 
responsible for the parallel clustering of mesothelioma and lung cancer in shipyard 
areas.11011
The incidence of bronchial carcinoma in shipyard workers from Barrow-in-Furness 
with pleural plaques was reported by Edge in 1979.11021 Pulmonary asbestosis 
was verified in chest x-rays of 429 male shipyard workers, this group was 
compared to age-matched males from Carlisle with no asbestos exposure. Over 
a 7 year period 127 deaths occurred among the shipyard workers, 19 from 
bronchial carcinoma and 23 from mesothelioma; in the control group 74 men died, 
4 from bronchial carcinoma and none from mesothelioma.
The hazardous effects of asbestos exposure were again highlighted by Selikoff et 
al in 1980 in a study of 286 ship repair workers.11031 The workers were retired 
or still active with at least 20 years of exposure; x-ray evidence of asbestosis was 
found in 86%, 5 cases of previously undiagnosed lung cancer were reported. 
Selikoff noted that ships constructed before 1975 contained extensive amounts of
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During World War 11, women were encouraged to replace men in shipyards with 
many becoming welders and insulators; upon demobilization they returned to other 
work and consequently had only limited durations of asbestos exposure. Boylen 
et al in 1983 presented one of the first studies on the frequency of asbestos-related 
diseases in such women.11041 In this study 60 women were considered, 13 of 
whom had sufficient asbestos exposure to produce stigmata after 40 years.
Kilbum in a series of reports during 1985-86 continued the investigation into 
asbestos-related disease among female shipyard workers and extended this to 
include family contacts of shipyard workers.[105' 106' 1071 In his first report 
71 female workers who had been employed before May 1961 were studied; 15 had 
x-ray signs of asbestos disease, of which 7 had irregular opacities in the lung 
parenchyma and 8 pleural disease (2 had pleural calcifications). Chronic 
bronchitis was diagnosed in 21% and symptoms of dyspnoea and wheezing in 71% 
and 42%, respectively. These prevalences were 50% higher than in the wives of 
male shipyard workers. In his later work the incidence o f asbestosis in 338 male 
and 81 female workers (each with at least 20 years asbestos exposure) and their 
families was investigated. The family members included 280 wives, 144 daughters 
and 81 sons. Among the workers there was x-ray evidence of asbestosis in 185 
males and 15 females. Among their family members with no occupational 
exposure to asbestos, the disease was found in 31 wives, 6 sons and 3 daughters. 
This was higher than the corresponding incidence in a control group taken from 
the general population. From this study, it was concluded that family members 
of shipyard workers face a serious asbestosis risk along with the workers of either 
sex.
asbestos and pointed out that the risks were not limited to ship repair workers,
they also extend to crew members who performed emergency repairs at sea.
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During World War II, women were encouraged to replace men in shipyards with 
many becoming welders and insulators; upon demobilization they returned to other 
work and consequently had only limited durations of asbestos exposure. Boylen 
et al in 1983 presented one of the first studies on the frequency of asbestos-related 
diseases in such women.11041 In this study 60 women were considered, 13 of 
whom had sufficient asbestos exposure to produce stigmata after 40 years.
Kilbum in a series of reports during 1985-86 continued the investigation into 
asbestos-related disease among female shipyard workers and extended this to 
include family contacts of shipyard workers. I105-106-107! in his first report 
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parenchyma and 8 pleural disease (2 had pleural calcifications). Chronic 
bronchitis was diagnosed in 21% and symptoms of dyspnoea and wheezing in 71% 
and 42%, respectively. These prevalences were 50% higher than in the wives of 
male shipyard workers. In his later work the incidence of asbestosis in 338 male 
and 81 female workers (each with at least 20 years asbestos exposure) and their 
families was investigated. The family members included 280 wives, 144 daughters 
and 81 sons. Among the workers there was x-ray evidence of asbestosis in 185 
males and 15 females. Among their family members with no occupational 
exposure to asbestos, the disease was found in 31 wives, 6 sons and 3 daughters. 
This was higher than the corresponding incidence in a control group taken from 
the general population. From this study, it was concluded that family members 
of shipyard workers face a serious asbestosis risk along with the workers of either 
sex.
asbestos and pointed out that the risks were not limited to ship repair workers,
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To summarise, by the early 1980s:
It was clear that the asbestos disease problem that has caused so much 
public concern could be traced, in part, to the use of asbestos aboard ships. 
Contributing to this problem was its massive use during World War II and 
immediately thereafter.
That first impressions of the problem suggested that only those workers 
continuously involved with asbestos were at risk. In the dockyards these 
would have been mattress workers, laggers, joiners, sailmakers working 
with asbestos cloth, and asbestos sprayers and strippers. However, 
experience has shown, that first impressions can be false, with light and 
intermittent exposure, indirect occupational exposure and non-occupational 
exposure carrying serious risks.
It is obvious that ships are not factories and that shipbuilding and repair 
conditions, and their asbestos exposures, must differ from those in asbestos mills 
and factories. These conditions in Royal Naval Dockyards are highlighted in the 
following section.
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2.4 Royal Naval Dockyard Asbestosis Studies.
During the late 1960s and early 1970s a series of research projects were supported 
jointly by the Institute of Naval Medicine (MOD), Alverstoke, and the Medical 
Research Council (MRC) Pneumoconiosis Unit, Penarth. These projects have 
been termed the ‘Royal Naval Dockyard Asbestosis Studies’. They were set up 
to investigate and answer the medical and hygiene problems associated with 
asbestos use in Royal Naval Dockyards. This section will concentrate on these 
studies, and in particular the work of Harries at Devonport Dockyard.
Harries was to bring to the attention of the scientific community the need for 
better preventive measures in asbestos handling. In a series of reports he looked 
at dust concentrations and dust sampling techniques involved in asbestos 
application and removal.[91,108,109’110,n15 In this work, the highest fibre 
concentrations were found in bagging and sweeping up debris and in the removal 
of sprayed crocidolite asbestos. Fewer fibres were observed in the removal of 
asbestos section and board (table 2.3). All debris had to be carried out by hand, 
through narrow passageways and vertical ladders (figures 2.7 and 2.8).
TABLE 2.3: Ranges of dust concentrations (data from Devonport dockyard).
Process monitored f/cc
Storerooms 0.1 36
Application of amosite sections 9 40
Application of asbestos cloth 0.05 - 0.26
Removal of amosite sections 29 1040
Removal of sprayed asbestos 112 1906
Removal of asbestos acoustic board 48 683
Bagging asbestos debris 106 3815
As mentioned in the last section, the high value found for bagging waste is 
approximately 20,000 times the current UK limit for amosite and crocidolite 
exposure. It should also be borne in mind that these fibre counts are generally
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much higher then those stressed as immediate goals in 1967 by the government 
advisory panel on asbestos who suggested a maximum range of 1.9-7.7 f/cc.^39'
It was also seen that average dust levels were much higher in boiler rooms then 
in engine rooms (table 2.4). A boiler room would have more insulating material, 
but would also have at least two levels and it was common place for debris to fall 
3-4 metres to the deck creating high levels of dust in the general atmosphere.
TABLE 2.4: Dust concentrations during application and removal of asbestos 
lagging (f/cc).
General Atmosphere
Mean value 
Range
Breathing Zone
Mean Value 
Range
R e mova1:
Boiler rooms 171 97
0.04 - 1062 25 - 220
Engine rooms 88 91
0.16 - 3021 2 - 490
Application:
Boiler rooms 22.4 16.8
1.0 - 61 0.1 - 68
Engine rooms 2.1 7.3
0.1 - 14 0.04 - 40
Additionally, in the above work Harries noted that adequate preventive measures 
were not introduced into Naval Dockyards until 1967; before this it was common 
to see asbestos waste left scattered about ships for most of the refit period 
(sometimes up to 3 years). This clearly shows that the health risks associated with 
asbestos dust and waste were not fully appreciated. Lumley in 1971 emphasized 
this point in a survey of sprayed asbestos in dockyard buildings.[112] In 
storehouses, roof insulation was found to be unsealed and damaged. Crocidolite 
dust concentrations of 0.3-52.6 f/cc were obtained from these floors. Roof 
dampness and birds nesting in the roof spaces were seen as the main reasons for 
asbestos debris falling onto ledges, boxes and the floor (figure 2.9 illustrates the 
extent of this debris).
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Harries also made an evaluation of respirators and respirator usage, with the 
following observations: for respirators to be efficient they had to be of good fit, 
comfortable to wear, and the workers had to be encouraged to wear them. In fact, 
almost the opposite was true with little encouragement given and no attempt made 
to see that a respirator fitted a worker’s face. Consequently, it was common for 
respirators not to be worn completely, if at all, over a working shift. It was, 
therefore, practically impossible to measure respirator efficiency in reducing 
asbestos dust exposure. Added to this was Harries commentary that many of the 
respirators issued were unfortunately fitted with fume cartridges and not dust 
filters.11101 This situation was soon to change with enforced use of air-stream 
hoods and better quality dust respirators.
The measures then taken to reduce the asbestos hazards, are described in the 
above publications and by the Ministry of Defence in 1970.11131 They included 
a review of the use of asbestos, and where possible the introduction of substitute 
materials (i.e. man-made mineral fibres and plastics) and enforcement of a Code 
of Practice.
The Code of Practice consisted of the following safeguards:
1. To isolate asbestos work, and restrict entry to those properly 
protected.
2. To reduce the amount of dust created by asbestos work by 
improving work methods and the materials themselves.
3. To protect all workers whether they worked directly with asbestos 
or not.
4. To keep a register of all men directly employed on asbestos work.
5. To ensure that all Registered Asbestos Workers have regular 
medical supervision.
6. To provide protective clothing adequate for the degree of risk 
involved and to provide changing and washing facilities.
7. To carry out regular dust monitoring whenever asbestos is handled.
The medical supervision of ‘asbestos workers’, before implementation of the code 
of practice, was shown in the above work by Harries to apply only to sprayers and 
laggers, all others were unsupervised. The Navy policy, from 1949 onwards, was
confused with recommendations of monthly, six monthly and annual examinations, 
enforcement of which was uncertain. From 1965 laggers were given annual 
medical examinations. The following articles show how ineffective this protection 
was for this group of workers, sizeable proportions developing asbestosis.
Before moving on to the dockyard medical reports it should be noted that by the 
early 1970s the following had occurred:
Sprayed crocidolite asbestos was completely removed from Royal Navy 
ships in the 1960s. It was removed, not for health reasons, but when it 
was found to be increasing the top weight of warships.
All forms of amphibole asbestos were prohibited from use after 1968. 
Only chrysotile asbestos and man-made mineral fibres were used from then 
on.
A detailed study of the clinical and radiological changes occurring in men exposed 
to asbestos at Devonport was reported on by Harries in 1971.[1101 This supported, 
and was founded on, the work of Sheers and Templeton in 1966, which was 
further continued by Harries et al in 1972 to cover Portsmouth, Chatham and 
Rosyth.( 79,1141 Here the prevalence of radiographic asbestos-related
abnormalities was related to both dockyard occupation and duration of exposure 
(table 2.5 shows prevalence by dockyard). No association was found between 
smoking habits and the incidence of parenchymal or pleural disease due to 
asbestos. Pleural abnormalities were reported 10 times more frequently than 
paranchymal disease. However, concern was expressed over the uncertainty of 
the prognosis in men with pleural abnormalities. At Devonport 37 men developed 
pleural mesothelioma and 128 asbestosis cases were reported since 1965.
A further component of Harries initial study was a proportional mortality 
analysis.[ 1101 In this analysis, which compared male Devonport dockyard workers 
with a control group of other Plymouth males, it was observed that lung cancer 
had only a slightly raised mortality rate that was not statistically different from that 
in the general public.
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TABLE 2.5: Prevalence of radiographic asbestos abnormalities (%) in 10% 
random sample.
Dockyard No. Examined No. with 
abnormality
Prevalence
Devonport 1414 63 4.5
Portsmouth 1017 32 3.1
Chatham 765 25 3.3
Rosyth 660 12 1.8
All yards 3856 132 3.4
The randomly selected 10% samples of the population at Devonport, chosen by 
Sheers and Templeton, at Portsmouth, Chatham and Rosyth, chosen by a team of 
investigators (including Sheers and Harries) formed the baseline data for future 
‘Royal Naval Dockyard Asbestosis Studies’ reported on in the late 1970s and early 
1980s. In these studies 10% samples and the complete workforce of the 
dockyards were scrutinised for radiographic abnormalities, morbidity and 
mortality.
Harries et al in 1975, in the first Royal Naval report on the asbestosis studies, 
summarised asbestos research in naval dockyards and reported on morbidity at 
Devonport, Chatham, Portsmouth and Rosyth.11151 Here the entire workforce 
of the four yards was examined radiographically, using mobile radiographic units. 
The results confirmed those of the 10% sample and gave an overall prevalence of 
radiographic asbestos abnormalities of 4.6% (table 2.6). In both tables 2.5 and
2.6 the term radiographic abnormalities is given to these workers with x-ray 
evidence of pleural thickening, pleural calcification, or either suspected or definite 
pulmonary fibrosis. Tuberculosis (active and clinically inactive) was not included 
in this definition. The higher prevalence seen at Devonport and Portsmouth is 
explained by the larger number of major warship refits undertaken at those 
dockyards. For pleural thickening the risk in smokers was shown to be 
approximately 25% greater than that for nonsmokers.
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TABLE 2.6: Prevalence of radiographic asbestos abnormalities (%) in entire 
workforce.
Dockyard No. Examined No. with 
abnormality
Prevalence
Devonport 10165 468 4 . 6
Portsmouth 6779 386 5 . 7j  Chatham 4820 179 3 . 7
Rosyth 2803 101 3 . 6
All yards 24575 1134 4 . 6
Evidence of an occupational effect due to asbestos exposure was sought by Lumley 
in 1976 when comparing cancer registrations for Devonport dockyard workers 
with those for Plymouth men in the same age groups for 1960-69 161 The
overall death rate was similar in both groups. However, an excess of cancers of 
the respiratory tract was found in this period (confined to pleural tumours). 
Twenty-two cases of pleural mesothelioma were recorded in the dockyard 
compared to only 3 in other Plymouth males. A trend of increasing annual excess 
of stomach and gastrointestinal registrations was also observed in the dockyard 
group.
Harries and Lumley in 1977 presented a survey of Registered Asbestos Workers 
(RAWs) in the four dockyards.11171 In this survey 990 male RAWs were 
studied, these included laggers, sprayers, storemen and workers indirectly exposed 
to asbestos (i.e. boilermakers, shipwrights, electrical fitters, etc). It was found 
that radiographic, clinical and physiological abnormalities associated with exposure 
to asbestos only occurred in older men exposed before enforcement of the Code 
of Practice.
In a sample of 1200 men aged 50-59 years from all four dockyards, Rossiter and 
Harries in 1979 confirmed that smoking partly accounts for the increasing 
dockyard prevalence rates of radiographic, clinical and lung function
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abnormalities.^118^ However, the prevalence of pleural calcification, seen to be 
related to duration of asbestos exposure, was highest in nonsmokers. The most 
extensive disease was seen in laggers and sprayers employed before 1957.
Sheers, also in 1979, reported on a follow-up of his 1966 cohort.11191 It was 
shown that of 971 workers with normal radiographs in 1966, 96 (9.9%) had 
developed nonmalignant asbestos-related abnormalities by 1977. Thirty-eight 
deaths from mesothelioma had occurred during the study interval among men aged 
35 to 64 with 20 or more years of asbestos exposure.
The incidence of mesothelioma among workers at Devonport dockyard was further 
scrutinized in 1980 by Sheers and Cole.11201 In this work, asbestos exposure 
histories were ascertained for 96 dockyard mesothelioma cases; the cases were 
classified as continuously or intermittently exposed to asbestos. The latency 
period from first exposure averaged 41 years; the shortest latency was associated 
with continuous exposure. Mesothelioma incidence was found to be correlated 
with both time from first exposure and occupation.
A nine year follow-up of men at Devonport dockyard was presented in 
1980.11211 In this Rossiter et al showed that despite the almost complete 
removal from exposure to asbestos in 1968, radiographic parenchymal 
abnormalities increased in a group of 253 workers initially seen in 1966 and 
followed for the next 9 years. Progression of disease was greater for smokers 
than nonsmokers. Also in 1980 Rossiter and Coles undertook a mortality study 
in Devonport dockyard.11221 In this study highly elevated risks were observed 
for mesothelioma and pulmonary fibrosis, but no clear excess risk was present for 
lung cancer. As was mentioned in chapter 1 this was a very striking result, but 
not completely unexpected. The proportional mortality study of Harries in 1971 
had already shown that there could well be only a negligible lung cancer risk at 
Devonport dockyard.11101 These studies, and the questions arising from them, 
effectively form the foundation of this thesis.
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In another follow-up study, this time at Devonport and Portsmouth dockyards, 
McMillan et al in 1980 reported on the attack rates of pulmonary and pleural 
lesions due to asbestos dust.1123,1241 The overall prevalence of asbestos- 
related lesions was over 13% at both yards, the prevalence rate being higher for 
current and ex-smokers than for nonsmokers. McMillan and Rossiter continued 
this work at Devonport dockyard and reported in 1982 on the development of 
parenchymal fibrosis in men with pleural lesions.[125] Here they concluded that 
the lesions may not be merely "markers" of previous asbestos exposure but may 
be identifiers of future parenchymal fibrosis.
McMillan in further work, at the Medical Research Unit of Devonport Dockyard 
over 1979-84, looked at the health of dockyard welders in relation to other trades,
i.e. boilermakers, drillers, fitters, joiners, painters, plumbers and 
shipwrights.1126,127,128,129,1301131,1321
One of McMillan’s conclusions was that there was no evidence of an association 
between shipyard exposure to welding fumes and gases and an increased risk of 
mortality due to respiratory diseases and gastrointestinal cancers. The risk of 
asbestos-related disease, apart from mesothelioma, among the welders being 
accredited to the heavy asbestos exposure during shipyard welding. It was shown 
that less than 1% of welders developed parenchymal fibrosis but that 13% had 
nonmalignant pleural lesions.
Wagner et al in 1986 reported on 333 necropsies on workers from Devonport 
dockyard.[133J These had been collected from 1966 to 1982. An exposure 
rating based on each worker’s occupation and the number of years employed was 
formed. Severity of asbestosis correlated with exposure rating and fibre count. 
The fibre counts of crocidolite and amosite fibres found in lung sections increased 
with severity of asbestosis, the counts for chrysotile remained constant. 
Mesothelioma was seen to occur in those with minimal or slight asbestosis and low 
exposure rating, pulmonary carcinoma with moderate to severe asbestosis and high
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rating. It was concluded that amphibole lung content may be correlated with 
severity of asbestosis.
In summary by the 1980s it was seen that:
The prevalence of asbestos-related disease, particularly asbestosis and 
mesothelioma, was increasing in Royal Naval Dockyards.
Before the mid 1960s there was no suggestion of any type of 
pneumoconiosis occurring in these yards, due to the long latency of these 
diseases. This must have been the main reason why energetic preventive 
measures were not undertaken earlier.
By the 1980s sufficient time had elapsed for the effects of asbestos 
exposure to be seen in multiple diseases. This was aided by more intensive 
and improved medical investigations.
All of the studies in this section have shown that in Royal Naval Dockyards 
workers were exposed to asbestos, not only directly, but also by working in close 
proximity to other workers handling asbestos products. Before enforcement of the 
Code of Practice, those workers handling asbestos may well have used some form 
of respiratory protection and come under a limited medical supervision scheme, 
those working nearby were completely unprotected.
Since the 1980s the attention of the medical and scientific community has begun 
to focus more on the health effects of the asbestos replacement material, man­
made mineral fibres. However, certain controversies concerning asbestos 
exposure still remain. Namely, is chrysotile asbestos less carcinogenic than the 
amphiboles, is lung cancer really only a complication of asbestosis, and is there 
a threshold dose below which asbestos is non-carcinogenic? These questions will 
be considered in the following section. The removal of asbestos from buildings 
insulated with asbestos material and the public’s concern with possible 
environmental exposure will also be considered.
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2.5 Current Concerns and Controversies in Asbestos Related Disease.
This section will consider the asbestos health related issues, debated in 
contemporary medical and scientific literature. It will focus on the concepts of 
cancer thresholds, linear dose-response relationships, the carcinogenic potential of 
different asbestos fibre types and dimensions, and the issue of 
fibrogenicity/carcinogenicity - which one comes first? It will consider the pros 
and cons of each side of the present debate. Specifically, the following questions 
will be addressed:
1. Is lung cancer a complication of pulmonary fibrosis (asbestosis), or 
a risk for exposed individuals with or without asbestosis? This 
question has been posed in many ways by researchers and linked 
with question two below. Browne in 1986 asked the question "is 
asbestos or asbestosis the cause of the increased risk of lung cancer 
in asbestos workers?"1’34' McDonald, at the 1991 British 
Occupational Hygiene Society Annual Conference, more directly 
asked "does asbestos cause lung cancer in the absence of 
fibrosis?"'135'
2. Is there a threshold dose of asbestos exposure beneath which 
asbestos is non-carcinogenic, and is a linear dose-response 
relationship for lung cancer and mesothelioma realistic?
3. Is chrysotile asbestos less carcinogenic than the amphiboles? This 
question has sometimes been rephrased in the literature as "are the 
amphiboles alone responsible for asbestos disease risk" and termed 
the "amphibole hypothesis".'136,137' The current debate 
concerns the contamination of chrysotile asbestos with fibrous 
tremolite and whether this is the cause of an increased lung cancer 
risk in textile plants, and a high rate of mesotheliomas in asbestos 
miners and m illers.'138'
Consideration will also be given to secondary questions, which concern smoking 
as a co-factor, and how the strikingly different dose-response gradients of risk 
observed, in the assorted asbestos trades and industries (over many studies), can 
be interpreted.
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High exposures to asbestos are clearly hazardous. The public controversy today 
concerns risk at low doses, and how large that risk is. The question arising from 
this is whether high occupational risks can be extrapolated to low public risks (the 
form of the dose-response relationship clearly has great importance in this 
question). An associated question commonly asked is; are we increasing exposure 
to the general public by improperly removing asbestos from buildings that is best 
left in place? This point will also be considered.
2.5.1 Background to the Controversies.
The link between asbestosis and lung cancer bears directly on the relationship 
between the amount of exposure to asbestos and risk of lung cancer (i.e. the 
dose-response relationship). At the low doses of exposure (below 0.001 fibres per 
millilitre of air) that are a public health issue today, there are no data that directly 
address this point, however, several possibilities exist. If asbestosis develops first 
(and then sharply increases the risk of lung cancer), the dose-response 
relationships for lung cancer and asbestosis should be similar. Many scientists 
now believe that exposures above a certain threshold are needed for asbestosis to 
develop, with 25 f/ml years being the best judgement of lifetime occupational 
exposure, below which clinical manifestations cannot advance.t139,140) If 
lung cancer is directly connected to asbestosis, its risk should also be zero below 
some threshold of exposure. Conversely, if asbestos can cause lung cancer in the 
absence of asbestosis, an individual might incur some risk even at low levels of 
exposure.
The relationship between asbestos dose and carcinogenic risk is clearly important. 
A linear relationship between dose and risk suggests that if the dose is halved, the 
risk is halved. This also implies that some risk remains, even at very low levels 
of asbestos exposure. In a nonlinear relationship, the risk may fall off faster at 
low doses, perhaps exhibiting a threshold exposure below which the risk is zero. 
Consequently, a linear dose-response relationship would imply higher (more
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conservative) levels of cancer risk at lower doses than a threshold or other 
nonlinear (perhaps sigmoid) model. For this reason alone the linear dose-response 
model has been supported by scientists and regulatory agencies.t3,1411 In 1984 
the National Academy of Sciences concluded in a review document that although 
a linear dose-response assumption may not be always justified it should lead to an 
appropriate upper bound for risk assessments of asbestos.11421
Differences in lung cancer and mesothelioma risk have been shown with both fibre 
type and industrial process in numerous studies, and these studies have in turn 
been extensively rev iew ed.1143,144,145, 146,147,1481 From these
reviews, the overall influence of asbestos exposure on health is clearly very 
substantial. An indication of the extent of this influence is shown in table 2.7, 
which summarizes the results of the cohort studies considered by McDonald and 
McDonald in 1987.[146,1471
TABLE 2.7*. Excess mortality in cohorts exposed to asbestos.
Disease group Chrysoti le 
only
Amphiboles 
only
Chrysotile-
amphibole
mixtures
Pneumocon i os i s 83/4996 102/2008 254/6471
(taken from 21 studies) 1.7X 5.1* 3 .9*
Lung cancer 102/5827 137/2187 772/10882
(taken from 42 studies) 1.8* 6.3* 7. IX
Mesothelioma 12/5476 78/2187 422/10904
(taken from 40 studies) 0.2* 3.6* 3.9*
Total excess 3.6* 14.9* 1 4.9X
Each cell in this table shows the excess number of deaths for each disease group 
divided by the total number of deaths, with the proportional mortality expressed 
below. This meta-analysis shows that even without data on age, sex, smoking and
Adapted from: McDonald JC (1990) "Cancer risks due to asbestos and 
man-made fibres" Recent Results in Cancer Research 120:122-131.
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asbestos exposure intensity there is a consistent pattern of mortality across asbestos 
fibre grouping. The excess mortality of cohorts exposed to the amphiboles and 
chrysotile-amphibole mixtures appears similar but several times worse than those 
exposed to chrysotile alone. This large difference is partly explained by the rarity 
of mesothelioma in the chrysotile only cohorts.
2.5.2 Different Dose-Response Gradients.
As cited by McDonald in 1990, a more reliable indication of risk would be 
obtained from those studies that have attempted to estimate individual asbestos 
exposures in terms of intensity and duration.1149 ^ When considering only lung 
cancer, this reduced the number of cohorts from those seen in the meta-analysis 
to 11 industrial populations presented by McDonald and McDonald in 1987.(1471 
Table 2.8 and figure 2.10 are taken from this publication. The exposure estimates 
from these studies were, however, considered to be usually scanty and inadequate 
in quality and little more than informed guesses.1147,1491 There was also the 
associated problem of conversion from total respirable dust particles to fibre 
concentrations, considered problematic at best, with no one simple conversion 
factor.^1441
From the review of McDonald and McDonald, summarized by table 2.8 and figure 
2.10, two features are evident. The first is that the exposure-response 
relationships appear linear and, if expressed as relative risks, pass through the 
origin. The second feature is that the gradients vary greatly with industrial 
process and fibre type. The risk of lung cancer from chrysotile exposure is seen 
to be far greater in the manufacture of textiles than in cement or friction products 
manufacture. Similarly, a difference of equal magnitude is exhibited between 
miners and millers of chrysotile and miners and millers exposed to tremolite. 
There were too few female lung cancer cases (23 over three industrial cohorts) to 
allow any interpretation. Although the relationships for mesothelioma were not 
as well quantified, higher risks were also observed in the same type of industry 
(e.g. mining, textiles and cement plants) when exposure included amphibole fibres 
rather than chrysotile alone.11461
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FIGURE 2.10: Relative risk of lung cancer for different industrial
processes and fibre types.
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TABLE 2.8: Cohort studies with individual estimates of accumulated exposure 
for male workers.
Lung Increase in
cancer relative risk
Reference Place Fibre deaths risk p e r  
f/ml— y e a r
I Mininq and milling
McDonald et al, 1979 [150] Quebec Chrysotile 230 0.0004
Amandus et al, 1987 [151] Montana Tremol ite 20 0.006
McDonald et al, 1986 [152] Montana Tremol ite 0.01
Textiles
Dement et al, 1982 [153] South Carolina Chrysotile 26 0.01
McDonald et al, 1983 [154] South Carolina Chrysotile 59 0.01
McDonald et al, 1983 [155] Pennsylvania Mixed 53 0.0009
Peto et al, 1985 [156] Rochdale Mixed 93 0.01
Building materials
Henderson and Enterline, USA Mixed 63 0.001
1979 [157]
Hughes and Weill, Louisiana Mixed 51 0.004
1980 [158]
Finkelstein, 1984 [159] Ontario Mixed 26 not 1 i n e a r
Albin et al, 1984 [160] Sweden Mixed 16 not 1i n e a r
Friction products
Berry and Newhouse, UK Mixed 143 effectively zero
1983 [161]
McDonald et al, 1984 [162] Connecticut Chrysotile 73 effectively zero
For lung cancer the picture seen in figure 2.10 had lead Liddell et al earlier to 
conclude, for the Quebec study, that "there was a clear direct relationship, which 
may well be linear, between excess lung cancer mortality and total dust 
exposure "T1631 This conclusion was for workplace exposures with little thought 
given to possible future extrapolations to the very low levels of airborne asbestos 
fibre concentration experienced by the general public, or as Gaensler termed in 
1992 to the following "pandemic of mediagenic disease".11641
When considering asbestos friction product manufacture, table 2.8 highlights a 
remarkable finding. Although environmental measurements were similar in order 
of magnitude to those in the chrysotile textile plants, there was little if any 
convincing evidence of excess lung cancer in either the USA or UK cohorts. 
Also, the exposures classified as mixed for the study of Berry and Newhouse, in
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fact consisted entirely of chrysotile asbestos, except for one well-defined work 
area were crocidolite asbestos was used for two short periods before 1944.1161 1 
In a follow-up study at this factory Newhouse and Sullivan in 1989 reported on 
13 mesothelioma deaths, 11 of which occurred to workers known to have been 
exposed to crocidolite in this work area.11651 No excess risk was observed for 
lung cancer in the workers followed-up from 1941 to 1986, and it was reported 
that since 1950 the asbestos fibre concentrations in air were maintained at between 
0 .5  and 1.0 f/ml.
Nicholson in 1986 showed, in a report to the EPA, that risk estimates for lung 
cancer derived from 14 asbestos-exposed cohorts varied by approximately two 
orders of magnitude.11451 This in part could reflect statistical variation, differences 
in hazards associated with different fibre types and dimensions, inaccuracies in 
exposure estimates, and/or the use of inappropriate lung cancer rates in calculating 
standardized mortality ratios. Nonetheless, wide variation was seen in the 
fractional increased risk of lung cancer for a one year exposure to one fibre per 
millilitre in all fibre groups (see figure 2.11). This report substantially covered 
the same ground as the review of McDonald; 10 of the 14 studies were also 
reviewed by McDonald. The EPA report, however, also included a separate 
section on insulation workers exposed to amosite asbestos.
In figure 2.11, considering chrysotile exposure, the highest unit exposure risk was 
found among workers in a textile plant that used chrysotile whereas the lowest risk 
was observed among chrysotile mine and mill workers; matching the pattern 
observed in figure 2.10. It was suggested that these differences may be related 
to differences found in the fibre size distributions (fibres being longer and more 
curly in mining and milling), and that fibre length and diameter strongly influences 
the potential for fibres to produce lung cancer.1145,162,1661 A further 
unsubstantiated suggestion has been that the high lung cancer rates seen in 
American textile plants were related to the use of a co-carcinogen, mineral oil 
spray that was used in these plants over a 30 year period to reduce airborne dust 
levels.11671 A further observation was that tremolite asbestos contaminated the
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FIGURE 2.11: Values of KL, the fractional increase in lung cancer per f-y/ml of exposure. The open bar reflects the
estimated 95% confidence limits associated with measures of response. The line represents the uncertainties 
associated with measures of exposure.
chrysotile asbestos used in these plants, with the suggestion that this may be 
partially responsible for the high lung cancer risk.[167] Figure 2.11 shows 95% 
confidence limits for the unit exposure and indicates that there are highly 
significant differences between the different estimates. Nicholson pointed out "that 
differences between studies using the same fibre type far exceed those that exist 
between studies using different fibres".
The review of Nicholson, therefore, attempted a formal analysis of the variation 
seen between the different cohorts. It presented explicit confidence intervals for 
each estimate KL, the fractional increase in lung cancer per fibre-year/ml of 
exposure, allowing for statistical variation and assuming a two-fold uncertainty in 
exposure estimates. In some cohorts, adjustments were made for suspected biases 
(i.e. the use of inappropriate lung cancer rates). When excluding the significantly 
lower risks per unit exposure for chrysotile mining and milling this analysis gave 
a geometric mean for KL of 0.01, with an associated 95% confidence interval of 
0.004 to 0.027 (i.e. approximately a factor of 2.5). This was based on an analysis 
of variance of 11 separate estimates. Nicholson estimated that the factor would 
be approximately 10 (i.e. a 10-fold range of uncertainty) for any unstudied 
exposure circumstance, with the proviso that it may be greater.
The only study to have a significantly higher unit risk than 0.01, in the 11 studies 
used in its estimation, was the Ontario asbestos cement products factory reported 
on by Finkelstein; a study considered to have questionable exposure estimates.11451 
Nicholson observed that the data illustrated in figure 2.11 provides no evidence 
of a substantially different lung cancer unit exposure risk among different fibre 
types (after excluding studies of chrysotile miners and millers).
Data presented on the unit risk for mesothelioma (K„) closely parallelled that 
found for lung cancer; very similar ratios of the unit exposure risks of 
mesothelioma and lung cancer were observed irrespective of the type of exposure 
experienced (although the magnitude of these varied greatly across fibre grouping). 
Suggesting that similar factors affect the variability of mesothelioma risk as affect
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lung cancer risk. The best estimate for K„ was found to be 1.0 x 10 8, with a 20- 
fold range of uncertainty. Nicholson noted that peritoneal mesothelioma was 
largely associated with amphibole exposure, whereas pleural mesothelioma was 
associated with exposure to chrysotile and crocidolite. Doll and Peto in their 1985 
review concluded that peritoneal mesothelioma is rarely or never caused by 
chrysotile exposure, and that crocidolite and amosite are more dangerous (fibre 
types) than chrysotile when used in the same way.1,1141
From the 1991 review undertaken by the Health Effects Institute (HEI) the clearest 
difference between the effects of different fibre types is seen in the proportion of 
mesotheliomas that are present in the peritoneum.11481 Almost all cases among 
chrysotile workers (usually with some exposure to crocidolite or tremolite) or 
among crocidolite miners are pleural, whereas workers with some amosite 
exposure have suffered similar and sometimes higher risks of peritoneal than 
pleural mesothelioma. The only exception appears to be female gas mask workers 
exposed mainly to crocidolite, among whom several mesotheliomas were 
peritoneal.1168,169,1701 The possibility of some amosite exposure in these
workers was not discussed by the authors of these reports. The inference is that 
most peritoneal mesotheliomas are caused by amosite exposure. For pleural 
mesothelioma a direct comparison was undertaken of workers employed for similar 
durations to different forms of asbestos in varying asbestos industries. This 
comparison displayed evidence of a higher risk for amphiboles than for chrysotile, 
supporting the conclusion of Doll and Peto.
There are marked differences between cohorts in the ratio of excess lung cancer 
to pleural mesothelioma.11441 The lowest reported ratio based on substantial 
numbers of mesothelioma cases occurred in British Dockyard workers exposed to 
a mixture of asbestos types.11221 This was the study of Rossiter and Coles at 
Devonport Dockyard, reporting a high mesothelioma risk with no corresponding 
excess of lung cancer, which was the foundation of this thesis. The highest 
occurred at a South Carolina chrysotile textile plant were there was a marked 
excess of lung cancer and no pleural mesothelioma.1153,1541 These data have been
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almost universally accepted as demonstrating that amphiboles, particularly 
crocidolite, cause a disproportionate mesothelioma risk.
Both Doll and Peto, and Nicholson showed that among men the ratio of excess 
lung cancer to pleural mesothelioma is approximately three times greater for 
chrysotile than crocidolite, varying from at least four for chrysotile to between one 
and two for crocidolite, with substantially lower ratios for women. It should be 
noted, however, that such pooling of often inconsistent cohort data is of dubious 
value. In fact, it conceals the most extreme inconsistencies, most notably the 
marked excess of mesothelioma without any detectable excess of lung cancer 
observed among British Dockyard workers, and in the subgroup of friction product 
workers with crocidolite exposure studied by Newhouse.5122,161,1655
The opposite view is that nearly all mesotheliomas are caused by amphibole 
exposure and that chrysotile causes a negligible mesothelioma risk. The only 
strong evidence against the inference that mesothelioma is almost never caused by 
chrysotile alone is the observation of substantial numbers of cases among Quebec 
chrysotile miners and millers. It has, however, been suggested that these are 
related to the presence of fibrous tremolite in the raw material.5130,1715 
Tremolite was found to compose less than 1 % of the raw fibre but more than half 
of the long fibres (> 5/um) found in the lung tissue of workers at autopsy.51675 
Similarly, high levels of crocidolite were found in lung tissue from British textile 
workers who were exposed mainly to chrysotile but suffered a high incidence of 
mesothelioma.51725 The evidence that chrysotile rarely causes pleural 
mesothelioma is consequently consistent but not conclusive.
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2.5.3 Smoking as a co-factor.
Any discussion of dose-response relationships for asbestos and cancer is 
complicated by the fact that asbestos seems to exert its effect synergistically with 
cigarette smoke, that is, the cancer risk is more than that from asbestos exposure 
and smoking considered separately. The usual reference for this is the 1979 study 
of insulation workers undertaken by Hammond et al.[s8' Table 2.9 is adapted 
from that study. A further complication is that from the numerous asbestos studies 
appraised above most considered only male workers employed initially over the 
period 1940 - 1960, a time when male industrial workers were known to be 
cigarette smokers. Therefore, the number of asbestos workers with lung cancer 
who had never smoked in these cohorts is small and their smoking histories very 
uncertain.
TABLE 2.9: Risks of lung cancer caused by asbestos exposure and smoking 
(multiplicative relationship).
Asbestos/smoking group Death
rate*
Mortality
difference
Mortality 
ratio
Predictive
equation
Nonsmoker, non asbestos exposed 11.3 0.0 1.00 1
Nonsmoker, asbestos exposed 58.4 47.1 5.17 5
Smoker, non asbestos exposed 122.6 111.3 10.85 11
Smoker, asbestos exposed 601.6 590.3 53.24 55
* rate p e r  100,000 person years
The third column of table 2.9 records the mortality ratios (i.e. the relative risks) 
of asbestos exposure with and without smoking. Based on this, Hammond et al 
suggested that the risks of asbestos and cigarette smoking combine in a 
multiplicative fashion. In fact the relative risks can be simplified to the following 
expression:
Relative Risk = (1 + a)(l + c )  = l +  a +  c + ac.
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Where a and c represent asbestos exposure and cigarette smoking and the term ac 
the synergistic effect between smoking and asbestos (a = 4, c = 10). Therefore, 
compared with a nonsmoker with no asbestos exposure, a smoker has a 11-fold 
higher risk for lung cancer, a nonsmoking asbestos worker has a 5-fold higher 
risk, and a smoker with asbestos exposure has a 55-fold higher risk. The results 
of this predictive equation agree remarkably well with the data (table 2.9). No 
other study has produced such a good fit to an equation like this that includes a 
multiplicative term. By contrast, McDonald in 1980 found something closer to an 
additive effect, in which the relative risk is close to the sum of risks from smoking 
and asbestos considered separately (table 2.10).[173'
TABLE 2.10: Risks of lung cancer caused by asbestos exposure and
smoking (additive relationship).
Smoking group Asbestos exposure
Little Moderate Heavy
Nonsmokers 1.0 2.0 6.9
Moderate smokers 6.3 7.5 12.8
Heavy smokers 11.8 13.3 25.0
Berry et al in 1985 pooled the results from 6 cohort studies (table 2.11) and 
expressed the relative asbestos effect (the ratio of the relative risk in nonsmokers 
to smokers) for each.11741 Except the study of Quebec miners and millers 
expected numbers of cases in smokers and nonsmokers were obtained from data 
outside the cohort database. For the three American studies this was obtained 
from samples matched for education and occupation from data collected by the 
American Cancer Society. For the remaining UK studies it was obtained from the 
results of Doll on lung cancer in British doctors.
From table 2.11 a multiplicative relationship between smoking and asbestos 
exposure is seen when the 95% confidence interval is significantly greater than 
one. Therefore, a multiplicative interaction is detected by this method only for
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which is directly cytotoxic, effectively absorbs hydrocarbons and this probably 
accounts for the higher (multiplicative) risk of lung cancer in individuals who have 
histories of asbestos and cigarette smoking.11,61 Amman additionally speculated 
that the lack of any relationship between cigarette smoking and malignant 
mesothelioma most likely reflects the earlier development and death from lung 
cancer in smokers, removing them from the risk pool for mesothelioma. An 
alternative, and more reasonable explanation, is that translocation may move 
fibres, but not the hydrocarbons.
When considering the probability of causation (i.e. the probability that asbestos 
caused any particular case of mesothelioma or lung cancer) the following appears 
to be the case for mesothelioma and lung cancer:
For mesothelioma, which is so rare that whenever it develops in an exposed 
individual the cause is usually assumed to be asbestos, asbestos appears to be the 
causative factor. Against this hypothesis, however, are cases of mesothelioma and 
lung cancer occurring in a Turkish village attributed to exposure to erionite, a 
locally obtained fibre used in building materials.[ 1771 Also against this argument 
are the cases of spontaneous mesothelioma occurring in the general public (i.e. the 
background level of mesothelioma). Pelnar in 1988 reviewed cases of non­
asbestos related mesothelioma; in this work spontaneously occurring mesothelioma 
included mesotheliomas of the tunica vaginalis testis, pericardium, anterior 
mediastinum, and myocardium.11701 It was also noted that the Salk polio 
vaccine, used by injection in the early 1960s, was contaminated with the SV40 
virus, a virus that was shown to cause mesothelioma in laboratory animals. It was 
pointed out by McDonald in 1985 that the background level of mesothelioma 
incidence (non-asbestos related) was approximately 2 cases per million, supporting 
the argument that mesothelioma is a rare disease despite the SV40 virus and the 
more spontaneous forms of mesothelioma.11791
Lung cancer is more difficult to attribute simply to asbestos because of the strong 
synergistic relationship between asbestos and smoking. Lung cancer in a
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nonsmoker would normally be attributed to asbestos when there is a history of 
asbestos exposure. With smokers the situation is not as clear. A nonsmoker 
exposed to asbestos is less at risk of lung cancer than a smoker with no exposure 
to asbestos. The inference from this is that smoking is the main causative factor, 
however, the combined risks of smoking and asbestos exposure far exceed those 
of smoking alone (by a factor of 5). Sound public health practice, whatever the 
form of the smoking/asbestos interaction, is accordingly to advise asbestos-exposed 
individuals not to smoke.
2.5.4 Fibre Dimensions.
Considering now the dimensions of the asbestos fibre, and the associated question 
of what are the critical fibre dimensions for carcinogenicity? The original fibre 
size, for regulatory purposes*, was set long before there was any consensus on 
biologically critical sizes and was based on the use of the membrane filter and 
light microscope methods. Each of the asbestos fibre types appears to possess its 
own size range in airborne and tissue evaluations with amosite fibres generally 
being the thickest in diameter followed by crocidolite and then chrysotile (the 
finest).[180,1811 Industrial hygienists currently classify fibres of asbestos as 
fibres that are greater than 5 microns (5/um) in length with a diameter greater than 
0.25/tm having an aspect ratio (length/diameter) greater than 3:1. This 
classification is often used to evaluate whether fibres are possibly carcinogenic 
(those longer than 5/vm are commonly taken as effective carcinogens). Generally, 
shorter fibres are considered less effective per fibre than long fibres (> 5^m) 
because the macrophages, the white blood cells, can envelop and remove these but 
not the long fibres.
* The original regulatory fibre size for asbestos fibres was: fibres with a 
minimum length of 5/tm, a diameter less than 3/im, and a length to 
diameter ratio greater than 3:1. The HSE regulatory document was MDHS 
39 issued in 1984, superseded in 1988 by MDHS 39/2, and finally 
superseded in 1990 by MDHS 39/3.ne2”1S3’
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Lippmann has comprehensively reviewed the available hygiene and medical data 
and concluded that fibres of different shapes and sizes cause different diseases, 
dependant on a certain critical minimum length that varies with 
disease.1185,1861 This length was stated to be 2/jm for asbestosis, 5/vm for
mesothelioma, and 10^m for lung cancer. For asbestosis and lung cancer, where 
the fibres must be retained in the lungs, fibres with a diameter less than 0.15//m 
appeared to pose no risk; for mesothelioma the hazard seemed linked to diameters 
finer than 0.5^/m. These conclusions on the biologically critical size of asbestos 
fibres support the regulatory guidelines that fibres longer than 5 fjm are effective 
carcinogens, however, they have not been conclusively established. McDonald et 
al in 1989 performed an autopsy study on 78 mesothelioma cases and matched 
controls.11871 In this study it was observed that long amphibole fibres (>  8/tm) 
differentiated effectively between cases and controls, whereas no difference was 
observed for chrysotile or short fibres. Suggesting here a minimum critical fibre 
length for mesothelioma of 8/vm.
It seems very probable that the proportion of airborne or tissue fibres of different 
size will vary with the origin and treatment of the asbestos, whether it is being 
mined or milled, and what it is being used to manufacture. As previously 
mentioned it is also probable that the physical attributes of the varying fibre types 
and their dimensions may control their carcinogenic potential.11'*4’1621 The debate 
being that the curlier chrysotile fibres found in mining and milling are less 
carcinogenic than the chrysotile fibres found in textile factories (these in turn being 
less carcinogenic than the sharper amphiboles), curlier fibres being more easily 
cleared from the upper bronchus. Timbrell showed that chrysotile fibres have a 
large effective diameter because of their curliness and so tend to be intercepted 
and deposited at the bifurcations of airways before they penetrate lung 
tissue.11881 Against this hypothesis are animal studies which show that 
chrysotile is more harmful than the amphiboles.1189,1901 The inference is that 
in humans, because of their longer life span, chrysotile fibres are removed from 
the lungs before disease can develop. Clearly fibres dissolve according to 
chronological time, but interactions with cells occur in relation to biological time,
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two very different time scales. Using life span as an index, human biological time 
runs approximately 30 times slower than that of a rat.
In all considerations of lung fibre dimension and burden the carcinogenic 
mechanism is important. If asbestos fibres are primary carcinogens, then retention 
is important. If they transport chemical carcinogens or activate some latent virus, 
then fibre retention may not be relevant. Whatever the case it may still be 
speculated that fibre type and dimension play a part in explaining the variable 
dose-response gradients seen across the numerous asbestos cohorts.
2.5.5 Low Level Environmental Exposure.
With respect to low level environmental asbestos exposure the 1991 review 
undertaken by the Health Effects Institute compiled the available American non­
litigation data, both published and unpublished.11481 From this the concentrations 
of asbestos fibres longer than 5/jm generally showed average concentrations in the 
order of 0.00001 f/ml for outdoor rural air (except near asbestos containing rock 
outcroppings) and average concentrations up to 10-fold higher in the outdoor air 
of urban environments. However, outdoor urban average concentrations above 
0.0001 f/ml were reported close to major roads (presumably due to vehicle 
braking) and near building demolitions. Data on ambient indoor levels of asbestos 
from direct transmission electron microscopy measurements were averaged from 
a number of buildings and building types (see figure 2.12). From 1,377 air 
samples (obtained from 197 buildings) the overall average concentrations (by 
building type) ranged from 0.00019 to 0.00051 f/ml. The overall recommendation 
from this was that asbestos containing materials in well-maintained buildings are 
unlikely to expose office workers and other general building occupants to toxic 
levels of asbestos fibre concentration, with the suggestion that it was better not to 
remove such material. This review felt that exposure to radon and environmental 
tobacco smoke was more of a health threat.
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Burdett et al in 1989 had undertaken a similar summary of UK buildings.11911 
The data supported the above recommendation, with indoor asbestos 
concentrations in the same range for well-maintained buildings (<0.001 f/ml). 
However, it was observed that after asbestos had been removed from buildings the 
average airborne concentrations increased for several months after removal. In 
certain cases the airborne levels were approximately 40 times higher than normal 
background levels 6 months after removal (figure 2.13). The authors concluded 
that the management (in place) of undamaged asbestos material may be preferable 
to large scale removal projects. In which case it would be unlikely that levels 
would exceed 0.0005 f/ml in normal occupancy. This view has wide support, 
with large scale removal seeming to give more risk from increased exposure. Peto 
addressing environmental health students in April 1994, theorised that among 
construction workers exposed to asbestos during removal operations the risk would 
eventually materialise in higher mesothelioma mortality rates.11921
These low level environmental exposure ranges should be placed in context, table 
2.12 attempts this. From this table typical average exposure ranges are illustrated 
for various settings with a crude ranking of exposure (taking building occupancy 
exposures as the baseline measure). From this we can see that past occupational 
exposures carried a very high risk when compared to present day general public 
exposures. The present day exposures being in the order of 4 x 10'6 smaller than 
dockyard and insulation exposures and 3 x 1(T5 less than those seen in textile 
factories, mining and milling, and asbestos cement manufacture. The data taken 
from Burdett et al support Peto’s theory showing that construction workers may 
well face an elevated risk of asbestos-related disease.11911 In Third World 
countries strip mining and milling of asbestos continues unabated (particularly in 
South America and India) with limited control measures and not surprisingly an 
increasing risk of asbestos-related disease matching that seen in industrialized 
countries 20 years ago.1193,1941
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T A B L E  2.12: Potential asbestos exposure ranges.
Occupational setting Average exposure Exposure
f/ml ranking
Building in normal occupation <0.001 1
: Construction workers (during asbestos 
removal, from figure 2.13)
0.29 290
Historical and potentially present 
! Third World exposures:
Asbestos miners and millers 4-50 27000
1 Textile workers 30 30000
j Asbestos cement workers 6-60 33000
Dockyard workers 10-500 255000
Insulation workers 50-500 275000
Peto in 1989 predicted that for an average fibre concentration of 0.001 f/ml the 
life long risk is of the order of 1 in 100,000 for 10 years building 
occupancy.11951 The number of individuals exposed to this level of airborne 
asbestos are unknown. However, Peto assumed that 1 in 5 of the population are 
exposed and concluded that this would imply approximately one death per year in 
the UK, 5 per year in the USA, or correspond to an average loss of expected life 
of about 15 minutes. For comparison, more than 100 deaths occur in the city of 
Leeds each year due to transport accidents.[ 1961 Peto’s calculation would imply 
that low level environmental asbestos exposure with concentrations less than 0.001 
f/ml presents a negligible public risk. It should be noted that asbestos 
concentrations in buildings, except during asbestos removal, are seldom much 
higher than concentrations in the air outside and that much of this small risk is 
related to the entry of outdoor fibres into the buildings with the ventilation air. 
The risk estimate would obviously increase when removal activity increases 
cumulative doses to both workers and occupants (and for individuals involved in 
other asbestos work). Peto concluded that the campaign to eliminate all asbestos 
on the grounds that ’one fibre can kill’, besides being a cost-benefit absurdity, 
may actually increase the public risk.
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2.5.6 The Principal Controversies.
In this section I will consider the arguments both for and against each of the 
principal asbestos controversies.
Controversy 1 concerns the possibly that lung cancer occurs in asbestos exposed 
workers as a complication of asbestos-induced fibrosis and not as a primary 
pathologic event. The issue could further be stated as whether fibrogenesis plays 
a role in carcinogenesis independent of exposure dose? The question addressed 
here, however, is:
Is lung cancer a complication of asbestosis, or a risk for exposed 
individuals with or without thus disease?
When considering disease prevention, if lung cancer risk was simply limited to 
those individuals with asbestosis then primary and secondary prevention of lung 
cancer could be obtained by both preventing sufficient exposure to induce fibrosis 
(assuming a threshold level exists for asbestosis) and then by focusing on those 
who have (or have a chance of developing) asbestosis. If pulmonary fibrosis is 
not the root cause of lung cancer, then the shape of the lung cancer dose-response 
relationship (whether linear or sigmoid, etc.) clearly becomes more significant and 
its implications applied to a larger population of exposed individuals both with and 
without non-malignant pulmonary disease.
The arguments that have been presented in support of lung cancer being a 
complication of asbestosis are as follows:
In laboratory inhalation experiments close relationships have been observed 
between the degree of asbestosis and the incidence of lung tumours in 
animals exposed to asbestos.[187,197,198,199] Also in laboratory 
experiments, asbestos fibres do not appear to be cancer initiators in any of 
the standard in vitro tests suggesting an alternate route for the observed in 
vivo carcinogenesis.^200' 201-202'203)
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In one of the largest and most detailed of the published asbestos cohort 
studies (the Quebec chrysotile miners and millers) most of the lung cancers 
occurred in a subgroup of individuals with prior radiographic evidence of 
asbestosis.12041 The study of Louisiana asbestos cement product 
workers, though much smaller, supports this finding.1158,2051 When 
reviewing the published mortality data from the remaining asbestos cohort 
studies (including those without exposure-dose data) a close association is 
observed between the relative risks of lung cancer and non-malignant 
respiratory disease.13,139,143,144,145,1481
Lung cancers in asbestos exposed workers are seen to frequently originate 
in the lower lobes; since the interstitial fibrosis of asbestosis normally 
begins in the lower lobes an aetiological connection is 
suggested.1134,206,207,208,209,2101 An excess of adenocarcinomas 
(the cell variant bearing the least relation to smoking) has also been 
observed in subjects with confirmed asbestosis, suggesting a potential 
mechanistic relationship.1207,208,2111 Certain other fibrotic lung diseases 
unrelated to asbestos (e.g. idiopathic pulmonary fibrosis) are associated 
with interstitial pneumonitis (the typical pathologic lesion in asbestosis) and 
are also associated with an increased risk of lung cancer.1212,213,2141 
This may imply that the lesion, not asbestos fibres, is the basis of 
succeeding lung cancers.
The arguments against lung cancer being a complication of asbestosis are as 
follows:
Asbestos fibres are not seen to have tumour-initiating properties in standard 
laboratory tests, but experimental animal models have demonstrated an in 
vitro tumour-promoting effect.1215,216,2171 These have included 
direct fibre acceleration of squamous metaplasia and intracellular fibre-bom 
delivery of polyaromatic hydrocarbons. These models would support a 
theoretical mechanism for asbestos carcinogenesis independent of any 
fibrogenic effect.
Lung cancers appear to occur in excess in heavily exposed individuals 
without clinical or pathologic evidence of asbestosis; giving no support to 
the argument that lung cancer is simply a complication of 
fibrosis.1172,2181
In the Quebec chrysotile miners and millers study a limited amount of the 
excess lung cancer mortality occurred in individuals without prior
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radiological evidence of asbestosis.12041 In the study of American friction 
products workers exposed to chrysotile asbestos (undertaken by the same 
research team as the Quebec project, viz. Professors JC McDonald and AD 
McDonald) it was further suggested that asbestos may be a complete 
carcinogen for mesothelial cells but only a promoter for bronchial 
cells.11621 A study of short term American amosite insulation workers also 
displayed a clear excess of lung cancer in workers with no demonstrable 
mortality from asbestosis.12191 In this study it was also concluded that 
asbestos acts as a classical tumour promoter (requiring earlier interaction 
with an initiator before malignant change can take place).
With the reported excess of adenocarcinomas in subjects with asbestosis, 
squamous cell tumours have also been observed in asbestos exposed 
workers.1218,2201 It is therefore likely that the phenomenon of 
adenocarcinoma being secondary to asbestosis would explain only a 
relatively small portion of the total cancer burden associated with asbestos 
exposure.
Finally, the multiplicative relationship between asbestos and tobacco is hard 
to equate with the view that fibrosis, which if at all, is only minimally 
related to smoking, is the primary pre-neoplastic lesion.
From these arguments the current data clearly supports the idea of a close 
biological relationship existing between these two respiratory tract toxicities of 
asbestos. However, the evidence that asbestosis is a required precursor to lung 
cancer remains at best unclear (there appears to be equally good evidence to both 
support and reject this hypothesis). It consequently remains plausible that asbestos 
could be carcinogenic without the interposition of asbestosis. From the available 
data a simple inference could be that where fibrogenic dust goes so goes 
carcinogenic dust. From this if it is assumed that the risk of asbestosis increases 
with increasing total dose of asbestos it cannot be firmly established whether an 
increase in lung cancer risk is due to cumulative asbestos exposure or the 
asbestosis itself. Because the effects of asbestos exposure combined with smoking 
increase the risk, any assessment of lung cancer risk must allow for smoking 
habits of the asbestos workers and comparisons. Until this is done the influence 
of asbestosis on the risk of developing lung cancer cannot be clearly established. 
Finally the question "Is it statistical?", meaning is this controversy really a
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statistical artefact (as it is very difficult to disentangle the causation from the 
association, when lung cancer has a number of causes) will also need to be 
addressed.
Controversy 2 concerns the likelihood of there being a threshold dose of asbestos 
below which there is no carcinogenic effect. This is a question of great 
importance, particularly to regulatory agencies. If a threshold can be shown for 
individuals occupationally exposed to asbestos then most of the anxieties about 
current environmental exposures are misplaced. Current environmental exposures 
are many orders of magnitude less then past occupational exposures and the 
anxieties are concerned with extrapolations of the linear dose-response model to 
these low levels, and the associated ’one fibre can kill’ theory. Conversely, if a 
threshold does not exist then this would be evidence against the idea that asbestosis 
is a prerequisite for the development of lung cancer (again assuming that 
asbestosis itself requires some minimal threshold dose). The question addressed 
here then is:
is there a threshold dose of asbestos exposure beneath which asbestos is 
non -carcinogenic, and is a linear dose-response relationship fo r  lung 
cancer and mesothelioma realistic?
The arguments that have been presented in support of a threshold for lung cancer 
are as follows:
If lung cancer is a complication of asbestosis (despite the arguments 
presented above), then the evidence that induction of asbestosis requires at 
least some minimum threshold dose of exposure would be prima facie 
evidence for a cancer threshold as well.
Reviewing the published asbestos studies that provided information on 
individual duration and intensity of exposure revealed evidence of a 
threshold of exposure below which the risk of lung cancer does not appear 
to be raised.[221^ Of the studies reviewed the study of UK friction 
product workers failed to show a significant excess at any measured dose,
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and several other studies in dockyards and asbestos cement factories 
showed no excess cancers despite other asbestos-related 
effects.[122,161' 165,222' 223,224,2251 One well-studied general 
population, non-mining residents of Quebec asbestos mining regions, has 
been shown to have higher than normal ambient exposures to asbestos but 
with no suggestion of an increased cancer risk.1100,226,2271 This would 
suggest a possible threshold effect in these settings.
A linear dose-response relationship is used by many regulatory agencies. 
Unfortunately, the inaccuracies in exposure estimates will tend to smooth 
curves and obscure thresholds, making a threshold response appear 
linear.t221,228]
Asbestos fibres do not appear to be tumour initiators.1200,201,202'2031 
Consequently there is no compelling theoretical reason for assuming 
absence of a threshold. In animal experiments spontaneous lung neoplasms 
periodically develop.1190,199,2081 The carcinogenic response to low dose 
exposures in the laboratory has accordingly not been positive, giving some 
support to the idea of a dose threshold.
It is difficult to believe that the physiological defence and repair 
mechanisms are without effect. Such mechanisms must surely prevent or 
reduce disease at low dust concentrations generating an effective threshold.
The arguments against a dose threshold are:
In the cohort mortality studies with dose information showing possible 
threshold levels, a linear dose-response has nevertheless also been 
demonstrated suggesting perhaps that methodological problems and not 
biological discontinuities are the reason for the apparent threshold 
observed. In particular, errors and bias in exposure assessment and in 
death certification may obscure excesses in the least exposed subjects.
In the 11 asbestos studies reviewed by McDonald and McDonald in 1987 
there is no clear evidence of a single potential threshold level.11471 Figure
2.14 illustrates the problem of detecting whether the 11 fitted dose-response 
lines show evidence of a threshold. Mortality ratios at zero exposure range 
from approximately 0.5 to 1.5, none passing through the origin. The 
explanation for this is presumably the incomparability of the reference 
populations.11491
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FIGURE 2.14: Lung Cancer SMR by exposure to asbestos fibres
(exposure-response relationships from 11 studies).
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In two asbestos cohorts with steep linear dose-response gradients (the 
chrysotile textile workers studied by Dement and the amosite insulation 
workers studied by Selikoff), workers with very low exposure (less than 5 
f/ml years in one, and less than 1 month exposure in the other) had an 
increased cancer risk.1153,219,2291 These studies and a further study of 
Australian crocidolite miners where asbestosis occurred at very low levels 
of exposure, therefore, produced evidence in favour of a linear no 
threshold model.1228,2301 This last point argues against the view that 
pulmonary fibrosis requires a minimal threshold dose. The inference being 
that even if asbestosis is a precursor for asbestos-induced lung cancer, there 
may still be no safe exposure threshold in terms of lung cancer risk.
There is growing evidence that asbestos is a direct tumour 
promoter.[21S,216,217] Linked with this is the knowledge that asbestos fibres 
can remain in the lung for many years. This provides a possible basis for 
concluding that a threshold is unlikely, as each fibre may confer a finite 
promotional effect. Animal inhalation studies have also shown a clear 
linear dose-response relationship for all levels of asbestos dose.[ 190,1981
The arguments for and against a dose threshold for cancer are each seen to lack 
conclusive evidence. For the argument against the threshold effect the strongest 
evidence is given by the studies of Dement and Selikoff were workers with low 
exposures, or limited duration of exposure, are seen to have a positive cancer risk. 
These analyses are weakened, however, by being standardized mortality studies 
in which the comparison with the general population could falsely elevate relative 
risks. Lamm et al in 1988 pointed out that finding an excess of lung cancer 
among workers with short durations of exposure and employment is common 
because of the effect of undocumented past exposures in previous 
employment.12311 This would also weaken the argument. The clearest evidence 
for a threshold is the absence of a significant excess of lung cancer at the lowest 
doses in the published occupational studies. Unfortunately, given the difficulties 
of past dose assessment and possible misclassification biases, it would be an error 
to over interpret these findings. On the other hand the biological argument for a 
threshold is fairly compelling but somewhat speculative.
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In all the published studies exposure is commonly expressed as the simple product 
of duration of employment and average dust concentration, the effect of these two 
components being used almost interchangeably. From these studies duration of 
employment is normally well documented but average dust concentrations are 
approximate at best. Considering this point the linear nature of the fitted dose- 
response lines might be more easily explained by duration of exposure with only 
a limited contribution from concentration.11471 This would be a problem since it 
is the relationship to dust concentration that is required to be generalised. 
McDonald in 1990 presented an analysis of 58 cases of lung cancer in the Quebec 
cohort with less than 2 years employment and of 98 controls matched for smoking 
habit, year of birth, date of employment, gross service and mining area.11491 No 
relationship (either linear or threshold) was seen in this analysis between dust 
concentration and lung cancer risk after allowing for duration of exposure (see 
table 2.13). This clearly underlines the problem in the linear dose-response 
models, is it duration of employment or average dust concentration that has a 
straight line effect? Only future studies will be able to definitely answer this 
point.
TABLE 2.13: Lung cancer in men employed less than 2 years.
Concentrat1on 
(f/ml)
Cases
(n)
Controls
(n)
Risk Ratio
<10 27 44 1
10-29 8 18 0.7
30-99 16 18 1.4
100+ 7 18 0.6
It is worth noting that where estimates of exposure are given, the threshold for 
increased risk of lung cancer appears to be somewhere between 25-100 f/ml 
years.12211 The lower end of this range matches the threshold for asbestosis 
suggested by the Ontario Royal Commission (25 f/ml years; equivalent to inhaling 
about 30,000 million fibres in a lifetime).131 A threshold for asbestos-related lung
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cancer at or above the threshold for asbestosis does not prove that the risks are 
linked. However, it is consistent with the hypothesis that an increased risk of lung 
cancer occurs in individuals with asbestosis. It should be noted that further work 
has been undertaken which implies that this threshold level for asbestosis may be 
too high. In an autopsy study of South African amphibole asbestos miners, 
significant proportions of the workforce exposed to fibre concentrations of 2 f/ml 
or less were seen to develop asbestosis. It was concluded that if there is an 
average fibre concentration to which workers can be exposed for prolonged 
periods without developing asbestosis it is certainly less than two fibres at the 
working placed 232 J
Regulatory agencies have taken a utilitarian view of the dose-response relationship. 
They have chosen to use a linear (non-threshold) model since the risk estimates 
from this would lead to the most conservative upper limits for risk assessment at 
low levels of asbestos exposure. Unfortunately, this view point has also caused 
much public anxiety when it resulted in the ’one asbestos fibre can kill’ theory. 
A theory difficult to apply under a threshold or sigmoid dose-response model. 
Which is the correct, or the best, dose-response model? Epidemiologically this 
question can only be answered by the long-term follow-up of those cohorts of 
workers who have had well-quantified but low-level exposures (e.g. present day 
construction workers involved in asbestos removal).
The arguments above also apply to mesothelioma, although here there are no data 
on the form of the relationship to cumulative dust exposure. Nonetheless these 
tumours because of their highly specific relationship to asbestos and their 
distinctive clinical features provide a measure of environmental impact. During 
the past two to three decades the patterns of mesothelioma incidence in North 
America and the United Kingdom have been very similar. Mortality attributed to 
mesothelioma has increased steeply in men but remained relatively unchanged in 
women. In the UK mortality rose from 4 per million in 1968 to 8 per million in 
1978 for men, whereas the incidence in females remained steady at 2 per 
million.[146J As was mentioned in section 2.5.3 McDonald has calculated that a
86
normal background level of mesothelioma incidence is approximately 2 per 
million.[,;9' The deduction from this is that the rate for males reflects an 
occupational effect, whereas that seen in females represents a more ambient 
environmental exposure. As there have certainly been some cases in women 
resulting from both occupational and domestic exposure, the absence of any 
increased risk over these years is striking. It suggests that cases due to very low 
level exposure are too few to be detectable. Supporting this is also the idea of a 
threshold for mesothelioma, although this has not been clearly proven.12331
Browne in 1987 when reviewing the ’one fibre’ theory summarised an address 
given by Professor M Kuschner at the WHO 1986 Copenhagen conference on 
man-made mineral fibres.12341 Professor Kuschner is reported to have 
concluded that it is his belief that fibres (presumably all mineral fibres) have a 
single pathological effect, not three separate pathologies, namely cancer of the 
lung, mesothelioma of the pleura and lung fibrosis. If this is the case then the 
threshold/non-threshold controversy for lung cancer also applies to mesothelioma. 
Whatever the case the arguments both for and against a dose threshold or a linear 
model for asbestos-related cancer are each seen to lack conclusive evidence.
Controversy 3 concerns the possibility that chrysotile asbestos is less potent as a 
lung carcinogen than amphibole asbestos. In a testimony to NIOSH, Lemen in 
1990 concluded that chrysotile is much more chemically and biologically reactive 
than amphibole fibres.12351 He further concluded that there is no compelling 
evidence at this time to justify different public health policies for different asbestos 
fibre types, with the scientific evidence suggesting that fibre shape and size are the 
most critical factors in the pathogenicity of asbestos. The arguments below will 
address this point, however, clearly the question of chrysotile’s potency is very 
important not only to regulatory agencies, and the many individuals exposed to it, 
but also to the asbestos mining and manufacturing interests.
Manufacturers would obviously benefit financially from an official report that said 
chrysotile is a less potent carcinogen than amosite or crocidolite and that
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mesothelioma does not occur among workers who used their chrysotile products. 
Equally the asbestos mining and manufacturing interests would very much like to 
prevent their remaining markets (in third world countries) from adopting policies 
to phase out the use of chrysotile.
However, the question addressed here will ignore the financial and political views 
and will consider the scientific issue:
Is chrysotile asbestos less carcinogenic than the amphiboles?
The background to this controversy has been thoroughly explored in sections 2.5.1 
and 2.5.2. The following arguments for and against chrysotile being less 
carcinogenic than the amphiboles are mainly derived from the material already 
given in section 2.5.2. The arguments in support of chrysotile being less potent 
are as follows:
The lower rates of lung cancer observed in heavily exposed chrysotile 
miners and millers, compared to those found in other industries with 
workers heavily exposed to either amphibole or a mixture of asbestos 
types. Suggesting pathogenic differences in fibre types, with chrysotile 
being the least pathogenic.
In asbestos cement manufacturer workers exposed to chrysotile alone have 
been observed to have no excess risk of lung cancer.1236•2371 in
friction product manufacture, an industry that has largely used only 
chrysotile asbestos, there is very little convincing evidence of excess lung 
cancer occurring.1161,162,1651 The conclusion from one UK study was that 
under good environmental conditions products containing chrysotile can be 
manufactured with no detectable excess mortality.11651
In animal studies chrysotile fibre clearance from the lung appears to be 
greater than that for amphibole fibres.11" 1 Human autopsy studies have 
shown that low levels of chrysotile dust are retained in the lungs (relative 
to apparent dose of exposure) when compared to amphibole 
levels.1167,2381 Suggesting that chrysotile has greater pulmonary 
clearance, which leads to a basis for its possible lower pathogenicity.
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The accumulated evidence favours chrysotile fibres being less potent as a 
cause of mesothelioma than the amphiboles.1122,153,154,2391 Suggesting 
a generally lower level of carcinogenicity for chrysotile fibres.
The arguments that have been presented against chrysotile being less carcinogenic 
are as follows:
The high rate of lung cancer seen among textile workers exposed 
exclusively to chrysotile.[ 153,1541 These studies have generated the steepest 
linear dose-response gradients. For mesothelioma the substantial number 
of cases observed in Quebec miners and millers, predominantly exposed to 
chrysotile, argues against chrysotile being generally less carcinogenic than 
the amphiboles.1139* 50,2041
Animal studies have shown that chrysotile is as potent as crocidolite in 
inducing mesothelioma after intrapleural injection and pulmonary 
neoplasms after inhalation exposure.12401 Animal studies have also 
shown a higher level of carcinogenicity for chrysotile at any given dose 
compared to amosite and crocidolite. I190-1" !
The analysis undertaken by Nicholson in 1986 clearly shows that certain chrysotile 
using industries (namely mining and milling) have significantly lower lung cancer 
risks than other asbestos industries.11451 Equally, from this work and that of 
McDonald and McDonald, and Doll and Peto, there is evidence to conclude that 
chrysotile alone has a limited mesothelioma producing potential, 1144,1461 The view 
of the Asbestos Institute was put forward by Dunnigan in 1988, who stated that 
amphiboles are mainly responsible (presumably for lung cancer and 
mesothelioma), whereas chrysotile alone has little or no mesothelioma producing 
potential.12411 These commentaries are very similar but Dunnigan’s view 
appears to close the case. In fact, the contemporary literature suggests, but does 
not prove, that a contaminant of some chrysotile ores, tremolite, has caused the 
mesothelioma seen in asbestos miners and millers.1138,1671 A truer conclusion 
would be that processed chrysotile has not been shown alone to cause 
mesothelioma; animal studies have been of little assistance in resolving this 
question. As mentioned earlier in this chapter, the evidence that chrysotile rarely 
causes mesothelioma is consequently consistent but not conclusive. A similar
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conclusion could be drawn for lung cancer, with the qualification that high risks 
have often been observed in chrysotile textile workers. It has been suggested that 
the fibre size distributions found in this industry (the fibres are commonly shorter 
and sharper than the chrysotile fibres found in mining) strongly affect the fibres 
potential for producing lung cancer.1145,1661 A further possibility concerns 
tremolite contamination. The American textile factories were mainly supplied with 
Quebec asbestos, therefore, the same problem of tremolite contamination holds for 
the textile workers as for the miners and millers (but reasonably with different 
fibre dimensions).11671 In the chrysotile textile plants, a flotation process was used 
to remove the tremolite from the chrysotile before weaving the cloth. However, 
United States lawyers have failed to find any evidence that the cloth contained any 
tremolite.1242 ] So where did the tremolite go? Could the flotation process have 
liberated the tremolite to be inhaled? Unfortunately, there appears to be no past 
environmental exposure data from the textile plants which analysed fibre type in 
this work area.12421
In conclusion, from animal studies chrysotile fibres are seen to be extremely 
carcinogenic, more so than the amphiboles, but are also cleared very efficiency 
from the lungs. In human studies low levels of chrysotile dust are seen to be 
retained in the lungs and there is evidence that chrysotile fibres may have less 
carcinogenic potential than amphibole fibres. This produces a theory where the 
longer human life span allows chrysotile fibres to be removed from the lungs 
before carcinogenesis can fully develop. The paradox here is that chrysotile on 
simple biological grounds might be evaluated to be both more or less harmful than 
the amphiboles. The conservative and most sensible view in these circumstances 
would be to support Lemen’s view and conclude that it is to soon to define a 
specific differential fibre factor, although the evidence is building up in favour of 
chrysotile being less carcinogenic.
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2 .5.7  Sum m ary.
There is clear agreement medically, scientifically and epidemiologically that 
exposure to asbestos can cause asbestosis, lung cancer and mesothelioma. 
However, wide disagreement exists in the medical and scientific literature on the 
shape of the dose-response curve (particularly at low levels of exposure), on the 
biologically relevant measure of dose, and on the relationship between 
carcinogenic potential and the fibrogenic properties of asbestos fibres. The 
inadequacies of historic exposure estimates, the use of inappropriate rates in 
calculating standardized mortality ratios, the effect of statistical variation, and the 
differential effect of variable fibre types (and other contaminants) may all have 
played a role in obscuring both the shape of the dose-response curve, the effect 
of a threshold, and the potency of chrysotile asbestos. These factors are likely 
also to partially explain the distinct dose-response gradients of lung cancer risk 
seen in the assorted asbestos trades and industries.
A WHO consultation meeting was held in 1992 to address the current debate on 
the interpretation and relevance to humans of data derived from various animal 
models to assess fibre carcinogenicity.[243] The meeting concentrated on man­
made fibres nonetheless the conclusions could be applied to all mineral fibres. 
From this meeting it was felt that to compare risks extrapolated from animal 
models, the full specifications of the fibrous materials used in the model needs to 
be allowed for. Comparisons on a simple fibre number basis were considered 
misleading because of the different size distributions of the fibres and the 
uncertainty about the fraction responsible for biological activity. It was also felt 
that comparisons of exposure-dose-response relationships should be made using a 
range of dose parameters until the most appropriate ones are defined. It is clear 
that these conclusions also hold for asbestos fibres and would help in answering 
the current asbestos controversies. It is equally clear that for asbestos a large 
amount of animal data has accumulated with results that are at odds with the 
human data from cohort studies. Possibly the answer is for further cohort 
investigations that include a full mineralogic analysis, as well as detailed
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information on the full distribution of fibre sizes occurring to the exposed 
population. This research is needed both at very low levels of asbestos exposure 
and also potentially at very high levels of airborne fibre concentration to confirm 
either a linear relationship, a sigmoid relationship (which is biologically plausible 
and consistent with the available data), or a threshold effect. To date it is 
conceivable that the linear model for lung cancer risk is valid only over a middle 
range of asbestos exposures, which probably cannot be applied to the current 
ambient environmental levels.
To conclude this review, the specific diseases primarily associated with dockyard 
asbestos exposure have been shown to be asbestosis and mesothelioma. There is 
however only limited evidence that lung cancer is associated with this form of 
exposure. This evidence comes mostly from studies outside of the naval 
dockyards. For example, from Belfast and Barrow-in-Furness shipyards, from 
American insulation workers, and from studies of Coastal North America. As 
mentioned in section 1.4 the lack of a statistically significant excess of lung cancer 
cases in naval dockyard workers may well be a statistical artefact or it may 
suggest that the asbestos exposure patterns somehow did not allow lung cancer to 
develop, but could induce asbestosis and mesothelioma. The following chapters 
will consider this point.
For all asbestos-related diseases the essential feature in prevention is the strict use 
and control of all materials containing asbestos. This statement holds for both past 
dockyard occupational exposures and the public environmental exposures causing 
concern today. However, in the shipbuilding and repair industry the damage has 
already been done, with the past uncontrolled use and removal of vast quantities 
of asbestos containing material. Ramazzini in his Treatise on the Diseases of the 
Tradesmen urged his fellow physicians to care for the well-being of workers and 
to "see to it that, so far as possible, they should exercise their callings without 
harm".12441 This credo was written nearly 280 years ago. In this work 
Ramazzini also recognized the need for dust control and ventilation long before 
the invention of industrial exhaust machines. If society had adopted Ramazzini’s 
credo at the start of the industrial revolution the shipbuilding asbestos problem 
might have been avoided.
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C h a p te r 3: M A T E R IA L S  A N D  M E T H O D S .
3.1 MATERIALS.
3.1.1 Introduction.
Medical surveys were carried out at each of the four Royal Naval Dockyards: 
Devonport, Chatham, Portsmouth and Rosyth over the period 1972-1973. These 
were morbidity surveys and commenced on the following dates: for Devonport 1st 
March 1972, for Chatham 4th September 1972, for Portsmouth 5th March 1973, 
and for Rosyth 1st August 1973. These surveys form the baseline data of this 
dissertation and their inception dates are taken as the enumeration dates of this 
work. In this study the workers enumerated at each dockyard are followed for 
exactly 17 years. Consequently, the follow-up ended on the following dates for 
each dockyard: for Devonport 28th February 1989, for Chatham 3rd September 
1989, for Portsmouth 4th March 1990, and for Rosyth 31st July 1990.
The study population in these morbidity surveys included all male employees, and 
female industrial employees on the dockyard payroll on these dates who had been 
employed for at least six months. Each worker was asked to complete and return 
a health questionnaire and to attend for a chest radiograph (small 100mm chest x- 
rays were used). Non-responders were identified and reissued with questionnaires 
and invited to attend once again for a radiograph. A further recall procedure was 
used for subjects with radiographs showing possible asbestos related abnormalities. 
These workers were given a more detailed questionnaire and a full size chest 
radiograph was taken.
Definition of the study population at each dockyard occurred approximately one 
month before the issue of questionnaires, and approximately three months before 
the radiographic screening. It is possible that the delay between the definition of 
the population and the start of these cross-sectional studies may have affected the
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TABLE 3.1: Response Rates’.
Dockyard Survey
Population
Either
X-ray
Responders
Either
Questionnaire
Responders
X-ray and 
Q u e s t  i onna i re
Absolute
Non-
Responders
Devonport:
In-yard males 13185 11107 (84X) 11568 (88Z) 10289 (78*) 798 ( 6*)
Outstation males 1079 782 (72*) 762 (71X) 647 (60*) 182 (17X)
Female workers - * - * -
Total 14264 11889 (83*) 12330 (86*) 10936 (77*) 980 ( 7X)
Chatham:
In-yard males 6694 5205 (78*) 4465 (67X) 4004 (60*) 1028 (15X)
Outstation males - - - - -
Female workers 434 270 (62*) 200 (46*) 166 (38*) 130 ( 30*)
Total 7128 5475 (77X) 4665 (65*) 4170 (58*) 1158 (16*)
Portsmouth:
In-yard males 10255 7877 (77*) 6904 (67*) 6122 (58*) 1597 (16*)
Outstation males 1256 466 (37*) 444 (35*) 246 (20*) 592 (47*)
Female workers 35 27 (77*) 4 (11*) 4 (11*) 8 (23X)
Total 11546 8370 (72*) 7352 (64*) 6372 (55*) 2197 (19X)
Rosyth:
In-yard males 6580 4782 (73*) 3420 ( 52*) 2925 (44*) 1303 (20*)
Outstation males 496 209 (42*) 187 (38*) 124 (25*) 224 (45*)
Female workers 261 157 (60*) 105 (40*) 85 (32*) 84 (32*)
Total 7337 5148 (70*) 3712 (51*) 3134 (43*) 1611 (22*)
All Dockyards:
In-yard males 36714 28971 (79X) 26357 (72*) 2 3 3 4 0  (64*) 4726 (13*)
Outstation males 2831 1457 (51*) 1393 (49X) 1017 (36*) 998 (35*)
Female workers 730 454 (62*) 309 (42*) 255 (35*) 222 (30*)
Grand Total 40275 30882 (77X) 28059 (79*) 2 4 6 1 2  (61*) 5946 (IS*)
This table is reproduced from: Harries PG, Rossiter CE, Coles RM (1976) 
"Royal Naval Dockyards Asbestosis Research Project, Report No. 1, December 
1975" Institute of Naval Medicine, CRWP Report 1/76, Gosport.
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response rates (see section 3.1.7). The rates are given in table 3.1. The non­
response rate varied from 7% at Devonport to 22% at Rosyth.
3.1.2 Basic Data.
In this work the data obtained from the questionnaire responses and chest 
radiographs have been combined with payroll/employment information and death 
certificate information to form the basic dataset for each dockyard. The format of 
this data is given in table A l.l. Briefly, the data consists of the following: a 
unique identifier, formed using the individuals national insurance number and the 
first three letters of the surname, the date of birth, year of employment, 
occupational code, medical history, cause and date of death. Smoking habits were 
determined from the questionnaire responses of the workforce. Section 3.1.7 
discusses the practical problems experienced in the creation of each dataset.
The initial characteristics of the morbidity data, i.e. prevalence rates of respiratory 
illness, etc., have been described in detail elsewhere by Harries et al.[11
3.1.3 Questionnaires.
The questionnaires used in the morbidity surveys were based on the Medical 
Research Council (MRC) Questionnaire on Respiratory Symptoms (1966). 
Questions included details of personal medical history, smoking history and 
employment history. Those workers who were recalled for full size x-ray were 
given a more detailed doctor-administered questionnaire. Copies of the health 
questionnaires are given in Appendix 1.
The doctor administered (‘controlled’) questionnaire more closely followed the 
format of the MRC questionnaire, asking detailed questions on past illnesses, 
cough, phlegm and breathlessness, and included a section on physiological tests. 
When responses were available to both questionnaires, those from the ‘controlled’ 
questionnaire were used in preference to those from the self-administered
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questionnaire. This was seen to give little if any resulting bias for the majority of 
the questionnaire derived variables, except possibly in the case of the question 
concerning breathlessness with had the lowest calculated sensitivity of test. In table
3.2 the questions concerning cough, breathlessness and smoking history have been 
used for illustrative purposes to show the level of agreement between the responses 
to the controlled and free questionnaire. The responses shown in this table are for 
those workers with both self-administered and controlled questionnaires (i.e. 4,762 
workers across all 4 dockyards). When taking the doctor controlled result as the 
’gold standard’ the diagnostic sensitivities and specificities were seen to be high for 
symptoms of cough and smoking habit; exceptionally so for cough (a perfectly valid 
diagnostic test would have a sensitivity and specificity both equal to 100%). For 
smoking habit, ex-smokers and those with unknown habit where included in the 
smoking group. For breathlessness it could be speculated that the sensitivity was 
reduced simply because it is very difficult for the workers to accurately define their 
own breathlessness (even given reasonable guidelines, see question 14 from the 
self-administered questionnaire in appendix 1).
TABLE 3.2: Questionnaire responses.
Control led questionnaire Sensitivity Specificity
C o u g h
Yes No Total
Yes 937 75 1012 95. 52 98.0Z
No 44 3706 3 750
Total 981 3781 4 7 6 2
Breath 1 essness
Sei f-administered
quest i onna i re Yes No Total
Yes 327 346 6 73 68. 5X 91.9%
No 150 3939 4089
Total 477 4285 4762
S moking
Yes No Total
Yes 963 17 980 89. 3X 99. 5%
No 115 3667 3782
Total 1078 3684 4762
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Table 3.3 shows the type of questionnaire and x-ray film used by dockyard. The 
slight differences seen in tables 3.1 and 3.3 are due to record duplication and some 
cases of prior enumeration at another dockyard. The difference in take-up rates of 
large film (400mm) x-ray and controlled questionnaire seen in table 3.3 are 
indicative of technical and equipment problems in the radiographic machinery and 
not abnormalities.111 This was particularly the case at Rosyth with approximately 
19% of the workforce recalled for controlled questionnaires, but 49% receiving 
large film x-rays. Overall, just under 9% of the dockyard population (from all four 
yards) appear to have received large film x-rays due to equipment failure of the 
100mm (small film) mobile x-ray unit.
TABLE 3.3: Type of x-ray and questionnaire (male workers).
Dockyard X
Small Film 
only
-ray
Large Film
Quest1o n n a 1re
Self-completed Controlled 
only
Devonport 9554 2335 (19.6*) 10431 1899 (15.4*)
Chatham 4283 920 (17.7*) 3829 634 (14.2*)
Portsmouth 6135 2204 (26.4*) 5798 1548 (21.IX)
Rosyth 2543 2448 (49.0*) 2926 681 (18.9X)
All yards 22515 7907 (26.OX) 22984 4762 (17.2X)
From the medical history section of the questionnaires the following questions will 
be considered in this study. Do you usually cough during the day or night at 
work? Do you usually bring up any phlegm from your chest first thing in the 
morning in winter? Do you get short of breath when walking with people of your 
own age on level ground? These questions are associated with the known 
symptoms of asbestos related respiratory illness: cough and breathlessness. The 
following two linked questions will be considered for chest-illness. During the past 
three years have you had any chest illness which has kept you from your usual 
activities for as much as a week? Did you bring up more phlegm than usual in any 
of these illnesses? Table 3.4 shows the positive responses to these questions by 
dockyard.
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TABLE 3.4: Medical History Questions.
Dockyard Cough P h legm Breathlessness Chest-i 1 loess
Devonport
Chatham
Portsmouth
Rosyth
2523 (20.5%) 
784 (17.6%) 
1620 (22.1%) 
688 (19.1%)
2 8 3 6  (23. OX) 
8 3 6  (18.7*) 
1 6 3 8  (22.3X) 
7 8 2  (21.71)
1102 (8.9%) 
305 (6.8%) 
608 (8.3%) 
254 (7.0%)
1119 (9.IX) 
319 (7.IX) 
585 (8.OX) 
223 (6.2X)
All yards 5615 (20.2%) 6 0 9 2  (22.01) 2269 (8.2X) 2246 ( 8. IX)
Smoking habits were also discerned from the questionnaire responses and the 
groups shown in table 3.5 were identified. Only 0.9% of the returned 
questionnaires were without smoking history. If a worker had given up smoking 
for less than a month before completion of the questionnaire he was considered a 
smoker. Smokers were further subdivided by amount of tobacco smoked per day 
into the following groups: < 15 gms/day, 15-24 gms/day, and > 25 gms/days. 
The amount of tobacco was determined by calculating cigarette-gramme 
equivalents; 1 manufactured cigarette = 1 gm. The following scale was used to 
convert other smoking types.
1 oz tobacco in hand rolled cigarettes/week 
1 oz tobacco in pipes/week 
1 large cigar/day 
1 small cigar/day
= 4 gms/day 
= 4 gms/day 
= 5 gms/day 
= 2 gms/day
TABLE 3.5: Smoking Status.
Dockyard Non-smokers Ex-smokers Smokers Unknown
Devonport
Chatham
Portsmouth
Rosyth
2838 (23.OX) 
1081 (24.2X) 
1700 (23.IX) 
956 (26.5X)
2 4 8 8  ( 20.2X) 
8 7 9  (19.7X) 
1 6 3 5  ( 22.3X) 
6 7 5  (18.7X)
6842 ( 55. 5X) 
2444 (54.8X) 
3970 (54.OX) 
1973 ( 54. 7X)
162 (1.3X) 
59 (1.3X) 
41 (0.6X) 
3 (0.1X)
All yards 6575 (23.7X) 5 6 7 7  ( 20. SX) 15229 (54.9X) 265 (0.9X)
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3.1.4 Occupational History.
Employment histories were sought from the questionnaire responses, the workers 
being asked to list and code all jobs held since leaving school. A list of dockyard 
jobs was given with a list of non-dockyard jobs thought to be in someway 
associated with exposure to asbestos and dusty environments such as mines and 
quarries. Table 3.6 gives this list and the occupational code numbers. The 
workers chronologically listed their employment to the nearest year.
To enable comparison with the past work of Sheers and Templeton ^ 2' the 
occupational codes, of the workers last held dockyard trade, were used to form the 
following four occupational groups:
Group 1. 
Group 2.
Group 3. 
Group 4.
All registered asbestos workers (RAWs).
Electrical fitters, burners, welders, riveters, caulkers, drillers, 
shipfitters, plumbers, coppersmiths.
Shipwrights, engine fitters.
All dockyard trades not in groups 1, 2 and 3.
TABLE 3.6: Occupational code numbers.
Dockyard employment Other employment
01 Labourer or skilled labour afloat 30 Royal Navy engine or boiler
02 Lagger afloat room branch
! 03 Lagger ashore or in mattress shop 31 Royal Navy - other than code 30
04 Asbestos storeman 32 Civilian Shipyard
05 Asbestos sprayer or stripper 40 lagger or insulation worker
06 Sailmaker lagger w ith asbestos
07 Mason afloat 41 Any other job with asbestos
08 Welder afloat 42 Coal miner - underground
09 Boilermaker afloat 43 Coal miner - surface
10 Engine fitter afloat 44 Any ot h e r  mine work
11 Electrical fitter afloat 45 Foundry work
12 Painter afloat 46 Steelworks
13 Coppersmith afloat 47 Quarrying
14 Plumber afloat 48 Pottery
15 Joiner afloat 49 Cotton, Flax, Hemp Mill
16 Burner, Riveter, Caulker, Driller 50 Refractory brick works
17 Foundry worker 51 Masons yard
18 Shipfitter afloat 52 Any other dusty job
19 Shipwright afloat 53 Any j o b  exposed to irritant gas
20 A 1 1 other dockyard jobs not o r  chemical fumes
listed above 60 All other jobs not listed above
22 Any other dusty job 61 Unemployed
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Group 1, the registered asbestos workers, consists of laggers, sprayers, masons, 
sailmakers, painters and asbestos storemen. This group differs from the other 
three, in that, it forms the core of the register of dockyard asbestos workers. 
Registers were formed in the late 1960s of all workers in the trades listed under 
group 1. This was to enable those workers heavily exposed to asbestos to be 
monitored in the dockyards even if they subsequently stopped working with 
asbestos. All RAWs supplied questionnaires and x-rays.
Clearly, these four groups may give fairly ambiguous measures of asbestos 
exposure, they only allow for the last job held and therefore only that exposure. 
In practice workers exposed to asbestos and affected by asbestos disease can be 
found in all the groups. Promotion and job transfer would account for this. Table 
3.7 gives a breakdown of the occupational groups by dockyard. In all, only 3.0% 
of the questionnaire responses omitted any mention of employment history.
TABLE 3.7: Occupational Group by Dockyard.
Dockyard
1
Occupational Group 
2 3 4 Unknown
Devonport 591 (4.8X) 1392 (11.3*) 1315 (10.7X) 8781 (71.2X) 251 (2.0*)
Chatham 196 (4.4%) 461 (10.3%) 462 (10.4*) 3255 (72.9X) 89 (2.0*)
Portsmouth 304 (4.IX) 747 (10.2X) 707 ( 9.6*) 5292 (72.0*) 296 (4.0*)
Rosyth 102 (2.8X) 281 ( 7.8*) 264 ( 7.3%) 2751 (76.3X) 209 (5.8*)
All yards 1193 (4.3%) 1429 (10.4X) 2748 ( 9.9%) 20079 (72.4X) 845 (3.0*)
3.1.5 Asbestos Exposure Rating.
The crude classification of asbestos exposure by occupational groups can be 
improved upon. For instance, a grading of High, Medium and Low exposure may 
be made by job type and years in service. For this, occupational codes 02-06 and 
codes 40 and 41 could form the high group; codes 01, 07-16, 18, 19, 22, 30 and 
32 could than be considered as the medium group; the residue would then form the
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low group. This takes us from four to three groups! A better approach would be 
to code asbestos exposure for each dockyard trade and produce an exposure rating.
This rating would take the form:
Exposure rating = Exposure code * Years in that job.
So a rating could be found for each worker by selecting the occupational codes 
given in the questionnaire and multiplying the years spent in those jobs by a 
number taken as the exposure code for that particular trade. Table 3.8 gives 
exposure codes used for all dockyard occupations. The codes were chosen by 
qualified dockyard industrial hygienists and medical officers.131 These codes were 
in fact empirically chosen, without verification with fibre counts. However, the 
hygienists involved believed these to be the best relative estimates available for 
each dockyard trade.14,51 These numbers can therefore only be considered to 
give informed relative guesses Cguestimates’) of dust exposure; however, they go 
further towards a more accurate reflection of asbestos exposure than, for example, 
describing a worker as a lagger when in fact he has lagged for only one year and 
worked as a labourer ashore for thirty.
TABLE 3.8: Asbestos Exposure Codes.
Exposure Occupation
Code
1 Office work, messengers, outstatlon personnel.
2 All industrial work ashore, non-Industrial supervisory 
staff with very occasional exposure afloat.
5 Foundry workers.
10 Labourer or skilled labourer afloat, joiner, coppersmith, 
riveter, plumber, caulker, burner, driller, shipfitter, 
engine fitter, electrical fitter.
12 Boilermaker, shipwright, welder.
15 Painter, mason.
20 Sailmaker lagger, asbestos storeman.
i 25 Lagger afloat and ashore, asbestos sprayer or stripper.
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Table 3.9 gives the calculated exposure rating for each dockyard. From this it can 
be seen that 4.7% of the responders had an unknown rating. Most of the 
workforce had a rating of less than 100 (e.g. were employed less than 10 years as 
labourers, or less than 4 years as laggers). Only 610 workers had a rating over 
400 (e.g. were employed as laggers for over 16 years).
TABLE 3.9: Exposure rating by Dockyard.
Dockyard Exposure Rating
<100 100- 200- 300- 400+ Unknown
Devonport 7851 (63.7X) 1966 (15.9X) 1077 (8.7X) 559 (4.5X) 275 (2.2X) 602 (4.9X)
Chatham 2 9 6 5  ( 6 6 . « ) 649 (14.5X) 363 (8.IX) 211 (4.7X) 113 (2.5X) 162 (3.6X)
Portsmouth 4 4 8 2  (61 -OX) 1205 (16.4X) 696 (9.5X) 449 (6.IX) 183 (2.5X) 331 (4.5X)
Rosyth 2 6  8 7  ( 74. SX) 418 (11.6X) 169 (4.7X) 85 (2.4X) 39 (1.IX) 209 (5.8X)
All yards 1 7 9 8 5  (64.81) 4238 (15.3X) 2305 (8.3X) 1304 (4.7X) 610 (2.2X) 1304 (4.7X)
In addition to the calculated exposure rating, estimates of individual periods of 
asbestos exposure are available. These estimates were obtained from additional 
questions present only in the controlled questionnaire, and are illustrated in table 
3.10. From this table it can be seen that 3,792 (9.6%) of the workforce assessed 
their period of asbestos exposure, with only 778 (2.0%) reporting more than 30 
years of exposure. The form of exposure, whether to asbestos materials only or 
to asbestos dust and debris is unknown. However, 35,746 (90.4%) of the 
workforce did not supply these estimates. The percentages shown in table 3.10 are 
based on the 4,762 workers with controlled questionnaire information.
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TABLE 3.10: Period of asbestos exposure by dockyard.
Dockyard
< 10
Asbestos exposu 
10-
re period (yrs) 
20- 30 ♦
Devonport
Chatham
Portsmouth
Rosyth
514 (27.IX) 
173 (27.3%) 
350 ( 22. 61)  
166 (24.4X)
445 (23.4X) 
113 (17.8X) 
291 (18.8X) 
127 (18.6X)
369 (19.4X) 
112 (17.7%) 
273 (17.6X) 
81 (11.9%)
293 (15.4%) 
114 (18.0%) 
312 (20.1%) 
59 ( 8.7%)
All yards 1203 (25.3%) 976 (20.5X) 835 (17.5X) 778 (16.3%)
3.1.6
All workers were invited to attend for chest x-rays. Small 100mm films were 
used, each film being read by two members of a panel of four readers. All 
subjects with films showing possible asbestos related abnormalities or technical 
faults were recalled for further investigation with large (400mm) films. Table 3.3 
shows the x-ray type used.
The readers scored each film according to the classification given in table 3.11. 
Each reading was then allocated to one of the following x-ray groups.
X-rav score X-rav group
00 or 19 1 . Normal and technical faults.
01 or 03 2. Pleural thickening.
02 or 04 3. Pleural calcification.
05 or 06 4. Suspected or definite pulmonary fibrosis.
07 or 08 5. Active or clinically significant healed pulmonary 
tuberculosis. Not primary complex.
09 to 18 6. All other abnormalities.
The prevalence of x-ray abnormalities are calculated by counting l/z for each 
reading and allocating that reading to the x-ray group. Therefore, a film with two 
readings of 00 would score 1 in group 1, a film with readings 00 and 01 would
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score '/ 2  in groups 1 and 2 respectively. Table 3.12 gives these prevalences by 
dockyard. In this table the more sensitive large film reading has been used, when 
recorded, in place of the small film score, to obtain the most accurate measure of 
disease prevalence.
TABLE 3.11: Classification for Chest Radiographs.
Code Numbers Disease
00 Normal
Suspected Asbestos Abnormalities
01 Limited pleural thickening without calcification
02 Limited pleural thickening with calcification
03 Extensive pleural thickening without calcification
04 Extensive pleural thickening with calcification
05 Pulmonary fibrosis suspected
06 Pulmonary fibrosis definite
Other diseases
07 Tuberculosis active
08 Tuberculosis inactive
09 Malignant tumours
10 Other tumours including thyroid enlargement
i  11 Lymphadenopath i es
12 Cardiovascular disease
13 Pulmonary infections
14 Pleural effusions
15 Emphysema
! 16 Simple unilateral costophrenic occlusion
17 Bilateral occlusion of costophrenic angles
18 Other abnormalities
19 Technical faults, poor position etc.
TABLE 3.12: X-ray Abnormalities by Dockyard.
Dockyard
1 2
X-ray
3
group
4 5 6
Devonport 10171 (85.6X) 467 (3.9X) 147 (1.2X) 119 (1.0X) 364 (3.IX) 621 (5.2X)
Chatham 4468 (8S.9X) 177 (3.4X) 53 (1.0X) 41 (0.8X) 152 (2.9X) 312 (6.OX)
Portsmouth 7019 (84.2X) 414 (5.OX) 120 (1.4X) 60 (0.7X) 198 (2.4X) 528 (6.3X)
Rosyth 4263 (8S.4X) 221 (4.4X) 43 (0.9X) 36 (0.7X) 124 (2.SX) 304 (6.IX)
All ya r d s 25921 (85.2X) 1279 (4.2X) 363 (1.2X) 256
COd 838 (2.7X) 1765 (5.8X)
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It should be clearly noted that the x-ray reading scale used predated that of the full 
ILO U/C 1971 classification which is considered one of todays standard methods. 
The classification used here (and used previously in dockyard surveillance 
studies12,61) was employed over the period 1972-1973, the full ILO classification 
was however only published in 1972.171 The initial studies effectively started too 
early to implement this new ILO classification; the readings being undertaken 
quickly after the x-ray examination using the then well established naval reading 
scale.141 This researcher is unaware why the UICC/Cincinnati 1968 classification, 
or the short ILO U/C 1968 classification was not used. It could be speculated that 
this was for the same reason that the full ILO classification was not implemented; 
possibly due to established techniques and/or naval policy.
TABLE 3.13: Comparison of reading methods.
Larqe film readinq positive Overa11 
agreement
Agreement among 
films positive 
at standard 
level
ILO standard level of
abnormality
Yes No Total
Small film positive Yes 71 12 83 90. 2* 56.8%
ILO standard level No 54 537 591
of abnormality
Small film positive Yes 80 43 123 86.91 64.0*
screening reading No 45 506 551
Large film positive Yes 87 57 144 85.9* 69.6%
screen i ng read i ng No 38 492 530
Screening level of
abnormality
Yes No Total
Small film positive Yes 83 40 123 84.4% 57.6*
screening reading No 61 490 551
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Subsequently attempts were made to validate what was then considered to be a 
screening method (the method described in this work) with the 1LO 
classification.[8,9] This validation was undertaken by Sheers et al in 1978 on a 
group of 674 men randomly drawn from all four dockyards for which both x-ray 
film types (100mm and 400mm) were available. This study was designed to 
attempt to decide which type of film (small or large), which method of 
classification, and how many film readers should be employed to achieve a 
satisfactory level of surveillance for asbestos workers. The study consisted of a 
controlled trial by five readers using the full 1LO classification, which was 
compared to the earlier screening classification (undertaken by two readers as 
earlier documented). Table 3.13 shows the study sensitivities obtained.
In order to compare the overall results of the two reading methods (i.e. to calculate 
the sensitivities seen in table 3.13) a common reference standard was defined. The 
standard was set as the 1LO classification with large films. The standard level was 
defined as: width b or more for pleural thickening, grade 2 or more for pleural 
calcification and category 1/1 or more for small opacities. This standard was 
chosen to deliberately exclude the lowest categories of small opacities and the 
lowest grading of pleural thickening and calcification in order to avoid the 
problems caused by borderline abnormalities. Table 3.13 clearly demonstrates that 
there is a deficiency in the detection of abnormalities by small film, when large and 
small films are read to the same standard (giving sensitivities of only 56.8% and 
57.6%). This is despite the fact that the screening reading includes all grades of 
abnormality (codes 1 to 6 in table 3.11) found by either reader. When considering 
only the ILO classification for small films the sensitivity was seen to increase when 
lower categories and grades of abnormality were scored (and when the number of 
readers was reduced). The sensitivities obtained from this approach were: 72.8%, 
80.0% and 92.8% (table 4, Sheers et al[9]). These were for any level of 
abnormality found by 3 readers, by 2 readers, and by any reader, respectively. 
This approach resembles the situation in the screening classification (i.e. 2 readers 
with any level of abnormality), when all grades of abnormality recorded by any 
reader on the small films would lead to recall of the subject for re-examination on
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large film. Table 3.13 also highlights a problem with the screening readings. 
When these are compared to the standard reading a deficiency is seen in the results 
of the screening reading regardless of film size (sensitivities of 64.0% and 69.6%).
The conclusion of this comparison study was that the screening classification 
showed a deficiency, independent of film size, of at least 30% in the detection of 
asbestos-related radiographic abnormalities. It was further concluded that for 
adequate diagnostic sensitivity the ILO U/C classification, with a minimum of 3 
readers, appears to be essential (having a minimum sensitivity of approximately 
73%). This creates limitations in the use of the dockyard screening classification, 
even though this method had a sensitivity of 64% for small films and approximately 
70% for large films. A possibility would be to reread all the radiographs to the 
full ILO classification, a massive and costly operation. However, these dockyard 
radiographs are no longer available.151 Accordingly the classification used in this 
work, with its estimated sensitivity of approximately 70%, is that used in the 
original dockyard surveillance studies. A final recommendation of the comparison 
study, on the grounds of cost-effectiveness, was the use of small films in large- 
scales studies were the abnormality rate is expected to be low, with a recall 
procedure used for the more sensitive (and expensive) large films.
The analysis of Sheers et al emphasised that the small film, regardless of the 
classification method used, had a much poorer diagnostic sensitivity then the large 
(i.e. a sensitivity of only 57.6% when using the dockyard reading scale). For this 
reason the large film reading will be used in the following analysis when both 
readings are present.
Table 3.12 gives an overall prevalence of dockyard asbestos-related abnormalities 
of 6.2% (groups 2, 3 and 4 combined). This result is somewhat higher than the 
prevalence found by Harries in 1972 and 1975 (illustrated in tables 2.5 and 
2.6).[1'61 Here the prevalence of asbestos-related abnormalities was quoted as 
being 3.4% (in a 10% sample) and 4.6% (in the entire population). By comparing 
the total number of workers examined (24,575 in 1975 against 30,422 in this
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work), it is clear that some 5,847 workers were excluded in 1975. By inspection 
of table 3.1, after allowing for enumeration errors (e.g. female workers coded as 
male workers), it is probable that the 1975 analysis included only those workers 
with both paired x-ray and questionnaire results. When the calculation was 
repeated allowing for this the prevalence of 6.2% was reduced slightly to 5.8%. 
However, the 1975 Naval report also quoted prevalence rates of radiographic 
abnormalities for workers with either large or small films (excluding outstation 
workers). Table 3.14 shows these rates. By estimation from this table there 
appears to be a total prevalence of x-ray abnormalities of 6.0% (again combining 
groups 2, 3 and 4). A result in very close agreement with the value of 6.2% 
presented here (which includes outstation workers). It should be noted that if group 
3 (i.e. pleural calcification) is omitted in the calculation of prevalence the results 
here closely match those of the 1975 study (i.e. 5.0% verses 4.6%). Section 3.1.7 
will further consider issues of data integrity and possible associated study 
restrictions.
TABLE 3.14: Prevalence rates of x-ray abnormalities by Dockyard.
Dockyard Number of X-ray group
workers
x-rayed
1 2 3 4 5 6
Devonport 11107 86.21 3.6X 1.3X 1. IX 3. OX 4.8X
Chatham 5205 84.21 3.21 1.0X 0.6X 2.4X 8. 5X
Portsmouth 7877 85. 8X 4.9X 1.4X 0.6X 1.8X 5.5X
Rosyth 4782 85.41 3.9X 1.0X 0.7X 2.6X 6.5X
3.1.7 Studv/Data Restrictions.
The Ministry of Defence (Navy) had available in the early 1970s, information only 
on current occupation for its civilian employees. Records of earlier jobs within or 
outside the dockyards, and their start dates, were not available. In fact, the 
occupational codes used in the definition of the morbidity surveys were obtained 
from the dockyard payroll grade codes. This crude occupational code has many
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drawbacks, not the least of these being the absence of any measure of intensity of 
asbestos exposure (i.e. length and type of exposure). Fortunately, the health 
questionnaires were augmented with questions on workers occupations since 
starting employment. The occupational codes used in this work are, therefore, 
based on the questionnaire data.
The use of questionnaire responses to assess occupation, and also respiratory illness 
and smoking habits, confines us to the questionnaire responders. However, 
radiographic abnormalities, as seen on either type of film, form an important part 
of this work, so responders to x-ray examination must also be considered. Both 
considerations restrict the following analysis to those workers who were not 
‘absolute non-responders’ in the initial cross-sectional studies, that is, 
approximately 85% of the defined population. It should be noted that the use of 
100mm film rather than full sized films, and reading to the simplified x-ray 
classification, rather than to the 1LO U/C classification may lead to a possible 
underestimation of the prevalence rates of asbestos abnormalities. This would be 
the case even though men were recalled for large films when there was any 
suspicion of asbestos related abnormally on the small film. This would clearly 
weaken the value of the x-ray groups illustrated in table 3.12, the results of which 
have to be used with caution.
From table 3.1 it can be seen that male employees fall into two categories, ‘in 
yard’ and ‘outstation’ workers, 2831 (7.0%) males being outstation workers. 
Outstation workers were dockyard employees working, at that moment, in dockyard 
outstations (substations outside the main yard); in yard workers were those working 
at the main dockyard. The workforce would have been very mobile with much 
interchange and exchange between these categories. Consequently no
differentiation is made in this work between in yard and outstation workers.
It should be noted that in all dockyards, the outstation workers had the highest non­
responder rates. This is likely to be due to the survey entry policies, cross- 
sectional studies being limited to one time point, and the outstation workers being
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more geographically difficult to pursue after study definition. The time delay of 
up to two months between issue of questionnaires and the x-ray screening must 
have exacerbated this.
The 730 female employees, who formed less than 2% of the original surveys, were 
not followed-up in this study. Overall females had a high non-response rate 30% 
(from table 3.1). Therefore, only 508 ‘responded’ females were omitted due to this 
exclusion. This was felt to produce little resulting bias and eliminated the need for 
female expected mortality rates to be calculated.
As in most mortality studies undertaken in the United Kingdom, details of all 
workers were submitted to the Office of Population Censures and Surveys (OPCS) 
to be flagged so that subsequent mortality could be recorded and analysed. The 
follow-up rate for Rosyth was particularly poor as the records submitted to the 
OPCS had to be passed to the equivalent office in Scotland if the required Health 
Service Number was believed to be of Scottish origin. No attempt was made to 
resubmit details of those not flagged at the first search. Table 3.15 shows the trace 
rates for the four dockyards over the 17 year period.
TABLE 3.15: Number of male workers in the Dockyards.
Dockyard Total male 
workers
OPCS 
f 1agged
No. of deaths/ 
emigrations
No. o f  valid 
responders*
OPCS 
f 1agged
No. of deaths/ 
emigrations
Devonport 14264 97.5% 2744 (19.2%) 13283 (93.1%) 98.3% 2441 (18.4%)
Chatham 6691 96.8% 1484 (22.2%) 5663 (84.6%) 97.5% 1147 (20.3%)
Portsmouth 11507 93. 7* 2358 (20.5%) 9319 (81.0%) 95.7% 1794 (19.2%)
Rosyth 7076 69.8% 926 (13.1%) 5549 (78.4%) 77.0% 733 (13.2%)
All yards 39538 91.3% 7512 (19.0%) 33814 ( 85.5%) 94.0% 6115 (18.1%)
« No. of male workers with either x-ray or questionnaire information.
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Because of the low follow-up rate at Rosyth (69.8%). in comparison with the other 
dockyards, and because of the overall lower response rates seen in table 3.1, 
Rosyth has been removed from all subsequent analyses in this dissertation. This 
has the advantage of eliminating the need for Scottish mortality rates in the 
following analysis and the use of the ‘Scottish OPCS’. The number of Dockyards 
actively analysed was, therefore, restricted to the three British yards (Devonport, 
Chatham, and Portsmouth) with 28,265 male workers followed-up for a 17 year 
period. The overall proportion traced by OPCS in these yards was 97.3%.
It can be seen that the main data and study restriction in this investigation is its use 
and reliance on the morbidity surveys study base. These cross-sectional studies 
were not planned as the first phase of a longitudinal study and this has resulted in 
restrictions on the use of the cross-sectional dockyard population of 40,275 male 
and female workers. These restrictions, the exclusion of female workers and the 
initial surveys non-responders and finally the exclusion of Rosyth Dockyard reduce 
the study population to 28,265 male civilian workers. Of these 5,031 (18.0%) have 
died and 351 (1.2%) emigrated over the study period (table 3.16).
TABLE 3.16: Number of Deaths/Emigrations in the 3 British Dockyards.
Dockyard
Responders
No. of Deaths Emigrations 
workers
Non-responders
No. o f  Deaths Emigrations 
w o r k e r s
Devonport 13283 2292 (17.3%) 149 (1.1X) 9 8 1  295 (30. IX) 8  (0.8X)
Chatham 5663 1046 (18.5X) 101 (1.8X) 1 0 2 8  321 (31.2X) 16 (1.6X)
Portsmouth 9319 1693 (18.2X) 101 (1.IX) 2 1 8 8  540 (24.7X) 24 (1.1X)
All yards 28265 5031 (18. OX) 351 (1.2X) 4 1 9 7  1156 ( 2 7.5X) 48 (1.IX)
From table 3.16 we can see that the emigration rates for responders and non­
responders are almost identical. However, the same is not true for the rates of 
death, the non-responders appear to have a higher death rate. This may be a 
measure of self-selection bias, the unhealthy workers deselecting themselves from
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Because of the low follow-up rate at Rosyth (69.8%), in comparison with the other 
dockyards, and because of the overall lower response rates seen in table 3.1, 
Rosyth has been removed from all subsequent analyses in this dissertation. This 
has the advantage of eliminating the need for Scottish mortality rates in the 
following analysis and the use of the ‘Scottish OPCS’. The number of Dockyards 
actively analysed was, therefore, restricted to the three British yards (Devonport, 
Chatham, and Portsmouth) with 28,265 male workers followed-up for a 17 year 
period. The overall proportion traced by OPCS in these yards was 97.3%.
It can be seen that the main data and study restriction in this investigation is its use 
and reliance on the morbidity surveys study base. These cross-sectional studies 
were not planned as the first phase of a longitudinal study and this has resulted in 
restrictions on the use of the cross-sectional dockyard population of 40,275 male 
and female workers. These restrictions, the exclusion of female workers and the 
initial surveys non-responders and finally the exclusion of Rosyth Dockyard reduce 
the study population to 28,265 male civilian workers. Of these 5,031 (18.0%) have 
died and 351 (1.2%) emigrated over the study period (table 3.16).
TABLE 3.16: Number of Deaths/Emigrations in the 3 British Dockyards.
Dockyard
Responders
No. of Deaths Emigrations 
workers
Non-responders
No. of Deaths Emigrations 
workers
Devonport 13283 2 292 (17.3%) 149 <1.IX) 981 295 (30.1%) 8 (0.8%)
Chatham 5663 1046 (18.5%) 101 (1.8%) 1028 321 (31.2%) 16 (1.6%)
Portsmouth 9319 1693 (18.21) 101 (1.1%) 2188 540 (24.7%) 24 (1.1%)
All yards 28265 5031 (18.0%) 351 (1.2%) 4197 1156 (27.5%) 48 (1.1%)
From table 3.16 we can see that the emigration rates for responders and non­
responders are almost identical. However, the same is not true for the rates of 
death, the non-responders appear to have a higher death rate. This may be a 
measure of self-selection bias, the unhealthy workers deselecting themselves from
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the initial studies. Selection bias is considered in section 3.2.5 and the non­
responder death rates studied in chapter 4.
When considering the final dockyard datasets generated for this work, a limitation 
is apparent. Lung function information is missing. Physiological tests were 
undertaken and recorded in the initial surveys, however, these were not available 
to this researcher. These tests were only performed for those workers recalled for 
the large x-ray and ‘controlled’ questionnaire, and should have been assembled into 
the separate dockyard data files at that time. These files were received at the 
London School of Hygiene and Tropical Medicine (LSHTM), by myself in 1986, 
from the MRC Pneumoconiosis Unit, Penarth. They were initially compiled at the 
Medical Research Unit of Devonport Dockyard. The files consisted of 
computerised magnetic tapes, computer listings and a haphazard number of both 
free and controlled questionnaires. This with the death certificates, which were 
reported directly to LSHTM from 1986, comprised all the available ’raw’ dockyard 
data. Unfortunately the physiological data was missing. This omission is likely 
to have happened during the exchange of data across its many sites. The final 
LSHTM datasets created by myself therefore omitted all physiological data.
Unfortunately, a further problem existed with the raw data. The magnetic tapes 
holding the radiographical information were all found to be corrupted and 
unreadable. To remedy this entailed many visits to Penarth and Devon, where 
further computer listings (and coding sheets) were eventually obtained and the x-ray 
scores were then reentered onto computer file. During the data entry of the x-ray 
and death certificate information, range and consistency checking was performed 
along with double entry of all data. By this technique data entry errors were 
minimised and an overall data entry error rate of less than 0.5% was achieved. 
The integrity of the remaining magnetic tape information was confirmed by 
undertaking a re-inputting of a 10% sample of the data documented on original 
Devonport Research Unit computer listing. Table 3.17 illustrates the final cohort 
numbers obtained in this re-generation of the data in relation to the first reported 
morbidity study. Apart from the point raised in section 3.1.6 concerning the
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prevalence of x-ray abnormalities the characteristics of the final LSHTM datasets 
match those earlier itemised by Harries.1’1 The very slight difference illustrated 
for male workers in table 3.17 is simply due to past record duplication; the larger 
difference for females is probably due to initial x-ray coding errors.
TABLE 3.17: Overall cohort numbers.
All Dockyards Population
Either
X-ray
Responders
Either
Quest i onna i re 
Responders
X-ray and 
Questionnaire
Absolute
Non-
Responders
1975 Naval 
report Til:
Male wo r k e r s 39545 30428 (77X) 27750 (70X) 24357 (62X) 5724 ( 14X)
Female wor k e r s 730 454 (62X) 309 (42X) 255 (35X) 222 (30X)
This study:
Male wo r k e r s 39538 30422 (77X) 27746 (70X) 24354 (62X) 5724 (14X)
Female wo r k e r s 711 319 (45X) 287 (40X) 203 (28X) 308 (43X)
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3.2 METHODS.
3.2.1 Introduction.
The main objective of this study is to consider the total mortality (generally, 
mortality from the causes listed in table A1.2) and mortality from the specific 
causes shown in table 3.18, with regard to dockyard occupation, length and 
intensity of asbestos exposure, however measured, for the workers described in 
section 3.1, followed-up for 17 years. The specific causes of death detailed in 
table 3.18 have been shown ‘a priori’, in the literature review, to be related to 
asbestos exposure. As was stated in chapter one, lung cancer and mesothelioma 
will be considered throughout with a view to addressing the research question of 
this work. Asbestosis has not been excluded from this question, however, since 
only 10 deaths were observed in the 17 year follow-up period for this disease 
definitive results are unlikely.
The objectives will be considered in the following ways:
1. Use of standardised mortality ratios (SMRs) as traditionally used in 
cohort studies.
2. Use of log-linear models, to explore the ways in which confounders 
relate to one another and to the exposure.
3. Use of logistic regression on nested case-referent data, evaluating 
smoking habits, using conditional maximum likelihood estimation.
4. Use of mathematical modelling to estimate the relationship between 
mesothelioma death rate and time since first exposure.
Where possible, these methods and their results are compared and contrasted. 
Time trends are isolated and analysed to give a view of the mortality patterns with 
time. The effect of confounders (i.e. age, length of employment, etc.) on mortality 
will be measured and, if possible, removed.
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A major problem in epidemiology is the existence of competing risks. These have 
to be allowed for when analysing mortality from a specific cause of death. 
Consideration will be given to this. As a consequence the results from analyses of 
cause specific mortality must be interpreted very cautiously. Selection bias is also 
a problem in epidemiology, particularly in occupational epidemiology. 
Consideration will also be given to this and its most common form, the healthy 
worker effect.
TABLE 3.18: Specific Causes of Death.
C a u s e s  of Death Deaths
(all 3 yards)
ICD (9th revision)
All Causes 5031 0 - 999
All Neoplasms 1729 ( 3 4 . « ) 140 - 239
Cancer of Stomach 160 (3.2*) 151
Cancer of Peritoneum (Mesothelioma) 13 ■ (0.3*) 158
Cancer of Lung 575 (11.4X) 162
Cancer of Pleura (Mesothelioma) 118 (2.3*) 163
Diseases of t he Circulatory System 2259 (44.9X) 10 - 18
Diseases of Pulmonary Circulation 36 (0.7*) 4 15 - 417
Diseases of t he Respiratory System 459 ( 9.IX) 460 - 519
Bronchitis, Emphysema and Asthma 119 (2.4X) 490 - 493
Asbestosis 10 (0.2X) 501
Pulmonary Fibrosis 4 (0.1X) 515
3.2.2 Standardised Mortality Ratios (SMRs).
The most elementary technique used to analyse cohort survival data is to calculate 
fixed-period survival rates for various subgroups of the cohort and use these rates 
to determine which of the subgroups have a better expectation of life.1101 
However, this approach has a certain weakness - it ignores mortality patterns 
during the period of follow-up. This method may be further criticised for making 
it cumbersome to compare two populations because of the multiplicity of the 
subgroups needed.[ 111
In all cohort studies subgrouping has to be undertaken. This grouping will be by 
exposure level and all other factors expected to influence mortality. The most
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important of these factors is age. This important determinant of mortality 
obviously changes with time and clearly in a cohort subjects move from one age 
group to another every year and generally die in an age group different to the one 
they started in. To show the true effect of age in these studies the age distribution 
of the deaths has to be divided by the corresponding age distribution of the person- 
years at risk. The technique of using person-years at risk, and the construction of 
age and cause specific mortality rate tables, leading to the use of standardised death 
rates, avoids, to some extent, the problem of multiple subgroup comparisons and 
overcomes the weaknesses of using simple fixed-period survival and fatality rates.
Thus in a cohort, the age distribution changes each year and this has to be reflected 
when calculating age-specific death rates. This is achieved by making each subject 
contribute a value to the person years at risk for each age group and year moved 
through in the study. The contribution will be one, a fraction, or zero, depending 
on whether the subject survives, dies during, or dies before that age and year. The 
subject contributes zero person-years to the ages he lived through before the start 
of the study. This process of calculating person-years at risk is often illustrated by 
a Lexis diagram.[12,131 In these diagrams a subjects life in a study is 
represented by a 45° line passing through the two time axes, age group and 
calendar time period.
Considering this 45° line, suppose we have N0 subjects in a cohort which is 
followed for a maximum period of T  years. Let ^Oi be the time in the study for 
a subject who dies or is lost to follow-up before the end of the study. So for each 
subject we have the following person-years at risk (yoi):
I toi, i f  the i n d iv i d u a l  d i e s  during the s tu d y  
y°t ~ | f ,  o th e rw ise.
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The person-years at risk for the whole cohort is, therefore, given by:
Y° = y«i •
I- 1
Stratifying into K age groups and J periods, and considering the number of person- 
years spent in each age-group/period cell, say y  for subject i ,  gives the 
following total person-years at risk for each cell:
If the total number of deaths occurring in the cohort is D, an estimate of the crude 
death rate in the cohort is given by:
If a distribution of the deaths by age at death and by calendar year of death is 
formed, with the same grouping as a table of age/calendar person-years at risk 
formed in a Lexis diagram, we can compute the age-period specific death rates as:
where d j k is the number of deaths occurring in age group k and period j .  Age- 
cause specific death rates can also be obtained using this procedure, limiting the 
calculation to the cause of death of interest. This is equivalent to treating the 
deaths from other causes as censored observations. An example of the mechanics 
of the person-years at risk calculation, applied to a cohort of asbestos workers, is 
given by Doll.[ 14]
Commonly in cohort studies it is necessary to compare mortality patterns across 
subgroups (i.e. calendar year period, cause of death, etc.). The problem of 
multiple comparisons is removed by calculating a single measure of mortality for 
each subgroup. To avoid comparison of two subgroups with different age
yjk = Y ^ yijk' J =1'2.... J > *=i.2.....k .1
y»
J; k = l , 2 K,
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distributions, this single statistic has to be standardised. Liddell suggested 
numerous methods for this standardisation.[1S1 The basis of all these methods is 
the comparison of the mortality of a defined group of subjects with the mortality 
that would have been expected if the group had experienced death rates similar to 
those of the community of which the group is a part. The expected mortality is 
usually calculated using published national or regional death rates (see section 3.2.7 
for a discussion on the rates used in this analysis).
The most commonly used mode of standardisation is the ‘indirect’ method. In this 
method age specific death rates of the ‘standard’ population (national or regional, 
etc.) are multiplied by the number at risk in the appropriate age groups in the study 
cohort to give the cohorts expected deaths. The total number of these expected 
deaths, over all ages, divided into the number of observed deaths produces the 
Standardised Mortality Ratio (SMR). This is the method used in this dissertation. 
This ratio should be equal to 1 (or 100%) if the mortality in the study cohort equals 
that of the standard population.
To compute the death rate in the chosen standard population for a particular age 
group and year entails dividing the number of deaths in that age group during the 
year by the midyear population of the age group. For example:
For periods that are greater than one calendar year an average age-specific annual 
death rate is obtained from:
To obtain the expected number of deaths in the j - k tu cell, i.e. for age group k  and 
period j ,  that cells population death rate is multiplied by the cohorts person-years 
at risk contribution.
J; k=X, 2 K.
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E]k -  ^ O j k  x  y j k
and from this we obtain:
Ei  = £  E»
k
which is the expected number of deaths over all ages in period j .  A more formal 
description of the properties of this person-years method has been given by 
Berry.[16]
If Dj is the observed number of deaths in the cohort during the same period j ,  the 
SMR for the cohort for that period is then given by:
SMRi =  100 X — i .
J Ei
SMRs for cause-specific mortality are calculated by the above method by using 
cause specific death rates in place of an all-cause rate.
Mortality in the study is then compared with mortality in the standard population 
by testing departures of the SMR from 1 (or 100%). This is commonly undertaken 
by constructing confidence intervals around the SMR. There are various methods 
and assumptions used in calculating these confidence intervals. One suggested by 
Gilbert is to assume that D is a Poisson variable with expectation £T.[17] The 
statistic
( D - E ) * / E ,
can then be treated as a X 2 variable with / degree of freedom. If E  is small, this 
Normal approximation to the Poisson loses accuracy and Poisson tables should be 
used. An alternative is to use the following variance estimate.
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V a r ( S M R ) D
E 2
to create a confidence interval for the SMR. The generalised (1 -a) 100% 
confidence limits for this would be:
[ ( ^ - - yfD)2/E.  ( * ± + & ) * / £ ) .
This can be simplified as:
a
SMR ± (ZT x - ^ ? )  ,
for a 95% confidence interval this becomes:
(D ± 1 .96  Xy/D) /E.
Again this approximation to the Poisson distribution can lose accuracy for small 
numbers. In this study the exact Poisson distribution was used in the formation of 
the SMR confidence limits when the observed deaths were less than 30 (D < 30).
The SMR and its confidence interval produced by the above technique compare the 
cohort mortality with the mortality pattern found in the standard population. In 
cohort studies this technique is sometimes used in the comparison of subgroups of 
the same cohort. Here the comparison of each group to the standard population 
would become a comparison between subgroups. This procedure has been 
criticised for not allowing for the separate age structures of each subcohort or 
strata.1181
A more formal approach for comparing subcohorts is given by using an extension 
of Armitage and Berry’s test of trend in proportions.1191 The test needed in the 
comparison of subgroup SMR’s is a test of homogeneity of these ratios (leading to
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a test of trend). If there are K subgroups (strata) to be compared, the test would 
then take the following form:
»0 : ¿>1 = ----- = b K
where bk is the coefficient of the kth binary indicator variable representing 
membership to subgroup k. Let,
= where Êk = D.
k
The test statistic, for the test of homogeneity, with K-1 degrees of freedom 
becomes:
Xi-x _ v -  (Dk~Ék) 22-r* ft* hk
If the groups correspond to levels of a single quantitative covariable with values 
X k , a test for trend in the SMR is given by:
* 1  =  iy ^ X k W k- Ê k ) ] 2/ [ ' £ X Î Ê k - l ' £ x kÊk ) 2/D ) .
k k k
An example of the application of tests of homogeneity and trend applied to 
subgroups of a cohort of smelter workers exposed to arsenic has been given by 
Breslow and Day.[ 201
A major objective of this study is to compare subcohort mortality patterns with 
each other. This will produce many multiple comparisons. How can we overcome 
this and the potential problem of varying age distributions in the subgroups? The 
problem is exacerbated if further subclassification on explanatory variables is 
attempted. One solution is to use a more parametric approach, that is, regression 
modelling to analysis mortality, in effect to smooth the data across the subgroups. 
Subsequently, the methods we now consider will be regression type procedures.
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3.2.3 Poisson Regression.
The most important use of an SMR is in the comparison of the mortality of a study 
cohort with that of a standard population from which the cohort was drawn. If a 
cohort can be characterised by other covariates, and an SMR is available for each 
of the subgroups resulting from the cross-classification of these covariates, it may 
be of interest to test the following.
1. That the SMRs are all equal.
2. That the SMRs are all equal to 1 (or 100%).
3. That the SMRs show a trend with increasing levels of an 
ordered categorical variable (i.e. exposure level).
Since the subgroups of the cohort are likely to have different age distributions, it 
may be necessary to use age and calendar year or follow-up period as additional 
classifying variables so that in the comparison of the different subgroups, the 
residual age and period effects are excluded.
To this end Poisson regression is considered in this section. In this form of 
regression a mathematical model is constructed in which the logarithm of the 
incidence rate is modelled as a linear combination of a set of risk factors. Poisson 
regression is used here since it can be formulated as an extension of the SMR 
method, and because the rate ratio estimates produced are unaffected by small 
numbers in particular strata. The number of deaths in each cross-classified 
subgroup is assumed to have an independent Poisson distribution.
Several authors have suggested a method for testing for homogeneity and trend in 
SMRs by way of regression parameters.t17,21,22] They have suggested the 
following model:
Aj(i) = exp (Z'j(i)b)kj(i)
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where A ^  ( i  ) is the death rate for the j th individual in the follow-up period i , and 
Z' j (  i  ) is that individuals covariate vector. From this,
Xj » A.} [ t w ( i ) , t 2J( i ) ]
is the rate determined by the individuals age t j j ( i )  and calendar period 
at that time. The model is similar to that proposed by Cox in 1972.[23) 
However, Cox’s hazard is replaced here by a known constant, i.e. the threshold 
rate. Indeed theoretical analysis has shown an inherent link between Poisson 
regression and the proportional hazards model.'24'
With classification into if subgroups such that Z ' j ( i )  = Z' k the log-likelihood 
can be written as:
L(b)  = £  [£>JCZJ/.b-exp (Zk'b) Ek] ,
k
where Dk is the total number of deaths in subgroup k  and Ek is the expected 
number depending on the person-years at risk in subgroup k. This log-likelihood 
is similar to that when Dk are independent Poisson variables with means,
ex p  (Zk'b) Ek,
where Ek are constants. This implies that standard routines for Poisson regression 
can be used once a distribution of observed and expected deaths is obtained. For 
example, in the statistical package GLIM you have only to specify that Dk have 
Poisson errors, invoke the logarithmic link function and introduce logEk in the 
model as OFFSETS.
The present data are cross-classified, so the covariate vector associated with each 
cell is in general a set of indicator variables showing membership/non-membership 
of the various levels of the factors of interest and their interactions. Because of 
this the linear predictor, Z' kb, can be written using the ANOVA notation outlined 
by Bishop.[25] The fitted model has the form:
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l o g E(Dijk) = logJFijJt+ a + a x ( i )  + a 2 ( j )  + a 3 (k) +
«4 ( ¿ j )  +a5 (ilc) +a6 (jlc) +a7 (.ijk) '
where, for example, there are I age-groups, J  follow-up periods, and K categories 
of asbestos exposure. The use again of GLIM ensures a unique solution by 
constraining to zero the parameters associated with terms involving the first level 
of any of the factors. All interaction terms which involve the first level of any of 
the factors are also set to zero. Testing the models goodness-of-fit can be based 
on the deviance found in GLIM, which is equivalent to the likelihood-ratio statistic:
G2 = -2 log(max L) ,
where G2 is approximately distributed as a Chi-square variable with h -  m degrees 
of freedom, h=lxJ*K, and m is the number of parameters in the model.
The model can be described by the h data points with h parameters. This would 
be fitting a ‘saturated’ model. More commonly a model is obtained with less than 
h parameters by including only those factors and interactions that are significant - 
in order to explain the underlying structure with as few parameters as possible, i.e. 
building a parsimonious model. In this work a forward selection approach will be 
used: after fitting the constant term, the factor which produces the largest change 
in G2 will be included, followed by the second and then the third, etc. Interaction 
between the factors with significant main effects will be considered in the following 
way. If there are at least two significant two-factor interactions than a three-factor 
interaction will be considered, and so forth. Interaction and effect modification is 
considered in section 3.2.6.
Significance testing for specific a  terms in the model can then be based on the 
difference between the G2 statistics for two ‘nested’ models, one of which does not 
contain the a  term being tested. This difference between the G2 statistics has an 
approximate Chi-square distribution with degrees of freedom equal to the difference 
in degrees of freedom of the two models. In GLIM the comparison of different 
models is undertaken through ‘Analysis of Deviance’.^261
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Testing for homogeneity and trend in the SMR can then be undertaken by the 
method outlined in the previous section. The parameters of the fitted model are 
interpretable as logarithms of the relative risks, i.e. the a k, k = 1 , . . . , n ,  
parameters are the logarithms of the SMRs in the k th subgroup relative to that in 
the first subgroup. Anti-logging these parameter estimates yields the mortality rates 
for particular subgroups relative to the first. This clearly takes the same form as 
that of the relative risks obtained using the traditional SMR method. For example, 
the relative risk associated with the k th subgroup is given by:
< |> *  =  SMRk/SMR0.
This is perhaps the major reason for the assumption of the multiplicative form of 
the model. Models specifying non-multiplicative relationships result in parameters 
not easily related to the relative risk, and may also pose estimation problems 
because of the range restrictions that have to be imposed on the parameters.
3.2.4 Logistic Regression.
Logistic regression techniques are employed in this thesis on nested case-control 
data sampled from the cohort population. Conditional maximum likelihood 
estimation is applied. This method is the modelling analogue of the Mantel- 
Haenszel stratification procedure.
The sampling method employed in this study is incidence density sampling. In this 
each case is matched to one or more controls selected at random from a set of 
subjects who are still at risk (the risk set) at the time that the case was identified. 
The risk set includes subjects who may subsequently develop the disease. Nested 
case-control data will yield unbiased estimates of the relative risk from the full 
cohort.
125
The parameter of interest in this type of study is the odds ratio. This ratio has the 
same value whether calculated from the disease or exposure probabilities. That is, 
the ratio of the odds of being exposed for the cases against the odds of exposure 
for the controls (exposure odds ratio) is equal to the ratio of the odds of having the 
disease in the exposed against the unexposed subjects (disease odds ratio). In the 
analysis the odds ratio estimates the increase in the odds of disease for the Acth 
factor (for example, exposure level) relative to the baseline level, k = 0, of that 
factor.
Logistic regression produces a mathematical model in which the log odds is 
modelled as a linear combination of a set of risk factors. This model is derived 
from the mathematical function:
f ( y )  ranges from zero to one, as a sigmoid curve, as y increases from negative 
to positive infinity. This regression technique is also known as linear logistic 
regression. The word linear referring to the property that the logit transformation,
is linear in y. The properties of this transformation are, therefore, used in 
epidemiology to model the risk of disease development during some specified time 
interval as a function of various independent variables known or suspected to be 
related to disease development.
If we now consider that Y is the odds of a subject being a case and that p is the 
proportion of subjects who are cases. This implies that:
f l y )  = 1 / ( 1  + e~y) w here  -<» < y  < +«>
l o g i t  f (y) = lo g f l y )1 - f l y )
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If we now consider the logarithm of the odds. A linear model can be created with 
the logit as the dependent variable in the following equation:
1 0 9  [ ( 1  p )  ] = “  *  “ l A '1 * ------- “ * * * '
where Xj ,  j  = 1, . . . ,  k are the set of k explanatory variables. From this we have 
a linear model sometimes called a multiple logistic regression model, multiple in 
its number of k  independent variables. So, the logit is the logarithm of the odds 
and logit differences are in turn logarithms of odds ratios. In GLIM you would 
perform a logistic analysis by specifying Binomial errors and declaring the link 
function to be logit. The goodness-of-fit of the generated models is then tested by 
scrutinising the deviances produced in GLIM.
Confidence intervals can then be used to test if the odds ratio produced is 
statistically different from unity. Miettinen has suggested an approximate 
confidence interval of the form:[27)
a
ifr", w h e r e  w = ( 1  ± Z  2 /y /x? )
and x 2 is the Mantel-Haenszel chi-square. An alternative is to calculate an 
estimate of the variance of the log odds and use the following logit confidence 
limits:
a
e x p  ( l o g  (t|t) ± Z 2 yJVar l l o g  (tjr) J ) .
A limitation of the multiple logistic model is the multiplicative relationship of 
separate explanatory variables in the model with each other. In the model each 
variable contributes towards the sum that is the log odds of disease. The different 
variables then have a multiplicative relationship with each other with regard to the 
rate of disease occurrence. This is equivalent to assuming a constant ratio measure 
of effect for a given factor over categories of the other factors.
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3.2.5 Bias. Confounding and the Healthy Worker Effect.
Selection bias, as defined by Rothman, is the distortion in result that occurs from 
the techniques by which study subjects are chosen from the total population that 
could theoretically be studied.[28] In theory every occupational epidemiology 
study should include every worker ever employed in a specific industry followed 
up to the end of their life. In practice most studies use a subset of this information 
and from these subsets bias may occur. Bias may also be increased by various 
methodological errors, for example, considering subjects lost to follow-up as alive 
at the end of the study.
The most common form of selection bias in occupational studies is the healthy 
worker effect. It occurs when ‘healthy’ individuals are more likely to gain 
employment and to remain employed than the ‘non-healthy’. In part this is due to 
self-selection, the individuals must be sufficiently healthy to seek work, and in part 
to employer selection, i.e. the use of pre-employment medical screenings. The 
effect can be typified by considering the general population. This population 
includes people who are too sick to work or who have been refused employment 
on health grounds and also employed people. Consequently, mortality rates in 
workforces are often lower than those of the general population. The healthy 
worker effect is the term sometimes used to refer to this phenomenon.
The healthy worker effect is of concern in the interpretation of occupational 
mortality studies because adverse effects of exposures at work may be wholly or 
partly masked by an apparent deficit of mortality in the workforce when compared 
to the general population. The inclusion of all person-time experience of every 
worker ever employed in a particular industry reduces bias, but it does not remove 
the bias resulting from initial selection of healthy workers into employment.
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Healthy worker effects were first described by Ogle in 1885.1291 He saw the 
"considerable standards of muscular strength and vigour" required of individuals 
in certain occupations as introducing a "great flaw in all calculations of death rates 
in different industries". In brief three factors have been recognised in the healthy 
worker effect:130]
1. The selection of healthy members from the source population.
2. The survival in the industry of healthier workers.
3. The length of time for which the population is followed.
Therefore, it is possible to characterise the healthy worker effect according to the 
events on which it operates, the start and end of work.
TABLE 3.19: SMRs by duration of follow-up in asbestos workers (taken
from McMicheal1181).
Causes of Death
0-4
Follow-up 
5-9
( ve a r s  )
10-15
All Causes 95 112 123
All Neoplasms 100 136 153
Non-cancers 83 100 106
It has been shown in many studies that the mortality of employed persons, 
compared with the general population, is lowest during the period immediately after 
starting employment (table 3.19).[ 18,30,311 A common characteristic of these 
studies has been low SMRs for the early years of follow-up, with these ratios 
approaching unity (or 100) and beyond as follow-up continued. The relative 
mortality advantage of employed persons then diminishes with length of follow-up. 
Conversely, the advantage is also most pronounced in workers with the longest 
duration of employment. This is attributable to the survival in the workforce of 
relatively healthier workers.1311
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The healthy worker effect is obviously most marked in chronic diseases that are 
readily detectable. McMicheal argued that heart disease is therefore more likely 
to be selected against than cancer, with its "long-deferred clinical manifestations", 
in the recruitment and retention of active workers.1181 This in turn would result 
in a reduction in ‘non-cancer’ mortality in comparison to ‘cancer’ mortality shortly 
after study definition in an occupational cohort (table 3.19). Fox and Collier also 
showed differential patterns in SMRs according to the cause of death examined.1301 
In their study of polyvinyl chloride production workers, SMRs for respiratory 
diseases were lowest and increased more slowly with time since entry to the 
industry (table 3.20). SMRs in this study were highest for cancer, those for 
circulatory disease were intermediate. Another example of differential patterns in 
SMRs is given by the OPCS Longitudinal Survey.1321 In this survey SMRs in 
employed males were lower for respiratory and circulatory diseases than for 
malignant neoplasms, all increasing with time since cohort definition.
TABLE 3.20: SMRs by time since entering the industry (taken from Fox
and Collier1301).
Time since enterinq the industry
Causes of Death
0-4 5-9 10-14 15+
All Causes 37 63 75 94
All Neoplasms 45 71 94 112
Circulatory Disease 22 70 85 91
Respiratory Disease 21 39 31 93
In Fox and Collier’s study of the polyvinyl chloride manufacturing industry a 
survival effect was shown by separating workers who survived 15 years, from 
study definition, according to whether they were still in the industry or not. The 
all cause mortality rate among those who left the industry was approximately 50% 
higher than those still employed. Other studies have supported the hypothesis that 
the healthy worker effect is strongest during active employment and rapidly 
disappears following the cessation of employment, particularly if this occurs before
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the usual retirement age.133,341 It has even been suggested that the term "active 
worker effect" be used in place of heathy worker effect.1351
Whether the effect is called ‘healthy worker’, ‘active worker’, 'comparison bias’, 
as suggested by Hemberg1361, or health-related selection bias, it is often observed 
in occupational cohorts. Its main characteristic are initial low mortality following 
study definition becoming less apparent with time. The effect is, therefore, time- 
dependent. This suggests a method of managing this form of bias. e.g. by 
investigating the way in which SMRs change with time since entry into a 
workforce, as opposed to using the overall magnitude of SMRs at any one point in 
time. As an alternative to this, regression models as outlined in section 3.2.3 may 
be used to eliminate any confounding due to the healthy worker effect, i.e. due to 
length of employment, length of follow-up and age.
Selection bias and confounding can be viewed as aspects of the same phenomenon: 
distortions that the investigator hopes to prevent or, if necessary to remove from 
the data. A method outlined by Rothman to counteract these is to consider any bias 
that can be controlled in the analysis as confounding.1281 Confounding can be 
considered as a mixing of the effect of the study factor/exposure of interest with 
the effect of other risk factors. A confounder is, therefore, a factor in someway 
associated with both exposure and disease. In occupational studies time-related 
factors are good predictors of disease states and will be confounders if they are also 
associated with exposure. For example, calendar year will be a confounder if 
disease incidence and exposure patterns vary over time. Another example of this 
concerning both bias and confounding would be if more recently employed workers 
(with better workplace conditions and lower levels of exposure), followed for a 
short period, are compared to workers employed in a previous period (with higher 
exposure levels).
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Confounding can be controlled in the study design, in the analysis or in both.
Controlling during study design can involve three methods:
1. Randomisation. That is, random allocation to exposure categories. 
This is not possible in occupational studies.
2. Restriction. Restricting the study to narrow the range of potential 
confounders (e.g. restricting a study to workers aged less than 45). 
This method as well as restricting confounding may also restrict the 
usefulness of a study.
3. Matching. Matching study subjects on potential confounders. This 
is the preferred method of control, its main limitation is that it is 
expensive in time and project costs. It is effective in cohort studies 
and very effective in nested case-control studies. It should be noted 
that matching does not remove the confounder, but aids in its control 
during analysis.
Controlling confounding during analysis involves the simultaneous control of all 
confounding factors. This is undertaken by stratifying the data according to the 
levels of the confounders and calculating an effect estimate that summarizes the 
information across each subgroup (strata) of confounder. The study size clearly 
restricts the number of confounders that can be simultaneously controlled. The ideal 
method of stratifying for all confounders has to be limited by the data, and care 
taken not to over stratify or produce too many strata cells with no data. The 
problem of over stratification can be solved by regression modelling, allowing for 
the simultaneous control of confounders by smoothing the data across subgroups.
Control of confounding is important and requires careful use of prior knowledge, 
and also inference from the observed data. Most occupations involve exposure to 
more than one potential risk factor and the possibility of confounding by other 
occupational exposures must be considered in the context of each study.
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3.2.6 Effect Modification (Statistical Interaction).
In epidemiology the concept of effect modification and interaction is more difficult 
to define than in experimental studies. The aetiology of a disease is often very 
complex, with many causative and confounding factors. For cancer, carcinogens 
may act at different stages independently of each other, but each stage is required 
to occur before the next one can start. The question is therefore, can occupational 
epidemiology and its use of probability theory to identify risk factors provide an 
insight into the biological mechanisms of disease causation? A following question 
is whether an interaction term in a regression model can be interpreted on any 
biological scale?
Other factors which complicate the issue are the statistical models used to analyse 
epidemiological data. The commonest model used is logistic regression, where the 
odds of disease, transformed by the logarithmic function, are related to a linear 
combination of risk factors. The logistic model assumes that the risk factors 
combine on a multiplicative scale to estimate the risk of disease. Thus, even when 
no interaction term (product term) is present in the model, the effect of the 
individual terms is additive on the log scale, i.e. multiplicative on the non-log 
scale. This leads to the question of whether there is independence of the risk 
factors if additivity on a log scale applies. The same question applies to poisson 
regression (log-linear modelling) since it also measures interaction on this scale.
Clearly to demonstrate biological interaction by means of statistical models requires 
knowledge of the underlying biological model and reasoning, and cannot be done 
mechanically. Helping to clarify the situation, Rothman in 1980 suggested that 
interaction in epidemiology can be defined in four broad contexts: statistical, 
biological, public health and individual decision making.t37] His definitions are 
as follows:
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Statistical interaction. This is dependent on the mathematical model fitted to the 
data. If the regression coefficient for the product term of the risk factors is 
significantly different from zero and the goodness-of-fit statistic shows that 
presence of the interaction term improves the fit, then statistical interaction is 
present and should be included in the model.
Biological interaction. This is present when two or more causative factors act 
interdependently to produce the disease. Two categories are of interest: 1) those 
in which the aetiological factors act interchangeably in the same step in a multiple 
process and thus the effect of each factor adds to the effect of the other. 2) those 
that act at different steps in the process. For example, smoking may cause damage 
to lung cells and subsequent exposure to dust acts on those cells to increase the 
probability of lung cancer. The two categories correspond to the statistical models 
in which the combined effect of exposure factors is assumed to be additive or 
multiplicative, respectively. The best fitting of the two models can suggest the 
nature of the interrelation between the causal factors.
Public-health interaction. This is present when the effect of one risk factor on the 
disease occurrence is modified by the presence of another and when departure from 
the additivity of the individual effects is observed. For statistical models, applied 
to test the combined effect, it means that a significant interaction term is present 
in the model that assumes additivity of relative risks, and that the model that 
assumes multiplicativity of the effects may fit the data significantly better than the 
model that assumes additivity of the effects.
Individual-decision making. This involves evaluating personal risk of disease 
considering that the causal factors acting in combination lead to an 
increased/decreased risk of disease above/below the sum of the individual risks.
Considering now a visual assessment of interaction. By plotting calculated relative 
risks against the exposure of interest, a trend in a dose-response relationship would 
be detected. If we choose a continuous variable for exposure X and a dichotomous
1 3 4
(0,1) indicator variable for exposure Y, then by plotting the relative risks for each 
exposure Y against the exposure X, an indication of whether an interaction affect 
is present or not can be detected. For example, if the exposure Y modifies the 
effect of the exposure X, then effect modification (interaction) is present. Figure 
3.1 shows some possible relationships.
The detection of the presence of an effect modification depends to some extent 
upon the transformation scale applied when analysing the data. When we try to 
infer the presence of an interaction from the data plotted in figure 3.1 in terms of 
the additive or the multiplicative models, the following can be observed:
1) [Figure 3.1a]:
2) [Figure 3.1b]:
3) [Figure 3.1c]:
The lines are parallel, therefore, there is no evidence of an 
interaction on the additive scale, but there is a negative 
interaction on the multiplicative scale.
There may be no interaction on the multiplicative scale, but 
a positive interaction on the additive scale.
An interaction is present, but may be detected only by means 
of indicator variables for the exposure X, in which case an 
additive relative risk model is more likely to detect the 
interaction.
Epidemiology should go beyond pure statistical modelling. The idea of effect 
modification and statistical interaction, linked as it is to an arbitrariness in the 
choice of model, can lack interpretation in occupational epidemiology since it does 
not rest on a definite theoretical foundation. Without implication for inference 
beyond the model, a purely statistical notion of interaction does not contribute to 
the study of occupational epidemiology. If the occurrence of interaction were 
simply a statistical construction that allowed contradictory interpretations from the 
same data, it would not contribute to scientific and medical knowledge.
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FIGURE 3.1:
a)
b)
The trends in relative risk that can be observed with 
two risk factors.
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3.2.7 Disease Groupings and Regional Adjustment Factors.
This section is concerned with the standard death rates used in this thesis and in 
particular their formation from the OPCS ‘Historic Mortality Data Files’ and the 
use of regional adjustment factors.
In the analysis of cohort mortality a pivotal role is frequently played by published 
national death rates (this was outlined in section 3.2.2). Clearly, their use restricts 
the researcher to the published structure of these rates. The Office of Population 
Censuses and Surveys (OPCS) recognised this limitation and in 1979 created their 
historic deaths file. This file contains death information by age, sex, and 
International Classification of Disease (ICD) code for England and Wales on a 
yearly basis from 1901. This data file is, therefore, a basic building block that 
when linked with corresponding population data can be formed to fit research 
project needs. The ICD codes recorded (i.e. 7th, 8th or 9th revision of ICD) are 
those in operation at the time of registration of death.
For this work OPCS supplied annual national death information for the years 1972 
to 1988. This period presents two problems in the construction of a death rate 
database. First, it overlaps two revisions of the ICD, the 8th revision was in force 
through 1968-1978, the 9th revision has been used since 1979. Secondly, the 
follow-up period in this study is 17 years and based on the enumeration dates 
presented in section 3.1.1 we have a study period extending between 1972 and 
1990.
The last problem was solved by using the death rates constructed for 1988 as ‘best’ 
estimates for those of 1989 and 1990. Considering the first problem, that is the 
overlapping ICD revisions. All observed deaths in this study have been coded by 
a nosologist to the 9th revision of the ICD. The death rates generated from the 
OPCS file for the years 1972-1978 are based on 8th revision disease groupings. 
Since these have to be compared with 9th revision observed deaths approximate 
disease groupings have been used for certain conditions. Table A2.1 lists the 
causes of death used in this study with their attendant 9th revision grouping and its
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8th revision estimate. From this table it can be seen that three disease groupings 
are principally affected by this approximation, namely, diseases of pulmonary 
circulation (9th 1CD: 415-417, estimated 8th: 426 and 450), chronic obstructive 
pulmonary disease (9th 1CD: 490-496, estimated 8th: 490-493 and 518) and 
pneumoconiosis (9th ICD: 500-508, estimated 8th: 515-516). All three of these 
groups are new to the 9th revision. Of these only disease of pulmonary circulation 
is used as a specific cause of interest in this study (table 3.18), this is to give an 
estimate of cor pulmonale mortality, a major constituent of the 9th revision 
grouping of codes 415-417. The disease grouping of bronchitis, emphysema and 
asthma (8th and 9th ICD: 490-493) is used as a surrogate for chronic obstructive 
pulmonary disease. The disease grouping of pneumoconiosis is considered only as 
a general grouping of interest, whereas, its included condition asbestosis (9th ICD: 
501, 8th ICD 515.2) is obviously considered as a specific cause.
The disease grouping of pneumoconiosis (9th ICD: 500-508) was mainly classified 
to codes 515 and 516 in the 8th revision. However, aspiration bronchopneumonia 
and aspiration pneumonitis, coded as part of 8th revision groups 485 and 486, are 
included in the 9th revision pneumoconiosis group under code 507 (pneumonitis 
due to solids and liquids).[38) The 8th revision codes, 485 and 486, are both 
broad codes covering unspecified bronchopneumonia and pneumonia. It is 
impossible to singly subtract the effect of aspiration bronchopneumonia and 
aspiration pneumonitis from these groups and include them in the construction of 
the 1972-1978 death rates for pneumoconiosis. The construction of pneumoconiosis 
death rates, from the OPCS historic deaths file, will, therefore, only produce 
approximate estimates of the true rates. This is particularly true for all disease 
groupings that are new in the 9th revision of the ICD.
Apart from changes to the classifications, new groupings etc., changes were also 
made in the rules for the coding of the underlying cause of death from the 8th to 
9th revision. The change that most affects this study is the removal of the 
precedence in coding for asthma when reported with bronchitis. This has resulted 
in an increase in the number of reported asthma cases and a decrease in the number 
with bronchitis from 1979. This rule change is effectively covered by using the
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broad disease group of bronchitis, emphysema and asthma. However, any change 
in coding rule adds extra problems to the use of death rates across 1CD revision. 
They tend, obviously, to make changes also to the measurement of disease 
frequency that can be both elusive and subtle and can only be counteracted by using 
broad disease groups.
The England and Wales death rates constructed for this study are given in appendix 
2. These rates are in 5 year age groups starting at age 10 and continuing until age 
84, ages over 84 are grouped together to form a ‘85 plus’ group. In total 50 
disease groups are given in this appendix.
Ideally, the standard population used in calculating expected mortality should be 
one that is similar in both demographic and environmental characteristics, apart 
from exposure history, to the cohort population. Attempts to achieve this include 
using standard populations that are of the same sex, race and geographical location 
as the occupational cohort. The standard population death rates created and used 
in this study are male rates for the whole of England and Wales. To produce rates 
that more closely characterise the cohort, i.e. regional rates instead of national 
rates, was not possible when using the OPCS historic deaths file. This data file 
was only available for the whole of England and Wales.
As an approximation to the direct formation of regional rates an alternative is 
needed. This alternative can take the form of applying a regional adjustment to the 
calculated national death rates. Considering the study period of this work, i.e. 
1972 to 1990, the microfiched area mortality information from the last decennial 
supplement of the OPCS that covers the years 1979 to 1983, approximately the 
midyears of this study, can be used to produce these regional adjustment 
factors.[39] From the decennial supplement SMRs are given for the standard 
regions of England and Wales, i.e. South East, North West, etc., for all ages, for 
the age group 15 to 64 and for the age group 65 plus. They are also given for both 
sexes and for selected causes of death. These SMRs, represented as proportions 
and not percentages, can be used as weighting factors to adjust the national rates
139
into regional estimates, for the relevant ages and causes of death. Table A2.2 
gives the regional adjustments used in this thesis.
From table A2.2 it can be seen that many causes of death considered in this study 
have no applicable adjustment factor from the 1979-1983 OPCS data. For these 
the nearest available OPCS area information is used. This is the data from the 
OPCS 1989 area mortality statistics microfiche.1401 Where the 1979-1983 
information is present it is used to produce an adjustment, when absent the 1989 
data have been used. For 18 causes of death, indicated in table A2.2, no 
adjustment factor was possible. Mesothelioma of the pleura and peritoneum and 
also asbestosis are included among the causes with no regional adjustment factor.
The regional adjustment factors used are for the South West and South East 
standard regions. The south west adjustment is used for Devonport dockyard and 
the south east for both Chatham and Portsmouth dockyards. When no adjustment 
is given, i.e. for ages 10 to 14 and for causes of death with no obvious factor, 
unity is used as the factor.
There are several reasons why national or regional death rates may not be 
completely appropriate to the group under study. For example, the social-class 
structure or the smoking habits of the group may differ from those of the region. 
Another reason is the healthy worker effect, due to the selective mechanisms that 
contribute to deciding an individuals occupation. As mentioned in section 3.2.5 the 
national population contains some people not fit enough to engage in certain types 
of work. These people contribute to the death rates of the national population but 
are inappropriate for comparison with a working population of which they could 
not be members. The difficulty of interpretation that arises because the 
comparisons may not be completely appropriate is an inevitable feature of the 
epidemiological approach, as opposed to the experimental one - but, of course, the 
experimental approach makes the assumption that the rat in his artificial 
environment is comparable to man in his ‘free’ environment.
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Chapter 4: MORTALITY PATTERNS IN ROYAL NAVAL 
DOCKYARDS.
4.1 Introduction.
This chapter describes the results of standardised mortality ratio (SMR) and 
Poisson regression analyses performed to investigate dockyard mortality patterns 
with regard to occupation, exposure to asbestos and time. Consideration is given 
to the effect of self-selection into the study base, i.e. the mortality rates of study 
non-responders, as defined in the last chapter, are appraised and compared to 
responder rates. Attention is also given to the healthy worker effect and its 
influence on mortality. This involves examining associations between mortality 
and the factors of greatest relevance to health-related selection, namely time since 
employment and duration of employment. Before describing the results of these 
analyses on the specific causes of death given in table 3.18, the overall mortality 
in the workforce is summarised for the 50 disease groups given in table A 1.2. 
Lung cancer and pleura mesothelioma are given special consideration throughout 
this chapter in an attempt to address the questions arising from the past dockyard 
studies (i.e. the finding of a non-significant lung cancer risk accompanied by a 
very significant mesothelioma risk[1,2]). Peritoneal mesothelioma and asbestosis 
will also be considered in this light, however, the small number of reported deaths 
from these causes (13 and 10 respectively) make any conclusive results unlikely.
The analyses performed in this chapter were undertaken only for those workers 
traced by the Office of Population Censuses and Surveys (OPCS): 27,502 workers 
across the three dockyards, that is, 97.3% of the study base. Workers that 
emigrated were considered lost to follow-up at their date of emigration. Censoring 
was undertaken for subjects who reached the age of 85, i.e. 85 was considered the 
age above which the reliability of data concerning the events of interest would be 
considered inadequate. This censoring prevents the bias that would result from 
allowing subjects to contribute time at risk to the rate denominator of the SMR,
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when they are not in fact at risk of suffering an event that could be both observed 
and counted in the numerator. This had the effect of reducing the number of 
observed deaths in the study by 5, i.e. from 5,031 to 5,026. The results for each 
dockyard are reviewed independently. The main results tables are given in 
appendix 3. Appendix 4 contains supplementary results.
4.2 Cause specific mortality for 50 disease groups.
This section is concerned both with the overall mortality pattern shown in the 50 
disease groups and the effect of regional adjustment on this pattern. The results 
for the three dockyards are given in tables 4.1 to 4.3.
From these tables it can be seen that the workforce experienced mortality rates 
that were, generally, 13-18% lower than national rates; the all-cause SMR was 87 
for Devonport (95%C1: 83-91), 85 for Chatham (95%CI: 80-91) and 82 for 
Portsmouth (95%C1: 78-85)*. The effect of applying a regional adjustment was 
to increase these SMRs to the following levels; 97 (93-101), 91 (86-97) and 88 
(83-92) for Devonport, Chatham and Portsmouth respectively. The observed 
mortality being generally significantly lower than expected, both with and without 
regional adjustment. The variation in all-cause SMR across dockyard was also 
found to be statistically significant [X2 = 9.7, P<0.01]**.
For the disease group ‘all-neoplasms’ a statistical deficit is not seen. This is best 
illustrated by considering the regionally adjusted all-neoplasm SMR. For the three 
dockyards in the order Devonport, Chatham and Portsmouth*** we have the 
following SMRs: 117 (109-125), 107 (96-118) and 98 (90-106). Devonport
Throughout, 95% confidence intervals will henceforth be shown in 
parentheses, e.g. (83-91) in place of (95%C1: 83-91).
Chi-squared tests for a difference between SMRs will be given, when 
appropriate, inside square brackets [ ].
This order of Devonport, Chatham and Portsmouth will be used throughout 
the remainder of this work.
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when they are not in fact at risk of suffering an event that could be both observed 
and counted in the numerator. This had the effect of reducing the number of 
observed deaths in the study by 5, i.e. from 5,031 to 5,026. The results for each 
dockyard are reviewed independently. The main results tables are given in 
appendix 3. Appendix 4 contains supplementary results.
4.2 Cause specific mortality for 50 disease groups.
This section is concerned both with the overall mortality pattern shown in the 50 
disease groups and the effect of regional adjustment on this pattern. The results 
for the three dockyards are given in tables 4.1 to 4.3.
From these tables it can be seen that the workforce experienced mortality rates 
that were, generally, 13-18% lower than national rates; the all-cause SMR was 87 
for Devonport (95%CI: 83-91), 85 for Chatham (95%C1: 80-91) and 82 for 
Portsmouth (95%CI: 78-85)*. The effect of applying a regional adjustment was 
to increase these SMRs to the following levels; 97 (93-101), 91 (86-97) and 88 
(83-92) for Devonport, Chatham and Portsmouth respectively. The observed 
mortality being generally significantly lower than expected, both with and without 
regional adjustment. The variation in all-cause SMR across dockyard was also 
found to be statistically significant [Xz = 9.7, P<0.01]**.
For the disease group ‘all-neoplasms’ a statistical deficit is not seen. This is best 
illustrated by considering the regionally adjusted all-neoplasm SMR. For the three 
dockyards in the order Devonport, Chatham and Portsmouth*** we have the 
following SMRs: 117 (109-125), 107 (96-118) and 98 (90-106). Devonport
Throughout, 95% confidence intervals will henceforth be shown in 
parentheses, e.g. (83-91) in place of (95%CI: 83-91).
Chi-squared tests for a difference between SMRs will be given, when 
appropriate, inside square brackets [ ].
This order of Devonport, Chatham and Portsmouth will be used throughout 
the remainder of this work.
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T A B L E  4 .1 :  Devonport Dockyard. Cause specific mortality for 50 disease
groups, with and without regional adjustment.
J Causes of Death Without regional adjustment 
Obs Exp SMR 95X Cl
With regional adj. 
SMR 9 5 X  Cl
All Causes 2289 2629.8 87 83- 91 97 93-101
Infectious an d  Parasitic Diseases 6 12.5 48 18-105 56 21-122
Tuberculosis 2 5.4 37 5-135 57 7-206
All N e o plasms 789 758.9 104 97-111 117 109-125
Ca. Lip, Oral Cavity and Pharynx 5 11.1 45 15-105 51 16-118
Ca. Di g e s t i v e  Organs and Peritoneum 244 220.9 110 97-124 118 103-132
Ca. Oesophagus 31 26.0 119 77-161 127 82-172
Ca. Stomach 81 66.9 121 95-147 145 113-176
Ca. Peritoneum (mesothelioma) 10 1.4 731 351-1344
Ca. Respiratory System 318 312.7 102 90-113
Ca. Lung 241 301.3 80 70- 90 99 87-112
Ca. Pleura (mesothelioma) 66 3.3 1983 1505-2461
Ca. Bone, Tissue, Skin and Breast 14 11.9 118 65-198
Ca. G e n  ito-ur inary Organs 84 87.6 96 75-116 90 71-110
Ca. Prostate 40 41.9 95 66-125 89 61-117
Ca. O t h e r  and Unspecified Sites 74 60.3 123 95-151
j Ca. L y m phatic and Haematopoietic Tissue 42 46.5 90 63-118 94 66-122
I Benign Neoplasms 3 2.2 138 28-402 172 36-504
U n specified Neoplasms 5 5.4 93 30-216
Endocrine a n d  Nutritional Diseases 29 28.4 102 68-147 101 6 7 - 1 4 5  |
Diseases o f  Blood and Blood-forming Organs 3 5.2 58 12-169 63 13-184
Diseases o f  the Nervous System 26 34.7 75 49-110 75 51-116
Diseases o f  the Circulatory System 1152 1310.4 88 83- 93 95 90-101
H ypertensive Disease 17 24.9 68 40-109 74 43-119
Ischaemic Heart Disease 868 924.0 94 88-100 102 95-109
D iseases of Pulmonary Circulation 28 12.3 227 151-329 232 154-335
C erebrovascu 1 ar Disease 148 205.8 72 60- 84 78 66 -  91
Diseases o f  t he Respiratory System 192 255.4 75 65- 86 95 82-109
Acute Respiratory Infections 1 2.8 36 91-199
Other Di s e a s e  of Upper Respiratory Tract 0 0.2 - 0-1836
P n e u monia and Influenza 39 79.6 49 34- 64
Bronchitis, Emphysema and Asthma 45 106.8 42 30- 54 60 4 3- 78
Chronic Obstructive Pulmonary Disease 85 156.8 54 43- 66 72 57- 88
P n e u mocon i os i s 7 3.6 197 79-406 352 141-726
C o a l  workers Pneumoconiosis 0 1.8 - 0-203
A s b e s t o s  is 7 0.4 1718 690-3538
S 1 1 i co s  is 0 0.3 - 0-1308
Other D iseases of the Respiratory System 8 11.3 71 30-139
P u l m o n a r y  Fibrosis 2 3.0 68 8-245
Diseases o f  t he Digestive System 33 65.9 50 33- 67 56 37- 76
Diseases of Oesophagus and Stomach 11 21.6 51 25- 91
Diseases o f  t he Genito-urinary System 11 24.7 45 22- 80 51 25 -  91
Diseases o f  t he Skin and Subcutaneous Tissue 1 1.0 102 3-568 91 2-506
Diseases o f  t he Musculoskeletal System 1 7.3 14 0- 76 15 0 -  83
Symptoms, S i g n s  and Ill-defined Conditions 0 2.4 - 0-153 - 0-199
Accidents, Poisonings and Violence 35 104.3 34 22- 45 34 23- 46
Tr a n s p o r t  Accidents 5 32.1 16 5- 36
Accidental Poisoning 2 4.1 49 6-177
Accidental Falls 1 10.8 9 0- 51
Suicide and Self-inflicted Injury 10 30.5 33 16- 60
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T A B L E  4.2: Chatham Dockyard. Cause specific mortality for 50 disease groups,
with and without regional adjustment.
Causes of Death Without regional adjustment 
Obs Exp SMR 95X Cl
With regional adj. 
SMR 95X C l
Al 1 Causes 1045 1223.9 85 80- 91 91 86- 9 7
Infectious and Parasitic Diseases 6 5.5 109 40-237 106 39-231
Tuberculosis 0 2.3 - 0-158 - 0 - 1 5 4
All Neoplasms 365 351.0 104 93-115 107 9 6 - 1 1 8
Ca. Lip, Oral Cavity and Pharynx 3 4.9 61 13-178 72 15-21 1
Ca. Digestive Organs and Peritoneum 103 102.0 101 81-120 112 9 0 - 1 3 4
Ca. Oesophagus 8 11.9 67 29-132 73 3 1 - 1 4 4
Ca. Stomach 34 31.1 109 72-146 122 8 1 - 1 6 2
Ca. Peritoneum (mesothelioma) 2 0.6 338 41-1222
Ca. Respiratory System 146 144.3 101 85-118
Ca. Lung 116 139.1 83 68- 99 85 70-101
Ca. Pleura (mesothelioma) 24 1.5 1638 1049-2437
Ca. Bone, Tissue, Skin and Breast 6 5.3 114 42-249
Ca. Genito-urinary Organs 38 42.4 90 61-118 90 6 1 - 1 1 8
Ca. Prostate 20 21.1 95 58-146 90 5 5 - 1 4 0
Ca. Other and Unspecified Sites 47 27.4 171 122-220
Ca. Lymphatic and Haematopoietic Tissue 18 21.0 86 51-135 86 5 1 - 1 3 7
Benign Neoplasms 1 1.0 104 3-580 116 3 - 6 4 6
Unspecified Neoplasms 3 2.5 121 25-354
Endocrine and Nutritional Diseases 8 13.4 60 26-118 62 2 7 - 1 2 3
Diseases of Blood and Blood-forming Organs 0 2.5 - 0-147 - 0-151
Diseases of the Nervous System 12 16.3 74 38-129 76 3 9 - 1 3 3
Diseases of the Circulatory System 487 610.2 80 73- 87 89 81- 9 6
Hypertensive Disease 14 11.4 123 67-206 124 6 8 - 2 0 8
Ischaemic Heart Disease 360 424.7 85 76- 93 94 8 4 - 1 0 3
Diseases of Pulmonary Circulation 4 5.8 69 19-177 66 18-170
Cerebrovascular Disease 71 99.8 71 55- 88 84 6 5 - 1 0 4
Diseases of the Respiratory System 107 124.0 86 70-103 93 7 5 - 1 1 0
Acute Respiratory Infections 2 1.3 155 19-559
Other Disease of Upper Respiratory Tract 0 0.1 - 0-3672
Pneumonia and Influenza 23 38.8 59 38- 89
Bronchitis, Emphysema and Asthma 35 50.9 69 46- 91 77 51-102
Chronic Obstructive Pulmonary Disease 62 76.1 82 61-102 89 66-111
Pneumocon i os i s 0 1.7 - 0-212 - 0 - 5 1 2
Coalworkers Pneumoconiosis 0 0.9 - 0-404
Asbestosis 0 0.1 - 0-1992
Silicosis 0 0.3 - 0-2639
Other Diseases of t he Respiratory System 3 5.5 55 11-160
Pulmonary Fibrosis 1 1.4 72 2-399
Diseases of the Digestive System 14 30.3 46 25- 78 49 27- 8 2
Diseases of Oesophagus and Stomach 7 10.2 69 28-142
Diseases of the Genito-urinary System 11 11.9 92 46-165 94 2 8 -142
Diseases of the Skin and Subcutaneous Tissue 0 0.5 - 0-777 - 0-771
Diseases of the Musculoskeletal System 1 3.5 28 1-159 30 1-166
Symptoms, Signs and 111-defined Conditions 0 1.1 - 0-335 - 0-271
Accidents, Poisonings and Violence 22 44.5 49 31- 75 51 32- 7 7
Transport Accidents 6 13.7 44 16- 96
Accidental Poisoning 2 1.7 117 14-422
Accidental Falls 1 4.9 21 1-115
Suicide and Self-inflicted Injury 6 12.8 47 17-102
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TABLE 4.3: Portsmouth Dockyard. Cause specific mortality for 50 disease
groups, with and without regional adjustment.
Causes of Death Without regional adjustment 
Obs Exp SMR 95X Cl
With regional adj. 
SMR 95X Cl
All Causes 1692 2072.7 82 78- 85 88 83- 92
Infectious and Parasitic Diseases 7 9.3 75 30-155 73 29-151
Tuberculosis 2 3.8 52 6-189 51 6-184
All Neoplasms 575 604.2 95 87-103 98 90-106
Ca. Lip, Oral Cavity a n d  Pharynx 12 8.7 138 71-240 164 85-286
Ca. Digestive Organs a n d  Peritoneum 164 175.6 93 79-108 104 88-120
Ca. Oesophagus 27 21.1 128 84-186 139 92-203
! Ca. Stomach 45 52.6 86 61-111 95 68-123
Ca. Peritoneum (mesothelioma) 1 1.0 99 2-551
Ca. Respiratory System 251 208.3 101 89-114
Ca. Lung 218 239.1 91 79-103 94 81-106
Ca. Pleura (mesothelioma) 28 2.7 1042 693-1506
Ca. Bone, Tissue, Skin and Breast 8 9.0 88 38-174
Ca. Genito-urinary O r g a n s 42 71.9 58 41- 76 58 41- 76
Ca. Prostate 26 35.6 73 48-107 70 46-102
Ca. Other and Unspecified Sites 62 48.2 129 97-161
Ca. Lymphatic and Haematopoietic Tissue 33 36.2 91 60-122 92 97-161
! Benign Neoplasms 2 1.6 122 15-439 136 61-124
Unspecified Neoplasms 1 4.3 23 1-130
Endocrine and Nutritional Diseases 17 .23.0 74 43-119 77 45-124
Diseases of Blood and Blood-forming Organs 4 4.2 95 26-242 97 26-248
Diseases of the Nervous S y s t e m 15 27.7 54 30- 89 56 31- 92
Diseases of the Circulatory System 820 1037.0 79 74- 84 88 82- 94
Hypertensive Disease 24 18.9 127 81-189 129 83-193
Ischaemic Heart Disease 582 731.4 80 73- 86 88 81- 95
Diseases of Pulmonary Circulation 4 9.5 42 11-108 40 11-103
Cerebrovascu1ar Disease 122 164.3 74 61- 87 88 72-104
Diseases of the Respiratory System 160 200.2 80 68- 92 86 73- 99
Acute Respiratory Infections 5 2.1 240 78-559
Other Disease of Upper Respiratory Tract 0 0.2 - 0-1530
Pneumonia and Influenza 29 59.0 49 33- 71
Bronchitis, Emphysema a n d  Asthma 39 81.2 48 33- 63 54 37- 71
Chronic Obstructive P u l m onary Disease 78 126.2 62 48- 76 67 52- 82
Pneumocon i os i s 3 2.8 106 22-310 251 52-733
Coal workers Pneumoconiosis 0 1.4 - 0-256
Asbestosis 3 0.3 905 187-2646
Si 1icosis 0 0.2 - 0-1669
Other Diseases of the Respiratory System 7 9.3 75 30-155
Pulmonary Fibrosis 1 2.4 43 1-237
Diseases of the Digestive S y s t e m 38 51.7 74 50- 97 78 57- 99
Diseases of Oesophagus a n d  Stomach 9 17.0 53 24-100
Diseases of the Genito-ur i n a r y  System 9 19.2 47 22- 89 48 22- 90
Diseases of the Skin and Subcutaneous Tissue 2 0.8 252 30-908 250 30-903
Diseases of the Musculoskeletal System 6 6.0 100 37-218 106 39-230
Symptoms, Signs and Ill-defined Conditions 0 1.8 - 0-201 - 0-160
Accidents, Poisonings and Viol e n c e 31 72.2 43 28- 58 44 29- 60
Transport Accidents 3 21.4 14 3- 41
Accidental Poisoning 1 2.7 37 1-205
Accidental Falls 2 8.0 25 3- 90
Suicide and Self-inflicted Injury 14 21.3 66 36-111
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showing a clear excess of cancer mortality. The difference in SMRs was 
significant [X2=10.5, PcO.Ol], This picture, of SMRs close to, or above, 100 
for cancer mortality and a deficiency in all-cause mortality, may imply the 
existence of the healthy worker effect. Accordingly, non-cancer disease groupings 
will now be considered and in particular the two groups, diseases of the 
circulatory system, and diseases of the respiratory system.
For diseases of the circulatory system the following regional SMRs were obtained: 
95 (90-101), 89 (81-96) and 88 (82-94) [X2 = 3.3, P>0.1], For diseases of the 
respiratory system we have: 95 (82-109), 93 (75-110) and 86 (73-99) [X2 = 0.1, 
P>0.1]. From this there is only a slight suspicion of the healthy worker effect, 
with the upper limit of the confidence intervals either overlapping 100 or being 
less than 6% beneath it. In the presence of the healthy worker effect a reduction 
in ‘non-cancer’ SMRs could have been expected in comparison to ‘cancer’ SMRs. 
However, this phenomenon may be obscured here by the long follow-up period. 
Accordingly, mortality patterns for the 12 specific disease groups will be 
scrutinised by time since start of employment for the healthy worker effect in 
section 4.5.
This pattern of SMRs, the ‘non-cancer’ SMRs having confidence intervals 
overlapping 100, generally holds for all subgrouped diseases within the circulatory 
system grouping, with the exception of disease of pulmonary circulation at 
Devonport dockyard. In this instance, the SMR is significantly elevated: 232 
(154-335). Clearly, this does not support the idea of an important healthy worker 
effect. However, this disease group is one of the three commented upon in the 
last chapter as being only an estimated grouping, and therefore having only 
estimated death rates (section 3.2.7). It is used here as a limited indicator of cor 
pulmonale mortality, a disease suspected ‘a priori’ to be related to asbestos 
exposure.f33 Caution should, however, be applied in the over interpretation of 
this single result.
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Within the ‘diseases of the respiratory system’ grouping, we have the following 
four interesting groups: 1) Pneumonia and Influenza, 2) Bronchitis, Emphysema 
and Asthma, 3) Asbestos is, and 4) Pulmonary Fibrosis. From these only 
bronchitis, emphysema and asthma is regionally adjusted, giving the following 
SMRs over the three dockyards: 60 (43-78) at Devonport, 77 (51-102) at 
Chatham, and 54 (37-71) at Portsmouth [Xz = 2.4, P>0.1], generally indicating 
a deficiency in mortality due to bronchitis, emphysema and asthma. This 
deficiency is also seen for pneumonia and influenza, the upper limit of the 
confidence intervals reaching only 89%. For asbestosis, a large excess mortality 
is clearly seen at two dockyards: the SMR at Devonport is 1718 (690-3538), no 
deaths from asbestosis were recorded at Chatham, and at Portsmouth the SMR is 
905 (187-2646). However, these SMRs are based upon only 7 and 3 deaths, 
respectively, [Xz = 0.9, P>0.1]. It is therefore likely that this large difference in 
SMRs has arisen simply due to statistical chance. For pulmonary fibrosis, that is, 
fibrosis coded without mention of asbestos on the death certificate, the following 
SMRs were obtained: 68 (8-245), 72 (2-399) and 43 (1-237). These, however, are 
based upon only 4 deaths across the three dockyards [X2 = 0.2, P > 0.1]. 
Asbestosis and pulmonary fibrosis (9th revision ICD codes 501 and 515), although 
arguably the same clinical condition without postmortem verification of the death 
certificate, are analysed separately throughout this work. All death certificates are 
analysed as coded by the nosologist (the professional death certificate coder) to 
avoid bias.
Pneumoconiosis is also a subgroup of diseases of the respiratory system. It has 
a regional adjustment factor and the following SMRs were produced: 352 (141 - 
726) at Devonport, no deaths were recorded at Chatham, and 251 (52-733) at 
Portsmouth [Xz = 0.2, P>0.1]. Clearly, the mortality due to pneumoconiosis at 
Devonport dockyard is significantly elevated. However, since this is again one 
of the estimated disease groups referred to in chapter three, care should be 
exercised in interpreting this result. Coalworkers’ pneumoconiosis and silicosis 
were also considered among the 50 disease groups. This was to allow for any
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effect of previous mining or quarrying employment, however, there were no 
recorded deaths from these conditions at any dockyard.
The final estimated disease group, that of chronic obstructive pulmonary disease, 
follows the same pattern as its surrogate group ‘bronchitis, emphysema and 
asthma’ with slightly higher regional SMRs of 72 (57-88) at Devonport, 89 (66- 
111) at Chatham, and 67 (52-82) at Portsmouth [X2 = 3.0, P>0.1]. Showing, as 
with its substitute grouping, a general deficiency in mortality due to chronic 
obstructive pulmonary disease. The grouping of bronchitis, emphysema and 
asthma will be used in place of the estimated group of chronic obstructive 
pulmonary disease in the analysis of the 12 specific disease groups.
Returning to all-neoplasms, by observation the two disease groups showing clear 
excess mortality across all three dockyards are cancers of the peritoneum and 
pleura, the two forms of mesothelioma. For pleural mesothelioma the following 
unadjusted SMRs are obtained: 1983 (1505-2461), 1638 (1049-2437), and 1042 
(693-1506); based on 66, 24 and 28 observed deaths [X2 = 8.4, P <  0.025]. For 
peritoneal mesothelioma we have the following: 731 (351-1344), 338 (41-1222), 
and 99 (2-551); based on 10, 2 and one death, respectively [X2 = 5.9, 
0.05 < P < 0.1], Stomach cancer showed a slight excess. Here the adjusted SMRs 
were: 145 (113-176), 122 (81-162), and 95 (68-123) [X2 = 5.2, 0 .05< P < 0 .1 ], 
Mortality due to lung cancer is not seen to be in excess. The three dockyards 
show the following regionally adjusted lung cancer ratios: 99 (87-112) at 
Devonport, 85 (70-101) at Chatham, and 94 (81-106) at Portsmouth [X2=1.8, 
P > 0.1], Lung cancer appears to be neither significantly in excess or in deficit at 
these dockyards, but would appear to be similar with the background population 
rate. Whereas, both forms of mesothelioma and asbestosis show potentially a 
large excess risk.
Regional adjustments were not available for the three disease groups that at this 
point show a clear excess mortality - namely asbestosis, and mesothelioma of both 
the pleura and peritoneum. By examination of the other disease groups it is
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apparent that any adjustment applied would very probably increase the calculated 
SMR. Only in four disease groups at Devonport and Portsmouth and in three at 
Chatham were the SMRs reduced by the regional adjustment. However, regarding 
asbestosis and the two forms of mesothelioma, would any form of regional 
adjustment be appropriate? Would this be comparing like with like? These are 
rare diseases and it is likely that the majority of reported cases in OPCS 'coastal’ 
regions (here the south west and south east regions) are concentrated around 
dockyard conurbations. If this is the case no regional adjustment should be 
undertaken. For lung cancer, the other ‘known’ asbestos related disease, a 
regional adjustment is both available and used. This has its main affect at 
Devonport dockyard, taking the lung cancer SMR from 80 (70-90) to 99 (87-112), 
i.e. taking the ratio from a statistically significant deficiency to being no different 
from that expected for the south west regional population. This affect is also seen 
at Chatham dockyard. Since lung cancer is a relatively more ‘common’ disease, 
the regional adjustment was judged to be required.
When considering the 50 disease groups there is slight evidence of a difference in 
mortality between the dockyards for certain diseases. Possibly, with the mortality 
rates at Devonport being higher than Chatham, which in turn may be higher than 
Portsmouth. However, the variation in SMRs across dockyard is not consistent 
over all groups, and the pattern of disease for each dockyard is very similar. As 
a footnote to this section, mortality due to accidents, poisoning and violence was 
significantly reduced in all three dockyards, as was disease of the digestive 
system.
149
4.3 Non-responder mortality.
The fifty disease groups were also scrutinised for those who were absolute non­
responders in the cross-sectional surveys. The results are given in tables A3.1 to 
A3.3. From these tables, it is readily apparent that the non-responders
experienced higher overall mortality rates than their colleagues who responded. 
The former were 7-41% higher than expected from the general population. The 
all-cause SMR being 141 (125-157) for Devonport, 126 (112-140) for Chatham, 
and 107 (98-116) at Portsmouth. With regional adjustment these become: 156 
(138-173), 135 (120-149) and 114 (104-124) [X2=19.6, P < 0.001], The SMRs 
all being elevated, and generally significantly so (i.e. they are unlikely to be 
chance statistical findings).
For all-neoplasms, the regionally adjusted SMRs are: 143 (111-176), 130 (104- 
157), and 125 (106-144) [X2=1.0, P>0.1]. Again all statistically elevated from 
100. In the case of lung cancer, the SMRs are all in excess of 100, but only 
Portsmouth reaches statistical significance. The lung cancer SMRs are: 142 (94- 
207), 121 (78-161), and 139 (106-169) [X2 = 0.6, P>0.1]. Pleural mesothelioma 
follows the same general pattern for non-responders and responders, with a clear 
statistical excess appearing at all yards. The SMRs are: 2917 (1070-6349), 1558 
(425-3989), and 907 (294-2117); based on 6, 4 and 5 deaths, respectively 
[X2 = 4.1, P>0.1]. Peritoneal mesothelioma is seen only at Devonport and 
Portsmouth: 1076 (27-5993) and 457 (12-2544); based on one case at each yard 
[X2 = 0.4, P>0.1].
This picture of excess mortality, occasionally reaching a statistical excess, is 
generally observed throughout the disease groups of all-neoplasms, diseases of the 
circulatory system, and diseases of the respiratory system. It is very apparent for 
tuberculosis and pulmonary fibrosis, though based on low numbers of observed 
deaths. The tuberculosis SMRs are: 363 (9-2022), 407 (49-1469), and 109 (3-609) 
for 4 cases in total [X2 = 1.4, P > 0.1], A single case of pulmonary fibrosis is seen 
at each dockyard, producing the following SMRs: 404 (10-2248) at Devonport,
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333 (8-1856) at Chatham, and 172 (4-956) at Portsmouth [X2 = 0.4, P > 0.1 ]. No 
cases of asbestos is were reported. No single cause of death was seen to have 
significantly reduced SMRs.
This suggests that an element of the non-responders may have been chronically ill 
and deselected themselves out of the initial surveys on health grounds. If this 
hypothesis is correct the non-responder mortality rates may be expected to be high 
at study definition, declining to ‘normal’ levels (i.e. responder levels) as follow-up 
continued. To explore this, non-responder mortality rates were initially examined 
by period of follow-up for the 12 specific causes of interest given in table 3.18. 
Table 4.4 gives these results.
From table 4.4 the largest SMRs generally appear to occur in the early years of 
follow-up (i.e. in either the group <5 years or the group of 5-9 years of follow­
up). There is an indication of significant differences in the SMRs over follow-up 
period at Devonport and Portsmouth, however, at Chatham the rate appears 
constant. For example, considering all-cause mortality, at Devonport a chi- 
squared test of the difference between SMRs approached statistical significance 
[X2 = 5.5, 0 .05<P<0.1], likewise at Portsmouth [X2 = 4.6, P = 0.1]. However, 
at Chatham no difference was seen [X2 = 0.05, P>0.1]. For all-neoplasms only 
the difference between SMRs at Portsmouth was statistically significant [X2 = 6.5, 
P<0.05]. For diseases of the respiratory system, the difference in SMRs at 
Devonport [X2 = 6.3, P<0.05] and Portsmouth [X2 = 9.3, P<0.01] were both 
significant. The large change in SMR at Devonport for pleural mesothelioma was 
also significant [X2 = 6.5, P<0.03], but was based on only 6 cases.
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TABLE 4.4: Cause specific mortality by follow-up period and dockyard 
for initial study non-responders.*
Caus e s  of Death Follow-up 
period 
(yrs)
Devonport
Obs
Chatham Portsmouth
Obs SMR 9SX Cl SMR 95X Cl Obs SMR 95X Cl
i All Caus e s <5 88 193 153-234 78 137 107-168 126 126 104-148
5-9 81 146 115-178 94 135 108-163 130 98 81-114
10+ 125 142 117-167 148 133 112-154 276 118 104-132
All Neoplasms <5 26 205 134-301 22 132 83-201 49 167 120-213
5-9 18 117 70-185 30 147 99-209 39 98 67-129
10+ 31 128 83-172 39 119 82-157 85 123 96-149
Ca. Stomach <5 4 319 87-816 2 124 15-449 7 251 101-518
5-9 1 71 2-397 3 168 35-491 4 118 32-301
10+ 2 103 12-370 7 280 112-577 6 114 42-248
Ca. Peritoneum <5 1 3235 82-18018 0 _ 0-10121 0 _ 0-5474
5-9 0 - 0-12467 0 - 0-10719 0 - 0-5541
10+ 0 0-11381 0 - 0-9500 1 1178 30-6560
Ca. Lung <5 9 177 81-337 10 137 66-251 19 148 89-231
5-9 8 137 59-271 13 150 80-257 19 114 69-179
10+ 10 123 59-226 11 90 45-161 39 151 103-198
Ca. Pleura <5 4 9344 2546-23921 1 1826 46-10171 3 2830 584-8272
5-9 2 3653 442-13188 2 2975 360-10741 0 - 0-2671
10+ 0 0-3412 1 742 19-4134 2 651 79-2351
Circul a t o r y  System <5 45 194 138-251 42 154 107-200 52 108 79-137
5-9 47 162 115-208 46 135 96-174 65 99 75-124
10+ 71 156 120-192 75 140 108-172 123 109 90-129
P u l m onary Circulation <5 2 868 105-3135 0 _ 0-1239 0 _ 0-709
5-9 2 512 62-1850 0 - 0-716 1 98 2-547
10+ 1 239 6-1331 1 197 5-1097 0 - 0-377
Respiratory System <5 13 293 156-502 10 161 77-296 22 214 134-325
5-9 10 179 86-328 14 177 97-296 11 75 38-135
10+ 9 103 47-195 15 121 68-199 30 120 81-172
Bronchitis, Emphysema <5 2 90 11-325 3 91 19-265 8 148 64-292
and Asthma 5-9 4 178 49-457 2 59 7-213 3 49 10-144
10+ 2 80 10-287 8 205 89-404 8 102 44-201
Asbestosis <5 0 _ 0-65776 0 _ 0-48884 0 _ 0-25250
5-9 0 - 0-43654 0 - 0-35608 0 - 0-17704
10+ 0 - 0-25513 0 - 0-20942 0 - 0-9634
P u l m onary Fibrosis <5 0 _ 0-5175 0 _ 0-4287 0 _ 0-2473
5-9 0 - 0-5683 1 1328 34-7398 0 - 0-2723
10+ 1 896 23-4992 0 0-2660 1 336 0-1871
The quoted SMRs from this table onwards will, where appropriate, be with 
regional adjustment.
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Annual patterns of mortality for both responders and non-responders, over the 17 
year follow-up period, were considered next (these are given in tables A3.4 to 
A3.6). These clearly illustrate, for each dockyard, a ‘fading-away’ affect in the 
non-responder mortality rate with time. Figure 4.1 demonstrates this affect 
graphically for Devonport dockyard for the disease groups of: all-causes, all­
neoplasms, lung cancer, and diseases of the circulatory system. For all-causes a 
chi-squared test of difference in SMRs for study responders was significant 
[X2 = 28.9, P<0.05] and a test of a decreasing trend in their SMRs was non­
significant [X2 for trend = 0.01, P>0.1], the non-responders produced both a 
significant difference and trend [X2 = 71.1, P<0.001; X2 for trend=10.3, 
P<  0.005]. For all-neoplasms the responders produced non-significant results in 
both tests [X2=18.7, P>0.1; X2 for trend =1.2, P>0.1], and again the non­
responders gave significant results [X2 = 33.6, P<0.01; X2 for trend = 9.6, 
P < 0.005]. It may be concluded from these results and observation of figure 4.1, 
that the responders do indeed represent a baseline level of mortality that the initial 
surveys non-responders slowly approach over time. These tables and figures then 
give some evidence to support the idea of certain non-responders being chronically 
ill at study definition and in turn succumbing to disease and death in the first years 
of follow-up, the overall non-responder mortality rate then reducing to responder 
levels.
Age effects on non-responder mortality were considered next. The only 
information available concerning the age of non-responders was their date of 
death. Accordingly, mortality rates by age at death are compared for responders 
and non-responders (these are given in tables A3.7 and A3.8). From these tables 
there appears to be a slight overall decline in SMR with age at death for study 
responders and a more substantial decline for non-responders. The rate of decline 
is affected by the relatively low numbers of observed deaths at the younger ages 
producing the highest SMRs. Figure 4.2 illustrates this point. After omitting the 
youngest group (<  35 years of age) the decline in SMR for non-responders was 
generally still very significant (P<0.01). This again gives support to the idea of
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certain non-responders being chronically ill, producing much higher than expected 
SMRs at younger ages in comparison to the responder SMRs.
It is possible that the overall excess mortality rates found in the non-responder 
group may explain, in part, the deficiency seen in section 4.2 for the study 
responders. To examine this the following three disease groups were considered: 
all-causes, all-neoplasms, and lung cancer. By combining the responder and non­
responder observed and expected mortality at each dockyard table 4.5 was 
produced.
TABLE 4.5: Responder and Non-responder mortality for the disease 
groups: All-Causes, All-Neoplasms and Lung Cancer.
Dockyard Obs SMR 9 5Z Cl
All Causes. Devonport: 2583 101 97-105
Chatham: 1365 99 93-104
Portsmouth: 2224 „ 93 89- 97
[X*«8.6, P<0.025]
All Neoplasms. Devonport: 864 119 111-127
Chatham: 456 111 101-121
Portsmouth: 748 „ 103 96-111
[X =8.4, P<0.025]
Lunq Cancer. Devonport: 268 102 90-114
Chatham: ISO 91 77-106
Portsmouth: 295 „ 103 91-114
[X^-l.?, P>0.1]
From this table it is clear that an ‘all-worker’ study would not have generally 
found a deficit mortality rate in these disease groups. The all-cause SMRs being 
more or less 100, the all-neoplasm SMRs being raised above 100 and showing no 
statistical deficit. The lung cancer SMRs show no signs of either a significant 
excess or deficit in mortality. It is possible that any healthy worker effect to be 
seen among the study responders may be overshadowed by the absolute deselection 
effect of the non-responders.
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It should be noted that the non-responders had poor OPCS trace rates. In total 
527 non-responders from the three yards could not be traced; by dockyard this 
was: 131 (13.4% of the non-responders) at Devonport, 72 (7.9%) at Chatham, and 
324 (14.8%) at Portsmouth'. This is likely to be an artifact of the initial surveys 
follow-up requirements (non-responders being invited to attend only once more 
after initial failure to attend), and a problem of definition of the study population. 
It has the effect of reducing the number of non-responders analysed in this section 
to 3,670 workers (i.e. to only those non-responders who were successfully flagged 
at OPCS).
4.4 Cause specific mortality according to questionnaire and x-rav type.
Before progressing to a more detailed analysis of mortality, the study responders 
are briefly inspected according to questionnaire and x-ray type. Tables A3.9 and 
A3.10 give the results of this. In these tables the mortality rates of workers 
replying to the self-administered (free) questionnaire are compared with those 
responding to both the free and doctor-administered questionnaire, and against 
those not supplying a questionnaire. For x-ray type, workers with only small x- 
rays are compared to those with both small and large x-ray, and to those with no 
x-ray.
By inspection the mortality rates by questionnaire type at Chatham dockyard 
appear reasonably constant; when tested all differences were non-significant 
(P>0.1). At Devonport significant differences were found in the SMRs for all­
cause mortality [X2 = 9.1, P<0.025], all-neoplasm mortality [X2=11.7,
P<0.005], mortality due to lung cancer [X2=10.0, P<0.01], and pleural 
mesothelioma [X2=13.2, P < 0.005], Similar results were observed for 
Portsmouth. Generally the pattern of mortality over questionnaire type at 
Devonport and Portsmouth is variable, no one type being seen to have consistently
At Rosyth 666 (43.3%) of the non-responders were untraced.
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higher mortality rates. This variability of rate is also observed over x-ray type for 
all three dockyards. From this it could be concluded that the questionnaire and 
x-ray non-responders (i.e. the groups designated ‘neither’ in tables A3.9 and 
A3.10) generally experienced similar mortality rates to the questionnaire and x-ray 
responders (the groups entitled either ‘free’ and ‘both’ in table A3.9 or ‘small’ and 
‘both’ in table A3.10).
The majority of the following analyses will exclude those workers with no 
questionnaire information. These workers are not initial survey ‘absolute non- 
responders’ since they all supplied x-ray information. However, no employment, 
medical history, or asbestos exposure information was available for these subjects. 
This reduces the number of observed deaths in the bulk of the following analyses 
from 5,026 to 4,373.
4.5 Cause specific mortality according to employment-time variables.
This section is concerned with a description of mortality over certain employment 
variables. These variables are all time related and consist of the following: time 
since start of employment, length of service, year of start of employment, and age 
at start of employment. Mortality related to these variables is cited when there are 
sufficient deaths to allow sensible analysis.
When analysed according to age, the patterns in each dockyard were similar 
(figure 4.3), with the SMRs generally appearing to be reasonably constant over 
recruitment age. The results are given in table A 3 .ll; these are illustrated, for 
Devonport only, in figure 4.4*. For the 12 causes of death analysed, the SMRs 
commonly showed little change over age at start of employment group, chi- 
squared tests of a difference in SMRs were mostly non-significant (P>  0.1). The
Throughout, SMR histograms are presented taking Devonport as a 
representative dockyard.
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FIGURE 4.4: Standardised mortality ratios by age at start of employment
and year of start of employment for Devonport dockyard.
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exception to this is lung cancer and pleural mesothelioma both of which 
approached a statistically significant difference in SMR with age [X2 = 9.4, 
P = 0.05 and X2 = 8.2, 0 .05< P < 0 .1 , at Devonport], lung cancer appearing to 
increase, while pleural mesothelioma appears to decrease with age. Pleural 
mesothelioma also showed a significant trend in its decreasing SMR [X2 for 
trend = 4.4, P<0.05], Both forms of mesothelioma and asbestosis continue to 
show a clear excess mortality. However, as noted before, the peritoneal 
mesothelioma and asbestosis SMRs are based on low numbers (similarly for 
pulmonary fibrosis).
Disease of pulmonary circulation shows a marked affect in table A3.11 and figure 
4.4; with high recorded SMRs over age at start of employment group, the SMRs 
appearing to increase with age. However, this increase is statistically non­
significant [e.g. X2 = 2.2, P > 0 .1 , at Devonport]. As mentioned previously this 
disease group was formed as a surrogate for cor pulmonale, which has been 
considered associated with both lung disease and asbestos exposure.131 It is 
possible that overly low estimates of expected numbers has resulted in these huge 
SMRs with their accompanying wide standard errors (producing chi-squared tests 
of a difference in SMRs that are non-significant). For this reason, disease of 
pulmonary circulation will not be considered further, however, it will continue to 
be tabulated in the appendix tables and illustrated in the forthcoming figures.
Calendar year of employment is considered next (figures 4.3, 4.4 and table 
A3.12). The associations seen are in slight contrast with those for age at start of 
employment. Overall, statistical differences are not seen in SMR across calendar 
period, however, lung cancer, pleural mesothelioma and diseases of the respiratory 
system are exceptions to this (generally, P<0.05). Another exception is all-cause 
mortality at Devonport dockyard [X2= 10.4, P < 0.05]. As with age at recruitment 
a trend in decreasing pleural mesothelioma SMR is seen at Devonport [X2 for 
trend = 14.7, P<  0.001], The highest SMRs for this disease all occurring before 
World War II. Mesothelioma SMRs prior to 1930 were: 5118 (2207-10082), 1424 
(36-7933), and 5072 (1643-11838); based on 14 deaths. Peritoneal mesothelioma
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FIGURE 4.5: Standardised mortality ratios by length of service and time
since start of employment for Devonport dockyard.
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in the same period produced SMRs of 2789 (338-10070) at Devonport and 3206 
(81-17857) at Chatham; based on 3 deaths. An increasing trend is also seen at 
Devonport for diseases of the respiratory system [X2 for trend = 8.4, P<  0.005].
Few notable patterns emerged when SMRs were analysed according to length of 
service (figure 4.5 and table A3.13). However, an increasing trend in SMR is 
seen for pleural mesothelioma (generally, PcO.Ol). By observation of table 
A3.13 there was a tendency for SMRs to be lowest for individuals employed for 
30 years or more. For these workers mortality due to all-causes, diseases of the 
circulatory and respiratory systems and bronchitis was seen to be significantly 
reduced from that expected in the regional population for Devonport and 
Portsmouth.
When analysing mortality by time since first employment (figure 4.5 and table 
A3.14) only respiratory system diseases showed a significant trend, indicating a 
decreasing SMR over time [X2 = 23.4, P<  0.001 at Devonport, and X2 = 20.9, 
P <  0.001 at Portsmouth], This decreasing trend was significant only at Devonport 
[X2 for trend = 12.7, P <  0.001]. A slight deficiency in mortality is seen at more 
than 30 years since first dockyard employment. This is again for all-causes, 
diseases of the circulatory and respiratory systems and bronchitis. However, apart 
from diseases of the respiratory system no other disease group gave any evidence 
of a systematic increase or decrease in SMR over time since first employment. 
SMRs for all causes of death combined for the three dockyards were very similar 
throughout the period of follow-up (figure 4.3), generally being just below 100 
and non-significant.
SMRs showed no obvious pattern when time since first employment was analysed 
by length of service stratum (table 4.6 gives the results for all-cause mortality, 
tables A3.15 and A3.16 for lung cancer and pleural mesothelioma). There is only 
a very slight hint that the lowest SMRs fall on the main diagonal of these tables; 
lowered SMRs on this diagonal are a feature common in studies showing the 
healthy worker effect. The empty cells to the right of the diagonal would have
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referred to individuals who had left dockyard employment (in this study this would 
be before the enumeration dates), a group whose mortality patterns are unavailable 
in this study. This is another factor that may aid in obscuring a healthy worker 
effect and assist in producing the patterns seen at the three dockyards of little, if 
any, overall excess or deficiency of mortality.
Only for those workers with 30 or more years of service and 40 plus years since 
first potential exposure were effects being seen with significant declines in all­
cause SMR showing at both Devonport and Portsmouth. Chatham dockyard had 
no result that was either in excess or significantly reduced. No obvious trends in 
mortality pattern were seen. This result is generally repeated for lung cancer. 
However, there is an indication of excess mortality occurring at long intervals 
from first exposure, i.e. for those workers with less than 20 years employment 
who had first been employed over 30 years ago, with an SMR of 199 (114-324) 
at Devonport. In fact for those workers with between 10 and 19 years of 
employment an increasing lung cancer SMR was observed at Devonport with time 
since first exposure. The SMRs were: 104 (52-186) for 10-19 years since first 
exposure, 122 (79-164) for 20-29 years, and 199 (114-324) for 30-39 years. 
However, this was not a statistically significant trend [X2 = 3.5, P >  0.1 and X2 for 
trend = 2.8, P>0.1], This pattern, also with a non-significant trend, was further 
observed for those workers with between 20 and 29 years of employment at 
Chatham.
When considering pleural mesothelioma the numbers become very small for 
Chatham and Portsmouth (table A3.16), however, it is clear that there is a large 
excess mortality at all three dockyards for this condition clustered among those 
workers with long follow-up and long duration of service. For the longest period 
of service and follow-up the following SMRs are observed: 3337 (2215-4459) at 
Devonport, 3080 (1725-5080) at Chatham, and 1756 (959-2946) at Portsmouth; 
based on 34, 15 and 14 deaths respectively. No clear trends are seen in this 
excess mortality, the SMRs being very variable and singly highly significant. At 
Chatham one mesothelioma death occurred for a worker within 10 years of first
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T A B L E  4 .6 : A ll cause mortality by length of service, time since first exposure,
and dockyard.
Time since first exposure (employment)
Length of - 9 10 - 19 20 - 29 30 - 39 40+
service
( y s ) Obs SMR O bs SMR Obs SMR Obs SMR Obs SMR
(95X Cl) (95X Cl) (95X Cl) (95X Cl) (95X Cl)
DEVONPORT
! <5 51 116 73 86 4 165 _ _
(84-148) (67-106) (45-422)
5 - 9 20 68 143 119 61 105 _ _
(41-105) (99-138) (78-131)
10 - 19 _ 108 105 223 87 81 94 _
(85-125) (75- 98) (74-115)
20 - 29 _ _ 109 91 257 97 65 120
(74-108) (85-109) (91-149)
30* _ _ _ 167 95 721 90
(81-110) (83- 97)
CHATHAM
1 <5 17 75 38 79 1 39 _ _
(44-121) (54-105) (1-218)
5 - 9 7 65 4 3  87 22 89 _ _
(26-135) (61-114) (56-135)
10 - 19 _ 14 61 57 93 16 69 _
(33-103) (69-118) (40-112)
20 - 29 _ _ 33 88 96 92 25 86
(58-118) (73-110) (55-126)
! 30+ _ _ _ 66 88 385 95
(66-109) (85-104)
PORTSMOUTH
<5 26 96 4 3  79 3 173 _ _
(63-140) (56-103) (36-507)
5 - 9 6 50 54 104 23 88 _ _
(18-108) (76-132) (56-133)
i 1 0 - 1 9 _ 49 84 143 95 41 91 _
(61-108) (79-111) (63-119)
20 - 29 _ _ 87 91 188 78 58 87
(72-110) (67- 90) (65-110)
30+ _ _ _ 108 103 502 81
(83-122) (74- 88)
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T A B L E  4.7: All cause mortality by year of start of employment, time since first
exposure, and dockyard.
Time si nee first exposure (employment)
j Year of 
Start
Obs
- 9 
SMR
(95X Cl)
10 - 19
Obs SMR 
(95X Cl)
20 - 29
O b s  SMR 
(95X Cl)
3 0 - 3 9
Obs SMR 
(95X Cl)
O b s
40*
SMR
(95X Cl)
DEV0NP0RT
Pre 1930 - - - - 3 29 86
(72- 99)
: 1930- - - 91 81
(64- 97)
4 9 3 92
(84-100)
1940- - - 53 107 
(78-136)
237 102
(89-115)
144 99
(83-115)
1950- - 44 93
(66-121)
214 84
(72- 95)
175 96
(82-111)
-
! I960* 71 96
(74-118)
280 107
(95-120)
132 99 
(82-116)
” -
CHATHAM
Pre 1930 - - - - 74 91
(70-111)
1930- - - 56 102
(75-129)
281 97
(86-109)
1940- - 15 75 
(42-124)
76 78
(61- 96)
5 5 85
(62-107)
1950- - 4 42
(11-108)
58 95 
(70-119)
46 90
(64-116)
-
1960* 24 72
(46-107)
91 82
(65- 99)
40 90 
(62-117)
“ ~
PORTSMOUTH
Pre 1930 - - - - 9 7 86
(69-103)
1930- - - - 61 105
(78-131)
331 78
(70- 87)
1940- - - 2 8  70 
(46-101)
176 87
(74- 99)
1 32 86
(72-101)
1950- - 11 49
(24- 87)
136 90 
(75-105)
100 78
(62- 93)
-
1960* 32 81
(53-109)
135 95
(79-111)
92 n o  
(88-133)
“ “
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T A B L E  4.8: A ll cause mortality by age at start of employment, time since first
exposure, and dockyard.
Time si nee first exposure (employment)
Age at 
start 
( y s )
0 - 9
Obs SMR 
( 9 5 %  Cl)
10 - 19
Obs SMR 
(95% Cl)
20 - 29
Obs SMR 
(95% Cl)
3 0 - 3 9
Obs SMR 
(95% Cl)
Obs
40+
SMR
(95% Cl)
DEVONPORT
<25 9 78
(36-149)
46 134
(95-173)
79 108
(84-132)
192 93 
(80-107)
613 92
(85- 99)
25- 1 31
(1-173)
28 144
(95-207)
71 93
(71-114)
181 100 
(85-114)
161 90
(76-104)
35- 7 83
(34-172)
58 89
(66-113)
138 83
(69- 97)
117 94 
(77-111)
12 106
(55-185)
45- 26 90
(59-132)
147 105
(88-122)
99 88
(71-106)
13 93 
(50-159)
-
55+ 28 127
(85-184)
45 89
(63-115)
12 126
(65-220)
" “
CHATHAM
<25 3 80
(17-235)
9 79
(36-149)
16 71
(40-115)
72 95 
(73-117)
299 91
(80-101)
25- - 3 59
(12-173)
18 83
(49-131)
68 83 
(63-103)
106 105
(85-125)
35- 3 107
(22-312)
15 92
(51-151)
46 116
(82-149)
37 91 
(61-120)
5 142
(46-331)
45- 12 117
(60-204)
37 82
(56-109)
23 73
(46-110)
1 27 
(1-153)
-
55+ 6 39
( 1 4 -  84)
31 74
(48-100)
10 96
(46-177)
“ ~
PORTSMOUTH
<25 3 62
(13-181)
15 97
(54-160)
33 80
(52-107)
124 88 
(73-104)
436 80
(72- 87)
25- 1 60
(2-334)
7 76
(30-156)
51 107
(78-137)
130 95 
(78-111)
no 84
(68-100)
35- 4 93
(25-238)
38 104
(71-137)
108 95
(77-113)
73 72 
(55- 88)
14 105
(58-177)
45- 11 75
(38-135)
62 85
(64-107)
62 93
(70-116)
10 99 
(48-182)
-
55+ 13 93
(49-159)
24 78
(50-117)
2 40
(5-146)
—
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dockyard exposure (the worker had less than 5 years dockyard employment). No 
previous occupational history was available for this worker.
The same picture is seen when considering time since first employment by period 
of first employment (tables 4.7, A3.17 and A3.18). No clear trends emerge from 
these tables. All-cause mortality together with lung cancer mortality is not seen 
to be in significant excess or deficit. Pleural mesothelioma, though again suffering 
from low numbers, can be seen to be generally in great excess, concentrating 
around those workers with long follow-up, having been first employed before 
World War II.
When examining age at start of employment strata over time since first 
employment period a problem arises. These factors are correlated, i.e. there are 
more recent recruits among younger workers than among older workers, etc. This 
problem will be addressed by the use of regression modelling (section 4.8). 
However, by inspection no obvious excess or deficit is seen for lung cancer and 
all-cause mortality (tables 4.8 and A3.19). Pleural mesothelioma (table A3.20) 
again shows an excess, mainly for those workers employed at a young age over 
30 years ago.
4.6 Cause specific mortality according to health-status variables.
Under this general heading the following factors will be considered: personal 
medical history, i.e. the prevalence of cough, phlegm, breathlessness and chest- 
illness, smoking habits and smoking history, and also x-ray grouping. This last 
category, x-ray group, is considered here since in its grouped form this also 
represents a health status variable, i.e. the presence or absence of pulmonary 
fibrosis, tuberculosis, etc. In this sense, x-ray group and the personal medical 
symptoms may be considered predictive variables of disease outcome.
Cough is examined in table A3.21. From this table it is reasonable to conclude 
that there is no overall difference seen in this possible symptom of asbestos related
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FIGURE 4.6: Standardised mortality ratios by x-ray group and duration of
smoking habit for Devonport dockyard.
169
respiratory illness over the dockyards. For all-cause mortality, the SMRs in each 
dockyard are significantly in excess for those workers responding positively to the 
question ‘do you usually cough during the day or night at work?’. However, there 
is no significant difference between the dockyards (P> 0.1). The SMRs are: 121 
(111-130), 119 (103-135), and 127(115-139). For those workers responding‘No’ 
to the above question the following significantly reduced SMRs are obtained: 88 
(83-93), 83 (76-89), and 73 (68-78). Not surprisingly, there are highly significant 
differences between the SMRs in the different response-type groups, i.e. between 
the yes or no response, (commonly, P<0.01). This pattern generally holds 
across all 12 disease groups. However, an obvious exception is for diseases of the 
circulatory system. Here the difference over response type has borderline 
significance at Devonport [X2 = 4.0, 0 .05<P<0.1], non-significance at Chatham 
[X2 = 0.6, P>0.1] and significance at Portsmouth [X2=15.3, P<0.01],
The patterns seen for cough are also generally observed for phlegm, breathlessness 
and chest-illness (tables A3.22 to A3.24). The significant and non-significant 
results are seen to be very variable over disease group and dockyard, with the 
likelihood of these being chance findings varying considerably. From tables 
A3.21 to A3.24 it is reasonable to conclude that the four medical symptoms may 
be used as predictive variables for lung disease and possibly asbestos related lung 
disease. Accordingly, these symptoms will be used in the following log-linear 
modelling.
As expected no obvious patterns or trends emerge over x-ray group, the grouping 
being a nominal scale (figure 4.6 and table A3.25). The ‘normal’ x-ray group, 
group 1, has significantly low overall SMRs for each dockyard: 91 (86-95), 85 
(79-91), and 80 (75-85); the variation over dockyard being significant [X2 = 9.8, 
P<0.01]. Group 4, the pulmonary fibrosis group, generally has significantly 
raised SMRs. For all-cause mortality the SMRs for group 4 are: 151 (112-191) 
at Devonport, 125 (77-191) at Chatham, and 151 (101-218) at Portsmouth; with 
no variation showing across dockyard [X2 = 0.6, P>0.1]. Not surprisingly the 
highest SMRs for this x-ray group are found in the disease groups of asbestosis
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(with an SMR of: 32287 (3919-116917) at Devonport), pulmonary fibrosis (with 
SMRs of: 2049 (52-11413) and 4637 (117-25829) at Devonport and Chatham, 
respectively), and the two forms of mesothelioma. Peritoneal mesothelioma 
occurring only at Devonport with an SMR of 5303 (134-29539), pleural 
mesothelioma occurring at Devonport and Portsmouth with SMRs of 4456 (539- 
16085) and 4405 (111 -24538). These are all based on very low numbers of 
deaths. The very high SMR for asbestosis at Devonport dockyard being based 
upon two reported cases. For lung cancer the following high SMRs were 
reported: 227 (104-430) at Devonport, 142 (29-415) at Chatham, and 375 (171- 
711) at Portsmouth. In absolute terms these lung cancer SMRs are smaller than 
those reported above, but it should still be noted that there is a clear excess risk 
being reported at Devonport and Portsmouth.
High SMRs are seen for subjects with pleural calcification, i.e. for x-ray group 
3, for peritoneal and pleural mesothelioma. Peritoneal mesothelioma being seen 
only at Devonport in this x-ray group and producing an SMR of 7761 (939- 
28016), based on two cases. Pleural mesothelioma is seen at all three dockyards 
with the following SMRs: 7910 (2563-18463), 7894 (955-28497), and 1760 (45- 
9805); based on 5, 2, and one death respectively. No deaths occurred, as 
anticipated, in this x-ray group from asbestosis and pulmonary fibrosis. For lung 
cancer the following non-significant SMRs occurred: 107 (39-234), 110 (23-323), 
and 52 (11-152).
Excessive SMRs are also seen for x-ray group 2, the workers with pleural 
thickening. These centre around pleural mesothelioma and asbestosis. For Pleural 
mesothelioma the following SMRs were produced: 4277 (1844-8426) at 
Devonport, 2137 (258-7693) at Chatham, and 3726 (1607-7339) at Portsmouth; 
based on 18 deaths in total. For asbestosis an SMR of 4060 (107-22614) was 
obtained at Devonport; based on one death. Lung cancer was again seen to be 
neither in excess or deficit with SMRs of: 95 (52-159), 64 (24-140), and 115 (73- 
173).
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High lung cancer SMRs are generally seen only for x-ray groups 3, 4 and 6; 
group 6 being a general catchment group of ‘all other abnormalities’. Lung cancer 
SMRs for this group were: 132 (86-195), 137 (75-230), and 123 (81-181). Pleura 
mesothelioma was reported with the following SMRs: 44 (11-2473), 3138 (647- 
9172), and 941 (114-3398); based on 6 deaths. There were no cases of asbestosis 
or peritoneal mesothelioma in group 6. Generally x-ray group 5, those workers 
with tuberculosis, gave non-elevated SMRs. Apart from pleura mesothelioma with 
SMRs of: 1894 (391-5538) at Devonport, no deaths at Chatham, and 1264 (32- 
7041) at Portsmouth. The SMRs for lung cancer were: 89 (44-159), 74 (20-190), 
and 180 (99-303); with the raised SMR at Portsmouth being very close to 
statistical significance (P = 0.056). From these results it would appear that x-ray 
groups 2, 3 and 4 (the groups indicating pleural thickening, pleural calcification 
and pulmonary fibrosis) could provide reasonable predictive properties for asbestos 
related lung disease. Therefore, these factors will be considered in the subsequent 
log-linear modelling.
When considering mortality by smoking habits no apparent differences appear 
between dockyards. However, a gradient of SMR from low in nonsmokers 
(significantly reduced), to higher in ex-smokers (with no difference from an SMR 
of 100), to significantly high in current smokers is generally observed over all 
disease groups in all three dockyards (table 4.9). Smoking habits were defined in 
the initial 1972-73 surveys; the definition of a current smoker is, therefore, a 
worker who smoked as much as one cigarette per day, or its equivalent, in the 
early 1970s. The above mentioned gradient produces a highly statistically 
significant trend over smoking habit for the following disease groups in each 
dockyard: all-cause mortality [X2 for trend = 82.9, P< 0.001]*, all-neoplasms [X2 
for trend = 33.1, P < 0.001], lung cancer [X2 for trend = 58.1, P < 0.001], diseases 
of the circulatory [X2 for trend = 14.7, P<  0.001] and respiratory systems [X2 for 
trend= 17.1, PcO.001], and bronchitis [X2 for trend = 8.0, P<0.005]. No trend
The tests for trend are for Devonport dockyard. Those for Chatham and 
Portsmouth were generally lower, however, still highly significant.
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T A B L E  4.9: Cause specific mortality by smoking habit and dockyard
Causes of Death Smoking
Hab i t
Obs
Devonport
Obs
Chatham
Obs
Portsmouth
SMR 95% ClSMR 95X Cl SMR 95X Cl
All Causes Non 251 72 63- 80 95 58 46- 70 171 58 49- 66
Ex 427 75 68- 82 165 70 59- 81 315 68 60- 75
C u rrent 1415 112 106-118 569 109 100-118 906 104 97-111
Unknown 37 76 52-101 14 73 40-123 8 83 36-163
All Neoplasms Non 77 78 61- 96 33 68 45- 92 57 64 47- 80
Ex 149 91 76-105 60 85 63-106 97 68 55- 82
C urrent 489 135 123-147 214 137 118-155 334 126 113-140
Unknown 13 96 51-165 3 55 11-162 2 67 8-243
C a . Stomach Non 10 126 60-231 3 77 16-226 4 56 15-144
Ex 18 131 78-208 7 120 48-247 12 104 54-182
Cur r e n t 48 159 114-205 20 155 95-240 24 112 72-167
U nknown 2 172 21-619 0 - 0-813 0 - 0-1546
Ca. Peritoneum Non 1 454 11-2530 1 1097 28-6111 0 _ 0-2241
Ex 2 634 77-2289 0 _ 0-3188 1 436 11-2429
C urrent 6 822 301-1789 0 - 0-1355 0 _ 0- 812
Unknown 0 “ 0-15847 1 123 311-68557 0 - 0-75109
i Ca. Lung Non 6 18 6- 38 3 16 3- 47 7 20 8- 41
Ex 32 54 35- 72 14 49 27- 82 24 42 27- 63
C urrent 183 140 120-160 78 124 97-152 156 148 125-171
U nknown 2 41 5-148 1 47 1-260 1 84 2-469
Ca. Pleura Non 13 2511 1337-4294 5 2246 728-5242 7 1605 644-3307
Ex 14 1776 971-2980 4 1350 368-3455 8 1287 555-2536
Cur r e n t 34 1912 1269-2555 12 1775 917-3101 11 911 455-1629
U nknown 1 1791 45-9978 0 “ 0-19160 0 - 0-27732
Circulatory System Non 131 75 62- 88 49 63 46- 81 92 65 52- 78
Ex 229 78 68- 88 76 66 51- 81 169 75 63- 86
Cur r e n t 703 109 101- 117 257 102 90-115 408 97 87-106
U nknown 161 72 42- 113 9 97 45-185 5 107 35-249
Pulmonary Circulation Non 3 176 36- 514 1 120 3-670 1 68 2-378
Ex 7 238 95- 490 0 - 0-294 0 _ 0-152
Cur r e n t 17 262 153- 420 3 108 22-317 1 22 1-124
Unknown 0 - 0- 1407 0 * 0-3505 0 - 0-7391
Respiratory System Non 18 64 38- 101 7 44 18- 91 5 18 6- 42
Ex 23 47 29- 70 16 66 38-107 26 56 37- 82
Cu r r e n t 130 121 100- 141 56 107 79-135 99 118 95-141
U nknown 4 84 23- 216 1 43 1-241 1 107 3-595
Bronchitis, Emphysema Non 4 39 11- 99 2 32 4-117 1 9 0- 52
and Asthma Ex 4 22 6- 56 5 52 17-122 6 33 12- 73
Cu r r e n t 32 80 52- 107 19 91 55-142 27 82 54-119
U nknown 1 59 1- 328 1 117 3-654 1 273 7-1523
Asbestosis Non 0 _ 0-6293 0 _ 0-14120 0 _ 0-7250
Ex 3 3008 621-8792 0 - 0-9509 0 - 0-4621
Cu r r e n t 4 1828 498-4679 0 - 0-4303 1 _ 17-3711
U nknown 0 - 0-48336 0 - 0-140652 0 - 0-217149
Pulmonary Fibrosis Non 0 _ 0- 884 0 _ 0-1911 0 _ 0-1052
Ex 0 - 0- 510 0 - 0-1256 0 _ 0-638
Cu r r e n t 2 158 15- 457 1 156 4-871 0 - 0-347
U nknown 0 0-5873 0
'
0-15707 0
*
0-31012
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T A B L E  4.10: Cause specific mortality by smoking amount and dockyard.
C a u s e s  of Death Smoking
amount
(gms/day)
Obs
Devonport
Obs
Chatham
Obs
Portsmouth
SMR 95% Cl SMR 95% Cl SMR 95% Cl
A1 1 Causes < 15 712 88 82- 95 359 94 84-103 485 85 77- 92
15-24 771 108 100-116 261 100 88-112 471 93 85-102
25 360 114 102-126 116 100 82-118 266 101 89-113
All Neoplasms < 15 236 102 89-115 139 120 100-140 177 102 87-117
15-24 272 133 117-149 90 115 91-139 159 103 87-119
* 25 131 144 119-168 45 129 92-167 95 119 95-143
C a . Stomach < 15 26 134 88-196 13 136 73-233 17 120 70-193
15-24 32 189 124-255 11 171 85-306 11 89 44-158
25 8 107 46-210 3 106 22-310 8 125 54-246
Ca. Peritoneum < 15 5 1142 370-2664 0 _ 0-1918 1 349 9-1945
15-24 2 480 58-1732 0 - 0-2720 0 - 0-1418
25 1 524 13-2918 0 - 0-6031 0 - 0-2670
Ca. Lung < 15 56 67 49- 84 42 90 63-118 51 73 53- 93
15-24 98 133 107-159 32 102 67-137 80 130 102-159
25 61 186 139-233 18 130 77-206 49 155 112-199
Ca. Pleura < 15 20 1852 1132-2861 • 12 2494 1289-4356 12 1559 805-2723
15-24 19 1865 1123-2912 2 590 71-2131 4 576 157-1474
a 25 10 2134 1025-3925 2 1290 156-4658 3 817 169-2389
C i r c u l a t o r y  System < 15 365 88 79- 97 159 85 72- 99 217 78 68- 89
15-24 376 103 93-114 126 100 83-118 238 97 85-110
25 191 118 101-135 50 90 65-115 123 97 80-114
P u l m o n a r y  Circulation < 15 10 238 114-438 1 49 1-270 0 _ 0-124
1S-24 9 248 113-470 2 145 18-522 1 38 1-214
25 5 313 101-730 0 - 0-614 0 - 0-274
R e s p i r a t o r y  System < 15 69 97 74-120 33 84 55-112 48 85 61-109
15-24 67 112 85-138 27 103 68-151 49 100 72-128
2 25 17 66 38-105 12 105 54-183 28 111 74-161
Bronchitis, Emphysema < 15 16 61 35- 98 12 76 39-133 12 55 28- 95
a nd Asthma 15-24 15 67 37-110 10 96 46-177 15 78 44-129
2 25 5 51 17-120 2 45 5-161 6 61 22-133
A s b e s t o s  is < 15 3 2170 448-6345 0 _ 0-5887 1 1018 26-5670
15-24 3 2413 498-7055 0 - 0-8586 0 - 0-4245
2 25 1 1781 45-9919 0 - 0-19123 0 - 0-8184
P u l m o n a r y  Fibrosis < 15 1 97 2-542 0 _ 0-773 0 _ 0-522
15-24 1 113 3-628 0 - 0-1157 0 - 0-596
2 25 0 0-948 1 711 18-3960 0 0-1157
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whatsoever is seen for stomach cancer and the two forms of mesothelioma 
(P>0.1, at all yards). Asbestosis and pulmonary fibrosis are again affected by 
low numbers. It should be noted, that for current smokers significantly elevated 
lung cancer SMRs were observed as follows: 140 (120-160) at Devonport, 124 
(97-152) at Chatham, and 148 (125-171) at Portsmouth; based on 417 deaths.
This picture of an increasing risk of death over smoking group is further 
considered by examining the amount of tobacco smoked (table 4.10). In this table 
the amount smoked per day by ex-smokers and current smokers is analysed by 
dockyard. Generally this analysis supports that shown by smoking habit, with its 
most obvious effect a lung cancer dose-response. At Devonport the lung cancer 
SMRs were: 67 (49-84) less than 15 gms/day, 133 (107-159) 15-24 gms/day, and 
186 (139-233) 25 or more gms/day. At Chatham: 90 (63-118), 102 (67-137), and 
130 (77-206). Similarly at Portsmouth: 73 (53-93), 130 (102-159), and 155 (112- 
199). In table 4.9 mortality gradients were seen with smoking group. However, 
from table 4.10 there appears to be a more limited gradient (i.e. dose-response) 
with amount smoked. This is clearly seen at Devonport and Portsmouth for all­
cause mortality [X2 for trend = 78.5 at Devonport and X2 for trend =48.3 at 
Portsmouth, both PcO.001], and lung cancer [X2 for trend = 74.7 at Devonport 
and X2 for trend = 46.1 at Portsmouth, P< 0.001]. At Chatham dockyard no 
specific cause of death produced a significant trend. Pleural and peritoneal 
mesothelioma have non-significant differences in their SMRs at each dockyard 
over amount smoked.
The amounts recorded by the workforce may have affected the results here. They 
appear generally low and have forced the creation of the groups < 15, 15-24, and 
25 or more grammes smoked per day, chosen to separate the smokers into 
approximately equal sized groups. To further scrutinise smoking history, duration 
of smoking was considered (figure 4.6 and table A3.26). This generally repeated 
the above findings, with an increasing SMR seen with duration of smoking. 
Considering Devonport dockyard, significant trends in SMR over smoking period 
are seen in the following disease groups: all-causes [X2 for trend = 69.0,
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P < 0.001 ], all-neoplasms [X2 for trend = 42.4, P < 0.001], and lung cancer [X2 for 
trend = 53.4, P< 0.001]. Significant differences, without a statistical trend, were 
approached in the SMRs for stomach cancer [X2 = 7.9, 0.05 < P <0.1 ], and 
peritoneal mesothelioma [X2 = 8.7, 0.05 < P < 0.1], with asbestosis producing a 
significant difference [X2 = 22.3, P<0.001], For asbestosis this difference reflects 
the very high SMR obtained for those workers with less then 10 years duration of 
smoking habit. However, these results should be treated with caution since they 
are again based on low numbers of deaths. From figure 4.6 diseases of the 
respiratory system appears to show a decreasing trend over time, however, this 
was statistically non-significant <P > 0.1). The remaining disease groups all 
produced non-significant results in tests of a difference between SMRs and tests 
of trend. Similar results were obtained for Chatham and Portsmouth, supporting 
the suggestion of a lung cancer time and dose-response.
Mortality has further been considered for these health-status variables, i.e. x-ray 
group, smoking habit etc., by time since first employment. The results of this 
examination are given in appendix 4 (tables A4.1 to A4.15). In these tables all­
cause mortality, lung cancer mortality and pleural mesothelioma mortality is 
analysed by health-status variable and time since first dockyard employment. 
Generally, little clear effect is seen on mortality in these tables, with no obvious 
novel patterns of an excess or deficiency in all-cause and lung cancer mortality 
demonstrated. Pleural mesothelioma continues to show excessive SMRs over each 
variable for each time period; however, based on low observed numbers.
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FIGURE 4.7 Standardised mortality ratios by occupational group, exposure group, and asbestos exposure period
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4 .7  Cause specific mortality according to ‘asbestos’ variables.
This section is concerned with the following 'asbestos' variables: occupational 
group (indicating registered asbestos workers, laggers and sprayers, etc.), asbestos 
exposure rating, asbestos exposure period, and period of continuous asbestos 
exposure. The results are given in tables A3.27 to A3.29, and illustrated in figure 
4.7.
Considering occupational group (table A3.27), the SMRs commonly showed little 
change over this grouping. For example, for lung cancer the SMRs found at 
Devonport were: 109 (56-190) for group 1, 99 (59-154) for group 2, 100 (50-178) 
for group 3, and 96 (82-11) for group 4. At Chatham these were slightly lower 
with SMRs of: 79 (26-185), 88 (35-181), 68 (14-200), and 86 (67-105). At 
Portsmouth: 106 (42-218), 157 (102-230), 77 (33-515), and 90 (75-105); with a 
significant result being obtained for group 2, the electrical fitters, and burners, etc. 
The exceptions to this limited change over grouping are pleural mesothelioma and 
asbestosis. For pleural mesothelioma a decreasing trend in SMR is observed from 
group 1 to group 4, for all dockyards [X2 for trend = 4.3, P < 0.05; at Devonport]; 
this is likely to be due to the high number of mesothelioma deaths occurring in 
group 4, the catchment group of ‘all other dockyard trades’. For asbestosis no 
trend is observed, however, the SMRs are significantly different over occupational 
grouping at Devonport (P<0.01). A further exception is seen at Portsmouth for 
stomach cancer which appears to decrease over grouping with SMRs of: 223 (46- 
653), 150 (48-351), 141 (29-413), and 93 (62-133). However this was not 
significant [X2 = 3.1, P>0.1 and X2 for trend = 2.5, P>0.05].
The nature of this occupational grouping, as defined in 3.1.4, with group 1 
indicating registered asbestos workers, etc., could well imply that this variable is 
a good substitute for asbestos exposure. Group 1 indicating very high exposure, 
group 2 high exposure, etc., down to group 4 which indicates low exposure. This 
is supported by the results for pleural mesothelioma; however, lung cancer has no
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trend whatsoever across this variable [X2 = 0.2, P> 0.1; at Devonport], nor indeed 
does peritoneal mesothelioma, giving no support to this theory.
A potentially better reflection of asbestos exposure is given by considering 
asbestos exposure rating (table A3.28). In this table increasing asbestos exposure 
should be seen with increasing rating. There is a general suggestion from the 
table that mortality increases with increasing rating; implying increasing SMR with 
increasing asbestos exposure. This is seen at all three dockyards. The following 
disease groups show increasing trends in their SMRs at Devonport: all-neoplasms 
[X2 for trend=16.2, PcO.OOl], peritoneal mesothelioma [X2 for trend = 21.7, 
PcO.OOl], pleural mesothelioma [X2 for trend = 50.9, PcO.OOl], and asbestosis 
[X2 for trend =10.4, P <  0.005], A borderline trend is also seen for all-cause 
mortality [X2 for trend = 3.0, 0.05 < P < 0.1]. Lung cancer, unlike the other 
asbestos related diseases, again has no clear statistical trend [X2 = 3.1, P>0.1]. 
However, by observation of the SMRs there is a hint of an increasing trend. For 
example, at Devonport the lung cancer SMRs are: 90 (74-107), 102 (68-135), 120 
(79-162), 98 (59-154), and 126 (69-212). At Chatham: 94 (70-117), 65 (31-120), 
81 (39-149), 67 (24-145), and 76 (24-176). At Portsmouth: 97 (78-116), 75 (48- 
112), 68 (39-110), 112 (69-170), and 193 (114-305). This last group at 
Portsmouth, those workers with an exposure rating of 400 or above, being clearly 
statistically significant. Pulmonary fibrosis has too few deaths to allow sensible 
analysis, 3 deaths over two dockyards.
An even better indication of asbestos exposure should be given by the workers 
own estimated period of asbestos exposure (table A3.29). The only limitation of 
this variable is the fact that less than 10% of the total workforce estimated this 
period. From the 3 dockyards 3359 workers responded to this question, out of 
which 887 (26.4%) have died. From table A3.29 increasing trends in mortality 
are seen at Devonport for: all-neoplasms [X2 for trend =18.6, PcO.OOl], 
peritoneal mesothelioma [X2 for trend = 21.0, P c  0.001], and pleura mesothelioma 
[X2 for trend = 37.4, P c  0.001], A decreasing trend is seen for lung cancer [X2 for 
trend = 9.0, P c 0.05], this is however not repeated at Chatham and Portsmouth.
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The lung cancer SMRs obtained at Devonport are: 75 (30-155), 222 (137-339), 
136 (76-225), and 95 (49-166). At Chatham these were: 83 (230212), 27 (1-148), 
44 (5-158), and 111 (70-108). At Portsmouth: 116 (56-213), 101 (46-191), 124 
(66-213), and 108 (63-174). An excess of lung cancer is therefore seen at 
Devonport for those workers with between 10 and 20 years of asbestos exposure. 
Non-significant results were obtained for asbestosis, and again the numbers were 
too small for pulmonary fibrosis.
From the workers who estimated their asbestos exposure period, 429 from the 3 
dockyards, also estimated their period of continuous exposure. From these 104 
(24.2%) have died. Table 4.11 shows the mortality by period of continuous 
exposure for these workers. The numbers are very small, however, there appears 
generally to be significantly raised SMRs at Devonport and Portsmouth for those 
workers with more than 10 years of continuous asbestos exposure. Particularly 
lung cancer has SMRs of: 361 (132-786) at Devonport, and 490 (211-965) at 
Portsmouth; clearly showing an excess risk for lung cancer in this group of 
workers. However, only based on 14 deaths. Pleura mesothelioma is once more 
seen to be very high: 9232 (1117-33328) at Devonport, and 4994 (126-27818); 
based on 3 deaths. The numbers are to small for peritoneal mesothelioma and 
asbestosis to allow evaluation.
Mortality has also been appraised for the ’asbestos’ variables by time since first 
employment. The results of this are given in appendix 4 (tables A4.16 to A4.27). 
In these tables all-cause, lung cancer and pleural mesothelioma mortality is 
analysed by the ‘asbestos’ variables and time since first dockyard employment. 
Similar to the health-status variables, no obvious new patterns of an excess or 
deficiency in all-cause and lung cancer mortality is generally apparent in these 
tables. Pleural mesothelioma again continues to show highly elevated SMRs over 
each variable for each time period. The results are obviously affected by low 
numbers, particularly in tables A4.25 to A4.27.
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T A B L E  4 .11: Cause specific mortality by period of continuous asbestos 
exposure and dockyard.
Causes of Death Continuous
asbestos
exposure
(yrs) Obs
Devonport
Obs
Chatham
Obs
Portsmouth
SMR 95X Cl SMR 95X Cl SMR 95X Cl
All Causes <10 23 117 74-176 16 143 82-233 15 119 67-197
10+ 27 170 112-247 5 108 35-251 18 138 82-218
All Neoplasms <10 4 71 19-181 9 264 121-502 5 132 43-307
10+ 14 308 168-517 1 73 2-408 14 346 189-580
Ca. Stomach <10 1 222 6-1239 2 723 88-2611 1 328 9-1882
10+ 1 260 7-1446 0 - 0-3167 0 - 0-1137
Ca. Peritoneum <10 0 _ 0-28311 0 _ 0-56870 0 _ 0-48353
10+ 1 11216 284-62475 0 - 0-181558 0 - 0-50799
Ca. Lung <10 1 50 1-280 2 147 18-530 0 0-253
10+ 6 361 132-786 0 - 0-666 8 490 211-965
! Ca. Pleura <10 0 _ 0-11421 1 6203 157-34550 2 9976 1207-36015
10+ 2 9232 1117-33328 0 - 0-77076 1 4994 126-27818
Circulatory System <10 12 121 63-212 5 93 30-218 4 67 18-172
10+ 7 85 34-174 2 88 11-317 4 63 17-161
Pulmonary Circulation <10 0 _ 0-3946 0 _ 0-6263 0 _ 0-6147
10+ 2 2370 287-8554 0 " 0-13985 0 - 0-5573
Respiratory System <10 5 340 110-793 2 194 24-702 2 186 23-673
10+ 6 427 157-929 2 373 45-1348 0 - 0-316
Bronchitis, Emphysema <10 1 183 5-1017 2 475 57-1714 0 _ 0-892
j and Asthma 10+ 1 190 5-1058 0 - 0-1752 0 - 0-784
Asbestosis <10 1 27969 708-155786 0 _ 0-188727 0 _ 0-166003
10+ 1 36317 919-202285 0 - 0-546965 0 - 0-151071
Pulmonary Fibrosis <10 1 4308 109-23995 0 _ 0-28027 0 _ 0-25595
10+ 0 0-18285 0
'
0-62290 0 0-23521
The ‘asbestos’ variables have been further scrutinised by smoking habit (tables 
A3.30, 4.12 and 4.13). In these tables all-cause, lung cancer and pleural 
mesothelioma mortality is again considered, here for nonsmokers, ex-smokers and 
current smokers. No obvious patterns occur when considering all-cause mortality 
(table A3.30). For lung cancer, significantly high SMRs are seen in ‘smoking 
groups’, the highest SMRs occurring in current smokers, except at Portsmouth 
where ex-smokers are seen to have generally high SMRs. Pleural mesothelioma 
(table 4.13) is affected by the low numbers of observed deaths, but significantly 
high SMRs are seen once again. These are however not related to smoking habit, 
there being no clear statistical trends (generally, P > 0.1). When considering lung 
cancer (table 4.12) increasing SMRs across smoking habit, which reach statistical 
significance, are seen only for occupational group 4. At Devonport these are: 72
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(52-92) for nonsmokers, 134 (104-163) for ex-smokers, and 177 (125-230) for 
smokers [X2 = 21.4, P<0.001 and X2 for trend = 21.6. PcO.OOl]. At Chatham: 
102 (70-135), 96 (61-143), and 137 (77-226) [X2=1.3, P>0.1 and X2 for 
trend = 0.6, P>0.1]. At Portsmouth: 72 (49-94). 119 (88-150), and 152(103-201) 
[X2 = 11.6, P < 0.005 and X2 for trend = 11.9, P < 0.001). Indicating generally that 
for occupational group 4 (i.e. the catchment group of all other dockyard workers) 
there is undoubtedly an increasing trend in lung cancer mortality by smoking 
habit.
The relationship between lung cancer and pleura mesothelioma to these asbestos 
variables will be further considered in section 4.8. Here Poisson regression 
techniques will be used to focus on these variables taking into account other 
factors such as smoking habit, and x-ray group, etc.
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T A B L E  4.12: Devonport Dockyard. Lung cancer mortality by
smoking habit and ‘asbestos' variables.
Non -smokers Ex-smokers Smokers
Obs SMR Obs SMR Obs SMR
(95% Cl) (95X Cl) (95X Cl)
Occupational group
1 3 88 5 140 3 151
(18-256) (45-327) (31-440)
2 2 32 9 143 7 226
(4-115) (65-271) (91-466)
3 1 30 3 82 6 289
(1-166) (17-241) (106-628)
4 49 72 79 134 44 177
(52- 92) (104-163) (125-230)
Exposure rating
< 100 26 58 56 141 2 5  140
(38- 85) (104-178) (91-207)
100- 7 52 13 119 15 294
(21-107) (63-204) (164-484)
200- 9 100 15 159 8 194
(46-190) (89-263) (84-383)
300- 5 67 5 80 8 342
(22-157) (26-186) (148-675)
400+ 5 132 6 164 3 181
(43-309) (60-358) (37-530)
Asbestos exposure period (yrs)
< 10 1 28 4 126 1 64
(1-155) (34-323) (2-356)
10- 6 181 7 189 7 449
(66-394) (76-389) (180-924)
i  20- 6 147 6 151 3 156
(54-321) (55-328) (32-456)
30+ 4 85 3 78 5 256
(23-218) (16-229) (03-597)
Continuous asbestos exposure (yrs)
< 10 - - 1 220 
(6-1228)
10- 4 601 2 285 _
(164-1540) (35-1030)
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T A B L E  4 .12  (coni.): Chatham Dockyard. L u n g cancer mortality
by smoking habit and ‘ asbestos’ variables.
Non-smokers Ex-smokers Smokers
Obs SMR 
(95% Cl)
Obs SMR 
(95% Cl)
Obs SMR 
(95% Cl)
Occupational g r o u p
1 2 57 
(7-205)
2 124 
(15-448)
1 73 
(3-761)
2 1 32 
(1-176)
4 165 
(45-423)
2 163 
(20-588)
3 - 1 63 
(2-352)
-
4 38 102 
(70-135)
24 96 
(61-143)
15 137 
(77-226)
Exposure rating
< 100 25 93 
(60-138)
21 123 
(76-167)
14 180
(99-303)
100- 5 82 
(26-191)
4 90
(25-231)
1 40
(1-225)
200- 7 129 
(52-267)
- -
300- 3 79 
(16-230)
2 68 
(8-247)
i no
(3-612)
400+ “ 3 133 
(28-390)
2 312 
(38-1127)
Asbestos exposure period (yrs)
< 10 3 131 
(27-384)
1 80 
(2-444)
-
10- - 1 87 
(2-483)
-
20- - 1 88 
(2-491)
1 135 
(3-753)
30+ 3 129 
(27-376)
2 105 
(13-379)
1 219 ! 
(6-1220)
Continuous asbestos e x p o s u r e  (yrs)
i < 10 1 143 
(4-799)
1 279 
(7-1556)
-
10- ” ~
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T A B L E  4.12 (cont.): Portsmouth Dockyard. Lung cancer
mortality by smoking habit and 'asbestos’
variables.
Non-smokers Ex-smokers Smokers
Obs SMR O b s  SMR Obs SMR
(95X Cl) (95X Cl) (95X Cl)
Occupational group
1 3 133 2 104 2 137
(27-388) (13-376) (17-493)
2 S 87 16 334 5 173
(28-204) (191-543) (56-403)
3 1 26 3 98 2 145
(1-147) (20-286) (18-523)
4 39 72 58 119 37 152
(49- 94) (88-150) (103-201)
Exposure rating
< 100 28 76 41 125 28 175
(50-110) (87-164) (116-252)
100- 6 51 10 113 6 119
(19-111) (54-207) (44-259)
200- 3 42 7 91 6 124
(9-122) (36-187) (46-270)
300- 7 102 12 212 2 70
(41-211) (109-369) (8-252)
400+ 4 126 9 273 3 293
(34-323) (125-519) (61-857)
Asbestos exposure period (yrs)
< 10 3 91 3 101 4 284
(19-266) (21-296) (77-728)
10- 2 49 7 283 _
(6-177) (114-583)
20- 4 106 6 196 3 137
(29-272) (72-427) (28-399)
30+ 3 47 10 212 4 201
(10-137) (102-389) (55-514)
Continuous asbestos exposure (yrs)
< 10 - - -
10- 3 617 4 574 1 429
(127-1803) (157-1470) (11-2388)
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T A B L E  4.13: Devonport Dockyard, 
mortality by smoking 
variables.
Pleural mesothelioma
habit and ‘ asbestos’
Non-smokers Ex-smokers Smokers
Obs SMR 
(95X Cl)
Obs SMR 
(95% Cl)
Obs SMR 
(95% Cl)
Occupational group
1 4 8564 
(2334-21925)
1 1893 
(48-10541)
1 3655 
(92-20357)
2 2 2304 
(279-8317)
3 3178 
(656-9290)
-
3 2 3421 
(414-12351)
2 2985 
(361-10775)
2 5559 
(673-20068)
4 12 1395 
(721-2436)
12 1522 
(786-2658)
7 2029 
(815-4181)
Exposure rating
¡ < 100 2 343 
(41-1238)
5 908 
(294-2120)
2 784 
(95-2830)
100- 6 3244 
(1189-7061)
3 1800 
(371-5261)
-
200- 4 3308 
(901-8467)
4 2934 
(799-7510)
5 8297 
(2688-19365)
300- 5 5589 
(1811-13045)
6 7820 
(2869-17030)
1 3245 
(82-18075)
400+ 3 7764 
(1602-22697)
“ 2 11178 
(1353-40353)
Asbestos exposure period (yrs)
< 10 1 2078 
(53-11573)
1 2330 
(59-12977)
-
10- 2 4440 
(537-16029)
2 3800 
(460-13718)
-
20- 4 7428 
(2024-19016)
4 7317 
(1994-18732)
1 4017
(102-22372)
30+ 3 6034 
(1245-17640)
1 2415 
(61-13451)
3 13569 
(2800-39667)
Continuous asbestos exposure (yrs)
< io - - -
! 10- 2 23469 
(2840-84724)
- -
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T A B L E  4 .13 (cont.): Chatham Dockyard, 
mortality by smoking 
variables.
Pleural mesothelioma
habit and 'asbestos'
Non-smokers Ex-smokers Smokers
Obs SMR 
(95% Cl)
Obs SMR 
(95% Cl)
O b s  SMR 
(95% Cl)
Occupational group
1 1 3035 
(77-16907)
- -
2 5 13775 
(4463-32150)
- 1 6863 
(174-38228)
3 1 4219 
(107-23501)
- -
4 5 1321 
(428-3082)
2 757 
(92-2734)
1 824 
(21-4590)
Exposure rating
< TOO - 1 535 
(14-2981)
"
TOO- - - 1 3357 
(85-18696)
200- 5 8416 
(2727-19643)
- -
300- 4 10720 
(2921-27443)
1 3366 
(85-18749)
1 11519 
(291-64163)
400* 2 8471 
(1025-30581)
~ “
Asbestos exposure period (yrs)
< 10 - - -
10- 1 4752 
(120-26471)
- -
20- 2 8720 
(1055-31480)
- -
30+ 2 8933 
(1081-32247)
~ 1 23190 
(587-129171)
Continuous asbestos exposure (yrs)
< 10 1 11188 
(283-62311)
- -
10- “ “
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T A B L E  4 .13  (cont.): Portsmouth Dockyard. Pleural mesothelioma
mortality by smoking habit and ‘asbestos’
variables.
Non-smokers Ex-smokers Smokers
Obs SMR 
(95% Cl)
Obs SMR 
(95% Cl)
Obs SMR 
(95% Cl)
1
Occupational group
2 2 2949 
(357-10646)
2 3255 
(394-11750)
-
3 - - 1 5193 
(131-28927)
4 10 1689 
(011-3106)
2 371 
(45-1330)
2 721 
(87-2604)
Exposure rating
< 100 4 973 
(265-2490)
-
100- 2 1496 
(181-5400)
- 1 1534 
(39-8542)
200- 2 2345 
(284-8465)
3 3432 
(708-10033)
-
300- 3 4156 
(857-12149)
- 1 3431 
(07-19108)
400+ 1 3453 
(87-19233)
1 3551 
(90-19778)
1 9505 
(240-52943)
Asbestos exposure period (yrs)
! < io 1 2632 
(67-14658)
- -
10- 2 4405 
(533-15903)
- -
20- - 1 3215 
(81-17909)
-
I 30-f 5 8359 
(2708-19511)
1 2216 
(56-12343)
1 5005 
(127-27880)
Continuous asbestos exposure (yrs)
< 10 1 10522 
(266-58610)
1 17455 
(442-97233)
-
10- ~ "
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4.8 Log-linear modelling.
The modelling presented in this section is for Devonport dockyard only, it has 
been chosen as a representative dockyard and for the cause of brevity. Chatham 
and Portsmouth have also been examined and generally have shown the same 
relationships, however, to a less significant level.
The two disease groups considered are the principal conditions seen to be of 
interest in this study, namely: lung cancer and pleural mesothelioma. The disease 
group of ‘all-causes’ is also examined. These three specific disease groupings 
have substantially enough numbers of observed deaths to allow sensible modelling. 
The groups of: pulmonary fibrosis with 2 deaths (at Devonport), asbestosis with 
7 deaths, and peritoneal mesothelioma with 10 have not been modelled.
Statistical variation in strata-specific mortality (SMRs) was assessed by comparing 
the fit of Poisson regression models with and without terms representing the 
stratifying factor, i.e. by the use of log-linear models for grouped data. The 
goodness-of-fit of each model was tested by considering the change in ‘deviance’ 
(the approximate Chi-squared statistic) found in GLIM; the technique used was 
that described in section 3.2.3.
When exponentiated, the coefficients gained from the regression analyses are 
relative standardised mortality ratios (RSMRs), i.e. the exponential coefficients 
estimate the mortality rate for workers in a particular stratum (subgroup) relative 
to that in stratum 1. From these RSMRs, tables similar to those given for the 
SMRs in appendix 3 can be produced. Generally the RSMRs have shown little 
variation from the SMRs, even when adjusted for statistical interactions and 
confounding factors, therefore, RSMR tables have not been furnished. In their 
place, this section will concentrate on describing the appropriateness of fit of the 
‘employment-time’, ‘health-status’, and ‘asbestos’ variables considered in sections
4.5 to 4.7, on the regression models.
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T A B L E  4.14: Devonport dockyard. Goodness-of-fit statistics obtained in 
Poisson regression models.
All Cause
Model
5
Adev df
Lunq Canee
Model Adev df
Ca. Pleura
Model Adev df
Constant* Constant* Constant*
ag 22.9** 4 ag 99.8** 4 ag 7.4 4
ys 7.9 4 ys 8.3 4 ys 10.1* 4
Is 6.4 4 Is 9.6* 4 Is 13.3** 4
1 ts 5.7 3 ts 6.1 3 ts 6.4 3
og 4. 1 3 og 4.3 3 og 8.0* 3
ex 6.3 4 ex 5.8 4 ex 14.1** 4
ae 3.7 3 ae 12.4** 3 ae 9.7* 3
ce 5.7* 1 ce 7.9** 1 ce _j CO 4.6* 1 CO 5.6* 1 CO 1.7 1
ph 2.6 1 ph 3.9* 1 ph 1.2 1
br 4.0* 1 br 4.2* 1 br 3.9* 1
ch 3.5 1 ch 3.6 1 ch 0.9 1
sm 12.2** 2 sm 25.1** 2 sm 2.5 2
pt 1.8 1 pt 2.7 1 pt 3.9* 1
pc 2.0 1 pc 3.7 1 pc 4.1* 1
Pf 3.6 1 pf 4.8* 1 pf 5.7* 1
Constant*ag+ Constant*ag* Constant*ex*
sm 12.8** 2 sm 37.6** 2 Is 18.1** 4
ce 6.2* 1 ce 10.9** 1 og 6.7 3
ae 3.8 3 ae 5.5* 3 ae 11.3* 3
pf 0.9 1 pf 2.8 1 pf 4.9* 1
Is 9.9* 4
Constant*ag*sm+ Constant*ag*sm* C onstant*ex*1s+
ce 1.3 1 ce 3.2 1 ae 7.2 3
pf 0.4 1 pf 7.8** 1 pf 3.7 1
c o 8.9** 1
br 6.3* 1
Constant*ag* Constant*ag* Constant*ex*
ag*sm 1.4 2 ag*sm 12.0** 2 ex* Is 6.7 4
ag*ce 0.1 1 ag*ce 0.7 1
ag*ae 0.3 4
Constant+ag*
ag*sm+CO 2.8 1
Adev = change in model deviance 
df = degrees of freedom
• P<0.05
** P<0.01
Grouped variable d e finitions:
‘Employment’ variables. „ ‘Health-status’ variables.
ts time since start of employment CO cough
Is length of service ph phlegm
ys year of start of employment br breathlessness
ch chest-i11 ness
sm smoking habit
‘Asbe s t o s ’ variables Pt pleural thickening
og occupational group pc pleural calcification
ex exposure rating pf pulmonary fibrosis
ae asbestos exposure period
ce continuous asbestos exposure ag age at death
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The results of the main regression models are given in table 4.14. Considering 
all-cause mortality, the models clearly show that there is a significant variation in 
the SMRs with age, smoking habit (nonsmokers, ex-smokers, etc.), breathlessness, 
asbestos exposure period and period of continuous asbestos exposure. It should 
be noted, as stated in the last section, that the continuous exposure variable is 
based on a limited number of workers (i.e. 429 in total). Occupation group, 
asbestos exposure rating and time since start of employment are seen to have no 
effect, the same is true of the remainder of the descriptive variables used in this 
modelling. No interaction terms produced statistically significant results. The 
conclusion for the disease group of ‘all-causes’ is that age and smoking are the 
main factors of interest. This result in no way contradicts the results given in 
earlier sections of this chapter, and supports the conclusions of no excess risk for 
the majority of the employment and asbestos variables considered.
For lung cancer the smoking dose-response is reinforced, and smoking with age 
seen to be a very good predictor of death. Age and smoking are in fact seen to 
have a significant interaction. Asbestos exposure period and period of continuous 
asbestos exposure are again seen to have significant variation in their SMRs. 
Cough, phlegm and breathlessness are also seen to be fairly good predictive 
variables of lung cancer mortality. Radiographs with pulmonary fibrosis present 
also show a slight predictive value. However, occupational group and asbestos 
exposure rating are not significant, i.e. the SMRs do not vary over occupational 
group and exposure rating, supporting the findings of section 4.7. The fact that 
man is a better predictor of his own health than exposure ratings is shown by the 
significance and high SMRs for cough, phlegm, breathlessness and chest-illness 
and supported by the regression analysis.
Pleural mesothelioma is not seen to be related whatsoever to smoking. The only 
significant variation in SMR seen in the regression models is with the employment 
and asbestos variables. The main predictive factors for mesothelioma in this 
dockyard appear to be asbestos exposure rating and length of service in the 
dockyard. Pulmonary fibrosis on radiograph is again seen to have reasonable
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predictive values together with pleural thickening and pleural calcification. The 
same is true for breathlessness and occupational group.
Generally, the results of the log-linear modelling support the previous SMR 
analyses, showing that smoking is a highly significant variable in predicting lung 
cancer death, whereas, occupational grouping is not. The reverse is seen for 
mesothelioma.
It should be noted that a major advantage of the models used in this section is their 
ease of implementation using such packages as GLIM or GENSTAT. These 
packages have the outstanding feature of enabling the user to specify factors and 
their interactions without having to generate the dummy variables him/herself, 
providing a useful means of carrying out detailed comparisons of mortality among 
subgroups defined by a multitude of covariates.
4.9 Summary.
For the three dockyards Devonport, Chatham and Portsmouth, a slight deficiency 
in all-cause mortality has been observed. Linked with this deficiency is the fact 
that mortality due to ‘all-neoplasms’ is not seen to be in either excess or deficit. 
For example, all-neoplasm SMRs are not generally different from 100, although 
at Devonport the SMR is statistically raised, i.e. 117 (109-125). Generally, ‘non­
cancer’ mortality is seen to be reduced, with SMRs commonly reduced below 100 
(but in most cases not significantly). For asbestosis and the two forms of 
mesothelioma, large significant excesses in mortality are seen, with SMRs 
commonly being at least an order of magnitude higher than 100. However, low, 
non-significant SMRs are seen for pulmonary fibrosis.
It is possible that there is some death certificate confusion between asbestosis and 
pulmonary fibrosis. They are indeed practically the same medical condition, and 
it is likely that a mis-coding may have transpired between these conditions. 
Although it may be argued that we are dealing with an ‘asbestos environment’, i.e.
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the dockyards, and that this fact may have influenced the reported death certificate 
cause of death, these conditions have been analysed separately in this work. It is 
hoped by this, that any recording bias by the nosologist will be balanced over all 
death certificates.
The interesting result of this study is the lack of notable excess lung cancer 
mortality. In fact, an overall significant deficiency in lung cancer mortality is also 
absent. For all three dockyards, we generally have neither a statistically 
significant excess or deficit of lung cancer mortality from that expected in the 
South West and South East regional populations. This gives little support to any 
suggestion that dockyard exposure to asbestos is an aetiological factor in lung 
cancer production.
The disease groups of all-cause and all-neoplasm mortality in the ‘absolute non­
responders’ from the initial surveys, have significantly high SMRs. For lung 
cancer, SMRs are all high, with the SMR at Portsmouth being statistically elevated 
from 100. Mesothelioma again shows a huge excess. Overall, an excess mortality 
is seen in all disease groups, occasionally reaching a statistical excess. It appears 
that a proportion of the non-responders may have been chronically ill at study 
definition, in the early 1970s, and deselected themselves out of the surveys for 
health reasons. These workers were reinvited to attend for interview and 
radiograph only once more after initial non-response. This deselection of workers 
also overshadows any healthy worker effect to be seen in the study responders.
Generally then, there was little, if any, overall excess or deficiency of mortality 
seen in the initial surveys responders, over the three dockyards, apart from the 
asbestos related diseases of pleural and peritoneal mesothelioma, and asbestosis. 
These disease groups together with the other 9 specific disease groups were also 
considered by ‘employment-time’, ‘health-status’, and ‘asbestos’ variables.
When considering mortality by the ‘employment-time’ variables (length of 
employment, time since start of employment, etc.), the lung cancer risk appears
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to increase with increasing age at start of employment. Whereas, mesothelioma 
appears to decrease, the youngest workers at start of employment having the 
highest mortality rates; showing the possible effects of early asbestos exposure. 
A decreasing trend in mesothelioma SMR is also seen over calendar year of 
employment, with the highest SMRs occurring for those workers employed before 
World War II. Lung cancer appears to increase with calendar period (figure 4.4), 
however, there is no statistical trend evident. Asbestosis and pulmonary fibrosis 
mortality is based on too few numbers to allow sensible analysis.
An increasing mortality trend is seen for pleural mesothelioma over length of 
service grouping, the highest mortality rates occurring in those workers with 30 
or more years employment. Supporting the suggestion of a long disease latency 
period. When considering time since first employment, only disease of the 
respiratory system showed a significantly increasing trend in mortality. No other 
disease group gave any evidence of a systematic increase or decrease in mortality 
with time since first employment and possible first exposure to asbestos. A huge 
excess of mesothelioma was, however, seen at all three dockyards, clustered 
around those workers with long follow-up and long duration of service. Lung 
cancer was seen only to be in excess for workers with between 10 and 19 years 
of employment first exposed to asbestos over 30 years ago.
From the ‘health-status’ variables (i.e. personal medical history, smoking habits, 
etc.) cough, phlegm, breathlessness and chest-illness, were seen to be reasonable 
predictive variables for lung disease. Radiographic grouping was another such 
variable, and in particular x-ray groups 2, 3 and 4. That is, the groups showing 
pleural thickening, pleural calcification, and pulmonary fibrosis, present on 
radiograph. When examining mortality by smoking history, a clear dose-response 
relationship was seen for lung cancer. The relative risks for lung cancer at 
Devonport across smoking group are: 1, 3, and 7.8; for nonsmokers, ex-smokers 
and smokers, respectively (table 4.9). No such relationship was seen for 
mesothelioma. Asbestosis and pulmonary fibrosis were again affected by low 
numbers. Considering the ‘asbestos’ variables, lung cancer shows no pattern
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whatsoever across these occupation and asbestos exposure parameters, except 
when analysed by smoking habit. When this is undertaken there appears to be an 
elevated lung cancer risk for the workers in occupational group 4 (i.e. the group 
of ‘all other workers’). Lung cancer risks are also present in the small group of 
429 workers (i.e. 1.5% of the cohort) who estimated their period of continuous 
asbestos exposure. Here workers with more than 10 years of continuous exposure 
appear most at risk. Pleural and peritoneal mesothelioma all show increasing 
trends with asbestos exposure rating.
In conclusion, there is only limited evidence in this study to link dockyard asbestos 
dust exposure aetiologically with lung cancer. There is, however, support for the 
idea of a lung cancer dose-response with tobacco smoking. For both forms of 
mesothelioma the reverse is seen; no relationship with smoking, but evidence of 
a relationship with asbestos exposure. The log-linear modelling supported these 
results. Indeed the two approaches used, the SMR and regression analyses, 
produced virtually the same results.
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C h a p te r  5: M O R T A L IT Y  R E V IS IT E D .
5.1 Introduction.
This chapter describes the results of nested case-control analyses performed on the 
workers from the three dockyards to further evaluate lung cancer and 
mesothelioma mortality, with regard to smoking habit and asbestos exposure. 
Pleural and peritoneal mesothelioma are grouped in this chapter as one cause of 
death ‘mesothelioma’. The cases are all lung cancer and mesothelioma deaths 
occurring in the dockyards over the 17 year study period. The controls are 
matched to the cases by age and year of first dockyard employment. Logistic 
regression, as described in chapter 3, will be used in this chapter to analysis the 
case-control data.
The relationship of mesothelioma with time since first possible asbestos exposure, 
i.e. first dockyard employment, is also scrutinised in this chapter. Section 5.3 
summarises a mathematical model relating dockyard mesothelioma incidence over 
all three dockyards, Devonport, Chatham and Portsmouth, exponentially with time 
since employment. This model is compared and contrasted to the model suggested 
by Peto in 1982.m
5.2 Nested c^sg-contrpl analysis.
The only conceptual difference between a full cohort study and a case-control 
study based on the same cohort is that the latter involves a sample of the study 
base rather than an analysis of the entire study base. There is little loss of 
precision in a nested case-control analysis compared to a full cohort analysis, 
indeed the case-control approach is particularly valuable if the study disease is rare 
or has a long induction period, as often happens with mesothelioma. In essence 
this chapter is chiefly concerned with mesothelioma. An advantage of the case-
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control method over a full cohort analysis is its ability to control confounders in 
the matching of cases and controls. An associated advantage is therefore its ability 
to negate the health worker effect.
In the analyses presented here, the controls were matched to the cases by 
incidence density sampling, according to age and year of first employment (± 1 
year for each of these). Four controls per case were employed, giving for 
mesothelioma: 70 case-control sets at Devonport, 23 at Chatham, and 26 at 
Portsmouth. For lung cancer 216 case-controls sets were obtained for Devonport. 
84 for Chatham, and 183 at Portsmouth. Only 2 mesothelioma deaths were 
unmatched, and omitted, in these analyses (one at both Devonport and 
Portsmouth). In total 24 lung cancer deaths were not matched to controls; 7 at 
Devonport, 12 at Chatham, and 5 at Portsmouth.
Table 5.1 summarises the results of the mesothelioma logistic regression analysis. 
From this table it can quickly be seen that after matching for age the main effect 
on mortality across all three dockyards was asbestos exposure rating. At 
Devonport occupational group was also seen to be significant in the regression 
model; at Chatham phlegm production takes the place of occupational group and 
is seen in the model. The other factors considered, cough, breathlessness, and 
smoking habits, etc., are not seen to have any effect.
When modelling just the exposure rating term the following elevated mesothelioma 
odds ratios were produced: 1.84 (95%CI: 1.45-2.33) at Devonport, 1.64 (95%CI: 
1.12-2.41) at Chatham, and 1.65 (95%CI: 1.17-2.33) at Portsmouth. These show 
a clear excess mortality due to mesothelioma over all three dockyards, when 
relating mesothelioma incidence to asbestos exposure rating.
Table 5.2 gives the lung cancer regression results. From this table it is apparent 
that occupational exposure to asbestos plays only a limited role in the production 
of lung cancer at the three dockyards, with cigarette smoking appearing to be the 
predominant casual factor. Other significant factors appear to be symptoms from
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T A B L E  5.1: Goodness-of-fit statistics obtained in Mesothelioma logistic 
regression.
Devonport Chatham Portsmouth
Model Adev df Model Adev df Model Adev df
og 5.6* 1 og 3.6 1 og 0.6 1co 0.1 1 CO 0.4 1 0.6 1
£ 0.5 1 0.2 1 £ 6.1* 1 0.1 1 £ 2.4 1 0.0 1ch 0.4 1 ch 0 .0  1 ch 0.2 1sm 0.5 1 sm 0.6 1 sm 1.4 1
| sa 0.0 1 sa 3.7 1 0.2 11 sd 0.4 1 sd 0.4 1 sd 0.8 1ex 30.1** 1 ex 7.2** 1 ex 9.1** 1Is 0.5 1 Is - Is 0 .0  1ao 0.2 1 ae 2.8 1 ae 1.8 1
ae+og 3 1 . 1 «  2 ae+og 7.3* 1
ae+pn 9.7** 1
ae+ae*og 31.5** 3
TABLE 5.2 Goodness-of-fit statistics obtained in Lung Cancer logistic
regression.
Devonport
Model Adev df
Chatham
Model Adev df
Portsmouth
Model Adev df
og 0.1 1 og 0.1 1 og 3.4 1
co 15.8** 1 co 14.4** 1 28.3** 1
1 Ph 16.4** 1 ph 4.7* 1 ph 44.3** 1&r 11.3** 1 Dr 4. 1* 1 or 8.8** 1
ch 0.6 1 ch 0.3 1 ch 1.3 1
sm 51.5** 1 sm 26.7** 1 sm 65.7** 1
sa 15.7** 1 sa 0.8 1 sa 19.0** 1
sd 3 8 . 9 «  1 sd 19.4** 1 sd 3 1 . 0 «  1
ex 6.5* 1 ex 0.7 1 ex 6.4* 1
Is 0.0 1 Is 0.3 1 Is 0.0 1
ae 0.6 1 ae 0.0 1 ae 0.4 1
sm+sd 40.1** 2 sm+sd 19.4** 2 sm+ph 87.4** 2
sm+sa 4 0 . 2 «  2 sm+co 33.5** 2 sm+co 75.5** 2
sm+co 57.9** 2 sm+ph 27.9** 2 sm+sd 51.7** 2
sm+ph 56.7** 2 sm+br 2 9 . 1 «  2 sm+sa 74.4** 2
sm+br 6 2 . 2 «  2 sm+br 73.0** 2
sm+ae 54.0** 2 sm+ex 7 3 . 5 «  2
sm+br+ae 61.6** 3 sm+co+br 3 4 . 0 «  3 sm+ph+co 88.4** 3
sm+br+co 65.0** 3 sm+co+ph 3 3 . 5 «  3 sm+ph+sa 89.8** 3
sm+br+ph 63.8** 3 sm+co+sd 24.9** 3 sm+ph+ex 91.4** 3
sm+br+sm*br 63.7** 4 sm+co+sm*co 21.4** 4 sm+ph+sm*ph 87.1** 4
Adev = change in model deviance 
df = degrees o f  freedom
* P<0.05
** P<0.01
Grouped variable definitions:
og occupational group co cough
ex e x p o s u r e  rating ph phlegm
Is l e n g t h  of service br breathlessness
ae a s b e s t o s  exposure period ch chest-i11ness
sm smoking habit
sa smoking amount
sd duration of smoking
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the workers personal medical history; with, for example, breathlessness having a 
significant effect at Devonport, cough at Chatham, and phlegm production at 
Portsmouth. Asbestos exposure rating is seen to be significant in the regression 
models at Devonport and Portsmouth, however, less significantly so than medical 
history.
When modelling only with the term relating to smoking habit the following highly 
elevated lung cancer odd ratios were produced: 2.55 (95%CI: 1.89-3.44) at 
Devonport, 2.85 (95%CI: 1.71-4.75) at Chatham, and 3.04 (95%CI: 1.83-5.04) 
at Portsmouth. Demonstrating an excess lung cancer risk.
Simply, this nested case-control analysis supports the results of chapter 4, showing 
for lung cancer that cigarette smoking is the dominant factor and not dockyard 
asbestos exposure (or its near surrogate). The opposite is seen for mesothelioma, 
no smoking effect, and elevated odds ratios for asbestos exposure rating.
5.3 Mesothelioma modelling.
In contrast to lung cancer, which has been commonly described by a linear dose- 
response relationship with asbestos exposure12^ , mesothelioma is best described by 
an absolute risk model in which the incidence of both pleural and peritoneal 
mesothelioma is independent of the age at first exposure (and cigarette smoking) 
and increases according to a power function of time since first exposure. This 
model was first suggested and used by Newhouse and Berry in 1976 to predict 
mesothelioma mortality in a group of asbestos factory workers.[3] They 
suggested the following model:
I M = b ( t - w ) k ,
where l M is the incidence of mesothelioma at time t  from first exposure, w is a 
delay in the expression of the risk, and b  and k are empirically derived constants.
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The incidence of asbestos induced mesothelioma in rats has also been seen to 
follow this time course. 141 From the work of Newhouse and Berry it was 
suggested that k lies between 1.4 and 2 and w between 9 and 11 years, i.e. a 
quadratic model was suggested with a time delay of approximately 10 years. Peto 
et al in 1982 further showed that the absolute incidence of mesothelioma was 
independent of age at first exposure and suggested the model:
J M = be  * ,
with 3.20  as his best estimate of k.[1] This model was based on the data from 
the study of North American insulation workers undertaken by Selikoff et al in 
1 9 7 9 (5] an£j mociei]ed 236 mesothelioma deaths. The model was seen to fit the 
data well between 20 and 45 years from first asbestos exposure. However, 
observed incidence rates for earlier times were less than those projected, and Peto 
suggested a return to the model of Newhouse and Berry, that is, the use of a 
quadratic time-dependence with a lag of 10 years. This quadratic expression fitted 
the data better up to 45 years from first exposure. The analysis of Peto et al 
excluded workers first employed before 1922 and after 1946, and over the age of 
80; the fit to the mortality of the entire group suggested a value of k  of about 5.
The model suggested by Peto has been used by Sullivan et al to model the 
mesothelioma incidence in the Royal Naval Dockyards (see appendix 5: supporting 
evidence) . 161 In this work the mortality experience of workers at Devonport, 
Chatham and Portsmouth was followed for 10 years, and 56 mesothelioma deaths 
were accumulated. The best estimate of the power parameter (k) was found to be 
in close agreement to Peto’s value; with k=3.  14. However, the constant of 
proportionality (£>), a measure of relative mesothelioma incidence, was seen to be 
nearly an order of magnitude less than that suggested by Peto. Suggesting that the 
risk of dying from mesothelioma for dockyard workers is much less than that seen 
for North American insulation workers.
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T A B L E  5 .3 : Distribution by tim e since first em ploym ent and age at first em ploym ent o f  120 m esotheliom a deaths.
Age f i r s t  
em ployed
(yrs) 0 -4 5 -9 10 -1 4
Y e a rs  s in c e  f i r s t  em ploym ent 
1 5 -1 9  2 0 -2 4  2 5 -2 9  30 -3 4 3 5 -3 9 4 0 -4 4 4 5 -4 9 50+
1 5 -2 4 P e r s o n - y e a r s 5505 18466 28060 34264 31053 26274 25845 26705 23590 18821 14022
O b serv ed 0 0 1 0 2 4 8 14 20 23 20
E x p e c te d 0 .6 3 1 .9 4 1 .3 0 3 .2 7 7 .6 6 8 .1 3 1 0 .3 2 1 9 .6 8 2 2 .9 7 2 0 .1 9
2 5 -3 4 P e r s o n - y e a r s 1137 3424 4805 6147 6618 8087 8389 8030 4870 2470 563
O b serv ed 0 0 0 1 1 7 3 0 3 3 1
E x p e c te d 0 .1 3 0 .3 3 0 .2 3 0 .7 0 2 .3 6 2 .6 4 3 .1 0 4 .0 6 3 .0 1 0.81
35 -4 4 P e r s o n - y e a r s 750 2720 4444 6214 6542 5576 3587 1477 305 10
O b serv ed 1 0 0 0 1 1 1 0 1 0
E x p e c te d 0 .0 9 0 .3 1 0 .2 4 0 .6 9 1 .6 2 1 .1 3 0 .5 7 0 .2 5 0 .0 1
4 5 -5 4 P e r s o n - y e a r s 920 3287 4822 5011 2994 1218 314 13
O b serv ed 0 0 2 1 1 0 0 0
E x p e c te d 0 .1 0 0 .3 3 0 .1 9 0.31 0 .3 5 0 .1 0 0 .0 0
55+ P e r s o n - y e a r s 471 1398 1356 1015 273 11 5
O b serv ed 0 0 0 0 0 0 0
E x p e c te d 0 .0 5 0 .0 9 0 .0 4 0 .0 3 0 .0 0 0 .0 0
T o ta l P e r s o n - y e a r s 8783 29296 43488 52651 47479 41166 38140 36225 28766 21300 14586
O bserved 1 0 3 2 5 12 12 14 24 26 21
A nnual d e a th r a t e  (per 1 0 0 .0 0 0 ) :
T h is  s tu d y 1 1 .3 9 0 6 .9 0 3 .8 0 1 0 .5 3 2 9 .1 5 3 1 .4 6 3 8 .6 5 8 3 .4 3 1 2 2 .0 6 1 4 3 .9 8
P e to  (1 9 8 2 ) 0 0 0 1 2 .0 2 32.31 1 5 4 .1 7 2 8 9 .2 5 5 2 5 .3 5 5 6 9 .3 5 1080 .72 6 6 4 .4 5
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T A B L E  5 .4 : D evonport D ockyard . Distribution by tim e since first em ploym ent and age at first em ploym ent o f 70 mesothelioma
deaths.
Age f i r s t  
em ployed  
( y r s ) 0 -4 5 -9 10 -1 4
Y e a rs  s in c e  f i r s t  em ploym ent 
1 5 -1 9  2 0 -2 4  2 5 -2 9  3 0 -3 4 35-39 4 0 -4 4 4 5 -4 9 50+
15 -2 4 P e r s o n - y e a r s 3213 10615 15853 19006 16842 13684 13269 12988 10891 8483 5912
O b se rv e d 0 0 0 0 1 3 6 6 7 16 10
E x p e c te d 1 .3 0 1 .3 0 2 .5 8 5 .11 6 .1 6 4 .5 3 8 .3 0 1 5 .8 6 1 0 .5 5
2 5 -3 4 P e r s o n - y e a r s 584 1896 2705 3541 3882 4200 4187 3585 2117 1135 250
O b serv ed 0 0 0 1 1 5 2 0 2 2 1
E x p e c te d 0 .2 2 0 .2 4 0 .6 0 1 .5 7 1 .9 4 1 .2 5 1.61 2 .1 2 0 .4 5
3 5 -4 4 P e r s o n - y e a r s 418 1517 2505 3474 3606 2875 1773 632 110 9
O b serv ed 0 0 0 0 1 0 1 0 1 0
E x p e c te d 0 .2 1 0 .2 4 0 .5 5 1 .0 7 0 .8 2 0 .2 2 0 .0 8 0 .0 2
4 5 -5 4 P e r s o n - y e a r s 476 1800 2667 2751 1654 642 159 7
O b serv ed 0 0 2 1 1 0 0 0
E x p e c te d 0 .2 2 0 .1 9 0 .2 5 0 .2 4 0 .0 7 0 .0 0
55+ P e r s o n - y e a r s 223 635 593 440 112 2 5
O b serv ed 0 0 0 0 0 0 0 T o ta l  num ber o f  p e r s o n - y e a r s : 1 8 7 .918
E x p e c te d 0 .0 5 0 .0 3 0 .0 2 0 .0 0 0 .0 0 D eath  r a t e  ( p e r  1 0 0 ,0 0 0 ): 3 7 .2 5
T o ta l P e r s o n - y e a r s 4913 16463 24322 29213 26095 21404 19388 17211 13119 9626 6161
O b serv ed 0 0 2 2 4 8 9 6 10 18 11
A nnual d e a th r a t e  ( p e r  1 0 0 ,0 0 0 ):
D e v o n p o rt 0 0 8 .2 2 6 .8 5 1 5 .3 3 3 7 .8 8 4 6 .4 2 3 4 .8 6 7 6 .2 3 1 8 6 .9 8 178 .5 4
A ll  y a r d s 1 1 .3 9 0 6 .9 0 3 .8 0 1 0 .5 3 2 9 .1 5 3 1 .4 6 3 8 .6 5 8 3 .4 3 1 2 2 .0 6 143 .9 8
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T A B L E  5 .5 : Chatham D ockyard. Distribution by time since first em ploym ent and age at first em ploym ent o f 23 m esotheliom a deaths.
Age f i r s t  
em ployed  
( y r s ) 0 -4 5 -9 10 -1 4
Y e a rs  s in c e  f i r s t  em ploym ent 
1 5 -1 9  2 0 -2 4  2 5 -2 9  3 0 -3 4 3 5 -3 9 4 0 -4 4 4 5 -4 9 50+
1 5 -2 4 P e r s o n - y e a r s 870 3517 5282 6627 5745 4653 4516 4960 4766 3911 3119
O bserved 0 0 1 0 0 0 0 4 8 4 2
E x p e c te d 0 .6 1 0 .6 6 0 .7 0 2 .8 7 7 .2 5 4 .3 2 1 .9 2
2 5 -3 4 P e r s o n - y e a r s 185 576 775 922 850 1179 1334 1692 1110 614 135
O bserved 0 0 0 0 0 0 1 0 1 1 0
E x p e c te d 0 .1 3 0 .1 0 0 .2 1 0 .9 8 1 .6 9 0 .6 8 0 .0 8
35 -4 4 P e r s o n - y e a r s 111 478 681 827 812 697 522 254 42
O bserved 1 0 0 0 0 0 0 0 0
E x p e c te d 0 .0 8 0 .0 8 0 .0 8 0 .1 5 0 .0 6
4 5 -5 4 P e r s o n - y e a r s 162 624 829 843 445 159 41 2
O bserved 0 0 0 0 ■ 0 0 0 0
E x p e c te d 0 .1 1 0 .1 0 0 .0 1 0 .0 0
55+ P e r s o n - y e a r s 101 382 411 313 101 9 5
O bserved 0 0 0 0 0 0 0 T o ta l  num ber o f  p e r s o n - y e a r s : 66 ,191
E x p e c te d 0 .0 7 0 .0 5 0 .0 0 D ea th  r a t e  ( p e r  1 0 0 ,0 0 ) : 3 4 .7 5
T o ta l P e r s o n - y e a r s 1430 5577 7977 9533 7953 6698 6417 6908 5919 4525 3254
O b serv ed 1 0 1 0 0 0 i 4 9 5 2
A nnual d e a th r a t e  ( p e r  1 0 0 .0 0 0 ) :
Chatham 69.91 0 1 2 .5 4 0 0 0 1 5 .5 8 5 7 .9 0 152 .0 6 1 1 0 .5 0 6 1 .4 6
A ll  y a rd s 1 1 .3 9 0 6 .9 0 3 .8 0 1 0 .5 3 2 9 .1 5 3 1 .4 6 3 8 .6 5 8 3 .4 3 122 .0 6 1 4 3 .9 8
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T A B L E  5 .6: Portsmouth Dockyard Distribution by time since first em ploym ent and age at first em ploym ent o f 27 m esotheliom a
deaths.
Age f i r s t  
em ployed
(yrs) 0 -4 5 -9 10 -1 4
Y e a rs  s in c e  f i r s t  em ploym ent 
1 5 -1 9  2 0 -2 4  2 5 -2 9  30 -34 3 5 -3 9 4 0 -4 4 45 -4 9 50+
15-24 P e r s o n - y e a r s 1422 4334 6925 8632 8467 7936 8060 8757 7932 6427 4991
O bserved 0 0 0 0 1 1 2 4 5 3 8
E x p e c te d 0 .6 3 2 .4 3 1.31 2 .8 9 4 .0 8 2 .7 0 7 .7 2
25 -3 4 P e r s o n - y e a r s 368 951 1325 1683 1886 2708 2869 2753 1643 722 179
O bserved 0 0 0 0 0 2 0 0 0 0 0
E x p e c te d 0 .1 4 0 .8 3 0 .4 6 0 .9 1 0 .8 4 0 .3 0 0 .2 8
35 -4 4 P e r s o n - y e a r s 221 726 1258 1912 2124 2003 1291 591 153 1
O bserved 0 0 0 0 0 1 0 0 0 0
E x p e c te d 0 .1 6 0 .61 0.21 0 .1 9 0 .0 8 0.00
4 5 -5 4 P e r s o n - y e a r s 282 863 1326 1417 895 416 114 4
O bserved 0 0 0 0 0 0 0 0
E x p e c te d 0.07 0 .1 3 0.02 0.00
55+ P e r s o n - y e a r s 146 381 353 261 60
O b serv ed 0 0 0 0 0 T o ta l  num ber o f  p e r s o n - y e a r s : 107 ,771
E x p e c te d 0 .0 0 D eath  r a t e  ( p e r  1 0 0 ,0 0 ) : 2 5 .0 5
T o ta l P e r s o n - y e a r s 2439 7255 11188 13905 13431 13063 12335 12106 9728 7140 5170
O bserved 0 0 0 0 1 4 2 4 5 3 8
A nnual d e a th  r a t e  ( p e r  1 0 0 .0 0 0 ) :
P o r tsm o u th 0 0 0 0 7 .4 5 3 0 .6 2 16.21 3 3 .0 4 5 1 .4 0 4 1 .9 6 1 5 4 .7 3
A ll  y a rd s 1 1 .3 9 0 6 .9 0 3 .8 0 1 0 .5 3 2 9 .1 5 3 1 .4 6 3 8 .6 5 8 3 .4 3 122 .06 1 4 3 .9 8
This analysis excluded ‘outstation’ workers and was performed on 20,426 male in­
yard workers followed from the early 1970s for 10 years. Their mortality 
experience was considered up to 49 years from first possible asbestos exposure. 
In all 193,560 person-years of observation were obtained and used in this model. 
Figure 5.1 shows the cumulative risk of dying from mesothelioma produced in this 
work. It has an identical form to figure 1 from Peto et al.t1} Signifying a similar 
pattern of risk between dockyard workers and insulation workers, though the risk 
is much smaller in the dockyard workers, i.e. the lifelong risk is 3% in dockyard 
workers compared to approximately 15% in insulation workers first employed at 
age 20 (where a lifetime risk of 3% means that 3 mesotheliomas will occur by age 
80 in a cohort of 1 0 0  men followed to extinction).
TABLE 5.7: Estimates of the power parameter (k) and the constant of 
proportionality (£>).
Devonport Chatham Portsmouth
Power parameter (k) 
C onstant (b)
For all time si n c e  first employment periods:
3.31 2.04 6.00 
3.96x1O-9 3.41x10"10 6.75x10"14 
For all 3 dockyards combined, k = 3.06, b = 8.18x10~9 .
Power parameter (k) 
Constant (b)
Qmittinq the first 3 periods:
3.33 1.24 6.00 
3.66x10 -9 7.64x10"® 6.75xl0"14 
For all 3 dockyards combined, k ■ 3.08, b ■ 7.57x10-9 .
Over the 17 years of follow-up considered in this work 361,880 person-years of 
observation have accrued, with 120 deaths accumulated over the 3 dockyards from 
pleural and peritoneal mesothelioma. Table 5.3 shows the distribution of these 
deaths by time since first employment and age at first employment. The expected 
values from this table have been calculated on the assumption that mesothelioma
2 0 5
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FIGURE 5.1*: Cumulative risk of dying of mesothelioma for workers first
employed in the dockyards at age 15-24 (-----), 25-34 (------ ),
or 35 and over (..... ) against age (upper graph) and years
since first employment (lower graph).
* Taken from: Sullivan KR, Lam TH, Rossiter CE (1988) "Mesothelioma 
and Time Since First Employment" Ann occup Hyg 32:491-496.
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mortality is independent of age, i.e. the expected numbers are calculated internally 
by multiplying the overall death rate in each quinquennium since first employment 
by the number of person-years in each cell in the corresponding column of table 
5.3. The fit is very close between the observed and expected deaths (e.g. X2 
goodness of fit = 5.95, df=9, P>0.5, for those aged 15-24 at first employment) 
and the annual death rate is seen to rise analogously to the rate reported by Peto. 
Tables 5.4 to 5.6 show the distribution of mesothelioma deaths for each dockyard.
A model of the form outlined by Peto was then fitted to the data in table 5.3 to 
gain the best estimates of the parameters b and k for the 1 2 0  mesothelioma deaths. 
This was undertaken in GLIM using a method of minimisation of fitted deviance, 
i.e. by minimizing the likelihood-ratio statistic. Table 5.7 shows the estimates 
produced for each dockyard. The following illustrates the GLIM macro used:
$ MACRO MIN 
$ CAL px = x**%a $
$ YVARY $
$ FIT $
$ FIT +px -%GM $
$ DISP R E S  
$ ENDMAC
From this table it can be seen that a combined dockyard estimate of the power 
parameter over all time since first employment periods is given by: k=3. 06 with 
an accompanying constant, b = 8 . 18x 10~9\ this model excludes only those workers 
over the age of 85. The model was fitted to observed mesothelioma deaths beyond 
50 years since first employment using 52.5 as an approximate mid-period value 
in the modelling. By inspection of tables 5.3 to 5.6 it is apparent that 4 
mesothelioma deaths have occurred at very early follow-up periods. At Chatham 
dockyard a single mesothelioma death occurred with less than 5 years possible 
dockyard exposure. No previous occupational history was available for these 4 
workers. If we assume a minimum latency period of at least 15 years from first 
exposure, then these 4 deaths should be excluded from a dockyard mesothelioma 
mortality model. Accordingly, the model parameters were recalculated omitting
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the first 15 years since first employment. This resulted in revised estimates of: 
k=3.08  and b=7.57*10~9. It also dramatically increased the constant of
proportionality, the measure of mesothelioma incidence, at Chatham.
These parameter estimates are very close, and are also close to the estimate given 
at 10 years of follow-up. A reasonable estimate of the parameters for dockyard 
mortality could, therefore, be given by: k=3. 1 with b=7. 01*10~9. This also 
avoids the spurious precision implied by a second decimal place in the estimates 
of the power parameter. Table 5.8 shows the effect of the various estimates in the 
calculation of an annual mesothelioma death rate 30 years after first employment 
(i.e. t=30, in each calculation).
TABLE 5.8: Estimates of an annual mesothelioma death rate.
Power
0 0
Relative 
incidence (b) 
xlO9
Calculated death 
rate per 10,000
This study:
Total follow-up 3.06 8.18 2.71
Minus first 15 years 3.08 7.57 2.68
Sullivan (1988): 3.20* 5.64 3.01
Peto (1982): 3.20 43.7 23.29
Dockyard estimate: 3.1 7.01 2.66
* Peto’s value of 3.20 was used in place of the estimated value 3.14 in this 
publication, in the calculation of b.
From table 5.8 it is clear that the relative mesothelioma incidence, and indeed 
mesothelioma risk, in any particular cohort could be summarised by the constant 
b. From this table the insulation workers clearly show a higher risk than the 
dockyard workers (generated from the larger constant value). It is also clear that 
the dockyard models have produced compatible estimates of annual death rates, 
and that a model fitted with an exponential time-dependence appears to be 
appropriate for dockyard mesothelioma incidence (the fit of observed and expected
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deaths were not significantly different at each dockyard). The model is also very 
robust and allows for the effect of mesothelioma latency, i.e. the removal or 
inclusion of the first 15 years of follow-up has minimal effect on the model 
parameters. An obvious limitation of this exponential model of mesothelioma 
incidence is, however, its lack of any measure of actual asbestos exposure. A 
model postulated by the World Health Organization modifies the exponential 
model and suggests a breakdown of the constant parameter (£>) into two terms; one 
for level of asbestos (in fibres per millilitre) and one a constant term characteristic 
of asbestos type and distribution of fibre dimension.(7) Due to the lack of actual 
fibre levels in this study it was not possible to implement the WHO model.
The result of this mesothelioma modelling strongly supports the conclusion of Peto 
in 1982, that mesothelioma mortality is related to time since first employment, and 
first possible asbestos exposure, and is independent of age. However, the ‘relative 
risk’ parameter b is much lower than that observed by Peto for insulation workers 
and four other occupational groups (namely, asbestos factory workers, chrysotile 
factory workers, crocidolite miners and amosite factory workers). These cohorts 
will be considered in the following chapter. This can be linked with the results 
of chapter 4, and particularly that of no overall excess or deficiency of lung cancer 
deaths, and suggests that the dockyard workers may well have been exposed to 
significantly less asbestos than the other occupational groups considered by Peto.
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C h a p te r  6: D IS C U S S IO N  A N D  C O N C L U S IO N .
6.1 Discussion.
A common objective of occupational mortality studies is to assess whether 
mortality in a particular industry, or workforce, is higher than expected because 
of adverse exposures in the workplace. In this study a screening process was 
undertaken in which 50 broad disease groups were inspected. This was followed 
by an analysis of 12 specific disease groupings that were scrutinised for any 
possible trends in mortality related to dockyard asbestos exposure. Throughout, 
however, special emphasis has been given to the two main asbestos-related 
diseases, i.e. lung cancer and mesothelioma (and specifically pleural
mesothelioma). The striking result found has been one of no overall excess in 
lung cancer mortality, together with excessively high mortality rates for both 
pleural and peritoneal mesothelioma. Asbestosis has shown high SMRs, but was 
based on too few observed deaths to allow sensible analysis. These results apply 
equally to all three dockyards, Devonport, Chatham and Portsmouth.
The only clear lung cancer dose-response found in this study, is its already well- 
documented relationship with cigarette smoking.^1,21 Additionally, an increasing 
lung cancer risk (with significant trend) was clearly observed across smoking habit 
for the workers in occupational group 4. This was the group created by Sheers 
and Templeton to represent potentially the lowest level of asbestos exposure, but 
as mentioned in section 3.1.4 these groups may in fact give ambiguous measures 
of asbestos exposure (with much worker interchange between groups).13^
No obvious lung cancer relationship was seen with potential asbestos indicators 
(asbestos exposure rating, occupational group, etc.), or with most employment 
history factors. However, an indication of excess lung cancer mortality was 
observed, occurring at long intervals from first possible dockyard exposure (i.e.
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for those workers with less than 20 years employment who had been first 
employed over 30 years ago). This agrees to some extent with the initial results 
reported on by McDonald for Quebec chrysotile miners and millers.141 Here 
workers with 20 or more years employment (considered at least 20 years after 
start of employment) were seen to have clear excesses; these were the group of 
workers exposed to the heaviest asbestos dust concentrations. However, little 
overall excess lung cancer was observed in McDonald’s study. Excess lung 
cancer risk was also observed for those workers with x-ray evidence of pulmonary 
fibrosis, giving some support to the suggestion of Browne that asbestosis is a 
precursor of lung cancer.151 For those workers who assessed their own period 
of asbestos exposure (i.e. 3359 workers over all yards), a significant excess was 
seen only at Devonport dockyard. This was observed in workers with potentially 
10 to 20 years of asbestos exposure. For the small subgroup of workers (i.e. 429 
workers over all yards) who further assessed their period of continuous exposure 
to asbestos, significantly raised lung cancer risks were observed for those workers 
with more than 10 years continuous asbestos exposure; however, this was based 
on a very small number of deaths. These results are, however, suggestive that a 
subgroup of the dockyard workforce may have been exposed to high levels of 
asbestos dust some 20 to 30 years ago, producing the lung cancer excesses 
observed in this study.
Overall, these results do not give much support (except for a small subgroup, who 
may have been the heaviest exposed) to the hypothesis that dockyard asbestos 
exposure is linked aetiologically with lung cancer. In the majority of the analyses 
lung cancer risk was not raised significantly above that expected in the general 
population.
Conversely, pleural mesothelioma is seen to have no relationship at all with 
smoking habit, another well-documented fact161, but is seen in this work to be 
related to possible asbestos exposure (specifically with asbestos exposure rating). 
This was a highly significant association, and could be taken as indicating that the
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exposure codes used are relevant surrogate measures of exposure. Mesothelioma 
incidence is also seen to be related to time since first dockyard employment (and 
first possible dockyard asbestos exposure). Large excess mesothelioma risks were 
observed to be clustered among those workers with long follow-up and long 
duration of service (i.e predominantly for workers first employed before World 
War II). However, significant mortality trends were not observed in these groups. 
Dockyard mesothelioma incidence also appeared to be well related to a mortality 
model fitted with an exponential time-dependence. The overall picture is then one 
of a limited lung cancer risk, with smoking its predominant casual factor, and a 
high mesothelioma risk related to past asbestos exposure.
The results therefore confirm and strengthen the conclusions drawn from earlier 
studies undertaken at Devonport Dockyard.17,81 The conclusions were that there 
is very little evidence of an overall excess mortality from lung cancer, despite a 
considerable number of mesothelioma deaths. This result is clearly not in 
complete accord with the other published studies of asbestos workers that either 
show excess mortality from both causes, or little excess from either. For 
example, the work of Hobbs in Australia for crocidolite miners and millers (excess 
in both), and McDonald in Quebec (little excess) for chrysotile miners and 
millers.[4,91 The asbestos studies of McDonald were extensively reviewed in 
chapter two.
From the literature review section of this dissertation (section 2.5), it can be seen 
that the results from this dockyard cohort are very striking, and at odds with the 
majority of published asbestos studies. Studies that have suggested that increasing 
lung cancer risks are clearly observed in cohorts exposed to amphibole asbestos, 
or mixtures of this with chrysotile asbestos; in the naval dockyards, however, all 
forms of asbestos (as itemised in chapter one) have been used over the years. 
Recent studies in and around dockyards have however produced further supporting 
evidence of a limited lung cancer risk, but high mesothelioma risk.110,111 In 
the first of these studies Sanden et al undertook a cohort investigation of 3,893
212
Swedish shipyard workers.i10] Here the workers were exposed mainly to 
chrysotile asbestos, and were seen to have no increased risk of lung cancer (SMR 
of 108, 95%CI:54-109, for workers defined as heavily exposed to asbestos). For 
pleural mesothelioma the risk was highly elevated (SMR of 1429, 95%CI:620- 
2810, also for heavily exposed workers). Their results are very similar to the 
findings of this dockyard study. The conclusion from this Swedish study was that 
asbestos may have different carcinogenic mechanisms in causing lung cancer and 
mesothelioma. They felt that asbestos acts as a promoter of lung cancer, but as 
a complete carcinogen in developing mesothelioma. In the next study mortality 
from mesothelioma and asbestosis around Plymouth docks was analysed by the 
Small Area Health Statistics Unit (SAHSU) using a computerised national health 
monitoring facility.11' 1 In this work elevated risks were seen within 3 km of the 
docks. For mesothelioma a high SMR of 841 (95%CI: 550-1230) was obtained 
based on 26 observed deaths, for asbestosis an SMR of 1364 (95%CI:500-2970) 
based on 6 deaths. This again supports the findings of this thesis.
Table 6.1 illustrates further studies, across varying asbestos industries, where no 
clear excess lung cancer risk has been observed. By inspection of this table the 
lowered dockyard risks for lung cancer generally correspond to a raised 
proportional mortality for mesothelioma. Suggesting that even without an excess 
lung cancer risk a very real asbestos-related disease problem exists in these 
workplaces. It should be noted, however, that for the studies cited in table 6.1 
longer periods of follow-up may eventually show higher SMRs for lung cancer.
Could it be concluded that it is not asbestos but rather asbestosis that prepares the 
basis for subsequent malignancy? This was the first controversy considered in 
chapter two. Would this hypothesis fit the pattern seen in this study of neither an 
overall excess nor a deficiency of lung cancer deaths, linked with low numbers of 
asbestosis deaths, but with an excess risk of mesothelioma? We also have an 
excess of lung cancer deaths in workers with x-ray evidence of previous
2 1 3
TABLE 6.1: Asbestos cohort studies showing no increase 
in lung cancer risk.
Industry Number of lung 
cancer deaths
SMR Proportional 
mortality 
mesothe1ioma
Dockyard
UK (Naval) [ 7) 84 84 3.0Z
UK (Civilian) [12] 35 104 4. OX
USA [13] 27 84 0.2X
Sweden [10] 11 108 6.6X
Asbestos Cement
Austria [14] 49 104 0.7X
Belgium [15] 21 94 0.5X
Sweden [16] 11 123 -
UK [17] 28 85 0.6X
UK [18] 34 89 0.3X
UK [19] 33 95 2.4X
Mining and
Manufacture
Italy [20] 22 no 0.5X
USA [21] 4 93
pulmonary fibrosis. For asbestosis to develop, high levels of asbestos exposure 
are needed, probably above 25 f/m l.[22] The results of this study would only 
support this hypothesis if it could be proved that dockyard asbestos exposures were 
less then this asbestosis threshold (i.e. if the exposures were only low enough to 
allow mesothelioma to develop and not asbestosis and then lung cancer). The 
problem is that this would be an attempt to prove a negative. A further problem 
occurs concerning the assumption that exposures should have been less than 25 
f/ml. Reported dockyard exposure values from the 1970s considerably exceed this 
limit. Table 2.3 presented a summary of the available dockyard exposure data, 
and clearly the processes monitored have a wide variation of possible exposures 
(ranging from 0.05 to 3815 f/cc). However, in a further report it was stated that 
"even though all processes involving work with asbestos insulating materials in 
Naval Dockyards give rise to asbestos dust concentrations of at least 2 f/cc, most 
processes have dust concentrations of 50 f/cc or more".1231 It is likely therefore 
that exposures before the 1970s would have been at least as high as this and
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probably higher. This, however, cannot be completely substantiated because 
exposure assessments prior to the work of Harries in the early 1970s were both 
rarely taken and often not consistently recorded. In fact the studies undertaken by 
Harries were performed in an attempt to give some idea of the potential past dust 
concentrations in the dockyard.1231 It consequently appears unlikely that dockyard 
exposures would be below the threshold value for asbestosis. However, it is 
possible that the intermittent nature of ship repair may play a role in this pattern 
of mortality. If it could be hypothesised that the workers were exposed to high 
peaks of exposure during rip-out operations, followed by low background levels 
the majority of the time, then their average exposures may possibly fall under this 
threshold limit. At the moment, however, the lung cancer - asbestosis question 
remains undecided for this dockyard cohort. The related question of whether there 
is a threshold dose of asbestos exposure below which asbestos is effectively non- 
carcinogenic to humans must also, for the same reasons, remain undecided. A 
recommendation of this work will be the creation of a detailed dockyard asbestos 
job-exposure matrix; once this is available more conclusive results should be 
possible.
It should be noted that McDonald and McDonald in a review of asbestos-related 
lung cancer also felt that despite the pathologic, experimental, radiologic and 
epidemiologic arguments put forward by Browne151 (concerning the asbestosis - 
lung cancer controversy) the basic question, as considered in section 2.5.6 of this 
thesis, remains unanswered.1241 They stated that there appears to be no certain 
evidence that fibrogenesis and carcinogenesis in the lung are linked except to the 
extent that they sometimes share the same aetiologic agents.
A method of overcoming the lack of definitive asbestos fibre measurements 
presents itself in this study, i.e. the use of the mesothelioma modelling introduced 
in chapter five. In these models the parameter b, a constant of proportionality, 
supplies a measure of relative mesothelioma incidence. This in turn could be taken
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as a simple measure of (or a guide to) asbestos exposure. The constant of 
proportionality could therefore be compared across studies to assess likely levels 
of incidence (and or asbestos exposure).
TABLE 6.2: Estimates of relative mesothelioma incidence.
Reference Data used Power
parameter k
Constant b 
xlOy
This thesis Naval dockyard workers 3.1 7
Peto [25] London textile workers [26] 3.2 49
American amosite factory [27] 49
American insulation workers [28] 44
Australian crocidolite miners [ 9] 51
Rochdale textile workers [29] 29
Hughes [30] American insulation workers [28] 3.2 3
& Meill Rochdale textile workers [29] 1
Ontario cement manufacturers [31] 22
Ontario [22] American insulation workers [28] 4.0 0.13
Royal Rochdale textile workers [29] 0.07
Commission Ontario cement manufacturers [31] 0.21
Table 6.2 presents estimates of relative mesothelioma incidence across many 
asbestos cohorts (asbestos textile workers, crocidolite miners, asbestos cement 
workers, etc.). These cohorts have all been cited previously in this thesis. The 
different fibre types involved in the studies in table 6.2, the relative proportions 
o f each, their dimensions, and the industrial process involved all possibly alter the 
carcinogenic effects of asbestos. Fibre dimensions and industrial processes are 
however undoubtedly related. When considering this information the modelling 
undertaken in table 6.2 appears too simplistic, producing a single value that can 
be compared across cohorts. However, Peto et al has shown that the most 
appropriate way of making comparisons statistically between studies is by 
describing incidence rates after adjustment for time from first exposure (i.e. this 
comparison technique).t25] When taking the Peto model from table 6.2 as 
standard it is clear that in absolute terms the dockyard workers mesothelioma risk 
is much less than that in the other cohorts. This implies that dockyard workers
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may have been exposed to significantly less asbestos than the other occupational 
groups. When considering the modified model of Hughes and Weill (a model 
which has a fixed power parameter and included duration of exposure information) 
the results are not so clear, with the risks in insulation and textile workers being 
of the same order of magnitude as dockyard workers, but the risks among asbestos 
cement workers being much more. The model of the Ontario Royal Commission 
has been included for reference only, its use of the slightly larger power term, 
prohibits direct comparison. A conclusion of this comparison could therefore be 
that the risk in dockyard workers is either of the same order of magnitude, or 
indeed much less, than these found in the other cohorts. This is not a very useful 
result. However, when considering the results of this thesis, i.e. no clear lung 
cancer risk and a very clear mesothelioma risk, it is probable that the risk for 
dockyard workers (and their exposure) is much less than that observed in the other 
cohorts.
A major limiting factor in this study has been both the lack of detailed exposure 
data as presented earlier, and the use of a non-standard x-ray screening 
classification. As previously described in section 3.1.6 it is likely that this 
screening classification will have a sensitivity of approximately 70% when 
compared to the ILO U/C 1971 classification. Resulting in a possible 
underestimation of the prevalence rates of asbestos-related abnormalities presented 
in table 3.12. Recently the ILO classification itself has been criticised for 
underestimating asbestosis.[32] This study suggests that the sensitivity of the ILO 
method is between 80% and 90%; it would appear therefore that each method has 
its limitations. The advantage of the ILO classification however still holds. It is 
an internationally agreed method of detecting asbestosis and other forms of 
pneumoconiosis.
Controversy three (section 2.5.6) concerns the amphibole hypothesis or more 
correctly the question: is chrysotile asbestos less carcinogenic than the 
amphiboles? This question cannot be directly addressed in this study since the
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workforce has potentially been exposed to both chrysotile and amphibole asbestos 
in many mixed forms (prior to 1968, as described in chapter one); with only very 
limited availability of asbestos fibre concentration in air measurements. The 
further use of a job-exposure matrix applied to this cohort, with details concerning 
type as well as amount of asbestos exposure, may address this issue. Numerous 
epidemiological studies (reviewed in section 2.5) have demonstrated increased lung 
cancer risk among past asbestos exposed workers; the evidence from these studies 
indicates that, except in the textile industry, where other exposures may play a 
role, the risk from chrysotile exposure is likely to be lower than that from 
amphiboles. There is no reason to suspect at present that this would be different 
in Naval Dockyards. Indeed an assumption could be that the lack of an overall 
lung cancer risk more likely reflects past chrysotile exposure than exposure to 
either crocidolite or amosite. The finding of Sanden et al of a deficiency of lung 
cancer cases in a cohort of chrysotile shipyard workers supports this 
assumption.1101
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6.2 Conclusion and Recommendations.
6.2.1 Conclusion.
The essential feature in preventing any asbestos related disease is, and has been, 
the control of the amount of asbestos to which individuals are exposed. It can be 
inferred that through control of dust levels in industry, medical surveillance of 
workers at risk, reduced use of asbestos and decreased cigarette smoking among 
exposed workers that asbestosis and related cancers will become increasingly rare. 
Opinion is that the risk of asbestosis is essentially nil at today’s industry 
standards.1331 No such forecast has been made for mesothelioma, except 
conceivably for countries where the use of amphibole asbestos is heavily 
proscribed. For mesothelioma there appears to be no level of exposure to 
amphibole fibres that is acceptable. For these reasons nations worldwide have 
imposed standards that effectively prevent the current and future use of crocidolite 
and amosite.
Unfortunately, as this work has highlighted, in shipbuilding the damage has 
already taken place with the initial use and subsequent uncontrolled removal of 
material containing virtually every form of asbestos (but predominantly crocidolite 
and amosite). At the moment the incidence of asbestos related disease is still 
increasing worldwide, due to past conditions, and projections made in the 1970s 
have indicated that the incidence of asbestos-related industrial cancers will only 
start to decline around the year 2000.1341 However, more recent work has 
indicated that a further epidemic of asbestos-related disease concentrated around 
construction workers and present day operations, involving the removal of asbestos 
from buildings, will continue this increased incidence over the next 20 to 40 
years.135,361
Recently the concept of a linear dose-response between asbestos exposure and lung 
cancer has been challenged, with support growing for the idea that a threshold
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exists for asbestos related lung cancer.124,37,381 This concept was considered in 
detail in section 2.5.6 of this thesis. It was noted that the dose-response may only 
have been observed in a mid-range of cumulative exposures and from this 
extrapolation has been made down to the low ambient environmental levels 
observed today. This has resulted in the ‘one fibre can kill’ theory and much 
public and media concern.1391 Information is clearly needed at both the low and 
high ends of the exposure scale to finally confirm the form of the lung cancer 
dose-response relationship. When considering lung cancer thresholds, the related 
question of whether lung cancer is simply a complication of asbestosis, or not, is 
frequently considered.15,401 High asbestos dust levels are required for the 
development of asbestosis, so if asbestosis is a pre-requisite for an increased lung 
cancer risk, this would imply high past dust exposures.
In this study there is no overall significantly increased (or decreased) lung cancer 
risk, only a very few recorded asbestosis deaths, and an excess risk for both forms 
of mesothelioma (pleura and peritoneal). However, a radiographical prevalence 
of pulmonary fibrosis of 0.9% (i.e. 220 cases over the 3 dockyards) was observed. 
This would only support the hypothesis of lung cancer being a complication of 
asbestosis (and potentially also the asbestos lung cancer threshold hypothesis) if 
it could be assumed that past dockyard asbestos exposures were quite low; low 
enough generally only to produce mesothelioma. A problem occurs with this 
assumption, i.e. the fact that recorded dockyard exposures reached approximately 
20,000 times the current UK limit for amosite and crocidolite, and also the 
observation that past dockyard working conditions were very dusty with men 
described as emerging from the compartments covered from head to foot in 
dust.141,421 The intermittent nature of these exposures may help to explain 
these results, with sharp peaks of exposure followed by periods of possibly only 
limited background exposure, resulting in lower average exposures. Consequently 
the lung cancer - asbestosis question, and the related threshold question, remain 
unresolved; due simply to the lack of consistent and well recorded past asbestos 
fibre data. However, clearly a threshold below which lung cancer is effectively
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non-carcinogenic would explain the observation seen here of an excess of 
mesothelioma, caused by potentially intermittent exposure, without an 
accompanying lung cancer excess. In consequence for dockyard workers, the idea 
of a lung cancer threshold is consistent but not proven conclusively.
It should also be noted that in mortality studies the frequency of asbestosis is likely 
to be underestimated, due to the difficulties involved in its diagnosis. Diagnosis 
is made on a history of asbestos exposure together with the clinical, physiological 
and radiographic features of this condition; each of which may be uncertain. 
More simply put, the absence of asbestos bodies in the sputum or on 
bronchopulmonary lavage are against a diagnosis of asbestosis. Accordingly, 
diagnosis can be made with a high degree of accuracy in advanced cases of the 
disease, but is uncertain and difficult in the early stages. If the frequency of 
asbestosis is underestimated this would obviously produce errors in any risk 
estimation, in particular at lower levels of exposure. In this work asbestosis has 
been seen to be in significant excess, however based on only 10 reported deaths 
over the three dockyards. It is possible that some misclassification has taken place 
with pulmonary fibrosis, resulting in lowered asbestosis SMRs. This would 
further obscure any relationship between lung cancer and asbestosis.
It should be noted that the establishment of dose-response relationships for 
asbestos exposure is beset with many problems. Among these should be included 
the long latent interval between initial exposure and evidence of an adverse effect, 
the features of which may be difficult to define: the unreliability of diagnosis 
leading to inexact death certification; the confounding effects of tobacco smoking; 
exposure to more than one type of asbestos each of which may have a different 
potential for producing an adverse effect; the inadequacy or even absence of data 
on past exposure; and until recently the crude methods in use for dust sampling 
and fibre identification and counting. Precision has, however, increased in 
epidemiological studies with the development and use of standardised 
questionnaires on respiratory symptoms and the use of international classifications
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for chest radiographs. Exposure assessment, that is, dust sampling methods have 
been greatly improved; the early practice of recording total particle counts has 
given way to fibre counting and this has become more precise with improvements 
in microscopy: the use of the eye piece graticule; phase contrast illumination; 
membrane filters; and the introduction of transmission and scanning electron 
microscopy for fibre identification. The use of these new techniques for future 
dockyard surveillance programmes of all forms of mineral fibre must form one of 
the recommendations of this dissertation.
To conclude, this study has shown that lung cancer is generally neither 
significantly in excess, or in deficit, in this dockyard cohort. This implies that the 
overall lung cancer risk is no different for dockyard workers than for the general 
population. A subgroup of the cohort, some 429 workers (i.e. 1.5% of the 
cohort), did however assess their own period of continuous asbestos exposure. 
From this group elevated lung cancer risks were seen with more than 10 years 
continuous exposure; however, these were based upon only 14 deaths in total. A 
relationship was observed between lung cancer risk and smoking, with significant 
trends showing particularly for the occupational group consisting of ‘all other 
dockyard workers’. Interestingly, this would have been the group with the least 
asbestos exposure according to the definition of Sheers and Templeton.131 For 
mesothelioma, the opposite appears to be true, that is, no apparent relationship 
seen with smoking, but a significant relationship observed with the surrogate 
asbestos exposure variable (i.e. with asbestos exposure rating). It is concluded, 
therefore, that there is no overall excess risk of lung cancer among Naval 
Dockyard workers, however, there is a very high excess mesothelioma risk.
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6.2.2 Recommendations.
The findings of this work, notably no clear excess or deficiency of lung cancer 
coupled with a very clear excess of mesothelioma needs to be confirmed or 
refuted. To this end further work is needed. The mortality experience of the 
dockyard workers continues to be recorded, and further follow-ups will be 
reported. However, these would still have the same limitations as this work: no 
definite asbestos exposure data (i.e. fibre counts in air); and the use of a non­
standard radiographical classification. Ideally past asbestos exposures should be 
obtained and the x-rays re-read to the full ILO U/C classification. Clearly this 
would be almost impossible. The exposures were rarely recorded before the 
1970s (and would have been static samples measuring particles, not personal 
samples measuring fibres)1211, and the radiographs are no longer available. A 
solution would be to investigate the current dockyard workforce. However, the 
work processes have changed dramatically over the last few decades with more 
mechanisation and the reduction in the number of workers (and the closure of the 
dockyards*), also asbestos has been removed from the yards and its use restricted.
A recommendation of this work, therefore, is for the future follow-up mortality 
studies to be supplemented, as far as possible, with all available work and 
exposure information. For this, current asbestos exposure information (mid 1970s 
- to date) should be collected, along with qualitative information (i.e. information 
derived from interviews with former dockyard workers, current workers employed 
some 20 years ago, etc.), for as many occupational codes (the codes listed in table 
3.6) as is possible. This extra information is essential and should be used to 
supplement the asbestos exposure codes used in this thesis. From all of this a 
detailed job-exposure matrix should be created to replace the asbestos exposure 
rating used here.
With the closure of the naval dockyards, the scenes depicted in figures 6.1 
and 6.2 of dockyard activity become simply a part of industrial history.
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Enough deaths are now beginning to accrue in the cohort for autopsy studies to be 
performed. A further recommendation would therefore be for these studies to be 
undertaken with the view to assessing asbestos lung burden, and characterising the 
fibre types and dimensions. As for example, in the work of Sebastien et al 
undertaken for two North American asbestos cohorts, where autopsy data was used 
to question the amphibole hypothesis considered in section 2.5 of this 
dissertation.t431 Similar work has in fact previously been undertaken at 
Devonport Dockyard, a necropsy study undertaken in 1986.1441 However, the 
recommendation here is for autopsy studies to be undertaken covering workers 
from all the Naval Dockyards. These studies would again be used to supplement 
further cohort analyses, with fibre information. It should be emphasised that these 
autopsy studies would only provide estimates of possible dose and not exposure.
It has been argued by McDonald et al that the risk of lung cancer in relation to 
asbestos exposure cannot be examined adequately by the subject-years 
method.t451 The authors stressed that it is becoming increasingly apparent that 
the linear relationships that have been found between SMRs and cumulative 
exposure are an oversimplification. They cite the work of Vacek and McDonald, 
in which a form of conditional logistic regression was used to create an exposure 
intensity model for assessing lung cancer risk among vermiculite miners1461. 
This model assumed that exposure variables (such as exposure intensity, average 
duration of exposure, and average time since last exposure) had multiplicative 
effects on lung cancer risk and that the relative risk increased exponentially with 
exposure duration at a specified intensity.1471 The authors concluded that in 
order to access exposure response relationships from epidemiological data 
accurately, exposure intensity as well as duration must be taken into account. 
Without definite asbestos exposure counts this is not directly possible. However, 
the model created by Vacek and McDonald could still be applied, in a limited 
form, to the dockyard cohort. This would be a further recommendation.
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One o f  the recommendations from this work would have been the controlled 
removal of asbestos from the dockyard environment. However, this process has 
been underway since the early 1970s, with asbestos being rapidly replaced by 
man-made mineral fibres (MMMFs). Mineral fibres that in their own right have 
been shown to be carcinogenic in laboratory animals.1481 Essentially it could be 
argued that the biological effects of MMMFs are the same as those produced by 
asbestos fibres, varying only in potency rather than in nature. In epidemiological 
studies conducted to date, there has been an excess of lung cancer observed in 
rockwool and slagwool production workers, but no significant excesses observed 
in glasswool or continuous filament production.149,50,511 The excesses seen 
in the rockwool and slagwool industries were for workers heavily exposed in the 
earlier years of production when exposure levels were less well controlled. There 
have been no reports of mesothelioma in occupational groups without co-exposures 
to asbestos. William Bunn, a vice president of the famous American asbestos 
company, the Manville Corporation (formerly the Johns-Manville Corporation), 
has questioned the potential toxic consequences involved in the manufacture and 
use of man-made mineral fibres and has cautioned that they "invoke the sense that 
we have been here before"!1521 If this is actually the case, it leads to a broad 
recommendation, that of, the highly controlled dockyard use of all mineral fibres, 
and strict adherence to codes of work practice already in place for asbestos.
Finally, the legacy of asbestos exposure continues even after the closure of the 
dockyards. Chatham and Portsmouth both closed in the early 1980s. The two 
remaining dockyards, Devonport and Rosyth, ceased to be operated by the 
Ministry of Defence in April 1987 when commercial management was introduced; 
at present Rosyth is threatened with closure. However, this work has shown that 
mesothelioma risk is currently in excess for the workers of these closed and 
closing dockyards. The closure of these Dockyards does not close the questions.
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T A B L E  A  1. 1: Coding Schedule of Dockyard Datasets.
Variable N a m e Position (length) Description
ID 1-12 (12) Unique identifer, formed from the 
national insurance number and first
3 characters of surname.
DOB 13-18 (6) Date of Birth.
SEX 19 O ) 0 - male, 1 = female.
D O C K Y A R D 20 (1) 1 - Devonport, 2 = Chatham,
3 « Portsmouth, 4 = Rosyth.
P A Y N O 21-25 (5) Dockyard payroll number.
S T A T U S 26 O ) 1 - traced and alive.
2 - traced and dead,
3 - traced and emigrated.
4 « untraced.
DOD 27-32 (6) Date of death.
ICD 33-37 (5) International Classification of Disease.
XRAY 38 (1) 1 « x-ray taken,
2 « no x-ray.
3 « large x-ray taken.
QUES 39 (1) 1 - questionnaire obtained.
2 - no questionnaire.
3 * controlled questionnaire obtained.
Small x - r a y
SRI 40 (1) R e ader one code.
SSI 41-42 (2) R e ader one score.
SR2 43 (1) R e ader two code.
SS2 44-45 (2) R e a d e r  two score.
Larqe x - r a y
LR1 46 (1) R e ader one code.
LSI 47-48 (2) R e ader one score.
LR2 49 (1) R e ader two code.
LS2 50-51 (2) R e ader two score.
The v a r i a b l e s  in this section and their descriptions are given in the accompanying
I q u e s t i o n n a i r e s  (see pages Al- 3 to A l -10).
Self Adm i n i s t e r e d  Questionnai re
Personal Medical History 52-64 0 3 ) 0 = yes, 1 = no.
Smoki ng Hi story 65-81 (17) 0 = yes, 1 = no.
Empl o y m e n t  History 82-201 0 2 0 ) 20 x Job code (2),
Start year (2), 
Stop year (2).
C o n t r o l l e d  Questionnaire
Medical H i s t o r y 202-217 (16) 0 = yes, 1 = no.
1 Smoking His t o r y 218-234 (17) 0 ■ yes, 1 = no.
! Medical H i s t o r y  (cont.) 235-243
O 0 )
0 = yes, 1 = no.
Asbestos Exposure 245-254
| Empl o y m e n t  History 255-314 (60) 10 x Job code (2),
Start year (2), 
Stop year (2).
A l - 2
S E L F  A D M I N I S T E R E D  Q U E S T I O N N A I R E .
MEDICAL-IN-CONFIDENCE ( whan co m p leted )
N aval D ockyard A sb e s to s  Su rvey
P le a s e  answer a l l  q u e s t io n s  c a r e f u l l y  to  th e  b e3 t  o f  your a b i l i t y  e i t h e r  by w r i t i n g  in  
th e  b o x es  p ro v id ed , o r  by p la c in g  a t i c k  in  th e  a p p r o p r ia te  box in  some c a s e s .
G e n e ra l Par t i  cu i arr,
1 . W rite  in  th e  boxes p ro v id ed  you r 
N a tio n a l In s u ra n c e  Number
( t h i s  i s  shown on you r c e r t i f i c a t e  o f  pay 
and tax  d e d u cted , Form P 60) .
2 .  P r i n t  in  th e  boxes p rov id ed  y ou r Surnam e. 
I f  th e re  a r e  n o t enough s p a c e s  c o n t in u e  
beyond th e  b o x e s .
W rite  on th e l i n e  below  y o u r F o ren am e(s)
3- W rite  in  th e  sp a c e  p ro v id ed  you r home 
a d d re s s : -
4 .  W rite  in th e  sp a c e  p ro v id ed  y ou r D ockyard 
o r  p a y ro ll number.
p . W rite  in  th e  box prov id ed  y o u r N a tio n a l 
H e a lth  S e r v ic e  number (w h ich  i s  shown on 
y o u r M ed ical C ard.
6 . W rite  in  th e  boxes p rov id ed  you r d a te  o f  
b i r t h .
7 » W rite  in  th e  b oxes p ro v id ed  you r h e ig h t  
t o  th e  b e s t  o f  you r k n ow led ge.
8.  W rite  in  th e  sp a c e  p ro v id ed  y o u r w eig h t 
t o  th e  b e s t  o f  you r kn ow led ge.
et lbs
A l - 3
S E L F  A D M I N I S T E R E D  Q U E S T IO N N A I R E  (continued).
P e r s o n a l U e d lca l H is to r y
9 .  Have you e v e r  h a d i-
An In ju r y  o r  o p e r a t io n  to  yo u r c h e s t?
P le u r is y ?
Pulm onary t u b e r c u l o s i s ?
B r o n c h i t i s ?
Any o th e r  s e r io u s  c h e s t  i l l n e s s ?
1 0 . Have you had a c h e s t  X—ra y  in  th e  l a s t  
12 m onths?
I f  " Y e s " ,  p le a s e  g i v e  d e t a i l s  r e q u ir e d  b e lo w :-
P la c e  a T ic k  in  th e  
a p p r o p r ia te  box
YES
YES
YES
YES
YES
YES Q
HO
HO
HO
HO
HO
HO | |
When?
Where?
1 1 . Do you u s u a lly  cough d u r in g  th e  day o r 
n ig h t  a t  work?
1 2 . Do you u s u a l ly  b r in g  up any phle® n from  y o u r 
c h e s t  f i r s t  th in g  i n  t h e  m orn ing in  w in te r?  
(HB Answer "Y e s ” i f  t h i s  i s  w ith  y o u r f i r s t  
sm oke) ■
HTL 1 2 3
13* In the past 3 years how many periods of
increased cough and phlegm lasting for 3 weeks 
or more have you had? Tick appropriate box. □  □ □ □ □
14. Do you get short of breath when walking with 
people of your own age on level ground?
15. During the past 3 years have you had any chest 
illness which has kept you from your usual 
activities for as much as a week?
16. Did you b r in g  up m o re  phlegm th a n  u su a l in  an y  
o f  th e s e  i l l n e s s e s ?  YES
17- How many illnesses like this have you had in 
the past 3 years? Tick appropriate box
NIL 1 m ore□  □  □
\t!i 1
A l - 4
S E L F  AD M INISTERED  Q U E S T IO N N A IR E  (continued).
^poking H is to r y
18. Have y ou  e v e r  smoked r e g u la r ly ?
(T h is  m oans as much as one c i g a r e t t e  o r  one 
sm all c i g a r  a day o r  one l a r g e  c ig a r  a week, 
o r one o u n ce  o f  to b a c c o  a month f o r  a s  lo n g  
as a y e a r )  •
I f  y o u r answ er i s  'NO' go d i r e c t  to  q u e s t io n  
No 2 7 .
19* Do you sm oke a t  p r e s e n t?
2 0 .  I f  you h a v e  given  up sm oking
a . was t h i s  more th an  one month ago?
b . how o ld  were you when you l a s t  g a v e  up?
2 1 . How o ld  w ere you when you s t a r t e d  sm oking 
r e g u la r ly ?
P la c e  a T ic k  in  th è  
a p p r o p r ia te  Box o r 
in 3o r t  th o  answer
□
□
□ NO □□
□
The n e x t  q u e s tio n s  a r e  ab o u t how much you now sm oke, 
o r  u sed  t o  smoke i f  you h av e now g iv e n  up.
2 2 . How many m anu factu red  c i g a r e t t e s  p er d ay?
23- How many ounces o f  hand r o l l e d  c i g a r e t t e  to b a c c o  
p er w eek?
2 4 . How many ounces o f  p ip e  to b a c c o  p er week?
25» How many sm all c ig a r s  p e r  day?
2 6 .  How many la r g e  c i g a r s  p er week?
A l - 5
S E L F  A D M I N I S T E R E D  Q U E S T IO N N A IR E  (continued).
E m p lo y m e n t  H i s t o r y
2 7 -  P le a s e  th in k  back o v e r a l l  th e  d i f f e r e n t  ty p o s o f  work you h a v e  done o r  su p e rv is e d  
s i n c e  you l e f t  s ch o o l b o th  i n s i d e  and o u t s id e  th e  D ock yard . We h av e  l i s t e d  below  v a r io u s  
jo b s  in  which we a r e  i n t e r e s t e d .  P le a s e  w r i te  down in  th e  o rd e r  in  which you d id  o r 
s u p e r v is e d —e a c h  jo b ,  th e  code n um ber f o r  t h a t  jo b ,  th e  y e a r  in  w hich you s t a r t e d  th e  jo b  
and th e  y e a r  in  which you f i n i s h e d  th e  jo b .  I f  any o f  y o u r p a r t i c u l a r  jo b s  a r e  n o t 
in c lu d e d  th en  p le a s e  u se  Code 2 0  f o r  a l l  " o t h e r  D ockyard jo b s ,  and code 60 f o r  a l l  
" o t h e r  jo b s "  n o t  l i s t e d  f o r  em ploym ent o u t s id e  th e  D ockyard .
d e  No D ockyard Employment Code No O th e r Employment
01 L a b o u re r  o r S k i l l e d  L a b o u r e r  A f lo a t 30 R oyal Navy EPigine o r  B o i l e r
02 L a g g e r  A flo a t Room B ran ch
0 3 L ag g er A shore o r  in  t i a t t r e s s  Shop 31 R oyal Navy -  o th e r  th an  Code JO
0 4 A sb e s to s  Storem an 32 C i v i l i a n  Sh ip yard
0 5 A sb e s to s  S p ra y e r  o r  S t r i p p e r 40 L ag g er o r  in s u la t io n  w orker
0 6 S a ilm a k e r  L ag g er (w ith  a s b e s t o s )
0 7 L ason  A flo a t 41 Any o t h e r  jo b  u s in g  a s b e s to s
0 8 W elder A flo a t 42 Coal L iin o r -  underground
0 9 B o ile rm a k e r  A flo a t 43 C o al i l in e r  — s u r fa c e  w orker
10 E n g in e  F i t t e r  A flo a t 44 Any o t h e r  mine
1 1 E T le c tr ic a l  F i t t e r  A f l o a t 45 Foundry work
12 P a in t e r  A flo a t ( a l l  g r a d e s ) 46 S te e lw o r k s
13 C oppersm ith  A flo a t 47 p a r r y i n g
14 P lu m ber A flo a t 48 P o t te r y
15 J o i n e r  A flo a t 49 C o tto n , F l a x ,  Hemp H i l l
16 B u rn e r , R iv e t e r ,  C a u lk e r ,  D r i l l e r 50 R e fr a c t o r y  B r ic k  Works
17 Foundry Worker 51 M asons Y ard
18 S h i p f i t t e r  A f lo a t 52 Any o t h e r  d u sty  jo b
19 S h ip w rig h t A f lo a t 53 Any jo b  exp osed  to  i r r i t a n t
20 A ll o t h e r  D ockyard jo b s  n o t g a s  o r  ch e m ica l fumes
l i s t e d  above 60 A ll  o t h e r  jo b s  n o t l i s t e d  abovo
61 Unemployed
Jo b  D e s c r ip t io n J o b  Code Y ear Y ear
No S t a r t e d  F in is h e d
1st 19 19
2nd 19 19
3rd 19 19
4 th 19 19
5th 19 19
6 th 19 19
7th 19 19
8 th 19 19
9th 19 19
10th 19 19
If there ie insufficient space for all your Jobs please continue 
on a separate sheet of paper and place a tick in this box.
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C O N T R O L L E D  Q U E S T I O N N A I R E
NAVAL DOCK Y AH Ü ASBESTOS SURVEY
K E P IC A L  IN C (U M  i* * C L  ¿w h en  c o m p l i e d )
I n p u t  C o d e
N a t i o n a l  I n s u r  n e e  No.
Su rn a m e
E o n c n a n e s ................... ................................................ .
D a t e  o f  i n t e r v i e w
Hare Acklress .........................................................
PACK NO
_ _ _ _ _ _ _  C o l
M * 5 !-3
8 - lc
17—1*
D o ck yard  Nc
N a t  1 o m  1 H eal th
D a t e  o f  B l r t *  . .
P l - c e  o f  E l '- t h  .  
C e n e r a i  P r a c t l t l
S e r v i c e  No
Day M onth
Town
o ne r 1 s  N in  e
Y e a r  
C ou nt o ’
a C a r e  • r. .  .
:
P r e s e n t  J o b
I n t e r v i e w e r *  s  Nr-vr.e ................................................................ O r d e □ '*r
3  t a n  c i n e  K e lg T t c a s 1 i J . . 'W
w e i g h t “s Í JJJ /«G-f
U se  t h e  a c t u a l  w o p d ln t o f  e a c h  q u e s t io n .  P u t  X In a p p r o p r i a t e  s q u a r e  a f t e r  e a c h  q u e c t 'o n .  
W hen I n  d o u b t  r e c c r c  NO.
PREAMBLE: *1  a c  g o in g  t o  a s k  yo u  some s im p le  q u e s t i o n s  a b o u t  y o u r  C h e s t .
P l e a s e  t r y  t o  a n s w e r  t h e  q u e s t i o n s  w h e r e v e r  p o s s i b l e  a s  TEC o r  NO. •
PACT ILLNESSES
1 .  R sv e  y o u  e v e r  had
a .  An I n j u r y  o r  o r * r r t l o n  a f f e c t i n g  y o u r  c h e s t ?
b .  P l e u r i s y ?
c .  P u lm o n a ry  T u b e r c u l o s i s 7
d .  B r o n c h i t i s 7
e .  P n e u m o n ia7
Any o t h e r  s e r l c u s  c h e s t  I l l n e s s 7f .
COUCH
PHLEGM
3. a.
Do yo u  u s u a l l y  c o u g h  d u r in g  t h e  day ( o r  a t  n i g h t  *h en  o n  n ! n h t - w o r k )?
I f  MO. g o  t o  } .
' o  yo u  co u g h  l i k e  t h i s  o n  m o s t d a y s  f o r  a s  m uch a s  3  m o n th s  e a c h  y e a r ?
Do y c u  u s u a l  l y  b r in g  up a n y  p h leg m  fro m  y o u r  c h e s t  f i r s t  t h i n g  In  t h e  m o r v ln g  In  t h e  w i n t e r ?  
If NO. g o  to 3c
Do y o u  br in g  u p  ph legm  l i k e  t h i s  on m o st d a y s  f o r  a s  much a s  t h r e e  m o n th s  e a c h  y e a r 7 
B a r e  yo u  e v e r  c o u g h e d  u o  a n y  b lo o d ?
I f  NO, go to  U .
When wn s U .; r 7  R e c o r d  a a c h  y e a r  o f  o c c u r r e n c e ................................. . . .......................................................................
Y i s
CD
B
30
31
36
57
38
39
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C O N T R O L L E D  Q U E S T IO N N A IR E  (continued).
BRzJ»THL£SSNCSS
U. a .  Do y o u  g e t  s h o r t  o f  b r e a t h  w a lk in g  w i t h  p e o p le  o f  y o u r  own a g e  o n  th e  l e v e l 7 
I f  NO, CO t o  5
b .  Do y o u  g e t  s h o r t  o f  b r e a t h  w a lk in g  a t  y o u r  cmn p a c e  on t h e  l e v e l ?
I f  HO , g o  t o  5
c .  Do y o u  g e t  s h o r t  o f  b r e a t h  on c a s h i n g  o r  d r e s s in g ?
CIOST ILLN E SSES
5 .  D u r in g  t h e  p a s t  3  y e a r s  h a v e  y o u  had  an y c h e s t  I l l n e s s  w h ic h  h a s  K e n t  yo u  fro m  y o u r  u s u a l  
a c t i v i t i e s  f o r  a s  o u c h  a s  a  w eek?
I f  N O, g o  t o  8
6 .  D id  y o u  b r i n g  up a c r e  p h le g m  th a n  u s u a l  In  t h l s / a n y  o f  t h e s e  i l l n e s s e s ' ;
7 .  How many I l l n e s s e s  l i k e  t h i s  h a v e  y o u  had  In  th e  p a s t  3  y e a r s ?
R e c o r d  nu m b er
TOBACCO SICKING
8 .  a .  B a r e  y o u  e v e r  r o o k e d ?
( T h i s  m e an s  a s  m uch a s  o n e  c i g a r e t t e  o r  o n e  s n a i l  c i g a r  a  d a y ,  o r  o n e  l a r g e  c i g a r  a  w e e k ,  
o r  o n e  o u n c e  o f  t o b a c c o  a  m onth f o r  a s  lo n g  a s  a  y e a r ) .  I f  N O , g o  t o  1 0 .
b .  Do y o u  sm oke a t  p r e s e n t ?
c .  H ave y o u  g iv e n  u p  r o o k i n g  In  t h e  l a s t  m onth?
d .  Bom o l d  w e r e  y o u  r h e n  y o u  s t a r t e d  s m o k in g  r e g u l a r l y ?  A g e
e .  Bow m any m a n u fa c t u r e d  c i g a r e t t e s  d o / d ld  yo u  u s u a l l y  sm oke p e r  d a y  I n c l u d i n g  
t h e  w e e k -e n d ^ ?
f .  B o v  m u ch  t o b a c c o  d o / d l  d  y o u  u s u a l l y  sm oke p e r  d a y  I n c lu d i n g  t h e  w e e k -e n d s  
I n  h a n d - r o l l e d  c i g a r e t t e s ?  ( O z s  p wk 1 U m gms p  <fay)
g .  Bow m u ch p i p e  t o b a c c o  d o / d l d  yo u  u s u a l l y  r o o k e  p e r  d ay  I n c l u d i n g  t h e  w e e k - e n d s ?  
( O z s  p  « ft X U •  n i is  p  d a y )
h .  Bow u n ity  e a l l  c i g a r s  d o / d l d  y o u  u s u a l l y  r o o k s  p e r  d ay I n c l u d i n g  th e  w e e k - e n d s ?
1 .  How m any l a r g e  c i g a r s  d o / d l d  y o u  u s u a l l y  sm oke p e r  w eek?
EX DICKERS CNLT
9 .  o l d  w e r e  y o u  when y o u  l a s t  g a v e  u p  sm o k in g ?
CHEST PAIN
1 0 .  a .  H a ve  y o u  e v e r  h a d  a n y  p a i n  o r  d is c o m f o r t  in  y o u r  c h e s t ?
b .  Do y o u  g e t  I t  w h en  y o u  « « lk  u p h i l l  o r  h u r r y ?
c .  Do y o u  g e t  I t  when y o u  w a lk  a t  o r d i n a r y  p a c e  on t h e  l e v e l ?
N tanber
Number
N um ber 7 8 - 7 9
Age m  20-21 
T M
22 
23 
2U
I f  YES t o  e i t h e r  1 0 b  o r  c ,  th e n
<L W hat d o  y o u  i f  y o u  g e t  I t  i r f i l le  y o u  a r e  « « U c ln g ?  S t o p  o r  s l o w  d o*n
R e c o r d  s t o p  o r  s l o w  d o w i I f  s u b j e c t  c a r r i e s  o n  C a r r y  on
a f t e r  t a k i n g  N i t r o g l y c e r i n e  ( T r l n l t r i n )
B2 526
e .  I f  y o u  s t a n d  s t i l l  t h a t  h a p p en s  t o  I t ?
f .  I f  r e l i e v e d  -  How s o o n ?
R e l i e v e d  
Mot r e l i e v e d
1 0  m i n u t e s  o r  l e s s  
M o re  t h a n  1 0  m in u t e s
2 7
26
2 9
3 0
A1 - 8
BBS
 BB
SS 
B 
BBB
BB-
:
C O N T R O L L E D  Q U E S T IO N N A IR E  (continued)
ASBESTCB EXPOSURE
T e a r  o f  F i r s t  E x p o s u re  
T y p e  o f  E x p o s u re  ...........
m T e a r o f  l a s t  e x p o s u r e  
C o n tin u o u s  ( Y r s )
coirairrs:
P e r i o d  o f  e x p o s u r e  ( Y r s )  
I n t e r m i t t e n t  C T rs )
mm
C ol
31-JG
57-ko
OtXUPATICNAL HISTORY
c o d e  h o D o c k y a r d  Q n p lo jrm e n t Code Ho (XJict  t ln p lo ym e n t
O l L a b o u r e r  o r  S k i l l e d  L a b o u r e r  A f l o a t 30 R o y a l  N a v y  E n g in e  o r  B o i l e r  Room B r a n c h
OP L a r g e r  A f l o n t 3 1 R o y a l  N a v y  -  o t h e r  t h a n  c o d e  30
03 L o g g e r  A h o  r e  o r  In  M at t r e s s  Sh op 32 C i v i l i a n  S h ip y a r d
OU A s b e s t o s  '.to r e m a n uc L a g g e r  o r  l n a i l a t l o n  w o rk e r  ( w i t h
0 5 A s b e s t o s  S p r a y e r  o r  S t r i p p e r a s b e s t o s )
0 6 S a l lm a k e r  L a g g e r U1 Any o t h e r  Job u s in g  a s b e s t o s
0 7 M ason  A f l o a t UP C o a l  M i n e r  -  u n d erg ro u n d
0 6 W e ld e r  A f l o a t U3 G o a l M in e r —  s u r f a c e  * o r k e r
0 9 B o i le r m a k e r  A f l o a t uu A n y o t h e r  m ine
l o E h g ln e  F i t t e r  A f l o a t kb F o u n d r y  war''.
1 1 E l e c t r i c a l  F i t t e r  A f l o a t k6 S t e e l w o r k s
1 2 P a i n t e r  A f l o n t  ( a l l  g r a d e s ) k7 Q u a r r y i n g
1 3 C o p p e r a n l t h  A f l o a t U3 P o t t e r y
1U P l u a b e r  A f l o a t U9 C o t t o n ,  F l a x ,  Hemp M i l l
1 5 J o i n e r  A i l o o t 50 R e f r a c t o r y  B r ic k  W orks
1 6 B u r n e r ,  R i v e t e r ,  C a u l k e r .  D r i l l e r 51 M a s o n s  Y a r d
1 7 F o u n d r y  W o r k e r 52 A n y o t h e r  d u s t y  Job
18 S h i  p f  I t  t e r  A f l o a t 53 A n y J o b  e x p o s e d  t o  I r r i t a n t  g a s  o r  c h e m ic a l
1 9 S h i  p w rlp .h t  A f l o a t n u t s
20 A l l  o t h e r  D o c k y a r d  J o b s  n o t  l i s t e d  a b o v e GO A l l  o t h e r  J o b s  n o t  l i s t e d  a b o v e
22 A n y o t h e r  d u s t y  J o b 6 1 U n e m p lo y e d
ACE E K PL O rO S NAME JOB
obn_ S i
1
|
______________________________________________________ 1J
S t a r t  F i n i s hm a nm m
2 0 -2 5
2 6 -»
> 2 - 3 7
38-iJ
5 0 -5 5
5&-&1
ÙP-G7
G ô -7 3
TU-79
A1 - 9
C O N T R O L L E D  Q U E S T IO N N A IR E  (continued).
I n p u t  Code 
Oper- t o r *  s  Name
FTV
1 .0
FVC
cm cm  
± j o ib
O p e r a t o r 's  Name
F i r s t  T e s t 
S e c o n d  T e s t
l t d  a
I n M n x m n t  No
U
T 1I
anm
□
□ ~ h
a n  a n
-  m
I n s t r u m e n t  No □
V InspŒÙ n a n a'  TFn  n m
CLINICAL
Hb cm
CVS
s y s t o l 1c d l "».stol l cL J J 1 rm
C y a n o s is
RS
R a le s
t±b
m
Oo R a le s  c l e a r  on  c o u g h in g m
R honch! m
P le u r a l  Rub cn
C lu b b in g  
A sb e s to s  C o rn s
U_J
LX3
Carme© t s  
29*11 F i l a  No
L e r g e  F i l a  No
C o l
1 -3
PO-21
2?
3^-57
y-K>
53-3*1
S3
3 ò -6 ‘ >
60-73
20-2?
?V -2B
29
30
31
32
33 
V i
33
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C O N T R O L L E D  Q U E S T IO N N A IR E  (continued)
I n p u l  Code 
O n er t o r ' s
FEV
1.0
FVC
O p e r a to r * s
CLINICAL
General
C oein efits  
anali Pila
Large Pila
! H1 • 13 1
amt* ..................... C ode 1
I n s t r u m e n t  No 1 1
cm cm CCD CCD LCD
□in Qib QD rrn n ti
imp . . . . . . . . LTD
V Ir .sp
I n s t r u m e n t  No | 
T a '  TF
F i r s t  T e s t _i □ cxi erra
S e c o n o  T e s t [TCI □L j  o re
N o. .  
No .
Hb
cvr.
B»
C y a n o s is
as
B a le s
Oo R a l e s  c l e a r  o n  coughlr.r*  
R honch!
P l e u r a l  Rub 
C lu b b in g
A s b e s to s  C o rn s
cm »
d i  ’. S t o l  J Crm ? s - r a
tb 2 9
CD 30CJJ 31
CD 32
CD «
CD Vi
CD 35
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APPENDIX 2.
A2 - 1
TABLE A2.1 : Causes of Death, and International Classification of Disease (1CD) 
groupings.
C a u s e s  of Death 9th Revision 
ICD’s
8 t h  Revision 
whe r e  different
•1. A l l  Causes 000-999
2. Infectious and Parasitic Diseases 001-139 001-136
3. Tuberculosis 010-018 010-019
*4. A l l  Neoplasms 140-239
5. Ca. Lip, Oral Cavity and Pharynx 140-149
6. Ca. Digestive Organs and Peritoneum 150-159
7. Ca. Oesophagus 150
*8. Ca. Stomach 151
*9. Ca. Peritoneum (mesothelioma) 158
10. Ca. Respiratory System 160-163
"'ll. Ca. Lung 162
*12. Ca. Pleura (mesothelioma) 163
13. Ca. Bone, Tissue, Skin and Breast 170-175 170-174
14. Ca. Genito-urinary Organs 179-189 180-189
15. Ca. Prostate 185
16. Ca. Other and Unspecified Sites 190-199
17. Ca. Lymphatic and Haematopoietic Tissue 200-208 200-209
18. Benign Neoplasms 210-229 210-228
19. Unspecified Neoplasms 230-239
20. Endocrine and Nutritional Diseases 240-279
21. Dise a s e s  of Blood and Blood-forming Organs . 280-289
22. Dise a s e s  of the Nervous System 320-389
*23. D iseases of the Circulatory System 390-459 390-458
24. Hypertensive Disease 401-405 400-404
25. Ischaemic Heart Disease 410-414
=*26. Diseases of Pulmonary Circulation 415-417 426,450
27. Cerebrovascular Disease 430-438
*28. D iseases of the Respiratory System 460-519
29. Acute Respiratory Infections 460-466
30. Other Disease of Upper Respiratory Tract 470-478 500-508
31. Pneumonia and Influenza 480-487 470-474,480-486
*32. Bronchitis, Emphysema and Asthma 490-493
=33. Chronic Obstructive Pulmonary Disease 490-496 490-493,518
=34. Pneumocon i os i s 500-508 515-516
35. Coalworkers Pneumoconiosis 500 515.1 !
*36. Asbestosis 501 515.2
37. Si 1icosis 502 515.0,515.9
! 38. Other Diseases of the Respiratory System 510-519 510-514,517,519
»39. Pulmonary Fibrosis 515 517
40. Diseases of the Digestive System 520-579 520-577
41. Diseases of Oesophagus and Stomach 530-537
42. Diseases of the Genito-urinary System 580-629
43. Diseases of the Skin and Subcutaneous Tissue 680-709
44. Diseases of the Musculosketelal System 710-739 710-738
45. Symptoms, Signs and Ill-defined Conditions 780-799 780-796
46. Accidents, Poisonings and Violence 800-999
47. Transport Accidents 800-848 800-845
i 48. Accidental Poisoning 850-869 850-877
49. Accidental Falls 880-888 880-887
50. Suicide and Self-inflicted Injury 950-959
S i g n i f i e s  a new code/disease grouping in the 9th revision. An estimate o f  this grouping 1s 
p r o d u c e d  for the 8 th revision (i.e. for before 1979).
S i g n i f i e s  a specific cause of interest in this study.
A 2 - 2
Death Rates for E n g lan d  and W ales.
The following pages (A2-4 to A2-20) give male death rates for England and Wales (xlO~8) 
For each of the 50 categories, the entries are arranged as follows:
Y ear
1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988
Age
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75-
80-
85+
For calendar years 1989 and 1990 the death rates for 1988 are taken as the best estimate
A 2 - 3
ALL CAUSES (0-999)
35991 34278 31983 33383 30567 28437 29592 29292
85571 86133 88901 86581 88227 83960 89706 84624
96986 104218 95736 98588 96222 91413 99503 91677
87170 93058 85245 84309 84812 87968 88091 90225
104809 107444 106824 103729 100104 95446 97440 100479
163803 159267 151328 148404 154347 148446 158049 146852
286804 288499 282728 267197 264380 253693 249682 251833
540835 536551 523186 507197 487229 480447 475984 463586
921001 899348 918544 906514 898510 873767 877604 857405
1556386 1569303 1535683 1449364 1470252 1411761 1440329 1465806
2585267 2494532 2455153 2436590 2474415 2381578 2426021 2422116
4276800 4125598 4066310 3983485 4000528 3858612 3873695 3807042
6801644 6558140 6551825 6399432 6432491 6157365 6169148 6094797
10149179 10002362 9750465 9844031 9993546 9555921 9634381 9612776
14783019 14729549 14644643 14601504 15032373 13970357 14205591 14384128
24291117 23850655  23697256 23542056 24322987 22657785 22765381 23204380
INFECTIOUS i  PARASITIC DISEASES (1-139)
415 709 690 820 622 666 430 484
982 1882 1517 492 957 466 606 686
1214 1192 1552 1046 752 1029 961 890
1285 1292 1224 844 1158 944 972 1100
1562 1336 1434 1209 980 1246 1092 1237
2244 2636 1647 1982 1732 2220 2322 1524
2885 3122 3238 2769 2429 2141 1907 2235
5484 5169 5865 3926 4732 4423 3618 3014
9310 8135 8676 7980 6882 5479 4876 6141
11636 11690 10412 10953 10027 8074 7395 7018
14897 15431 13435 14259 10510 11158 11568 11120
25289 21490 18627 18811 16904 14587 13858 14627
32192 27460 25342 28275 21758 20737 19428 20354
37354 38262 32528 37029 35499 31661 26916 29395
42677 33527 39286 42901 42572 34874 44731 39679
53650 46288 54031 56924 47819 54954 45939 43796
TUBERCULOSIS ( 1 0 -1 8 )
0 0 0 0 0 95 0 48
58 228 337 164 106 0 51 0
331 341 402 290 174 114 226 111
335 108 213 211 211 111 172 290
611 401 456 318 61 340 55 161
1122 1179 275 479 416 832 888 265
1786 2012 1689 1136 929 500 636 768
3634 3893 3137 2342 3132 2106 1206 933
6341 5488 5742 5839 3675 3219 2926 2047
8045 7818 6247 6402 6239 4787 4314 2913
10705 10412 9382 9204 6828 6964 7377 3883
17959 14176 12567 12629 9597 8963 8157 6131
23425 20497 17739 20496 15472 14457 12564 8805
27123 26925 23002 22217 24957 20354 16699 11306
29650 22798 25446 29633 24390 17001 26667 16885
25506 27074 23156 31436 29362 34971 18868 12165
28699 28058 27196 27631 28888 23004 25683 25858
02009 78210 74437 71446 67598 71290 70907 69931
03105 86376 82322 83900 82288 81956 84781 83008
83936 82800 82714 82492 77249 79915 77653 78272
93847 97114 96237 93329 92236 95306 100558 96033
133445 129617 130256 127849 130880 130024 129445 130116
239210 231084 224199 213311 219520 210896 205479 211965
432117 412250 413771 399072 385713 383876 365309 378299
786985 759441 724209 705064 701417 676012 642418 673282
1391870 1361302 1321007 1266439 1247141 1208293 1183989 1213141
2214705 2167697 2193445 2157160 2175439 2122518 2026523 2108160
3583956 3596309 3617919 3500306 3423729 3329351 3227110 3326730
5795287 5768838 5686622 5446023 5567463 5435020 5277100 5426527
9024084 9002246 8823054 8463804 8789797 8602173 8193035 8528335
13769704 13781500 13508621 12989488 13568764 12997852 12296697 12954437
22615873 22303077 22071590 21130562 22313287 21481654 19159856 20984932
451 617 423 662 345 787 763 631
1040 1031 707 1011 836 998 1225 1019
527 518 705 680 710 704 889 767
882 588 639 964 1045 906 1083 1011
910 1134 935 1065 1192 1545 1116 1284
1494 1154 1557 1968 1570 1783 1821 1724
2468 1479 2284 1479 1896 1883 2027 1935
3577 3869 2384 3142 3124 3156 2362 2880
4305 4992 3802 3924 3654 3823 4046 3841
7706 6004 5796 6086 5381 6396 6292 6023
7418 9077 9504 9904 9147 8696 7555 8466
13963 12945 13118 14292 13442 13439 10352 12411
16864 17226 14164 14651 16522 16719 15420 16220
24792 26611 26121 25666 26316 30037 29467 28606
34218 38602 37241 44678 40468 43265 37416 40383
44444 33077 40693 67104 63636 61374 52885 59298
0 0 53 55 0 0 0 0
142 0 0 0 148 50 0 66
53 155 0 146 47 0 47 31
176 0 58 113 55 160 0 71
321 170 117 177 238 238 176 217
498 173 334 164 217 108 114 146
1128 423 554 336 450 251 405 371
1387 1460 722 857 852 646 644 714
1220 2243 877 1184 895 1124 1573 1197
2899 2242 2054 2078 1569 1355 1516 1480
2445 3287 2245 2241 2624 2463 2676 2587
5514 4958 5928 3981 4091 4013 3034 3712
7148 7002 4869 5398 5287 4904 5178 5123
9917 11405 8595 9378 9041 9906 7879 8942
11918 12017 15862 13798 14543 12S81 10816 12646
20635 6154 12057 17505 21678 16678 12019 16791
26999
83453
87383
84203
94320
141751
244213
443777
823303
1431588
2304543
3675059
5885875
9266169
13970791
22244866
544
1291
867
821
1495
1807
2225
3329
5840
7498
9813
13598
17220
25870
31643
60032
0
0
108
235
374
516
765
724
2137
3439
4230
5702
5965
9838
12170
18167
D
eath R
ates for England and W
ales (continued)
ALL NEOPLASMS (140-239)
7271 7139 5421 6320 5214 5136 6215 5713
7795 8214 8710 8308 7707 7515 8435 8232
11371 11409 11435 10109 10241 10348 9888 9118
15367 14971 14580 14869 14899 13820 14415 13493
19359 21315 19814 20619 19053 20902 20416 19149
33378 31285 30609 30761 34638 33019 33946 31743
66360 64720 62641 56080 63594 56376 55093 56289
132946 130832 130251 128728 122347 123640 116850 113224
246037 240493 251108 245232 254694 246233 252943 239235
453311 470320 457909 427998 436233 419120 433687 444290
762914 735506 734219 727348 747526 736884 723950 729856
1146784 1142483 1146168 1126910 1137612 1119508 1127533 1108522
1601781 1591381 1608084 1581183 1599299 1572343 1575966 1558719
1971925 1987955 2019284 2056553 2107573 2078331 2108841 2104579
2187332 2240948 2321875 2367979 2343681 2421099 2407742 2535669
2371152 2381659 2400515 2429057 2441275 2448793 2516817 2619627
CA L IP , ORAL CAVITY & PHARYNX ( 1 4 0 -1 4 9 )
52 51 49 0 48 0 48 97
58 57 0 55 213 104 101 147
0 57 172 0 58 0 170 167
391 54 53 105 158 56 172 116
68 0 261 191 613 340 437 323
491 277 412 342 623 486 410 663
824 763 1056 781 1429 1356 706 1536
1850 2282 2387 2411 2088 2457 2483 2655
4318 4326 4057 4412 4610 3562 3344 3953
6896 7591 6648 6633 7428 8145 6847 7216
8759 7940 8482 9808 10894 10999 10562 10767
15210 14447 12567 14307 14527 11336 13595 15065
22740 18657 18753 19632 19340 18367 19428 15895
34975 29995 27416 30072 28399 21382 23576 29584
41330 43362 33036 40248 37251 40976 36559 43056
65963 63755 53173 71368 55369 58285 46760 48662
CA DIGESTIVE ORGANS AND PERITONEUM ( 1 5 0 -1 5 9 )
104 101 0 0 48 95 0 145
520 57 281 273 372 104 202 147
938 738 690 988 289 343 735 334
1341 2208 1224 1793 1895 1277 1030 1564
3464 4210 3389 4900 4043 3908 3548 2905
8555 8532 7755 8066 9283 9295 8606 8416
20403 20394 20341 16469 18221 17198 16104 16621
36738 40209 40235 38983 34936 36439 37531 36880
73399 70760 71656 71688 77170 70822 73981 76168
133171 136253 132078 124489 126495 121535 129339 132936
223611 215131 210388 206488 216264 214291 207310 210661
357981 346456 352317 350349 341786 327417 331462 324604
498356 495204 498606 490554 490995 470553 476966 482790
667380 654464 651719 661355 673623 649671 644990 632561
828841 809566 796875 824414 792461 848736 767312 821866
929639 915284 880789 914189 898490 863447 890894 933496
5059 6064 4868 5074 5111 3995 4259 4455
7993 6607 7726 7222 6642 6136 6841 6539
7857 9218 8157 8740 7907 7886 7209 7667
12646 9226 12605 12416 10227 11401 10261 10629
17068 16724 17296 17033 16386 14379 17034 15933
26839 28913 29867 29735 29553 27820 28563 28645
59450 56573 52745 54790 53409 52347 50269 52008
109708 107023 106423 111175 102677 104935 103515 103709
227579 219577 216129 217427 210365 198501 201978 203614
433298 424810 421161 412869 410806 395064 386172 397347
697098 682683 705979 725873 715550 709635 697859 707681
1098186 1086761 1091633 1111882 1082895 1066449 1055863 1068402
1552937 1574350 1613478 1593963 1590814 1592956 1580437 1588069
2080751 2052704 2093360 2132938 2176784 2167758 2153010 2165850
2563629 2565550 2593793 2801577 2822004 2702976 2738673 2754551
2764286 2775385 2825923 3146608 3274126 3164777 3173678 3204193
100 51 53 55 0 0 0 0
47 47 188 48 246 50 153 149
105 207 201 49 142 188 234 188
353 118 174 113 55 53 258 122
321 170 117 473 238 119 352 236
747 462 723 601 487 648 626 587
1128 1902 1038 1412 1896 1444 2259 1866
2920 2774 3251 2499 2982 3945 3293 3406
5381 5933 5191 6145 6264 5172 5544 5660
9332 8608 7631 9722 9043 7525 9021 8529
11819 10486 12497 13302 11846 12006 11805 11885
15386 13129 15839 16435 13248 15026 14724 14332
17087 18115 20471 19828 18835 16273 16110 17072
19302 21427 24604 19743 20988 22208 20013 21069
33449 30590 32069 31537 19602 23320 24847 22589
43651 36923 45968 40846 33566 37358 27043 32655
100 51 53 55 115 0 64 59
331 187 47 48 492 249 153 298
580 621 604 583 521 516 468 501
1235 705 813 1077 1100 1598 1598 1432
3050 2551 3155 2721 2979 2258 3289 2842
6663 6983 8176 8144 7794 6536 7112 7147
18900 15288 17305 16403 15689 15441 14073 15067
33139 31245 34896 35202 30675 30770 31785 31076
67585 65258 68363 66627 66145 63118 64654 64639
128667 120506 120845 122235 125177 120551 121522 122416
202886 195399 204221 209427 200330 206711 204549 203863
330487 313900 312603 327991 315020 309286 305640 309982
454992 457324 468518 467614 457099 454191 448101 453130
621569 595127 632120 627674 623830 634926 609991 622915
773549 798616 791724 819645 846032 786131 796258 809473
938889 856154 938206 958425 985315 925284 932692 947763
4401
6695
10293
11669
17882
30066
55544
114616
234955
431795
717114
1098167
1569387
2081800
2504260
2682464
0
96
0
176
320
1032
1599
2315
4772
8255
12605
12370
19021
20040
30832
45024
0
335
488
938
3309
7549
17518
35818
72288
127743
207597
323537
465053
635088
782961
906793
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A
2 -
CA OESOPHAGUS (150-150)
0 0 0
0 0 0
55 0 0
112 54 53
136 334 196
631 555 549
1649 1734 2252
4229 3491 4569
6679 7296 7116
11852 14346 14017
20886 21948 20791
30786 28081 31462
45890 41387 43588
53295 51488 59480
62893 74654 66964
90589 74236 72041
STOMACH ( 1 5 1 -1 5 1 )
0 0 0
0 0 0
166 284 115
168 646 160
883 1069 912
2594 2150 2471
5496 6798 6334
9911 13358 12480
22128 24404 23532
47191 45848 41890
86465 79476 79336
136797 132460 134938
182466 181842 178662
238401 225083 222119
285714 266428 248214
273527 270742 253859
PERITONEUM (M eso) ( 1 5 8 - '
0 0 0
115 57 0
0 114 0
112 377 53
204 200 130
70 416 343
687 208 422
463 470 546
1214 904 811
1293 1366 1602
1872 1348 1651
2932 2619 1961
3151 3416 1901
3093 2598 3950
1348 894 6250
1759 2620 858
0 0 0 0
0 0 0 49
0 0 0 56
105 0 114 0
306 510 55 269
762 555 478 928
1429 1855 1625 1955
4663 3651 3760 2798
9020 8904 9613 8895
14558 16005 14310 15492
22325 23502 25484 24181
32224 32777 34208 33021
38680 39934 46301 44597
58520 62089 60904 55587
64745 73235 65806 69228
88087 64946 78753 78670
0 0 0 48
0 0 0 0
58 57 57 0
421 333 114 232
796 623 764 484
2217 2705 1981 2121
5288 4210 4732 3422
9952 9900 10429 10117
23385 21164 20759 21107
39664 35724 39849 38133
73878 72565 68321 63896
125022 112830 115867 109223
177445 165304 170195 166495
224828 221217 201768 208404
249667 273758 256774 246518
260906 232306 274815 264396
0 0 0 48
159 0 51 49
58 57 113 0
105 56 114 58
123 283 109 0
69 208 273 66
572 214 212 210
348 632 780 574
735 548 766 918
817 1143 1438 662
1074 1266 1593 706
1057 2285 1667 2190
2418 2014 3025 1830
2367 3906 2358 942
3104 1308 3441 1266
839 1665 4922 0
0
0
58
105
382
752
1562
4546
7136
13266
20671
32147
41980
60817
69438
76466
0
55
349
316
1018
2119
4401
11227
24329
41342
74236
125673
179158
219479
281734
266780
58)
0
55
116
316
255
273
71
482
973
1234
1132
1325
1729
1571
2211
2549
0 0 0 0
48 0 47 0
0 0 52 101
117 235 118 116
107 214 283 292
710 685 808 834
1529 1551 1832 2007
3907 3942 3212 5057
12107 9040 8971 9505
16028 16896 16492 16436
24448 26736 25980 25369
37372 37887 40856 36731
41981 40652 48122 49906
59574 68532 61172 66397
78702 69973 79752 79655
71880 75397 70769 92690
0 0 0 0
0 95 47 0
54 158 104 101
117 59 118 116
320 321 510 526
1419 1121 1270 1613
4380 4937 3593 4222
9334 7810 8030 7731
17235 17004 17508 16890
38247 37752 32043 31991
61755 58934 52352 65105
107466 106990 93922 99213
160158 154791 147699 150160
206595 198335 189390 200202
221907 221838 235615 251724
255134 252381 255385 254710
0 0 0 0
143 47 0 0
108 105 104 101
117 118 0 58
53 161 0 117
194 125 115 334
348 353 282 346
507 438 219 144
570 574 362 1097
1169 990 723 1101
931 652 1096 898
2456 889 826 1360
1688 1675 2223 1992
729 1948 1382 1180
1623 3845 1821 1724
1580 2381 3846 754
0 0 0 0
0 0 0 0
47 141 0 62
165 107 52 108
477 238 411 375
650 1080 1252 994
1896 2009 2143 2016
4971 4160 4582 4571
9396 8771 10264 9477
20925 17910 18801 19212
31769 30322 33527 31879
43639 38264 42388 41430
53090 58738 57422 56416
67485 63429 73432 68115
91053 88371 92371 90598
90909 95397 92548 92951
0 0 0 0
49 0 0 16
47 47 47 47
0 373 309 227
596 238 764 532
1407 1242 1536 1395
3007 2950 2780 2912
6817 6814 7588 7073
14989 13568 12886 13814
30491 30025 28808 29774
51807 54410 51000 52405
88934 88754 79243 85643
131182 135310 127043 131178
193736 187410 179956 187034
234587 233200 223619 230468
276923 250167 254207 260432
57 0 0 19
0 100 51 50
95 141 47 94
55 53 103 70
119 0 0 39
217 108 57 127
327 188 0 171
781 215 215 403
298 675 899 624
822 677 531 676
750 1770 1259 1259
1169 840 892 967
2864 1226 1956 2015
1453 1598 1261 1437
2529 3068 1754 2450
2098 1334 2404 1945
0
0
49
113
237
820
1681
4427
8291
16179
27543
43181
50782
66469
70959
79504
0
0
97
57
355
2022
3092
7783
15916
32136
57616
91058
149152
198585
235545
263311
0
48
49
57
0
273
269
500
592
8161012
1021
1652
2303
657
1459
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CA RESPIRATORY SYSTEM (160-163)
104 51 49 0 48 48 0 145
231 57 169 0 159 104 101 49
552 568 230 407 463 286 283 56
1006 1131 905 949 1000 722 744 405
2513 3074 3063 2100 2144 1869 1747 1829
6171 6867 5559 5674 6304 6035 6898 5832
19372 17897 17948 16256 17149 14415 14268 13269
55306 51151 50259 48970 46628 44724 39447 37957
109897 106011 111604 110289 108238 110959 106583 99322
213619 223167 219944 198072 204709 188340 196303 199073
374083 356554 357877 347341 353740 342486 336407 339952
534451 534898 527718 515764 514967 518190 506885 496365
700822 705689 706285 682430 691285 686100 682527 661750
707828 756731 766264 788600 801635 817229 823772 838138
568733 628073 693304 711632 704656 762860 797849 837062
452067 439301 508576 497876 517617 531224 580804 618005
CA LUNG (1 6 2 -1 6 2 )
0 51 0 0 0 0 0 0
173 57 56 0 106 0 0 49
497 511 172 116 405 172 170 0
950 1023 745 738 842 555 515 405
2174 2806 2803 1655 2022 1699 1583 1560
5960 6382 5284 5400 5542 5411 6079 5368
18204 16648 16962 15049 16292 13345 12926 12361
52399 48130 47941 47180 43705 42407 37247 36234
106928 102008 107484 105424 103494 106507 101846 94381
207298 215956 212495 190204 195796 181909 187949 190798
365474 347191 347144 336100 343767 331962 326934 329891
521715 520632 513369 500927 499472 504657 491711 481738
679178 681119 682970 659835 672066 666074 663564 644483
683084 730987 739080 765260 772590 790707 797839 811004
539982 600358 655357 689960 669623 732781 763011 806669
422164 404367 483705 467290 488255 504580 548811 588808
CA PLEURA (M eso) (1 6 3 -1 6 3 )
52 0 0 0 48 0 0 0
58 0 56 0 0 52 51 0
0 0 0 232 58 57 57 0
56 108 53 53 53 167 172 0
204 200 0 191 61 57 55 54
0 208 137 68 277 347 205 265
69 277 211 568 214 428 494 279
859 806 955 344 1322 562 922 718
877 968 999 1362 1269 1438 1463 988
1939 1822 1282 1928 2525 1715 1986 1655
1348 2247 2177 2565 2455 2849 2431 2295
1741 2167 1693 3003 3170 3076 4035 3066
2740 2234 2914 4075 2297 4147 2908 3202
1190 2834 2556 3142 2582 3906 4519 4711
3594 1788 2232 2211 1774 3923 4731 2533
2639 1747 3431 1699 839 B33 3281 0
50 51 0 0 0 0 64 21
47 94 47 0 98 100 51 83
105 155 50 97 95 141 94 110
1176 176 290 397 385 426 103 304
1391 1531 1227 1360 953 832 1057 947
4421 5078 4116 4209 4493 4646 3869 4336
13893 13668 12459 12303 11702 11926 10540 11389
35766 36210 31862 32060 31740 31774 28420 30644
89611 83201 79330 74771 73005 65367 63755 67375
186921 178807 181745 167285 169345 155918 140626 155296
317493 298067 313702 311285 306568 296368 287817 296917
468428 470162 474784 462229 448178 436771 425843 436930
648984 650811 671019 638907 620994 617811 615650 618151
816540 776568 787159 773445 787698 759386 745982 764355
847366 834304 858966 880092 874486 820804 840398 845229
646032 700000 698568 743982 793007 789860 736178 773015
50 0 0 0 0 0 64 21
0 0 47 0 0 50 51 33
53 155 0 97 47 94 94 78
882 176 290 340 330 320 52 234
1391 1361 993 1301 953 772 999 908
3736 4617 3726 3662 4222 4322 3528 4024
12130 12400 11213 11496 10329 10984 9382 10231
33358 34239 29550 29632 29894 28260 26272 28142
86024 79222 74212 70995 67338 61319 57537 62064
178791 170416 172793 158602 160227 147490 131150 146289
304777 287112 300681 297188 292922 281976 273572 282823
453042 455196 458070 448550 433762 418105 407371 419746
627541 632252 652318 619740 596431 594739 593556 594908
793519 751339 765420 753044 764127 734622 723290 740679
816993 809541 829310 844941 842871 790120 810582 814524
618254 667692 675961 716265 764336 755837 695313 738495
0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0
59 0 0 0 0 0 52 17
0 57 0 0 0 59 59 39
62 115 222 273 217 108 228 184
776 564 554 269 588 502 811 633
511 511 1228 1071 1136 1363 787 1095
933 868 2120 1333 1864 1874 2547 2095
2545 2170 3375 3266 3811 3988 3942 3913
3424 3052 3817 4771 5098 4925 5194 5072
3646 3030 4761 4900 4189 5226 5979 5131
3686 4001 4869 5508 6388 7133 6559 6693
2833 2938 2696 4278 3875 6870 5358 5367
3076 2185 6552 5585 5375 7057 7015 6482
1587 2308 3014 1459 6993 2668 2404 4021
99
96
108
645
1281
4194
13695
38712
90592
189585
327299
492236
673945
809619
850710
666667
99
48
54
469
1228
4065
12444
36469
85535
180918
316471
478375
655374
786664
821501
640600
0
0
0
0
0
129
487
1013
1852
2614
2199
3597
3714
3644
2434
1580
D
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A
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CA BONE, TISSUE, SKIN & BREAST (170-175)
727 1063 1084 965 813 713
1155 1939 1798 1366 850 1399
1380 1589 1494 1510 1041 800
1205 1346 958 1318 1369 1277
1291 1136 1304 1400 1532 1699
1332 1318 1990 1846 1801 1526
3091 2844 2182 2272 3573 2997
3172 3424 3205 3375 3897 4283
445 3 4842 4244 4801 6214 4521
5818 6224 7849 5553 7279 7859
9208 8539 7206 8525 10203 9338
12095 13995 12834 12982 10829 12039
17397 15110 18880 16298 16681 17538
2 3793 25980 24396 22666 24312 19737
35490 38891 34375 35383 36364 34874
49252 52402 39451 45030 48658 54954
CA GENITO-URINARY ORGANS ( 1 7 9 -1 8 9 )
260 203 99 289 191 95
577 913 955 711 531 829
1711 1760 2011 1336 2083 2058
2738 2639 2767 2953 2738 2442
3193 3207 2607 2736 2879 3229
3576 3746 2539 3555 4087 3885
4671 4925 4364 3336 5216 4639
8722 8391 8320 8747 7864 8706
15516 16980 17415 14143 17906 16918
32467 34765 30116 31238 31197 34224
64306 61573 63499 65636 68508 67184
118563 120903 119964 120198 130569 125220
216575 218237 213761 224349 221927 212940
366643 350968 361989 368492 372849 370888
517071 522128 537946 537373 551220 522232
678980 693450 692110 641461 668624 698585
CA PROSTATE ( 1 8 5 -1 8 5 )
0 0 0 0 0 0
0 0 0 0 53 0
0 0 57 0 0 0
56 0 0 0 0 0
0 0 0 0 0 57
70 69 137 0 0 0
69 208 422 71 143 143
793 738 818 689 696 632
2766 3034 2871 2984 2673 2945
9266 9792 7769 8099 10027 9431
23656 22472 22442 25198 27465 26668
54792 55621 52139 54844 62599 59930
116164 116148 114673 120879 119183 116009
225791 216580 223745 222846 218373 222039
342318 346446 370982 359575 363193 343941
459982 481223 485420 440102 447987 458784
—872
1862
1946
1390
1667
2319
3073
4520
4377
6951
9973
10423
15323
18466
33770
50284
145
490
1223
2374
2098
2916
3352
7606
16024
34293
64160
127879
111778
163859
147488
¡90998
0
0
0
58
0
0
0
502
3812
8937
26917
60787
742 801 1182 582 496 804 666 572 680
1052 2034 1500 1696 1637 1132 1497 1225 1284
1896 1107 1450 1259 1651 1136 1596 1170 1300
997 1412 940 1278 1701 1430 1652 980 1354
1655 1766 1928 1519 1597 1430 1723 1880 1677
2645 2491 2655 2836 2624 3031 3025 2731 2929
3476 3173 3523 2492 3092 3138 3452 2896 3162
3039 4161 3358 4768 4356 4473 3443 4080 3998
6339 5524 4847 4899 6219 5891 6297 5094 5760
6329 6292 6438 6824 8461 6801 7299 8339 7479
9898 7744 9703 8157 9036 9072 10620 10074 9922
10527 12807 12119 13701 14394 13637 11293 13296 12742
15982 17869 15226 15160 20599 17623 15716 18412 17250
16396 20365 19008 25110 21882 22603 23167 24582 23450
22312 31142 30226 31379 32852 32880 28230 29524 30211
39494 38095 49231 47476 48140 56643 50700 54087 53810
49 100 103 106 110 0 121 0 40
622 615 328 471 144 49 200 357 202
1625 844 725 755 923 994 939 562 831
2463 1529 1175 2207 1474 990 1279 1289 1186
2295 1177 1814 1519 1656 1490 1070 1997 1519
2968 2055 2020 1947 2186 1732 1675 2447 1951
3337 4090 3311 3738 3630 3595 3013 3301 3303
7598 7226 7373 7080 8711 6888 7244 7731 7287
16523 16932 15917 16963 17841 15735 17391 16182 16436
34739 34217 35443 36173 34956 34377 37023 31916 34438
64292 62439 64872 67425 68387 73474 75189 70360 73007
121677 130736 124495 133515 136076 137054 139711 135374 137379
218571 217445 225383 238796 237938 256526 258582 256732 257280
365458 357535 366511 371925 383021 401518 413485 425622 413541
535903 558247 539694 566207 660644 631363 639153 638118 636211
720379 727778 741538 718915 913202 927273 848566 892428 889422
0 50 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 50 0 47 47 0 31
0 0 0 0 0 0 0 0 0
0 0 0 0 59 0 0 0 0
0 62 0 0 0 0 0 57 19
209 141 282 138 269 261 126 232 206
1158 730 803 506 643 710 717 1289 905
3134 3659 2894 3144 4146 3207 4648 2847 3567
11626 10675 10199 11079 11058 11210 11739 11371 11440
26647 24209 26371 27165 28483 28940 33400 31639 31326
60356 62878 61605 69381 73397 72570 76435 73443 74149
123917 124525 126695 137103 137475 154422 153032 155351 154268
225178 221356 232417 231378 243008 259929 271769 282225 271307
346450 363706 352877 376552 435611 422700 437251 450161 436704
483412 492063 486923 477016 630926 656643 617745 630409 634932
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CA OTHER & UNSPECIFIED SITES (190-199)
1870 2127 1232 1351 1052 1427 1721 1017
924 913 1461 1148 1329 1140 1263 1029
1822 1703 1494 1685 1620 1658 1469 1279
2515 2693 2554 2162 2369 2442 3203 1911
3260 3675 3454 3182 2573 3455 3494 3711
4838 4093 5422 4648 5404 4786 5328 4838
8106 7492 8094 7667 8789 6565 7840 8799
12026 12016 12480 12880 13293 14042 13196 10691
18350 18077 21035 18944 20178 19452 24800 21530
30384 31501 32119 31855 29563 29151 31017 35816
39677 41273 44509 44361 47181 47005 52058 50481
49386 52731 57398 55021 60838 67926 67801 71910
65479 60307 71338 65317 78206 80934 77943 89194
72329 72744 82017 84829 101549 102796 93713 104579
83109 84041 99107 86245 104213 103313 111828 127058
75638 82096 94340 98556 112416 114072 119770 121655
CA LYMPHATIC i  HAEMATOPOIETIC TISSUE (2 0 0 -2 0 8 )
3583 2886 2563 3136 2631 2615 3346 2760
3811 3879 3259 4318 3827 3265 3687 3871
4416 4541 4827 3892 4166 4631 4068 3558
5644 4631 5906 5167 4843 4718 5034 4922
5026 5680 5149 5346 4779 5721 6059 5917
6662 5341 5971 6084 6166 6659 7035 5765
8518 9295 7672 7951 8003 7564 8829 8101
12555 10338 10775 10813 11413 11093 12203 10763
17001 16528 18164 18295 16837 17329 18042 15460
26433 26340 24509 24990 24289 26293 26498 23833
36982 38202 36103 39155 35596 39962 36969 37066
50944 51648 54011 50870 55115 51933 58767 52203
69178 68848 70705 73713 69745 76431 73174 70555
87081 85026 96190 89767 93158 84087 107859 103071
98383 102369 112054 118974 103326 92415 126452 107218
92348 115284 120069 133390 119128 109908 143560 134631
BENIGN NEOPLASMS (2 1 0 -2 2 9 )
415 304 246 338 144 95 143 0
289 57 506 328 266 363 303 98
221 341 172 116 405 286 283 56
224 162 0 158 316 333 400 290
272 67 326 318 368 340 546 161
912 555 549 137 623 277 410 265
412 763 563 497 643 856 565 279
1189 873 1159 1102 1183 702 568 574
1147 1033 1061 1492 1336 1438 1393 635
1868 1518 1842 2160 2525 1786 1232 927
2396 2397 2702 2112 1764 2137 2599 2030
3482 2257 3832 3533 3170 2548 2894 2365
4384 3679 3294 4075 4352 4147 4188 2287
5472 4724 3020 5162 6024 4317 5697 2261
7188 6705 8036 7961 7539 9154 7742 2111
18470 11354 6861 13594 10067 8326 7383 2433
1335 1352 1285 899
1483 1277 797 1036
1950 1055 1450 1410
1876 1941 1528 2730
2829 4173 3005 3681
4904 4483 3924 4950
8133 8322 8102 6853
12446 14453 13214 12427
23859 24394 23730 22446
36390 37610 42387 37714
50842 54777 59081 56050
72550 75240 87679 77446
89589 108220 113136 111652
120969 132460 149300 134311
133874 161092 191551 164828
142180 215873 230769 183120
2027 2154 2724 2593
2582 3453 3327 3957
3684 3744 4039 3575
4046 4353 3585 4647
5551 4494 4876 5493
5936 5231 5944 6174
6535 8604 8032 7822
12156 10438 11024 10548
18090 14564 17002 16743
23801 24956 25244 25974
38575 32768 36388 38240
56321 53984 51506 54805
75183 ■ 75162 78684 77349
98743 94563 103508 104314
126166 134179 115805 129655
138231 132540 132308 177091
0 100 51 212
143 47 0 94
163 158 259 0
235 176 176 58
214 0 170 117
323 374 404 167
278 282 423 415
507 0 365 433
427 717 651 585
1169 1485 868 1247
1438 978 783 1197
2369 2312 1744 2429
3151 2457 2334 2102
3279 3542 2419 2528
5680 4614 2913 4828
5529 2381 3846 2261
1321 908 1081 1103
1082 948 1072 1034
1231 1173 1358 1254
1649 1918 1598 1721
3992 2555 2526 3024
5142 4916 4950 5002
7845 8097 9266 8402
13136 15493 12385 13671
24758 22114 24573 23815
40356 35894 40255 38835
66127 61875 65717 64573
86012 86421 90487 87640
118075 121601 122900 120858
171779 172711 180429 174973
226367 229211 235604 230394
266434 286191 298077 283567
2470 1998 2225 2231
3149 3043 3573 3255
3314 2910 2996 3073
3959 4049 4073 4027
4767 5110 4816 4897
6279 5078 6316 5891
8368 7909 7066 7781
11219 10831 14031 12027
16033 16417 19404 17284
21897 26262 30248 26135
41610 41712 41791 41704
60004 57676 59611 59097
86023 94851 90104 90326
118825 116313 120233 118457
155232 146364 147033 149543
176224 186791 186899 183304
57 61 0 39
49 0 51 33
95 141 0 78
165 53 155 124
298 119 470 295
217 324 171 237
327 502 290 373
568 502 358 476
373 600 599 524
747 1656 1213 1205
1799 1231 1495 1508
2533 2706 3570 2936
3525 3901 2877 3434
3229 3195 4255 3559
6639 3375 3508 4507
8392 2668 5409 5489
1158
1637
1408
2381
3430
5302
8067
14780
25614
40151
63182
86668
117537
166338
217148
242888
2758
3322
3593
4762
5145
5630
9076
11782
16805
25976
44603
58289
78101
115169
130420
163384
55
48
97
227
59
273
269
500
1110
520
2024
2348
2974
2632
4928
4376
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UNSPECIFIED NEOPLASMS (230-239)
156 354 99 241 239 48 191 533
231 342 281 109 159 207 455 392
331 114 345 174 116 286 170 389
224 108 213 264 211 555 172 463
272 267 261 445 123 340 382 484
841 555 412 410 346 69 273 729
962 347 422 852 572 785 706 1117
1388 2148 1432 1446 1044 1194 709 1507
1956 1937 1873 1168 2205 1233 1533 1624
2658 2960 2803 3008 2748 1786 2191 2979
3893 3895 3453 3923 3376 3482 3186 4501
4673 5147 5526 3886 5811 2900 4298 7270
6849 5650 6462 4815 6769 5332 7562 9034
6424 7322 6273 5610 6024 8224 7073 11871
7188 5811 7143 5750 6652 6539 9032 16041
8795 8734 5146 13594 10906 9992 7383 19465
ENDOCRINE & NUTRITIONAL DISEASES ( 2 4 0 -2 7 9 )
1143 1367 1133 1254 1435 999 1530 1114
693 1312 899 1312 1222 1451 1313 1470
662 1135 1207 1394 1041 1086 904 1390
1173 916 1064 1265 1263 1998 1316 1100
1630 1270 1760 2227 1225 1643 1638 1452
2875 3122 2677 2529 2771 2220 2391 2121
3091 4162 4293 4117 4430 3854 4097 3632
4625 5639 6069 4959 5568 4985 5392 4592
8770 7941 8239 7007 8018 9452 8220 6706
12786 13360 13136 13344 13221 11646 12530 11387
19239 21723 20791 19842 23705 22632 18442 19681
34451 37472 37522 35945 33281 35325 35260 32495
54521 57417 58540 57661 54756 54390 55375 54545
96122 84554 81320 87298 83477 82237 80550 81590
130728 130085 141964 115436 122395 115519 117849 106796
158311 144105 143225 168224 166107 151540 133716 132198
DISEASES OF BLOOD & BLOOD-FORMING ORGANS (2 8 0 -2 8 9 )
156 456 345 96 335 285 287 242
289 171 337 547 159 518 354 245
55 341 460 523 579 515 678 500
168 269 213 316 421 333 114 521
340 67 0 382 245 397 164 269
280 208 480 547 277 416 137 265
412 486 211 568 429 357 494 349
661 738 887 551 626 702 780 574
1147 1227 874 1492 1336 1301 627 1059
1508 1974 1842 1080 1931 1786 2054 1986
4492 2397 2702 2565 3376 2374 2263 3795
6780 6862 6684 6182 5987 5360 5526 6920
11781 12351 12164 13705 11241 10191 8609 10863
27123 24799 24861 20422 22806 19120 17878 23554
47170 47385 49107 38479 37251 30950 37849 35458
102023 107424 102916 90909 88087 65779 68089 68938
148 301 462 317
287 142 234 141
379 158 259 302
235 353 705 290
427 642 624 292
323 374 1270 612
834 917 2325 623
1881 1533 1460 1011
1994 2439 2966 1316
3302 3535 6148 2641
4061 6032 7512 4191
6316 8182 11935 6122
8441 10721 13003 7635
11660 14875 18490 10785
14604 19992 21850 13448
18167 18254 24615 14318
1236 1152 1285 1270
1339 1040 750 1413
1192 1107 1087 1510
997 1059 1175 1220
1388 1124 1587 993
2710 2179 1616 1613
3198 3385 2607 2353
5137 5328 4234 6286
7407 6027 7597 7677
12933 12230 11284 11446
17934 16710 16198 16164
27283 33529 29838 29735
56275 46795 50011 49131
85079 83407 82426 79373
118458 114187 115805 113103
134201 158730 150769 147702
643 301 257 106
383 473 281 141
217 475 414 403
176 235 235 290
107 107 340 292
387 623 289 278
695 494 493 415
1013 876 657 795
1567 1435 1085 1170
2476 1697 2025 1541
3468 4076 3913 3143
6141 6492 6519 7482
11818 10610 10224 10623
20404 20365 22119 17863
37728 39216 32411 35172
74250 62698 58462 50490
287 121 254 220
344 50 204 199
284 188 281 251
440 320 155 305
238 535 411 394
325 810 228 454
654 502 347 501
852 932 1074 952
2088 2024 1723 1945
2690 2784 2426 2633
4348 3232 3620 3733
6819 6626 6604 6683
11455 9140 8861 9818
25993 21569 21116 22892
28770 25775 22508 25684
26573 37358 39063 34331
1551 1090 1144 1261
1378 1497 817 1230
1089 1220 1545 1284
1814 2557 1702 2024
1788 2674 4170 2877
2111 3025 5462 3532
3792 4770 4807 4456
6817 6455 7016 6762
8203 8471 10788 9154
13302 15953 18118 15791
21517 25781 25106 24134
40912 42930 41317 41719
73797 80361 72727 75628
127704 133887 125433 129008
202656 217858 196726 205746
337762 313542 266827 306043
287 363 127 259
344 499 204 349
379 282 421 360
330 266 567 387
536 238 235 336
487 324 171 327
523 565 290 459
852 430 859 713
1044 900 899 947
2541 2483 2426 2483
4348 4156 4722 4408
6526 7839 7139 7168
15310 13486 13464 14086
31159 28599 29467 29741
59437 60448 49693 56526
123077 135424 105168 121223
331
289
243
170
473
601
403
1285
1851
3340
4337
7350
10245
22705
23982
30635
1324
722
1554
1304
1360
1804
3227
4855
8217
12840
21470
33483
63450
109905
184297
250206
276
241
243
397
355
328
672
428
1407
1484
4337
7248
13770
29121
50591
117433
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DISEASES OF THE NERVOUS SYSTEM ( 3 2 0 -3 8 9 )
2597 2582 2661 2074 2583 2473 1912 1840 2126 2154 1850 1958 2702 1895 2058 2161 2038
4331 4278 5001 5083 4199 3472 4192 4214 3682 3973 4217 3392 4574 5166 4739 5003 4969
3754 4711 5172 4009  3587 4402 3899 3503 3792 3533 3521 3877 4273 4309 3661 4354 4108
2626 4147 4044 3374 3948 3330 3547 3243 3284 3529 3878 2904 3345
3959 3197 3403 3519
3940 4410 4302 3309 3492 3172 3166 3873 3843 3852 3855 4207 4317 4230 3624
4112 3988
4348 4093 6451 4853  4503 3885 4303 4573 4000 3985 4097 4616 3717 5034 5564 5576 5391
5496 5203 6546 5679 6359 5638 5227 6355 4588 4513 6623 5399 5647 7518 5963 6081 6520
8590 7854 7570 7852 7447 7583 7024 8897 7959 7591 6935 5924 8568 7598 8392 8304 8098
11334 10330 10673 9926 10757 10274 9544 10871 9187 8681 10708 8262 10882 10515 11994 8990 10499
14366 14954 14658 15118 13444 14576 14447 16485 14515 15977 13382 13060 16773 17786 15201 15768 16251
22234 20749 22142 19992 21864 20337 21125 23917 19288 22008 20737 20804 23711 28190 26012 25185 26462
33077 34402 32620 31794 33457 32074 30611 33722 32284 31750 34521 34010 49102 47243 45730 43637 45536 n
52055 54921 51571 50624 54636 50835 50256 56261 51097 55729 59680 61525 81626 91750 87606 87457
88937 v j
o
78753 75579 77602 82585 80465 80387 73870 86866 89087 100761 108346 104483 162389 167904 173191 151907
164334 03
123989 110863 101339 112340 106874 98954 100215 138455 123732 146867 146395 166897 268068 289598 284750 258696 277681 5
125770 134498 132075 118097 110738 134055 147662 161395 156398 182540 210000 228335 419402 429371 422282
377404 409685 TO
DISEASES OF THE CIRCULATORY SYSTEM (3 9 0 -4 5 9 ) a
1662 1975 2119 1303 1339 1759 908 1307 1533 1703 822 1693 827 1493 1150
1017 1220 o'
3753 2966 3203 3170 3242 2540 2829 3528 3396 3169 2624 3298 3178 2116 3093 3267 2825 n
4747 4655 5402 4764  4687 4574 4407 4503 4713 4219 5230 4078 3884 3740 3098 3839 3559 rn10002 9209 8407 8225  7423 6771 8523 8513 8502 7705 8286 7319 7314 7148 6979 4744 6290 3
21193 21649 21704 20364 17828 17786 17250 17804 16761 17496 16384 15075 15318 13466 14557 14567 14196 00
53783 54523 50580 47987 49255 46337 51089 46918 42583 42219 37338 37597 33452 34263 35815 32091 34056 e> 130315 128746 128730 122595 113898 117177 114211 105594 104484 101410 92222 89776 82487 84526 77956 78300 80260 3to
279701 273612 264525 256009 243162 242154 240866 240080 221129 218102 199591 206054 187290 182063 178238 163433 1745781
478108 472658 482117 481705  457273 457329 461860 457998 435083 414622 396252 378811 358010 357047 343928 322370 341115 3*—* 786094 781691 779175 747628 756518 742569 748716 764978 748641 718841 694901 679800 652145 624094 608398 595330 609274 a
1294879 1259026 1247542 1244285 1246030 1209069 1264565 1259465 1182133 1133844 1111198 1115917 1089641 1089369 1052024 997875
1046422
2181235 2109977 2087166 2053254 2036714 2000176 2012981 1960322 1891920 1040982 1827121 1858711 1784504 1720826 1664209 1617973
1667669 <
3498082 3377217 3391662 3306458 3251783 3195639 3213006 3162607 3033652 3013290 2929206 2889233 2783322 2825752 2717454 2638435 2727213
5371401 5238073 5142426 5138016 5056583 4926398 4950884 4928962 4738568 4530016 4540003 4415908 4303554 4429286 4312190 4101639 4281038
8105121 8033080 7861161 7820433 7740133 7206190 7362581 7264669 7092089 6833910 6756373 6528276 6459921 6692697 6324026 6040339
6352354
13759894 13310917 13116638 12882753 12503356 11827644 11931091 11960260 11186414 11144444 10764615 10601356 10380744 10665035 10203469 9170072 10012858 o0
HYPERTENSIVE DISEASE (4 0 1 -4 0 5 ) 5*
0 0 49 0 0 0 48 48 99 0 0 0 55 0 0 0 0
co0 0 56 109 106 52 0 49 0 189 0 0 96 49 150 51 83 a
221 284 57 116 116 57 113 167 108 158 155 101 0 47 94 94 78
726 323 426 422 211 111 286 58 352 176 118 290 227 220 107 52 126
611 1002 1108 827  735 906 273 1022 534 482 340 234 414 179 59 352 196
1753 1873 1029 2051 1593 1595 1366 1723 1097 810 635 334 328 379 486 455 440
3984 4301 4645 3833 3716 2569 1836 1676 2155 1904 1339 1938 1210 1438 816 1042 1098
8590 7048 8388 7439 5707 5757 5108 4951 4052 4745 4015 2818 3142 2343 2080 1933 2118
12750 13042 13295 12845 11692 9384 7454 8753 6267 7390 5716 4972 5848 4922 5022 4645
4863
23344 20874 22747 19360 16935 16433 14926 14499 12657 12018 12514 10419 10094 7922 8353 7353 7876
40051 36854 35352 32969 30917 30466 30598 24711 23771 21519 21285 18185 17205 16644 16700
12907 15417
67436 56975 58200 57935 56700 48682 45435 43356 36758 35486 33327 30609 28277 28054
26972 21149 25391
93836 93286 84516 86924 73734 80460 72010 63465 60101 55506 46455 47803 46596 42846 40682
37860 40462
154176 141001 136385 122756 116394 101357 111591 96476 81253 79157 70848 73643 65482 61027 53203 48219 54149
181941 185069 174554 169394 164523 150828 145376 134234 113590 106882 104516 85517 88371 94531 78245 65770 79515
294635 230568 229846 211555  208054 213156 178835 194647 153239 138889 136923 122080 131291 110490 101401 92548
101479
A
2 - 12
ISCHAEMIC HEART DISEASE (410-414)
52 o 49 48 0 0 48 0 49 100 0 53 55 0 61
0 20
231 57 281 109 319 104 51 196 191 47 187 94 193 98
50 102 83
497 738 460 871 926 629 509 612 867 738 673 403 825 379 329 281
329
2459 2962 2395 1951 2316 1943 2460 2722 2815 2765 2174 2033 2551 1814 1598
1392 1601
10800 10825 10363 10882 8822 9176 8079 9790 8701 9845 8957 8239 7866 6256 7130
7930 7105
36673 34892 33491 30487 32698 31285 35585 30219 29357 28831 24700 25195 22083 22788
24363 21394 22848
94868 92952 96213 91574 85173 87990 87795 80522 80222 76375 71720 68180
62387 63869 59377 58609 60618
213559 209438 202332 200703 187974 187109 189216 188563 175470 171679 157103
163500 150660 146560 141587 131076 139741
364838 359416 369265 375178 352442 354521 365657 360440 345346 330105 314933 303283 287015 286801
280135 259365 275433
575420 573326 571406 556730 575578 563661 579391 582853 576598 551573 535552 531000 521746 499066
483483 477219 486589
894370 880599 879231 881026 885846 869431 918518 920660 874461 852054 826199 836713 829538 841505
799369 766567 802480
1410024 1380767 1374332 1364303 1351118 1355448 1370231 1326881 1306606 1272056 1268729 1316879 1280421 1252776 1205693
1193646 1217371
2059315 2014847 2033452 2012224 2018736 1995853 2026640 1977702 1916939 1935336 1900311 1890450 1852831 1909682 1828021
1780783 1839495
2847728 2801842 2739545 2818896 2823580 2818051 2858153 2764650 2719439 2641403 2684638 2636333 2609576 2698095
2666241 2530728 2631688
1 7 ? 5 » 5 3782143 3832817 3869180 3679163 3819785 3630224 3603651 3571319 3587036 3537586 3587057 3758141 3508131 3378837 3548369
5379947 5468122 5422813 5327103 5323826 
DISEASES OF PULMONARY CIRCULATION (4 1 5 -4 1 7 )
5314738 5419196 4882401 4808057 4969841 4834615 4920121 4927790 5223077 5037358 4579327 4946587
0
o
o 49 0 0 0 0 97 49 0 51 106 110 57 0 0 19
57 112 164 0 52 51 98 143 142 141 236 48 148 100 153 133
110 170 172 116 58 172 57 56 163 211 362 101 194 142
141 47 n o
391 108 0 211 105 111 57 116 176 294 118 349 113 220
160 206 195
272 134 196 255 184 113 164 215 267 161 57 351 118
0 0 235 78
280 902 343 410 277 416 137 596 581 685 173 278 219
217 216 284 239
1305 1110 985 852 500 928 989 489 1529 776 775 623 538
392 251 521 388
1652 1947 1296 1722 1670 1194 1277 2798 1954 1679 2336 1951 571 568
646 501 571
4048 3874 3308 3763 3608 4178 3344 4659 3846 3731 3617 4387 1407 1790
1199 1124 1371
6321 6073 7769 5939 7576 5716 5546 9599 9218 9756 8318 7191 3191
3886 3161 2729 3258
11978 11311 13135 11015 13042 11395 11485 18092 15735 15487 16355 14667 6578 6598
6234 5431 6087
19791 20587 19519 21461 19194 19332 18332 30744 26230 26770 27819 25459 10106 9838 9426
8299 9187
33973 35606 31804 31238 30340 32468 29781 47684 48959 ' 52044 42009 41717 18616 19055
18725 18067 18615
39971 45111 45074 47576 48838 45641 44990 74242 67408 64105 69293 70104 36690 34872
33072 32619 33521
AT7Q9 58036 64131 69180 67568 67527 111017 105477 101499 104151 96897 46649 53114 52777 47647 51179
69481 71616 94340 81563 
CEREBROVASCULAR DISEASE (4 3 0 -4 3 8 )
98993 90758 107465 123277 132701 132540 127692 113791 73669 64336 70714 61298
65449
831 861 739 338 478 713 191 436 593 551 257 476 110
517 242 318 359
1270 856 843 1148 850 726 859 931 1052 1088 422 1225 674 640
998 970 869
1601 1419 2069 1685 1389 1544 1639 1445 1517 896 1864 1460 1117 1089
986 1030 1035
3353 2100 2395 2689 2158 2331 2460 2432 2932 2294 2468 2382
2041 2474 2131 1134 1913
4891 4544 4236 3246 2941 3059 3930 3496 3470 3103 3742 3214 3253
2920 4219 2937 3358
6872 8532 8373 6357 7135 6174 7718 7687 6388 6289
6637 6452 6286 6279 5996 5576 5950
9658
14083 15400 14217 14552 12504 13630 12361 12571 11470 11707 10286 9760
10353 10394 8850 9730
30924 29670 28369 26517 25054 27733 24122 26118 22504 22190 20295 22975 18493 19740
19796 16393 18643
53768 54426 51807 50149 48239 48425 46395 48496 45367 42474 40515 36558
36941 36913 32609 33338 34286
101853 103234 102203 91786 86236 86882 82027 86594 84130 78402 74286 73960
68577 64868 67650 61860 64792
201827 192659 183367 187778 173456 168394 169168 165828 150157 137757 139369 134850 140678 130379 132292
121124 127931
413231 397381 385205 363155 359658 341388 341110 325129 302658 294468 280114
271597 283075 258134 248903 232108 246381
519066
794795 754829 731247 707742 667714 644152 644835 644597 593585 578736 554012 535244 554968 536623
525524 495052
1371163 1338687 1298327 1247756 1192986 1156867 1138310 1166196 1102204 1038073 1015206
957364 1006252 1039070 989775 941223 990022
1698305
2348158 2281627 2159375 2089341 2034146 1837838 1852903 1831575 1801217 1716647 1667152 1613103
1700394 1752134 1726296 1616486
4052770 3851528 3639794 3532710 3404362 3139883 3157506 3180049 2954976 2907937 2819231 2696307 2921225
2997902 2854570 2536058 2796176
D
eath R
ates for England and W
ales (continued)
A
2 - 13
DISEASES OE THE RESPIRATORY SYSTEM (460-519)
2597 2532 2710 2171 3348 2045 1721 2130 2522 2003 2210 1799 1489 1091 1211 1271 1191
5139 4563 5170 4099 4837 2747 3586 3185 3539 3311 3187 2450 1878 2362 1746 2144 2084
5410 4995 4597 4648 4455 3773 3334 4003 3088 3638 2952 3625 2816 2131 2535 2294 2320
4582 4524 4363 4587 4528 4052 4119 3069 4046 4294 3761 3717 2438 2694 2451 3094 2746
6725 5412 5475 6873 7229 3908 5459 4626 4430 3906 4422 4149 2957 3396 3862 2819 3359
11570 8740 8441 7929 8590 7839 7377 6163 6194 5667 5771 5061 3553 5142 4646 3755 4514
18616 15954 15695 13133 14291 12488 12007 12571 10497 9027 10356 10175 6790 6995 8034 7008 7345
35946 36182 30074 31476 27977 24573 26321 23606 21491 18467 21390 18424 13638 13775 13198 13387 13453
73939 70437 63230 60919 67215 54932 52734 51249 46222 39532 41239 32902 28280 30276 28636 23150 27354
154575 150979 133921 124875 125084 103530 110168 103012 99608 95723 97794 90836 68577 73163 67800 61026 67329
309253 282322 257299 250622 267357 235895 234387 221516 205143 188865 184443 190601 145883 168016 153225 134976 152072
621312 555576 514260 500839 527734 449385 447943 443286 401526 372999 403874 395880 299510 313657 286981 262984 287874
1175205 1078965 1036113 1024077 1085459 928665 926477 902001 827462 792495 815070 760319 562679 605463 594628 548331 582807
1986914 1948276 1782063 1852334 2029905 1773232 1819646 1761070 1658954 1609881 1628650 1562690 1072228 1156765 1109922 976678 1081121
3053010 3123380 3053125 3121628 3639024 3134263 3148387 3255382 3104665 3043445 3109250 3069655 1991130 2177996 2068119 1760304 2002139
5560246 5623581 5699828 
ACUTE RESPIRATORY INFECTIONS
5705183 6895134 
( 4 6 0 -4 6 6 )
6112406 6015587 6189781 6052133 6265079 6404615 6201959 4221007 4704895 4515677 3682091 4300887
208 203 345 145 239 95 143 145 198 0 103 159 110 172 0 64 78
520 342 281 437 372 155 152 98 0 236 187 47 96 148 100 51 99
386 284 402 407 0 286 113 167 108 158 52 252 146 0 47 0 15
279 269 372 316 211 333 286 0 352 118 176 58 57 385 53 155 197
272 267 261 318 490 170 164 269 53 0 57 117 118 179 119 117 138
280 416 343 410 416 208 342 331 387 125 58 445 109 162 162 57 127
481 555 704 710 429 571 424 140 348 212 352 415 202 131 628 405 388
1123 873 887 1033 348 843 639 933 289 438 219 433 143 142 143 215 166
1619 1227 1560 908 1604 1301 1115 847 641 646 651 219 518 597 750 225 524
1580 2960 2243 2391 1931 1715 2396 1125 1376 778 651 1101 520 1046 903 910 953
4492 4120 3753 3772 3836 2691 2766 2824 1438 2038 1565 973 1157 2399 2078 1889 2122
9621 8488 5615 6535 4930 4569 4736 3153 3597 3646 2663 2526 2756 2630 2333 1606 2189
18219 13664 12038 12347 13901 8413 9190 7204 5515 6478 7113 4758 3855 4736 5127 4028 4630
29265 26216 19284 22890 20439 16859 17682 13002 11842 9208 9677 11122 8391 9041 7030 6776 7615
50764 45597 46875 40690 43016 32258 39570 29548 27586 21530 21122 18966 11827 18653 19638 10523 16271
88830 89956 88336 83263 107383 84929 
OTHER DISEASES OF UPPER RESPIRATORY TRACT (4 7 0 -4 7 8 )
68089 79481 58452 59524 47692 37679 43764 46853 37358 25240 36483
52 51 0 145 0 48 0 48 49 0 0 53 0 0 0 0 0
115 228 112 109 0 0 152 0 48 0 0 47 0 148 50 51 83
no 114 172 0 174 0 57 56 0 53 52 50 0 95 141 47 94
0 54 0 158 53 111 114 0 0 118 59 0 0 0 0 52 17
272 67 0 64 0 170 109 161 107 54 57 0 59 0 0 0 0
0 69 69 137 69 277 68 133 65 0 58 0 109 54 0 57 37
69 139 0 0 286 71 0 70 0 0 70 138 0 0 0 0 0
66 67 68 69 70 211 213 144 72 0 73 72 0 0 215 143 119
135 65 250 195 134 137 70 141 71 0 289 73 74 0 0 0 0
72 0 160 231 297 71 0 199 138 141 0 147 74 149 0 303 150
225 150 225 377 77 79 84 265 0 0 235 75 0 0 308 0 102
641 181 178 265 352 88 351 88 439 0 275 97 102 97 93 0 63
411 526 634 123 363 355 582 572 338 223 333 443 441 441 223 345 336
476 945 465 449 0 1028 786 377 1093 0 346 169 0 646 320 630 532
449 447 446 442 887 0 1290 844 811 384 364 690 1314 632 921 29 2 615
880 1747 1715 850 2517 0 0 811 790 0 769 0 0 0 667 1202 623
D
eath R
ates for England and W
ales (continued)
PNEUMONIA & INFLUENZA ( 4 8 0 -4 8 7 )
1402 1215 1577 1013 2153 951 908 1114 1483 851 719 582 221 230 545 254 343
3002 2567 3653 2186 3348 1969 2424 1911 2056 1419 1312 1036 241 689 649 562 633
3312 3292 2931 2614 3124 2287 2260 2502 1788 1476 1295 1410 825 663 657 421 580
2515 2639 2714 2636 2948 2387 2288 1448 2170 1823 1410 2033 794 715 639 980 778
3600 3074 3324 4582 4901 2096 3221 2636 2455 1766 2381 1870 1005 1132 1664 1116 1304
6942 4509 4049 3896 4849 4509 3347 3115 3097 2864 3693 2670 984 2436 1513 910 1619
9892 8116 7531 6034 7646 5638 5933 6425 5283 3949 5002 4707 2218 2484 2573 2954 2670
14140 15976 12752 14670 12736 10812 12274 9543 9117 7956 10147 6936 3642 3479 4304 4152 3978
26243 26600 23594 21993 27794 21849 18321 20613 16879 15569 14904 11260 6145 6861 5847 4270 5659
48484 49719 42851 42499 46795 36582 38138 34558 34945 32167 28861 29276 11801 11060 11137 11144 11113
93352 91011 76785 77480 96663 80161 76369 76692 70891 66107 63150 60316 21904 24067 23549 19440 22352
210189 195756 172282 175130 209808 167047 164284 167645 149750 137051 148090 141386 49918 49192 44330 39443 44321
457808 436079 407501 421040 498006 407631 398325 394511 361058 344427 354968 325329 109495 115762 114690 97238 109230 U
917678 948040 860595 895197 1075301 899054 907466 883738 852432 827519 808018 788675 278052 297546 293338 238418 276434 09
1759209 1856951 1788839 1871296 2340133 1900174 1904516 1977628 1878296 1842753 1894028 1847931 708607 804932 742559 608594 718695 3*
3782762 3947598 4027444 4022940 5129195 4478768 4320755 4549878 4445498 4619841 4692308 4532027 2344274 2643357 2483656 1991587 2372866 TO
BRONCHITIS, EMPHYSEMA t  ASTHMA ( 4 9 0 -4 9 3 )
09
s
935 962 739 724 765 856 574 678 742 952 1285 952 1103 402 605 699 568 S'
1039 1198 787 1148 1063 518 707 784 1148 1324 1265 1084 1396 1132 898 1276 1102 n
1325 1135 862 988 868 915 565 834 813 1529 1191 1359 1359 994 1549 1685 1409
1620 1077 958 1265 1053 833 1087 1274 1173 1765 1880 1278 1361 1320 1279 1547 1382 3
1630 1804 1369 1400 1225 906 1419 1130 1334 1284 1417 1636 1124 1668 1485 1292 1481 00
3015 2636 2951 2393 2286 1734 2459 1657 1807 2117 1154 1390 1421 1516 1675 1707 1632 3*
> 6045 5757 5419 5040 4216 4995 3885 4539 3059 3526 3100 2630 3092 2811 3013 2085 2636 3i o
17444 15976 13298 13362 11413 9057 9720 8682 8249 7007 6935 7008 5784 6178 4877 4725 52601
41625 38350 33082 33346 31202 25274 25566 21954 21010 17004 16712 13307 12215 13423 10945 9739 11369
09
3
93808 89191 78574 70497 62913 53658 54776 52565 46640 42418 41374 36686 30800 30192 24983 21454 25543 a
193742 170262 159949 151264 142079 127008 127001 113494 96016 82410 74497 76106 61736 68376 57103 48009 57829
369342 319639 304367 287733 270470 234974 229278 217921 179753 159374 158924 147216 127807 118644 104526 83705 102291 <
641507 572986 556513 528954 494863 434649 428106 409377 352167 311146 285619 250858 221855 225355 190927 161105 192462
962170 892537 819470 835278 817771 737664 760118 700584 608125 541881 531363 442872 397664 383113 318262 248503 316626
1151842 1109075 1095536 1093764 1102882 1025719 1022366 1038835 939959 846213 806628 712759 659658 619665 525928 405729 517107
1507476 1420087 1408233 1386576 1421141 1304746 1382281 1282238 1224329 1155556 1128462 1019593 927790 933566 834556 586538 784886 o0
CHRONIC OBSTRUCTIVE PULMONARY DISEASE ( 4 9 0 -4 9 6 )
3
3*
935 962 788 724 765 856 574 678 742 1002 1285 952 1103 402 605 763 590
Co
1155 1255 955 1203 1063 518 758 882 1243 1372 1406 1084 1444 1181 898 1276 1118 a
1435 1249 919 1046 1099 915 735 945 1029 1529 1295 1611 1457 1042 1549 1732 1441
1676 1508 1011 1265 1211 944 1258 1390 1231 1941 1939 1336 1417 1375 1438 1547 1453
2377 1871 1695 1655 1593 1246 1528 1183 1548 1498 1531 1753 1360 1668 1723 1292 1561
3787 3191 3294 3144 2771 2289 3210 2121 2258 2553 1443 1613 1804 1840 2215 2219 2091
7144 6451 6264 5537 4573 5281 4450 5168 3893 4443 4227 3807 3899 3792 4017 2954 3587
18766 17386 14594 14051 12875 9759 10500 10978 10420 8613 9198 9681 8140 8876 7101 7660 7879
43176 39641 34517 34060 32939 26849 26681 25907 25283 21022 23441 19668 19544 19985 18591 16032 18202
95891 91089 81698 73120 65364 55373 57104 62032 57990 56133 60976 53929 51136 55078 49063 43818 49319
197335 174232 163702 153678 146298 130648 130019 132380 122325 110694 109398 118387 111834 129555 114514 104360 116143
374382 325598 310873 292944 274872 239895 234278 253569 228880 215226 231546 233602 227746 240503 221185 200518 220735
651096 581527 566016 536239 503928 440692 434272 469868 430276 407639 416426 399469 413058 447847 436023 409701 431217
976445 907889 835270 850539 832616 750000 772102 802337 736564 714185 752030 703573 716025 775105 737178 655846 722709
1171608 1130979 1116071 1110571 1118847 1041848 1042581 1173491 1132252 1095732 1109250 1102759 1156702 1232690 1187174 1023385 1147749
1535620 1441048 1431389 1413764 1441275 1328893 1402789 1437956 1433649 1426190 1518462 1478523 1619256 1773427 1772515 1463341 1669761
A
2 - 15
PNEUMOCONIOSES (500-508)
0 0 0
0 0 0
0 0 57
0 0 0
0 0 0
0 0 0
69 69 0
463 201 205
742 775 624
2083 2581 2082
4342 5019 2927
11178 10023 9358
17397 15110 12671
20462 17005 13243
10332 16987 16071
12313 12227 12007
COALHORKERS PNEUMOCONIOSES
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
132 67 0
202 516 375
1293 1670 961
2620 3446 1876
7422 6953 5526
11507 10905 8363
13562 12045 9526
6289 14752 12946
11434 11354 6003
ASBESTOSIS (5 0 1 -5 0 1 )
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 69 0
132 67 0
270 65 0
359 228 320
75 375 225
183 90 446
548 394 380
238 472 0
0 0 446
0 0 858
0 0 0 0
0 0 0 98
0 0 0 56
0 0 0 0
0 0 0 54
0 139 0 0
143 71 141 70
209 211 142 144
802 411 488 635
1931 1215 959 1258
3682 3719 3437 2295
7396 6854 6491 6482
16923 10783 9772 11435
17427 18092 18075 20916
15965 21796 16344 20262
15101 14988 17227 21087
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
70 140 0 0
134 137 70 212
891 286 479 397
1918 2137 1593 706
4490 3339 3421 3241
12692 6043 6166 6975
12694 13569 11002 13755
11530 16129 14194 16041
12584 12490 13126 13788
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 69 0 0
0 71 141 0
0 70 0 0
67 68 139 71
297 286 342 199
307 396 335 530
264 703 789 526
484 829 465 343
0 0 196 377
443 0 0 844
0 0 0 811
0
0
0
0
0
0
0
207
973
1774
5432
8390
11977
21320
18134
16143
(500-500)
0
O
O
O
0
0
0
0
195
848
3093
4769
7779
15934
12826
13594
0
O
0
0
0
0
0
69
260
309
528
530
494
898
885
0
49 0 0 0 0
0 47 0 94 0
54 53 0 151 49
0 59 0 0 0
0 54 170 0 0
0 125 58 0 0
0 141 0 346 134
72 73 219 144 214
499 430 217 73 296
963 1273 1374 1394 1336
2792 3016 2895 2245 2313
5878 4536 5325 4276 4390
11367 11168 10780 10402 10355
15850 18063 16935 18874 16617
15010 17301 18208 22759 23325
22117 34127 17692 25622 31364
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
142 0 0 0 0
138 141 506 514 223
1269 897 1174 898 940
3070 2490 3030 2624 2042
5853 ' 6701 5779 5311 5288
8745 10802 9850 12302 9707
8519 10381 9832 15862 12155
11848 22222 6923 9043 16776
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
72 73 219 72 71
285 143 217 73 222
275 283 289 440 371
423 489 391 449 578
263 534 459 389 306
1013 558 889 996 661
182 531 1382 843 987
0 0 0 0 0
0 0 0 2261 0
115 0 0 38
49 0 0 16
0 0 0 0
55 0 0 18
0 0 0 0
54 108 284 148
65 126 116 102
71 72 143 95
224 750 225 399
448 1129 758 778
2024 2617 1338 1993
5065 4013 3391 4156
10133 9028 7595 8918 O
15660 17255 15128 16014 (PW
24344 26388 25431 25387 3 *
33566 38692 29447 33901
70
0 J
V.
0 0 0 0 TJ*
0 0 0 0 O
0 0 0 0
w0 0 0 0
0 0 0 0 < S
0 0 0 0 5 T
0 0 0 0 3
0 0 0 0 a
0 150 0 50 p
224 151 152 175 Q .
1125 1000 472 865
1851 2147 1517 1838
5287 5461 3913 4887
10010 10066 10243 10106 V5
14859 18411 16662 16644
17483 26017 16827 20109 r T
5’
0 0 0 0 C
0 0 0 0 O .
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 58 19
0 0 0 0
149 150 150 149
0 452 379 277
225 693 315 411
877 747 625 749
661 1115 1036 937
1453 799 1103 1118
948 614 877 813
699 0 1202 633
A
2 - 16
SILICOSIS (502-502)
0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 70
0 67 68 0 0 0 0 0
67 0 0 0 67 0 70 0
0 304 240 77 0 71 0 66
524 449 150 302 384 317 168 177
1008 1084 1248 971 1057 1054 702 701
2055 1839 634 1235 1209 1185 698 1144
2617 1653 1162 1346 1291 1028 1965 2261
3145 1341 446 885 1774 1308 860 1266
0 873 2573 1699 0 833 2461 1622
OTHER DISEASES OF THE RESPIRATORY SYSTEM ( 5 1 0 -5 1 9 )
0 101 0 145 144 48 48 145
289 171 169 109 53 104 101 196
110 57 115 523 58 286 113 278
112 54 106 158 105 222 172 232
68 134 196 127 245 227 218 323
210 277 412 273 208 347 342 464
550 416 704 710 786 642 848 698
925 1141 1023 964 1253 1615 2057 1866
1349 1485 1810 1752 2539 3425 5225 3106
3591 2201 2883 3008 5868 7073 9038 3840
5989 4195 6230 6035 12888 15114 18107 7060
10354 8397 10695 11304 24476 26626 31488 12350
21096 24570 28637 31856 43515 49413 63518 18411
33547 35664 38336 49820 70353 76275 92927 40701
49865 60349 66964 68554 104656 127289 128602 53609
124890 126638 129503 157179 183725 191507 201805 100568
PULMONARY FIBROSIS (5 1 5 -5 1 5 )
0 0 0 0 48 48 48 48
58 0 0 55 0 0 0 0
55 0 0 58 0 0 57 0
0 0 160 53 0 56 0 0
136 0 0 127 0 0 218 54
351 277 275 68 277 69 68 66
412 208 493 142 429 214 212 70
463 537 546 482 487 1123 497 359
675 646 874 1038 1403 959 836 988
2873 2429 2002 1851 2897 1500 2533 1324
3518 3596 3678 3848 3913 3482 3605 1765
4948 7133 5258 6270 5899 4306 6315 3241
9178 7489 8616 10495 8824 11376 10819 4574
9041 12518 14870 12118 13769 11924 10609 6972
10782 12070 17857 11942 15521 10898 15484 10131
14952 4367 9434 11045 15940 13322 4922 13788
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 217 147
508 408 157 150
702 267 367 194
1125 893 778 553
1275 885 1210 1348
811 1922 728 1379
1580 1587 1538 1507
0 150 103 53
191 236 281 141
108 369 259 151
293 235 176 290
267 535 227 409
387 0 462 334
973 282 705 761
1520 1387 1533 1156
2849 1865 1736 1609
4196 5232 5931 4989
7698 7010 7199 8606
12984 12540 15975 13993
18908 22560 25450 19918
41173 40907 41645 40276
50710 65744 66278 76552
91627 125397 127692 128109
0 50 0 0
48 0 0 0
0 53 52 101
0 59 0 58
53 0 0 0
65 0 115 0
209 141 70 138
217 219 365 217
712 287 289 146
825 566 1085 367
2369 2038 2035 1796
3158 2757 3489 3790
5290 5919 4890 4537
10567 8854 6739 8763
8925 9996 11653 11379
9479 7937 14615 10550
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 75 0 25
0 0 0 0
75 385 79 179
682 93 178 317
881 780 230 630
1292 1598 315 1068
2213 614 877 1234
2098 1334 1202 1544
172 61 191 141
148 50 204 134
331 141 94 188
165 320 361 282
417 357 294 356
595 648 228 490
523 690 579 597
1207 1363 1074 1214
2610 2699 2397 2568
5381 5569 4094 5014
9972 10159 7949 9360
16170 15026 18026 16407
26545 29536 29344 28475
58767 54801 59880 57816
96744 91439 92078 93420
207692 182789 171274 187251
0 0 0 0
0 0 0 0
47 0 0 15
55 53 103 70
60 0 0 20
54 0 0 18
0 314 232 182
142 72 0 71
373 525 300 399
1420 1505 758 1227
2249 2386 944 1859
4091 3640 5087 4272
6939 7468 7365 7257
12593 11983 13552 12709
16756 14728 16369 15951
16783 18012 21034 18609
0
0
0
0
0
0
0
0
0
0
217
612
1212
1481
2300
1459
55
96
340
170
414
547
336
1499
1703
3711
8675
14598
24675
53142
89356
182349
0
48
0
0
59
55
67
357
444
891
2096
3369
6169
11188
15769
22611
D
eath R
ates for England and W
ales (continued).
A
2 - 17
DISEASES OF THE DIGESTIVE SYSTEM (520-579)
935 861 887 579 765 618 765 581
982 1312 899 1039 744 777 556 686
1656 1646 919 2091 1620 1315 1074 1612
2235 2747 2607 2425 1895 1998 1945 1795
3396 3742 4302 2864 3431 3512 2948 3389
6591 6382 5696 5947 4849 6104 5737 6163
9274 11307 10698 10435 10218 7778 7769 10126
14669 17856 16571 16186 17538 16921 14544 16144
24219 24663 27277 25821 25924 26644 24730 25625
37997 40914 40368 35789 38847 36510 35262 40185
54200 58277 54192 58091 54929 53652 51471 58247
88144 89391 90196 86108 86811 81986 74116 89516
153288 154382 148632 137795 144808 133428 119707 134134
217702 217525 227928 214991 218589 225123 200786 230639
351303 335717 353571 324193 348115 296425 324731 346138
478452 488210 507719 553951 522651 462115 454471 566910
DISEASES OF OESOPHAGUS t  STOMACH (5 3 0 -5 3 7 )
156 51 49 48 0 48 96 48
58 456 56 219 106 155 101 98
331 284 57 232 463 172 170 222
559 108 479 369 158 500 229 347
747 1336 652 573 674 680 437 699
1402 1595 1373 1094 554 1179 683 1127
2610 2636 2745 3265 2644 2070 1483 2235
5352 4699 4774 4270 4872 4634 3902 3659
8365 7425 9051 7720 8352 7603 6409 5153
13791 14954 13536 13806 11810 11503 10339 13439
22384 24345 20866 23086 19946 21287 18610 17562
40224 38284 39750 37446 35658 32513 28506 31006
70411 69242 68044 64082 63459 54390 50372 53288
93980 95418 101533 97621 96816 96834 90766 93461
142408 151989 155357 134896 157428 117698 140215 142676
193492 205240 234991 235344 219799 186511 200984 209246
DISEASES OF THE GENITO-URINARY SYSTEM (5 8 0 -6 2 9 )
571 304 542 531 335 190 574 145
866 1141 562 711 957 363 556 441
1546 1022 1322 1162 810 743 735 667
1900 1400 1330 1265 1158 1277 801 984
2649 2806 1955 1845 2205 1190 1528 1237
2875 3468 2402 2187 1940 2705 1912 1325
4809 3607 5419 3620 3144 3925 3673 1606
6740 4967 6342 6199 5568 4915 4895 3588
11401 8587 10112 9277 7684 5479 6966 4447
14797 13815 15138 13421 12107 13075 12872 10195
26501 23371 24844 23161 24012 22711 23975 19328
47828 41986 44296 41243 42349 41652 36313 33021
84658 78702 85403 77170 85217 75246 76664 77301
161075 164384 160316 151481 155120 155016 150098 150367
311770 296379 319643 284830 291353 281604 292903 289574
645558 572052 590909 578590 661074 566195 605414 613950
396 701 308 159
622 520 843 424
1409 1055 777 604
1407 1471 1587 1859
2829 3371 3061 3097
6388 5106 5021 4505
10080 9027 10075 9414
15991 14161 13944 13944
21651 25685 20764 19668
40036 35914 36094 32284
56763 58771 57360 51186
89131 76841 79692 76960
133258 132790 131918 117074
223356 218346 200968 199528
340365 346790 374727 328276
520537 568254 542308 560663
0 50 51 0
239 47 187 141
325 211 155 201
352 176 353 290
907 214 510 351
839 872 404 834
1946 1551 1832 1523
3111 3358 2555 2240
4843 5453 4269 5922
10387 10251 10488 8658
19457 16710 18077 17212
30704 28637 29288 25459
53686 48247 51789 42935
93460 89782 85537 79879
146856 139562 156227 125172
201422 234127 213077 204974
198 100 206 53
191 426 281 330
325 316 155 50
528 588 940 523
534 749 680 643
968 1059 1270 1335
2364 1269 1902 1454
2967 2774 1971 2890
4843 4592 3256 3363
9218 8908 9403 7557
17765 14346 16355 14892
32810 34240 32134 29540
65954 64440 65126 60197
148114 148752 141524 135322
268560 281430 292061 270000
584518 584921 602308 574228
287 0 381 222
836 499 510 615
758 845 796 799
1704 1012 1547 1421
2741 3268 3994 3334
5467 5996 5519 5660
9414 9352 8919 9228
14273 13771 15964 14669
24310 21439 18130 21293
35722 33185 33204 34037
55930 56411 53282 55207
79193 83528 61385 81368
130521 125279 125086 126962
222312 212334 204853 213166
366108 364222 347559 359296
665035 646431 557692 623052
0 0 127 42
197 100 102 133
142 235 140 172
440 160 258 286
596 178 705 493
1028 486 603 732
1504 753 985 1080
2059 2510 2362 2310
4623 4573 3521 4239
10687 7751 8112 8850
17019 15930 14796 15915
26885 29211 24897 26997
49234 46478 41657 45789
88634 86595 72644 82624
148277 135011 129787 137691
234965 248833 191106 224968
57 121 254 144
148 200 102 150
189 563 187 313
330 586 258 391
358 713 587 552
650 378 626 551
1242 1004 869 1038
2059 1291 1432 1594
3729 3523 2472 3241
5082 5493 4624 5066
11096 12006 10467 11189
21625 24732 19543 21966
56394 50045 52129 52856
136422 129094 120076 128530
275055 274624 250804 266827
644755 615744 519832 593443
276
770
923
1701
2957
5466
9345
14566
20654
31320
54218
77276
126570
205166
348883
601021
55
193
49
283
296
711
1748
2785
3702
8461
16771
28583
44834
80454
136662
208607
110
433
291
510
355
601
874
1785
3405
5937
12217
27562
52985
125864
257884
658643
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DISEASES OF THE SKIN S SUBCUTANEOUS TISSUE (680-709)
0 0 49 0 0 48 0 0
0 114 0 0 53 104 0 49
0 0 57 0 0 57 0 0
0 54 0 0 105 0 57 0
68 0 0 0 123 0 55 0
H O 69 69 0 139 69 137 133
275 277 422 71 143 143 212 210
264 67 68 207 70 140 284 144
202 194 187 130 200 0 139 353
718 304 400 540 297 214 616 265
749 824 826 1056 614 475 838 971
1466 1354 1337 1325 1233 264 965 876
2055 1971 3041 1605 2659 2488 2327 2287
2855 5905 4182 5386 4518 2878 3929 4711
8985 4917 6696 8403 6652 5231 6452 9287
14952 16594 23156 14444 13423 7494 16407 17843
DISEASES OF THE MUSCULOSKETELAL SYSTEM ( 7 1 0 -7 3 9 )
104 0 99 96 144 48 96 48
115 342 225 109 106 155 152 392
497 284 172 116 116 343 283 111
168 215 266 105 263 167 229 58
272 267 326 64 123 397 109 108
491 486 549 752 416 624 273 199
687 902 704 568 643 500 777 698
1057 1544 1364 1446 1183 1404 1419 861
1687 2195 1748 2336 2539 1644 1811 1271
3376 3568 3124 3625 3045 2644 3560 2516
5764 5169 5329 5206 5447 5539 5449 5383
10995 8939 8467 8302 7836 7996 9648 7533
16027 13664 15585 15064 12813 13746 12913 13265
19986 25272 23699 21993 24312 24260 25540 22989
45822 31739 38839 42459 35033 37925 41290 52343
99384 77729 87479 92608 93960 91590 101723 109489
SYMPTOMS. SIGNS & ILL-DEFINED CONDITIONS ( 7 8 0 -7 9 9 )
0 0 49 241 96 48 96 97
115 285 225 55 0 104 202 294
386 341 115 465 579 286 226 111
168 700 372 369 263 444 229 463
475 134 521 382 735 113 328 377
140 416 206 205 416 347 888 663
343 277 422 923 500 571 777 768
793 873 477 620 835 421 568 574
1214 516 811 908 668 822 1463 918
718 1139 1121 1388 1188 429 1575 1589
1123 1348 1201 1584 1304 1187 1090 1324
2566 1986 1961 2561 1761 2548 2544 2365
8630 8015 6842 6297 5923 6280 5584 2173
22127 19839 15799 17504 16351 15419 13556 6783
86253 77783 62500 61035 52328 57977 46022 23639
416887 401747 343053 304163 262584 253122 216571 150041
0 0 0 0
0 47 0 0
54 53 0 0
0 59 0 0
0 0 57 0
0 125 0 111
0 141 70 138
72 73 365 217
285 646 145 146
69 283 217 147
677 897 470 599
1053 1245 1194 583
2589 1452 1445 2877
5101 4781 3974 4044
6491 8458 8740 11724
18957 27778 26154 22607
198 150 51 159
143 95 187 188
163 211 52 50
293 176 294 0
374 107 57 58
129 560 115 111
348 846 493 554
1085 1533 949 722
2493 1435 1375 1462
2614 2757 2821 1834
4399 5624 5791 4864
7895 7204 10007 9620
14406 12285 15559 13279
24048 25854 24883 25110
40162 54979 44064 47586
94787 124603 110769 127355
148 50 0 0
239 0 94 94
217 527 207 352
410 235 411 465
374 161 454 409
839 187 289 278
834 423 1127 761
724 876 730 1156
783 933 1230 1316
825 1767 1374 1614
1269 1875 1487 2095
1842 1156 2295 1360
1238 2457 2890 2766
7105 8146 6221 4719
20284 18839 17480 20690
138231 116667 122308 119819
0 0 0 0
49 0 0 16
0 0 0 0
55 0 52 35
0 0 0 0
0 0 114 38
65 126 116 102
213 0 72 95
373 300 75 249
299 452 455 402
675 539 944 719
1364 1120 1696 1393
2974 2341 2301 2538
7588 7829 5358 6925
10433 14115 9062 11203
30769 32688 28245 30567
57 121 191 123
246 150 153 183
189 94 94 125
220 53 155 142
358 238 0 198
325 540 114 326
784 251 579 538
781 932 573 762
1641 1874 1349 1621
3288 3236 3260 3261
5548 6695 5824 6022
13345 11386 9281 11337
19606 21734 19793 20377
36487 34990 38134 36537
84097 81927 70740 78921
206993 220147 177284 201474
115 303 64 160
197 150 102 149
663 469 421 517
605 639 464 569
358 59 940 452
650 810 797 752
654 942 1158 918
1420 1291 1432 1381
1119 1874 1274 1422
1644 1656 1668 1656
2324 2540 1968 2277
2533 2800 2142 2491
2203 2675 3337 2738
7427 8468 10085 8660
21182 26082 30985 26083
127273 158773 179087 155044
o
o
o
o
o
55
134
143
148
223
723
1021
1322
5265
8870
43034
110
48
291
397
177
273
807
286
1703
3043
6434
12862
21701
36525
77201
179431
0
144
340
454
414
492
471
1499
1036
891
1446
2654
1322
6910
18397
99927
D
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13121
58506
61211
52004
43785
42545
47769
44342
47438
56273
60454
62451
80389
132655
210215
396594
7359
43806
35804
21716
14523
13320
13548
11552
14471
16948
18092
16642
21727
29960
43900
41363
242
1372
2835
2664
1990
2054
1886
1866
1412
2383
1059
1839
1830
3392
3377
6488
ACCIDENTS, POISONINGS & VIOLENCE (800-999)
15425 13519 12813 14858 11815 11793
57856 56471 58949 58267 61228 60482
61824 68570 59591 63499 64167 60256
45876 49599 42782 43763 44643 4 9895
40144 42563 42365 40919 40985 38292
42073 41690 39531 39647 41289 39748
41217 46476 39766 43728 41372 39892
44535 47929 48213 45044 47324 45426
48641 46937 49061 49241 51046 49658
58325 60270 58791 49132 53257 52301
62434 61124 63649 61335 59992 54206
67620 66095 68093 60231 59518 58699
99452 92760 93386 83838 88360 81052
135617 152102 132435 132855 131885 116776
248428 221278 251339 208757 212417 203575
430959 454148 403945 437553 428691 385512
TRANSPORT ACCIDENTS (8 0 0 -8 4 8 )
8881 7291 6653 7670 6266 6182
42554 41412 43664 41323 45549 4 6178
35604 41324 33674 35671 35873 35102
23748 24019 19741 19719 19742 21257
17932 18976 16359 14764 15622 13368
16058 15954 14755 12509 13440 12833
14770 17134 11684 13488 12576 11703
13414 16379 12821 13637 10926 11865
15449 16463 13794 13883 15100 13219
19825 22393 18742 14886 14930 15647
23132 20899 21917 17503 19716 18042
23090 21129 22549 19253 16904 17047
32740 32716 31931 23213 24175 23699
46871 44639 43913 41068 37220 28166
75472 51408 70982 51305 51885 48387
68602 71616 66895 64571 65436 74105
ACCIDENTAI POISONING (8 5 0 -8 6 9 )
260 101 246 531 191 95
1674 799 1236 1257 1276 1347
1766 2384 2931 3137 2719 2973
1397 1777 1756 2056 1948 2609
1494 1403 1173 2100 2328 1699
1823 1457 1990 2256 2009 2012
1923 2150 2182 2414 2287 2284
2048 2551 3478 2824 2088 2949
1956 2389 2185 1557 2138 3151
2729 1746 2163 2160 1857 1858
2695 1573 2102 1735 1381 1504
2107 2528 2317 1590 1937 1494
2466 2496 2408 2716 2538 2133
2379 2362 1626 2693 3657 2262
4043 4917 3125 2654 3991 3923
5277 5240 6861 2549 5872 1665
10978 13323 12282 12434
58680 58125 54639 51258
57533 57055 59137 55687
48610 48409 48716 47514
41849 41520 44390 44992
41809 41472 41724 40656
46437 44076 43821 44923
44645 46423 47598 45661
48928 48142 47388 46428
55995 51608 55913 49013
61585 55836 51021 50737
60707 55407 59310 58984
80135 74268 75572 69935
116415 122366 120270 103809
197566 197232 182811 189655
362559 369048 315385 339864
6033 5910 6629 7619
43807 32208 38425 34816
35322 24731 33194 31016
19233 13411 19040 18994
12651 10326 14400 14199
11291 8220 12119 11290
12930 8674 11272 11490
11143 8832 11024 10765
14600 8538 11793 11845
14583 10604 14250 12400
19203 11738 12755 11674
15703 10939 12578 13215
24086 '1 5 6 3 5 19671 19697
27874 25146 29376 24267
50304 38447 36781 37241
49763 30952 45385 32404
148 250 308 265
1387 1561 1593 1837
2275 2953 2537 2316
3342 3706 3173 3079
2295 2889 2891 3155
1936 1806 2712 1557
2850 1834 2184 1730
2098 2482 2555 1734
1994 2439 2098 1682
2339 1414 1953 1541
1354 2201 1643 1197
1228 1690 1469 1360
2251 1675 1667 775
2551 3719 2419 2022
2840 2691 4370 3793
3160 6349 2308 4521
15047 9867 11634 12182
43540 46994 46506 45680
56531 57125 58284 57313
43600 46137 45839 45192
43913 45276 46696 45295
42382 39650 40683 40905
46087 44125 41235 43815
45445 47482 44312 45746
45414 45952 42403 44589
47007 45752 48291 47016
52257 53948 48717 51640
55328 54130 53632 54363
72585 74008 66053 70882
112367 107685 95178 105076
183686 179503 164864 176017
326573 317545 265625 303247
9534 6417 7883 7944
29617 30581 30834 30344
29544 29994 28744 29427
17154 18380 18769 18101
12513 14557 13451 13507
11204 9669 10982 10618
10852 9415 9787 10018
10722 11620 10380 10907
11633 11019 9589 10747
11210 10008 12433 11217
11396 13468 10153 11672
13637 13252 12672 13187
17513 22403 16686 18867
28253 27001 22849 26034
34145 34060 37708 35304
34266 36691 34856 35271
345 121 0 155
1181 948 1072 1067
2273 1455 2481 2069
2089 2078 1702 1956
2443 2317 2526 2428
2273 2323 2048 2214
1896 2448 1969 2104
2272 2582 1145 1999
1491 1799 1423 1571
1270 1957 1592 1606
1350 1462 1810 1540
1169 1400 1071 1213
1101 1672 1611 1461
1776 1917 1418 1703
1265 2455 2046 1922
4196 1334 3606 3045
12850
48337
55739
47228
43116
42416
43630
47554
44936
46905
47929
55227
71271
107601
184297
315828
7390
33219
31268
19560
13130
12298
10555
12139
11179
9945
11133
13985
17405
27147
39093
39387
662
1926
1894
1701
2839
2241
2487
1499
1555
1336
1807
1531
991
1974
2957
729
D
eath R
ates for England and W
ales (continued).
A
2 - 20
ACCIDENTAL FALLS (880-888)
987 810 1133 917 1005 571 478 533
1444 1597 1630 1366 1754 985 1010 882
2594 2214 2126 1917 2083 1944 1526 1557
2570 2154 1596 1635 1685 2331 1716 1853
2038 2806 2542 1845 1960 2946 2347 2528
2524 2358 2471 1777 2148 2844 2595 1789
3366 2983 2956 2627 2715 2070 2825 4400
3899 4162 4705 3375 3619 3440 3902 4018
5599 4713 5430 5644 5078 4795 4180 3883
6034 8046 6087 5939 5125 5644 6436 6157
8759 7491 8331 9280 6751 6964 8970 9620
11545 11377 12656 11393 10829 8699 12192 12000
25616 22730 22301 21978 21999 19315 21638 18525
48061 57156 46933 46230 46256 44819 45383 45789
114106 108628 125446 107032 101552 95466 98065 91600
292876 310044 262436 286321 271812 235637 240361 240065
SUICIDE l  SELF-INFLICTED INJURY (9 5 0 -9 5 9 )
260 152 49 96 144 48 287 291
3060 2339 2641 3389 3189 3213 3637 4116
9329 9025 8964 9470 8968 9662 10623 9396
9499 10286 9365 10334 10792 12599 12127 12740
9510 8954 11862 10309 10353 11102 11081 13340
10869 11931 11461 10800 11777 11654 12499 13386
12159 13319 11191 11713 11718 13273 13491 15294
14008 13895 15753 13500 16424 15446 16531 15355
13965 13300 15168 14078 13764 16301 14559 15389
15371 15637 15058 13112 16193 15719 14242 16816
15496 16779 16588 17503 18105 12978 16347 16503
18692 18962 17647 14131 16200 17135 16665 15591
19589 18263 20400 19756 18977 17656 20940 16810
18558 20784 18820 17504 20869 18914 19450 24308
22462 25928 21429 17691 22616 21360 20215 26171
12313 17467 18010 19541 15940 22481 16407 21898
890 1102 668 635
1483 3642 1265 1178
1246 3533 1864 1712
1994 2412 1469 1568
2402 2782 1871 2104
2258 2366 2078 2392
2920 3032 3170 2769
3256 3869 3139 4118
3703 4879 3979 4021
5710 5797 4774 5430
7783 6358 6965 7409
10001 9249 9916 10689
17558 16194 15670 15160
38076 36657 37843 30839
86410 84198 79388 80690
231438 225397 174615 220799
99 200 206 106
4017 4162 3655 3957
8993 9808 9528 9617
12138 14705 14691 12953
13505 14018 14287 15017
14840 14883 14658 15628
15850 15726 15147 16751
15051 16496 18981 16328
15597 18439 17942 18279
17197 18522 19458 18050
18611 17933 15807 18185
18423 16009 17077 18171
17558 17199 17559 16820
22226 21427 20563 21739
19473 23068 23307 25172
20537 23016 29231 19593
459 545 636 546
886 948 868 900
1752 1502 1358 1537
1155 1438 1392 1328
2026 1248 1762 1678
2869 1783 1764 2138
3269 2887 2606 2920
2343 4017 3078 3146
4176 3898 4270 4114
3587 4214 4928 4243
7197 6388 5903 6496
9059 7839 9281 8726
15200 13375 13809 14128
31644 29877 27734 29751
76510 70881 61093 69494
199301 186791 150240 178777
115 121 254 163
4280 4240 5258 4592
11979 12955 13014 12649
15065 13639 13458 14054
15492 15746 15800 15679
15426 14153 14851 14810
17389 16006 14421 15938
17965 16210 15320 16498
16257 16942 14609 15936
17487 15953 17436 16958
18668 16546 18180 17798
16852 17732 15795 16793
16962 17499 15880 16780
21472 19971 18122 19855
24976 29150 22216 25447
20280 22015 22837 21710
c
3
5'c
938
1155
1505
1701
1952
2186
2891
3213
2887
4527
6506
10208
15202
31589
78187
191831
55
4333
10633
13777
14254
15305
18017
18708
17619
18480
15253
15619
18506
21882
24967
19694
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T A B L E  A 2.2: Regional Adjustment Factors for the South West (SW) and South 
East (SE) Standard Regions, for the years 1979-83 and 1989.
Causes o f  Death
1979
15-64 65+
- 83*
SE
15-64 65+
1989*
SW SE 
All ages
1. All Causes 0.89 0.91 0.91 0.95 0.91 0.92
2. Infectious and Parasitic Diseases 0.88 0.82 1.05 0.99 0.83 1.09
3. Tuberculosis 0.63 0.70 1.03 1.02 0.62 1.12
4. All Neoplasms 0.87 0.91 0.92 1.01 0.91 0.94
5. Ca. Lip, Oral Cavity and Pharynx 0.90 0.88 0.84 0.84 0.77 0.86
6. Ca. Digestive Organs and Peritoneum 0.94 0.90
7. Ca. Oesophagus 0.97 0.90 0.88 0.95 1.06 0.88
8. C a . Stomach 0.80 0.87 0.88 0.91 0.88 0.87
=9. Ca. Peritoneum (mesothelioma)
*10. Ca. Respiratory System
11. Ca. Lung 0.78 0.83 0.89 1.04 0.79 0.93
*12. Ca. Pleura (mesothelioma)
«13. Ca. Bone, Tissue, Skin and Breast
14. Ca. Genito-urinary Orga n s 1.06 1.00
15. Ca. Prostate 0.94 1.11 1.03 1.05 1.15 1.00
.16. Ca. O t h e r  and Unspecified Sites
17. Ca. Lymphatic and Haematopoietic Tissue 0.96 0.99
1 18. Benign Neoplasms 0.75 0.88 0.85 0.96 0.83 1.01
«19. Unspecified Neoplasms
20. Endocrine and Nutritional Diseases 1.03 1.00 0.92 0.98 0.99 1.02
! 21 • Diseases o f  Blood and Blood-forming Organs 1.04 0.85 1.03 0.95 1.21 0.94
22. Diseases o f  the Nervous System 0.96 0.94 0.96 0.97 0.92 1.00
23. Diseases o f  the Circulatory System 0.89 0.95 0.87 0.92 0.94 0.88
I 2 4 - Hypertensive Disease 0.87 0.97 0.92 1.04 0.93 1.08
25. Ischaemic Heart Disease 0.90 0.94 0.87 0.93 0.92 0.85 !
26. Diseases of Pulmonary Circulation • 0.98 1.04
27. Cerebrovascular Disease 0.84 0.96 0.81 0.86 0.98 0.86
' 28. Diseases o f  the Respiratory System 0.77 0.80 0.89 0.95 0.78 0.93
.29. Acute Respiratory Infections
=30. Other Disease of Up p e r  Respiratory Tract
=31. Pneumonia and Influenza
32. Bronchitis, Emphysema and Asthma 0.70 0.70 0 . 8 5 0.92 0.77 0.91
33. C h ronic Obstructive Pulmonary Disease 0.75 0.92
34. Pneumocon i os i s 0.50 0.59 0.67 0.31
=35. Coal workers Pneumoconiosis
.36, Asbestos is
-37. S i 1 i cos i s
=38. Other Diseases of the Respiratory System
=39. Pulmonary Fibrosis
40. Diseases o f  the Digestive System 0.86 0.92 0 . 9 3 0.95 0.91 0.98
=41. Diseases of Oesophagus and Stomach
42. Diseases o f  the Genito-urinary System 0.82 0.92 0 . 9 8 0.99 0.98 0.98
43. Diseases o f  the Skin and Subcutaneous Tissue 1.43 0.93 0.96 1.03 0.76 1.10
44. Diseases o f  the Musculosketelal System 0.88 0.95 0.84 1.01 1.01 0.88
45. Symptoms, Signs and Ill-defined Conditions 0.59 1.06 1.48 0.95 1.18 1.05
46. Accidents, Poisonings and Violence 1.02 0.80 0.99 0.89 0.98 0.96
-47. Transport Accidents
=48. Accidental Poisoning
=49. Accidental Falls
-50. Suicide and Self-inflicted Injury
* Taken from the O P C S  1981 decennial supplement microfiche.
iH Taken from the O P C S  1989 area mortality statistics microfiche.
= N o  adjustment factor possible.
A2 - 21
APPENDIX 3.
A3 - 1
T A B L E  A 3 .1 : Devonport Dockyard, non-responders. Cause specific mortality for
50 disease groups, with and without regional adjustment.
Causes of Death Without regional adjustment 
Obs Exp SMR 95X Cl
W i t h  regional adj. 
SMR 95% Cl
All Causes 294 209.1 141 125-157 156 138-173
Infectious and Parasitic Diseases 3 0.9 333 69-974 394 81-1151
I Tuberculosis 1 0.4 242 6-1350 363 9-2022
All Neoplasms 75 58. 3 129 100-158 143 111-176
Ca. Lip, Oral Cavi t y  and Pharynx 2 0.8 262 32-945 295 36-1064
Ca. Digestive Organs and Peritoneum 21 17.1 123 76-188 131 81-200
Ca. Oesophagus 1 1.9 53 1-297 58 1-322
Ca. Stomach 7 5.4 129 52-266 152 61-313
I Ca. Peritoneum (mesothelioma) 1 0.1 1076 27-5993
Ca. Respiratory System 33 24.2 136 90-183
Ca. Lung 27 23.4 116 76-168 142 94 207
Ca. Pleura (mesothelioma) 6 0.2 2917 1070-6349
Ca. Bone, Tissue, Skin and Breast 2 0.8 250 30-902
Ca. Gen1to-urinary Organs 8 7.4 109 47-214 102 44-202
Ca. Prostate 3 3.8 79 16-230 72 15-211
Ca. Other and Unspecified Sites 6 4.2 141 52-308
Ca. Lymphatic and Haematopoietic Tissue 2 3.3 60 7-218 63 8-227
Benign Neoplasms 0 0.2 - 0-2445 - 0-2982
Unspecified Neoplasms 1 0.4 251 6-1399
Endocrine and Nutritional Diseases 3 2.2 135 28-394 134 28-391
Diseases of Blood and Blood-forming Organs 1 0.4 230 6-1283 258 6-1437
Diseases of the N ervous System 4 2.7 150 41-385 159 43-407
Diseases of the Circulatory System 163 104.8 156 132-179 167 141-192
Hypertensive Disease 1 2.1 49 1-271 52 1-289
Ischaemic Heart Disease 113 70.8 160 130-189 172 140-204
Diseases of Pulmonary Circulation 5 1.1 472 153-1100 481 156-1123
Cer e b r o v a s c u 1ar Disease 23 18.4 125 79-187 134 85-200
Diseases of the Respiratory System 32 23.7 135 88-182 170 111-229
Ac u t e  Respiratory Infections 2 0.2 840 102-3032
Other Disease of Upper Respiratory Tract 0 0.0 - 0-14688
Pneumonia and Influenza 10 8.1 124 59-228
Bronchitis, Emphysema and Asthma 8 10.0 80 35-158 115 50-226
Chronic O b structive Pulmonary Disease 14 13.9 100 55-169 134 73-225
Pneumocon i os i s 0 0.3 - 0-1105 _ 0-1934
Coalworkers Pneumoconiosis 0 0.2 - 0-1987
Asbestosis 0 0.0 - 0-12936
Si 1icosis 0 0.0 - 0-12908
Ot h e r  Diseases of the Respiratory System 1 1.0 104 3-580
Pulmonary Fibrosis 1 0.3 404 10-2248
Diseases of the Digestive System 6 5.0 119 44-260 133 49-289
Diseases of Oesophagus and Stomach 2 1.8 111 13-402
Diseases of the Genito-urinary System 3 2.3 133 27-390 149 31-435
Diseases of the Skin and Subcutaneous Tissue 0 0.1 - 0-4345 - 0-4163
Diseases of the Musculosketelal System 1 0.6 168 4-937 180 5-1005
Symptoms, Signs and 111-defined Conditions 0 0.2 - 0-2105 - 0-2430
Accidents, Poisonings and Violence 2 6.4 31 4-113 33 4-119
Transport Accidents 1 2.0 50 1-277
Accidental Poisoning 0 0.2 - 0-1567
Accidental Falls 0 0.8 - 0-466
Suicide and Self-inflicted Injury 0 1.8
'
0-210
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T A B L E  A 3.2: Chatham Dockyard, non-responders. Cause specific mortality for
50 disease groups, with and without regional adjustment.
Causes of Death Without regional adjustment 
Obs E xp SMR 95% Cl
W ith regional adj. 
SMR 95% Cl
All Causes 320 253.4 126 112-140 135 120-149
Infectious and Parasitic Diseases 2 1.1 187 23-674 184 22-663
Tuberculosis 2 0.5 417 50-1505 407 49-1469
All Neoplasms 91 71.1 128 102-154 130 104-157
Ca. Lip, Oral Cavity and Pharynx 0 0.9 - 0-396 - 0-471
Ca. Digestive Organs and Peritoneum 27 20.7 130 86-189 145 95-210
Ca. O e sophagus 2 2.3 86 10-311 93 11-336
Ca. S t o m a c h 12 6.5 183 95-320 204 105-356
Ca. P e r i t o n e u m  (mesothelioma) 0 0.1 - 0-3363
Ca. R e s p i r a t o r y  System 38 29.5 129 88-170
Ca. Lung 34 28.5 119 79-160 121 78-161
Ca. P l e u r a  (mesothelioma) 4 0.3 1558 425-3989
Ca. Bone, Tissue, Skin and Breast 0 1.0 - 0-382
Ca. Gen1to-uri nary Organs 8 9.0 88 38-174 88 38-174
Ca. P r o s t a t e 5 4.7 106 34-247 101 33-236
Ca. Other and Unspecified Sites 10 5.2 191 91-352
Ca. Lymphatic and Haematopoietic Tissue 8 4.0 199 86-392 201 87-396
Benign Ne o p l a s m s 0 0.2 - 0-2036 - 0-2238
Unspecified Neoplasms 0 0.5 “ 0-759
Endocrine and Nutritional Diseases 3 2.7 110 23-322 114 24-334
Diseases of Blood and Blood-forming Organs 0 0.5 - 0-693 - 0-716
Diseases of the N e r v o u s  System 6 3.3 184 68-401 191 70-415
Diseases of the Ci r c u l a t o r y  System 163 127.1 128 109-148 142 120-163
Hypertensive Disease 2 2.4 82 10-296 82 10-296
Ischaemic H e a r t  Disease 107 86. 1 124 101-438 136 111-162
Diseases of P u l m onary Circulation 1 1.3 79 2-438 76 192-422
Cerebrovascular Disease 29 22.2 130 87-187 154 103-221
Diseases of the R e spiratory System 39 28.4 138 94-181 147 101-193
Acute Re s p i r a t o r y  Infections 1 0 .3 356 9-1981
Other Disease o f  Upper Respiratory Tract 0 0.0 - 0-7344
Pneumonia and Influenza 12 9.5 126 65-221
Bronchitis, E m p h ysema and Asthma 13 11.8 111 59-189 123 65-210
Chronic Ob s t r u c t i v e  Pulmonary Disease 16 16.9 95 54-154 103 59-167
Pneumocon i os i s 0 0.4 - 0-923 - 0-2383
Coal w o r k e r s  Pneumoconiosis 0 0.2 - 0-1672
Asbestosis 0 0.0 - 0-10385
S 1 11cosis 0 0.0 - 0-10994
Other Diseases o f  the Respiratory System 1 1.2 84 2-470
Pulmonary Fibrosis 1 0 .3 333 8-1856
Diseases of the Di g e s t i v e  System 6 6.1 99 36-214 104 38-227
Diseases of O e s o p h a g u s  and Stomach 1 2.2 46 1-257
Diseases of the Genito-urinary System 4 2.7 149 40-380 150 41-385
Diseases of the S k i n  and Subcutaneous Tissue 0 0.1 - 0-3581 - 0-3533
Diseases of the Musculosketelal System 0 0.7 - 0-501 - 0-517
Symptoms, Signs a nd Ill-defined Conditions 0 0.2 - 0-1722 - 0-1487
Accidents, Pois o n i n g s  and Violence 3 7.5 40 8-116 42 9-122
Transport Ac c i d e n t s 0 2.4 - 0-156
Accidental Poisoning 0 0.3 - 0-1347
Accidental F a l l s 0 0.9 - 0-391
Suicide and Self-inflicted Injury 1 2.1 49 1-272
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T A B L E  A 3.3 Portsmouth Dockyard, non-responders. Cause specific mortality
for 50 disease groups, with and without regional adjustment.
Causes of Death Without regional adjustment 
O bs Exp SMR 95X Cl
With regional adj. 
SMR 9 5 %  Cl
All Causes 532 498.0 107 98-116 114 104-124
Infectious and Parasitic Diseases 2 2.1 95 11-343 93 11-337
Tuberculosis 1 0.9 112 3-625 109 3-609
All Neoplasms 173 141.4 122 104-141 125 106-144
! Ca. Lip, Oral Cavity and Pharynx 2 1.9 105 13-379 125 1 5-452
Ca. Digestive Organs and Peritoneum 45 41.2 109 77-141 121 86-157
Ca. Oesophagus 6 4.7 127 46-276 137 50-298
Ca. Stomach 17 12.7 134 78-214 149 86-238
Ca. Peritoneum (mesothelioma) 1 0.2 457 12-2544
Ca. Respiratory System 86 58.0 148 117-179
Ca. Lung 77 56.0 138 107-168 139 106-169
| Ca. Pleura (mesothelioma) 5 0.6 907 294-2117
Ca. Bone, Tissue, Skin and Breast 4 2.0 203 55-521
Ca. Genito-urinary Organs 11 18.0 61 31-110 61 31-110
C a . Prostate 4 9.4 43 12-109 41 11-104
I Ca. Other and Unspecified Sites 17 10.8 158 92-252
Ca. Lymphatic and Haematopoietic Tissue 7 8.1 86 35-177 87 35-179
Benign Neoplasms 0 0.4 - 0-1025 - 0-1129
Unspecified Neoplasms 1 1.0 101 3-560
E n d o crine and Nutritional Diseases 4 5.5 73 20-186 75 21-1 9 3
D iseases of Blood and Blood-forming Orga n s 2 1.1 188 23-677 194 23-699
Diseases of the Nervous System 13 6.6 196 104-336 203 108-347
Diseases of the Circulatory System 240 249.9 96 84-108 106 93-1 2 0
Hypertensive Disease 4 4.6 87 24-222 87 2 4 - 2 2 3
Ischaemic Heart Disease 170 171.2 99 84-114 109 93-1 2 6
Diseases of Pulmonary Circulation 1 2.4 41 2-230 40 1-221
Cerebrovascular Disease 26 42.9 61 40-89 71 4 7 - 1 0 5
Diseases of the Respiratory System 63 53.2 118 89-148 127 9 5 - 1 5 8
Acu t e  Respiratory Infections 0 0.5 - 0-706
Ot h e r  Disease of Upper Respiratory Tract 0 0.0 - 0-7494
Pneumonia and Influenza 8 16.9 47 20-100
Bronchitis, Emphysema and Asthma 19 21.5 88 53-138 98 59-153
C h ronic Obstructive Pulmonary Disease 36 32.5 111 75-147 120 8 1 - 1 6 0
Pneumoconi os i s 0 0.8 - 0-488 - 0-1249
Coalworkers Pneumoconiosis 0 0.4 - 0-904
Asbestosis 0 0.1 - 0-5003
Si 1icosis 0 0.1 - 0-6009
O t h e r  Diseases of the Respiratory S y stem 6 2.3 257 94-559
Pulmonary Fibrosis 1 0.6 172 4-956
Diseases of the Digestive System 13 12.2 107 57-182 113 6 0 - 1 9 4
Diseases of Oesophagus and Stomach 3 4.2 71 15-208
Diseases of the Genito-urinary System 6 5.1 117 43-255 119 4 3 - 2 5 8
Diseases of the Skin and Subcutaneous Tissue 0 0.2 - 0-1798 - 0-1776
Diseases o f  the Musculosketelal System 0 1.5 - 0-250 - 0 - 2 5 8
Symptoms, Signs and Ill-defined Conditions 1 0.4 236 6-1316 200 5-1112
Accidents, Poisonings and Violence 10 14.9 67 32-124 70 34-1 2 9
Transport Accidents 1 4.4 23 1-126
Accidental Poisoning 1 0.5 187 5-1041
Acc i d e n t a 1 Falls 2 1.9 108 13-389
S u icide and Self-inflicted Injury 2 4.2 48 6-172
A3 - 4
T A B L E  A3.4 Devonport Dockyard. Cause specific mortality for 12 disease
groups by calendar year period, for study responders and non­
responders.
All Causes All Neoplasms
Non- responders Non- responders
Year Obs SMR 95X CI Obs SMR 95% CI Obs SMR 95% CI Obs SMR 95% CI
1972 50 73 53- 93 29 420 281-603 13 71 38-121 11 582 290-1041
1973 70 79 61- 98 15 173 97-285 20 84 51-130 3 126 26-367
1974 93 98 78-118 10 108 52-198 33 127 84-171 4 155 42-396
1975 122 122 100-144 17 178 103-284 44 160 113-208 4 150 41-384
1976 104 96 78-114 15 151 85-250 37 122 83-162 4 144 39-368
1977 125 in 92-131 20 198 121-306 34 107 71-143 7 247 99-508
1978 134 109 91-128 11 101 51-181 40 117 80-153 0 _ 0-123
1979 104 79 64- 94 16 141 81-229 33 90 59-121 3 97 20-285
1980 142 104 87-121 14 122 66-204 44 113 80-146 5 156 51-364
1981 142 100 84-117 20 177 108-273 47 115 82-148 2 63 8-228
1982 142 95 79-110 13 m 59-190 52 121 88-154 3 93 19-273
1983 137 86 72-101 26 213 139-312 59 128 96-161 5 148 48-346
1984 139 84 70- 98 36 300 202-397 46 93 66-120 6 175 64-382 I
1985 170 96 81-110 13 104 55-178 64 124 93-154 4 116 32-296
1986 183 99 85-114 16 128 73-208 63 117 88-146 7 202 81-416
1987 195 104 89-119 10 80 39-148 66 118 90-147 2 57 7-208
1988 203 99 85-113 10 72 35-133 82 140 110-170 4 109 30-278
1989 34 100 66-134 3 132 27-385 12 125 64-218 1 167 4-932
Total 2289 97 93-101 294 156 138-173 789 117 109-125 75 143 111-176
Ca. Stomach Ca. P e r 1toneum
Non-responders Non- responders
Year Obs SMR 95% CI Obs SMR 95% CI Obs SMR 95% CI Obs SMR 95% CI
1972 1 59 1-329 0 _ 0-1949 0 _ 0-5185 0 _ 0-58373
1973 3 133 27-390 1 418 11-2327 1 1205 30-6710 1 14485 366-80684
1974 3 123 25-361 1 382 10-2126 0 - 0-4280 0 - 0-54056
1975 8 314 135-618 1 379 10-2114 1 1288 33-7174 0 - 0-65498
1976 5 182 59-425 1 371 9-2067 1 1579 40-8793 0 - 0-83970
1977 1 36 1-201 0 - 0-1411 1 1176 30-6551 0 - 0-55194
1978 2 65 8-236 0 - 0-1306 0 - 0-3810 0 - 0-52199
1979 5 157 51-368 0 - 0-1297 0 - 0-4944 0 - 0-67254
1980 5 149 48-349 1 344 9-1917 1 1095 28-6101 0 - 0-59993
1981 9 258 118-489 0 - 0-1302 0 - 0-5503 0 - 0-82675
1982 4 118 32-302 0 - 0-1383 0 - 0-5616 0 - 0-79844
1983 3 78 16-228 0 - 0-1267 0 - 0-4240 0 - 0-70300
1984 6 152 56-330 0 - 0-1296 1 1267 32-7055 0 - 0-76809
1985 5 128 42-300 0 - 0-1364 0 - 0-4032 0 - 0-70336
1986 8 193 83-380 0 - 0-1349 0 - 0-4819 0 - 0-90135
1987 3 73 15-215 0 - 0-1408 3 3992 824-11670 0 - 0-97163
1988 7 157 63-324 2 698 84-2521 1 1200 30-6686 0 - 0-82656
1989 3 410 84-1197 0 0-7929 0 - 0-27366 0 - 0-509200
Total 81 145 113-176 7 461 61-313 10 731 351-1344 1 1076 27-5993
Ca. Lunq Ca. Pleura
Non- responders Non- responders
Year Obs SMR 95% CI Obs SMR 95% CI Obs SMR 95% CI Obs SMR 95% CI
1972 4 56 15-143 5 647 210-1511 1 1508 38-8399 2 37734 4566-136219
1973 7 76 30-156 0 - 0-381 1 1013 26-5640 0 - 0-45523
1974 13 128 68-218 2 192 23-693 4 4416 1203-11305 1 14043 355-78221
1975 10 94 45-173 1 94 2-526 3 2434 502-7116 0 - 0-36460
1976 15 129 72-213 1 91 2-509 2 1399 169-5050 1 9208 233-51287
1977 14 114 62-191 3 268 55-783 3 2137 441-6248 1 9413 238-52432
1978 13 100 53-171 0 - 0-320 6 3831 1405-8339 0 - 0-32640
1979 6 43 16- 94 2 171 21-617 2 1520 184-5489 0 - 0-39020
1980 14 96 52-161 2 165 20-595 3 1719 355-5026 1 8558 217-47668
1981 11 74 37-132 1 86 2-480 3 1652 341-4828 0 - 0-31705
1982 21 136 84-207 1 87 2-482 9 5351 2450-10155 0 - 0-34540
1983 16 96 55-156 3 249 51-727 5 2002 649-4673 0 - 0-26185
1984 9 53 24-100 2 172 21-620 5 1869 606-4362 0 - 0-24799
1985 20 113 69-175 1 86 2-482 2 687 83-2480 0 - 0-24017
1986 19 106 64-166 3 266 55-777 10 3028 1453-5569 0 - 0-20390
1987 20 111 68-171 0 - 0-336 5 1483 480-3461 0 - 0-21562
1988 25 130 84-192 0 - 0-317 2 6 1 5 74-2220 0 - 0-22243
| 1989 4 127 35-326 0 - 0-1965 0 - 0-7024 0 - 0-138567
Total 241 99 87-112 27 142 94-207 66 1983 1505-2461 6 2917 1070-6349
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T A B L E  A 3 .4  (coni.) Devonport Dockyard. Cause specific mortality for 12
disease groups by calendar year period, for study
responders and non-responders.
C i rculatory System Pulmonary Circulation
Non- responders Non- responders
Year Obs SMR 95* CI Obs SMR 95* CI Obs SMR 95* Cl Obs SMR 95* Cl
1972 29 87 59-126 15 437 245-721 1 321 8-1788 1 3021 76-16827
1973 41 96 66-125 10 230 110-422 1 247 6-1376 0 - 0-8720
1974 50 107 77-136 5 106 34-246 3 644 133-1883 1 2094 53-11662
1975 60 119 89-150 9 182 83-346 1 208 5-1161 0 - 0-7390
1976 57 106 78-133 6 119 43-258 3 547 113-1600 0 . 0-7230
1977 71 124 95-153 10 189 91-348 2 362 44-1307 1 1912 48-10648
1978 72 114 87-140 10 174 84-321 3 523 108-1528 0 - 0-6931
1979 54 79 58-100 10 168 80-308 4 394 107-1008 0 - 0-4024
1980 78 n o 86-135 4 66 18-169 3 295 61-861 0 - 0-4004
1981 74 101 78-123 13 218 116-373 2 179 22-646 1 1038 26-5781
1982 72 94 72-115 3 49 10-144 3 265 55-775 0 - 0-4074
1983 66 80 61-100 18 284 168-449 2 172 21-621 0 - 0-8126
1984 62 72 54- 90 26 415 271-608 0 - 0-655 1 1065 27-5933
1985 83 91 71-111 8 124 53-244 0 - 0-600 0 - 0-7908
1986 91 97 77-117 6 94 34-204 0 - 0-589 0 - 0-8078
1987 88 92 73-111 5 78 25-183 0 - 0-580 0 - 0-8032
1988 92 87 70-105 4 56 15-144 0 - 0-511 0 - 0-7042
1989 12 69 36-120 1 85 2-476 0 - 0-3066 0 - 0-42608
| Total 1152 95 90-101 163 167 141-192 28 232 154-335 5 481 156-1123
Respiratory System Bronchitis , Emphysema and Asthma
Non- responders Non- responders
j Year Obs SMR 95Z CI Obs SMR 95* CI Obs SMR 95* Cl Obs SMR 95* Cl
1972 7 119 48-246 2 293 35-1057 2 65 8-234 1 272 7-1514
1973 7 94 38-194 2 237 29-856 2 53 6-190 0 - 0-848
1974 10 131 63-241 0 - 0-424 2 51 6-183 0 - 0-812
1975 16 194 111-314 3 328 68-959 1 24 1-134 1 216 5-1204
1976 7 73 29-150 4 396 108-1013 1 23 1-130 0 - 0-816
1977 13 142 76-243 3 309 64-904 0 - 0-89 1 231 6-1287
1978 19 182 110-284 1 91 2-506 4 86 24-221 1 211 5-1173
1979 6 53 19-115 1 85 2-473 2 41 5-149 1 206 5-1145
1980 12 102 53-178 3 256 53-749 1 22 1-121 1 224 6-1247
1981 10 82 40-152 3 263 54-770 5 112 36-262 0 - 0-915
1982 7 50 20-103 4 307 83-785 2 43 5-156 0 - 0-901
1983 7 47 19- 96 1 73 2-404 1 2 2 1-120 0 - 0-937
1984 12 96 50-168 1 95 2-529 5 112 36-261 1 276 7-1539
1985 10 68 32-124 1 84 2-469 5 103 33-241 0 - 0-995
1986 14 91 50-153 1 85 2-471 5 113 37-263 1 311 8-1733
1987 20 133 81-205 1 87 2-487 5 129 42-301 0 - 0-1356
1988 12 67 34-116 1 71 2-396 2 39 5-142 0 - 0-1001
1989 3 99 20-289 0 - 0-1564 0 * 0-435 0 - 0-6042
| Total 192 95 82-109 32 170 111-230 4 5 60 43- 78 8 115 49-226
Asbestosis Pulmonary F 1bros i s
Non- responders Non- responders
i Year Obs SMR 95* CI Obs SMR 9 5* CI Obs SMR 95 *  Cl Obs SMR 95* Cl
1972 0 _ 0-34323 0 _ 0-522308 0 _ 0-3620 0 _ 0-36482
1973 0 - 0-32413 0 - 0-395299 0 - 0-2941 0 - 0-26693
1974 0 - 0-38685 0 - 0-361651 0 - 0-2693 0 - 0-27241
1975 0 _ 0-17974 0 . 0-210879 0 - 0-2431 0 - 0-23598
1976 0 _ 0-30429 0 - 0-379734 0 - 0-1975 0 - 0-22300
1977 0 - 0-17531 0 - 0-198398 0 - 0-2379 0 - 0-25635
1978 0 - 0-15896 0 - 0-205032 0 - 0-1804 0 - 0-19347
1979 0 - 0-20148 0 - 0-279759 0 - 0-3120 0 - 0-37204
1980 0 _ 0-16493 0 - 0-198595 1 787 20-4382 0 - 0-33422
1981 1 4219 107-23498 0 - 0-230643 0 - 0-3065 0 - 0-34085
1982 0 _ 0-13175 0 - 0-181210 0 - 0-2636 0 - 0-34179
1983 2 6947 841-25080 0 - 0-182846 0 - 0-2636 1 8962 227-49919
1984 3 10290 2123-30081 0 - 0-200623 1 539 13-2932 0 - 0-25085
1985 0 - 0-13373 0 - 0-186207 0 - 0-1604 0 - 0-21378
1986 0 - 0-8982 0 - 0-162488 0 - 0-1476 0 - 0-21011
1987 1 2746 69-15293 0 - 0-175534 0 - 0-1419 0 - 0-19766
1988 0 _ 0 9864 0 - 0-173902 0 - 0-1318 0 - 0-18882
1989 0 - 0-60669 0 - 0-999999 0 - 0-7380 0 - 0-115531
Total 7 1718 690-3539 0 - 0-12936 2 68 8-245 1 404 10-2248
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T A B L E  A3.5: Chatham D ockyard. Cause specific mortality for 12 disease groups
by calendar year period, for study responders and non-responders.
All Causes All Neoplasms
Non- r e s ponders Non- responders
j Year Obs SMR 95* Cl Obs S M R 95X Cl Obs SMR 9 5 *  Cl Obs SMR 95* Cl
1972 2 15 2- 56 10 3 0 3 145-557 0 _ 0-102 4 427 116-1093
1973 22 53 33- 80 13 124 66-212 7 59 24-123 3 100 21-291
1974 33 73 48- 97 6 5 3 19-116 14 107 59-180 0 - 0-112
1975 50 103 75-132 15 127 71-210 22 158 99-239 4 117 32-299
1976 47 90 64-115 23 1 85 117-278 16 104 60-170 7 191 77-394
1977 67 124 94-153 15 119 67-197 27 168 110-244 5 133 43-312
1978 61 104 78-130 23 170 108-255 20 116 71-179 7 178 71-366
1979 67 106 81-132 24 174 112-259 25 135 88-200 10 251 120-461
1980 68 104 80-129 13 9 4 50-161 22 113 71-171 5 122 39-285
1981 66 98 74-122 12 8 4 43-146 22 108 68-164 3 70 14-205
1982 64 90 68-113 24 162 103-240 21 99 61-151 6 137 50-299
1983 63 84 64-105 27 174 115-253 19 84 50-131 5 109 35-255
1984 64 82 62-102 32 2 1 0 137-282 26 107 70-157 12 258 133-451
1985 71 85 65-105 17 108 63-173 24 95 61-141 7 150 60-310
1986 99 117 94-140 21 134 83-206 28 109 72-157 8 173 74-340
i 1987 82 96 76-117 22 142 89-215 23 87 55-131 4 86 23-221
1988 75 82 63-100 15 91 51-149 26 95 62-139 0 - 0-79
1989 44 67 48- 87 8 71 31-140 23 120 76-180 1 32 1-176
Total 1045 91 86- 97 320 135 120-149 365 107 96-118 91 130 104-157
Ca. Stomach Ca. Peritoneum
Non- r e s ponders Non- responders
Year Obs SMR 95* Cl Obs SMR 95* Cl Obs SMR 9 5 *  Cl Obs SMR 95* Cl
1972 0 _ 0-1045 0 _ 0-3862 0 _ 0-29237 0 _ 0-128012
1973 1 87 2-484 0 - 0-1224 0 - 0-10013 0 - 0-45574
1974 1 79 2-442 0 - 0-1125 0 - 0-9960 0 - 0-44684
1975 7 529 212-1090 0 - 0-1109 0 - 0-10692 0 - 0-54461
1976 1 71 2-394 0 - 0-1064 0 - 0-13457 0 - 0-67211
1977 2 141 17-507 2 594 72-2146 0 - 0-9629 0 - 0-45964
i 1978 1 65 2-362 1 278 7-1549 0 - 0-8732 0 - 0-43180
1979 4 251 68-642 0 - 0-1044 0 - 0-11031 0 - 0-56375
i 1980 3 181 37-529 0 - 0-1034 0 - 0-9217 0 - 0-49311
1981 0 - 0-214 0 - 0-1002 0 - 0-12871 0 - 0-69246
1982 2 121 15-435 3 860 177-2514 0 - 0-12835 0 - 0-66820
1 1983 1 54 1-300 0 _ 0-974 0 - 0-9957 0 - 0-58470
1984 2 105 13-379 4 1081 294-2766 2 6007 727-21685 0 - 0-64969
1985 0 - 0-198 2 574 69-2074 0 - 0-9328 0 - 0-57903
1986 3 155 32-454 0 - 0-1053 0 - 0-11819 0 - 0-74910
1987 1 53 1-297 0 - 0-1104 0 - 0-12059 0 - 0-77482
1988 3 149 31-435 0 - 0-1060 0 - 0-10762 0 - 0-70428
1989 2 142 17-511 0 - 0-1572 0 - 0-15807 0 - 0-106081
T o t a l 34 122 81-162 12 204 105-356 2 338 41-1222 0 - 0-3363
Ca. Lunq Ca. P l e u r a
Non-responders Non- responders
Year Obs SMR 95* Cl Obs SMR 95* Cl Obs SMR 9 5* Cl Obs SMR 95* Cl
1972 0 _ 0-237 1 240 6-1335 0 _ 0-31267 1 39232 993-218519
1973 2 40 5-143 2 150 18-540 0 - 0-8232 0 - 0-37732
1974 8 142 61-279 0 - 0-252 1 2434 62-13560 0 - 0-42352
1975 8 134 58-264 3 199 41-583 1 1773 45-9877 0 - 0-29624
1976 8 123 53-241 4 250 68-640 0 - 0-5783 0 - 0-27892
i 1977 11 159 79-284 1 61 1-338 0 - 0 - 5818 0 - 0-28192
1978 6 82 30-179 4 236 64-604 3 4283 884-12522 0 - 0-26542
1979 6 77 28-168 3 176 36-516 3 5119 1056-14966 1 8739 221-48676
1980 4 49 13-126 1 57 1-320 1 1337 34-7445 1 7169 181-39933
1981 7 85 34-174 2 114 14-410 3 3821 788-11169 0 - 0-25292
1982 7 82 33-168 3 169 35-493 3 4138 854-12096 0 - 0-27857
1983 7 7 7 31-158 2 108 13-391 1 955 24-5320 0 - 0-21005
j 1984 8 85 37-168 2 112 14-404 1 889 22-4950 0 - 0-19805
1985 9 94 43-178 2 114 14-411 3 2491 514-7281 0 - 0-19513
1986 6 63 23-137 2 117 14-424 3 2190 452-6402 1 4574 116-25476
1987 4 42 11-107 1 60 2-335 0 - 0-2717 0 - 0-17883
1988 6 60 22-130 0 - 0-220 1 764 19-4258 0 - 0-19052
1989 9 130 59-246 1 89 2-496 0 - 0-2437 0 - 0-28815
T o t a l 116 85 70-101 34 121 80-161 24 1638 1050-2437 4 1558 425-3989
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T A B L E  A 3 .5  (cont.) Chatham Dockyard. Cause specific mortality for 12 disease
groups by calendar year period, for study responders and
non-responders.
Circul a t o r y  System Pulmonary Circulation
Non--responders Non- responders
Year Obs SMR 9 5 X  Cl Obs SMR 95X Cl Obs SMR 95X Cl Obs SMR 9SX Cl
1972 2 33 4-121 4 257 70-657 0 _ 0-5979 0 _ 0-22685
1973 14 72 39-121 6 121 44-263 0 - 0-1855 0 - 0-7057
1974 13 61 32-104 4 74 20-189 0 - 0-1562 0 - 0-6099
1975 22 95 60-144 8 140 60-276 0 - 0-1515 0 - 0-5937
1976 21 85 52-130 13 218 116-373 1 362 9-2016 0 - 0-5562
! 1977 34 130 86-174 10 163 78-299 0 - 0-1326 0 - 0-5537
1978 32 112 73-151 8 120 52-236 0 _ 0-1291 0 _ 0-5427
1979 36 117 79-155 9 133 61-252 0 - 0-725 0 - 0-3232
1980 38 120 8 2 -158 7 103 42-213 0 _ 0-730 0 - 0-3310
i 1981 34 103 6 9 -138 9 128 58-242 1 180 5-1002 0 - 0-2982
! 1982 28 82 54-118 14 194 106-326 0 - 0-667 0 - 0-3125
1983 28 77 51-112 17 226 131-362 1 177 4-985 0 - 0-3034
1984 27 71 47-104 10 134 65-247 0 - 0-1332 0 - 0-6392
1985 27 67 44- 98 6 79 29-172 1 332 8-1851 0 - 0-6217
1986 48 119 85-1 5 2 10 134 64-246 0 - 0-1225 0 - 0-6358
1987 39 96 66-127 13 176 94-300 0 - 0-1221 1 1721 44-9584
; 1988 33 75 49-101 10 126 61-232 0 - 0-1098 0 - 0-5834
1989 11 35 18- 63 5 93 30-216 0 - 0-1527 0 - 0-8505
Total 487 89 8 1- 97 .163 142 120-163 4 66 18-170 1 76 2-422
Respiratory Syst e m Bronchitis, Emphysema an d  Asthma
Non- responders Non- responders
Year Obs SMR 95 X  Cl Obs SMR 95X Cl Obs SMR 95X Cl Obs SMR 95X Cl
1972 0 _ 0- 2 8 5 1 270 7-1502 • 0 _ 0-507 1 471 12-2622
1973 1 25 1-137 3 262 54-767 1 45 1-251 0 - 0-583
1974 6 140 51-305 2 168 20-605 2 84 10-304 0 - 0-550
1975 5 106 34-248 2 158 19-570 2 78 9-283 2 288 35-1041
1976 9 164 75-311 2 140 17-504 2 76 9-273 0 - 0-530
1977 6 115 42-2 5 0 0 - 0-273 2 78 9-282 0 - 0-558
1978 6 103 38-223 7 458 184-943 3 106 22-311 0 - 0-508
1979 3 46 10-135 4 253 69-648 1 33 1-186 2 277 33-1000
1980 3 45 9-131 0 - 0-238 2 71 9-255 0 - 0-564
1981 4 58 16-148 0 - 0-229 0 - 0-135 0 - 0-585
1982 3 38 8-111 3 163 34-476 0 - 0-130 0 - 0-574
1983 9 108 49-204 2 101 12-366 3 108 22-314 2 320 39-1155
1984 4 57 16-146 4 266 72-680 1 37 1-205 2 350 42-1262
1985 9 108 50-206 1 59 1-330 3 103 21-300 1 171 4-955
1986 12 142 73-248 1 60 1-333 4 153 42-392 0 - 0-732
1987 11 136 68-244 1 62 2-346 4 178 49-457 1 235 6-1309
1988 10 105 51-194 4 209 57-535 4 138 37-352 1 181 5-1008
! 1989 6 86 32-188 2 151 18-544 1 48 1-266 1 264 7-1469
Total 107 93 75-110 39 147 101-193 35 77 51-102 13 123 65-210
Asbestosis Pulmonary F 1bros i s
Non- responders N on-responders
Year Obs SMR 9 5X Cl Obs SMR 95X Cl Obs SMR 95X Cl Obs SMR 95X Cl
1972 0 _ 0-199408 0 _ 0-999999 0 _ 0-19432 0 _ 0-76421
1973 0 - 0 -69098 0 _ 0-311802 0 - 0-6223 0 - 0-22967
I 1974 0 - 0 -78456 0 - 0-299069 0 - 0-5730 0 - 0-22891
1975 0 - 0-38476 0 - 0-170507 0 - 0-5041 0 - 0-19844
1976 0 - 0-65351 0 - 0-296432 0 - 0-4242 0 - 0-18206
1977 0 - 0 -37440 0 - 0-165875 0 - 0-5088 0 - 0-21607
1978 0 - 0-34629 0 - 0-167570 0 - 0-3864 0 - 0-16247
1979 0 - 0-43049 0 - 0-217374 0 - 0-6761 0 - 0-31634
1980 0 - 0-37227 0 _ 0-177923 0 - 0-6241 0 - 0-28995
1981 0 - 0-35522 0 - 0-181720 0 - 0-6471 0 - 0-28296
1982 0 - 0-30272 0 . 0-150944 0 - 0-5731 1 7431 188-41389
1983 0 - 0-29111 0 _ 0-152066 0 - 0-5800 0 - 0-26584
1984 0 - 0 -30018 0 _ 0-167493 0 - 0-4297 0 - 0-20768
j 1985 0 - 0 -29448 0 - 0-150740 1 951 24-5299 0 - 0-17732
1986 0 - 0-21379 0 - 0-130024 0 - 0-3321 0 - 0-17478
1987 0 - 0-23884 0 - 0-141161 0 - 0-3168 0 - 0-16429
1988 0 - 0 -23598 0 - 0-147876 0 - 0-3028 0 - 0-16534
1989 0 - 0-34524 0 - 0-223842 0 - 0-4252 0 “ 0-24291
Total 0 - 0 - 1992 0 - 0-10385 1 72 2-399 1 333 8-1856
A 3 - 8
T A B L E  A3.6: Portsmouth Dockyard. C ause specific mortality for 12 disease
groups by calendar year period, for study responders and non-
responders.
A l l C a u s e s A l l N e o p la sm s
Non- r e s p o n d e r s N o n - r e s p o n d e r s
Y e a r O b s SMR 95%  C l O bs SMR 95% C l O b s SMR 95% C l O b s SMR 95% C l
1 9 7 3 19 36 2 1 -  55 37 2 5 3 1 7 1 -3 3 4 4 27 7 -  68 2 0 4 7 7 2 9 1 - 7 3 7
1 9 7 4 4 8 6 9 4 9 -  88 18 94 5 6 - 1 4 9 2 0 100 6 1 - 1 5 4 7 126 5 0 - 2 5 9
1 9 7 5 71 94 7 2 - 1 1 6 21 104 6 4 - 1 5 9 2 0 93 5 6 - 1 4 3 8 136 5 9 - 2 6 8
1 9 7 6 6 6 80 6 1 -  99 2 2 102 6 4 - 1 5 5 2 2 91 5 7 - 1 3 8 9 142 6 5 - 2 6 9
1 9 7 7 79 92 7 2 - 1 1 2 2 5 115 7 4 - 1 6 9 2 2 86 5 4 - 1 3 0 3 46 9 - 1 3 4
1 9 7 8 9 8 105 8 4 - 1 2 6 21 8 7 5 4 - 1 3 3 30 109 7 3 - 1 5 5 8 112 4 8 - 2 2 1
1 9 7 9 1 0 4 104 8 4 - 1 2 3 30 115 7 7 - 1 6 4 2 6 87 5 7 - 1 2 8 6 79 2 9 - 1 7 1
198 0 9 5 90 7 2 - 1 0 9 19 71 4 3 -1 1 1 2 9 91 6 1 -1 3 1 7 88 3 5 - 1 8 1
1981 8 7 79 6 3 -  96 26 95 6 2 - 1 3 9 4 3 128 9 0 - 1 6 6 8 97 4 2 - 1 9 1
198 2 1 1 0 9 5 7 7 - 1 1 2 34 121 8 0 -1 6 1 4 7 133 9 5 -1 7 1 10 118 5 7 - 2 1 7  1
1 9 8 3 1 0 3 84 6 8 - 1 0 0 38 127 8 6 - 1 6 7 41 108 7 5 -1 4 1 13 144 7 7 - 2 4 6
1 9 8 4 9 3 72 5 7 -  86 4 6 148 1 0 5 -1 9 1 2 8 68 4 5 -  98 17 178 1 0 4 - 2 8 5
1 9 8 5 1 1 5 82 6 7 -  97 2 9 8 9 5 9 - 1 2 8 4 4 102 7 2 - 1 3 2 3 31 6 -  9 0
1 9 8 6 1 5 0 104 8 7 - 1 2 0 4 5 138 9 7 - 1 7 8 4 8 107 7 7 - 1 3 7 1 5 153 8 5 - 2 5 2
1 9 8 7 1 4 5 99 8 3 - 1 1 5 38 120 8 2 - 1 5 8 4 6 100 7 1 - 1 2 8 12 123 6 4 - 2 1 5
1 9 8 8 1 2 8 80 6 6 -  94 3 3 93 6 2 - 1 2 5 4 5 92 6 5 - 1 1 9 7 68 2 7 - 1 4 0
1 9 8 9 1 4 8 88 7 4 - 1 0 2 4 6 124 8 8 - 1 6 0 5 0 99 7 1 - 1 2 6 2 0 191 1 1 6 - 2 9 4
1 9 9 0 3 3 n o 7 2 - 1 4 3 4 62 1 7 - 1 5 9 10 112 5 4 - 2 0 6 0 - 0 - 2 0 4
j T o t a l 1 6 9 2 8 8 8 3 -  92 5 3 2 114 1 0 4 - 1 2 4 5 7 5 98 9 0 - 1 0 6 1 7 3 125 1 0 6 - 1 4 3
C a . S to m a c h C a . P e r i t o n e u m
N on- r e s p o n d e r s N o n - r e s p o n d e r s
Y e a r O b s SMR 95%  C l O bs SMR 95% C l O b s SMR 95% C l O b s SMR 95% C l
1 9 7 3 0 _ 0 - 2 5 3 5 1201 3 8 9 - 2 8 0 3 0 _ 0 - 7 5 2 3 0 _ 0 - 3 0 6 7 5
1 9 7 4 2 105 1 3 - 3 8 0 1 55 5 - 1 0 1 5 0 - 0 - 5 7 2 5 0 - 0 - 2 4 2 6 5
1 9 7 5 2 98 1 2 - 3 5 4 1 57 4 - 9 8 3 0 - 0 - 6 4 2 5 0 _ 0 - 2 8 9 5 5
1 9 7 6 0 - 0 - 1 6 7 0 - 0 - 6 2 0 0 - 0 -7 9 0 1 0 - 0 - 3 5 5 1 6
1 9 7 7 1 44 1 - 2 4 8 0 - 0 - 6 3 4 0 _ 0 - 5 8 6 0 0 - 0 - 2 4 4 1 0
1 9 7 8 1 41 1 - 2 2 7 1 155 4 - 8 6 3 0 - 0 - 5 1 7 4 0 - 0 - 2 2 7 5 9
1 9 7 9 2 79 1 0 - 2 8 4 2 2 9 8 3 6 -1 0 7 4 0 - 0 - 6 6 1 3 0 - 0 - 2 8 1 2 8
1 9 8 0 3 112 2 3 - 3 2 7 0 - 0 - 5 3 4 0 - 0 - 5 4 0 7 0 - 0 - 2 4 1 7 9
1981 7 2 4 8 9 9 - 5 1 0 1 142 4 - 7 8 9 0 - 0 - 7 6 0 6 0 - 0 - 3 4 3 8 8
1 9 8 2 7 2 5 6 1 0 3 - 5 2 6 0 - 0 -5 5 1 0 - 0 - 7 5 4 8 0 - 0 - 3 2 0 9 4
1 9 8 3 5 161 5 2 - 3 7 6 1 134 3 - 7 4 6 0 - 0 - 5 6 8 4 1 738 0 1 8 7 - 4 1 1 0 8
1 9 8 4 1 31 1 - 1 7 4 0 - 0 - 4 8 7 0 - 0 - 6 4 1 4 0 - 0 - 3 0 0 6 2
1 9 8 5 1 32 1 - 1 7 6 0 - 0 - 5 0 9 0 - 0 -5 4 1 1 0 - 0 - 2 6 6 1 2
1 9 8 6 3 90 1 8 - 2 6 2 2 2 7 0 3 3 - 9 7 4 1 1772 4 5 - 9 8 7 3 0 - 0 - 3 3 6 3 3
1 9 8 7 2 61 7 - 2 2 0 2 286 3 5 - 1 0 3 2 0 - 0 - 6 6 0 4 0 - 0 - 3 5 3 9 4
1 9 8 8 3 84 1 7 - 2 4 5 0 - 0 - 4 8 3 0 - 0 - 6 0 2 5 0 - 0 - 3 1 5 2 0
1 9 8 9 4 107 2 9 - 2 7 5 1 128 3 - 7 1 4 0 - 0 - 5 9 5 7 0 - 0 - 3 1 2 7 1
1 9 9 0 1 152 4 - 8 4 7 0 - 0 - 2 7 4 9 0 - 0 -3 4 2 1 1 0 - 0 - 1 8 3 4 0 3
i T o t a l 4 5 9 5 6 8 - 1 2 3 17 149 8 6 - 2 3 8 1 99 2 -5 5 1 1 457 1 2 - 2 5 4 4
C a . Lunq C a . P l e u r a
N on- r e s p o n d e r s N o n - r e s p o n d e r s
' Y e a r Obs SMR 95%  C l O b s SMR 95% C l O b s SMR 95% C l O b s SMR 95% C l
1 9 7 3 1 16 0 -  87 7 382 1 5 3 - 7 8 6 0 _ 0 - 6 0 1 6 1 6 7 0 5 1 7 0 - 3 7 3 4 4
1 9 7 4 8 93 4 0 - 1 8 3 1 41 1 - 2 2 7 1 1454 3 7 - 8 0 9 7 1 6 2 1 9 1 5 7 - 3 4 6 3 7
1 9 7 5 6 65 2 4 - 1 4 2 4 156 4 2 - 3 9 9 2 2171 2 6 3 - 7 8 3 7 0 - 0 - 1 6 4 6 4
1 9 7 6 1 0 98 4 7 - 1 7 9 2 73 9 - 2 6 2 2 1848 2 2 4 - 6 6 7 1 1 4 0 1 5 1 0 2 - 2 2 3 6 5
1 9 7 7 10 91 4 4 - 1 6 8 3 105 2 2 - 3 0 6 1 946 2 4 - 5 2 6 7 0 - 0 - 1 5 1 6 7
1 9 7 8 1 4 120 6 6 - 2 0 2 4 131 3 6 -3 3 4 0 - 0 - 3 1 0 7 0 - 0 - 1 3 4 6 7
1 9 7 9 1 4 112 6 1 - 1 8 8 2 61 7 - 2 2 2 0 - 0 - 3 7 0 7 0 - 0 - 1 6 1 3 6
1 9 8 0 11 8 3 4 1 - 1 4 8 1 30 1 - 1 6 5 0 - 0 - 2 8 2 5 0 - 0 - 1 2 8 6 6
1981 1 6 117 6 7 - 1 9 0 4 118 3 2 - 3 0 3 6 4351 1 5 9 5 -9 4 7 1 0 - 0 - 1 2 3 2 6
1 9 8 2 1 5 105 5 9 - 1 7 3 9 261 1 1 9 - 4 9 5 4 3 1 3 8 8 5 5 - 8 0 3 4 0 - 0 - 1 3 2 5 1
1 9 8 3 14 91 5 0 - 1 5 2 7 191 7 7 -3 9 4 3 1577 3 2 5 -4 6 1 1 0 - 0 - 9 6 4 9
1 9 8 4 11 69 3 4 - 1 2 3 11 299 1 4 9 - 5 3 5 3 1470 3 0 3 - 4 2 9 6 1 2471 6 2 - 1 3 7 6 2
1 9 8 5 2 4 145 9 3 - 2 1 6 2 54 7 - 1 9 6 0 - 0 - 1 6 7 9 0 - 0 - 8 7 6 0
1 9 8 6 21 125 7 8 - 1 9 2 7 193 7 7 -3 9 7 2 807 9 8 - 2 9 1 5 0 - 0 - 7 5 6 9
1 9 8 7 1 3 77 4 1 - 1 3 1 4 113 3 1 - 2 9 0 1 4 0 0 1 0 - 2 2 2 6 1 2 1 5 8 5 5 - 1 2 0 2 0
1 9 8 8 11 61 3 0 - 1 0 9 3 80 1 7 - 2 3 5 1 4 1 5 1 0 - 2 3 1 0 0 - 0 - 8 2 6 5
1 9 8 9 17 91 5 3 - 1 4 6 6 160 5 9 - 3 4 9 1 414 1 0 - 2 3 0 8 0 - 0 - 8 4 0 1
1 9 9 0 2 61 7 - 2 2 1 0 - 0 - 5 7 7 1 2 3 9 7 6 1 - 1 3 3 5 3 0 - 0 - 4 9 4 8 9
T o t a l 2 1 8 94 8 1 - 1 0 6 7 7 139 1 0 8 - 1 7 0 2 8 1042 6 9 3 - 1 5 0 6 5 907 2 9 4 - 2 1 1 7
A 3 - 9
T A B L E  A3.6 (coni.) Portsmouth Dockyard. Cause specific mortality for 12
disease groups by calendar year period, for study
responders and non-responders.
C i r c u l a t o r y  S y s te m P u lm o n a r y  C i r c u l a t i o n
N on- r e s p o n d e r s N on- r e s p o n d e r s
Y e a r O bs SMR 9 SX C l O b s SMR 95X  C l O b s SMR 95X  C l O bs SMR 95X C l
1 9 7 3 11 4 4 2 2 -  79 10 145 6 9 - 2 6 6 0 _ 0 - 1 4 6 7 0 _ 0 - 5 1 4 2
1 9 7 4 21 6 4 3 9 -  97 9 98 4 5 - 1 8 6 0 - 0 - 1 0 2 2 0 - 0 -3 6 3 1
1 9 7 5 35 9 7 6 5 - 1 2 9 7 72 2 9 - 1 4 8 0 - 0 - 9 9 4 0 _ 0 - 3 5 1 5
1 9 7 6 29 74 5 0 - 1 0 6 7 68 2 7 - 1 4 0 0 - 0 - 8 4 5 0 - 0 - 3 2 1 9
1 9 7 7 46 111 7 9 - 1 4 3 18 169 1 0 0 - 2 6 8 0 - 0 - 8 4 4 0 _ 0 - 3 2 5 8
1 9 7 8 55 121 8 9 - 1 5 3 12 101 5 2 - 1 7 6 0 - 0 - 8 1 8 0 - 0 - 3 0 7 6
1 9 7 9 59 1 2 0 8 9 - 1 5 1 1 3 101 5 4 - 1 7 2 0 - 0 - 4 5 9 0 - 0 - 1 7 1 2
1 9 8 0 4 9 9 5 6 9 - 1 2 2 10 76 3 7 - 1 4 0 1 1 2 5 3 - 6 9 5 0 - 0 - 1 7 2 8
1981 34 6 3 4 2 -  85 12 89 4 6 - 1 5 6 0 - 0 - 4 1 4 1 4 2 9 1 1 -2 3 8 8
1 9 8 2 4 0 71 4 9 -  93 19 139 8 4 - 2 1 7 0 - 0 - 4 0 6 0 - 0 -1 6 6 1
1 9 8 3 4 5 7 5 5 3 -  97 17 117 6 8 - 1 8 7 1 1 0 9 3 - 6 0 6 0 _ 0 - 1 5 9 3
198 4 4 2 6 7 4 7 -  87 2 2 146 9 1 - 2 2 0 1 2 2 6 6 - 1 2 5 6 0 - 0 - 3 1 9 6
1 9 8 5 57 8 5 6 3 - 1 0 7 12 76 3 9 - 1 3 3 1 2 0 2 5 - 1 1 2 5 0 _ 0 - 3 0 3 4
1 9 8 6 70 101 7 8 - 1 2 5 2 2 141 8 8 - 2 1 3 0 - 0 - 7 3 1 0 _ 0 - 3 0 9 4
1 9 8 7 72 1 0 3 7 9 - 1 2 7 1 5 99 5 5 - 1 6 3 0 - 0 - 7 2 3 0 - 0 - 3 1 6 3
! 1 9 8 8 6 2 81 6 1 - 1 0 1 16 94 5 4 - 1 5 3 0 - 0 - 6 4 0 0 - 0 - 2 7 5 9
1 9 8 9 8 0 9 9 7 7 - 1 2 0 19 107 6 4 - 1 6 7 0 - 0 - 5 9 7 0 _ 0 -2 5 9 1
! 1 9 9 0 13 9 0 4 8 - 1 5 4 0 * 0 - 1 2 0 0 - 0 - 3 3 2 6 0 - 0 - 1 4 8 4 3
T o t a l 8 2 0 8 8 8 2 -  94 2 4 0 106 9 3 - 1 2 0 4 4 0 1 1 - 1 0 4 1 4 0 1 -2 2 1
R e s p i r a t o r y  S y s t e m B r o n c h i t i s . E m physem a a n d  A s th m a
N o n - r e s p o n d e r s N on- r e s p o n d e r s
Y e a r O b s SMR 9 SX C l O b s SMR 95X  C l O bs SMR 95X  C l O bs SMR 95X C l
1 9 7 3 3 6 0 1 2 - 1 7 7 7 4 6 5 1 8 6 - 9 5 7 0 _ 0 - 1 3 7 4 4 8 1 1 3 1 -1 2 3 1
1 9 7 4 7 1 1 3 4 5 - 2 3 3 1 52 1 - 2 9 1 0 - 0 - 1 0 8 0 - 0 - 3 4 3
! 1 9 7 5 14 2 0 2 1 1 0 - 3 3 9 6 291 1 0 7 - 6 3 3 3 8 0 1 6 - 2 3 4 2 1 7 7 2 1 - 6 3 8
1 9 7 6 14 171 9 3 - 2 8 7 4 171 4 7 - 4 3 8 3 76 1 6 - 2 2 2 0 - 0 - 3 2 4
1 9 7 7 10 1 2 8 6 1 - 2 3 5 4 185 5 0 - 4 7 5 4 1 0 4 2 8 - 2 6 6 2 1 8 7 2 3 - 6 7 4
1 9 7 8 12 138 7 1 - 2 4 1 0 - 0 - 1 4 5 0 - 0 -  8 7 0 - 0 -3 0 1
1 9 7 9 7 7 3 2 9 - 1 5 0 2 69 8 - 2 5 1 4 8 9 2 4 - 2 2 8 1 7 5 2 - 4 2 0
! 1 9 8 0 5 4 9 1 6 - 1 1 5 0 - 0 - 1 2 7 2 4 6 6 - 1 6 6 0 - 0 -3 0 1
1981 4 3 8 1 0 -  97 3 102 2 1 - 2 9 9 1 2 3 1 -1 3 1 0 - 0 - 3 1 8
! 1 9 8 2 13 106 5 7 - 1 8 2 5 154 5 0 - 3 5 9 3 6 7 1 4 - 1 9 7 1 8 6 2 -4 8 1
1 9 8 3 8 62 2 7 - 1 2 2 4 113 3 1 - 2 8 8 2 4 5 5 - 1 6 3 1 8 6 2 - 4 7 9
1 9 8 4 7 64 2 6 - 1 3 1 3 101 2 1 - 2 9 6 2 4 6 6 - 1 6 7 1 8 8 2 -4 9 1
1 1 9 8 5 10 7 5 3 6 - 1 3 8 7 2 0 6 8 3 - 4 2 4 2 4 2 5 -1 5 1 2 1 6 9 2 0 - 6 0 8
1 9 8 6 16 116 6 6 - 1 8 8 6 177 6 5 - 3 8 6 5 1 1 4 3 7 - 2 6 7 2 1 9 3 2 3 - 6 9 7
1 9 8 7 9 6 7 3 1 - 1 2 7 4 128 3 5 - 3 2 8 4 1 0 5 2 9 - 2 6 9 2 2 3 4 2 8 - 8 4 6
j 1 9 8 8 10 6 3 3 0 - 1 1 5 3 78 1 6 - 2 2 7 3 6 0 1 2 - 1 7 6 1 8 7 2 - 4 8 2
1 9 8 9 8 4 6 2 0 -  91 2 47 6 - 1 6 9 0 - 0 -  6 9 0 - 0 - 2 9 8
! 1 9 9 0 3 9 5 2 0 - 2 7 8 2 2 6 6 3 2 - 9 6 0 1 1 0 4 3 - 5 8 0 0 - 0 - 1 7 0 6
T o t a l 1 6 0 8 6 7 3 -  99 6 3 127 9 5 - 1 5 8 39 54 3 7 -7 1 19 9 8 5 9 - 1 5 3
A s b e s t o s i s P u lm o n a r y  F i b r o s i s
N o n - r e s p o n d e r s N on- r e s p o n d e r s
Y e a r O b s SMR 9 5 X  C l O bs SMR 95X  C l O bs SMR 9SX C l O bs SMR 95X C l
1 9 7 3 0 _ 0 - 5 0 1 7 1 0 _ 0 - 2 0 2 6 3 6 0 _ 0 - 4 9 8 9 0 _ 0 - 1 6 9 8 0
1 9 7 4 0 - 0 - 5 0 2 9 3 0 - 0 - 1 7 8 4 8 3 0 - 0 - 3 7 1 5 0 - 0 - 1 3 4 8 4
1 9 7 5 0 - 0 - 2 3 4 8 3 0 _ 0 - 9 4 8 9 3 0 _ 0 - 3 3 0 6 0 - 0 - 1 1 7 6 5
1 9 7 6 0 - 0 - 3 9 0 0 9 0 - 0 - 1 6 2 6 7 2 0 - 0 - 2 6 3 4 0 - 0 - 1 0 3 3 4
1 9 7 7 0 - 0 - 2 3 4 2 0 0 - 0 - 9 1 5 3 1 0 - 0 - 3 2 0 9 0 - 0 - 1 2 9 8 3
1 9 7 8 0 - 0 - 2 0 7 3 6 0 - 0 - 8 4 8 0 8 0 - 0 - 2 4 5 2 0 - 0 - 9 1 7 2
1 9 7 9 0 - 0 - 2 4 9 1 9 0 - 0 - 1 0 9 6 5 1 0 - 0 - 4 1 7 3 0 - 0 - 1 6 4 3 3
1 9 8 0 0 - 0 - 2 2 1 5 0 0 - 0 - 8 9 6 6 9 0 - 0 - 3 8 7 7 0 - 0 - 1 5 1 4 0
1981 0 - 0 - 2 0 2 1 8 0 - 0 - 9 0 1 5 6 0 - 0 - 4 0 9 3 0 - 0 - 1 5 2 0 2
1 9 8 2 1 4811 1 2 2 - 2 6 8 0 0 0 - 0 - 7 6 2 5 5 1 9 3 6 2 4 - 5 2 1 5 0 - 0 -1 4 3 1 1
! 1 9 8 3 1 4 5 5 9 1 1 5 - 2 5 3 9 4 0 - 0 - 7 3 2 7 6 0 - 0 - 3 5 8 5 0 - 0 - 1 4 1 5 5
1 9 8 4 1 4 6 3 6 1 1 7 - 2 5 8 2 2 0 - 0 - 7 8 2 6 1 0 - 0 -2 6 7 1 0 - 0 - 1 0 3 7 9
1 9 8 5 0 - 0 - 1 7 2 9 6 0 - 0 - 7 3 2 5 5 0 - 0 - 2 1 2 7 0 - 0 - 8 6 8 3
1 9 8 6 0 - 0 - 1 1 6 3 2 0 - 0 - 5 8 8 0 9 0 - 0 - 1 9 5 8 1 2 2 8 2 5 8 -1 2 7 1 1
! 1 9 8 7 0 - 0 - 1 3 2 9 3 0 - 0 - 6 5 2 0 2 0 - 0 -1 8 6 1 0 - 0 - 8 0 4 4
1 9 8 8 0 - 0 - 1 2 7 9 8 0 - 0 - 6 4 6 3 7 0 - 0 - 1 7 3 7 0 - 0 - 7 6 5 6
1 9 8 9 0 - 0 - 1 2 6 1 0 0 - 0 - 6 6 5 0 3 0 - 0 - 1 6 3 7 0 - 0 - 7 3 7 6
1 9 9 0 0 - 0 - 7 2 6 2 3 0 - 0 - 3 9 2 4 4 0 0 - 0 - 9 1 9 2 0 - 0 -4 2 5 2 1
T o t a l 3 9 0S 1 8 7 - 2 6 4 6 0 - 0 - 5 0 0 3 1 4 3 1 - 2 3 7 1 1 7 2 4 - 9 5 6
A 3  - 10
T A B L E  A 3.7: Cause specific mortality by age at death for the 3 dockyards.
C a u s e s  o f  D e a th A ge a t D e v o n p o r t C h a th a m P o r t s m o u th
d e a t h
( y r s )
Obs SMR 95% C l O bs SMR 95% C l O bs SMR 95% C l
A l l C a u s e s < 35 55 1 4 5 1 0 7 -1 8 4 2 3 131 8 3 - 1 9 7 26 1 1 7 7 6 -1 7 1
3 5 - 8 5 120 9 5 - 1 4 6 30 n o 7 4 - 1 5 8 51 1 2 0 8 7 - 1 5 3
4 5 - 265 n o 9 7 - 1 2 3 8 5 89 7 0 - 1 0 8 157 9 6 8 1 -1 1 1
5 5 - 785 104 9 7 -1 1 1 305 9 5 8 4 - 1 0 6 554 9 3 8 6 -1 0 1
6 5 - 867 86 8 0 -  91 4 6 6 87 7 9 -  9 5 7 2 5 8 2 7 6 -  88
75+ 232 92 8 0 - 1 0 4 136 8 6 7 1 - 1 0 0 179 78 6 7 -  90
A l l N e o p la s m s < 35 15 251 1 4 1 -4 1 4 4 141 3 8 - 3 6 2 4 111 3 0 -2 8 5
3 5 - 25 159 1 0 3 -2 3 5 13 2 0 6 1 1 0 - 3 5 3 14 1 4 3 7 8 -2 4 0
4 5 - 82 127 9 9 -1 5 4 31 1 3 0 8 4 - 1 7 5 4 8 1 0 5 7 5 - 1 3 5
5 5 - 280 122 1 0 8 -1 3 6 110 109 8 9 - 1 3 0 199 1 0 6 9 1 -1 2 1
6 5 - 308 103 9 2 - 1 1 5 162 97 8 2 - 1 1 2 2 6 2 9 4 8 3 - 1 0 5
75+ 79 126 9 8 - 1 5 4 4 5 1 0 9 7 7 - 1 4 0 4 8 79 5 6 -1 0 1
C a . S to m a c h < 35 1 714 1 8 -3 9 7 9 0 _ 0 -5 2 7 1 0 _ 0 - 4 1 0 0
3 5 - 0 - 0 - 3 7 3 0 - 0 - 9 2 2 1 1 5 9 4 - 8 8 4
4 5 - 8 163 7 0 -3 2 1 4 2 1 2 5 8 - 5 4 2 1 2 8 1 -1 5 5
5 5 - 30 160 1 0 9 -2 3 0 12 140 7 2 - 2 4 5 15 9 6 5 4 -1 5 9
6 5 - 34 130 8 6 - 1 7 4 16 116 6 6 - 1 8 8 2 5 111 7 2 -1 6 4
75+ 8 1 5 3 6 6 -3 0 1 2 61 7 - 2 2 2 3 6 3 1 3 - 1 8 5
C a . P e r i t o n e u m < 35 1 2 5 0 0 6 3 - 1 3 9 2 5 1 5 0 0 0 1 2 6 - 2 7 8 5 0 0 _ 0 - 1 8 4 5 0
3 5 - 0 - 0 - 3 6 9 0 0 - 0 - 9 2 2 5 0 - 0 - 7 3 8 0
4 5 - 2 8 0 0 9 7 - 2 8 8 8 0 - 0 - 4 1 0 0 0 - 0 -2 1 7 1
5 5 - 6 120 0 4 4 0 -2 6 1 2 0 - 0 - 1 7 5 7 1 2 6 3 7 -1 4 6 6
6 5 - 1 2 4 4 6 - 1 3 5 9 1 5 0 0 1 3 - 2 7 8 5 0 - 0 - 1 0 8 5
75+ 0 0 - 9 2 2 5 0 - 0 - 1 2 3 0 0 0 - 0 - 9 2 2 5
C a . L ung <35 3 8 5 7 1 7 7 -2 5 0 6 1 5 8 8 1 5 - 3 2 7 6 2 9 0 9 1 1 0 -3 2 8 2
3 5 - 5 177 5 7 -4 1 2 1 8 5 2 - 4 7 2 1 5 3 1 - 2 9 6
4 5 - 22 104 6 5 - 1 5 8 6 71 2 6 - 1 5 5 14 8 8 4 8 - 1 4 7
5 5 - 90 102 8 1 - 1 2 3 38 90 6 1 - 1 1 9 8 0 1 0 2 8 0 - 1 2 5
6 5 - 97 88 7 0 -1 0 5 58 8 3 6 2 - 1 0 5 104 9 0 7 3 - 1 0 7
75+ 24 1 2 3 7 9 -1 8 3 12 8 3 4 3 - 1 4 5 17 8 0 4 6 - 1 2 8
C a . P l e u r a <35 0 _ 0 - 1 8 4 5 0 0 _ 0 - 7 3 8 0 0 0 _ 0 - 1 8 4 5 0
3 5 - 2 1 5 3 8 1 8 6 -5 5 5 4 1 166 7 4 2 - 9 2 8 3 2 2 5 0 0 3 0 3 -9 0 2 5
4 5 - 11 2 2 4 5 1 1 2 0 -4 0 1 6 3 1 7 6 5 3 6 4 - 5 1 5 9 4 1 1 7 6 3 2 1 -3 0 1 2
5 5 - 29 2 1 6 4 1 4 4 9 -3 1 0 8 10 1 8 1 8 8 7 3 - 3 3 4 4 11 1 0 2 8 5 1 3 -1 8 3 9
6 5 - 20 1709 1 0 4 4 -2 6 4 0 8 137 9 5 9 5 - 2 7 1 7 10 971 4 6 6 - 1 7 8 5
75+ 4 2 5 0 0 681 - 6 4 0 0 2 2 0 0 0 2 4 2 - 7 2 2 0 1 6 6 7 1 7 -3 7 1 3
A 3 - 11
T A B L E  A 3 .7  (corn.): Cause specific mortality by age at death for the 3
dockyards.
C a u s e s  o f  D e a th A ge a t  
d e a t h
( y s )
D e v o n p o r t
O bs
C h a th a m
O b s
P o r t s m o u th
O bs SMR 95X Cl SMR 95X  Cl SMR 95X Cl
C i r c u l a t o r y  S y s te m < 3 5 17 3 6 3 2 1 2 - 5 8 2 7 3 4 5 1 3 8 - 7 1 0 1 0 3 8 5 1 8 5 - 7 0 7
3 5 - 34 1 2 9 8 5 - 1 7 2 9 9 5 4 3 - 1 8 0 21 139 8 6 - 2 1 3
4 5 - 151 1 2 3 1 0 3 - 1 4 2 41 9 8 6 8 - 1 2 8 7 8 98 7 6 - 1 2 0
5 5 - 4 0 9 107 9 6 - 1 1 7 150 9 6 8 1 - 1 1 2 2 5 8 89 7 8 - 1 0 0
6 5 - 4 3 2 8 0 7 3 -  8 8 221 84 7 3 -  95 3 5 2 81 7 2 -  8 9
7 5 * 1 0 9 8 2 6 7 -  9 8 59 7 7 5 7 -  96 101 91 7 3 - 1 0 9
P u l m o n a r y  C i r c u l a t i o n < 35 0 _ 0 - 6 1 5 0 0 _ 0 - 9 2 2 5 1 2 5 0 0 6 3 - 1 3 9 2 5
3 5 - 0 - 0 - 1 6 0 4 0 - 0 - 4 6 1 3 0 - 0 - 2 6 3 6
4 5 - 4 4 1 2 1 1 2 -1 0 5 6 0 - 0 - 1 0 2 5 0 - 0 - 5 5 1
5 5 - 17 4 2 5 2 4 8 -6 8 1 1 57 1 - 3 1 5 0 - 0 - 1 1 3
6 5 - 7 124 5 0 - 2 5 6 3 9 8 2 0 - 2 8 8 3 6 3 1 3 - 1 8 4
75+ 0 - 0 -2 1 7 1 0 * 0 - 4 9 9 0 - 0 - 3 6 5
R e s p i r a t o r y  S y s te m < 35 12 7 6 4 3 9 5 - 1 3 3 5 5 6 2 5 2 0 3 - 1 4 5 9 4 3 9 6 1 0 8 - 1 0 1 4
3 5 - 13 4 6 9 2 5 0 - 8 0 3 1 8 6 2 - 4 8 0 6 3 3 3 1 2 2 - 7 2 6
4 5 - 16 136 7 8 - 2 2 0 6 127 4 7 - 2 7 7 17 1 9 3 1 1 2 - 3 0 8
5 5 - 61 no 8 2 - 1 3 8 31 1 1 5 7 4 - 1 5 6 5 8 1 2 0 8 9 - 1 5 1
6 5 - 6 5 6 5 4 9 -8 1 4 5 74 5 3 -  96 6 2 64 4 8 -  8 0
75+ 2 5 8 4 5 4 - 1 2 4 19 8 9 5 3 - 1 3 9 1 3 44 2 3 -  75
B r o n c h i t i s ,  E m physem a < 35 1 2 5 0 6 - 1 3 9 3 0 _ 0 - 1 7 5 7 0 _ 0 - 1 3 6 7
a n d  A s th m a 3 5 - 1 1 2 0 3 -6 7 1 0 - 0 - 9 9 7 0 - 0 - 6 4 7
4 5 - 5 102 3 3 - 2 3 8 2 9 7 1 2 -3 5 1 4 1 0 5 2 9 - 2 6 9
5 5 - 15 59 3 3 -  9 8 13 101 5 4 - 1 7 2 1 6 71 4 0 - 1 1 5
6 5 - 19 53 3 2 -  8 3 16 6 7 3 8 - 1 0 8 16 4 3 2 5 -  70
75+ 4 52 1 4 - 1 3 3 4 6 6 1 8 - 1 6 9 3 36 7 - 1 0 6
A s b e s t o s  i s < 35 1 1 3 8 8 9 3 5 1 -7 7 3 6 1 0 _ 0 - 3 6 9 0 0 0 1 2 1 2 7 7 5 3 8 -1 1 8 5 1 1
3 5 - 0 - 0 - 1 2 3 0 0 0 0 - 0 - 1 8 4 5 0 0 1 2 5 0 0 0 6 3 2 - 1 3 9 2 5 0
4 5 - 0 - 0 - 9 2 2 5 0 - 0 - 3 6 9 0 0 0 - 0 - 2 8 3 8
5 5 - 2 1 2 5 0 1 5 1 -4 5 1 2 0 - 0 -5 2 7 1 0 - 0 - 1 2 3 0 0
6 5 - 3 1 7 6 5 364 -  5 1 5 8 0 - 0 - 4 6 1 3 1 6 6 7 1 7 - 3 7 1 3
75+ 1 3 3 3 3 8 4 - 1 8 5 6 7 0 - 0 - 1 8 4 5 0 0 - 0 - 1 2 3 0 0
P u l m o n a r y  F i b r o s i s < 35 0 _ 0 - 3 6 9 0 0 0 _ 0 - 7 3 8 0 0 0 _ 0 - 5 6 8 0 0
3 5 - 0 - 0 - 6 1 5 0 0 - 0 - 1 8 4 5 0 0 - 0 - 1 2 3 0 0
4 5 - 0 - 0 - 1 6 7 7 0 - 0 -5 2 7 1 0 - 0 - 2 4 6 0
5 5 - 1 1 0 3 3 - 5 7 4 0 - 0 - 9 0 0 1 139 4 - 7 7 4
6 5 - 1 78 2 - 4 3 5 0 - 0 - 5 6 8 0 - 0 - 3 4 5
75+ 0
'
0 - 9 4 6 1 4 3 5 1 1 - 2 4 2 2 0
‘
0 - 1 0 5 4
A3 - 12
T A B L E  A3.8: Non-responder cause specific mortality by age at death for the 3
dockyards.
C a u s e s  o f  D e a t h A ge a t  
d e a t h  
( y s )
O bs
D e v o n p o r t
O bs
C h a th a m
O b s
P o r t s m o u th
SMR 9 5 Z  C l SMR 95% C l SMR 95X  C l
A l l C a u s e s < 35 18 726 4 3 0 - 1 1 4 7 13 4 2 5 2 2 6 - 7 2 6 9 192 8 8 - 3 6 5
3 5 - 11 3 6 5 1 8 2 - 6 5 4 15 534 2 9 9 - 8 8 0 1 8 240 1 4 2 -3 8 1
4 5 - 30 312 2 1 1 - 4 4 6 15 145 8 1 - 2 3 9 4 2 163 1 1 3 - 2 1 2
5 5 - 78 188 1 4 6 - 2 2 9 74 137 1 0 6 -1 6 8 1 5 3 139 1 1 7 -1 6 1
6 5 - 118 124 1 0 1 - 1 4 7 153 126 1 0 6 -1 4 6 2 3 0 100 8 7 - 1 1 3
75+ 39 105 7 2 - 1 3 8 50 109 7 9 -1 3 9 8 0 90 7 0 - 1 1 0
A U N e o p la s m s < 35 5 1282 4 1 5 - 2 9 9 2 0 _ 0 - 7 8 5 2 2 6 3 3 2 - 9 5 0
3 5 - 2 2 8 9 3 6 - 1 0 7 8 4 6 2 5 1 7 0 -1 6 0 0 5 291 9 4 - 6 7 8
4 5 - 7 2 7 2 1 0 9 -5 6 1 4 139 3 8 - 3 5 6 1 5 207 1 1 6 - 3 4 2
5 5 - 22 176 1 1 0 - 2 6 6 22 131 8 2 - 1 9 8 5 3 153 1 1 2 - 1 9 4
6 5 - 29 107 7 1 - 1 5 4 4 5 121 8 6 - 1 5 7 7 4 104 8 0 - 1 2 8
75+ 10 110 5 3 - 2 0 2 16 136 7 8 - 2 2 0 2 4 103 6 6 - 1 5 3
C a . S to m a c h < 35 0 _ 0 - 3 6 9 0 0 0 _ 0 - 7 3 8 0 0 0 _ 0 - 3 6 9 0 0
3 5 - 0 - 0 - 9 2 2 5 0 - 0 - 7 3 8 0 0 - 0 - 3 3 5 6
4 5 - 1 500 1 3 - 2 7 8 5 0 - 0 - 1 6 0 4 0 - 0 - 6 4 7
5 5 - 2 189 2 3 -6 8 1 0 - 0 -2 5 1 6 204 7 5 - 4 4 4
6 5 - 3 119 2 4 - 3 4 7 8 2 4 9 1 0 7 -4 9 1 7 117 4 7 -2 4 1
75+ 1 132 3 - 7 3 3 4 4 3 0 1 1 7 -1 1 0 1 4 2 2 0 6 0 - 5 6 2
C a . P e r i t o n e u m < 35 0 _ 0 - 1 4 1 9 2 3 0 _ 0 - 7 3 8 0 0 0 _ 0 - 9 2 2 5 0
3 5 - 0 - 0 - 5 5 0 7 4 0 - 0 - 4 6 1 2 5 1 10 0 0 0 2 5 3 - 5 5 7 0 0
4 5 - 0 - 0 - 3 6 9 0 0 0 - 0 - 3 6 9 0 0 0 - 0 - 1 2 3 0 0
5 5 - 1 3 3 3 3 8 4 - 1 8 5 6 7 0 - 0 - 1 2 3 0 0 0 - 0 -5 2 7 1
6 5 - 0 - 0 - 9 2 2 5 0 - 0 - 7 3 8 0 0 - 0 - 4 1 0 0
75+ 0 - 0 - 3 6 9 0 0 0 - 0 - 3 6 9 0 0 0 - 0 - 3 6 9 0 0
C a . L ung < 35 1 100 0 2 5 3 - 5 5 7 0 0 0 _ 0 - 1 2 3 0 0 0 _ 0 - 9 2 2 5
3 5 - 1 8 3 3 2 1 - 4 6 4 2 2 166 7 2 0 1 - 6 0 1 7 2 606 7 3 - 2 1 8 8
4 5 - 2 2 3 3 2 8 - 8 3 9 1 96 2 - 5 3 6 8 316 1 3 6 - 6 2 3
5 5 - 9 182 8 4 - 3 4 6 10 140 6 7 - 2 5 8 2 4 166 1 0 6 - 2 4 7
6 5 - 9 8 8 4 0 - 1 6 6 14 8 9 4 8 - 1 4 9 3 7 124 8 4 - 1 6 4
75+ 5 178 5 8 - 4 1 5 7 1 7 0 6 8 -3 5 1 6 74 2 7 - 1 6 2
C a . P l e u r a < 35 0 _ 0 - 2 0 5 0 0 0 0 _ 0 - 5 2 7 1 4 0 _ 0 - 9 2 2 5 0
3 5 - 0 - 0 - 7 6 8 7 5 0 - 0 - 4 1 0 0 0 0 - 0 - 3 6 9 0 0
4 5 - 1 5000 0 - 2 7 8 5 0 0 - 0 - 1 8 4 5 0 0 - 0 - 7 3 8 0
5 5 - 2 285 7 3 4 6 - 1 0 3 1 4 2 2 5 0 0 3 0 3 - 9 0 2 5 4 2 2 2 2 6 0 6 - 5 6 8 9
6 5 - 3 333 3 6 8 8 - 9 7 4 4 2 1 8 1 8 2 2 0 - 6 5 6 4 0 - 0 - 1 5 3 7
75+ 0
'
0 - 1 8 4 5 0 0 0 - 1 8 4 5 0 1 1667 4 2 - 9 2 8 3
A 3 - 13
T A B L E  A 3.8 (com.): Non-responder cause specific mortality by age at death for
the 3 dockyards.
C a u s e s  o f  D e a th A ge a t  
d e a t h  
( y r s )
O b s
D e v o n p o r t
O bs
C h a th a m
O bs
P o r t s m o u t h
SMR 95X C l SMR 95X  C l SMR 9SX C l
C i r c u l a t o r y  S y s te m < 35 8 2 7 5 9 1 1 9 0 - 5 4 3 4 5 1 5 1 5 4 9 1 - 3 5 3 6 3 5 6 6 1 1 7 -1 6 5 5
3 5 - 7 5 0 6 2 0 2 - 1 0 3 7 7 7 2 2 2 9 0 - 1 4 8 7 9 3 4 5 1 5 8 -6 5 4
4 5 - 19 3 8 6 2 3 2 - 6 0 3 5 9 8 3 2 - 2 3 0 18 142 8 4 - 2 2 5
5 5 - 40 1 8 9 1 3 1 - 2 4 8 4 0 152 1 0 5 - 1 9 9 6 8 127 9 7 - 1 5 7
6 5 - 70 1 3 8 1 0 5 - 1 7 0 78 1 3 0 1 0 1 - 1 5 8 108 9 5 7 7 - 1 1 3
75+ 19 9 8 5 8 - 1 5 2 28 1 2 6 8 4 - 1 8 2 34 79 5 2 - 1 0 5
P u lm o n a r y  C i r c u l a t i o n < 35 0 _ 0 - 9 4 6 1 5 0 _ 0 - 4 1 0 0 0 0 _ 0 -9 2 2 5 0
3 5 - 0 - 0 - 3 6 9 0 0 0 - 0 - 3 6 9 0 0 0 - 0 -1 8 4 5 0
4 5 - 1 2 5 0 0 6 3 - 1 3 9 2 5 0 - 0 - 9 2 2 5 0 - 0 - 3 3 5 5
5 5 - 3 1 3 0 4 2 6 9 - 3 8 1 3 0 - 0 - 1 2 3 0 0 - 0 - 6 0 5
6 5 - 1 1 6 9 4 - 9 4 4 0 - 0 - 5 0 5 1 74 2 - 4 1 0
75+ 0 - 0 - 2 0 5 0 1 4 3 5 1 1 - 2 4 2 2 0 - 0 - 9 0 0
R e s p i r a t o r y  S y s te m < 35 2 2 2 2 2 2 6 9 - 8 0 2 2 3 2 3 0 8 4 7 6 - 6 7 4 6 4 1 8 1 8 4 9 5 - 4 6 5 5
3 5 - 1 9 0 9 2 3 - 5 0 6 4 2 1 6 6 7 2 0 2 - 6 0 1 7 0 - 0 - 1 1 5 3
4 5 - 2 4 0 8 4 9 - 1 4 7 3 4 6 9 0 1 8 8 - 1 7 6 5 4 2 8 4 7 7 -7 2 6
5 5 - 9 2 7 8 1 2 7 - 5 2 7 8 1 7 0 7 3 - 3 3 5 19 2 0 6 1 2 4 -3 2 1
6 5 - 16 1 56 8 9 - 2 5 3 18 1 2 4 7 3 - 1 9 6 27 101 6 7 - 1 4 7
75+ 2 4 4 5 - 1 5 8 4 6 2 1 7 - 1 5 8 9 75 3 4 - 1 4 3
B r o n c h i t i s ,  Em physem a < 35 1 5 0 0 0 1 2 7 - 2 7 8 5 0 . 0 _ 0 - 9 2 2 5 0 _ 0 - 6 1 5 0
a n d  A s th m a 3 5 - 0 - 0 - 1 2 3 0 0 1 2 5 0 0 6 3 - 1 3 9 2 5 0 - 0 - 3 6 9 0
4 5 - 0 - 0 - 1 8 4 5 1 3 8 5 1 0 - 2 1 4 2 2 3 2 8 4 0 - 1 1 8 4
5 5 - 2 1 2 8 1 5 - 4 6 3 3 1 2 8 2 6 - 3 7 5 8 1 8 0 7 8 - 3 5 5
6 5 - 5 1 2 6 4 1 - 2 9 4 7 1 1 5 4 6 - 2 3 8 7 6 5 2 6 - 1 3 4
75+ 0 0 - 3 1 3 1 54 1 3 8 - 3 0 3 2 5 9 7 -2 1 4
A s b e s t o s i s < 35 0 _ 0 -2 6 3 5 7 1 0 _ 0 - 8 2 0 0 0 0 _ 0 - 1 0 8 5 2 9
3 5 - 0 - 0 - 1 0 5 4 2 9 0 - 0 - 4 9 2 0 0 0 - 0 - 8 0 2 1 7
4 5 - 0 - 0 - 6 1 5 0 0 0 - 0 - 4 1 4 6 0 - 0 - 7 3 8 0 0
5 5 - 0 - 0 - 5 8 5 7 1 0 - 0 - 3 6 9 0 0 0 - 0 - 1 8 4 5 0
6 5 - 0 - 0 - 1 8 4 5 0 0 - 0 - 1 8 4 5 0 0 - 0 - 9 2 2 5
75+ 0 0 - 3 6 9 0 0 0 - 0 - 5 2 7 1 4 0 - 0 - 3 6 9 0 0
P u lm o n a r y  F i b r o s i s < 35 0 _ 0 - 5 7 6 5 6 0 _ 0 - 1 4 7 6 0 0 0 _ 0 -8 2 0 0 0
3 5 - 0 - 0 - 9 2 2 5 0 0 - 0 - 8 2 0 0 0 0 - 0 -7 3 8 0 0
4 5 - 0 - 0 - 3 6 9 0 0 0 - 0 - 3 6 9 0 0 0 - 0 - 1 2 3 0 0
5 5 - 1 1 6 6 7 4 2 - 9 2 8 3 1 1 4 2 9 3 6 - 7 9 5 7 0 - 0 - 2 6 3 6
6 5 - 0 - 0 - 2 8 3 8 0 - 0 - 2 4 6 0 1 3 5 7 9 - 1 9 8 9
75+ 0
‘
0 - 6 1 5 0 0
'
0 - 6 1 5 0 0
'
0 - 2 8 3 8
A 3 - 14
T A B L E  A 3 . 9 : Cause specific mortality by dockyard for questionnaire type (Free 
or Controlled).
C a u s e s  o f  D e a th Q u e s .
t y p e
Obs
D e v o n p o r t
O b s
C h a th a m
O bs
P o r t s m o u t h
SMR 95% C l SMR 95% C l SMR 95%  C l
A l l  C a u s e s F r e e * 1634 94 8 9 -  9 8 6 6 3 89 8 2 -  96 941 79 7 4 -  84
B o th 496 101 9 2 - 1 3 7 180 92 7 9 - 1 0 6 4 5 9 100 9 1 - 1 0 9
N e i t h e r 159 119 1 0 0 - 1 3 7 2 0 2 100 8 6 - 1 1 3 2 9 2 101 8 9 - 1 1 3
A l l  N e o p la s m s F r e e 540 109 1 0 0 - 1 1 8 241 109 9 5 - 1 2 2 3 1 9 89 7 9 -  99
B o th 188 132 1 1 3 -1 5 1 6 9 116 8 8 - 1 4 3 171 121 1 0 3 - 1 3 9
N e i t h e r 61 161 1 2 1 -2 0 1 5 5 92 6 8 - 1 1 6 8 5 98 7 7 - 1 1 9
C a . S to m a c h F r e e 62 152 1 1 4 - 1 8 9 21 116 7 2 - 1 7 7 2 3 80 5 1 - 1 2 0
B o th 16 1 3 3 7 6 - 2 1 7 9 183 8 4 - 3 4 7 17 148 8 6 - 2 3 7
N e i t h e r 3 96 2 0 - 2 8 2 4 82 2 2 - 2 0 9 5 72 2 3 - 1 6 8
C a . P e r i t o n e u m F r e e 5 4 8 9 1 5 8 - 1 1 4 0 2 511 6 2 - 1 8 4 4 0 _ 0 - 5 8 6
B o th 4 1506 4 1 0 - 3 8 5 5 0 - 0 - 3 8 5 4 1 - 1 1 - 2 4 9 1
N e i t h e r 1 1267 3 2 - 7 0 5 5 0 - 0 - 3 5 6 2 0 - 0 - 2 3 5 1
C a . L ung F r e e 154 8 7 7 2 -1 0 1 8 0 91 7 1 -1 1 1 121 8 6 7 0 - 1 0 1
B o th 69 132 1 0 1 - 1 6 3 16 66 3 8 - 1 0 7 67 117 8 9 - 1 4 5
N e i t h e r 18 134 7 9 -2 1 1 2 0 84 5 2 -1 3 1 30 8 8 6 0 - 1 2 6
C a . P l e u r a F r e e 37 1 4 9 5 1 0 1 3 - 1 9 7 6 14 144 7 7 9 1 - 2 4 2 8 12 719 3 7 1 - 1 2 5 6
B o th 25 3 7 2 2 2 4 3 5 - 5 5 5 3 . 7 2 8 3 5 1 1 3 8 -5 8 4 0 14 2 2 9 8 1 2 5 5 - 3 8 5 5
N e i t h e r 4 2 1 2 2 5 7 8 - 5 4 3 2 3 1194 2 4 6 -3 4 9 1 2 4 9 0 5 9 - 1 7 7 0
C i r c u l a t o r y  S y s te m F r e e 8 5 0 96 8 9 - 1 0 2 3 0 9 86 7 7 -  96 4 5 8 80 7 3 - 8 8
B o th 231 91 7 9 - 1 0 2 9 5 86 6 7 - 1 9 5 2 1 6 96 8 4 - 1 0 9
N e i t h e r 71 1 0 5 8 1 - 1 2 9 9 6 99 8 0 - 1 1 9 146 106 8 9 - 1 2 3
P u lm o n a r y  C i r c u l a t i o n F r e e 19 2 1 6 1 3 0 - 3 3 7 4 102 2 8 - 2 6 2 1 17 0 - 9 2
B o th 8 3 1 0 1 3 4 -6 1 1 0 - 0 - 3 4 6 1 41 1 - 2 3 1
N e i t h e r 1 149 4 - 8 2 9 0 - 0 - 3 5 0 2 137 1 7 - 4 9 6
R e s p i r a t o r y  S y s te m F r e e 132 90 7 4 - 1 0 5 6 3 84 6 3 - 1 0 5 8 8 77 6 1 -  9 4
B o th 43 100 7 0 - 1 3 0 17 85 5 0 - 1 3 7 4 3 95 6 7 - 1 2 3
N e i t h e r 17 151 8 8 - 2 4 2 2 7 131 8 6 - 1 9 0 29 106 7 1 - 1 5 3
B r o n c h i t i s ,  E m physem a F r e e 31 57 3 7 -  77 2 0 6 8 4 1 - 1 0 5 24 54 3 5 -  81
a n d  A s th m a B o th 10 62 3 0 - 1 1 4 7 88 3 5 -1 8 1 11 62 3 1 - 1 1 0
N e i t h e r 4 97 2 6 - 2 4 7 8 99 4 3 - 1 9 4 4 38 1 0 -  97
A s b e s t o s i s F r e e 4 1342 3 6 6 - 3 4 3 5 0 _ 0 - 3 0 6 8 1 4 9 5 1 3 - 2 7 5 8
B o th 3 345 7 7 1 3 - 1 0 1 0 7 0 - 0 - 1 1 5 6 0 0 - 0 - 4 5 8 1
N e i t h e r 0 - 0 - 1 6 2 9 5 0 - 0 - 1 1 1 7 2 2 4091 4 9 5 - 1 4 7 6 8
P u 1m o n a r y  F i  b r o s  i  s F r e e 0 _ 0 - 1 7 2 1 I l l 3 - 6 1 6 0 _ 0 - 2 5 8
B o th 2 3 1 5 3 8 - 1 1 3 9 0 - 0 - 1 5 0 0 0 - 0 - 6 3 8
N e i t h e r 0
'
0 - 2 2 3 9 0
'
0 - 1 4 9 4 1 2 9 0 7 - 1 6 1 8
* F r e e  
B o th
T h e  f r e e  q u e s t i o n n a i r e
B o th  t h e  f r e e  a n d  c o n t r o l l e d  q u e s t i o n n a i r e s .
A 3 - 15
T A B L E  A 3.10 : Cause specific mortality by dockyard for x-ray type (Small or 
Large).
C a u s e s  o f  D e a th X - r a y
t y p e
O bs
D e v o n p o r t
O bs
C h a th a m P o r t s m o u th
SMR 95X C l SMR 95X  C l O b s SMR 95X  C l
| A l l  C a u s e s S m a ll* 1334 8 9 8 4 -  9 3 6 6 7 8 8 8 1 -  94 8 5 9 78 7 3 -  8 3
B o th 622 1 0 7 9 9 - 1 1 5 2 7 6 1 0 2 8 7 - 1 1 4 601 1 0 2 9 3 - 1 1 0
N e i t h e r 3 2 3 1 2 0 1 0 7 - 1 3 3 102 94 7 5 - 1 1 2 2 3 2 1 0 2 8 4 - 1 0 8
A l l  N e o p la s m s S m a ll 4 4 5 1 0 3 9 3 - 1 1 2 2 2 8 101 8 8 - 1 1 4 2 8 0 8 4 7 4 -  9 4
B o th 230 1 3 7 1 1 9 -1 5 4 97 1 1 7 9 4 - 1 4 1 2 1 8 1 2 0 1 0 4 - 1 3 6
N e i t h e r 114 1 5 2 1 2 4 -1 7 9 4 0 1 2 3 8 5 - 1 6 2 77 1 0 7 8 3 - 1 3 1
C a . S to m a c h S m a ll 50 141 1 0 2 -1 8 0 24 1 3 0 8 4 - 1 9 4 16 6 0 3 5 -  9 8
B o th 2 3 1 6 2 1 0 3 -2 4 4 9 131 6 0 - 2 4 9 21 1 4 2 8 8 - 2 1 8
N e i t h e r 8 1 2 4 5 4 - 2 4 5 1 37 1 - 2 0 6 8 1 3 5 5 8 - 2 6 6
C a .  P e r i t o n e u m Sm al 1 5 5 4 8 1 7 8 - 1 2 7 9 2 4 9 2 6 0 - 1 7 7 6 0 _ 0 - 6 1 5
B o th 5 1 5 9 0 5 1 5 - 3 7 1 0 0 - 0 - 2 7 8 2 1 3 3 9 9 - 1 8 8 6
N e i t h e r 0 - 0 - 2 6 1 2 0 - 0 - 7 1 4 2 0 * 0 - 3 2 1 9
C a .  L ung S m a ll 127 8 3 6 8 -  97 70 79 6 0 -  97 101 7 8 6 2 -  9 3
B o th 80 1 3 0 1 0 1 - 1 5 8 32 9 5 6 2 - 1 2 8 8 6 1 1 7 9 2 - 1 4 2
N e i t h e r 34 1 2 5 8 3 - 1 6 7 14 1 0 7 5 9 - 1 8 0 31 1 0 8 7 0 - 1 4 6
C a .  P l e u r a S m a ll 33 1 4 8 7 9 7 9 - 1 9 9 4 16 1 5 9 6 9 1 3 - 2 5 9 1 10 6 2 8 3 0 1 - 1 1 5 4
B o th 26 3 3 2 6 2 1 7 2 - 4 8 7 3 7 2 0 6 9 8 3 1 - 4 2 6 2 16 1 9 9 7 1 1 4 2 - 3 2 4 3
N e i t h e r 7 2 1 4 2 8 6 0 - 4 4 1 2 1 8 0 4 2 0 - 4 4 7 7 2 6 8 4 8 3 - 2 4 6 8
C i r c u l a t o r y  S y s te m S m a ll 704 91 8 5 -  98 3 1 3 8 6 7 6 -  9 5 4 3 0 8 2 7 4 -  8 9
B o th 2 9 3 9 7 8 6 - 1 0 8 1 2 6 9 5 7 8 - 1 1 2 2 8 9 9 7 8 6 - 1 0 8
N e i t h e r 155 1 1 3 9 5 - 1 3 0 4 8 91 6 5 - 1 1 7 no 9 4 7 7 - 1 1 2
P u lm o n a r y  C i r c u l a t i o n S m a ll 17 2 2 4 1 3 1 - 3 5 9 0 _ 0 -  9 3 2 3 6 4 - 1 3 1
B o th 7 2 2 9 9 2 - 4 7 3 1 6 8 2 - 3 7 7 2 6 5 8 - 2 3 4
N e i t h e r 4 2 8 0 7 6 - 7 1 7 3 5 0 3 1 0 4 - 1 4 7 2 0 - 0 - 2 8 6
R e s p i r a t o r y  S y s te m S m a ll 102 81 6 5 -  97 64 8 4 6 4 - 1 0 5 71 6 9 5 3 -  8 5
B o th 57 1 1 2 8 2 -1 4 1 35 1 2 5 8 4 - 1 6 7 61 1 0 6 7 9 - 1 3 2
N e i t h e r 33 2 5 8 7 - 1 7 7 8 6 8 3 0 - 1 3 5 2 8 1 1 0 7 3 - 1 6 0
B r o n c h i t i s ,  E m physem a S m a ll 21 4 5 2 8 -  69 18 61 3 6 -  96 12 3 0 1 6 -  5 3
a n d  A s th m a B o th 13 6 8 3 6 - 1 1 6 15 1 3 4 7 5 - 2 2 1 16 7 0 4 0 - 1 1 4
N e i t h e r 11 1 1 9 5 9 - 2 1 3 2 4 3 5 - 1 5 6 11 1 1 2 5 6 - 2 0 0
A s b e s t o s i s S m a ll 2 7 6 2 9 2 -2 7 5 1 1 0 _ 0 - 3 0 0 6 3 1 5 8 8 3 2 8 - 4 6 4 2
B o th 4 3 9 1 8 1 0 6 8 - 1 0 0 3 0 0 - 0 - 8 1 1 2 0 - 0 - 3 5 5 3
N e i t h e r 1 2 3 2 6 5 9 - 1 2 9 5 3 0 - 0 - 2 1 7 2 3 0 - 0 - 9 5 5 4
P u lm o n a r y  F i b r o s i s S m a ll 1 54 1 - 3 0 0 0 _ 0 - 4 0 3 1 7 6 2 - 4 2 5
B o th 1 1 3 3 3 - 7 4 3 1 291 0 - 1 6 2 3 0 - 0 - 4 9 9
N e i t h e r 0 0 -1 0 7 1 0 0 - 2 6 9 6 0
'
0 - 1 2 2 5
* S m a ll  
B o th
T h e  s m a l l  100mm r a d i o g r a p h
B o th  t h e  s m a l l  a n d  l a r g e  r a d i o g r a p h s .
A 3 - 16
T A B L E A 3 . i l :  Cause specific mortality by age at start of employment and
dockyard.
C a u s e s  o f  D e a th A ge a t  
s t a r t  
( y r s )
O bs
D e v o n p o r t
O bs
C h a th a m
O bs
P o r t s m o u th
SMR 95X  C l SMR 9SX C l SMR 95X C l
A 1 1 C a u s e s < 25 9 3 9 9 5 8 9 - 1 0 1 399 9 0 8 1 -  9 9 611 8 2 7 5 -  88
2 5 - 4 4 2 96 8 7 - 1 0 5 195 9 2 8 0 - 1 0 5 2 9 9 92 8 1 - 1 0 2
3 5 - 3 3 2 88 7 9 -  9 8 106 1 0 3 8 3 - 1 2 2 2 3 7 8 8 7 7 -  99
4 5 - 2 8 5 97 8 6 - 1 0 8 73 81 6 2 -  99 145 88 7 4 - 1 0 3
55+ 8 5 104 8 2 - 1 2 6 47 6 8 4 9 -  88 39 79 5 4 - 1 0 3
U nknow n 4 7 141 1 0 0 -1 8 1 23 9 8 6 2 - 1 4 8 69 8 0 6 1 -  99
A l l  N e o p la s m s < 25 3 3 7 120 1 0 7 - 1 3 2 156 1 1 7 9 9 - 1 3 5 2 3 5 104 9 0 -1 1 7
2 5 - 150 114 9 6 - 1 3 2 75 1 1 9 9 2 - 1 4 6 9 5 95 7 6 -1 1 4
3 5 - 113 105 8 5 - 1 2 4 33 1 0 6 7 0 - 1 4 2 76 93 7 2 -1 1 4
4 5 - 8 3 98 7 7 - 1 1 9 23 8 3 5 3 - 1 2 5 49 9 8 7 1 - 1 2 6
55+ 33 146 9 6 - 1 9 6 14 7 3 4 0 - 1 2 3 14 9 5 5 2 -1 5 9
U nknow n 12 125 6 5 - 2 1 9 9 1 2 9 5 9 - 2 4 5 21 80 5 0 - 1 2 3
C a .  S to m a c h <25 35 156 1 0 5 - 2 0 8 16 151 8 6 - 2 4 5 2 3 129 8 2 - 1 9 3
2 5 - 17 153 8 9 - 2 4 5 7 1 3 2 5 3 - 2 7 2 9 111 5 1 -2 1 0
3 5 - 13 141 7 5 - 2 4 2 3 1 1 5 2 4 - 3 3 6 4 59 1 6 -1 5 2
4 5 - 11 149 7 5 - 2 6 7 1 44 1 - 2 4 3 3 73 1 5 -2 1 2
55+ 1 4 8 1 - 2 6 9 2 1 2 0 1 5 - 4 3 3 1 80 2 -4 4 4
U nknow n 1 1 2 3 3 - 6 8 8 1 1 7 4 4 - 9 6 8 0 - 0 - 1 7 3
C a .  P e r i t o n e u m < 25 9 1 3 7 0 6 2 7 - 2 6 0 1 2 7 5 8 9 2 - 2 7 3 5 1 2 2 8 6 -1 2 7 1
2 5 - 0 - 0 - 1 4 6 8 0 - 0 - 3 7 6 3 0 - 0 - 2 2 7 5
3 5 - 0 - 0 - 1 9 3 3 0 - 0 - 7 3 6 7 0 - 0 -3 0 2 7
4 5 - 0 - 0 - 2 6 7 8 0 - 0 - 9 1 8 0 0 - 0 -5 2 3 4
55+ 0 - 0 - 1 0 9 8 4 0 - 0 - 1 5 8 3 4 0 - 0 - 1 9 2 3 0
U nknow n 0 * 0 - 1 9 8 5 3 0 * 0 - 3 1 7 5 0 0 - 0 - 8 9 3 9
C a .  L ung < 25 9 3 9 5 7 5 - 1 1 4 44 8 5 6 0 - 1 1 0 78 8 8 6 9 - 1 0 8
2 5 - 36 75 5 1 - 1 0 0 22 8 6 5 4 - 1 3 0 35 87 5 8 -1 1 6
3 5 - 52 131 9 5 - 1 6 6 12 9 4 4 9 - 1 6 5 36 109 7 3 -1 4 4
4 5 - 26 8 3 5 4 -1 2 1 10 8 8 4 2 - 1 6 2 2 3 1 1 3 7 1 - 1 6 9
55+ 12 144 7 4 -2 5 1 5 6 5 2 1 - 1 5 3 7 116 4 6 - 2 3 9
U nknow n 4 114 3 1 - 2 9 3 3 1 0 8 2 2 - 3 1 5 9 8 6 3 9 -1 6 3
C a .  P l e u r a < 25 4 0 2 5 2 7 1 7 4 4 - 3 3 1 0 17 2 5 7 0 1 4 9 7 - 4 1 1 5 2 3 196 9 1 2 4 8 -2 9 5 4
2 5 - 14 2 2 4 4 1 2 2 6 - 3 7 6 5 3 1 2 4 3 2 5 6 - 3 6 3 3 2 4 5 6 5 5 -1 6 4 5
3 5 - 3 6 2 2 1 2 8 - 1 8 1 8 1 7 7 8 2 0 - 4 3 3 3 1 306 8 - 1 7 0 2
4 5 - 4 1 1 9 3 3 2 5 - 3 0 5 4 0 - 0 - 3 5 1 4 0 - 0 - 1 9 7 2
55+ 0 - 0 - 5 1 6 1 0 - 0 - 7 5 1 5 0 - 0 -7 9 1 4
U nknow n 1 2 2 8 0 5 8 - 1 2 7 0 1 0 - 0 - 1 2 8 9 5 0
*
0 - 3 3 4 4
A3 - 17
T A B L E  A 3 .11  (corn.): Cause specific mortality by age at start of employment and
dockyard.
1 C a u s e s  o f  D e a th A ge a t  
s t a r t
( y s )
O bs
D e v o n p o r t
O b s
C h a th a m
O b s
P o r t s m o u th
SMR 9 5 X  C l SMR 9 5 Z  C l SMR 9 5 Z  C l
j  C i r c u l a t o r y  S y s te m < 25 4 6 7 9 5 8 6 - 1 0 4 181 8 6 7 4 -  99 2 8 0 79 6 9 -  88
2 5 - 2 3 0 97 8 4 - 1 0 9 8 6 8 3 6 6 - 1 0 1 1 4 7 92 7 7 - 1 0 7
3 5 - 163 8 3 7 0 -  96 4 9 97 7 0 - 1 2 4 1 2 4 94 7 7 - 1 1 0
4 5 - 150 97 8 2 - 1 1 3 39 8 8 6 0 - 1 1 6 6 6 82 6 2 - 1 0 2
55* 44 102 7 2 - 1 3 2 2 4 71 4 5 - 1 0 6 18 74 4 4 - 1 1 7
Unknow n 27 158 1 0 4 - 2 3 0 12 107 5 5 - 1 8 6 3 9 9 3 6 4 - 1 2 2
P u lm o n a r y  C i r c u l a t i o n < 25 10 2 1 2 1 0 2 - 3 9 0 2 91 1 1 - 3 2 7 1 27 1 - 1 5 3
2 5 - 4 166 4 5 - 4 2 6 1 8 6 2 - 4 7 8 0 - 0 - 2 1 7
3 5 - 6 2 9 9 1 1 0 - 6 5 0 1 177 4 - 9 8 7 1 69 2 - 3 8 3
4 5 - 6 371 1 3 6 - 8 0 7 0 - 0 - 7 4 5 0 _ 0 - 4 1 1
55* 0 - 0 - 7 7 9 0 - 0 - 9 0 5 0 - 0 - 1 3 1 0
U nknow n 1 572 1 4 - 3 1 8 4 0 - 0 - 2 9 3 8 0 - 0 - 8 1 2
R e s p i r a t o r y  S y s te m < 25 74 99 7 6 - 1 2 1 31 78 5 0 - 1 0 5 4 9 74 5 3 -  9 5
2 5 - 37 91 6 2 - 1 2 1 21 92 5 7 -1 4 1 31 96 6 2 - 1 3 0
3 5 - 29 84 5 6 - 1 2 1 14 130 7 1 - 2 1 8 2 6 91 6 0 - 1 3 4
4 5 - 27 95 6 3 - 1 3 8 8 8 4 3 6 - 1 6 5 16 91 5 2 - 1 4 7
55+ 5 56 1 8 - 1 3 1 5 53 1 7 - 1 2 4 6 103 3 8 - 2 2 4
U nknow n 3 103 2 1 - 3 0 0 1 41 1 - 2 2 9 3 34 7 - 1 0 0
B r o n c h i t i s ,  E m physem a < 25 19 68 4 1 - 1 0 6 . 1 0 6 3 3 0 - 1 1 6 14 55 3 0 -  91
a n d  A s th m a 2 5 - 6 40 1 5 -  87 8 8 8 3 8 - 1 7 3 5 40 1 3 -  9 3
3 5 - 7 55 2 2 - 1 1 3 5 116 3 8 -2 7 1 9 81 3 7 - 1 5 4
4 5 - 8 75 3 3 - 1 4 9 3 79 1 6 -2 3 1 4 58 1 6 - 1 4 9
55* 1 31 1 - 1 7 0 1 29 1 - 1 6 0 3 133 2 7 - 3 8 7
U nknow n 0 - 0 - 3 3 2 0 0 - 3 8 3 0 - 0 - 1 0 8
A s b e s t o s i s < 25 4 2 3 0 3 6 2 8 - 5 8 9 7 0 _ 0 - 4 8 9 6 0 _ 0 - 2 8 0 9
2 5 - 1 1 2 5 3 3 2 - 6 9 8 2 0 - 0 - 1 1 0 2 4 0 - 0 - 6 5 1 2
3 5 - 1 15 4 0 3 9 - 8 5 7 6 0 - 0 - 2 1 5 2 3 0 - 0 - 8 1 5 0
4 5 - 1 2 0 3 3 5 1 - 1 1 3 2 6 0 - 0 - 2 4 1 3 8 0 - 0 - 1 3 5 2 8
5 5 * 0 - 0 - 3 1 7 1 1 0 - 0 - 4 4 1 7 3 1 13471 3 4 1 - 7 5 0 3 5
U nknow n 0 - 0 - 6 5 0 0 1 0 0 - 9 9 9 8 7 0 - 0 - 2 5 4 0 3
P u lm o n a r y  F i b r o s i s <25 1 86 2 - 4 8 1 0 _ 0 - 7 1 6 0 _ 0 - 4 2 5
2 5 - 0 - 0 - 6 3 2 0 - 0 - 1 3 7 4 0 - 0 - 9 0 5
3 5 - 1 204 5 - 1 1 3 9 0 - 0 - 2 8 4 6 0 - 0 - 1 0 7 2
4 5 - 0 - 0 - 9 2 8 1 8 5 0 2 2 - 4 7 3 7 0 - 0 - 1 7 3 6
55* 0 - 0 - 3 2 3 8 0 - 0 - 4 1 0 8 0 - 0 - 5 5 8 0
U nknow n 0
'
0 - 8 6 1 8 0 ~ 0 - 1 2 8 7 2 0
'
0 - 3 4 3 0
A 3  - 18
T A B L E  A 3 .12 : Cause specific mortality by year of start of employment and by
dockyard.
i C a u s e s  o f  D e a th Y e a r  o f  
s t a r t
O bs
D e v o n p o r t
O bs
C h a th a m
O b s
P o r t s m o u th
SMR 9 5 *  C l SMR 95 X  C l SMR 95X Cl
A l l C a u s e s P r e  1 9 3 0 149 86 7 2 -  99 74 91 7 0 - m 9 7 86 6 9 - 1 0 3
1 9 3 0 - 584 90 8 3 -  97 3 3 7 98 8 8 - 1 0 9 3 9 2 81 7 3 -  89
1 9 4 0 - 4 3 4 102 9 2 -1 1 1 146 80 6 7 -  93 3 3 6 85 7 6 -  94
1 9 5 0 - 4 3 3 89 8 1 -  98 108 89 7 2 - 1 0 5 2 4 7 82 7 2 -  92
1 960+ 4 8 3 103 9 4 - 1 1 2 1 5 5 82 6 9 -  95 2 5 9 98 8 6 - 1 1 0
U nknow n 4 7 141 1 0 0 -1 8 1 2 3 98 6 2 - 1 4 8 6 9 80 6 1 -  99
A l l N e o p la s m s P r e  1 9 3 0 56 116 8 6 - 1 4 6 2 6 109 7 1 - 1 5 9 4 4 133 9 4 - 1 7 2
1 9 3 0 - 2 1 3 113 9 7 - 1 2 8 129 123 1 0 2 - 1 4 4 1 4 8 99 8 3 - 1 1 5
1 9 4 0 - 152 123 1 0 3 - 1 4 2 59 106 7 9 - 1 3 3 101 83 6 7 -  99
1 9 5 0 - 1 4 3 104 8 7 - 1 2 1 4 0 112 7 7 - 1 4 7 8 3 92 7 2 -1 1 1
1 960+ 152 117 9 9 - 1 3 6 4 7 87 6 2 - 1 1 2 9 3 119 9 5 - 1 4 3
U nknow n 12 125 6 5 - 2 1 9 9 129 5 9 - 2 4 5 21 80 5 0 - 1 2 3
C a . S to m a c h P r e  1 9 3 0 6 136 5 0 - 2 9 6 6 2 8 8 1 0 6 - 6 2 7 2 71 9 - 2 5 5
1 9 3 0 - 2 5 155 1 0 1 - 2 2 9 11 126 6 3 - 2 2 5 1 8 148 8 8 - 2 3 4
1 9 4 0 - 21 2 0 9 1 2 9 - 3 2 0 7 155 6 2 - 3 2 0 11 113 5 6 - 2 0 2
1 9 5 0 - 11 98 4 9 - 1 7 5 2 70 8 - 2 5 3 4 55 1 5 -1 4 1
1 9 6 0 + 14 135 7 4 - 2 2 7 3 70 1 4 - 2 0 4 5 82 2 7 - 1 9 2
U nknow n 1 123 3 - 6 8 8 1 174 4 - 9 6 8 0 - 0 - 1 7 3
C a . P e r  i  to n e u m P r e  1 9 3 0 2 2 7 8 9 3 3 8 - 1 0 0 7 0 . 1 320 6 8 1 - 1 7 8 5 7 0 _ 0 - 8 7 7 8
1 9 3 0 - 1 3 1 0 8 - 1 7 2 8 0 - 0 -2 3 3 1 1 4 5 8 1 2 -2 5 4 9
1 9 4 0 - 4 151 8 4 1 4 - 3 8 8 7 0 - 0 -3 5 1 1 0 - 0 - 1 6 9 2
1 9 5 0 - 2 6 4 6 7 8 - 2 3 3 3 0 - 0 - 4 8 3 3 0 - 0 -2 1 0 1
1 9 6 0 - 0 - 0 - 1 2 1 6 1 9 5 5 2 4 - 5 3 1 9 0 - 0 - 2 3 3 8
U nknow n 0 - 0 - 1 9 8 5 3 0 0 - 3 1 7 5 0 0 - 0 - 8 9 3 9
! C a . L u n g P r e  1 9 3 0 14 79 4 3 - 1 3 2 8 81 3 5 - 1 6 0 1 5 I l l 6 2 - 1 8 4
1 9 3 0 - 61 86 6 5 - 1 0 8 39 90 6 2 - 1 1 8 6 0 98 7 3 - 1 2 3
1 9 4 0 - 4 3 96 6 8 - 1 2 5 19 8 5 5 1 - 1 3 3 3 2 66 4 3 -  89
1 9 5 0 - 4 5 93 6 6 - 1 2 1 14 104 5 7 - 1 7 4 31 8 9 5 7 - 1 2 0
1 960+ 56 126 9 3 - 1 5 9 13 6 3 3 4 - 1 0 9 41 138 9 6 - 1 8 0
U nknow n 4 114 3 1 - 2 9 3 3 108 2 2 - 3 1 5 9 86 3 9 - 1 6 3
C a . P l e u r a P r e  1 9 3 0 8 5 1 1 8 2 2 0 7 - 1 0 0 8 2 1 1424 3 6 - 7 9 3 3 5 50 7 2 1 6 4 3 -1 1 8 3 8
1 9 3 0 - 2 3 2791 1 7 6 9 - 4 1 8 7 14 3 4 0 8 1 8 6 2 - 5 7 1 9 11 1821 9 0 9 - 3 2 5 9
1 9 4 0 - 14 2 0 0 6 1 0 9 6 - 3 3 6 7 4 138 8 3 7 8 - 3 5 5 4 4 642 1 7 5 -1 6 4 4
1 9 5 0 - 11 1467 7 3 2 - 2 6 2 5 1 549 1 4 - 3 0 5 5 5 1091 3 5 3 - 2 5 4 7
1 960+ 5 748 2 4 2 - 1 7 4 7 1 427 1 1 - 2 3 7 8 1 260 7 -1 4 4 8
U nknow n 1 2 2 8 0 5 8 -1 2 7 0 1 0
'
0 - 1 2 8 9 5 0
'
0 - 3 3 4 4
A 3 - 19
T A B L E  A 3 .1 2  (cont.): Cause specific mortality b y  year of start of employment and
by dockyard.
C a u s e s  o f  D e a th Y e a r  o f  
s t a r t
O bs
D e v o n p o r t
O bs
C h a th a m
O b s
P o r t s m o u t h
SMR 95X  C l SMR 95X  C l SMR 95X C l
i C i  r c u 1a t o r y  S y s te m P r e  1 9 3 0 73 80 6 1 -  98 37 92 6 2 - 1 2 2 4 4 79 5 6 - 1 0 3
1 9 3 0 - 308 91 8 1 -1 0 1 157 9 3 7 9 - 1 0 8 186 79 6 7 -  90
1 9 4 0 - 224 101 8 8 - 1 1 5 58 65 4 8 -  8 2 169 8 7 7 4 - 1 0 0
1 9 5 0 - 2 2 2 90 7 8 - 1 0 2 51 8 8 6 4 - 1 1 2 1 2 3 8 4 7 0 -  99
1 9 6 0 + 2 2 7 101 8 8 - 1 1 4 76 88 6 8 - 1 0 8 1 1 3 9 3 7 6 - 1 1 0
U nknow n 27 158 1 0 4 - 2 3 0 12 1 0 7 5 5 - 1 8 6 39 9 3 6 4 - 1 2 2
P u lm o n a r y  C i r c u l a t i o n P r e  1 9 3 0 3 2 9 9 6 2 - 8 7 5 2 4 1 7 5 0 - 1 S 0 4 1 1 5 3 4 - 8 5 4
1 9 3 0 - 6 173 6 3 - 3 7 6 1 53 1 - 2 9 6 0 - 0 - 1 4 4
1 9 4 0 - 3 141 2 9 - 4 1 3 0 - 0 - 3 9 8 1 50 1 - 2 7 9
1 9 5 0 - 8 3 3 5 1 4 5 - 6 6 0 1 1 6 6 4 - 9 2 3 0 - 0 - 2 4 6
I 9 6 0 - 6 2 6 9 9 9 - 5 8 5 0 - 0 - 3 8 9 0 - 0 - 2 9 0
U nknow n 1 572 1 4 - 3 1 8 4 0 - 0 - 2 9 3 8 0 - 0 - 8 1 2
R e s p i r a t o r y  S y s te m P r e  1 9 3 0 12 64 3 3 - 1 1 2 7 70 2 8 - 1 4 5 6 4 4 1 6 -  9 5
1 9 3 0 - 39 66 4 6 -  87 34 95 6 3 - 1 2 7 3 3 6 7 4 4 -  91
1 9 4 0 - 40 118 8 2 - 1 5 5 15 91 5 1 - 1 5 0 4 0 111 7 6 - 1 4 5
1 9 5 0 - 32 82 5 3 - 1 1 0 7 62 2 5 - 1 2 7 21 75 4 7 - 1 1 5
1 9 6 0 - 49 132 9 5 - 1 6 9 16 8 5 4 9 - 1 3 9 2 8 1 1 9 7 9 - 1 7 2
U nknow n 3 1 0 3 2 1 - 3 0 0 1 41 1 - 2 2 9 3 34 7 - 1 0 0
B r o n c h i t i s ,  E m physem a P r e  1 9 3 0 4 59 1 6 - 1 5 0 3 76 1 6 - 2 2 2 0 _ 0 -  70
a n d  A sth m a 1 9 3 0 - 8 36 1 6 -  72 12 84 4 3 - 1 4 6 9 4 7 2 1 -  8 9
1 9 4 0 - 11 87 4 4 - 1 5 6 4 61 1 7 - 1 5 6 11 78 3 9 - 1 3 9
1 9 5 0 - 9 62 2 9 - 1 1 8 1 2 3 1 - 2 6 7 6 5 2 6 - 1 3 3
1 9 6 0 + 9 66 3 0 - 1 2 5 7 97 3 9 - 2 0 0 8 8 8 3 8 - 1 7 3
U nknow n 0 - 0 - 3 3 2 0 - 0 - 3 8 3 0 - 0 - 1 0 8
A s b e s t o s i s P r e  1 9 3 0 1 3 9 2 8 9 9 - 2 1 8 7 9 0 _ 0 - 3 1 6 8 9 0 _ 0 - 2 2 8 1 8
1 9 3 0 - 2 1 7 3 7 2 1 0 - 6 2 7 2 0 - 0 - 6 3 4 4 0 - 0 - 4 3 7 4
1 9 4 0 - 1 1251 3 2 - 6 9 6 8 0 - 0 - 1 1 1 0 9 0 - 0 - 5 0 5 5
1 9 5 0 - 1 1191 3 0 - 6 6 3 4 0 - 0 - 1 9 3 3 8 0 - 0 - 7 1 4 4
1 9 6 0 + 2 2 6 7 6 3 2 4 -9 6 6 1 0 - 0 - 1 3 4 0 7 1 2 3 3 5 5 9 - 1 3 0 0 7
U nknow n 0 - 0 -6 5 0 0 1 0 - 0 - 9 9 9 8 7 0 * 0 - 2 5 4 0 3
P u lm o n a r y  F i b r o s i s P r e  1 9 3 0 0 _ 0 - 1 5 2 9 0 _ 0 - 3 3 9 3 0 _ 0 -2 4 5 1
1 9 3 0 - 0 - 0 - 4 3 0 0 - 0 - 8 3 5 0 - 0 - 5 9 4
1 9 4 0 - 2 3 9 3 4 8 - 1 4 1 7 0 - 0 - 1 7 2 5 0 _ 0 - 7 8 6
1 9 5 0 - 0 - 0 - 6 3 2 1 7 2 3 1 8 - 4 0 2 5 0 - 0 -1 0 4 1
1 9 6 0 + 0 - 0 - 6 7 3 0 - 0 - 1 6 8 9 0 - 0 - 1 2 1 9
U nknow n 0
'
0 - 8 6 1 8 0
'
0 - 1 2 8 7 2 0
'
0 - 3 4 3 0
A3 - 20
T A B L E  A 3 .13 : Cause specific mortality by length of service and dockyard.
C a u s e s  o f  D e a t h L e n g t h  o f  
s e r v i c e  
( y r s )
Obs
) e v o n p o r t
O bs
C h a th a m P o r t s m o u th
SMR 95X  C l SMR 9 5 Z  C l O b s SMR 9SX  C l
A l l C a u s e s < 5 128 9 8 8 1 - 1 1 5 56 77 5 7 -  97 7 2 8 7 6 7 - 1 0 7
5 - 224 1 0 8 9 4 - 1 2 2 72 8 5 6 5 - 1 0 5 8 3 92 7 2 - 1 1 2
1 0 - 412 9 2 8 3 - 1 0 1 87 81 6 4 -  98 2 3 3 92 8 0 - 1 0 4
2 0 - 431 9 8 8 9 - 1 0 7 154 90 7 6 - 1 0 4 3 3 3 8 3 7 4 -  92
30+ 888 91 8 5 -  97 451 94 8 5 - 1 0 2 6 1 0 84 7 7 -  90
U nknow n 47 141 1 0 0 -1 8 1 2 3 9 8 6 2 - 1 4 8 6 9 80 6 1 -  99
A l l N e o p la s m s < 5 45 1 2 6 8 9 - 1 6 3 18 87 5 1 - 1 3 7 2 6 107 7 0 - 1 5 7
5 - 55 9 5 7 0 - 1 2 0 22 91 5 7 - 1 3 7 2 9 109 7 3 - 1 5 7
1 0 - 143 1 1 3 9 5 - 1 3 2 28 91 6 0 - 1 3 1 8 5 112 8 8 - 1 3 6
2 0 - 141 111 9 3 - 1 3 0 62 119 8 9 - 1 4 9 9 6 78 6 3 -  94
30+ 332 1 1 8 1 0 5 - 1 3 0 171 117 9 9 - 1 3 4 2 3 3 104 9 1 - 1 1 7
U nknow n 12 1 2 5 6 5 - 2 1 9 9 129 5 9 - 2 4 5 21 8 0 5 0 - 1 2 3
C a . S to m a c h < 5 5 1 8 2 5 9 - 4 2 6 2 122 1 5 - 4 4 0 1 53 1 - 2 9 8
5 - 6 1 3 0 4 8 - 2 8 3 1 51 1 - 2 8 5 2 97 1 2 - 3 5 0
1 0 - 10 97 4 6 - 1 7 8 0 - 0 - 1 5 0 5 8 3 2 7 - 1 9 3
2 0 - 15 1 4 6 8 2 - 2 4 1 6 142 5 2 - 3 1 0 8 81 3 5 - 1 6 0
30+ 41 1 7 0 1 1 8 - 2 2 2 2 0 164 1 0 0 - 2 5 3 2 4 131 8 4 - 1 9 5
U nknow n 1 1 2 3 3 - 6 8 8 1 174 4 - 9 6 8 0 - 0 - 1 7 3
C a . P e r i t o n e u m < 5 0 _ 0 - 4 2 1 4 1 2501 6 3 - 1 3 9 3 3 0 _ 0 - 7 4 9 9
5 - 0 - 0 - 2 7 3 2 0 - 0 - 8 0 8 5 0 - 0 - 6 7 9 0
1 0 - 1 3 5 5 9 - 1 9 7 6 0 - 0 - 5 3 9 6 0 - 0 - 2 5 0 9
2 0 - 5 1 7 9 8 5 8 3 - 4 1 9 8 0 - 0 - 3 7 4 9 1 2 9 4 0 - 1 6 6 4
30+ 3 6 1 5 1 2 7 - 1 7 9 8 1 4 4 8 1 1 - 2 4 9 5 0 - 7 - 1 6 4 0
U nknow n 0 - 0 - 1 9 8 5 3 0 0 - 3 1 7 5 0 0 - 0 - 8 9 3 9
C a . L ung < 5 11 9 2 4 6 - 1 6 5 4 51 1 4 - 1 3 0 12 131 6 8 - 2 2 8
5 - 21 1 0 6 6 6 - 1 6 2 8 86 3 7 - 1 6 9 12 1 1 9 6 2 - 2 0 9
1 0 - 58 131 9 8 - 1 6 5 8 70 3 0 - 1 3 7 32 1 0 9 7 1 - 1 4 7
2 0 - 40 8 9 6 1 - 1 1 7 2 3 112 7 1 - 1 6 8 36 75 5 0 -  9 9
30+ 89 8 5 6 7 - 1 0 3 50 8 3 6 0 - 1 0 6 8 7 9 5 7 5 - 1 1 5
U nknow n 4 1 1 4 3 1 - 2 9 3 3 108 2 2 - 3 1 5 9 8 6 3 9 - 1 6 3
C a . P l e u r a < 5 2 1 0 4 0 1 2 6 - 3 7 5 3 1 1082 2 7 - 6 0 2 4 0 _ 0 - 3 0 2 6
5 - 1 3 3 8 9 - 1 8 8 2 0 - 0 - 3 6 4 3 0 - 0 - 2 8 1 3
1 0 - 9 1 3 6 6 6 2 5 - 2 5 9 1 0 - 0 - 2 3 7 7 3 8 1 2 1 6 8 - 2 3 7 4
2 0 - 10 1 3 9 5 6 6 9 - 2 5 6 5 4 152 9 4 1 7 - 3 9 1 4 4 6 5 2 1 7 8 - 1 6 7 0
30+ 39 3 1 6 7 2 1 7 3 - 4 1 6 1 16 2 7 8 3 1 5 9 1 - 4 5 1 8 19 2 0 3 7 1 2 2 7 - 3 1 8 2
U nknow n 1 2 2 8 0 5 8 - 1 2 7 0 1 0 0 - 1 2 8 9 5 0
'
0 - 3 3 4 4
A 3  - 21
T A B L E  A 3 .13  (cont.): Cause specific mortality by length o f  service and dockyard.
C a u s e s  o f  D e a th L e n g th  o f  
s e r v  i c e  
( y r s )
O b s
D e v o n p o r t
O bs
C h a th a m
O bs
P o r t s m o u t h
SMR 9SZ  C l SMR 95%  C l SMR 95%  C l
C i r c u l a t o r y  S y s t e m < 5 5 6 93 6 9 - 1 1 7 24 73 4 6 - 1 0 8 2 8 75 5 0 - 1 0 8
5 - 1 1 5 114 9 3 - 1 3 5 35 90 6 0 - 1 1 9 37 90 6 1 - 1 1 9
1 0 - 2 0 5 91 7 8 - 1 0 3 4 6 92 6 5 - 1 1 9 111 92 7 5 - 1 0 9
2 0 - 2 2 8 101 8 8 - 1 1 4 66 79 6 0 -  9 8 172 8 8 7 5 - 1 0 1
30+ 4 5 0 88 8 0 -  96 2 0 8 8 8 7 6 - 1 0 0 2 8 7 8 0 7 1 -  90
U nknow n 2 7 158 1 0 4 - 2 3 0 12 107 5 5 - 1 8 6 39 9 3 6 4 - 1 2 2
P u lm o n a r y  C i r c u l a t i o n < 5 0 _ 0 - 6 2 7 0 _ 0 - 1 0 2 5 0 _ 0 - 9 5 4
5 - 4 400 1 0 9 - 1 0 2 5 0 - 0 - 8 4 9 0 - 0 - 8 5 8
1 0 - 7 316 1 2 7 -6 5 1 1 190 5 - 1 0 6 1 0 - 0 - 2 9 3
2 0 - 5 231 7 5 - 5 3 9 0 - 0 - 4 2 3 1 4 9 1 - 2 7 4
30+ 1 0 190 9 1 - 3 5 0 3 113 2 3 - 3 3 1 1 26 1 - 1 4 4
U nknow n 1 572 1 4 - 3 1 8 4 0 - 0 - 2 9 3 8 0 - 0 - 8 1 2
R e s p i r a t o r y  S y s t e m < 5 1 4 146 8 0 - 2 4 6 7 98 3 9 - 2 0 2 7 9 8 3 9 - 2 0 2
5 - 2 4 144 9 2 - 2 1 4 8 92 4 0 - 1 8 2 11 139 6 9 - 2 4 8
1 0 - 3 2 87 5 7 - 1 1 7 5 49 1 6 - 1 1 6 19 8 0 4 8 - 1 2 5
2 0 - 3 4 99 6 5 - 1 3 2 14 89 4 8 - 1 4 9 40 107 7 4 - 1 4 0
30+ 6 8 76 5 8 -  94 4 5 89 6 3 - 1 1 5 51 6 9 5 0 -  88
U nknow n 3 103 2 1 - 3 0 0 1 41 1 - 2 2 9 3 34 7 - 1 0 0
B r o n c h i t i s ,  E m physem a < 5 0 _ 0 - 1 0 4 3 111 2 3 - 3 2 4 3 109 2 2 - 3 1 7
a n d  A sth m a 5 - 6 98 3 6 - 2 1 3 4 120 3 3 - 3 0 6 3 97 2 0 - 2 8 5
1 0 - 1 0 73 3 5 - 1 3 5 0 - 0 -  9 5 5 55 1 8 - 1 2 7
2 0 - 1 0 78 3 8 - 1 4 4 4 64 1 7 - 1 6 3 12 8 2 4 3 - 1 4 4
30+ 1 5 45 2 5 -  74 16 79 4 5 - 1 2 8 12 4 2 2 1 -  72
U nknow n 0 - 0 - 3 3 2 0 - 0 - 3 8 3 0 - 0 - 1 0 8
A s b e s t o s i s < 5 0 _ 0 - 1 7 8 0 9 0 _ 0 - 3 4 1 2 7 0 _ 0 - 2 7 5 3 0
5 - 2 60 3 7 7 3 0 - 2 1 7 9 3 0 - 0 - 2 9 9 9 2 1 6 8 8 8 1 7 4 - 3 8 3 6 9
1 0 - 0 - 0 - 4 9 9 9 0 - 0 - 2 3 7 7 3 0 - 0 - 8 9 1 8
2 0 - 2 24 2 7 2 9 4 -8 7 6 1 0 - 0 - 1 1 9 9 5 0 - 0 - 5 0 6 9
30+ 3 1774 3 6 6 - 5 1 8 5 0 - 0 - 4 6 0 0 0 - 0 -2 9 3 1
U nknow n 0 - 0 - 6 5 0 0 1 0 - 0 - 9 9 9 8 7 0 - 0 - 2 5 4 0 3
P u lm o n a r y  F i b r o s i s < 5 0 _ 0 - 2 5 5 5 0 _ 0 - 4 4 5 7 0 _ 0 - 3 9 9 7
5 - 0 - 0 - 1 5 0 9 0 - 0 - 3 7 0 1 0 - 0 - 3 6 3 2
1 0 - 0 - 0 - 6 8 0 1 8 3 2 2 1 - 4 6 3 4 0 - 0 - 1 2 3 3
2 0 - 1 189 5 - 1 0 5 4 0 - 0 - 1 8 0 3 0 - 0 - 7 6 6
3 0 * 1 78 2 - 4 3 5 0 - 0 - 6 0 1 0 - 0 - 4 0 0
Unknow n 0 0 - 8 6 1 8 0
'
0 - 1 2 8 7 2 0
*
0 - 3 4 3 0
A3 - 22
T A B L E  A 3 .14 : Cause specific mortality by time since start of employment and by
dockyard.
C a u s e s  o f  D e a t h T im e  s i n c e  
s t a r t  o f  
e m p lo y .
O bs
D e v o n p o r t
O bs
C h a th a m
O bs
P o r t s m o u th
SMR 95X C l SMR 95X C l SMR 95X C l
A l l C a u s e s < 10 71 9 6 7 4 - 1 1 8 24 7 2 4 6 - 1 0 7 32 81 5 3 - 1 0 9
1 0 - 324 1 0 5 9 4 - 1 1 6 9 5 7 9 6 3 -  9 5 146 8 9 7 4 - 1 0 3
2 0 - 3 9 9 91 8 2 - 1 0 0 1 1 3 9 0 7 3 - 1 0 6 2 5 6 9 3 8 2 - 1 0 5
30+ 128 9 9 3 8 8 -  98 5 8 8 9 2 8 5 - 1 0 0 8 9 7 8 3 7 8 -  8 9
U nknow n 47 141 1 0 0 -1 8 1 2 3 9 8 6 2 - 1 4 8 6 9 8 0 6 1 -  9 9
A l l N e o p la s m s < 10 19 101 6 1 - 1 5 8 8 8 8 3 8 - 1 7 4 10 9 3 4 5 - 1 7 2
1 0 - 95 111 8 8 - 1 3 3 28 81 5 4 - 1 1 7 50 1 0 3 7 4 -1 3 1
2 0 - 132 1 0 7 8 9 - 1 2 5 36 9 9 6 7 -1 3 1 8 5 104 8 2 - 1 2 6
30+ 4 7 0 1 1 7 1 0 7 -1 2 8 2 2 9 1 1 8 1 0 2 - 1 3 3 324 9 8 8 7 - 1 0 8
U nknow n 12 1 2 5 6 5 - 2 1 9 9 1 2 9 5 9 - 2 4 5 21 8 0 5 0 - 1 2 3
C a . S to m a c h < 10 1 6 3 2 - 3 5 0 1 1 2 3 3 - 6 8 6 0 _ 0 - 4 0 2
1 0 - 12 171 8 8 - 2 9 8 2 7 2 9 - 2 6 0 4 102 2 8 - 2 6 2
2 0 - 9 8 8 4 0 - 1 6 8 2 6 7 8 - 2 4 3 5 75 2 4 - 1 7 4
30+ 55 1 6 5 1 2 1 -2 0 9 24 151 9 7 - 2 2 4 31 1 1 7 7 6 - 1 5 8
Unknow n 1 1 2 3 3 - 6 8 8 1 1 7 4 4 - 9 6 8 0 - 0 - 1 7 3
C a . P e r i t o n e u m < 10 0 _ 0 - 5 4 3 2 0 _ 0 - 1 4 3 6 8 0 _ 0 - 1 1 2 6 2
1 0 - 1 4 6 7 1 2 -2 6 0 2 1 1 4 7 2 3 7 -8 2 0 1 0 _ 0 - 3 5 1 9
2 0 - 0 - 0 - 1 3 0 8 0 - 0 - 4 7 5 0 0 _ 0 - 2 2 3 9
30+ 8 1 1 3 3 4 8 8 -2 2 3 1 1 3 2 9 8 - 1 8 3 0 1 196 5 - 1 0 9 3
Unknow n 0 - 0 - 1 9 8 5 3 0 - 0 - 3 1 7 5 0 0 - 0 - 8 9 3 9
C a . L ung < 10 6 8 9 3 3 -1 9 4 3 81 1 7 - 2 3 8 4 9 5 2 6 - 2 4 3
1 0 - 30 9 9 6 7 - 1 4 2 8 6 0 2 6 - 1 1 9 2 5 1 3 2 8 5 - 1 9 5
2 0 - SO 1 1 6 8 4 - 1 4 8 11 7 9 4 0 - 1 4 2 32 100 6 5 - 1 3 4
30+ 133 91 7 6 - 1 0 7 71 9 0 6 9 -1 1 1 118 8 9 7 3 - 1 0 5
Unknow n 4 1 1 4 3 1 - 2 9 3 3 1 0 8 2 2 - 3 1 5 9 8 6 3 9 - 1 6 3
C a . P l e u r a < 10 0 _ 0 - 4 3 8 5 1 2 8 8 0 7 3 - 1 6 0 4 3 0 _ 0 - 7 9 1 2
1 0 - 4 9 6 5 2 6 3 -2 4 7 1 0 - 0 - 2 5 6 8 0 - 0 - 1 6 1 9
2 0 - 11 1 7 1 7 8 5 7 -3 0 7 1 0 - 0 - 2 1 4 0 5 1 2 8 4 4 1 6 - 2 9 9 6
30+ 46 235 1 1 6 7 2 -3 0 3 0 20 2 3 9 6 1 4 6 4 -3 7 0 0 21 1 3 9 6 8 6 4 - 2 1 3 4
U nknow n 1 2 2 8 0 5 8 -1 2 7 0 1 0 0 - 1 2 8 9 5 0
'
0 - 3 3 4 4
A 3 - 23
T A B L E  A 3 .14  (cont.): Cause specific mortality by time since start of employment
and by dockyard.
C a u s e s  o f  D e a t h T im e  s i n c e  
s t a r t  o f  
e m p lo y .
D e v o n p o r t
O bs
C h a th a m
O bs
P o r t s m o u t h
O bs SMR 95X  C l SMR 95X  C l SMR 95X C l
C i r c u l a t o r y  S y s t e m < 10 33 1 0 2 6 7 - 1 3 7 10 6 9 3 3 - 1 2 6 10 5 9 2 8 - 1 0 8
1 0 - 1 6 5 n o 9 3 - 1 2 7 4 8 87 6 2 - 1 1 2 70 9 2 7 1 -1 1 4
2 0 - 2 0 6 9 3 8 0 - 1 0 5 58 97 7 2 - 1 2 3 123 9 3 7 7 - 1 1 0
30+ 6 5 0 9 0 8 3 -  97 2 6 3 84 7 4 -  94 4 3 2 8 2 7 4 -  90
U nknow n 27 1 5 8 1 0 4 - 2 3 0 12 107 5 5 - 1 8 6 39 9 3 6 4 - 1 2 2
P u lm o n a r y  C i r c u l a t i o n < 10 1 3 0 7 8 - 1 7 0 8 0 _ 0 -2 2 4 1 0 _ 0 - 1 8 8 6
1 0 - 7 4 3 9 1 7 6 - 9 0 4 0 - 0 - 5 6 6 0 - 0 - 4 3 3
2 0 - 5 2 2 6 7 3 - 5 2 7 1 1 5 9 4 - 8 8 6 0 - 0 -2 6 1
30+ 13 1 8 4 9 8 - 3 1 4 3 8 8 1 8 - 2 5 8 2 3 6 4 -1 3 1
U nknow n 1 5 7 2 1 4 - 3 1 8 4 0 - 0 - 2 9 3 8 0 - 0 - 8 1 2
R e s p i r a t o r y  S y s t e m < 10 15 2 7 3 1 5 3 - 4 5 0 5 157 5 1 - 3 6 6 9 2 7 2 1 2 5 -5 1 7
1 0 - 29 1 1 8 7 9 - 1 6 9 8 6 8 2 9 -1 3 1 11 7 5 3 7 -1 3 4
2 0 - 27 76 5 0 - 1 1 0 8 67 2 9 -1 3 1 31 1 2 2 7 9 -1 6 5
30+ 101 8 3 6 7 -  99 58 8 9 6 6 - 1 1 2 77 7 2 5 6 -  8 8
U nknow n 3 1 0 3 2 1 - 3 0 0 1 41 1 - 2 2 9 3 3 4 7 - 1 0 0
B r o n c h i t i s ,  E m physem a < 1 0 0 _ 0 - 1 4 4 2 127 1 5 - 4 5 7 2 1 2 6 1 5 -4 5 5
a n d  A s th m a 1 0 - 8 8 2 3 5 -1 6 1 3 64 1 3 - 1 8 6 3 4 9 1 0 -1 4 4
2 0 - 7 53 2 1 - 1 0 8 3 6 3 1 3 - 1 8 5 9 8 7 4 0 - 1 6 5
30+ 26 59 3 9 -  8 7 19 7 5 4 5 - 1 1 7 21 5 2 3 2 -  7 9
U nknow n 0 - 0 - 3 3 2 . 0 0 - 3 8 3 0 - 0 - 1 0 8
A s b e s t o s i s < 10 0 _ 0 - 3 7 6 7 6 0 _ 0 - 8 7 1 7 4 0 _ 0 - 6 8 4 5 2
1 0 - 1 2 0 6 4 5 2 - 1 1 4 9 7 0 - 0 - 2 1 0 0 4 1 3 7 7 2 9 5 -2 1 0 1 1
2 0 - 1 1 3 7 8 3 5 - 7 6 7 8 0 - 0 - 1 9 4 3 8 0 - 0 - 8 2 5 7
30+ 5 2 0 1 3 6 5 2 - 4 6 9 8 0 - 0 - 3 3 9 0 0 - 0 - 1 9 2 7
U nknow n 0 - 0 - 6 5 0 0 1 0 - 0 - 9 9 9 8 7 0 0 - 2 5 4 0 3
P u lm o n a r y  F i b r o s i s < 10 0 _ 0 - 3 8 3 8 0 _ 0 - 8 4 2 4 0 _ 0 - 7 5 1 6
1 0 - 0 - 0 - 1 0 1 8 0 - 0 - 2 7 5 0 0 - 0 - 1 9 6 3
2 0 - 0 - 0 - 6 9 3 1 6 5 9 1 7 - 3 6 6 9 0 - 0 - 1 1 2 5
30+ 2 1 1 4 1 4 - 4 1 2 0 - 0 - 4 6 6 0 - 0 - 2 7 7
U nknow n 0
*
0 - 8 6 1 8 0
'
0 - 1 2 8 7 2 0 ~ 0 - 3 4 3 0
A3 - 24
T A B L E  A 3 .15: Lung cancer mortality by length of service, time since first
exposure, and dockyard.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
L e n g th  o f  
s e r v i c e  
( y s )
0 - 9
O b s  SMR 
( 9 5 X  C l )
1 0  -  19
O b s  SMR 
(95%  C l )
2 0  -  29
O b s  SMR 
(9 5 X  C l )
3 0 - 3 9
O b s  SMR 
(9 5 X  C l )
40+
O b s  SMR 
(95%  C l )
DEV0NP0RT
<5 5  1 2 8  
( 4 2 - 3 0 0 )
6  76  
( 2 8 - 1 6 6 )
- - -
5 - 9 1 36  
( 1 - 1 9 8 )
1 3  111 
( 5 9 - 1 8 9 )
7  132  
( 5 2 - 2 7 3 )
“ j
1 1 0 - 1 9 - 11 104  
( 5 2 - 1 8 6 )
31 122  
( 7 9 - 1 6 4 )
1 6  1 9 9  
( 1 1 4 - 3 2 4 )
'
J 2 0 - 2 9 - - 1 2  9 8  
( 5 1 - 1 7 1 )
21 77  
( 4 8 - 1 1 8 )
7 126 
( 5 1 - 2 6 0 )
30+ - - " 16  8 2  
( 4 7 - 1 3 3 )
7 3  86  
( 6 6 - 1 0 5 )
CHATHAM
<5 1 41
( 1 - 2 2 6 )
3  58  
( 1 2 - 1 7 0 )
- - -
5 - 9 2  164  
( 2 0 - 5 9 1 )
3  54  
( 1 1 - 1 5 7 )
3  1 1 9  
( 2 5 - 3 4 8 )
- -
10  -  19 - 2  79  
( 1 0 - 2 8 4 )
5  76  
( 2 5 - 1 7 8 )
1 4 2  
0 - 2 3 4 )
-
i 2 0 - 2 9 - - 3  6 6  
( 1 4 - 1 9 4 )
1 3  1 0 3  
( 5 5 - 1 7 7 )
7  2 0 3  
( 8 1 - 4 1 8 )
30+ " - 1 0  1 0 3  
( 4 9 - 1 8 9 )
4 0  79  
( 5 5 - 1 0 4 )
PORTSMOUTH
<5 3  1 0 4  
( 2 1 - 3 0 3 )
9  1 4 8
( 6 8 - 2 8 0 )
- - -
5 - 9 1 77  
( 2 - 4 2 6 )
9  1 5 2  
( 6 9 - 2 8 8 )
2  71 
( 9 - 2 5 7 )
- “
10  -  19 - 7 1 0 2  
( 4 1 - 2 1 0 )
21 1 2 0  
( 7 4 - 1 8 3 )
4  8 2
( 2 2 - 2 0 9 )
-
2 0  -  2 9 - - 9  7 8  
( 3 6 - 1 4 7 )
21 73  
( 4 5 - 1 1 1 )
6  77 
( 2 8 - 1 6 8 )
30+ “ “ 1 2  9 0  
( 4 7 - 1 5 8 )
7 5  96  
( 7 4 - 1 1 8 )
A 3 - 25
T A B L E  A 3.16: Pleural mesothelioma mortality by length of service, time
since first exposure, and dockyard.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
L e n g t h  o f  
s e r v i c e
( y - s )
0 - 9
O bs SMR 
(9 5 %  C l )
10  -  19
O b s  SMR 
(95%  C l )
2 0  -  2 9
O b s  SMR 
(95%  C l )
30  -  39
O bs SMR 
(95%  C l )
40+
O bs SMR 
(95%  C l )
DEVONPORT
<5 - 2  146 8  
( 1 7 8 - 5 3 0 0 )
- - -
1 5 - 9 - 1 621 
( 1 6 - 3 4 6 2 )
- - -
1 0 - 1 9 1 8 5 6  
( 2 2 - 4 7 6 9 )
7 1 8 1 9  
( 7 3 0 - 3 7 4 7 )
1 6 3 7  
( 1 6 - 3 5 4 7 )
-
2 0 - 2 9 - - 4  2 7 0 0  
( 7 3 6 - 6 9 1 3 )
5 1 1 0 5  
( 3 5 8 - 2 5 7 8 )
1 8 6 4  
( 2 2 - 4 8 1 2 )
30+ “ “ “ 5 2 3 5 4  
( 7 6 3 - 5 4 9 5 )
34  3 3 3 7  
( 2 2 1 5 - 4 4 5 9 )
CHATHAM
< 5 1 4 1 1 7  
( 1 0 4 - 2 2 9 3 3 )
- - - -
5 - 9 - - - - -
1 0  -  19 - - - - -
2 0  -  2 9 - - - 4 2 5 0 9  
( 6 8 4 - 6 4 2 3 )
-
30+ “ “ 1 1 1 3 7  
( 2 9 - 6 3 3 3 )
1 5  3 0 8 0  
( 1 7 2 5 - 5 0 8 0 )
PORTSMOUTH
< 5 - - - - -
5 - 9 - - - - -
1 0  -  19 - - 3  1 3 3 5  
( 2 7 5 - 3 9 0 2 )
- -
2 0 - 2 9 - - 2  1 6 9 8  
( 2 0 6 - 6 1 3 1 )
1 2 6 2  
( 7 - 1 4 5 8 )
1 8 8 5  
( 2 2 - 4 9 3 1  )
30+ ~ “ ” 5 3 7 0 7  
( 1 2 0 1 - 8 6 5 3 )
14  1 7 5 6  
( 9 5 9 - 2 9 4 6 )
A3 - 26
T A B L E  A 3 .17: L u n g cancer mortality by year of start of employment, time
since first exposure, and dockyard.
T im e s i  n e e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
Y e a r  o f  
S t a r t
0 - 9
O b s  SMR 
(95%  C l )
10  -  19
O b s  SMR 
(95%  C l )
2 0  -  2 9
O bs SMR 
(9 5 %  C l )
3 0  -  39
O b s  SMR 
(95%  C l )
O b s
4 0 +
SMR
(95%  C l )
DEVON PORT
! P r e  1 9 3 0 - - - - 14 79
( 4 3 - 1 3 2 )
! 1 9 3 0 - - - - 1 0  78  
( 3 7 - 1 4 3 )
51 88
( 6 4 - 1 1 3 )
1 9 4 0 - - - 8  1 5 6  
( 6 7 - 3 0 8 )
2 0  8 2  
( 5 0 - 1 2 7 )
15 98
( 5 5 - 1 6 2 )
1 9 5 0 - - 1 21 
( 1 - 1 1 6 )
21 81 
( 5 0 - 1 2 4 )
2 3  131 
( 8 3 - 1 9 6 )
*
1 9 6 0 + 6  8 9  
( 3 3 - 1 9 4 )
2 9  114 
( 7 6 - 1 6 4 )
21 1 7 0  
( 1 0 5 - 2 5 9 )
“ “
CHATHAM
P r e  1 9 3 0 - - - - 8 81
( 3 5 - 1 6 0 )
1 9 3 0 - - - - 1 0  1 3 9  
( 6 7 - 2 5 6 )
2 9 8 0
( 5 4 - 1 1 5 )
1 9 4 0 - - - - 9  7 5  
( 3 5 - 1 4 3 )
10 127
( 6 1 - 2 3 3 )
1 9 5 0 - - 1 9 5  
( 2 - 5 3 1 )
8  1 1 6
( 5 0 - 2 2 9 )
5  9 0  
( 2 9 - 2 1 0 )
“
1 9 6 0 + 3  81 
( 1 7 - 2 3 8 )
7 57  
( 2 3 - 1 1 8 )
3  6 6  
( 1 4 - 1 9 2 )
- -
PORTSMOUTH
P r e  1 9 3 0 - - - - 15 I l l
( 6 2 - 1 8 4 )
1 9 3 0 - - - - 11 1 4 5
( 7 2 - 2 5 9 )
4 9 91
( 6 6 - 1 1 7 )
1 9 4 0 - - - 1 2 0  
( 1 - 1 1 2 )
1 4  56  
( 3 1 -  9 4 )
17 92
( 5 3 - 1 4 7 )
1 9 5 0 - - 2  74  
( 9 - 2 6 8 )
17 9 5  
( 5 5 - 1 5 2 )
1 2  8 3  
( 4 3 - 1 4 5 )
1 9 6 0 + 4  94
( 2 6 - 2 4 3 )
2 3  142 
( 9 0 - 2 1 2 )
14 151
( 8 2 - 2 5 3 )
~
A 3  - 27
T A B L E  A 3.18 : Pleural mesothelioma mortality by year of start of
employment, time since first exposure, and dockyard.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
Y e a r  o f  
S t a r t
0 - 9
O b s  SMR 
(95%  C I )
10  -  19
O b s SMR 
(95%  C I )
2 0  -  29
O b s  SMR 
(95%  C I )
3 0 - 3 9
O b s SMR 
(95%  C I )
4 0 +
O bs SMR 
(95%  C I )
DEVONPORT
P r e  193 0 - - - - 8  5 1 1 8  
( 2 2 0 7 - 1 0 0 8 2 )
1 9 3 0 - - - - 1 7 7 2  
( 2 0 - 4 2 9 9 )
22  3 1 6 7  
( 1 9 8 5 - 4 7 9 6 )
1 9 4 0 - - - 1 1684 
( 4 3 - 9 3 7 7 )
8  2 2 5 6  
( 9 7 3 - 4 4 4 4 )
5  1 7 6 3  
( 5 7 1 - 4 1 1 4 )
1 9 5 0 - - - 9  251 2  
( 1 1 5 0 - 4 7 6 7 )
2  5 9 2  
( 7 2 - 2 1 3 7 )
-
1 9 6 0 + 4 1 1 0 8  
( 3 0 2 - 2 8 3 7 )
1 4 4 8
( 1 1 - 2 4 9 6 )
_ _
CHATHAM
P r e  1 9 3 0 - - - - 1 1 4 2 4
( 3 6 - 7 9 3 3 )
1 9 3 0 - - - - - 14  3 9 9 5  
( 2 1 8 3 - 6 7 0 4 )
1 9 4 0 - - - 4  2 8 4 8  
( 7 7 6 - 7 2 9 0 )
1 9 5 0 - - - - 1 1 1 2 0  
( 2 8 - 6 2 3 9 )
-
1 960+ 1 2 8 8 0  
( 7 3 - 1 6 0 4 3 )
~ * - “
PORTSMOUTH
P r e  193 0 - - - - 5 5 0 7 2  
( 1 6 4 3 - 1 1 8 3 8 )
1 9 3 0 - - - - 2  2 8 6 1  
( 3 4 9 - 1 0 4 0 0 )
9  1 6 8 4  
( 7 7 1 - 3 1 9 5 )
1 9 4 0 - - - - 3 1 0 0 9  
( 2 0 8 - 2 9 5 1 )
1 361 
( 9 - 2 0 0 8 )
1 9 5 0 - - - 4  195 3  
( 5 3 2 - 4 9 9 9 )
1 4 4 0
( 1 1 - 2 4 5 3 )
-
1 9 6 0 ^ " “ 1 733  
( 1 9 - 4 0 8 3 )
“
A 3 - 28
T A B L E  A 3 .19 : Lung cancer mortality by age at start of employment, time
since first exposure, and dockyard.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
A ge a t -  9 10  -  19 2 0  -  29 3 0  -  39 40+
s t a r t
( y s ) O bs SMR O bs SMR O b s  SMR O b s SMR O bs SMR
( 9 5 *  C l ) ( 9 5 *  C l ) ( 9 5 *  C l ) ( 9 5 *  C l ) ( 9 5 *  C l )
DEVON PORT
< 2 5 _ 3 4 4 5 4  9 5 1 9  9 2 6 7 92
( 9 2 - 1 3 0 1 ) ( 2 6 - 2 4 4 ) ( 5 6 - 1 4 4 ) ( 7 0 - 1 1 4 )
2 5 - _ 2 1 5 3 6  74 15  71 13 7 5
( 1 9 - 5 5 3 ) ( 2 7 - 1 6 1 ) ( 4 0 - 1 1 8 ) ( 4 0 - 1 2 9 )
3 5 - _ 11 155 2 4  1 2 5 17  142 _
( 7 7 - 2 7 7 ) ( 8 0 - 1 8 6 ) ( 8 3 - 2 2 7 )
4 5 - 2 61 9 56 1 3  1 1 8 2  1 9 4 _
( 7 - 2 1 9 ) ( 2 6 - 1 0 6 ) ( 6 3 - 2 0 1 ) ( 2 4 - 7 0 1 )
5 5 + 4 154 5 99 3  4 2 3 _ _
( 4 2 - 3 9 3 ) ( 3 2 - 2 3 2 ) ( 8 7 - 1 2 3 8 )
CHATHAM
< 2 5 _ _ 1 7 5 8  9 4 35 8 3
( 2 - 4 2 0 ) ( 4 1 - 1 8 5 ) ( 5 6 - 1 1 1 )
2 5 - _ _ 1 38 11 1 0 0 10 8 6
( 1 - 2 1 0 ) ( 5 0 - 1 7 9 ) ( 4 1 - 1 5 8 )
3 5 - _ 1 50 4  7 5 5  1 0 4 2 6 2 0
( 1 - 2 8 1 ) ( 2 0 - 1 9 1 ) ( 3 4 - 2 4 4 ) ( 7 5 - 2 2 4 0 )
4 5 - 1 76 5 8 3 4  1 0 9 _ _
( 2 - 4 2 3 ) ( 2 7 - 1 9 3 ) ( 3 0 - 2 7 9 )
5 5 + 2 9 7 2  4 3 1 1 1 5 _ _
( 1 2 - 3 5 1 ) ( 5 - 1 5 4 ) ( 3 - 6 4 0 )
PORTSMOUTH
< 2 5 _ 1 3 0 3 1 36 9  57 67 97
( 0 - 1 5 1 1 9 ) ( 8 - 1 6 8 6 ) ( 2 6 - 1 0 7 ) ( 7 4 - 1 2 0 )
2 5 - _ 2 2 9 7 6  1 0 5 1 5  81 12 79
( 3 6 - 1 0 7 3 ) ( 3 8 - 2 2 8 ) ( 4 6 - 1 3 4 ) ( 4 1 - 1 3 7 )
3 5 - _ 7 155 1 5  9 8 12  1 0 2 2 1 6 8
( 6 2 - 3 2 0 ) ( 5 5 - 1 6 2 ) ( 5 3 - 1 7 8 ) ( 2 0 - 6 0 7 )
4 5 - 1 54 11 113 1 0  127 1 1 0 9 _
( 1 - 3 0 0 ) ( 5 6 - 2 0 2 ) ( 6 1 - 2 3 3 ) ( 3 - 6 0 6 )
55+ 3 1 5 8 4 109 _ _ _
( 3 3 - 4 6 1 ) ( 3 0 - 2 7 8 )
A 3 - 29
T A B L E  A3.20: Pleural mesothelioma mortality by age at start of
employment, time since first exposure, and dockyard.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
j A ge a t  
s t a r t  
( y r s )
0 - 9
O b s  SMR 
(95%  C l )
1 0  -  19
O b s  SMR 
(95%  C l )
2 0  -  29
O b s  SMR 
(95%  C l )
3 0 - 3 9
O b s  SMR 
( 9 5 1  C l )
4 0 +
O b s  SMR 
(95%  C l )
DEVONPORT
< 2 5 - - 3  194 8  
( 4 0 2 - 5 6 9 5 )
8  1891 
( 8 1 5 - 3 7 2 5 )
29  3 0 1 4  
( 2 0 1 9 - 4 3 2 9 )
2 5 - - 1 2 4 2 6  
( 6 1 - 1 3 5 1 3 )
6 4 1 7 7  
( 1 5 3 2 - 9 0 9 2 )
2  7 4 5  
( 9 0 - 2 6 8 9 )
5 3 0 0 6  
( 9 7 4 - 7 0 1 7 )
3 5 - - - 1 4 4 6  
( 1 1 - 2 4 8 3 )
1 8 2 3  
( 2 1 - 4 5 8 5 )
1 1 6 1 2 9  
( 4 0 8 - 8 9 8 3 8 )
4 5 - - 3  170 0  
( 3 5 1 - 4 9 7 0 )
1 8 9 0  
( 2 3 - 4 9 5 6 )
- -
5 5 + “ ” “ “
CHATHAM
< 2 5 - - - 4  2 7 1 7  
( 7 4 0 - 6 9 5 6 )
13  2 8 6 8  
( 1 5 2 7 - 4 9 0 5 )
2 5 - - - - 1 9 8 0  
( 2 5 - 5 4 6 1 )
2  2 2 4 5  
( 2 7 2 - 8 0 1 5 )
3 5 - 1 2 2 1 7 0  
( 5 6 1 - 1 2 3 4 8  5 )
- - - -
4 5 - - - - - -
5 5 + - - - - -
PORTSMOUTH
< 2 5 - - 2  2 2 8 3  
( 2 7 6 - 8 2 4 2 )
6  2 0 6 9  
( 7 5 9 - 4 5 0 4 )
15  194 4
( 1 0 8 9 - 3 2 0 6 )
2 5 - - - 2 2 3 5 3  
( 2 8 5 - 8 4 9 5 )
- -
3 5 - - 1 6 7 4  
( 1 7 - 3 7 5 6 )
- -
4 5 - - - - - -
5 5 + - - - - -
A3 - 30
T A B L E  A 3 .2 1: Cause specific mortality by m edical symptom - cough.
C a u s e s  o f  D e a t h C o u g h
O b s
D e v o n p o r t
O b s
C h a th a m
O bs
P o r t s m o u t h
SMR 95% C l SMR 95% C l SMR 95% C l
A l l  C a u s e s Y es 5 9 0 121 1 1 1 - 1 3 0 2 1 0 1 1 9 1 0 3 - 1 3 5 4 6 4 1 2 7 1 1 5 - 1 3 9
No 1 5 4 0 88 8 3 -  9 3 6 3 3 8 3 7 6 -  8 9 9 3 6 7 3 6 8 - 7 8
A l l  N e o p la s m s Y es 2 2 0 157 1 3 6 - 1 7 8 7 7 1 4 5 1 1 3 - 1 7 7 176 1 5 8 1 3 5 -1 8 1
No 5 0 8 102 9 3 -1 1 1 2 3 3 102 8 9 - 1 1 5 3 1 4 81 7 2 -  9 0
C a . S to m a c h Y es 18 154 9 1 - 2 4 3 8 1 8 3 7 9 - 3 6 0 12 1 3 3 6 9 - 2 3 2
No 6 0 146 1 0 9 - 1 8 2 2 2 1 1 8 7 4 - 1 7 8 2 8 9 0 6 0 - 1 3 0
C a . P e r  i to n e u m Y es 2 712 8 6 - 2 5 7 2 0 _ 0 - 4 0 8 1 0 _ 0 - 1 9 4 8
No 7 694 2 7 9 - 1 4 3 0 2 5 0 4 6 1 - 1 8 1 9 1 151 4 - 8 3 9
C a . L u n g Y es 9 3 183 1 4 6 - 2 2 0 3 6 1 6 8 1 1 3 - 2 2 3 8 5 1 9 0 1 5 0 -2 3 1
No 1 3 0 73 6 0 -  8 5 0 6 0 66 4 9 -  8 3 1 0 3 6 7 5 4 -  8 0
C a . P l e u r a Y e s 16 2 3 3 8 1 3 3 7 - 3 7 9 6 5 2 2 2 6 7 2 1 - 5 1 9 4 4 8 0 2 2 1 9 - 2 0 5 3
No 4 6 1 8 7 3 1 3 3 2 - 2 4 1 5 16 1 6 1 7 9 2 4 - 2 6 2 5 22 1 2 3 6 7 7 5 - 2 0 5 3
C i r c u l a t o r y  S y s t e m Y e s 2 6 6 106 9 3 - 1 1 9 8 0 94 7 3 - 1 1 4 1 9 2 1 0 9 9 3 - 1 2 4
No 0 1 5 92 8 5 -  9 8 311 8 5 7 5 -  9 4 4 8 2 7 8 7 1 -  8 5
P u lm o n a r y  C i r c u l a t i o n Y e s 10 397 1 9 1 - 7 3 0 0 _ 0 - 3 9 2 1 5 2 1 - 2 9 2
No 17 192 1 1 2 - 3 0 7 4 9 9 2 7 - 2 5 5 1 1 5 0 -  8 5
R e s p i r a t o r y  S y s t e m Y es 6 8 162 1 2 4 -2 0 1 3 9 2 1 9 1 5 0 - 2 8 8 6 2 1 7 5 1 3 1 - 2 1 8
No 1 0 7 72 5 8 -  8 6 41 53 3 7 -  6 9 6 9 5 6 4 3 -  6 9
B r o n c h i t i s ,  E m p h y sem a Y e s 21 134 8 3 - 2 0 4 1 7 2 3 8 1 3 9 - 3 8 2 1 8 1 2 8 7 6 - 2 0 3
a n d  A s th m a No 2 0 36 2 2 -  56 1 0 3 3 1 6 -  61 17 3 6 2 1 -  57
A s b e s t o s i s Y e s 3 353 6 7 2 9 - 1 0 3 3 6 0 _ 0 - 1 2 7 2 0 0 _ 0 - 5 8 6 6
No 4 131 3 3 6 3 - 3 4 1 3 0 - 0 - 2 9 6 8 1 4 5 5 1 2 - 2 5 3 6
P u lm o n a r y  F i b r o s i s Y e s 1 163 4 - 9 0 7 0 _ 0 - 1 6 9 1 0 _ 0 - 8 2 3
No 1 46 1 - 2 5 7 1 1 0 7 3 - 5 9 8 0 0 - 2 3 7
A3 - 31
T A B L E  A 3.22: Cause specific mortality by medical symptom - phlegm.
C a u s e s  o f  D e a th P h le g m
O bs
D e v o n p o r t
O b s
C h a th a m
O b s
P o r t s m o u th
SMR 95X Cl SMR 9 SX C l SMR 9 5 Z  C l
A l l  C a u s e s Y es 6 7 8 1 1 3 1 0 5 -1 2 2 2 2 6 112 9 8 - 1 2 7 4 7 3 122 1 1 1 - 1 3 3
No 1452 8 9 8 4 -  93 6 1 7 8 3 7 7 -  9 0 9 2 7 74 6 9 -  79
A l l  N e o p l a s m s Y es 2 3 5 137 1 1 9 -1 5 4 74 122 9 4 - 1 4 9 1 7 9 151 1 2 9 - 1 7 3
No 4 9 3 106 9 6 - 1 1 5 2 3 6 107 9 3 -1 2 1 311 82 7 3 -  91
C a . S t o m a c h Y es 23 160 1 0 1 - 2 3 9 6 119 4 4 - 2 6 0 16 166 9 5 - 2 7 0
No 55 143 1 0 5 -1 8 1 24 133 8 5 - 1 9 8 24 78 5 0 - 1 1 7
C a . P e r i t o n e u m Y es 2 597 7 2 - 2 1 5 4 0 _ 0 - 3 6 1 8 0 _ 0 - 1 8 6 9
No 7 734 2 9 5 - 1 5 1 2 2 519 6 3 - 1 8 7 4 1 152 4 - 8 4 9
C a . L u n g Y es 94 151 1 2 0 -1 8 1 3 3 134 8 9 - 1 8 0 94 198 1 5 8 - 2 3 8
No 129 77 6 4 -  91 6 3 72 5 4 -  9 0 94 62 5 0 -  75
C a . P l e u r a Y es 15 1834 1 0 2 7 -3 0 2 5 1 3 9 3 1 0 - 2 1 8 9 2 3 8 3 4 6 - 1 3 8 3
No 47 2 0 2 4 1 4 4 5 -2 6 0 3 2 0 2 0 8 4 1 2 7 3 - 3 2 1 9 2 4 136 6 8 7 5 - 2 0 3 3
C i r c u l a t o r y  S y s te m Y es 3 1 5 102 9 1 - 1 1 3 1 0 5 108 8 7 - 1 2 8 1 9 8 105 9 0 - 1 2 0
No 766 92 8 6 -  99 2 8 6 81 7 1 -  9 0 4 7 6 79 7 2 -  8 6
P u l m o n a r y  C i r c u l a t i o n Y es 8 2 5 7 1 1 1 - 5 0 6 0 _ 0 -3 4 1 2 98 1 2 - 3 5 5
No 19 2 3 0 1 3 8 - 3 5 9 4 103 2 8 - 2 6 4 0 0 - 5 8
; R e s p i r a t o r y  S y s te m Y es 79 151 1 1 8 -1 8 4 2 9 142 9 5 - 2 0 3 6 3 1 6 5 1 2 4 - 2 0 6
No 96 70 5 6 -  8 3 51 69 5 0 -  8 7 6 8 56 4 3 -  7 0
B r o n c h i t i s ,  Em physem a Y es 27 1 3 8 9 1 -2 0 1 11 134 6 7 - 2 4 0 14 9 3 5 1 - 1 5 6
a n d  A s th m a No 14 27 1 5 -  46 16 55 3 1 -  8 9 21 4 5 2 8 -  6 9
A s b e s t o s  i s Y es 3 2 9 0 6 6 0 0 - 8 4 9 4 0 _ 0 - 1 1 1 1 9 0 _ 0 - 5 5 5 5
No 4 1 4 2 0 3 8 7 -3 6 3 6 0 - 0 -3 0 7 1 1 4 6 3 1 2 - 2 5 7 7
P u l m o n a r y  F i b r o s i s Y es 1 132 3 - 7 3 3 0 _ 0 - 1 4 7 6 0 _ 0 - 7 6 9
No 1 49 1 - 2 7 5 1 111 3 - 6 1 9 0 0 - 2 4 2
A 3 - 32
T A B L E  A3.23: Cause specific mortality by medical symptom - breathlessness.
C a u s e s  o f  D e a th B r e a t h l e s s
O b s
D e v o n p o r t
O b s
C h a th a m
O b s
P o r t s m o u th
SMR 95% C l SMR 95X C l SMR 95% C l
A l l  C a u s e s Y es 4 1 0 1 4 3 1 3 0 - 1 5 7 1 2 6 149 1 2 3 - 1 7 5 2 7 8 161 1 4 2 - 1 8 0
No 1 7 2 0 8 8 8 4 -  9 2 7 1 7 84 7 8 -  90 1 1 2 2 76 7 2 -  81
A l l  N e o p la s m s Y es 1 4 6 1 7 9 1 5 0 - 2 0 0 3 5 136 9 1 -1 8 1 8 2 156 1 2 2 - 1 8 9
No 5 0 2 1 0 5 9 6 - 1 1 3 2 7 5 1 0 8 9 5 - 1 2 0 4 0 8 91 8 2 - 1 0 0
C a .  S to m a c h Y es 1 0 1 4 2 6 8 -2 6 1 4 186 5 1 - 4 7 6 7 161 6 4 - 3 3 1
No 6 0 1 4 0 1 1 3 - 1 8 3 2 6 124 8 1 - 1 8 2 3 3 92 6 1 - 1 2 3
C a . P e r  i  to n e u m Y es 4 2 6 6 5 7 2 6 - 6 8 2 3 1 2 4 3 6 6 2 - 1 3 5 7 0 0 _ 0 - 4 4 2 4
No 5 4 3 9 1 4 2 - 1 0 2 5 1 2 2 4 6 - 1 2 4 8 1 130 3 - 7 2 3
C a .  L ung Y es 5 3 1 7 6 1 2 9 - 2 2 3 16 152 8 7 - 2 4 6 41 191 1 3 2 - 2 4 9
No 1 7 0 8 5 7 3 -  9 8 8 0 79 6 1 -  96 1 4 7 8 3 7 0 -  9 6
C a .  P l e u r a Y es 0 2 2 3 4 9 6 3 - 4 4 0 0 2 197 2 2 3 9 - 7 1 1 8 3 1 3 8 9 2 8 7 - 4 0 6 0
No 54 1941 1 4 2 3 - 2 4 5 9 19 170 7 1 0 2 8 - 2 6 6 6 2 3 1 1 1 5 7 0 7 - 1 6 7 3
C i r c u l a t o r y  S y s te m Y es 1 0 9 1 2 7 1 0 9 - 1 4 5 64 1 5 5 1 1 7 - 1 9 3 1 2 7 151 1 2 4 - 1 7 7
No 0 9 2 9 0 8 4 -  9 6 3 2 7 79 7 1 -  8 8 5 4 7 77 7 1 -  8 4
P u lm o n a r y  C i r c u l a t i o n Y es 1 2 7 7 8 4 0 2 - 1 3 6 0 0 _ 0 - 7 9 1 1 107 3 - 5 9 5
No 1 5 1 5 2 8 5 -2 5 1 4 8 9 2 4 - 2 2 8 1 13 0 - 7 4
R e s p i r a t o r y  S y s te m Y es 5 5 2 0 9 1 5 4 -2 6 4 2 5 2 8 3 1 8 3 - 4 1 8 5 5 3 1 2 2 3 0 - 3 9 4
No 1 2 0 7 3 6 0 -  8 6 5 5 6 4 4 7 -  81 7 6 54 4 2 -  6 6
B r o n c h i t i s ,  E m physem a Y es 2 2 221 1 3 8 - 3 3 5 1 3 3 6 2 1 9 2 - 6 1 7 2 0 2 8 3 1 7 3 - 4 3 7
a n d  A s th m a No 19 31 1 9 -  4 9 14 41 2 3 -  6 9 1 5 2 7 1 5 -  4 5
A s b e s t o s i s Y es 1 2 0 8 4 5 3 - 1 1 6 0 8 0 _ 0 - 2 6 4 7 9 0 _ 0 - 1 2 6 1 8
No 6 1701 6 5 3 - 3 8 7 6 0 - 0 - 2 6 4 7 1 3 9 5 1 0 - 2 1 9 9
P u lm o n a r y  F i b r o s i s Y es 0 _ 0 - 9 9 0 0 _ 0 - 3 4 2 3 0 _ 0 - 1 6 8 5
No 2 8 3 1 0 - 2 9 9 1 96 2 - 5 3 4 0 0 - 2 0 6
A3 - 33
T A B L E  A 3 .2 4 : Cause specific mortality by medical symptom - chest-illness.
C a u s e s  o f  D e a th C h e s t -  
i l l  n e s s
O b s
D e v o n p o r t
O bs
C h a th a m
O bs
P o r t s m o u th
SMR 9 5 *  C l SMR 9 5 *  C l SMR 9 5 *  C l
A l l  C a u s e s Y es 2 7 9 108 9 5 - 1 2 1 9 3 1 2 8 1 0 2 -1 5 4 165 107 9 1 - 1 2 4
No 1851 94 8 9 -  9 8 7 5 0 8 6 8 0 -  9 3 1 2 3 5 8 3 7 8 -  87
A l l  N e o p la sm s Y es 9 5 129 1 0 3 - 1 5 4 22 101 6 3 - 1 5 2 49 105 7 6 - 1 3 5
No 6 3 3 112 1 0 3 -1 2 1 2 8 8 111 9 8 - 1 2 4 441 97 8 8 - 1 0 6
C a . S to m a c h Y es 11 176 8 8 - 3 1 5 2 no 1 3 - 3 9 7 1 26 6 7 - 1 4 7
No 6 7 144 1 0 9 - 1 7 8 2 8 1 3 2 8 8 -1 9 1 39 107 7 3 -1 4 1
C a . P e r i t o n e u m Y es 4 2 8 6 2 7 8 0 - 7 3 2 8 0 _ 0 - 9 9 8 7 0 _ 0 - 4 8 8 3
No 5 4 3 5 1 4 1 - 1 0 1 5 2 4 4 4 5 4 - 2 6 0 4 1 129 3 - 7 1 6
C a . L ung Y es 36 134 9 0 - 1 7 8 8 9 0 3 9 - 1 7 7 27 144 9 5 - 2 1 0
No 1 8 7 92 7 9 - 1 0 6 8 8 8 5 6 7 - 1 0 3 161 90 7 6 - 1 0 3
C a . P l e u r a Y es 5 1 4 6 7 4 7 5 - 3 4 2 3 2 2 2 1 4 2 6 8 - 7 9 9 4 1 500 1 3 - 2 7 8 3
No 57 2 0 3 6 1 5 0 8 - 2 5 6 5 19 1691 1 0 1 8 - 2 6 4 0 2 5 120 3 7 7 8 - 1 7 7 5
C i r c u l a t o r y  S y s t e m Y e s 1 1 9 89 7 3 - 1 0 5 4 6 131 9 3 - 1 6 9 75 101 7 8 - 1 2 3
No 9 6 2 9 5 8 9 - 1 0 2 3 4 5 8 3 7 4 -9 1 5 9 9 8 3 7 7 -  90
P u lm o n a r y  C i r c u l a t i o n Y e s 7 514 2 0 6 - 1 0 5 9 1 2 5 3 6 - 1 4 0 9 0 _ 0 - 4 5 6
No 2 0 199 1 2 1 - 3 0 8 3 6 6 1 4 - 1 9 2 2 26 3 -  9 5
R e s p i r a t o r y  S y s te m Y es 4 7 2 0 4 1 4 5 - 2 6 2 18 2 4 3 1 4 4 - 3 8 4 32 2 0 8 1 3 6 - 2 8 0 4
No 1 2 8 77 6 3 -  9 0 6 2 71 5 3 -  8 9 99 69 5 5 -  8 3
B r o n c h i t i s ,  E m p h y sem a Y e s 14 163 8 9 - 2 7 4 10 3 3 2 1 5 9 - 6 1 0 15 2 4 9 1 3 9 - 4 1 0
a n d  A sth m a No 2 7 44 2 9 -  6 3 17 4 9 2 9 -  79 20 36 2 2 -  55
A s b e s t o s i s Y e s 3 6 8 1 2 1 4 0 6 - 1 9 9 1 5 0 _ 0 - 3 1 1 0 7 0 _ 0 - 1 4 1 5 8
No 4 1 1 7 4 3 2 0 - 3 0 0 4 0 - 0 - 2 6 0 9 1 390 1 0 - 2 1 7 2
P u lm o n a r y  F i b r o s i s Y e s 0 _ 0 - 1 1 1 6 0 _ 0 - 4 1 1 2 0 _ 0 - 1 9 2 8
No 2 81 1 0 - 2 9 4 1 9 4 2 - 5 2 5 0 0 - 2 0 3
A3 - 34
T A B L E  A3.25: Cause specific mortality by x-ray group and dockyard.
C a u s e s  o f  D e a th X - r a y
g r o u p
O bs
D e v o n p o r t
O bs
C h a th a m
O bs
P o r t s m o u t h
SMR 9 5 *  C l SMR 9 5 *  C l SMR 9 5 *  C l
A l l C a u s e s 1 1 4 2 8 91 8 6 -  95 6 7 4 8 5 7 9 -  91 9 8 5 8 0 7 5 -  85
2 123 8 9 7 3 - 1 0 5 67 90 6 8 -1 1 1 161 101 8 5 - 1 1 7
3 55 1 0 5 7 7 - 1 3 3 17 77 4 5 - 1 2 4 39 8 5 5 8 -1 1 9
4 56 151 1 1 2 -1 9 1 21 125 7 7 -1 9 1 29 151 1 0 1 - 2 1 8
5 96 8 2 6 6 -  99 60 136 1 0 2 -1 7 1 73 1 1 6 9 0 - 1 4 3
6 2 0 8 1 1 6 1 0 1 -1 3 2 104 124 1 0 0 - 1 4 7 173 101 8 6 - 1 1 7
A l l N e o p la s m s 1 491 109 9 9 - 1 1 9 241 102 8 9 - 1 1 5 3 2 8 8 8 7 8 -  97
2 50 1 2 5 9 0 - 1 5 9 20 88 5 4 - 1 3 6 63 1 2 8 9 6 - 1 6 0
3 27 1 7 9 1 1 8 -2 6 1 8 120 5 2 - 2 3 7 12 8 5 4 4 - 1 4 9
4 21 1 9 8 1 2 2 -3 0 2 7 137 5 5 - 2 8 3 14 2 4 0 1 3 1 -4 0 2
5 32 9 5 6 2 - 1 2 7 11 8 3 4 1 - 1 4 8 22 1 1 5 7 2 -1 7 4
6 54 1 0 5 7 7 - 1 3 3 38 151 1 0 3 - 1 9 9 59 1 1 4 8 5 - 1 4 3
■ C a . S to m a c h 1 56 1 5 2 1 1 2 -1 9 2 24 125 8 0 -1 8 6 1 22 74 4 6 - 1 1 2
2 5 1 4 8 4 8 - 3 4 6 3 159 3 4 - 4 6 4 3 7 5 1 5 -2 1 9
3 3 231 4 8 - 6 7 5 0 - 0 - 6 6 7 3 2 6 0 5 4 - 7 6 0
4 0 - 0 - 3 9 8 1 231 6 - 1 2 8 7 1 2 0 5 5 -1 1 4 3
5 4 1 4 0 3 8 - 3 6 0 2 180 2 2 - 6 4 9 0 - 0 - 2 3 5
6 5 114 3 7 - 2 6 6 3 142 2 9 - 4 1 6 8 1 8 7 8 1 - 3 6 9
C a . P e r i t o n e u m 1 6 6 2 9 2 3 1 - 1 3 6 8 2 4 7 0 5 7 - 1 6 9 7 0 _ 0 - 5 4 4
2 1 1 3 5 5 3 4 - 7 5 5 0 0 - 0 - 1 0 1 5 5 0 - 0 - 4 7 3 3
3 2 7761 9 3 9 - 2 8 0 1 6 0 - 0 - 3 7 3 6 7 1 4 8 1 2 1 -2 6 6 8 0
4 1 5 3 0 3 1 3 4 - 2 9 5 3 9 0 - 0 - 4 8 5 8 2 0 - 0 - 4 2 0 7 9
5 0 - 0 - 5 9 3 7 0 - 0 - 1 7 2 7 7 0 - 0 -1 2 4 0 1
6 0 0 - 4 0 2 0 0 - 0 - 9 5 5 5 0 * 0 - 4 6 2 8
C a . L u n g 1 1 4 2 8 9 7 4 - 1 0 3 72 77 5 9 -  95 112 76 6 2 -  90
2 14 9 5 5 2 -1 5 9 6 64 2 4 - 1 4 0 2 3 1 1 5 7 3 - 1 7 3
3 6 107 3 9 - 2 3 4 3 110 2 3 - 3 2 3 3 52 1 1 -1 5 2
4 9 2 2 7 1 0 4 -4 3 0 3 142 2 9 - 4 1 5 9 3 7 5 1 7 1 -7 1 1
5 11 8 9 4 4 - 1 5 9 4 74 2 0 - 1 9 0 14 1 8 0 9 9 - 3 0 3
6 2 5 1 3 2 8 6 - 1 9 5 14 137 7 5 - 2 3 0 26 1 2 3 8 1 -1 8 1
C a . P l e u r a 1 4 0 1 7 2 2 1 1 8 8 -2 2 5 6 16 151 7 8 6 8 - 2 4 6 3 13 7 1 9 3 8 3 - 1 2 2 9
2 8 4 2 7 7 1 8 4 4 -8 4 2 6 2 2 1 3 7 2 5 8 - 7 6 9 3 8 3 7 2 6 1 6 0 7 - 7 3 3 9
3 5 7 9 1 0 2 5 6 3 - 1 8 4 6 3 2 789 4 9 5 5 - 2 8 4 9 7 1 1 7 6 0 4 5 - 9 8 0 5
4 2 4 4 5 6 5 3 9 - 1 6 0 8 5 0 - 0 - 2 0 0 6 3 1 4 4 0 5 1 1 1 -2 4 5 3 8
5 3 1 8 9 4 3 9 1 - 5 5 3 8 0 - 0 - 6 9 3 2 1 1 2 6 4 3 2 -7 0 4 1
6 1 4 4 4 1 1 - 2 4 7 3 3 3 1 3 8 6 4 7 - 9 1 7 2 2 941 1 1 4 - 3 3 9 8
X - r a y  g r o u p : 1
2
3
4
5
6
N o rm al
P l e u r a l  t h i c k e n i n g  
P l e u r a l  c a l c i f i c a t i o n  
P u lm o n a r y  f i b r o s i s  
P u lm o n a r y  t u b e r c u l o s i s  
A l l  o t h e r  a b n o r m a l i t i e s .
A3 - 35
T A B L E  A 3.25 (corn.): Cause specific mortality by x-ray group and dockyard.
j C a u s e s  o f  D e a th X - r a y
g r o u p
D e v o n p o r t
O b s
C h a th am
O b s
P o r t s m o u th
O bs SMR 95X C l SMR 95X  C l SMR 95X C l
j C i r c u l a t o r y  S y s te m 1 7 4 3 9 3 8 6 - 1 0 0 3 1 6 83 7 4 -  9 3 4 8 6 8 2 7 5 -  90
2 55 77 5 6 - 1 0 0 3 3 90 5 9 -1 2 1 72 9 2 7 1 -1 1 4
3 20 73 4 5 - 1 1 3 11 74 3 2 - 1 4 6 2 3 1 0 2 6 5 - 1 5 4
4 21 108 6 7 - 1 6 6 8 109 5 0 - 2 0 7 9 9 6 4 4 - 1 8 2
5 4 5 74 5 2 -  96 2 9 134 9 0 - 1 9 3 34 111 7 3 - 1 4 8
6 1 1 3 121 9 9 - 1 4 4 4 4 107 7 5 - 1 3 9 8 6 1 0 3 8 1 - 1 2 5
P u lm o n a r y  C i r c u l a t i o n 1 1 5 191 1 0 7 - 3 1 5 1 24 1 - 1 3 6 2 3 2 4 - 1 1 7
2 1 138 3 - 7 6 8 0 - 0 - 9 0 8 0 - 0 - 4 4 0
3 0 - 0 - 1 3 0 4 0 - 0 - 3 0 3 7 1 4 0 7 1 0 -2 2 6 5
4 1 491 1 2 - 2 7 3 3 0 - 0 - 3 8 3 2 0 - 0 - 3 4 9 4
5 2 327 4 0 - 1 1 8 2 0 - 0 - 1 5 2 6 1 2 9 7 8 - 1 6 5 6
6 5 522 1 6 9 - 1 2 1 8 0 - 0 - 7 9 5 0 - 0 - 4 0 3
R e s p i r a t o r y  S y s te m 1 9 3 72 5 7 -  8 6 5 7 73 5 4 -  92 7 9 6 9 5 4 -  84
2 9 74 3 4 -1 4 1 6 78 2 9 - 1 7 0 17 1 0 9 6 3 - 1 7 4
3 6 123 4 5 - 2 6 8 0 - 0 - 1 5 5 2 4 3 5 - 1 5 3
4 12 346 1 7 9 - 6 0 4 4 216 5 9 - 5 5 2 4 1 9 9 5 4 - 5 1 0
5 16 155 8 9 - 2 5 2 1 5 323 1 8 1 - 5 3 2 12 1 8 6 9 6 - 3 2 5
6 2 3 140 8 9 - 2 1 1 1 7 186 1 0 8 - 2 9 8 18 1 0 2 6 1 - 1 6 2
B r o n c h i t i s ,  Em physem a 1 19 40 2 4 -  6 2 1 4 46 2 5 -  77 1 3 2 9 1 6 -  50
and Asthma 2 1 22 1 - 1 2 3 2 6 5 8 - 2 3 3 3 4 9 1 0 - 1 4 2
3 0 - 0 - 2 0 2 0 - 0 - 3 9 4 0 - 0 -2 0 1
4 4 300 8 2 - 7 6 7 0 - 0 - 4 8 9 1 1 2 4 3 - 6 9 0
5 2 52 6 - 1 8 9 8 429 1 8 5 - 8 4 5 6 2 3 7 8 7 - 5 1 7
6 B 131 5 6 - 2 5 7 9 248 1 1 4 -4 7 1 5 7 3 2 4 - 1 6 9
A s b e s t o s i s 1 3 1096 2 2 6 - 3 2 0 5 0 _ 0 - 2 8 6 1 3 1 4 0 3 2 9 0 - 4 1 0 3
2 1 4 0 6 0 1 0 7 - 2 2 6 1 4 0 - 0 - 2 9 5 3 4 0 - 0 - 1 3 0 1 2
3 0 - 0 -4 1 4 5 1 0 - 0 - 1 0 3 3 0 5 0 - 0 - 4 6 8 7 4
4 2 3 2 2 8 7 3 9 1 9 - 1 1 6 9 1 7 0 - 0 - 1 3 9 0 3 1 0 - 0 -1 1 3 9 6 1
5 0 - 0 - 1 7 8 3 2 0 - 0 - 5 1 1 4 0 0 - 0 - 3 4 5 6 9
6 0 0 - 1 2 1 0 3 0 0 - 2 7 6 4 1 0 0 - 1 2 7 7 2
P u lm o n a r y  F i b r o s i s 1 0 _ 0 - 1 9 2 0 _ 0 - 3 8 7 1 6 8 2 - 3 7 9
2 1 561 1 4 - 3 1 2 3 0 - 0 - 3 9 2 7 0 - 0 - 1 8 4 5
3 0 - 0 -5 3 1 1 0 - 0 - 1 3 0 4 2 0 - 0 - 6 2 9 8
4 1 2 0 4 9 5 2 -1 1 4 1 3 1 463 7 1 1 7 - 2 5 8 2 9 0 - 0 - 1 4 9 5 5
5 0 - 0 - 2 4 4 8 0 - 0 -6 6 1 1 0 - 0 -4 6 4 1
6 0
'
0 - 1 5 7 9 0
'
0 - 3 4 3 7 0
'
0 - 1 7 0 6
X - r a y  g r o u p : 1
2
3
4
5
6
N o rm a l
P l e u r a l  t h i c k e n i n g  
P l e u r a l  c a l c i f i c a t i o n  
P u lm o n a r y  f i b r o s i s  
P u lm o n a r y  t u b e r c u l o s i s  
A l l  o t h e r  a b n o r m a 1 i  t  i e s .
A 3  - 36
T A B L E  A 3.26 Cause specific mortality by duration of smoking habit and
dockyard.
C a u s e s  o f  D e a th D u r a t i o n  
o f  s m o k in g  
( y s )
O bs
D e v o n p o r t
O b s
C h a th a m P o r ts m o u th
SMR 95% C l SMR 9 5 *  C l O b s SMR 95X Cl
A l l C a u s e s < 10 6 7 9 8 7 5 - 1 2 2 16 56 3 2 -  91 3 0 6 3 4 2 -  89
1 0 - 137 8 6 7 2 - 1 0 0 4 7 79 5 6 - 1 0 1 7 6 64 5 0 -  79
2 0 - 306 96 8 5 - 1 0 6 9 2 8 2 6 6 -  99 1 6 5 75 6 4 -  87
3 0 - 6 6 6 100 9 2 - 1 0 8 2 6 4 101 8 9 - 1 1 3 4 7 7 100 9 1 - 1 0 9
4 0 + 6 6 5 107 9 9 - 1 1 5 3 1 4 106 9 5 - 1 1 8 4 7 2 100 9 1 - 1 0 9
U nknow n 2 8 9 72 6 4 -  81 1 1 0 60 4 9 -  71 1 8 0 59 5 0 -  67
A l l N e o p la s m s < 10 20 117 7 2 -1 8 1 4 53 1 4 - 1 3 5 9 67 3 1 - 1 2 8
1 0 - 46 1 0 5 7 4 - 1 3 5 15 87 4 9 - 1 4 3 2 5 72 4 6 - 1 0 6
2 0 - 92 9 8 7 8 - 1 1 9 34 99 6 6 - 1 3 2 56 8 3 6 1 - 1 0 5
3 0 - 2 2 5 114 9 9 - 1 2 9 1 0 5 130 1 0 5 - 1 5 4 171 114 9 7 -1 3 1
4 0 + 2 5 4 146 1 2 8 - 1 6 4 1 1 5 132 1 0 8 - 1 5 6 1 7 0 120 1 0 2 -1 3 8
U nknow n 91 81 6 4 -  9 8 37 69 4 6 -  91 5 9 64 4 8 -  80
C a . S to m a c h < 10 4 3 4 8 9 5 -8 9 1 1 189 5 - 1 0 5 1 2 2 0 8 2 5 - 7 5 0
1 0 - 3 90 1 9 - 2 6 3 2 152 1 8 - 5 4 9 1 38 1 - 2 1 0
2 0 - 5 6 9 2 2 - 1 6 0 2 74 9 - 2 6 7 5 9 5 3 1 -2 2 1
3 0 - 28 172 1 1 4 - 2 4 9 8 121 5 2 - 2 3 9 1 3 108 5 8 - 1 8 5
4 0 + 26 1 6 5 1 0 8 - 2 4 2 14 186 1 0 1 - 3 1 1 1 5 125 7 0 - 2 0 6
U nknow n 12 131 6 8 - 2 2 9 3 69 1 4 - 2 0 1 4 54 1 5 -1 3 9
C a . P e r i t o n e u m < 1 0 2 3 3 9 3 4 1 1 - 1 2 2 4 8 0 _ 0 - 1 7 2 2 4 0 _ 0 -1 1 0 8 4
1 0 - 1 756 1 9 - 4 2 1 0 0 - 0 - 8 1 5 1 0 - 0 - 4 3 7 2
2 0 - 3 1 3 2 5 2 7 3 - 3 8 7 4 0 - 0 - 5 1 0 8 0 - 0 - 2 7 2 5
3 0 - 1 2 7 6 7 - 1 5 3 8 0 - 0 - 2 8 3 0 1 4 1 2 1 0 -2 2 9 3
4 0 + 1 3 7 7 1 0 - 2 0 9 9 0 - 0 - 3 1 1 9 0 - 0 - 1 9 6 5
U nknow n 1 4 1 0 1 0 - 2 2 8 5 2 2 0 0 8 2 4 3 - 7 2 4 8 0 0 - 2 1 7 6
C a . L u n g « 10 1 21 1 - 1 1 5 0 _ 0 - 1 4 9 3 6 5 1 3 -1 8 9
1 0 - 9 64 2 9 -1 2 1 0 - 0 -  60 4 32 9 -  81
2 0 - 34 104 6 9 - 1 3 8 7 53 2 1 - 1 0 8 1 6 61 3 5 - 1 0 0
3 0 - 70 9 5 7 3 - 1 1 7 36 1 0 8 7 3 - 1 4 4 6 9 113 8 6 - 1 4 0
4 0 + 101 156 1 2 6 - 1 8 7 4 9 1 3 6 9 8 - 1 7 4 8 8 151 1 2 0 -1 8 3
U nknow n 8 20 9 -  40 4 19 5 -  4 9 8 22 1 0 -  44
C a . P l e u r a < 10 2 186 6 2 2 6 - 6 7 3 7 0 _ 0 - 9 0 4 1 0 _ 0 - 5 0 0 2
1 0 - 4 135 6 3 7 0 - 3 4 7 2 0 - 0 - 3 5 3 5 4 1909 5 2 0 -4 8 8 7
2 0 - 9 1 4 8 5 6 8 0 - 2 8 1 9 5 2 4 8 5 8 0 5 - 5 7 9 9 6 155 2 5 6 9 -3 3 7 8
3 0 - 21 2 1 6 8 1 3 4 2 - 3 3 1 4 8 2 2 5 6 9 7 3 - 4 4 4 3 6 8 6 0 3 1 5 -1 8 7 1
4 0 - 11 1 8 6 7 9 3 2 - 3 3 3 9 3 1 1 0 9 2 2 9 - 3 2 4 3 3 6 5 0 1 3 4 -1 9 0 1
U nknow n 15 2 6 1 4 1 4 6 4 -4 3 1 1 5 2061 6 6 8 - 4 8 0 9 7 155 7 6 2 5 - 3 2 0 8
A 3  - 37
T A B L E  A 3.26  (cont.): Cause specific mortality by duration of smoking habit and
dockyard.
C a u s e s  o f  D e a th D u r a t i o n  
o f  s m o k in g
C y r s )
D e v o n p o r t
O bs
C h a th a m
O b s
P o r t s m o u th
O bs SMR 9 5 *  C l SMR 9 5 *  C l SMR 9 5 *  C l
C i r c u l a t o r y  S y s te m < 10 30 1 1 2 7 6 -1 6 0 6 5 5 2 0 - 1 1 9 10 50 2 4 -  9 3
1 0 - 6 8 8 9 6 8 - 1 1 0 24 8 8 5 6 -1 3 1 4 0 73 5 0 -  96
2 0 - 179 1 0 9 9 3 - 1 2 5 46 8 5 6 0 - 1 0 9 77 72 5 6 -  8 8
3 0 - 334 9 6 8 6 - 1 0 7 114 8 9 7 3 - 1 0 5 2 2 4 96 8 3 - 1 0 8
40+ 321 9 8 8 7 - 1 0 9 143 9 9 8 2 - 1 1 5 2 2 5 97 8 4 - 1 1 0
U nknow n 149 7 5 6 3 -  8 6 58 6 7 4 9 -  84 9 8 67 5 4 -  8 0
P u l m o n a r y  C i r c u l a t i o n < 10 0 _ 0 - 1 4 6 7 0 _ 0 - 3 2 3 4 0 _ 0 - 1 8 5 4
1 0 - 1 1 4 6 4 - 8 1 2 0 - 0 - 1 3 8 2 0 _ 0 - 7 0 3
2 0 - 4 2 7 0 7 4 -6 9 2 0 - 0 - 6 8 8 0 _ 0 - 3 5 3
3 0 - 11 3 1 9 1 5 9 -5 7 2 0 _ 0 - 2 6 6 0 _ 0 - 1 5 0
40+ 8 2 2 5 9 7 - 4 4 3 3 1 7 4 3 6 -5 1 0 1 37 1 - 2 0 8
U nknow n 3 1 5 2 3 1 -4 4 4 1 1 0 6 3 -5 9 1 1 66 2 - 3 6 6
R e s p i r a t o r y  S y s te m < 10 6 1 5 0 5 5 -3 2 6 1 4 7 1 -2 6 2 3 8 3 1 7 -2 4 1
1 0 - 12 1 1 3 5 8 -1 9 8 2 4 2 5 -1 5 0 6 64 2 3 - 1 3 9
2 0 - 21 9 6 5 9 -1 4 6 5 5 5 1 8 -1 2 9 13 71 3 8 - 1 2 2
3 0 - 58 1 0 5 7 8 -1 3 2 27 1 0 6 7 0 -1 5 5 4 8 108 7 7 - 1 3 8
40+ 56 8 6 6 3 - 1 0 8 37 1 0 5 7 1 - 1 3 9 5 5 101 7 4 - 1 2 7
U nknow n 22 6 6 4 1 - 1 0 0 8 4 4 1 9 -  86 6 21 8 -  46
B r o n c h i t i s ,  E m physem a < 10 1 7 0 2 -3 9 1 0 _ 0 - 4 6 3 0 _ 0 -2 7 1
a n d  A sthm a 1 0 - 2 5 2 6 - 1 8 8 0 - 0 - 2 0 2 2 56 7 - 2 0 3
2 0 - 4 4 9 1 3 -1 2 5 3 8 4 1 7 - 2 4 5 4 57 1 5 - 1 4 5
3 0 - 13 6 2 3 3 -1 0 6 7 6 9 2 8 - 1 4 2 11 62 3 1 - 1 1 2
40+ 16 6 6 3 8 -1 0 8 14 100 5 4 -1 6 7 16 75 4 3 - 1 2 2
Unknow n 5 4 1 1 3 -  96 3 4 2 9 - 1 2 4 2 18 2 -  66
A s b e s t o s i s < 10 2  2 3 2 9 6 2 8 1 9 - 8 4 0 9 9 0 _ 0 - 1 0 5 6 0 7 0 _ 0 - 5 2 9 0 0
1 0 - 0 - 0 - 1 4 4 4 4 0 - 0 - 4 0 9 3 8 0 - 0 - 1 9 3 1 8
2 0 - 1 1 5 6 7 4 0 - 8 7 2 8 0 - 0 - 1 7 0 7 6 0 - 0 - 8 8 1 8
3 0 - 3 2 3 5 4 4 8 6 -6 8 8 1 0 - 0 -7 8 0 1 0 - 0 - 4 1 1 3
40+ 1 1 0 7 3 2 7 - 5 9 7 8 0 - 0 - 8 5 7 9 1 138 3 3 5 - 7 7 0 5
U nknow n 0 0 - 5 5 6 6 0 - 0 - 1 2 7 7 6 0 - 0 - 7 0 1 5
P u l m o n a r y  F i b r o s i s < 10 0 _ 0 -6 1 2 1 0 _ 0 - 1 4 0 9 3 0 _ 0 - 7 7 7 5
1 0 - 0 - 0 - 2 1 9 5 0 - 0 - 5 9 7 5 0 - 0 - 2 9 4 5
2 0 - 0 - 0 - 1 0 1 6 0 - 0 - 2 9 2 8 0 - 0 - 1 4 7 7
3 0 - 1 1 1 7 3 - 6 5 2 0 _ 0 - 1 1 2 4 0 _ 0 - 6 2 3
40+ 1 1 1 7 3 - 6 5 0 1 2 5 6 6 - 1 4 2 8 0 - 0 - 5 8 8
U nknow n 0 0 - 7 6 6 0
'
0 - 1 6 9 5 0
*
0 - 1 0 1 8
A3 - 38
T A B L E  A 3.27: Cause specific mortality by occupational group and dockyard.
C a u s e s  o f  D e a t h O c c u p .
g r o u p
O bs
D e v o n p o r t
O bs
C h a th a m
O b s
P o r t s m o u t h
SMR 95% C l SMR 95% C l SMR 95% C l
A l l C a u s e s 1 112 1 0 5 8 5 - 1 2 4 38 7 3 5 0 -  96 50 9 0 6 5 - 1 1 5
2 1 8 8 98 8 4 - 1 1 2 77 114 8 8 - 1 3 9 132 9 6 8 0 - 1 1 3
3 118 100 8 2 - 1 1 9 38 9 3 6 3 - 1 2 2 73 8 0 6 2 -  99
4 1651 93 8 9 -  9 8 6 6 5 8 8 8 1 -  9 5 1 0 7 7 8 5 7 9 -  89
U nknow n 61 124 9 3 - 1 5 6 2 5 104 6 7 - 1 5 3 6 8 79 6 0 -  97
A l l N e o p la s m s 1 4 7 1 5 3 1 0 9 - 1 9 7 15 96 5 4 - 1 5 8 2 0 1 1 9 7 3 - 1 8 3
2 69 126 9 7 - 1 5 6 36 1 7 7 1 1 9 - 2 3 5 61 1 4 5 1 0 9 -1 8 2
3 36 110 7 3 - 1 4 5 14 118 6 4 - 1 9 8 2 8 1 0 3 6 8 - 1 4 9
4 5 5 5 110 1 0 1 - 1 1 9 2 3 7 1 0 5 9 1 - 1 1 8 361 9 3 8 4 - 1 0 3
U nknow n 21 149 9 2 - 2 2 7 8 7 1 1 0 4 8 - 2 1 7 2 0 76 4 6 - 1 1 7
C a . S to m a c h 1 3 1 1 8 2 4 - 3 4 6 2 1 5 5 1 9 - 5 5 9 3 2 2 3 4 6 - 6 5 3
2 6 136 5 0 - 2 9 6 5 307 9 9 - 7 1 5 5 1 5 0 4 8 -3 5 1
3 3 1 1 9 2 4 - 3 4 7 0 - 0 - 4 0 2 3 141 2 9 - 4 1 3
4 61 144 1 0 8 -1 8 1 2 3 124 7 8 - 1 8 5 2 9 9 3 6 2 - 1 3 3
U nknow n 5 421 1 3 6 - 9 8 2 0 0 0 - 6 1 3 0 - 0 - 1 7 2
C a . P e r i t o n e u m 1 1 1 5 8 7 4 0 - 8 8 4 2 0 _ 0 - 1 4 6 9 7 0 _ 0 - 1 2 0 8 5
2 2 1 6 8 3 2 0 4 - 6 0 7 4 0 - 0 - 9 4 7 0 1 1 3 0 5 3 3 - 7 2 6 9
3 0 - 0 - 4 2 4 3 1 3 6 2 8 9 2 - 2 0 2 0 6 0 - 0 - 6 5 7 7
4 6 6 0 4 2 2 2 - 1 3 1 6 1 261 7 -1 4 5 1 0 - 0 - 5 6 9
U nknow n 0 0 - 1 3 4 4 1 0 * 0 - 3 1 2 3 8 0 - 0 - 8 8 8 6
C a . L ung 1 12 1 0 9 5 6 - 1 9 0 6 79 2 6 - 1 8 5 7 1 0 6 4 2 - 2 1 8
2 19 99 5 9 - 1 5 4 7 8 8 3 5 - 1 8 1 2 6 1 5 7 1 0 2 -2 3 0
3 11 100 5 0 - 1 7 8 3 6 8 1 4 - 2 0 0 8 7 7 3 3 - 5 1 5
4 176 96 8 2 -1 1 1 78 8 6 6 7 - 1 0 5 1 3 9 9 0 7 5 - 1 0 5
U nknow n 5 97 3 2 - 2 2 7 3 102 2 1 - 2 9 9 8 7 6 3 3 - 1 4 9
C a . P l e u r a 1 6 3 8 8 6 1 4 2 5 - 8 4 5 8 1 1 5 9 0 4 0 - 8 8 5 6 0 _ 0 -4 5 7 1
2 7 2 4 3 8 9 7 9 -5 0 2 1 6 6 3 1 8 2 3 1 6 - 1 3 7 5 1 6 2 8 7 8 1 0 5 5 - 6 2 6 5
3 8 3 9 6 2 1 7 0 8 - 7 8 0 5 3 4 6 5 7 9 6 1 - 1 3 6 1 4 2 1 3 8 8 1 6 8 -5 0 1 1
4 40 1 6 4 6 1 1 3 6 - 2 1 5 6 11 1 1 4 3 5 7 1 - 2 0 4 5 18 1 0 3 8 6 1 5 - 1 6 4 0
U nknow n 1 1 5 0 9 3 8 - 8 4 0 5 0 0 - 1 2 3 7 5 0
'
0 - 3 3 2 2
O c c u p a t i o n a l  g r o u p :  1
3
4
R e g i s t e r e d  a s b e s t o s  w o r k e r s .
E l e c t r i c a l  f i t t e r s ,  b u r n e r s ,  w e l d e r s ,  r i v e t e r s ,  c a u l k e r s ,  
d r i l l e r s ,  s h i p f i t t e r s ,  p l u m b e r s  a n d  c o p p e r s m i t h s .  
S h i p w r i g h t s ,  e n g i n e  f i t t e r s .
A l l  d o c k y a r d  t r a d e s  n o t  i n  g r o u p s  1 ,  2  a n d  3 .
A3 - 39
T A B L E  A 3 .2 7  (com.): Cause specific mortality by occupational group and
dockyard.
C a u s e s  o f  D e a th O c c u p .
g r o u p
O bs
D e v o n p o r t
O bs
C h a th a m
O bs
P o r t s m o u th
SMR 95X C l ,SMR 95X C l SMR 95X C l
C i r c u l a t o r y  S y s te m 1 53 97 7 1 - 1 2 3 19 7 5 4 5 - 1 1 7 24 9 0 5 8 -1 3 4
2 91 94 7 5 - 1 1 4 31 9 7 6 3 -1 3 1 53 81 5 9 -1 0 2
3 59 104 7 7 - 1 3 0 14 7 6 4 1 - 1 2 7 33 77 5 1 -1 0 4
4 8 4 8 93 8 7 - 1 0 0 312 8 5 7 6 -  9 5 5 2 5 8 5 7 8 -  92
Unknown 30 119 8 0 - 1 7 0 15 1 2 8 7 2 -2 1 1 39 9 3 6 3 - 1 2 2  1
P u lm o n a r y  C i r c u l a t i o n 1 2 3 6 9 4 5 - 1 3 3 1 0 _ 0 - 1 3 2 0 0 - 0 - 1 3 2 5 5
2 2 2 1 2 2 6 - 7 6 4 0 - 0 - 1 0 7 5 0 - 0 -5 4 4
3 2 3 7 7 4 6 - 1 3 6 2 0 - 0 - 1 9 4 2 0 - 0 -8 5 1
4 20 2 1 9 1 3 4 - 3 3 9 4 9 9 2 7 - 2 5 5 2 30 4 - 1 1 0
Unknown 1 392 1 0 - 2 1 8 1 0 - 0 - 2 8 2 0 0 - 0 - 8 0 7
R e s p i r a t o r y  S y s te m 1 7 78 3 1 - 1 6 2 1 1 8 0 - 1 0 2 3 5 8 1 2 -1 7 1
2 14 91 5 0 - 1 5 2 7 111 4 5 - 2 2 8 10 81 3 9 -1 4 9
3 11 1 3 3 6 6 - 2 3 8 5 1 4 7 4 8 - 3 4 3 5 6 4 2 1 -1 4 9
4 138 90 7 5 - 1 0 5 66 8 6 6 5 - 1 0 6 110 8 8 7 2 -1 0 5
U nknow n 5 117 3 8 - 2 7 4 1 4 0 1 -2 2 1 3 3 4 7 -1 0 0
B r o n c h i t i s ,  E m physem a 1 3 90 1 9 - 2 6 3 0 _ 0 - 1 7 3 1 50 1 - 2 7 8
a n d  A s th m a 2 3 53 1 1 - 1 5 4 1 4 0 1 -2 2 1 5 1 0 4 3 4 -2 4 2
3 2 66 8 - 2 3 6 4 1 5 0 1 8 - 5 4 2 0 - 0 - 1 2 3
4 33 58 3 8 -  7 8 24 7 9 5 0 - 1 1 7 29 6 0 4 0 -  86
Unknow n 0 - 0 - 2 2 9 0 - 0 - 3 6 9 0 - 0 - 1 0 8
1 1 5 3 3 9 1 3 5 - 2 9 7 3 6 0 - 0 - 4 3 7 1 6 0 _ 0 - 3 8 5 1 6
2 3 9 0 0 4 1 8 5 8 - 2 6 3 2 2 0 - 0 - 3 2 8 3 8 0 - 0 -1 4 9 3 5
3 0 _ 0 - 1 8 5 5 7 0 - 0 - 5 6 6 8 9 0 - 0 -2 3 6 7 7
4 3 9 8 5 2 0 3 - 2 8 8 0 0 - 0 - 2 9 9 5 1 2 2 1 2 -2 5 5 5
U nknow n 0 - 0 - 4 3 5 5 4 0 - 0 - 9 4 5 3 1 0 " 0 -2 5 3 4 0
P u lm o n a r y  F i b r o s i s 1 0 _ 0 - 2 7 7 9 0 _ 0 - 5 6 1 7 0 - 0 - 5 5 8 6
2 0 - 0 - 1 6 0 0 0 - 0 - 4 5 9 7 0 - 0 -2 2 6 1
3 0 _ 0 - 2 8 7 3 0 - 0 - 8 4 1 4 0 - 0 - 3 5 9 2
4 2 90 1 1 - 3 2 4 1 1 0 8 3 - 5 9 9 0 - 0 - 2 3 6
U nknow n 0 " 0 - 5 8 8 3 0 0 - 1 2 3 2 5 0 0 -3 4 0 9
O c c u p a t i o n a l  g r o u p :  1
3
4
R e g i s t e r e d  a s b e s t o s  w o r k e r s .
E l e c t r i c a l  f i t t e r s ,  b u r n e r s ,  w e l d e r s ,  r i v e t e r s ,  c a u l k e r s ,  
d r i l l e r s ,  s h i p f l t t e r s ,  p lu m b e r s  a n d  c o p p e r s m i t h s .  
S h i p w r i g h t s ,  e n g i n e  f i t t e r s .
A l l  d o c k y a r d  t r a d e s  n o t  i n  g r o u p s  1 ,  2  a n d  3 .
A3 - 40
T A B L E  A3.28: Cause specific mortality by exposure rating and dockyard.
Causes o f  Death Exposure
rating
Obs
Devonport
Obs
Chatham 
SMR 95X Cl
Portsmouth 
Obs SMR 95X  ClSMR 95X Cl
All C a u s e s < 1 0 0 1149 9 4 8 8 -  99 4 7 2 87 7 9 -  9 4 734 8 5 7 9 -  91
1 0 0 - 316 91 8 1 -1 0 1 1 0 8 8 3 6 7 -  9 9 211 79 6 9 -  9 0
2 0 0 - 224 8 8 7 7 - 1 0 0 9 7 97 7 8 - 1 1 6 159 8 2 6 9 -  9 5
3 0 0 - 185 1 0 3 8 8 - 1 1 8 8 3 115 9 0 - 1 4 0 139 9 3 7 8 - 1 0 9
4 0 0 + 125 1 2 0 9 9 -1 4 1 4 3 81 5 7 - 1 0 5 78 1 0 5 8 1 - 1 2 8
Unknown 131 1 0 6 8 8 - 1 2 5 4 0 100 6 9 - 1 3 2 79 8 3 6 5 - 1 0 1
All Neoplasms < 100 367 1 0 6 9 5 - 1 1 6 167 1 0 3 8 8 - 1 1 9 2 3 3 8 9 7 8 - 1 0 1
1 0 0 - 104 1 0 4 8 4 - 1 2 4 4 3 n o 7 7 - 1 4 3 75 9 3 7 2 - 1 1 4
2 0 0 - 97 1 3 2 1 0 6 -1 5 8 3 5 114 7 6 - 1 5 2 59 1 0 0 7 4 - 1 2 5
3 0 0 - 70 134 1 0 3 -1 6 6 32 146 9 5 - 1 9 6 58 1 2 5 9 3 - 1 5 8
4 0 0 + 53 1 7 8 1 3 0 -2 2 6 15 9 3 5 2 - 1 5 4 40 1 7 6 1 2 1 - 2 3 1
Unknown 37 1 0 5 7 1 - 1 3 9 18 1 5 0 8 9 - 2 3 8 2 5 8 6 5 6 - 1 2 7
Ca. S tomach < 1 0 0 42 1 4 6 1 0 2 -1 9 1 15 114 6 4 - 1 8 7 14 6 7 3 6 - 1 1 2
1 0 0 - 10 1 2 2 5 9 - 2 2 5 5 158 5 1 - 3 6 9 8 1 2 3 5 3 - 2 4 3
2 0 0 - 7 1 1 5 4 6 - 2 3 7 4 159 4 3 - 4 0 8 7 1 4 7 5 9 - 3 0 2
3 0 0 - 6 1 3 6 5 0 - 2 9 6 3 164 3 4 - 4 8 0 6 1 6 0 5 9 - 3 4 9
4 0 0 + 6 2 3 0 8 4 - 5 0 0 2 147 1 8 - 5 3 2 5 2 6 4 8 6 - 6 1 7
Unknown 7 2 3 6 9 5 - 4 8 6 1 101 3 - 5 6 1 0 - 0 - 1 5 6
Ca. P er i  toneum < 1 0 0 2 2 8 0 3 4 - 1 0 1 0 2 704 8 5 - 2 5 4 3 0 . 0 - 8 0 7
1 0 0 - 0 - 0 - 1 7 2 5 0 - 0 - 5 0 1 8 0 _ 0 - 2 5 7 2
2 0 0 - 2 1 3 4 9 1 6 3 -4 8 6 9 0 - 0 - 6 9 6 6 0 _ 0 - 3 6 8 3
3 0 0 - 2 214 1 2 5 9 - 7 7 2 8 0 - 0 - 1 0 7 9 7 1 1 3 6 6 3 5 - 7 6 1 0
4 0 0 + 3 6 0 7 2 1 2 5 3 -1 7 7 5 1 0 - 0 - 1 6 3 9 7 0 _ 0 - 1 1 2 2 7
Unknown 0 - 0 - 5 3 1 0 0 - 0 - 1 8 3 2 2 0 - 0 - 7 9 6 1
Ca. Lung < 1 0 0 112 9 0 7 4 - 1 0 7 60 94 7 0 - 1 1 7 100 9 7 7 8 - 1 1 6
1 0 0 - 36 1 0 2 6 8 - 1 3 5 10 6 5 3 1 - 1 2 0 24 7 5 4 8 - 1 1 2
2 0 0 - 32 1 2 0 7 9 - 1 6 2 10 81 3 9 - 1 4 9 16 6 8 3 9 - 1 1 0
3 0 0 - 19 9 8 5 9 -1 5 4 6 67 2 4 - 1 4 5 21 1 1 2 6 9 - 1 7 0
4 0 0 + 14 1 2 6 6 9 - 2 1 2 5 76 2 4 - 1 7 6 18 1 9 3 1 1 4 - 3 0 5
Unknown 10 78 3 8 - 1 4 4 5 104 3 4 - 2 4 2 9 77 3 5 - 1 4 6
Ca. P l eura < 100 13 761 4 0 5 - 1 3 0 2 2 2 8 8 3 5 - 1 0 4 1 6 4 9 8 1 8 3 - 1 0 8 4
1 0 0 - 12 2 2 7 5 1 1 7 6 -3 9 7 4 3 1604 3 3 1 - 4 6 8 8 3 7 8 3 1 6 2 - 2 2 8 8
2 0 0 - 14 3 6 7 8 2 0 1 0 - 6 1 7 2 5 358 4 1 1 6 1 - 8 3 6 4 6 2 1 8 3 8 0 0 - 4 7 5 1
3 0 0 - 15 6 2 8 4 3 5 1 9 - 1 0 3 6 4 7 791 0 3 1 7 5 - 1 6 2 9 5 6 2 9 2 0 1 0 7 0 - 6 3 5 5
4 0 0 + 7 5 9 7 2 2 3 9 7 - 1 2 3 0 3 3 5 4 1 0 1 1 1 6 - 1 5 8 1 6 5 5 8 4 3 1 8 9 3 - 1 3 6 3 8
Unknown 1 5 9 3 1 5 -3 3 0 1 1 199 4 5 0 - 1 1 1 0 8 0 ~ 0 - 2 9 5 6
A 3 - 41
T A B L E  A 3.28  (corn.): Cause specific mortality by exposure rating and dockyard.
Causes of Death Exposure
rating
Devonport
Obs
C h atham
Obs
Portsmouth
Obs SMR 95X Cl SMR 95X Cl SMR 95X Cl
Circulatory S y stem < 1 0 0 6 0 3 97 9 0 - 1 0 5 221 8 5 7 4 -  9 6 3 5 7 8 6 7 7 -  95
1 0 0 - 166 9 3 7 9 -1 0 7 50 8 0 5 8 - 1 0 2 104 81 6 5 -  96
2 0 0 - 89 68 5 4 -  82 4 5 9 2 6 5 - 1 1 9 76 8 0 6 2 -  98
3 0 0 - 9 5 101 8 1 - 1 2 2 34 9 6 6 4 - 1 2 9 67 92 7 0 -1 1 4
4 0 0 + 60 no 8 2 - 1 3 8 2 2 8 4 5 3 - 1 2 8 26 71 4 6 -1 0 4
Unknown 68 107 8 2 - 1 3 3 19 9 8 5 9 - 1 5 3 44 9 5 6 7 - 1 2 3
Pulmonary Circulation < 1 0 0 16 2 5 9 1 4 8 -4 2 0 3 1 0 5 2 2 - 3 0 6 1 2 3 1 -1 2 7
1 0 0 - 5 2 8 7 9 3 -6 7 1 0 - 0 - 5 5 5 1 74 2 - 4 1 2
2 0 0 - 1 77 2 - 4 3 0 0 _ 0 - 6 9 5 0 _ 0 -3 7 1
3 0 0 - 2 2 1 0 2 5 -7 5 6 0 - 0 - 9 4 4 0 _ 0 - 4 7 4
4 0 0 - 1 1 7 3 4 - 9 6 6 0 - 0 - 1 2 3 2 0 - 0 - 8 9 8
Unknown 2 3 1 3 3 8 -1 1 2 9 1 4 6 4 1 2 - 2 5 8 2 0 - 0 - 7 3 5
Respiratory System < 1 0 0 93 9 0 7 1 - 1 0 8 4 6 8 3 5 9 - 1 0 8 8 3 100 7 9 - 1 2 2
1 0 0 - 22 77 4 8 -1 1 7 10 8 0 3 9 - 1 4 8 14 55 3 0 -  93
2 0 0 - 2 5 118 7 6 -1 7 4 5 51 1 7 - 1 2 0 13 6 9 3 7 - 1 1 9
3 0 0 - 14 8 7 4 8 -1 4 7 12 161 8 3 -2 8 1 8 55 2 4 - 1 0 9
4 0 0 + 7 6 9 2 8 - 1 4 3 6 101 3 7 - 2 1 9 9 1 1 3 5 2 -2 1 4
Unknown 14 130 7 1 -2 1 9 1 2 4 1 - 1 3 6 4 4 2 1 1 -1 0 7
Bronchitis, Emphysema < 1 0 0 19 4 9 3 0 -  77 16 74 4 2 - 1 2 0 2 2 6 8 4 3 - 1 0 3
j and Asthma 1 0 0 - 4 38 1 0 -  97 4 8 2 2 2 - 2 1 0 4 41 1 1 -1 0 4
2 0 0 - 8 102 4 4 - 2 0 0 1 2 6 1 - 1 4 3 5 6 9 2 2 -1 6 1
3 0 0 - 2 33 4 -1 2 1 5 1 6 7 5 4 - 3 9 0 3 53 1 1 -1 5 4
4 0 0 + 4 106 2 9 -2 7 1 1 4 2 1 - 2 3 5 1 32 1 -1 7 7
Unknown 4 100 2 7 - 2 5 5 0 0 - 2 2 5 0 - 0 -  99
Asbestosis < 1 0 0 1 481 1 2 -2 6 8 0 0 _ 0 - 4 2 4 5 1 6 8 0 1 7 -3 7 8 7
1 0 0 - 1 163 7 4 1 - 9 1 1 8 0 - 0 - 1 6 9 0 7 0 _ 0 - 8 0 2 8
2 0 0 - 2 4 3 5 8 5 2 7 -1 5 7 3 2 0 - 0 - 2 1 0 7 3 0 - 0 -1 0 8 6 7
3 0 0 - 1 3 1 3 9 7 9 -1 7 4 8 7 0 - 0 - 3 0 2 0 3 0 - 0 -1 3 7 0 6
4 0 0 + 2 1 1 7 3 8 1 4 2 0 -4 2 3 7 4 0 - 0 - 4 4 2 4 7 0 - 0 - 2 9 9 0 9
Unknown 0 - 0 - 1 7 4 2 8 0 0 - 5 6 8 5 5 0 - 0 - 2 2 6 8 2
Pulmonary Fibrosis < 1 0 0 1 6 6 2 - 3 6 8 1 151 4 - 8 4 2 0 _ 0 - 3 5 3
1 0 0 - 0 - 0 - 8 6 8 0 - 0 - 2 3 8 9 0 - 0 -1 1 5 2
2 0 0 - 0 - 0 - 1 1 7 3 0 - 0 - 3 0 1 2 0 _ 0 - 1 5 5 3
3 0 0 - 1 4 2 9 1 1 -2 3 9 0 0 - 0 - 3 9 9 7 0 - 0 -1 9 7 4
4 0 0 + 0 - 0 -2 6 3 1 0 - 0 - 5 2 8 5 0 - 0 - 3 8 2 3
Unknown 0 0 -2 3 6 2 0 — 0 - 7 4 8 4 0 “ 0 - 3 1 0 5
A3 -42
T A B L E  A 3.29 Cause specific mortality by asbestos exposure period and
dockyard.
C a u s e s  o f  D e a th A s b e s t o s
e x p o s u r e
( y r s )
O bs
D e v o n p o r t
O bs
C h a th a m
O b s
P o r t s m o u th
SMR 95X C l SMR 95X  C l SMR 95X  C l
A l l C a u s e s < 10 8 7 97 7 6 - 1 1 7 32 8 0 5 2 - 1 0 8 6 4 91 6 8 - 1 1 3
1 0 - 84 93 7 3 - 1 1 2 20 6 5 4 0 - 1 0 0 7 6 1 0 5 8 1 - 1 2 8
2 0 - 1 1 8 117 9 6 - 1 3 8 38 1 0 5 7 1 - 1 3 8 9 2 1 1 0 8 8 - 1 3 3
30+ 114 9 8 8 0 - 1 1 6 48 1 1 3 8 1 - 1 4 4 1 1 4 9 3 7 6 - 1 1 0
U nknow n 172 7 94 9 0 -  9 9 7 0 5 8 9 8 3 -  9 6 1 0 5 4 81 7 7 -  8 6
A l l N e o p l a s m s < 10 2 5 96 6 2 - 1 4 2 17 141 8 2 - 2 2 6 2 5 1 1 5 7 5 - 1 7 0
1 0 - 35 1 3 3 8 9 - 1 7 8 7 7 5 3 0 - 1 5 4 31 139 9 0 - 1 8 8
2 0 - 4 8 162 1 1 6 - 2 0 7 10 9 0 4 3 - 1 6 5 34 1 3 2 8 8 - 1 7 6
30+ 4 5 1 3 3 9 4 - 1 7 2 2 3 1 7 6 1 1 1 - 2 6 3 4 6 121 8 6 - 1 5 6
U nknow n 5 7 5 1 1 0 1 0 1 - 1 1 9 2 5 3 1 0 7 9 4 - 1 2 1 3 5 4 90 8 1 - 1 0 0
C a . S t o m a c h < 10 2 9 4 1 1 - 3 3 9 4 4 0 5 1 1 0 - 1 0 3 7 5 2 8 9 9 4 - 6 7 5
1 0 - 2 92 1 1 - 3 3 4 0 - 0 - 4 8 2 1 56 1 - 3 1 0
2 0 - 3 122 2 5 - 3 5 6 0 _ 0 - 4 0 2 3 144 3 0 - 4 2 0
30+ 3 102 2 1 - 2 9 9 4 3 6 6 1 0 0 - 9 3 6 6 192 7 0 - 4 1 8
U nknow n 68 1 5 7 1 2 0 - 1 9 5 22 1 1 4 7 1 - 1 7 3 2 5 79 5 1 - 1 1 7
C a . P e r  i  t-o n eu m « 10 0 _ 0 - 6 9 8 9 0 _ 0 - 1 8 0 0 0 0 _ 0 - 9 7 0 4
1 0 - 0 - 0 - 6 8 1 4 0 - 0 - 2 3 0 1 4 0 - 0 - 9 6 7 1
2 0 - 1 1 7 5 6 4 4 - 9 7 8 0 0 - 0 - 2 0 0 1 3 0 - 0 - 8 8 4 8
30+ 3 5 3 6 3 1 1 0 7 - 1 5 6 7 7 0 _ 0 - 1 8 6 3 1 1 1 8 0 0 4 6 - 1 0 0 2 6
U nknow n 5 4 6 8 1 5 2 - 1 0 9 2 . 2 4 8 5 5 9 - 1 7 5 0 0 - 0 - 5 4 3
C a . L u n g < 10 7 7 5 3 0 - 1 5 5 4 8 3 2 3 - 2 1 2 10 1 1 6 5 6 - 2 1 3
1 0 - 21 2 2 2 1 3 7 - 3 3 9 1 2 7 1 - 1 4 8 9 101 4 6 - 1 9 1
2 0 - 15 136 7 6 - 2 2 5 2 4 4 5 - 1 5 8 1 3 124 6 6 - 2 1 3
30+ 12 9 5 4 9 - 1 6 6 6 111 4 1 -2 4 1 17 1 0 8 6 3 - 1 7 4
U nknow n 168 9 0 7 6 - 1 0 4 8 3 8 9 7 0 - 1 0 8 1 3 9 9 0 7 5 - 1 0 5
C a . P l e u r a < 10 3 2 3 1 6 4 7 8 - 6 7 7 1 0 _ 0 - 7 1 8 5 1 9 6 2 2 4 - 5 3 5 9
1 0 - 5 3 6 7 9 1 1 9 2 - 8 5 8 6 1 2 3 7 9 6 0 - 1 3 2 5 3 3 2 9 0 6 6 0 0 - 8 4 9 4
2 0 - 9 6 0 7 2 2 7 8 0 - 1 1 5 2 4 2 4 0 7 7 4 9 3 - 1 4 7 1 9 1 8 6 5 2 2 - 4 8 2 0
30+ 8 5 8 1 2 2 5 0 6 - 1 1 4 4 9 4 7851 2 1 4 0 - 2 0 1 0 0 9 5 9 1 5 2 7 0 8 - 1 1 2 2 6
U nknow n 37 1 4 2 9 9 6 9 - 1 8 9 0 14 1371 7 4 9 -2 3 0 1 12 6 6 5 3 4 4 - 1 1 6 2
A3 - 43
T A B L E  A 3.29 (corn.): Cause specific mortality by asbestos exposure period and
dockyard.
1 C a u s e s  o f  D e a th A s b e s t o s
e x p o s u r e
O b s
D e v o n p o r t
O b s
C h a th a m
O b s
P o r t s m o u th
SMR 9S X  C l SMR 95X C l SMR 95X  C l
! C i r c u l a t o r y  S y s te m < 10 4 7 102 7 3 - 1 3 1 12 62 3 2 -1 0 9 2 8 8 2 5 5 - 1 1 9
1 0 - 37 79 5 4 - 1 0 5 11 73 3 7 -1 3 1 34 96 6 4 - 1 2 9
2 0 - S3 101 7 4 - 1 2 8 2 3 129 8 2 - 1 9 4 4 3 1 0 5 7 4 - 1 3 7
30+ S3 87 6 3 - 1 1 0 17 81 4 7 - 1 3 0 50 8 3 6 0 - 1 0 6
U nknow n 8 9 1 9 5 8 9 - 1 0 2 3 2 8 86 7 7 -  96 5 1 9 8 3 7 6 -  90
j P u lm o n a r y  C i r c u l a t i o n < 10 0 _ 0 - 8 1 4 0 _ 0 - 1 7 3 2 0 _ 0 - 1 0 4 0
1 0 - 2 4 3 5 5 3 - 1 5 6 9 0 - 0 -2 2 7 4 1 2 6 7 7 -1 4 8 7
2 0 - 3 574 1 1 8 - 1 6 7 7 0 - 0 - 1 8 9 3 0 - 0 - 8 4 8
30-*- 0 - 0 - 5 7 7 0 - 0 -1 5 8 1 0 - 0 - 5 5 7
U nknow n 2 2 2 3 6 1 4 8 - 3 5 8 4 96 2 6 - 2 4 6 1 1 5 0 -  84
R e s p i r a t o r y  S y s te m < 10 7 9 3 3 7 - 1 9 2 2 50 6 - 1 7 9 5 77 2 5 - 1 7 9
1 0 - 9 121 5 5 - 2 2 9 0 - 0 -1 2 1 4 58 1 6 - 1 4 9
2 0 - 1 3 154 8 2 - 2 6 3 2 56 7 -2 0 2 10 124 6 0 - 2 2 9
30+ 7 64 2 6 - 1 3 1 5 112 3 6 -2 6 1 1 3 103 5 5 - 1 7 7
U nknow n 1 3 9 89 7 4 - 1 0 4 71 8 9 6 8 - 1 1 0 9 9 79 6 4 -  9 5
B r o n c h i t i s ,  E m physem a < 10 3 108 2 2 - 3 1 5 2 125 1 5 -4 5 0 1 3 9 1 - 2 1 9
| a n d  A s th m a 1 0 - 2 71 9 - 2 5 8 0 - 0 - 3 0 9 1 37 1 - 2 0 5
2 0 - 2 62 8 - 2 2 4 0 - 0 - 2 5 7 3 9 5 2 0 - 2 7 6
30+ 1 24 1 - 1 3 5 2 I l l 1 3 -3 9 9 3 60 1 2 - 1 7 6
U nknow n 3 3 57 3 8 -  77 2 3 7 3 4 6 - 1 1 0 2 7 56 3 7 -  81
A s b e s t o s i s < 10 1 6 2 7 6 1 5 9 - 3 4 9 5 8 0 _ 0 - 5 5 7 5 9 0 _ 0 - 2 9 2 8 3
1 0 - 0 - 0 - 2 2 6 3 5 0 - 0 - 7 0 1 1 8 0 - 0 - 2 8 6 8 4
2 0 - 1 5 3 4 3 1 3 5 - 2 9 7 6 2 0 - 0 - 5 7 9 7 8 0 - 0 - 2 4 7 2 7
30+ 1 S009 1 2 7 - 2 7 9 0 3 0 - 0 - 5 1 3 9 3 0 - 0 - 1 7 1 9 3
U nknow n 4 1274 3 4 7 - 3 2 6 2 0 - 0 - 2 8 8 5 1 4 5 3 1 1 - 2 5 2 4
P u lm o n a r y  F i b r o s i s < 10 0 _ 0 - 3 2 7 1 0 _ 0 - 7 5 4 8 0 _ 0 - 4 3 2 8
1 0 - 0 - 0 - 3 2 9 2 0 - 0 - 9 7 8 4 0 - 0 - 4 1 5 4
2 0 - 0 - 0 - 2 8 8 7 0 - 0 -8 1 4 1 0 - 0 - 3 5 4 3
3 0 + 1 6 3 7 1 6 - 3 5 4 9 0 - 0 - 6 6 6 7 0 - 0 - 2 3 2 3
U nknow n 1 44 1 - 2 4 5 1 104 3 - 5 7 9 0
'
0 - 2 3 5
A 3 - 44
T A B L E  A3.30: Devonport Dockyard. All cause mortality by
smoking habit and ‘asbestos’ variables.
N o n - s m o k e r s E x - s m o k e r s S m o k e rs
O b s  SMR O b s SMR O b s SMR
(95%  C l ) (95%  C l ) (95%  C l )
O c c u p a t i o n a l  g r o u p
1 2 9  8 8 4 9  1 4 2 17 87
( 5 9 - 1 2 7 ) ( 1 0 2 - 1 8 2 ) ( 5 1 - 1 4 0 )
2 4 9  8 0 7 0  1 1 2 3 9 128
( 5 8 - 1 0 3 ) ( 8 6 - 1 3 8 ) ( 8 8 - 1 6 8 )
3 2 9  8 5 4 6  1 1 8 2 3 106
( 5 7 - 1 2 2 ) ( 8 4 - 1 5 3 ) ( 6 7 - 1 5 9 )
4 5 8 4  8 9 5 9 0  1 0 4 2 6 8 113
( 8 2 -  9 6 ) ( 9 6 - 1 1 3 ) ( 1 0 0 - 1 2 7 )
E x p o s u r e  r a t i n g
< too 3 8 0  8 7 4 2 4  1 0 9 1 8 8 108
( 7 8 -  9 6 ) ( 9 9 - 1 2 0 ) ( 9 3 - 1 2 4 )
1 0 0 - 1 0 3  79 1 1 4  106 5 9 118
( 6 4 -  9 4 ) ( 8 7 - 1 2 6 ) ( 8 8 - 1 4 8 )
2 0 0 - 6 8  79 91 102 41 105
( 6 0 -  9 8 ) ( 8 1 - 1 2 3 ) ( 7 3 - 1 3 7 )
3 0 0 - 6 9  100 6 4  1 0 9 2 7 1 2 5
( 7 7 - 1 2 4 ) ( 8 2 - 1 3 6 ) ( 8 3 - 1 8 2 )
' 4 0 0 + 5 0  141 3 6  104 2 3 151
( 1 0 2 - 1 8 0 ) ( 7 0 - 1 3 8 ) ( 9 6 - 2 2 7 )
A s b e s t o s  e x p o s u r e  p e r i o d  ( y r s )
< 1 0 2 7  79 3 7  1 1 9 1 5 100
( 5 2 - 1 1 6 ) ( 8 1 - 1 5 7 ) ( 5 6 - 1 6 4 )
1 0 - 3 2  101 31 8 9 16 106
( 6 6 - 1 3 6 ) ( 5 7 - 1 2 0 ) ( 6 0 - 1 7 2 )
2 0 - 4 2  112 3 8  104 2 4 136
( 7 8 - 1 4 6 ) ( 7 1 - 1 3 7 ) ( 8 7 - 2 0 3 )
3 0 + 5 0  115 2 8  7 8 2 2 1 2 3
( 8 3 - 1 4 7 ) ( 5 2 - 1 1 3 ) ( 7 7 - 1 8 7 )
C o n t i n u o u s  a s b e s t o s  e x p o s u r e ( y r s )
< 1 0 6  96 8  124 6 133
( 3 5 - 2 0 9 ) ( 5 3 - 2 4 4 ) ( 4 9 - 2 8 9 )
1 0 - 17  2 6 8 8  119 1 72
( 1 5 6 - 4 3 0 ) ( 5 1 - 2 3 4 ) ( 2 - 4 0 3 )
A 3 - 45
T A B L E  A 3.30 (corn.): Chatham Dockyard. A ll cause
mortality by smoking habit and
‘ asbestos’ variables.
N o n - s m o k e r s E x - s m o k e r s S m o k e rs
O b s SMR O b s SMR O bs SMR
(9 5 X  C l ) (9 5 %  C l ) (95%  C l )
O c c u p a t i o n a l  g r o u p
1 21 72 11 8 3 5 8 5
( 4 5 - 1 1 0 ) ( 4 2 - 1 4 9 ) ( 2 7 - 1 9 7 )
2 3 9  151 17  8 3 14 131 Í
( 1 0 4 - 1 9 8 ) ( 4 3 - 1 4 7 ) ( 7 2 - 2 2 0 )
3 11 77 12  8 4 7 1 2 6
( 3 8 - 1 3 8 ) ( 4 3 - 1 4 7 ) ( 5 1 - 2 5 9 )
4 2 7 8  91 2 1 6  104 395  94
( 8 0 - 1 0 1 ) ( 9 1 - 1 1 8 ) ( 7 4 - 1 1 4 )
E x p o s u r e  r a t i n g
< 1 0 0 1 8 8  8 4 1 5 2  1 0 5 67  101
( 7 2 -  9 6 ) ( 8 9 - 1 2 2 ) ( 7 6 - 1 2 5 )
1 0 0 - 4 2  8 2 3 9  1 0 5 13  6 3
( 5 8 - 1 0 7 ) ( 7 2 - 1 3 8 ) ( 3 4 - 1 0 8 )
2 0 0 - 57  131 19  72 13 1 0 7
( 9 7 - 1 6 5 ) ( 4 3 - 1 1 2 ) ( 5 7 - 1 8 2 )
3 0 0 - 41 1 3 5 21 8 9 11 1 5 3
( 9 4 - 1 7 7 ) ( 5 5 - 1 3 6 ) ( 7 6 - 2 7 4 )
4 0 0 + 14  6 3 3 8  94 8  1 5 9
( 3 4 - 1 0 5 ) ( 5 5 - 1 5 0 ) ( 6 8 - 3 1 3 )
A s b e s t o s  e x p o s u r e  p e r i o d ( y s )
< 10 15  79 1 0  97 3 74
( 4 4 - 1 3 0 ) ( 4 7 - 1 7 9 ) ( 1 5 - 2 1 6 )
1 0 - 11 6 6 7  75 2 8 2
( 3 3 - 1 1 8 ) ( 3 0 - 1 5 5 ) ( 1 0 - 2 9 6 )
2 0 - 21 1 2 6 8  8 9 9 1 5 3
( 7 8 - 1 9 3 ) ( 3 8 - 1 7 5 ) ( 7 0 - 2 9 0 )
3 0 + 2 7  1 4 9 14  9 3 5 1 4 3
( 9 8 - 2 1 7 ) ( 5 1 - 1 5 6 ) ( 4 6 - 3 3 4 )
C o n t in u o u s  a s b e s t o s  e x p o s u r e  ( y r s )
< 10 7 1 2 2 7 2 4 2 1 162
( 4 9 - 2 5 2 ) ( 9 7 - 4 9 8 ) ( 4 - 9 0 4 )
1 0 - 2  70 2  2 3 6 1 1 0 9
( 9 - 2 5 4 ) ( 2 9 - 8 5 1 ) ( 3 - 6 0 7 )
A 3  - 4 6
T A B L E  A3.30 (cont.): Portsmouth Dockyard. A ll cause
mortality by smoking habit and
‘asbestos’ variables.
N o n -s m o k e rs E x - s m o k e r s S m o k e rs
O bs SMR O bs SMR O bs SMR
(9 5 Z  C l ) (95%  C l ) ( 9 5 *  C l )
O c c u p a t i o n a l  g r o u p
1 21 114 12 76 12 96
( 7 1 - 1 7 5 ) ( 3 9 - 1 3 3 ) ( 4 9 - 1 6 7 )
2 4 3  92 50 127 2 5 104
( 6 5 - 1 2 0 ) ( 9 2 - 1 6 2 ) ( 6 7 - 1 5 4 )
3 2 6  8 2 2 0  74 11 91
( 5 3 - 1 2 0 ) ( 4 5 - 1 1 5 ) ( 4 5 - 1 6 3 )
4 3 7 7  8 5 3 6 9  92 2 0 2 100
( 7 6 -  9 3 ) ( 8 3 - 1 0 2 ) ( 8 6 - 1 1 4 )
E x p o s u r e  r a t i n g
1 < 100 2 4 7  81 2 5 7  9 5 136 1 0 0
( 7 1 -  9 1 ) ( 8 .3 - 1 0 6 ) ( 8 3 - 1 1 7 )
1 0 0 - 77  79 6 3  8 5 41 9 8
( 6 1 -  9 7 ) ( 6 4 - 1 0 6 ) ( 6 8 - 1 2 8 )
2 0 0 - 58  99 4 8  76 37 94
( 7 4 - 1 2 5 ) ( 5 4 -  9 7 ) ( 6 4 - 1 2 4 )
3 0 0 - 4 7  8 7 57  1 2 7 21 92
( 6 2 - 1 1 2 ) ( 9 4 - 1 6 0 ) ( 5 7 - 1 4 0 )
4 0 0 + 35  140 2 3  8 6 12 1 4 3
( 9 4 - 1 8 7 ) ( 5 5 - 1 3 0 ) ( 7 4 - 2 5 0 )
A s b e s t o s  e x p o s u r e  p e r i o d  ( y r s )
1 < 10 26  97 14 59 17 1 4 6
( 6 3 - 1 4 2 ) ( 3 2 -  9 8 ) ( 8 5 - 2 3 4 )
1 0 - 32  96 2 3  116 13 1 0 4
( 6 3 - 1 2 9 ) ( 7 3 - 1 7 4 ) ( 5 5 - 1 7 8 )
2 0 - 34  1 1 3 36  1 4 8 18 102
( 7 5 - 1 5 1 ) ( 1 0 0 - 1 9 6 ) ( 6 0 - 1 6 1 )
30+ 52 1 0 3 3 8  101 15 9 6
( 7 5 - 1 3 1 ) ( 6 9 - 1 3 3 ) ( 5 4 - 1 5 9 )
C o n t i n u o u s  a s b e s t o s  e x p o s u r e ( y r s )
< 10 6  100 2  57 6 3 1 2
( 3 7 - 2 1 9 ) ( 7 - 2 0 6 ) ( 1 1 4 - 6 7 8 )
1 0 - 9 2 3 0 6 no 2 107
( 1 0 5 - 4 3 7 ) ( 4 0 - 2 4 0 ) ( 1 3 - 3 8 5 )
A 3  - 47

T A B L E  A 4.1: All cause mortality by x-ray group and by time since first
exposure.
T i m e  s  i  n e e f i r s t  e x p o s u r e  ( e m p l o y m e n t )
X - r a y 0 -  9 10 -  1 9 2 0  -  29 3 0 - 3 9 40+
g r o u p
O bs SMR O bs SMR O b s SMR O b s SMR O b s  SMR
(95X  C l ) ( 9 5 X  C l ) ( 9 5 X  C l ) (9 5 X  C l ) (9 5 X  C l )
DEVON PORT
1 4 7 88 214 9 7 2 6 4  85 3 1 6  91 4 3 5  8 5
( 6 3 - 1 1 3 ) ( 8 4 - 1 1 0 ) ( 7 5 -  9 5 ) ( 8 1 - 1 0 1  ) ( 7 7 -  9 3 )
2 2 135 3 3 4 2 4  107 36  97 5 3  8 2
( 1 6 - 4 8 9 ) ( 7 -  9 8 ) ( 6 9 - 1 5 9 ) ( 6 6 - 1 2 9 ) ( 6 0 - 1 0 4 )
3 1 3 5 8 3 2 2 0 _ 6  70 4 2  1 0 6
( 9 - 1 9 9 3 ) ( 4 5 - 6 4 3 ) ( 2 6 - 1 5 3 ) ( 7 4 - 1 3 9 )
4 1 119 7 2 0 4 5  71 16  1 6 3 2 7  1 7 0
( 3 - 6 6 4 ) ( 8 2 - 4 2 0 ) ( 2 3 - 1 6 6 ) ( 9 3 - 2 6 4 ) ( 1 1 2 - 2 4 7 )
s 2 69 17 1 2 3 16 8 3 1 8  7 5 3 3  74
( 8 - 2 4 9 ) ( 7 1 - 1 9 6 ) ( 4 8 - 1 3 5 ) ( 4 4 - 1 1 8 ) ( 4 9 - 1 0 0 )
6 6 114 28 1 2 7 3 9  122 3 9  9 8 7 4  1 0 8
( 4 2 - 2 4 9 ) ( 8 4 - 1 8 3 ) ( 8 4 - 1 6 0 ) ( 6 7 - 1 2 9 ) ( 8 3 - 1 3 2 )
CHATHAM
1 14 56 65 7 4 7 5  8 3 1 1 2  8 0 2 3 8  8 6
( 3 1 -  9 4 ) ( 5 6 -  9 3 ) ( 6 4 - 1 0 2 ) ( 6 5 -  9 5 ) ( 7 5 -  9 7 )
2 1 185 2 6 7 6  99 1 3  7 6 4 0  1 0 4
( 5 - 1 0 2 8 ) ( 8 - 2 4 3 ) ( 3 6 - 2 1 5 ) ( 4 0 - 1 2 9 ) ( 7 2 - 1 3 7 )
3 _ 1 71 _ 4  i n 11 74
( 2 - 3 9 3 ) ( 3 0 - 2 8 4 ) ( 3 7 - 1 3 2 )
4 _ _ 2  147 2  72 1 3  1 6 8
( 1 8 - 5 3 2 ) ( 9 - 2 5 9 ) ( 8 9 - 2 8 7 )
5 1 89 8 1 8 4 8  115 1 5  1 9 0 1 3  1 2 0
( 2 - 4 9 4 ) ( 7 9 - 3 6 3 ) ( 5 0 - 2 2 7 ) ( 1 0 7 - 3 1 4 ) ( 6 4 - 2 0 5 )
6 4 2 1 0 6 8 0 11 137 14  9 9 4 5  3 2 2 9
( 5 7 - 5 3 7 ) ( 2 9 - 1 7 4 ) ( 6 9 - 2 4 6 ) ( 5 4 - 1 6 6 ) ( 9 9 - 1 8 0 )
PORTSMOUTH
1 13 47 91 81 141 8 0 1 8 2  76 2 8 3  74
( 2 5 -  8 1 ) ( 6 5 -  9 8 ) ( 6 7 -  9 4 ) ( 6 5 -  8 7 ) ( 6 5 -  8 2 )
2 4 2 6 3 5 61 21 103 4 4  1 0 5 8 0  9 5
( 7 2 - 6 7 2 ) ( 2 0 - 1 4 2 ) ( 6 4 - 1 5 8 ) ( 7 4 - 1 3 6 ) ( 7 5 - 1 1 6 )
3 _ 1 1 0 4 3  109 1 3  1 8 2 21 6 0
( 3 - 5 8 1 ) ( 2 3 - 3 1 9 ) ( 9 7 - 3 1 1 ) ( 9 7 - 3 1 1 )
4 1 7 4 7  163 7 1 2 0 1 3  171
( 2 - 4 1 3 ) ( 6 5 - 3 3 6 ) ( 4 8 - 2 4 7 ) ( 9 1 - 2 9 2 )
5 4 277 5 9 4 12  125 1 0  76 2 5  131
( 7 6 - 7 1 0 ) ( 3 1 - 2 2 0 ) ( 6 5 - 2 1 8 ) ( 3 6 - 1 3 9 ) ( 8 5 - 1 9 4 )
6 4 1 1 5 19 1 2 2 3 3  126 3 3  1 0 3 4 8  8 5
( 3 1 - 2 9 3 ) ( 7 3 - 1 9 0 ) ( 8 3 - 1 6 9 6 ) ( 6 8 - 1 3 8 ) ( 6 1 - 1 0 9 )
A4 - 2
T A B L E  A 4.2: Lung cancer mortality by x-ray group and by time since
first exposure.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p l o y m e n t )
X - r a y 0 - 9 10 -  19 2 0  -  29 3 0 - 3 9 40-f
g r o u p
O b s  SMR O b s SMR O b s  SMR O b s SMR O bs SMR
(95%  C l ) (9 5 X  C l ) (95%  C l ) (9 5 X  C l ) (95%  C l )
DEVONPORT
! i 4  8 6 17 8 0 3 5  116 31 8 6 3 8  69
( 2 3 - 2 2 0 ) ( 4 7 - 1 2 8 ) ( 7 7 - 1 5 4 ) ( 5 6 - 1 1 7 ) ( 4 7 -  9 2 )
2 _ _ 3  127 3  76 8  115
( 2 6 - 3 7 0 ) ( 1 6 - 2 2 3 ) ( 5 0 - 2 2 7 )
3 _ 1 6 4 6 _ _ 5  120
( 1 6 - 3 5 9 6 ) ( 3 9 - 2 8 0 )
4 _ 1 261 _ 4 3 8 2 4  2 3 8
( 7 - 1 4 5 4 ) ( 1 0 4 - 9 7 7 ) ( 6 5 - 6 1 0 )
5 _ 3 201 1 51 3  1 1 7 3  64
( 4 1 - 5 8 6 ) ( 1 - 2 8 2 ) ( 2 4 - 3 4 1 ) ( 1 3 - 1 8 6 )
6 1 1 7 2 2 8 4 7 2 1 0 4  9 5 9  123
( 4 - 9 5 9 ) ( 1 0 - 3 0 4 ) ( 8 4 - 4 3 2 ) ( 2 6 - 2 4 4 ) ( 5 6 - 2 3 4 )
CHATHAM
1 1 3 7 4 4 2 7  72 14 8 4 31 90
( 1 - 2 0 7 ) ( 1 2 - 1 0 9 ) ( 2 9 - 1 4 9 ) ( 4 6 - 1 4 1 ) ( 5 8 - 1 2 2 )
2 _ 1 2 6 7 _ 1 4 6 3 6 3
( 7 - 1 4 8 6 ) ( 1 - 2 5 6 ) ( 1 3 - 1 8 4 )
! 3 _ 1 581 _ _ 1 55
( 1 5 - 3 2 4 8 ) ( 1 - 3 0 5 )
4 - - " - 1 104 
( 3 - 5 8 1 )
5 _ 1 1 8 5 _ 2  2 1 5 _
( 5 - 1 0 2 9 ) ( 2 6 - 7 7 8 )
6 _ 1 1 1 6 3  3 2 8 2  1 1 4 5 1 2 5
( 3 - 6 4 8 ) ( 6 8 - 9 5 7 ) ( 1 4 - 4 1 0 ) ( 4 1 - 2 9 3 )
PORTSMOUTH
! i 3  1 0 6 12 9 6 16  80 16 56 3 5  73
( 2 2 - 3 0 9 ) ( 5 0 - 1 6 8 ) ( 4 6 - 1 3 0 ) ( 3 2 -  9 1 ) ( 4 9 -  9 7 )
2 _ 1 9 6 3  119 4 7 7 14 133
( 2 - 5 3 4 ) ( 2 4 - 3 4 7 ) ( 2 1 - 1 9 6 ) ( 7 3 - 2 2 3 )
3 _ _ _ 1 1 0 8 2  46
( 3 - 6 0 3 ) ( 6 - 1 6 6 )
4 _ _ _ 2 2 7 7 7 7 3 7
( 3 4 - 1 0 0 0 ) ( 2 9 6 - 1 5 1 7 )
5 _ 3 4 3 6 1 86 3 1 9 0 5 2 0 8
( 9 0 - 1 2 7 6 ) ( 2 - 4 7 8 ) ( 3 9 - 5 5 5 ) ( 6 8 - 4 8 7 )
6 _ 4 201 7 2 1 5 5 1 2 7 7 100
( 5 5 - 5 1 6 ) ( 8 6 - 4 4 4 ) ( 4 1 - 2 9 7 ) ( 4 0 - 2 0 6 )
A 4  -  3
T A B L E  A 4.3: Pleural mesothelioma mortality by x-ray group and by time
since first exposure.
Tim e s i  n e e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
t X - r a y 0 - 9 1 0  -  19 2 0  -  2 9 3 0  -  39 40+
g r o u p
O b s  SMR O bs SMR O bs SMR O b s SMR O bs SMR
(95%  C l ) (95%  C l ) ( 9 5 %  C l ) (95%  C l ) (95%  C l )
DEVON PORT
i 1 _ 3  9 7 3 8  1 6 8 0 5  8 6 5 19 2 6 7 8
( 2 0 1 - 2 8 4 5 ) ( 7 2 5 - 3 3 1 0 ) ( 2 8 0 - 2 0 2 0 ) ( 1 6 1 2 - 4 1 8 2 )
2 _ _ 2  6 8 1 8 1 1833 5 5 8 1 2
( 8 2 5 - 2 4 6 1 3 ) ( 4 6 - 1 0 2 1 1 ) ( 1 8 8 3 - 1 3 5 6 4 )
3 * * - 5 1 0 7 9 9  
( 3 4 9 9 - 2 5 2 0 4 )
4 - - 2  10431 
( 1 2 6 2 - 3 7 6 5 6 )
5 - 3  8411 
( 1 7 3 5 - 2 4 5 8 8 )
-
6 ~ * ~ “ 1 1 1 4 7  
( 2 9 - 6 3 8 9 )
CHATHAM
1 _ _ _ 5  2 3 8 9 9 2 4 9 4
( 7 7 4 - 5 5 7 7 ) ( 1 1 4 2 - 4 7 3 4 )
2 _ _ _ _ 2 412 1
( 4 9 9 - 1 4 8 7 6 )
3 _ _ _ _ 2 1 1 9 5 5
4 - - - -
( 1 4 4 7 - 4 3 1 5 8 )
5
6 1 5 3 3 0 5 1 2 6 7 5
( 1 3 4 9 - 2 9 6 9 1 1 ) ( 6 8 - 1 4 8 9 8 )
PORTSMOUTH
1 _ _ 4  1 5 0 5 3  7 6 5 4 7 4 9
( 4 1  0 - 3 8 5 3 ) ( 1 5 8 - 2 2 3 7 ) ( 2 0 4 - 1 9 1 9 )
2 _ _ 1 3 7 9 0 1 1671 6 5 4 1 6
( 9 6 - 2 1 1 1 2 ) ( 4 2 - 9 3 0 5 ) ( 1 9 8 6 - 1 1 7 8 8 )
3 - - - - 1 2 3 7 4  
( 6 0 - 1 3 2 2 3 )
4 - - - - 1 1 0 6 6 0  
( 2 7 0 - 5 9 3 7 9 )
5 - - - - 1 3 7 8 6  
( 9 6 - 2 1 0 8 5 )
6 _ _ _ 1 2 3 2 3 1 1 4 1 6
( 5 9 - 1 2 9 4 1 ) ( 3 6 - 7 8 8 7 )
A4 - 4
T A B L E  A 4 .4 : A ll cause mortality by medical history and by time since
first exposure.
T im e  s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
M e d i c a l 0 - 9 10  -  19 2 0  -  2 9 3 0  -  39 4 0 +
h i s t o r y
O b s SMR O bs SMR O b s SMR O b s  SMR O bs SMR
(9 5 X  C l ) (95%  C l ) (9 5 %  C l ) (9 5 %  C l ) (95%  C l )
DEVONPORT
C o u g h 19 124 9 0  131 1 1 6  1 1 7 1 4 3  1 2 0 2 1 2  1 1 7
( 7 5 - 1 9 4 ) ( 1 0 4 - 1 5 8 ) ( 9 6 - 1 3 8 ) ( 1 0 1 - 1 4 0 ) ( 1 0 2 - 1 3 3 )
P h le g m 2 5 140 1 0 3  1 2 3 1 2 7  1 0 5 1 6 0  1 1 6 2 4 9  1 0 8
( 9 0 - 2 0 6 ) ( 1 0 0 - 1 4 7 ) ( 8 7 - 1 2 3 ) ( 9 8 - 1 3 4 ) ( 9 5 - 1 2 1 )
B r e a t h l e s s 14 162 6 2  154 79  1 3 6 1 0 3  1 5 5 150  1 3 7
( 8 9 - 2 7 2 ) ( 1 1 6 - 1 9 2 ) ( 1 0 6 - 1 6 6 ) ( 1 2 5 - 1 8 5 ) ( 1 1 5 - 1 5 9 )
C h e s t - 10 1 2 8 41 119 51 1 0 6 6 0  1 0 2 114  1 0 7
i l l  n e s s ( 6 1 - 2 3 5 ) ( 8 2 - 1 5 5 ) ( 7 7 - 1 3 5 ) ( 7 6 - 1 2 8 ) ( 8 7 - 1 2 6 )
CHATHAM
C o u g h 7 116 2 4  112 2 3  1 0 2 4 8  1 3 2 1 0 5  1 2 4
( 4 6 - 2 3 8 ) ( 7 2 - 1 6 6 ) ( 6 5 - 1 5 3 ) ( 9 5 - 1 6 9 ) ( 1 0 0 - 1 4 7 )
P h le g m 5 8 3 31 1 2 8 31 1 1 5 4 6  1 0 3 105  n o
( 2 7 - 1 9 4 ) ( 8 3 - 1 7 3 ) ( 7 4 - 1 5 5 ) ( 7 3 - 1 3 3 ) ( 8 9 - 1 3 1 )
B r e a t h l e s s 6 195 1 3  126 16 1 4 4 3 2  1 9 2 52 131
( 7 2 - 4 2 5 ) ( 6 7 - 2 1 5 ) ( 8 3 - 2 3 4 ) ( 1 2 5 - 2 5 8 ) ( 9 5 - 1 6 6 )
C h e s t - 1 56 16  2 3 9 9  9 7 1 3  7 8 50  1 3 8
i l l  n e s s ( 1 - 3 1 0 ) ( 1 3 7 - 3 8 8 ) ( 4 4 - 1 8 3 ) ( 4 1 - 1 3 3 ) ( 1 0 0 - 1 7 6 )
PORTSMOUTH
C o u g h 15 157 4 8  124 81 131 1 1 5  1 3 5 180  1 2 2
( 8 8 - 2 5 9 ) ( 8 9 - 1 5 9 ) ( 1 0 3 - 1 6 0 ) ( 1 1 0 - 1 6 0 ) ( 1 0 4 - 1 4 0 )
P h le g m 1 3 140 52  129 8 9  1 3 4 1 0 3  1 1 6 1 9 3  1 1 8
( 7 4 - 2 3 9 ) ( 9 4 - 1 6 4 ) ( 1 0 6 - 1 6 4 ) ( 9 4 - 1 3 9 ) ( 1 0 1 - 1 3 5 )
B r e a t h l e s s 5 1 1 8 32  187 52  1 7 6 7 2  181 101 1 4 0
( 3 8 - 2 7 4 ) ( 1 2 2 - 2 5 1 ) ( 1 2 8 - 2 2 4 ) ( 1 3 9 - 2 2 3 ) ( 1 1 3 - 1 6 8 )
C h e s t - 3 81 14 76 4 4  161 3 5  9 7 59 9 5
i l l  n e s s ( 1 7 - 2 3 8 ) ( 4 2 - 1 2 8 ) ( 1 1 3 - 2 0 9 ) ( 6 5 - 1 3 0 ) ( 7 1 - 1 1 9 )
A 4  - 5
T A B L E  A4.5: Lung cancer mortality by medical history and by time since
first exposure.
Tim e s i n c e f i r s t  e x p o s u r e  ( e m p l o y m e n t )
M e d ic a l 0 - 9 10 -  19 20  -  29 3 0  -  39 40+
h i s t o r y
O bs SMR O b s  SMR O bs SMR O b s  SMR O bs SMR
(9 5 X  C l ) (95X  C l ) (9 5 X  C l ) ( 9 5 X  C l ) (9 5 X  C l )
DEVONPORT
C o u g h 2 137 11 157 19 189 2 4  194 37 1 9 3
( 1 7 - 4 9 5 ) ( 7 9 - 2 8 2 ) ( 1 1 4 - 2 9 5 ) ( 1 2 4 - 2 8 8 ) ( 1 3 1 - 2 5 5 )
P h le g m 4 2 2 8 12 139 17 140 2 5  174 36 1 4 7
( 6 2 - 5 8 3 ) ( 7 2 - 2 4 2 ) ( 8 1 - 2 2 4 ) ( 1 1 3 - 2 5 7 ) ( 9 9 - 1 9 5 )
B r e a t h l e s s 1 107 5 116 13  2 1 7 1 7  2 4 3 17 1 4 7
( 3 - 5 9 5 ) ( 3 7 - 2 7 0 ) ( 1 1 6 - 3 7 1 ) ( 1 4 2 - 3 9 0 ) ( 8 6 - 2 3 6 )
C h e s t - 1 126 5 140 10 2 0 6 7  114 13 1 1 5
i l l  n e s s ( 3 - 7 0 1 ) ( 4 5 - 3 2 7 ) ( 9 9 - 3 7 9 ) ( 4 6 - 2 3 5 ) ( 6 1 - 1 9 7 )
CHATHAM
C o u g h 1 145 6  2 4 5 4 156 9  2 0 0 16 151
( 4 - 8 1 0 ) ( 9 0 - 5 3 3 ) ( 4 2 - 3 9 9 ) ( 9 2 - 3 8 0 ) ( 8 6 - 2 4 5 )
P h le g m 2 2 9 2 6  2 1 4 1 32 11 198 13 1 1 0
( 3 5 - 1 0 5 4 ) ( 7 8 - 4 6 5 ) ( 1 - 1 7 8 ) ( 9 9 - 3 5 4 ) ( 5 8 - 1 8 8 )
B r e a t h l e s s 1 2 6 2 1 78 2 144 4  190 8 1 6 2
( 7 - 1 4 5 8 ) ( 2 - 4 3 6 ) ( 1 7 - 5 1 9 ) ( 5 2 - 4 8 6 ) ( 7 0 - 3 1 9 )
C h e s t - _ 1 128 _ 2  98 5 n o
i l l  n e s s ( 3 - 7 1 5 ) ( 1 2 - 3 5 3 ) ( 3 6 - 2 5 8 )
PORTSMOUTH
C o u g h 2  194 16  350 10 135 1 7  163 36 1 9 5
( 2 4 - 7 0 1  ) ( 2 0 0 - 5 6 9 ) ( 6 5 - 2 4 9 ) ( 9 5 - 2 6 0 ) ( 1 3 1 - 2 5 9 )
P h le g m 2  2 0 0 16 336 11 138 1 5  138 4 5 221
( 2 4 - 7 2 3 ) ( 1 9 2 - 5 4 6 ) ( 6 9 - 2 4 7 ) ( 7 8 - 2 2 8 ) ( 1 5 6 - 2 8 6 )
B r e a t h l e s s 1 187 7 3 2 8 3  80 11 2 2 3 18 201
( 5 - 1 0 4 4 ) ( 1 3 2 - 6 7 6 ) ( 1 7 - 2 3 4 ) ( 1 1 1 - 3 9 9 ) ( 1 1 9 - 3 1 7 )
C h e s t - _ 4  179 7 2 1 3 5  115 11 1 4 3
i l l n e s s ( 4 9 - 4 5 8 ) ( 8 6 - 4 3 9 ) ( 3 7 - 2 6 8 ) ( 7 1 - 2 5 6 )
A4 - 6
T A B L E  A 4 .6 : Pleural mesothelioma mortality by medical history and by
time since first exposure.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
M e d i c a l
h i s t o r y
0 - 9
O b s  SMR 
(95%  C l )
10  -  19
O bs SMR 
(95%  C l )
2 0  -  2 9
O b s  SMR 
(95%  C l )
3 0 - 3 9
O b s SMR 
(9 5 %  C l )
4 0 +
O b s SMR 
(9 5 %  C l )
DEVONPORT
C o u g h - 4  1 2 5 0  
( 3 4 1 - 3 2 0 1 )
8  1 6 1 3  
( 6 9 6 - 3 1 7 7 )
7 1 0 8 7  
( 4 3 6 - 2 2 3 8 )
2 7  3 0 1 8  
( 1 9 8 8 - 4 3 9 0 )
P h l e g m - - 2  1 1 8 8  
( 1 4 4 - 4 2 8 7 )
3 1 4 6 8
( 3 0 3 - 4 2 9 2 )
9  2 9 9 2  
( 1 3 7 0 - 5 6 7 8 )
B r e a t h l e s s - - - 1 111 1  
( 2 8 - 6 1 8 9 )
7 5221 
( 2 0 9 6 - 1 0 7 5 5 )
C h e s t -
i l l  n e s s
— ” 5  3 7 0 4  
( 1 2 0 0 - 8 6 4 6 )
CHATHAM
C o u g h - - - 1 1 9 8 4  
( 5 0 - 1 1 0 5 3 )
4 3 9 6 2  
( 1 0 8 0 - 1 0 1 4 3 )
P h le g m - " - 1 1 6 2 2  
( 4 1 - 9 0 3 4 )
-
B r e a t h l e s s - - - - 2  4 4 8 9  
( 5 4 3 - 1 6 2 0 7 )
C h e s t -
i l l  n e s s
— “ " 1 4 5 6 8  
( 1 1 6 - 2 5 4 4 5 )
1 2 3 4 7  
( 5 9 - 1 3 0 7 3 )
PORTSMOUTH
C o u g h - - 1 1 1 7 8  
( 3 0 - 6 5 5 9 )
1 8 0 1  
( 2 0 - 4 4 6 4 )
2  1 0 5 0  
( 1 2 7 - 3 7 8 9 )
P h le g m " " 1 1 0 9 5  
( 2 8 - 6 1 0 1 )
- 1 4 7 8  
( 1 2 - 2 6 6 3 )
B r e a t h l e s s - - - 1 1 9 6 3  
( 5 0 - 1 0 9 3 5 )
2  2 3 0 2  
( 2 7 9 - 8 3 1 1 )
C h e s t -
11  1 n e s s
~ “ “ 1 1 2 8 0  
( 3 2 - 7 1 3 0 )
A4 - 7
T A B L E  A 4.7: A ll cause mortality by smoking habit and b y  time since first
exposure.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
S m o k in g 0 - 9 1 0  -  19 2 0  -  29 30  -  39 40+
h a b i t
O b s SMR O b s SMR O bs SMR O bs SMR Obs SMR
(95%  C l ) (95%  C l ) (95%  C l ) (95%  C l ) (95%  C l )
DEVONPORT
Non 7 57 4 3 94 4 4  6 5 4 9 57 101 7 5
( 2 3 - 1 1 8 ) ( 6 6 - 1 2 2 ) ( 4 6 -  8 4 ) ( 4 1 -  7 3 ) ( 6 0 -  9 0 )
Ex 11 6 5 50 67 8 5  77 1 1 5 8 5 163 71
( 3 2 - 1 1 6 ) ( 4 9 -  8 6 ) ( 6 0 -  9 3 ) ( 7 0 - 1 0 1 ) ( 6 0 -  8 2 )
C u r r e n t 51 1 1 7 2 2 3 122 2 6 5  1 0 5 331 1 1 3 511 1 0 8
( 8 5 - 1 4 9 ) ( 1 0 6 - 1 3 8 ) ( 9 5 - 1 1 8 ) ( 1 0 1 - 1 2 5 ) ( 9 9 - 1 1 8 )
U nknow n 2 1 8 3 8 152 5 6 3 8 6 3 11 5 5
( 2 2 - 6 6 0 ) ( 6 6 - 3 0 0 ) ( 2 0 - 1 4 7 ) ( 2 7 - 1 2 5 ) ( 2 8 -  9 9 )
CHATHAM
Non 1 14 1 5 52 18 74 15 50 4 3 6 5
( 0 -  7 7 ) ( 2 9 -  8 6 ) ( 4 4 - 1 1 6 ) ( 2 8 -  8 2 ) ( 4 5 -  8 4 )
Ex 6 8 9 10 4 3 21 8 3 37 72 90 7 3
( 3 3 - 1 9 4 ) ( 2 1 -  7 9 ) ( 5 1 - 1 2 7 ) ( 4 9 -  9 5 ) ( 5 8 -  8 8 )
C u r r e n t 16 8 5 7 0 106 71 97 1 2 5 108 2 7 0 1 1 4
( 4 8 - 1 3 8 ) ( 8 1 - 1 3 0 ) ( 7 5 - 1 2 0 ) ( 8 9 - 1 2 6 ) ( 1 0 1 - 1 2 8 )
Unknow n 1 2 4 0 _ 3 9 8 1 19 7 8 8
( 6 - 1 3 3 4 ) ( 2 0 - 2 8 7 ) ( 0 - 1 0 8 ) ( 3 5 - 1 8 1 )
PORTSMOUTH
Non 1 15 16 59 26  6 0 4 8 72 66 5 0
( 0 -  8 6 ) ( 3 4 -  9 7 ) ( 3 9 -  8 8 ) ( 5 1 -  9 2 ) ( 3 8 -  6 2 )
Ex 5 57 21 51 66  8 6 76 6 5 138 6 6
( 1 8 - 1 3 2 ) ( 3 2 -  7 9 ) ( 6 5 - 1 0 7 ) ( 5 0 -  8 0 ) ( 5 5 -  7 7 )
C u r r e n t 2 6 109 1 0 7 1 1 3 160  1 0 5 2 1 3 104 3 5 5 1 0 3
( 7 1 - 1 6 0 ) ( 9 1 - 1 3 4 ) ( 8 9 - 1 2 1 ) ( 9 0 - 1 1 8 ) ( 9 2 - 1 1 3 )
U nknow n _ 2 9 8 4  1 5 8 _ 1 4 3
( 1 2 - 3 5 3 ) ( 4 3 - 4 0 4 ) ( 1 - 2 4 1 )
A4 - 8
T A B L E  A 4 .8 : Lung cancer mortality by smoking habit and by time since
first exposure.
T im e s i  n e e f i r s t  e x p o s u r e  ( e m p l o y m e n t )
S m o k in g 0 - 9 10  -  19 2 0  -  2 9 3 0  -  39 40+
h a b i t
O b s  SMR O b s  SMR O b s SMR O b s SMR O b s SMR
( 9 5 *  C l ) (9 5 X  C l ) (9 5 %  C l ) (95%  C l ) (95%  C l )
DEV0NP0RT
Non _ 2  5 3 2  3 3 1 11 1 7
( 6 - 1 9 3 ) ( 4 - 1 1 9 ) ( 0 -  6 4 ) ( 0 -  3 9 )
Ex _ 3  3 9 11 9 8 10 71 8 3 3
( 8 - 1 1 5 ) ( 4 9 - 1 7 5 ) ( 3 4 - 1 3 0 ) ( 1 4 -  6 5 )
C u r r e n t 6  148 2 5  137 3 6  1 4 3 4 2 1 3 8 71 141
(  5 4 -3 2 1  ) ( 8 8 - 2 0 2 ) ( 9 6 - 1 9 0 ) ( 9 6 - 1 8 0 ) ( 1 0 8 - 1 7 4 )
U nknow n ~ “ 1 1 2 2  
( 3 - 6 8 2 )
“
CHATHAM
Non _ _ _ _ 2 2 4
( 3 -  8 8 )
Ex 1 124 _ 1 3 5 3 4 7 9 59
( 3 - 6 8 9 ) ( 1 - 1 9 3 ) ( 1 0 - 1 3 8 ) ( 2 7 - 1 1 2 )
C u r r e n t 2  96 8  1 0 8 1 0  121 21 1 4 8 3 5 1 1 9
( 1 2 - 3 4 6 ) ( 4 7 - 2 1 3 ) ( 5 8 - 2 2 3 ) ( 9 1 - 2 2 5 ) ( 7 9 - 1 5 8 )
U nknow n ~ ~ ” 1 1 0 5
( 3 - 5 8 5 )
PORTSMOUTH
Non _ _ 2  44 1 13 3 18
( 5 - 1 5 7 ) ( 0 -  7 1 ) ( 4 -  5 3 )
Ex _ 2  41 3  3 2 6 4 2 13 50
( 5 - 1 4 6 ) ( 7 -  9 5 ) ( 1 6 -  9 2 ) ( 2 7 -  8 6 )
C u r r e n t 2  155 2 3  2 0 9 2 6  1 4 5 3 0 121 6 5 151
( 4 2 - 3 9 7 ) ( 1 3 3 - 3 1 4 ) ( 9 5 - 2 1 2 ) ( 8 2 - 1 7 3 ) ( 1 1 4 - 1 8 7 )
U nknow n _ - 1 3 2 7  
( 8 - 1 8 2 3 )
_ -
A 4 - 9
T A B L E  A4.9: Pleural mesothelioma mortality by smoking habit and by
time since first exposure.
Tim e s i n c e  f r s t  e x p o s u r e  ( e m p lo y m e n t )
S m o k in g
h a b i t
0 - 9
O b s SMR 
(9 5 %  C l )
10 -  19
O b s SMR 
(95%  C l )
2 0  -  2 9
O b s SMR 
( 9 5 Z  C l )
30  -  39
O b s SMR 
(95%  C l )
4 0 +
O bs SMR 
( 9 5 %  C l )
DEVON PORT
N on - 2  348 8  
( 4 2 2 - 1 2 5 9 2 )
3  2 8 0 5  
( 5 7 9 - 8 2 0 1 )
- 8  4 3 3 2  
( 1 8 6 8 - 8 5 3 3 )
Ex - - 3  1 9 0 7  
( 3 9 4 - 5 5 7 6 )
2  971 
( 1 1 7 - 5 7 1 9 )
9  3 0 1 4  
( 1 3 8 0 - 5 7 1 9 )
C u r r e n t - 2  795  
( 9 6 - 2 8 7 2 )
5 1 3 6 3  
( 4 4 2 - 3 1 8 2 )
9  19 9 5  
( 9 1 3 - 3 7 8 7 )
18  2 8 5 6  
( 1 6 9 3 - 4 5 1 4 )
U nknow n “ ~ —
CHATHAM
N on - - - 2  4 0 5 7  
( 4 9 1 - 1 4 6 4 7 )
3  3 4 0 6  
( 7 0 3 - 9 9 5 8 )
Ex - - - - 4  2 6 2 5  
( 7 1 5 - 6 7 2 0 )
C u r r e n t 1 5 0 2 5  
( 1 2 7 - 2 7 9 8 8 )
- - 3  181 9  
( 3 7 5 - 5 3 1 8 )
8  2 7 0 2  
( 1 1 6 5 - 5 3 2 3 )
U nknow n “ “ ~ ” —
PORTSMOUTH
N on - - - 2  1 7 3 3  
( 2 1 0 - 6 2 5 7 )
5 2 7 6 0  
( 8 9 4 - 6 4 4 3 )
Ex - - 1 9 8 4  
( 2 5 - 5 4 8 3 )
3  179 2  
( 3 7 0 - 5 2 3 9 )
4 1 4 8 9  
( 4 0 6 - 3 8 1 2 )
C u r r e n t - - 4  184 9  
( 5 0 4 - 4 7 3 5 )
1 324  
( 8 - 1 8 0 6 )
6  1 3 1 2  
( 4 8 1 - 2 8 5 5 )
U nknow n "
'
A 4  - 10
T A B L E  A4.10: A ll  cause mortality by smoking amount and by time since
first exposure.
T im e s i  n e e f i r s t  e x p o s u r e e m p lo y m e n t )
S m o k in g 0 - 9 10  -  19 2 0  -  2 9 3 0  -  39 4 0 +
a m o u n t
( g m s / d a y ) O bs SMR O b s  SMR O b s SMR O bs SMR O b s SMR
(9 5 X  C l ) ( 9 5 *  C l ) ( 9 5 *  C l ) ( 9 5 *  C l ) ( 9 5 *  C l )
DEVONPORT
1 < 15 18 8 5 9 0  8 7 141 91 164 87 281 8 7
( 5 0 - 1 3 4 ) ( 6 9 - 1 0 5 ) ( 7 6 - 1 0 6 ) ( 7 4 - 1 0 1 ) ( 7 7 -  9 7 )
1 5 - 2 4 31 118 1 3 2  129 1 3 3  9 5 1 9 0 114 2 7 4 101
( 7 6 - 1 5 9 ) ( 1 0 7 - 1 5 1 ) ( 7 9 - 1 1 2 ) ( 9 8 - 1 3 0 ) ( 8 9 - 1 1 3 )
25+ 13 100 51 97 76  1 1 2 92 126 1 1 9 1 1 3
( 5 3 - 1 7 1 ) ( 7 1 - 1 2 4 ) ( 8 7 - 1 3 7 ) ( 1 0 1 - 1 5 2 ) ( 9 3 - 1 3 3 )
CHATHAM
< 15 13 114 41  9 3 3 8  76 71 81 1 8 6 1 0 2
( 6 1 - 1 9 4 ) ( 6 5 - 1 2 2 ) ( 5 2 - 1 0 0 ) ( 6 2 - 1 0 0 ) ( 8 7 - 1 1 6 )
1 5 - 2 4 7 79 2 8  97 3 2  9 6 6 2 1 0 9 1 2 7 101 I
( 3 2 - 1 6 3 ) ( 6 4 - 1 4 0 ) ( 6 3 - 1 3 0 ) ( 8 2 - 1 3 6 ) ( 8 3 - 1 1 8 )
25+ 2 36 11 6 3 2 2  1 4 4 2 9 1 2 3 4 9 9 4
( 4 - 1 2 9 ) ( 3 2 - 1 1 3 ) ( 9 0 - 2 1 8 ) ( 8 2 - 1 7 7 ) ( 6 7 - 1 2 0 )
PORTSMOUTH
< 15 8 61 4 2  78 8 6  91 127 90 2 0 4 8 5
( 2 6 - 1 2 1 ) ( 5 4 - 1 0 2 ) ( 7 2 - 1 1 1 ) ( 7 5 - 1 0 6 ) ( 7 3 -  9 6 )
1 5 - 2 4 11 84 5 4  1 0 3 9 2  1 0 9 1 0 5 8 9 1 8 8 8 8
( 4 2 - 1 5 0 ) ( 7 5 - 1 3 0 ) ( 8 7 - 1 3 2 ) ( 7 2 - 1 0 6 ) ( 7 5 - 1 0 1 )
25+ 12 185 3 3  1 1 3 4 8  9 4 57 9 0 1 0 0 1 0 0
( 9 6 - 3 2 4 ) ( 7 4 - 1 5 1 ) ( 6 8 - 1 2 1 ) ( 6 6 - 1 1 3 ) ( 8 0 - 1 1 9 )
A 4 - 11
T A B L E A 4 . i l :  Lung cancer mortality by smoking amount and by time
since first exposure.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
S m o k in g
a m o u n t
0 - 9 10  -  19 2 0  -  2 9 3 0  -  39 40+
( g m s / d a y ) O bs SMR O b s SMR O bs SMR O b s SMR O bs SMR
(95%  C l ) (95%  C l ) (95%  C l ) (9 5 %  C l ) (95%  C l )
DEVONPORT
j < 15 _ 10  9 5 13  8 3 1 0  51 2 2 64
( 4 6 - 1 7 4 ) ( 4 4 - 1 4 2 ) ( 2 4 -  9 4 ) ( 4 0 -  9 7 )
1 5 - 2 4 5 2 0 2 13  1 2 8 18 1 3 0 2 6  1 4 9 35 121
( 6 5 - 4 7 1  ) ( 6 8 - 2 1 9 ) ( 7 7 - 2 0 5 ) ( 9 7 - 2 1 9 ) ( 8 1 - 1 6 1 )
25+ 1 8 0 5 96 16 2 3 5 16  2 1 2 2 2 193
( 2 - 4 4 5 ) ( 3 1 - 2 2 3 ) ( 1 3 4 - 3 8 2 ) ( 1 2 1 - 3 4 4 ) ( 1 2 1 - 2 9 2 )
CHATHAM
< 15 2  1 4 8 3  59 4 7 0 11 1 0 2 21 9 3
( 1 8 - 5 3 4 ) ( 1 2 - 1 7 2 ) ( 1 9 - 1 8 0 ) ( 5 1 - 1 8 3 ) ( 5 7 - 1 4 2 )
1 5 - 2 4 1 1 0 3 2  6 3 5 1 3 2 8  1 1 5 15 96
( 3 - 5 7 3 ) ( 8 - 2 2 8 ) ( 4 3 - 3 0 9 ) ( 4 9 - 2 2 6 ) ( 5 4 - 1 5 8 )
25+ _ 3  160 2 l i e 5 1 7 2 8 122
( 3 3 - 4 6 8 ) ( 1 4 - 4 2 5 ) ( 5 6 - 4 0 2 ) ( 5 3 - 2 4 0 )
PORTSMOUTH
« 15 2 1 3 0 7 109 10 8 8 7 41 2 2 73
( 1 6 - 4 7 1 ) ( 4 4 - 2 2 4 ) ( 4 2 - 1 6 2 ) ( 1 7 -  8 5 ) ( 4 6 - 1 1 1 )
1 5 - 2 4 1 71 9  146 11 1 1 0 2 3  1 6 0 34 128
( 2 - 3 9 5 ) ( 6 7 - 2 7 8 ) ( 5 5 - 1 9 7 ) ( 1 0 1 - 2 4 0 ) ( 8 5 - 1 7 1 )
2 5 + 1 151 9  2 6 9 8  1 3 5 6  78 2 2 176
( 4 - 8 4 3 ) ( 1 2 3 - 5 1 1 ) ( 5 8 - 2 6 6 ) ( 2 9 - 1 7 0 ) ( 1 1 0 - 2 6 6 )
A4 - 12
T A B L E  A 4 .12: Pleural mesothelioma mortality by smoking amount and by
time since first exposure.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
S m o k in g  
a m o u n t  
( g m s / d a y )
0 - 9
O b s SMR 
(95%  C l )
10  -  19
O b s SMR 
(95%  C l )
2 0  -  2 9
O bs SMR 
( 9 5 X  C l )
3 0 - 3 9
O b s  SMR 
(9 S X  C l )
4 0 +
O b s  SMR 
(95%  C l )
DEVONPORT
< 15 - - 3  1 4 0 6  
( 2 9 0 - 4 1 0 9 )
6  218 1  
( 8 0 0 - 4 7 4 8 )
11 266 1  
( 1 3 2 8 - 4 7 6 0 )
1 5  -  2 4 - 1 7 1 0  
( 1 8 - 3 9 5 6 )
4  1 9 2 0  
( 5 2 3 - 4 9 1 6 )
4  1 5 1 3  
( 4 1 2 - 3 8 7 3 )
9  2 4 6 7  
( 1 1 2 9 - 4 6 8 2 )
2 5 + “ 1 1 3 9 2  
( 3 4 - 7 4 0 4 )
1 9 7 8  
( 2 5 - 5 4 4 6 )
1 8 5 0  
( 2 1 - 4 7 3 2 )
7 4 6 3 1  
( 1 8 5 9 - 9 5 4 0 )
CHATHAM
< 15 1 8 0 5 5  
( 2 0 4 - 4 4 8 6 6 )
- - 2  1 6 8 3  
( 2 0 4 - 6 0 7 7 )
9  4 0 1 7  
( 1 8 3 9 - 7 6 2 4 )
1 5 - 2 4 - - - 1 1 2 2 4  
( 3 1 - 6 8 1 9 )
1 631 
( 1 6 - 3 5 1 6 )
2 5 + “ “ “ 2  2 9 8 4  
( 3 6 1 - 1 0 7 7 2 )
PORTSMOUTH
< 15 - - 4  3 1 0 2  
( 8 4 5 - 7 9 4 2 )
2  9 7 5  
( 1 1 8 - 3 5 2 1 )
6  1 9 1 6  
( 7 0 2 - 4 1 7 0 )
1 5 - 2 4 - - 1 8 4 2  
( 2 1 - 4 6 8 9 )
1 5 6 7  
( 1 4 - 3 1 5 6 )
2  7 1 8  
( 8 7 - 2 5 9 1 )
2 5 + ~ - — 1 1 0 5 0  
( 2 7 - 5 8 4 9 )
2  1 4 8 3  
( 1 7 9 - 5 3 5 2 )
A 4  - 13
T A B L E  A 4 .13 : All cause mortality by duration of sm oking habit and by
time since first exposure.
T im e s i  n e e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
D u r a t i o n  
o f  s m o k in g  
( y r s )
0 - 9
O b s  SMR 
(9 5 %  C l )
1 0  -  19
O b s  SMR 
(95%  C l )
2 0  -  2 9
O b s  SMR 
(95%  C l )
3 0 - 3 9
O b s  SMR 
(95%  C l )
O bs
40+
SMR
(95%  C l )
DEVONPORT
< 10 6 8 3
( 3 0 - 1 8 0 )
17 99
( 5 8 - 1 5 9 )
13  1 0 2  
( 5 4 - 1 7 4 )
9 6 5
( 3 0 - 1 2 4 )
17 102
( 5 9 - 1 6 3 )
1 0 - 2 33
( 4 - 1 1 8 )
37 141
( 9 6 - 1 8 7 )
3 7  8 9  
( 6 0 - 1 1 7 )
34 8 4
( 5 6 - 1 1 2 )
26 60
( 3 9 -  8 8 )
2 0 - 8 8 2
( 3 5 - 1 6 1 )
3 8 87
( 5 9 - 1 1 4 )
6 4  9 5  
( 7 1 - 1 1 8 )
1 0 3 1 0 9
( 8 8 - 1 3 0 )
91 9 0
( 7 2 - 1 0 9 )
| 3 0 - 2 3 1 1 3
( 7 1 - 1 6 9 )
8 6 98
( 7 7 - 1 1 9 )
1 2 6  1 0 2  
( 8 4 - 1 2 0 )
1 6 6 1 0 8
( 9 2 - 1 2 5 )
2 5 6 94
( 8 2 - 1 0 5 )
4 0 + 2 3 1 3 6
( 8 6 - 2 0 4 )
9 5 115
( 9 1 - 1 3 8 )
1 1 0  9 4
( 7 7 - 1 1 2 )
1 3 4 1 0 7
( 8 9 - 1 2 6 )
2 8 3 106
( 9 4 - 1 1 9 )
CHATHAM
< 10 2 8 2
( 1 0 - 2 9 7 )
5 80
( 2 6 - 1 8 8 )
1 2 5  
( 1 - 1 4 1 )
3 7 0
( 1 4 - 2 0 4 )
5 44
( 1 4 - 1 0 2 )
1 0 - 2 9 0
( 1 1 - 3 2 7 )
7 8 3
( 3 3 - 1 7 1 )
16  1 3 8  
( 7 9 - 2 2 5 )
9 6 4
( 2 9 - 1 2 2 )
13 58
( 3 1 - 1 0 0 )
2 0 - 2 7 5
( 9 - 2 7 1 )
5 45
( 1 4 - 1 0 4 )
10  61 
( 2 9 - 1 1 3 )
3 5 1 0 9
( 7 3 - 1 4 5 )
39 8 4
( 5 7 - 1 1 0 )
3 0 - 10 111
( 5 3 - 2 0 3 )
2 8 96
( 6 4 - 1 3 8 )
2 8  9 9  
( 6 6 - 1 4 3 )
54 9 2
( 6 7 - 1 1 6 )
1 3 7 1 0 5
( 8 8 - 1 2 3 )
4 0 + s 6 5
( 2 4 - 1 4 1 )
3 5 102
( 6 8 - 1 3 6 )
3 6  9 4  
( 6 3 - 1 2 5 )
61 1 0 4
( 7 8 - 1 3 1 )
166 111
( 9 4 - 1 2 8 )
PORTSMOUTH
! < 10 3 9 4
( 1 9 - 2 7 5 )
8 97
( 4 2 - 1 9 1 )
4  4 4
( 1 2 - 1 1 3 )
6 52
( 1 9 - 1 1 4 )
8 6 0
( 2 6 - 1 1 8 )
1 0 - 2 6 3
( 8 - 2 2 8 )
11 76
( 3 8 - 1 3 6 )
19  8 6  
( 5 2 - 1 3 4 )
15 50
( 2 8 -  8 2 )
2 6 56
( 3 7 -  8 2 )
2 0 - 3 6 2
( 1 3 - 1 8 1 )
17 77
( 4 5 - 1 2 4 )
3 3  8 4
( 5 5 - 1 1 2 )
54 8 2
( 6 0 - 1 0 4 )
51 6 5
( 4 7 -  8 2 )
3 0 - 12 1 1 3
( 5 8 - 1 9 7 )
4 3 93
( 6 5 - 1 2 1 )
8 5  1 1 2  
( 8 8 - 1 3 6 )
1 0 7 9 4
( 7 7 - 1 1 2 )
211 1 0 0
( 8 7 - 1 1 4 )
4 0 + 11 1 0 2
( 5 1 - 1 8 3 )
4 9 no
( 7 9 - 1 4 1 )
8 5  1 0 3  
( 8 1 - 1 2 5 )
1 0 6 1 0 5
( 8 5 - 1 2 5 )
1 9 7 96
( 8 2 - 1 0 9 )
A 4 - 14
T A B L E  A 4 .14 : Lung cancer mortality by duration of smoking habit and by
time since first exposure.
T im e s i n c e f i r s t  e x p o s u r e ( e m p lo y m e n t )
D u r a t i o n  
o f  s m o k in g  
( y r s )
0 - 9
O b s SMR 
(9 5 %  C l )
10  -  19
O bs SMR 
(95%  C l )
2 0  -  2 9
O bs SMR 
(95%  C l )
3 0 - 3 9
O b s  SMR 
(95%  C l )
O b s
40+
SMR
(95%  C l )
DEVONPORT
1 < 10 - - 1 121 
( 3 - 6 7 3 )
- -
1 0 - - 3  164 
( 3 4 - 4 8 0 )
2  6 4  
( 8 - 2 3 1  )
2  5 2  
( 6 - 1 8 6 )
2 4 3
( 5 - 1 5 4 )
i 2 0 - - 5  1 1 3  
( 3 7 - 2 6 4 )
6  92  
( 3 4 - 1 9 9 )
12  1 2 4  
( 6 4 - 2 1 7 )
11 100
( 5 0 - 1 7 9 )
3 0 - 1 4 4
( 1 - 2 4 4 )
11 111 
( 5 6 - 1 9 9 )
19  139  
( 8 4 - 2 1 7 )
14  8 4  
( 4 6 - 1 4 0 )
2 4 8 0
( 5 1 - 1 1 9 )
40+ 5 2 4 7  
( 8 0 - 5 7 6 )
9  9 8  
( 4 5 - 1 8 6 )
19 156  
( 9 4 - 2 4 3 )
2 4  1 8 6  
( 1 1 9 - 2 7 6 )
4 2  156 
( 1 0 9 - 2 0 3 )
CHATHAM
< 10 - - - - -
1 0 - - - - - -
2 0 - - 1 76 
( 2 - 4 2 2 )
1 56 
0 - 3 1 2 )
2  5 4  
( 7 - 1 9 5 )
3 51
( 1 0 - 1 4 8 )
1 3 0 "
1 8 7  
( 2 - 4 8 3 )
6 162  
( 6 0 - 3 5 4 )
2 55  
( 7 - 2 0 0 )
10  1 3 3  
( 6 4 - 2 4 5 )
1 7 1 0 3
( 6 0 - 1 6 5 )
4 0 + 2  1 6 4
( 2 0 - 5 9 3 )
1 24  
( 1 - 1 3 5 )
8  1 7 3  
( 7 4 - 3 4 0 )
12  1 6 3  
( 8 4 - 2 8 4 )
2 4 133
( 8 5 - 1 9 7 )
PORTSMOUTH
< 10 - 2  5 2 6  
( 6 4 - 1 8 9 9 )
- - -
1 0 - - - - - 3 52
( 1 1 - 1 5 2 )
2 0 - - 4  1 5 4  
( 4 2 - 3 9 5 )
4 90
( 2 5 - 2 3 0 )
3  3 9  
( 8 - 1 1 3 )
5 51
( 1 6 - 1 1 8 )
3 0 - 1 7 6  
( 2 - 4 2 2 )
9 1 5 0  
( 6 9 - 2 8 5 )
9  92  
( 4 2 - 1 7 5 )
14  9 8  
( 5 4 - 1 6 5 )
3 3 1 2 3
( 8 1 - 1 6 5 )
4 0 + 3  2 0 5  
( 4 2 - 6 0 0 )
10  174  
( 8 3 - 3 1 9 )
16  1 5 5  
( 8 9 - 2 5 1 )
19  1 5 4  
( 9 3 - 2 4 1 )
3 7  149 
( 1 0 1 - 1 9 7 )
A4 - 15
T A B L E  A 4 .15 : Pleural mesothelioma mortality by duration of sm oking
habit and by time since first exposure.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
D u r a t i o n  
o f  s m o k in g  
( y s )
0 - 9
O b s  SMR 
(95%  C l )
10  -  19
O b s  SMR 
(95%  C l )
2 0  -  2 9
O b s SMR 
(95%  C l )
3 0  -  39
O b s  SMR 
(95%  C l )
4 0 +
O b s SMR 
(9 5 %  C l )
DEVONPORT
« 10 - - - 1 3 5 6 4  
( 9 0 - 1 9 8 5 1 )
1 3 5 4 3  
( 9 0 - 1 9 7 3 2 )
1 0 - - - 1 1 1 7 0  
( 3 0 - 6 5 1 6 )
1 1 1 3 2  
( 2 9 - 6 3 0 4 )
2  3 0 6 9  
( 3 7 1 - 1 1 0 7 8 )
2 0 - - - 3  2 3 7 5  
( 4 9 0 - 6 9 4 4 )
3  1 5 0 0  
( 3 1 0 - 4 3 8 6 )
3  1 6 6 2  
( 3 4 3 - 4 8 5 8 )
3 0 - " 1 791 
( 2 0 - 4 4 0 7 )
2 1 1 3 6  
( 1 3 7 - 4 1 0 1 )
6  2 6 6 2  
( 9 7 6 - 5 7 9 4 )
12  2 9 8 1  
( 1 5 4 0 - 5 2 0 7 )
4 0 + ~ 1 1 2 3 3  
( 3 1 - 6 8 7 0 )
2  1 8 1 2  
( 2 1 9 - 6 5 4 1 )
“ 8  3 1 7 0  
( 1 3 6 7 - 6 2 4 6 )
CHATHAM
< 10 - - - -
1 0 - - - - - -
2 0 - - - - 2  3 2 6 7  
( 3 9 5 - 1 1 7 9 4 )
3  3 5 9 8  
( 7 4 2 - 1 0 5 1 9 )
3 0 - 1 9 3 8 7  
( 2 3 7 - 5 2 2 8 7 )
* - 1 1 2 4 6  
( 3 2 - 6 9 3 9 )
6  3 3 9 8  
( 1 2 4 6 - 7 3 9 7 )
4 0 + ” “ ~ 3 2 1 2 9  
( 4 3 9 - 6 2 2 3 )
PORTSMOUTH
< 1 0 - - - - -
1 0 - - - 1 2 1 8 3  
( 5 5 - 1 2 1 5 8 )
2  3 2 0 8  
( 3 8 8 - 1 1 5 8 1 )
1 1 4 6 9  
( 3 7 - 8 1 8 2 )
2 0 - - - 3  4 4 9 6  
( 9 2 8 - 1 3 1 4 3 )
1 7 8 0  
( 2 0 - 4 3 4 7 )
2  1 5 2 7  
( 1 8 5 - 5 5 1 2 )
3 0 - - * 1 5 9 5  
( 1 5 - 3 3 1 4 )
5 165 1  
( 5 3 5 - 3 8 5 4 )
4 0 + - ” 1 1 2 6 6  
( 3 2 - 7 0 4 9 )
“ 2  9 8 6  
( 1 1 9 - 3 5 6 1 )
A 4  - 16
T A B L E  A 4 .16: A ll cause mortality by occupational group and by time since
first exposure.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p l o y m e n t )
O c c u p a t i o n a l 0 - 9 1 0  -  19 2 0  -  2 9 3 0  -  39 40+
g r o u p
O bs SMR O b s  SMR O b s SMR O b s SMR O bs SMR
(9 5 %  C l ) (95%  C l ) (95%  C l ) (95%  C l ) (95%  C l )
DEVONPORT
1 4 138 1 6  102 19  6 9 3 8 153 35 9 8
( 3 8 - 3 5 3 ) ( 5 8 - 1 6 6 ) ( 4 1 - 1 0 7 ) ( 1 0 5 - 2 0 2 ) ( 6 6 - 1 3 0 )
2 3  75 19  135 19 79 4 3 92 103 1 0 0
( 1 6 - 2 2 0 ) ( 8 1 - 2 1 1 ) ( 4 7 - 1 2 3 ) ( 6 5 - 1 2 0 ) ( 8 0 - 1 1 9 )
3 3  77 1 6  99 2 7  9 3 3 0 82 42 131
( 1 6 - 2 2 6 ) ( 5 6 - 1 6 0 ) ( 6 1 - 1 3 6 ) ( 5 6 - 1 1 8 ) ( 9 2 - 1 7 1 )
4 61 98 2 7 0  104 3 2 9  9 3 3 8 8 94 599 8 8
( 7 3 - 1 2 3 ) ( 9 2 - 1 1 6 ) ( 8 3 - 1 0 3 ) ( 8 4 - 1 0 3 ) ( 8 1 -  9 5 )
U n k n o w n _ 3  104 5  1 5 0 4 103 7 1 1 2
( 2 2 - 3 0 5 ) ( 4 9 - 3 5 1 ) ( 2 8 - 2 6 3 ) ( 4 5 - 2 3 1 )
CHATHAM
| 1 1 36 8  8 9 5  72 8 74 16 7 3
( 1 - 2 0 1 ) ( 3 8 - 1 7 5 ) ( 2 3 - 1 6 9 ) ( 3 2 - 1 4 5 ) ( 4 2 - 1 1 9 )
2 1 71 2  58 11 1 6 2 1 9 118 44 1 1 0
( 2 - 3 9 7 ) ( 7 - 2 1 0 ) ( 8 1 - 2 9 0 ) ( 7 1 - 1 8 4 ) ( 7 8 - 1 4 3 )
3 1 100 4  116 6  1 0 5 11 108 16 7 9
( 3 - 5 5 7 ) ( 3 2 - 2 9 8 ) ( 3 9 - 2 2 9 ) ( 5 4 - 1 9 3 ) ( 4 5 - 1 2 8 )
4 21 75 81 78 8 9  8 4 1 4 0 8 5 3 3 3 9 5
( 4 6 - 1 1 4 ) ( 6 1 -  9 5 ) ( 6 7 - 1 0 2 ) ( 7 1 -  9 9 ) ( 8 4 - 1 0 5 )
U n k n o w n _ _ 2  3 1 8 _ 1 1 7 8
( 3 9 - 1 1 4 9 ) ( 5 - 9 9 1 )
PORTSMOUTH
1 1 56 5 63 11 92 1 5 99 18 9 7
( 1 - 3 1 0 ) ( 2 0 - 1 4 7 ) ( 4 6 - 1 6 5 ) ( 5 5 - 1 6 3 ) ( 5 8 - 1 5 4 )
2 _ 7  111 16  107 3 9 1 1 7 69 8 5
( 4 4 - 2 2 8 ) ( 6 1 - 1 7 4 ) ( 8 0 - 1 5 4 ) ( 6 5 - 1 0 5 )
3 2  190 7  119 9  4 9 2 3 8 0 32 8 8
( 2 3 - 6 8 5 ) ( 4 8 - 2 4 5 ) ( 2 2 -  9 2 ) ( 5 1 - 1 2 0 ) ( 5 7 - 1 1 8 )
4 2 9  82 1 2 7  8 8 2 2 0  96 2 6 0 8 3 441 8 0
( 5 5 - 1 1 8 ) ( 7 3 - 1 0 3 ) ( 8 3 - 1 0 9 ) ( 7 3 -  9 3 ) ( 7 2 -  8 7 )
U n k n o w n “ “ “ ” "
A4 - 17
T A B L E  A 4 .1 7 : Lung cancer mortality by occupational group and by time
since first exposure.
T im e  s i  n e e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
O c c u p a t i o n a l 0 - 9 10 -  19 2 0  -  2 9 3 0  -  39 4 0 +
g r o u p
O b s  SMR O b s SMR O b s SMR O b s SMR O bs SMR
(95%  C l ) (95%  C l ) (95%  C l ) (9 5 %  C l ) (9 5 %  C l )
DEVONPORT
1 _ 4  2 6 2 2  7 0 2 78 4 1 0 4
( 7 1 - 6 7 1 ) ( 8 - 2 5 2 ) ( 9 - 2 8 1 ) ( 2 8 - 2 6 7 )
2 _ _ 2  9 5 6 1 2 5 11 9 9
( 1 1 - 3 4 2 ) ( 4 6 - 2 7 2 ) ( 4 9 - 1 7 7 )
3 _ 3  2 5 3 1 4 0 2  55 5 1 4 3
( 5 2 - 7 4 0 ) ( 1 - 2 2 4 ) ( 7 - 1 9 8 ) ( 4 6 - 3 3 5 )
4 6  100 2 3  8 8 4 4  1 2 4 4 3  9 9 6 0 84
( 3 7 - 2 1 9 ) ( 5 6 - 1 3 2 ) ( 8 7 - 1 6 1 ) ( 7 0 - 1 2 9 ) ( 6 3 - 1 0 5 )
U n k n o w n _ _ 1 3 0 5 _ _
( 8 - 1 6 9 7 )
CHATHAM
' 1 _ 2  1 8 6 1 1 2 2 _ 2 7 5
( 2 3 - 6 7 2 ) ( 3 - 6 8 0 ) ( 9 - 2 7 1 )
2 _ _ _ 2 104 5 9 9
( 1 3 - 3 7 4 ) ( 3 2 - 2 3 1 )
3 _ _ 1 2 1 3 _ 2 7 8
( 5 - 1 1 8 4 ) ( 9 - 2 8 3 )
4 3  9 3 6  51 9  76 2 2  1 0 9 38 8 7
( 1 9 - 2 7 3 ) ( 1 9 - 1 1 1 ) ( 3 5 - 1 4 4 ) ( 6 8 - 1 6 5 ) ( 5 9 - 1 1 5 )
U n k n o w n “ ~ “ _ “
PORTSMOUTH
1 _ _ 3  2 0 8 1 54 3 131
( 4 3 - 6 0 9 ) ( 1 - 2 9 9 ) ( 2 7 - 3 8 3 )
2 _ 1 1 7 2 1 6 4 5 1 2 6 18 174
( 4 - 9 5 9 ) ( 2 - 3 5 4 ) ( 4 1 - 2 9 4 ) ( 1 0 3 - 2 7 5 )
1 3 _ _ 1 52 3  8 9 4 8 6
( 1 - 2 8 9 ) ( 1 8 - 2 6 2 ) ( 2 4 - 2 2 1 )
4 4  102 2 4  141 2 7  1 0 0 2 8  74 56 8 2
( 2 8 - 2 6 0 ) ( 9 0 - 2 1 0 ) ( 6 6 - 1 4 5 ) ( 4 9 - 1 0 7 ) ( 6 0 - 1 0 3 )
U n k n o w n “ “ “ “
A 4  -  18
T A B L E  A 4.18: Pleural mesothelioma mortality by occupational group and
by time since first exposure.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
O c c u p a t i o n a l
g r o u p
0 - 9
O b s  SMR 
(95%  C l )
1 0  -  19
O b s  SMR 
(95%  C l )
2 0  -  2 9
O b s  SMR 
(95%  C l )
3 0 - 3 9
O b s SMR 
(95%  C l )
40+
O b s  SMR 
(95%  C l )
DEV0NP0RT
! 1 - - 3  6 9 9 2  
( 1 4 4 3 - 2 0 4 4 0 )
3  8 1 0 5  
( 1 6 7 2 - 2 3 6 9 5 )
-
2 - - 1 2491  
( 6 3 - 1 3 8 7 5 )
1 124 7  
( 3 2 - 6 9 4 4 )
5  348 4  
( 1 1 2 9 - 8 1 3 2 )
3 - - - 1 1 3 6 4  
( 3 5 - 7 5 9 7 )
7  12861 
( 5 1 6 3 - 2 6 4 9 3 )
' 4 - 4  115 0  
( 3 1 3 - 2 9 4 5 )
7 1 3 9 2  
( 5 5 9 - 2 8 6 8 )
6  9 6 0  
( 3 5 2 - 2 0 8 9 )
2 3  2 6 1 2  
( 1 6 5 6 - 3 9 1 9 )
U nknow n “ ” “ ” _
CHATHAM
1 - - - - 1 4 0 8 2  
( 1 0 3 - 2 2 7 3 7 )
2 - - - 1 3 9 6 0  
( 1 0 0 - 2 2 0 5 7 )
5  9 0 6 6  
( 2 9 3 7 - 2 1 1 6 0 )
3 - - - 1 5 1 3 3  
( 1 3 0 - 2 8 5 9 1 )
2  709 4  
( 8 5 8 - 2 5 6 1 1 )
4 1 3 3 9 3  
( 8 6 - 1 8 8 9 7 )
- - 3  1 2 9 8  
( 2 6 8 - 3 7 9 3 )
7  1 6 0 5  
( 6 4 4 - 3 3 0 7 )
U nknow n " “ _ “ “
1
PORTSMOUTH
2 - - - 3 5 2 5 8  
( 1 0 8 5 - 1 5 3 7 1 )
3  2 5 0 9  
( 5 1 8 - 7 3 3 6 )
3 - - - - 2  3 7 3 0  
( 4 5 1 - 1 3 4 6 7 )
4 - - 5  1 5 7 7  
( 5 1 1 - 3 6 8 0 )
3 651 
( 1 3 4 - 1 9 0 3 )
1 0  140 2  
9 6 7 3 - 2 5 7 8 )
U nknow n “ “
A 4 - 19
T A B L E  A 4 .19 : A ll cause mortality by exposure rating and by time since
first exposure.
T im e s i  n e e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
E x p o s u r e 0 - 9 10 -  1 9 2 0  -  29 3 0 - 3 9 4 0 +
r  d  t  i ilQ
O b s  SMR 
(95%  C l )
O bs SMR
(95%  C l )
O b s SMR 
( 9 5 X  C l )
O b s  SMR 
(9 5 %  C l )
O b s SMR
(95%  C l )
DEVON PORT
< 1 0 0 6 7  9 5  
( 7 2 - 1 1 8 )
2 7 6 1 0 7
( 9 4 - 1 1 9 )
2 5 4  92  
( 8 1 - 1 0 4 )
2 4 2  9 2  
( 8 0 - 1 0 3 )
3 1 0 8 7
( 7 7 -  9 6 )
1 0 0 - 1 1 5 5  
( 4 - 8 6 4 )
30 9 7
( 6 5 - 1 3 8 )
8 3  8 9  
( 7 0 - 1 0 8 )
9 3  1 0 2  
( 8 1 - 1 2 3 )
1 0 9 8 2
( 6 7 -  9 8 )
2 0 0 - - 2 4 7
( 6 - 1 6 8 )
3 4  8 0  
( 5 3 - 1 0 8 )
8 8  9 2  
( 7 3 - 1 1 1 )
1 0 0 9 0
( 7 2 - 1 0 7 )
3 0 0 - - - 4 64
( 1 7 - 1 6 4 )
4 9  1 1 5  
( 8 2 - 1 4 7 )
1 3 2 101
( 8 4 - 1 1 9 )  1
4 0 0 + - 1 3 8 0  2 0  160  
( 9 6 2 - 2 1 1 7 4 1 )  ( 4 - 8 9 1 )
1 7 0  1 5 6  
( 9 1 - 2 5 0 )
2 5 1 1 1 5
( 9 3 - 1 3 6 )
U nknow n 3  112  
( 2 3 - 3 2 9 )
15 1 0 3
( 5 8 - 1 7 0 )
2 3  110  
( 7 0 - 1 6 5 )
14  6 5  
( 3 6 - 1 0 9 )
2 9 94
( 6 3 - 1 3 5 )
CHATHAM
< 1 0 0 2 3  72  
( 4 5 - 1 0 7 )
87 7 9
( 6 2 -  9 5 )
8 3  92  
( 7 3 - 1 1 2 )
8 9  7 9  
( 6 3 -  9 5 )
1 9 0 9 5
( 8 2 - 1 0 9 )
1 0 0 - - 4 7 0
( 1 9 - 1 7 9 )
14  67  
( 3 6 - 1 1 2 )
2 9  8 9  
( 6 0 - 1 2 8 )
61 8 7
( 6 5 - 1 0 8 )
2 0 0 - - 2 2 5 4
( 3 1 - 9 1 6 )
11 9 9  
( 4 9 - 1 7 7 )
3 2  9 8  
( 6 4 - 1 3 2 )
5 2 94
( 6 8 - 1 1 9 )
3 0 0 - - - 2  190  
( 2 3 - 6 8 6 )
17  1 0 9  
( 6 3 - 1 7 4 )
6 4 1 1 6
( 8 7 - 1 4 4 )
4 00-f - - - 9  1 5 5  
( 7 1 - 2 9 4 )
3 4 72
( 4 8 -  9 7 )
U nknow n 1 1 1 3  
( 3 1 6 3 2 )
2 6 6
( 8 - 2 3 9 )
3  124 
( 2 6 - 3 6 1 )
2  5 5  
( 7 - 1 9 7 )
9 1 2 5
( 5 7 - 2 3 7 )
PORTSMOUTH
< 1 0 0 3 0  78  
( 5 3 - 1 1 2 )
131 9 0
( 7 5 - 1 0 6 )
1 8 6  103  
( 8 8 - 1 1 8 )
1 6 0  7 9
( 6 7 -  9 1 )
2 2 6 76
( 6 6 -  8 6 )
1 0 0 - 2  59  
( 4 1 - 1 2 1 7 )
15 9 4
( 5 3 - 1 5 5 )
4 4  73  
( 5 1 -  9 4 )
6 2  8 6  
( 6 5 - 1 0 7 )
8 8 7 5
( 6 0 -  9 1 )
2 0 0 - - - 1 9  74  
( 4 4 - 1 1 5 )
61 8 6  
( 6 5 - 1 0 8 )
7 9 8 3
( 6 5 - 1 0 1 )
3 0 0 - - - 5  129 
( 4 2 - 3 0 0 )
3 9  1 1 6  
( 8 0 - 1 5 3 )
9 5 8 5
( 6 8 - 1 0 2 )
4 0 0 + - - - 11 1 1 8
( 5 9 - 2 1 2 )
6 7 1 0 5
( 8 0 - 1 3 1 )
U nknow n “ “ 2  9 3  
( 1 1 - 3 3 4 )
4  2 0 2  
( 5 5 - 5 1 6 )
5 1 5 9
( 5 1 - 3 7 0 )
A 4 - 20
T A B L E  A4.20: Lung cancer mortality by exposure rating and by time since
first exposure.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
E x p o s u r e
r a t i n g
0 - 9
O b s SMR 
(95%  C l )
1 0  -  19
O b s SMR 
(95%  C l )
2 0  -  2 9
O b s  SMR 
(95%  C l )
3 0 - 3 9
O bs SMR 
(95%  C l )
4 0 +
O b s SMR
(9 5 %  C l )  i
DEVONPORT
< 100 6 9 4  
( 3 4 - 2 0 4 )
2 5  99  
( 6 4 - 1 4 6 )
3 4  1 2 5  
( 8 3 - 1 6 7 )
19 70  
( 4 2 - 1 0 9 )
2 8  7 4  
( 4 9 - 1 0 7 )
1 0 0 - - 4  132
( 3 6 - 3 3 8 )
8  8 9  
( 3 8 - 1 7 5 )
15  162  
( 9 1 - 2 6 7 )
9 6 4
( 2 9 - 1 2 1 )
2 0 0 - - - 5 1 1 7  
( 3 8 - 2 7 3 )
14  141
( 7 7 - 2 3 6 )
1 3  1 0 9  
( 5 8 - 1 8 6 )
3 0 0 - - - 2  2 9 3  
( 3 5 - 1 0 5 7 )
3  6 4  
( 1 3 - 1 8 7 )
14  101  
( 5 5 - 1 6 9 )
1 4 0 0 + - 1 6 9 5 2 0 5  
( 1 7 5 8 9 - > 9 9 9 9 9 9 )
1 8 2  
( 2 - 4 5 7 )
12  1 2 2  
( 6 3 - 2 1 4 )
U nknow n - “ 1 4 9
( 1 - 2 7 2 )
1 4 4
( 1 - 2 4 7 )
4  1 2 4
( 3 4 - 3 1 7 )
CHATHAM
< 100 3  8 4  
( 1 7 - 2 4 7 )
7  57 
( 2 3 - 1 1 8 )
8  81 
( 3 5 - 1 6 0 )
18  131 
( 7 8 - 2 0 7 )
2 4  9 8  
( 6 3 - 1 4 5 )
1 0 0 - - 1 1 6 3  
( 4 - 9 1 0 )
1 4 6
( 1 - 2 5 6 )
2 54 
( 7 - 1 9 7 )
6  6 8  
( 2 5 - 1 4 7 )
2 0 0 - - - 2  1 3 3  
( 1 8 - 5 4 1 )
2  50  
( 6 - 1 8 0 )
6 8 7  
( 3 2 - 1 8 8 )
3 0 0 - - - - 1 50  
( 1 - 2 7 9 )
5  7 3  
( 2 4 - 1 7 0 )
4 0 0 + - - - 1 1 3 2  
( 3 - 7 3 5 )
4  6 9  
( 1 9 - 1 7 7 )
U nknow n - - - 2  2 3 1  
( 2 8 - 8 3 4 )
PORTSMOUTH
< 100 4  9 8
( 2 7 - 2 5 1 )
2 3  138  
( 8 7 - 2 0 7 )
2 5  1 1 9  
( 7 7 - 1 7 5 )
19 78  
( 4 7 - 1 2 2 )
2 8  7 6  
( 5 0 - 1 0 9 )
1 0 0 - - 2  111 
( 1 3 - 3 9 9 )
2 2 9  
( 3 - 1 0 3 )
7 8 3  
( 3 4 - 1 7 2 )
1 3  8 9  
( 4 8 - 1 5 3 )
2 0 0 - - - 4 1 3 0  
( 3 6 - 3 3 4 )
4  4 7
( 1 3 - 1 1 9 )
8  6 8
( 3 0 - 1 3 5 )
3 0 0 - - - 1 2 0 8  
( 5 - 1 1 5 7 )
4  94
( 2 6 - 2 4 2 )
16 1 1 3  
( 6 5 - 1 8 4 )
40 0 + - - - 3 2 5 4  
( 5 2 - 7 4 3 )
15  1 8 9  
( 1 0 6 - 3 1 1 )
U nknow n - ' “ 1 2 4 7  
( 6 - 1 3 7 5 )
A 4 - 21
T A B L E  A 4 .21: Pleural mesothelioma mortality by exposure rating and by
time since first exposure.
T im e s i  n e e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
E x p o s u r e
r a t i n g
0 - 9 10  -  19 2 0  -  2 9 3 0 - 3 9 4 0 +
O bs SMR 
(95%  C l )
O b s SMR 
(95%  C l )
O b s SMR 
(9 5 %  C l )
O b s  SMR 
(95%  C l )
O b s  SMR 
(95%  C l )
DEVONPORT
< 100 - 4  1131 
( 3 0 8 - 2 8 9 4 )
3  7 4 8  
( 1 5 4 - 2 1 8 5 )
3  7 5 8  
( 1 5 6 - 2 2 1 6 )
3  631 
( 1 3 0 - 1 8 4 6 )
1 0 0 - - - 3 2 0 6 8  
( 4 2 7 - 6 0 4 4 )
3  1 8 2 9  
( 3 7 7 - 5 3 4 7 )
6  3321  
( 1 2 1 8 - 7 2 2 9 )
2 0 0 - - - 4 7 1 0 5  
( 1 9 3 6 - 1 8 1 8 8 )
1 6 3 9  
( 1 6 - 3 5 5 7 )
9  5 5 2 5  
( 2 5 2 9 - 1 0 4 8 5 )
3 0 0 - - - - 4  711 1  
( 1 9 3 8 - 1 8 2 0 5 )
11 6 3 1 4  
( 3 1 5 1 - 1 1 2 9 7 )
4 0 0 + - - 1 1 2 9 4 4 7  
( 3 2 7 5 - 7 2 1 0 1 8 )
- 6  5 8 1 7  
( 2 1 4 0 - 1 2 7 0 6 )
U nknow n “ ~ “ ~
CHATHAM
< 100 - - - 1 6 2 7  
( 1 6 - 3 4 9 4 )
1 4 0 5  
( 1 0 - 2 2 5 3 )
1 0 0 - - - - 1 1 9 3 7  
( 4 9 - 1 0 7 8 9 )
2  2 0 7 6  
( 2 5 1 - 7 4 9 6 )
2 0 0 - - - - 2  4 1 1 9  
( 4 9 8 - 1 4 8 6 9 )
3  3 9 4 6  
( 8 1 4 - 1 1 5 3 5 )
3 0 0 - - - - 1 5 3 8 5  
( 1 3 6 - 2 9 9 9 6 )
6  8 7 5 6  
( 3 2 1 0 - 1 9 0 5 8 )
4 0 0 + - - - - 3  6 1 6 9  
( 1 2 7 3 - 1 8 0 3 5 )
U nknow n 1 1 0 4 8 4 2  
( 2 6 5 3 - 5 8 3 9 7 2 )
“ " ~ ~
PORTSMOUTH
< 100 - - 3  1 1 6 7  
( 2 4 1 - 3 4 1 2 )
- 3  7 5 6  
( 1 5 6 - 2 2 1 1 )
1 0 0 - - - 1 1 1 4 0  
( 2 9 - 6 3 4 7 )
1 8 5 2  
( 2 2 - 4 7 4 3 )
1 6 3 6  
( 1 6 - 3 5 4 3 )
2 0 0 - - - 1 2 9 2 8  
( 7 4 - 1 6 3 0 8 )
3 2 6 8 8  
( 5 5 5 - 7 8 5 8 )
2 1 5 7 7  
( 1 9 1 - 5 6 9 2 )
3 0 0 - - - - 2 4 3 3 1  
( 5 2 4 - 1 5 6 3 5 )
4  2 5 9 7  
( 7 0 8 - 6 6 4 9 )
40 0 + - - - - 5  7 0 2 9  
( 2 2 7 7 - 1 6 4 0 6 )
U nknow n ~ “
' '
A 4  - 2 2
T A B L E  A4.22: All cause mortality by asbestos exposure period and by time
since first exposure.
A s b e s t o s
e x p o s u r e
( y r s )
0 - 9
O b s  SMR 
(95%  C l )
T im e s i n c e
10 -  19
O bs SMR 
(95%  C l )
f i r s t  e x p o s u r e  ( e m p lo y m e n t )
2 0 - 2 9  3 0 - 3 9
O b s  SMR O b s SMR 
(95%  C l )  (95%  C l )
O bs
40+
SMR
(95%  C l )
DEV0NP0RT
< 10 7 158 21 123 1 5  8 6 1 3  7 2 31 9 4
( 6 4 - 3 2 6 ) ( 7 6 - 1 8 8 ) ( 4 8 - 1 4 1 ) ( 3 8 - 1 2 1 ) ( 6 1 - 1 2 7 )
1 0 - - 5 59 2 4  8 7 2 6  9 9 29 1 0 4
( 1 9 - 1 3 7 ) ( 5 6 - 1 2 9 ) ( 6 4 - 1 4 5 ) ( 7 0 - 1 4 9 )
2 0 - - 5 121 1 5  1 1 7 3 5  1 0 7 6 3 1 2 4
( 3 9 - 2 8 3 ) ( 6 6 - 1 9 3 ) ( 7 2 - 1 4 3 ) ( 9 4 - 1 5 5 )
30+ _ 3 74 7  9 4 1 3  7 4 91 1 0 4
( 1 5 - 2 1 7 ) ( 3 8 - 1 9 4 ) ( 3 9 - 1 2 6 ) ( 8 3 - 1 2 6 )
U nknow n 6 4 94 2 9 0  106 3 3 8  91 4 1 6  9 7 572 8 7
( 7 1 - 1 1 8 ) ( 9 3 - 1 1 8 ) ( 8 1 - 1 0 0 ) ( 8 7 - 1 0 6 ) ( 8 0 -  9 4 )
CHATHAM
< 10 _ 5 56 4  91 1 1 4 22 1 2 9
( 1 8 - 1 3 1 ) ( 2 5 - 2 3 2 ) ( 0 -  7 8 ) ( 8 1 - 1 9 6 )
1 0 - _ 1 58 3  61 5 5 2 11 76
( 1 - 3 2 5 ) ( 1 3 - 1 7 7 ) ( 1 7 - 1 2 2 ) ( 3 8 - 1 3 7 )
2 0 - _ 1 173 1 36 16  1 2 2 20 1 0 2
( 4 - 9 6 4 ) ( 1 - 1 9 9 ) ( 7 0 - 1 9 7 ) ( 6 2 - 1 5 8 )
3 0 + _ 1 92 1 106 6  1 0 4 40 1 1 6
( 2 - 5 1 2 ) ( 3 - 5 8 9 ) ( 3 8 - 2 2 6 ) ( 8 0 - 1 5 2 )
U nknow n 2 4 8 0 8 7  81 1 0 4  92 1 5 0  9 0 3 1 7 91
( 5 1 - 1 1 9 ) ( 6 4 -  9 8 ) ( 7 4 - 1 1 0 ) ( 7 5 - 1 0 4 ) ( 8 1 - 1 0 1 )
PORTSMOUTH
< 10 4 157 13  133 11 1 0 5 11 7 7 25 74
( 4 3 - 4 0 2 ) ( 7 1 - 2 2 8 ) ( 5 3 - 1 8 8 ) ( 3 9 - 1 3 8 ) ( 4 8 - 1 1 0 )
1 0 - 1 182 9 161 21 104 19  7 9 26 1 1 8
( 5 - 1 0 1 3 ) ( 7 4 - 3 0 6 ) ( 6 5 - 1 5 9 ) ( 4 7 - 1 2 3 ) ( 7 7 - 1 7 2 )
2 0 - _ _ 11 8 6 4 2  1 2 6 39 1 1 2
( 4 3 - 1 5 4 ) ( 8 8 - 1 6 4 ) ( 7 7 - 1 4 8 )
3 0 + _ 1 38 6  78 2 9  1 5 0 78 8 4
( 1 - 2 1 2 ) ( 2 8 - 1 6 9 ) ( 1 0 0 - 2 1 5 ) ( 6 5 - 1 0 2 )
U nknow n 2 7 75 1 2 3  85 2 0 7  9 3 2 3 6  7 9 3 9 2 7 8
( 5 0 - 1 0 9 ) ( 7 0 - 1 0 0 ) ( 8 0 - 1 0 5 ) ( 6 9 -  8 9 ) ( 7 0 -  8 5 )
A 4  - 23
T A B L E  A4.23: Lung cancer mortality by asbestos exposure period and by
time since first exposure.
T im e s i n c e f i r s t  e x p o s u r e e m p lo y m e n t )
A s b e s t o s
e x p o s u r e
( y r s )
0 - 9
O bs SMR 
(95%  C l )
1 0  -  19
O b s SMR 
(95%  C l )
2 0  -  29
O b s SMR 
(9 5 X  C l )
3 0  -  39
O b s  SMR 
(95%  C l )
O b s
40+
SMR
(95%  C l )
DEVONPORT
< 1 0 - 2  117 
( 1 4 - 4 2 4 )
1 57 
( 1 - 3 1 8 )
- 4 1 1 5
( 3 1 - 2 9 4 )
1 0 - 2  89  
( 2 7 - 8 1 5 )
7 2 4 8  
( 9 9 - 5 1 0 )
6  2 2 2  
( 8 1 - 4 8 3 )
6 1 9 9
( 7 3 - 4 3 3 )
2 0 - - 2  4 3 3  
( 5 2 - 1 5 6 3 )
3 2 1 4  
( 4 4 - 6 2 5 )
3  8 5  
( 1 7 - 2 4 8 )
7 1 2 7
( 5 1 - 2 6 2 )
3 0 + - - 1 121 
( 3 - 6 7 5 )
1 51 
( 1 - 2 8 1 )
10 1 0 8
( 5 2 - 1 9 8 )
U nknow n 6 9 8  
( 3 6 - 2 1 3 )
2 4  90  
( 5 8 - 1 3 4 )
38  104  
( 7 1 - 1 3 7 )
4 3  97  
( 6 8 - 1 2 6 )
5 3 76
( 5 6 -  9 7 )
CHATHAM
< 10 - 2  189 
( 2 3 - 6 8 2 )
- - 2 9 6
( 1 2 - 3 4 6 )
1 0 - - - - - 1 57
( 1 - 3 1 6 )
2 0 - - - - - 2 8 2
( 1 0 - 2 9 6 )
3 0 + - - - - 6 1 3 8
( 5 0 - 3 0 0 )
U nknow n 3 91 
( 1 9 - 2 6 5 )
6  51 
( 1 9 - 1 1 1 )
11 8 9  
( 4 5 - 1 6 0 )
2 4  119  
( 7 6 - 1 7 7 )
3 6 8 3
( 5 6 - 1 1 0 )
PORTSMOUTH
< 1 0 - 3  264  
( 5 4 - 7 7 2 )
1 79 
( 2 - 4 4 1 )
1 56  
( 1 - 3 1 5 )
5 1 1 9
( 3 9 - 2 7 8 )
1 0 - - - 3  121 
( 2 5 - 3 5 4 )
1 34
( 1 - 1 9 2 )
5 1 8 0
( 5 8 - 4 2 0 )
2 0 - - - 2  121 
( 1 5 - 4 3 8 )
5  120  
( 3 9 - 2 8 0 )
6 1 3 8
( 5 1 - 3 0 1 )
3 0 + - - - 3  121 
( 2 5 - 3 5 4 )
14 1 1 9
( 6 5 - 1 9 9 )
U nknow n 4 104
( 2 8 - 2 6 7 )
2 2  133  
( 8 3 - 2 0 1 )
2 6  101 
( 6 6 - 1 4 8 )
2 7  76  
( 5 0 - 1 1 0 )
51 81
( 5 9 - 1 0 4 )
A 4  -  2 4
T A B L E  A4.24: Pleural mesothelioma mortality by asbestos exposure period
and by time since first exposure.
T im e s i  n e e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
A s b e s t o s
e x p o s u r e
( y r s )
0 - 9
O b s  SMR 
(95%  C l )
10  -  19
O b s SMR 
(95%  C l )
2 0  -  29
O b s SMR 
(95%  C l )
3 0 - 3 9
O bs SMR 
(9 5 %  C l )
4 0 +
O b s  SMR 
(9 5 %  C l )
DEVONPORT
1 < 1 0 - 1 3 9 6 0  
( 1 0 0 - 2 2 0 5 5 )
- - 2  4 5 9 9  
( 5 5 7 - 1 6 6 0 4 )
1 0 - - - 1 2 4 2 7  
( 6 1 - 1 3 5 1 9 )
1 2 2 5 4  
( 5 7 - 1 2 5 5 2 )
3  7 7 0 3  
( 1 5 8 9 - 2 2 5 1 8 )
2 0 - - - 1 5 7 7 3  
( 1 4 6 - 3 2 1 5 5 )
3  6 2 3 0  
( 1 2 8 5 - 1 8 2 1 2 )
5  6 5 4 5  
( 2 1 2 1 - 1 S 2 7 6 )
3 0 + - - - 1 4 8 2 2  
( 1 2 2 - 2 6 8 6 0 )
7 6 8 4 2  
( 2 7 4 7 - 1 4 0 9 5 )
U n k n o w n 3  8 1 5  
( 1 6 8 - 2 3 8 4 )
9  164 8
( 7 5 4 - 3 1 2 7 )
6  8 8 2  
( 3 2 3 - 1 9 1 9 )
1 8  2061 
( 1 2 2 2 - 3 2 5 7 )
CHATHAM.
< 1 0 - - - - -
1 0 - - - - - 1 552 7  
( 1 4 0 - 3 0 8 7 3 )
2 0 - - - - - 1 7 4 7 2  
( 9 0 4 - 2 6 9 7 3 )
1 3 0 + - - - - 4  9581 
( 2 6 1 1 - 2 4 5 2 7 )
U n k n o w n 1 3 2 2 8  
( 8 2 - 1 7 9 7 9 )
“ 5 2 0 5 8  
( 6 6 7 - 4 8 0 3 )
8  182 7  
( 7 8 8 - 3 5 9 8 )
PORTSMOUTH
< 1 0 - - - - 1 2 2 0 7  
( 5 6 - 1 2 2 9 4 )
1 0 - - - 1 3 6 3 5  
( 9 2 - 2 0 2 4 8 )
1 2 7 6 0  
( 7 0 - 1 5 3 7 3 )
1 3 1 4 5  
( 8 0 - 1 7 5 1 8 )
2 0 - - - 1 2 1 2 4  
( 5 4 - 1 1 8 3 3 )
-
3 0 + - - 1 1 0 8 3 8  
( 2 7 4 - 6 0 3 7 0 )
1 4 3 1 8  
( 1 0 9 - 2 4 0 5 1 )
7 6 0 3 5  
( 2 4 2 3 - 1 2 4 3 2 )
U n k n o w n “ “ 3  9 3 7  
( 1 9 3 - 2 7 3 8 )
3  6 4 5  
( 1 3 3 - 1 8 8 6 )
6  8 9 8  
( 3 2 9 - 1 9 5 5 )
A4 - 25
T A B L E  A 4 .2 5 : All cause mortality by period of continuous asbestos
exposure and by time since first exposure.
Time si nee first exposure (  employment)
Continuous 0 - 9 10  -  19 2 0  -  2 9 3 0 - 3 9 4 0 +
asbestos
exposure Obs SMR Obs SMR Obs SMR Obs SMR O b s  SMR
(yrs) ( 9 5 Z  Cl) ( 9 5 Z  Cl) (9 5 Z  Cl) ( 9 5 Z  Cl) ( 9 5 Z  Cl)
DEVONPORT
< 10 3  2 7 6 6  125 4 9 7 4 1 3 9 6  9 0
( 5 7 - 8 0 7 ) ( 4 6 - 2 7 2 ) ( 2 6 - 2 4 8 ) ( 3 8 - 3 5 5 ) ( 3 3 - 1 9 6 )
10+ _ 1 96 3 8 9 7 1 3 0 1 6  2 6 2
( 2 - 5 3 3 ) ( 1 8 - 2 6 0 ) ( 5 2 - 2 6 8 ) ( 1 5 0 - 4 2 6 )
CHATHAM
i  < 10 _ 5 135 2 1 2 3 2 9 5 7 2 7 4
( 4 4 - 3 1 6 ) ( 1 5 - 4 4 5 ) ( 1 2 - 3 4 4 ) ( 1 1 0 - 5 6 4 )
10+ _ _ _ 2 1 0 4 3  1 5 8
( 1 3 - 3 7 4 ) ( 3 3 - 4 6 2 )
PORTSMOUTH
< 10 4  4 2 2 3 99 1 51 3 1 6 6 4  8 3
( 1 1 5 - 1 0 8 1 ) ( 2 0 - 2 9 0 ) ( 1 - 2 8 3 ) ( 3 4 - 4 8 4 ) ( 2 3 - 2 1 3 )
10+ _ _ 4 1 3 5 5 9 4 9  2 1 6
( 3 7 - 3 4 5 ) ( 3 0 - 2 1 9 ) ( 9 9 - 4 1 0 )
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T A B L E  A 4.26: Lung cancer mortality by period of continuous asbestos
exposure and by time since first exposure.
T im e  s i  n e e f i r s t  e x p o s u r e  ( e m p lo y m e n t )
C o n t i n u o u s
a s b e s t o s
e x p o s u r e
( y s )
0 - 9
O b s  SMR 
(95%  C l )
10  -  19
O b s SMR 
(9 5 %  C l )
2 0  -  2 9
O bs SMR 
(95%  C l )
3 0 - 3 9
O b s SMR 
(95%  C l )
4 0 +
O b s  SMR 
(95%  C l )
DEVONPORT
< 10 - - 1 2 4 3  
( 6 - 1 3 5 6 )
- -
10+ “ 1 9 2 5  
( 2 3 - 5 1 5 2 )
1 2 8 2  
( 7 - 1 5 7 1 )
1 182 
( 5 - 1 0 1 4 )
3  4 6 2  
( 9 5 - 1 3 5 2 )
CHATHAM
< 10 - 2  4 7 3  
( 5 7 - 1 7 0 7 )
- - -
10+ " “ “ “ “
PORTSMOUTH
« 10 - - - - -
10+ - - - 2  301 
( 3 6 - 1 0 8 6 )
6  1 1 1 6  
( 4 0 9 - 2 4 3 0 )
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T A B L E  A 4 .27: Pleural mesothelioma mortality by period of continuous
asbestos exposure and by time since first exposure.
T im e s i n c e f i r s t  e x p o s u r e  ( e m p l o y m e n t )
C o n t i n u o u s
a s b e s t o s
e x p o s u r e
( y r s )
0 - 9
O b s  SMR 
(9 5 X  C l )
10  -  19
O bs SMR 
(95%  C l )
2 0  -  29
O b s SMR 
(9 5 X  C l )
3 0 - 3 9
O b s  SMR 
(95%  C l )
4 0 +
O b s SMR 
( 9 5 X  C l )
DEVONPORT
j  < 10 - - - - -
10+ - - 1 2 2 5 0 3  
( 5 6 9 - 1 2 5 3 4 3 )
- 1 11 5 4 1  
( 2 9 2 - 6 4 2 8 6 )
CHATHAM
< 10 - - - - 1 2 8 7 5 9  
( 7 2 8 - 1 6 0 1 8 7 )
10+ - ~ “ “
PORTSMOUTH
< 10 - - 1 2 6 1 0 6  
( 6 6 0 - 1 4 5 4 1 3 )
- 1 1 6 3 2 7  
( 4 1 3 - 9 0 9 4 4 )
10+ _ “ “ 1 1 1 7 0 6  
( 2 9 6 - 6 5 2 0 0 ) '
A4 - 28
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